Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,collagen fibril organization (GO:0030199),0.768524223433205,2.1898420770888736,0.0,0.0,0.0,29/88,5.18%,COL15A1;COL4A1;CYP1B1;COL24A1;COL18A1;COL1A2;COL4A2;COL27A1;COL7A1;COL1A1;COL3A1;LUM;COL8A1;TLL2;COL6A3;COL23A1;COL5A2;COL11A2;COL5A3;COL5A1;PLOD2;ADAMTS2;COL13A1;DPT;COL11A1;SERPINH1;DDR2;NF1;BMP1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.8405606076453265,-2.133453698140968,0.0,0.023288257983247868,0.024,5/13,4.05%,ATP1A2;ATP1B3;SLC12A2;ATP1B1;KCNJ2
prerank,cellular component disassembly (GO:0022411),0.770107326583557,2.1255597396333186,0.0,0.0,0.0,21/53,8.76%,MMP3;MMP13;SCUBE1;MMP2;TLL2;MMP14;SH3PXD2B;LAMC1;TIMP1;MMP11;KLK2;CTSS;BMP1;ADAMTS15;ADAMTS5;ADAMTS4;CTSK;CTSL;CAPN2;MMP16;LCP1
prerank,extracellular matrix disassembly (GO:0022617),0.7698324228622315,2.1176910601539927,0.0,0.0003405990172754392,0.001,21/53,8.76%,MMP3;MMP13;SCUBE1;MMP2;TLL2;MMP14;SH3PXD2B;LAMC1;TIMP1;MMP11;KLK2;CTSS;BMP1;ADAMTS15;ADAMTS5;ADAMTS4;CTSK;CTSL;CAPN2;MMP16;LCP1
prerank,external encapsulating structure organization (GO:0045229),0.6970670489689693,2.101378038227108,0.0,0.0002554492629565794,0.001,65/205,8.73%,MMP3;MMP13;COL15A1;COL4A1;MMP27;COL24A1;COL18A1;COL1A2;COL4A2;IBSP;COL27A1;COL7A1;COL1A1;DCN;COL3A1;MMP2;LAMA2;SPP1;POSTN;LUM;COL8A1;COL6A3;ITGB8;COL23A1;COL5A2;MMP14;HSPG2;LAMB1;FBN2;SPARC;ADAM19;BGN;COL11A2;LAMA1;COL5A3;NID1;COL5A1;ADAMTS2;COL13A1;ADAM12;ITGB5;ST7;LAMC1;ITGA8;VCAN;MMP11;COL11A1;LAMA4;FBN1;DDR2;NF1;ADAMTS15;ADAMTS5;ADAMTS4;ICAM1;ADAMTS14;LOXL1;ADAMTS12;ADAMTS1;ITGA11;ADAMTS9;ADAMTS18;ITGA3;MMP16;PXDN
prerank,extracellular structure organization (GO:0043062),0.6946201172236045,2.0925705321819974,0.0,0.0004087188207305271,0.002,66/204,9.03%,MMP3;MMP13;COL15A1;COL4A1;MMP27;COL24A1;COL18A1;COL1A2;COL4A2;IBSP;COL27A1;COL7A1;COL1A1;DCN;COL3A1;MMP2;LAMA2;SPP1;POSTN;LUM;COL8A1;COL6A3;ITGB8;COL23A1;COL5A2;MMP14;HSPG2;LAMB1;FBN2;SPARC;ADAM19;BGN;COL11A2;LAMA1;COL5A3;NID1;COL5A1;ADAMTS2;COL13A1;ADAM12;ITGB5;ST7;LAMC1;ITGA8;VCAN;MMP11;COL11A1;LAMA4;FBN1;DDR2;NF1;ADAMTS15;ADAMTS5;ADAMTS4;ICAM1;ADAMTS14;LOXL1;ADAMTS12;ADAMTS1;ITGA11;ADAMTS9;ADAMTS18;ITGA3;MMP16;PXDN;TGFBR1
prerank,extracellular matrix organization (GO:0030198),0.6862082066516516,2.087800397277445,0.0,0.0005108985259131588,0.003,83/276,8.76%,MMP3;MMP13;COL15A1;COL4A1;MMP27;SCUBE1;CYP1B1;COL24A1;COL18A1;COL1A2;COL4A2;IBSP;COL27A1;COL7A1;COL1A1;DCN;COL3A1;MMP2;LAMA2;CREB3L1;GPM6B;SPP1;POSTN;LUM;COL8A1;TLL2;COL6A3;ITGB8;COL23A1;COL5A2;MMP14;SH3PXD2B;HSPG2;LAMB1;FBN2;SPARC;ADAM19;BGN;COL11A2;LAMA1;COL5A3;NID1;COL5A1;PLOD2;ADAMTS2;COL13A1;ADAM12;ITGB5;FLRT2;ST7;LAMC1;DPT;TIMP1;ITGA8;VCAN;MMP11;COL11A1;LAMA4;FBN1;KLK2;SERPINH1;CTSS;DDR2;NF1;BMP1;ADAMTS15;ADAMTS5;ADAMTS4;CTSK;ICAM1;ADAMTS14;CTSL;LOXL1;ADAMTS12;CAPN2;ADAMTS1;ITGA11;ADAMTS9;ADAMTS18;ITGA3;MMP16;PXDN;LCP1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.782617251084679,-2.0152357368613205,0.0,0.10200256996662567,0.177,8/12,18.73%,DMD;ATP1B3;ATP1B1;WNK4;WNK3;ANK3;WNK2;FXYD1
prerank,regulation of humoral immune response (GO:0002920),0.762882045301009,2.0136947096112316,0.0,0.004525101229516549,0.023,8/44,6.33%,C6;CFH;C3;SERPING1;GATA6;PROS1;C1QB;C7
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7589079525232227,1.9987761350363806,0.0,0.006003057679479617,0.036,9/42,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCR1;CCL5;CXCL10
prerank,regulation of immune effector process (GO:0002697),0.7561385021005689,1.9850510272568997,0.0,0.007039046357025743,0.05,7/41,6.33%,C6;CFH;C3;SERPING1;PROS1;C1QB;C7
prerank,response to interferon-gamma (GO:0034341),0.7027795033787239,1.9822689542338185,0.0,0.006846040247236329,0.054,20/67,10.36%,CCL11;CCL7;IL23R;STAT1;SYNCRIP;TLR2;CD40;XCL1;CASP1;AIF1;LGALS9;CYP27B1;TRIM21;SHFL;CCL5;SP100;WNT5A;GBP7;GAPDH;CCL2
prerank,regulation of complement activation (GO:0030449),0.757587217247921,1.9674521456890595,0.0,0.009753517312887578,0.083,7/40,6.33%,C6;CFH;C3;SERPING1;PROS1;C1QB;C7
prerank,potassium ion import across plasma membrane (GO:1990573),-0.5259924237091318,-1.9664124355068333,0.0,0.1328983255577345,0.31,11/41,7.30%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B1;SLC12A6;KCNJ2;KCNJ3;KCNJ13;ABCC9;KCNJ10
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6794344579334786,-1.964488209335713,0.0033112582781456954,0.10316698286578807,0.32,5/18,5.18%,UNC13C;UNC13B;GRID2;GRIK4;GRIA2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.7427415246454555,1.9633558933047033,0.0,0.010047671009625458,0.093,8/38,3.66%,RORA;NR1H4;ADIPOQ;TNIP1;STAT1;TNFAIP3;TLE1;TREM2
prerank,muscle cell development (GO:0055001),-0.5889697842913098,-1.952501530400754,0.004273504273504274,0.09874221384897097,0.369,9/30,9.42%,NEBL;DMD;SGCZ;ANK2;MYOF;CXADR;RAMP2;DYSF;IGF1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.7372607593295551,-1.950915221062899,0.0,0.08399298379291399,0.374,5/13,5.26%,DDO;GLUL;MTHFS;ASPA;GLUD1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.7628099262209204,1.948749382073993,0.0,0.013519160993394355,0.132,15/34,14.12%,RORA;ENPP1;ADIPOQ;YAP1;ASXL1;ZFP36L2;ZFPM2;E2F1;RUNX1T1;TRIO;WNT5A;WWTR1;TNF;SMAD3;TRIB3
prerank,response to peptide (GO:1901652),0.7599568535400321,1.9446238430239955,0.0,0.013721274695953408,0.146,11/33,11.01%,MMP3;MMP13;MMP2;CACNA1A;STAT1;IRS1;STAT3;STAT5A;ANXA1;GNAI1;ERBIN
prerank,membrane repolarization (GO:0086009),-0.7028372461334901,-1.9423117063234816,0.0,0.0809100620217983,0.409,5/15,4.05%,ATP1A2;ATP1B3;KCND3;ATP1B1;KCNJ2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.8080144029772989,1.9404733457954708,0.0,0.01382832010138283,0.153,5/24,0.97%,RORA;CYP1B1;C3;SULF1;CCBE1
prerank,endoderm formation (GO:0001706),0.7539411055473914,1.935049232040502,0.0,0.014496745672785883,0.169,10/35,3.96%,COL4A2;COL7A1;MMP2;COL8A1;MMP14;LAMB1;ITGB5;DUSP2;DUSP5;COL11A1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7947254285585478,1.9345868928905119,0.0,0.01376420734518981,0.171,5/26,0.97%,RORA;CYP1B1;C3;SULF1;CCBE1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5456638116542575,-1.9343175865664846,0.0,0.07941295972287524,0.451,15/37,16.29%,GRM7;GRM1;GRID2;GRIK4;GRM8;PLCB1;GRIN3A;GRIA2;GRM3;HOMER2;CLN3;APP;GRIN2B;GRIK2;GRM5
prerank,potassium ion homeostasis (GO:0055075),-0.6197452589288877,-1.9272372735019565,0.0038910505836575876,0.07690300302912519,0.475,7/23,4.05%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B1;SLC12A6;KCNJ2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6873293722338034,-1.926867167813344,0.0,0.06958531485394465,0.475,5/15,5.52%,GRM7;GRM1;GRM8;GRM3;HOMER2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5788067474660411,-1.9240720086803327,0.0,0.06546117607654765,0.488,17/30,9.23%,TJP1;DMD;SLC12A2;TJP2;OCLN;JAM2;PECAM1;CLDN5;ESAM;ACTB;CDH5;GJB6;SLC1A1;WNK3;LSR;CLDN12;VCL
prerank,regulation of T cell proliferation (GO:0042129),0.6795590510643601,1.9131919662184804,0.0,0.02213893612290355,0.265,12/61,8.96%,GLMN;IL23R;VSIG4;TNFRSF21;SPN;CD276;NCK1;AIF1;NCK2;CCL5;GPNMB;ANXA1
prerank,regulation of sodium ion transport (GO:0002028),-0.5552425477379407,-1.9128746332053859,0.0,0.06963189136991113,0.54,14/34,8.96%,FGF12;NKAIN2;SLMAP;SNTA1;WNK4;WNK3;PER1;NKAIN3;ATP2B4;NKAIN4;GPD1L;SIK1;NKAIN1;ANK3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.7536366424306216,1.9104266213957102,0.0,0.022855986685588685,0.28,7/33,4.31%,RUNX1;IL34;IL23R;ZFP36L1;TNFSF11;PRKCA;CCR1
prerank,response to UV-A (GO:0070141),0.8727283949115295,1.9045208257690431,0.0,0.025953645116388466,0.321,5/14,5.20%,MMP3;MMP2;TIMP1;EGFR;PPID
prerank,signal release from synapse (GO:0099643),-0.5149250506847757,-1.9024791755986552,0.0,0.07366255140547326,0.579,17/43,17.24%,SNAP25;SYN3;NRXN1;LIN7A;PCLO;NRXN2;CPLX1;RIMS1;SNAPIN;DNAJC5;GAD1;SYN2;PTPRN2;LIN7C;NAAA;SNPH;PIP5K1C
prerank,establishment of endothelial barrier (GO:0061028),-0.5772401671834161,-1.901857445021526,0.0,0.0691328572702701,0.581,13/29,12.63%,TJP1;TJP2;PECAM1;PPP1R16B;RAPGEF3;EZR;RAPGEF2;RAPGEF6;PDE4D;PDE2A;RAP1A;ROBO4;RDX
prerank,regulation of acute inflammatory response (GO:0002673),0.8360415053837504,1.9008426023283032,0.0,0.026518066345016342,0.34,3/18,2.01%,OSMR;PTGES;CREB3L3
prerank,response to amyloid-beta (GO:1904645),0.7121655823849758,1.8978240326840377,0.0,0.026984731232322295,0.358,11/44,6.91%,MMP3;MMP13;CASP4;MMP2;CACNA1A;LRP1;CACNA2D1;TREM2;CACNB1;CD36;ICAM1
prerank,regulation of protein processing (GO:0070613),0.8098369608551816,1.8973229158226452,0.0,0.02638901951238403,0.364,5/21,2.43%,RUNX1;CCBE1;NKD2;SERPINE2;LRRK2
prerank,chondrocyte differentiation (GO:0002062),0.7566660091319195,1.894745511370291,0.0,0.027333071136353995,0.385,6/32,1.86%,RUNX1;SLC39A14;RUNX2;RUNX3;SULF1;SOX5
prerank,cellular response to chemokine (GO:1990869),0.7062271158514889,1.8943631102858662,0.0,0.0264441077012651,0.386,9/46,6.32%,CCL11;CXCL5;CCL7;CXCL1;CXCL12;XCL1;CCR1;CCL5;CXCL10
prerank,negative regulation of axon extension (GO:0030517),-0.5688764002402819,-1.8938901782791153,0.0,0.07191414065226942,0.63,22/30,30.08%,MAP2;SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;DIP2B;SEMA4D;CDKL3;SEMA5A;MAG;SEMA5B;SEMA3G;TRIM46;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F;RTN4R
prerank,cartilage development (GO:0051216),0.7017306752149637,1.8865901547119217,0.0,0.030418112235137303,0.429,8/49,1.86%,RUNX1;SLC39A14;RUNX2;RUNX3;SULF1;ITGB8;COL11A2;SOX5
prerank,acute inflammatory response (GO:0002526),0.7919232572485326,1.8830232438933756,0.0,0.03160001993611019,0.451,4/23,2.18%,HP;HPR;LBP;CRP
prerank,regulation of steroid metabolic process (GO:0019218),0.7773431188531079,1.8806549317462335,0.0,0.03204063612512524,0.468,6/23,4.96%,RORA;NR1H4;APOE;ABCA2;ABCG1;EPHX2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.7332742577339456,1.864109775281605,0.0,0.04319735122548501,0.574,7/31,8.49%,GLMN;VSIG4;TNFRSF21;SPN;BLK;ATM;GPNMB
prerank,regulation of defense response (GO:0031347),0.6656222512655808,1.8594205539753388,0.0,0.04601492723391183,0.611,24/76,9.14%,CASP4;ZBP1;IL1RL2;SBNO2;PTGES;BCL6;LACC1;IL1R1;JAK2;XCL1;BIRC3;CASP1;TREM2;APOE;CASP12;PIK3AP1;IRF1;ADAMTS12;TIRAP;CELF1;AREL1;PSMA6;ANXA1;WNT5A
prerank,cellular response to UV-A (GO:0071492),0.8971697698351135,1.8577417757046417,0.0,0.04555237179432164,0.62,4/11,5.20%,MMP3;MMP2;TIMP1;PPID
prerank,negative regulation of nervous system development (GO:0051961),0.8092856250248406,1.8562262837491093,0.0014285714285714286,0.04540610649053199,0.63,5/17,6.36%,CCL11;ROBO2;TLR2;SLIT1;PCM1
prerank,cellular response to interferon-gamma (GO:0071346),0.6389309146118398,1.8529889820950836,0.0,0.04656917472566006,0.656,25/88,10.36%,CCL11;CCL7;MID1;JAK1;STAT1;SYNCRIP;TLR2;IRF7;JAK2;XCL1;CASP1;CAMK2D;AIF1;LGALS9;TRIM21;CCL5;ICAM1;IRF1;TRIM8;SP100;WNT5A;OASL;GBP7;GAPDH;CCL2
prerank,neurotransmitter secretion (GO:0007269),-0.5005719710772529,-1.8508750563973089,0.0,0.11510221508220261,0.812,17/44,17.24%,SNAP25;SYN3;NRXN1;LIN7A;PCLO;NRXN2;CPLX1;RIMS1;SNAPIN;DNAJC5;GAD1;SYN2;PTPRN2;LIN7C;NAAA;SNPH;PIP5K1C
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.6330514975422177,-1.8504557855430137,0.0036231884057971015,0.10855068015250359,0.812,12/17,32.22%,ANK2;SNTA1;GPD1L;KCNQ1;NEDD4L;KCNE4;SCN3B;RYR2;KCNJ8;PKP2;KCNH2;SCN5A
prerank,camera-type eye development (GO:0043010),0.7642580835185588,1.8418891446353758,0.0013245033112582781,0.05634910212277488,0.724,7/25,5.10%,CYP1B1;FBN2;LAMA1;CACNA1C;TENM3;FBN1;NF1
prerank,negative regulation of T cell activation (GO:0050868),0.7137641833754966,1.841497145272247,0.0,0.0550894581941789,0.725,4/35,1.37%,GLMN;VSIG4;TNFRSF21;SPN
prerank,positive regulation of lipid transport (GO:0032370),0.8732824071780941,1.8362418570429875,0.0,0.059377762011684904,0.756,4/12,3.78%,ADIPOQ;SPP1;LRP1;APOE
prerank,regulation of lipid storage (GO:0010883),0.7611863710090254,1.8319293724007146,0.0,0.062937175165194,0.784,10/22,12.29%,C3;CRP;IKBKE;VSTM2A;FBXW7;LPL;FTO;MEST;PTPN2;TNF
prerank,regulation of small molecule metabolic process (GO:0062012),0.7303510173297887,1.8298050779525703,0.0013192612137203166,0.0637009793625407,0.792,7/28,5.70%,RORA;NR1H4;ADIPOQ;NCOR2;APOE;EPHX2;FOXK2
prerank,endodermal cell differentiation (GO:0035987),0.7262755585069042,1.8285542021312815,0.0012919896640826874,0.0634562169108549,0.799,8/31,3.96%,COL4A2;COL7A1;MMP2;COL8A1;MMP14;LAMB1;ITGB5;COL11A1
prerank,regulation of fat cell differentiation (GO:0045598),0.6481457981566253,1.8281995144199084,0.0,0.06230407523510972,0.801,26/74,14.55%,RORA;ENPP1;ADIPOQ;YAP1;ZFP36L1;ASXL1;CMKLR1;ZFP36L2;ZFPM2;FRZB;E2F1;ASXL2;SFRP1;PPARG;RUNX1T1;CARM1;LPL;TRIO;FTO;WNT5A;WWTR1;TNF;WDFY2;SMAD3;TRIB3;TRPM4
prerank,positive regulation of leukocyte migration (GO:0002687),0.742708964656957,1.8195312064431022,0.005031446540880503,0.07027969966220038,0.842,8/27,7.08%,EDN3;PTN;PLVAP;XCL1;MDK;AIF1;ICAM1;MIA3
prerank,regulation of B cell activation (GO:0050864),0.7428979319998189,1.817320067946069,0.0,0.07140415112167244,0.849,5/25,6.40%,ZFP36L1;SH3KBP1;ZFP36L2;TNFAIP3;AHR
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.853950337701763,1.8169235742140022,0.0015384615384615385,0.07017131846611897,0.852,4/13,4.42%,RUNX1;RUNX3;GLI3;SHH
prerank,lipid catabolic process (GO:0016042),0.7997284561419208,1.8157926125955215,0.0,0.07008598869117788,0.859,5/18,8.79%,CEL;PLA1A;LIPC;LPL;HSD11B1
prerank,skin development (GO:0043588),0.6414963657253131,1.8156487716747072,0.0,0.06871017508503194,0.86,13/65,9.14%,COL1A2;COL1A1;COL3A1;COL5A2;COL5A3;COL5A1;GATA6;UGCG;JAG1;ERRFI1;ITGA3;ANXA1;WNT5A
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.6295409529986034,1.8145450644962866,0.0,0.06861589332807598,0.864,25/72,13.07%,RUNX1;ZBP1;JAK1;STAT1;TNFAIP3;JAK2;BIRC3;CFLAR;TSLP;IRAK3;PTPN6;IRAK2;IFNAR2;PTPN1;ABCE1;CDC37;IL7;LIFR;TNFRSF1A;CBFB;TRIM44;PTPN2;CASP8;TNF;TRAF2
prerank,pyroptosis (GO:0070269),0.81348759731175,1.8128234318781127,0.0,0.06909087299370294,0.871,4/15,3.66%,CASP4;ZBP1;CASP1;TREM2
prerank,triglyceride homeostasis (GO:0070328),0.7510940854051489,1.811744707945607,0.0,0.06892872612111701,0.878,5/26,5.58%,RORA;NR1H4;LIPC;APOE;ANGPTL4
prerank,response to fatty acid (GO:0070542),0.7874248507757896,1.8045688254383432,0.0029498525073746312,0.07771913494197319,0.913,7/17,9.23%,NR1H4;IRS1;CD36;GLDC;PID1;LPL;FOXO3
prerank,regulation of inflammatory response (GO:0050727),0.594828576741146,1.8017713290831152,0.0,0.08029281233251204,0.918,38/190,9.14%,RORA;MMP3;NR1H4;CASP4;ZBP1;ADIPOQ;IL1RL2;SBNO2;PTGES;TNIP1;IL16;BCL6;TLR2;LACC1;IL1R1;TNFAIP3;JAK2;CCN4;XCL1;BIRC3;CASP1;TSLP;APOE;MDK;CASP12;MVK;CCL5;PPARG;PIK3AP1;TLR7;ADAMTS12;CELF1;AREL1;PLA2G7;LPL;PSMA6;ANXA1;WNT5A
prerank,positive regulation of interleukin-12 production (GO:0032735),0.706579962853785,1.801423085728347,0.002600780234070221,0.07931950055255671,0.919,8/31,7.99%,IL23R;IL16;TLR2;CD40;MDK;LGALS9;TIRAP;MAPK11
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.6397106770542806,-1.7952769129835602,0.0030211480362537764,0.1888418964019366,0.956,5/16,15.01%,CLDN5;CLDN12;CLDN11;CLDN14;CLDN1
prerank,positive regulation of lipid localization (GO:1905954),0.85515731490832,1.7936098618086092,0.001589825119236884,0.08842474486958518,0.944,5/11,8.76%,C3;LRP1;IKBKE;VSTM2A;LPL
prerank,positive regulation of interleukin-17 production (GO:0032740),0.7480256385854764,1.7912908816027018,0.0013531799729364006,0.09032300354351507,0.952,3/22,0.90%,NR1H4;IL23R;RFTN1
prerank,T cell differentiation in thymus (GO:0033077),0.8108912254070536,1.7910863783348154,0.0061162079510703364,0.08882065483838397,0.953,4/14,4.42%,ZFP36L1;GLI3;ZFP36L2;SHH
prerank,intestinal lipid absorption (GO:0098856),0.8565347961794664,1.790243893405933,0.0015432098765432098,0.08839473404708399,0.955,4/11,5.55%,CEL;UGCG;LIMA1;CD36
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7694731328839934,1.7901245023018943,0.0014705882352941176,0.0869074885330134,0.955,7/19,8.14%,NR1H4;LBP;LGALS9;LY96;PIK3AP1;TIRAP;CD14
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8450762569676776,1.7864818604634858,0.0,0.0903842234264613,0.961,4/11,5.04%,RUNX1;RUNX3;XCL1;LGALS9
prerank,negative regulation of blood coagulation (GO:0030195),0.6803996118745689,1.7858847982579686,0.0024630541871921183,0.08963626551193626,0.961,7/38,6.23%,KNG1;PDGFRA;SERPING1;SERPINE2;APOE;APOH;PLAT
prerank,positive regulation of glial cell differentiation (GO:0045687),0.7812216035990847,1.7856113439581736,0.0,0.08839410428002585,0.961,8/17,9.55%,IL34;SERPINE2;PTN;MDK;PTPRZ1;TENM4;CXCR4;DICER1
prerank,response to cytokine (GO:0034097),0.5938457759763652,1.784350449872758,0.0,0.08862386429506929,0.961,42/141,11.96%,COL3A1;IL23R;ADIPOQ;IL1RL2;OSMR;PTPN7;STAT1;CD40;TIMP1;IL1R1;JAK2;PRKCA;DPYSL3;CASP1;REL;IRAK3;STAT3;IKBKE;PTPN13;ALDH1A2;BCL2;LGALS9;CYP27B1;TRIM21;SHFL;DDOST;EIF2AK2;PTPN6;IRAK2;PTPN18;IFNAR2;PID1;SP100;ANXA1;CXCR4;SETD2;LIFR;PTPN23;PTPN9;PTPN2;CASP8;RHOA
prerank,toll-like receptor signaling pathway (GO:0002224),0.6154717547548018,1.7793992315769347,0.0,0.09392157491131414,0.968,21/84,9.80%,NR1H4;LBP;RFTN1;COLEC12;TNIP1;TLR2;BIRC3;IRAK3;CTSS;LGALS9;CD36;LY96;PIK3AP1;CTSK;TLR7;IRAK2;CTSL;TIRAP;CD14;IRAK4;CTSB
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6697847986913382,-1.779065965843627,0.0060790273556231,0.20900598691070665,0.97,4/14,1.87%,ATP1B3;ATP1B1;ACTN2;ANK2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7594668284938447,1.7774419238113608,0.0029069767441860465,0.09543914076010009,0.971,4/19,6.74%,RUNX1;CREB3L1;TGFB3;EMILIN1
prerank,negative regulation of T cell proliferation (GO:0042130),0.7127795068635283,1.776579191498199,0.001349527665317139,0.0952541918313645,0.971,6/28,8.49%,GLMN;VSIG4;TNFRSF21;SPN;LGALS9;GPNMB
prerank,regulation of fibrinolysis (GO:0051917),0.8351411261205849,1.7754031444600362,0.0,0.09528257508280413,0.973,3/13,5.63%,FAP;USF1;APOH
prerank,epithelial cell morphogenesis (GO:0003382),0.7762053770347209,1.7722757605797135,0.0014705882352941176,0.09857983556927444,0.977,3/17,3.31%,COL15A1;COL18A1;SIPA1L3
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.8420912644378749,1.765400048376928,0.0031545741324921135,0.10773766187362643,0.982,5/11,7.58%,JAK1;STAT1;JAK2;STAT3;CANX
prerank,regulation of spindle organization (GO:0090224),0.7822156428575444,1.7592608434970287,0.0013679890560875513,0.11630185548100744,0.99,9/18,10.99%,CLTC;PARP3;DYNC1H1;RAE1;GPSM2;BORA;TPX2;SENP6;GNAI1
prerank,regulation of extracellular matrix organization (GO:1903053),0.7850445411291498,1.7572950610518767,0.005856515373352855,0.11801755948593969,0.992,4/15,5.07%,RUNX1;FAP;LRP1;DDR2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.8229002054919436,1.751008529974621,0.0029850746268656717,0.12825774298359038,0.996,5/12,5.97%,ABCA1;ADIPOQ;CRP;ABCG1;PPARG
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5841137643131746,-1.7469757545165172,0.013468013468013467,0.2767110813569512,0.992,16/20,29.80%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;SEMA4D;SEMA5A;SEMA5B;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6622271983112369,-1.743513591120306,0.012987012987012988,0.2717407017245266,0.992,8/13,24.47%,GLUL;NOS3;ALDH4A1;GLUD1;PRODH;GAD1;GLS;GLS2
prerank,negative regulation of B cell activation (GO:0050869),0.7407741668545603,1.7432480522745475,0.0013908205841446453,0.14102259025277222,0.998,6/21,5.95%,PARP3;TNFRSF21;TNFAIP3;BLK;ATM;SFRP1
prerank,supramolecular fiber organization (GO:0097435),0.5654563176874662,1.7430286557534496,0.0,0.13930979523491205,0.998,58/333,7.53%,COL15A1;COL4A1;LTBP3;LTBP2;CYP1B1;COL24A1;COL18A1;COL1A2;COL4A2;COL27A1;COL7A1;COL1A1;COL3A1;LUM;COL8A1;TLL2;COL6A3;COL23A1;COL5A2;HSPG2;IAPP;COL11A2;MYO1B;PPP1R9B;COL5A3;COL5A1;PLOD2;ADAMTS2;COL13A1;RND3;DPT;USP9X;COL11A1;DYNC1H1;SERF1A;NCKAP5;KIF2A;HOOK2;SERPINH1;DDR2;NF1;BMP1;RHOD;CD36;CARMIL1;MYO5A;PCM1;CDC42;FAT1;SIAH2;MYO1D;EMILIN1;CGNL1;MYO1H;ADAMTS14;LOXL1;TMOD1;MYO7A
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.7660546298039594,1.7428810928622671,0.0058823529411764705,0.13764457785643688,0.998,3/16,6.17%,RUNX1;CREB3L1;TGFB3
prerank,regulation of cation transmembrane transport (GO:1904062),-0.52392184291476,-1.741648525237949,0.012605042016806723,0.26421587239175764,0.992,9/29,6.42%,KCNIP4;FGF12;DPP10;DPP6;SLMAP;SNTA1;WNK3;ATP2B4;SLC30A5
prerank,tight junction assembly (GO:0120192),-0.47512158267897425,-1.739854685086632,0.006024096385542169,0.25750738131737383,0.992,18/49,21.14%,OCLN;PECAM1;CLDN5;ESAM;CDH5;RAMP2;APC;LSR;CLDN12;PARD3;PATJ;CLDN11;CLDN14;CLDN1;PARD6G;AFDN;RAB13;MPP7
prerank,protein autoprocessing (GO:0016540),0.7698007411299996,1.7396791930487188,0.008571428571428572,0.1412179514503523,0.998,5/17,7.12%,CASP4;CASP1;FXN;OMA1;CTSL
prerank,regulation of plasminogen activation (GO:0010755),0.8211236122299697,1.7364296548598972,0.005970149253731343,0.14510898942760503,0.999,3/12,6.24%,RUNX1;SERPINE2;ENO1
prerank,neutrophil migration (GO:1990266),0.6350830804494033,1.7351299136924272,0.002285714285714286,0.14599436276494426,0.999,14/58,11.44%,CCL11;CXCL5;CCL7;CXCL1;EDN3;JAML;PRTN3;XCL1;CCL5;CXCL10;GBF1;IRAK4;CCL2;TGFB2
prerank,sodium ion homeostasis (GO:0055078),-0.5833896323722321,-1.734646500852295,0.010238907849829351,0.25970289027651916,0.996,4/21,1.45%,ATP1A2;ATP1B3;SLC12A2;ATP1B1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.8478173223721439,1.7338067830624448,0.0015748031496062992,0.14664132163512694,0.999,4/10,9.14%,WNT2;FZD1;LRP6;WNT5A
prerank,cellular response to cytokine stimulus (GO:0071345),0.5580189993242585,1.733360011050669,0.0,0.1456923354805343,0.999,103/416,13.89%,RORA;MMP3;CCL11;COL1A2;MMP2;CCL7;IL34;IL23R;IL1RL2;CXCL1;LBP;OSMR;ZEB1;SBNO2;TNFRSF21;CXCL12;ZFP36L1;TEC;GHR;PTPN7;TNFSF11;JAK1;IL16;BCL6;NUMBL;STAT1;SYNCRIP;GAB2;TLR2;ZFP36L2;CD40;TIMP1;IL1R1;PRTN3;JAK2;XCL1;DPYSL3;BATF;CASP1;IRAK3;STAT3;FSCN1;CCR1;PTPN13;BCL2;CEBPD;AIF1;LGALS9;CD36;CCL5;PTPRZ1;SFRP1;STAT5A;NPR2;PTPN6;CXCL10;IL3RA;ICAM1;IRAK2;PTPN18;IRF1;ADAMTS12;IFNAR2;PID1;MAPK11;SDC1;CBL;GRB2;POU2F1;ANXA1;CXCR4;WNT5A;FOXO3;IL7;IRAK4;JUNB;GREM2;GBP7;LIFR;TCF7;GAPDH;CCL2;TNFRSF1A;PTPRJ;PTPN23;PTPN9;PTPN2;ERBIN;SOCS5;YWHAZ;NFE2L2;RHOA;VAV1;TNF;GSK3B;FGF2;ADAMTS7;UBE2K;TANK;PIK3R1;YBX3;SMAD3;IL20RB
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5466287029119447,-1.733187993940049,0.007326007326007326,0.2525937613894997,0.996,6/26,1.88%,ATP1B3;ATP1B1;FHL1;ACTN2;ANK2;WWP2
prerank,eye morphogenesis (GO:0048592),0.7397132138512199,1.733153242064184,0.007032348804500703,0.14428298370275722,0.999,7/19,5.10%,COL5A2;FBN2;COL5A1;TENM3;STAT3;FBN1;NF1
prerank,carnitine shuttle (GO:0006853),-0.6898268660706685,-1.732766182116719,0.005333333333333333,0.24370266277238772,0.996,2/11,0.67%,PRKAG2;PRKAA2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.5692083865136011,1.731501959899542,0.0,0.14556081039561236,0.999,48/175,17.14%,PSMA7;CCL11;CCL7;MAP3K14;TNFRSF21;ZFP36L1;TNFSF11;STAT1;ZFP36L2;CD40;PLVAP;JAK2;XCL1;BIRC3;LIMS1;CCL5;TNFRSF12A;SFRP1;ADAMTS12;PID1;PYDC1;PSMB8;PSMA6;FOXO3;EDA2R;CCL2;TNFRSF1A;ERBIN;EDA;NFE2L2;TNFRSF4;TNF;PSMF1;ADAMTS7;COMMD7;TANK;TRAF2;YBX3;CX3CL1;RIPK1;PSMA8;PSMD2;PSMD12;PSMD11;TRAF5;BAG4;PSMD14;AKT1
prerank,lymphocyte chemotaxis (GO:0048247),0.6832365168009629,1.7314142654697409,0.0013003901170351106,0.1438945698234412,0.999,6/34,6.32%,CCL11;CYP7B1;CCL7;XCL1;CCL5;CXCL10
prerank,regulation of interleukin-12 production (GO:0032655),0.6428506534582947,1.7296005100118768,0.00243605359317905,0.1458142237291408,0.999,11/47,8.33%,IL23R;IL16;CMKLR1;TLR2;CD40;IRAK3;MDK;LGALS9;TIRAP;MAPK11;MAST2
prerank,activin receptor signaling pathway (GO:0032924),0.777428900263723,1.7291444551582975,0.0030120481927710845,0.14487088444552157,0.999,9/15,18.07%,SMAD2;ACVR1;INHBB;TGFBR1;ACVR1B;ACVR2A;ACVR1C;SMAD3;INHBA
prerank,response to nitric oxide (GO:0071731),0.7952076022116291,1.7290017121077592,0.006339144215530904,0.14339628987557768,0.999,1/13,0.03%,MMP3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7689688673047208,1.7267201511472228,0.005805515239477504,0.14605615715807851,0.999,3/16,3.05%,SLC39A14;C3;PRKCA
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8452144394432386,1.7261065011519634,0.009478672985781991,0.1455760270307848,0.999,3/10,5.18%,ABCA1;APOE;BMP1
prerank,granulocyte chemotaxis (GO:0071621),0.6350047423029043,1.7248491425101073,0.002317497103128621,0.14644965652106035,0.999,13/55,11.44%,CCL11;CXCL5;CCL7;CXCL1;EDN3;JAML;XCL1;CCL5;CXCL10;GBF1;ANXA1;CCL2;TGFB2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.7192762661456789,1.7244858722970713,0.009817671809256662,0.14555322831360407,0.999,5/22,7.77%,LBP;TNFAIP3;TREM2;RAB7B;TIRAP
prerank,zymogen activation (GO:0031638),0.650018567536765,1.722884886178874,0.0049261083743842365,0.1468368808794956,0.999,8/39,7.12%,HP;HPR;MMP14;KLK2;APOH;OMA1;PLAT;CTSL
prerank,neutrophil chemotaxis (GO:0030593),0.6406118745479172,1.722499716446645,0.004672897196261682,0.1459332845591497,0.999,12/53,11.44%,CCL11;CXCL5;CCL7;CXCL1;EDN3;JAML;XCL1;CCL5;CXCL10;GBF1;CCL2;TGFB2
prerank,regulation of immune response (GO:0050776),0.5828260117057597,1.722372396702587,0.0,0.14451616302996884,0.999,19/135,7.77%,COL1A2;C3;COL1A1;COL3A1;SPN;ULBP1;COLEC12;JAML;BCL6;CD276;IRF7;CD40;BIRC3;ADCY7;TREM2;AHR;ICAM1;IRF1;TIRAP
prerank,cellular lipid catabolic process (GO:0044242),0.694839504760157,1.721831970988186,0.0025940337224383916,0.1440733843075108,0.999,2/27,0.18%,CEL;CYP1B1
prerank,acylglycerol homeostasis (GO:0055090),0.7460265587740039,1.7212127289976182,0.0028089887640449437,0.14364023120945396,0.999,5/20,8.76%,RORA;LIPC;APOE;ANGPTL4;LPL
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.8363663776195581,1.7187647976403695,0.00676818950930626,0.14643560329829203,0.999,5/10,11.00%,ADIPOQ;APOD;LRP1;PTPRJ;PTPN2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.8425102605116284,1.7177404638717948,0.004934210526315789,0.14670396820689346,0.999,2/11,0.27%,FAP;DLC1
prerank,lymphocyte migration (GO:0072676),0.6743160259318675,1.7156830976362265,0.006321112515802781,0.14910707925756045,0.999,6/32,10.36%,CCL11;CCL7;XCL1;CCL5;MSN;CCL2
prerank,embryonic digestive tract development (GO:0048566),0.7530687457629902,1.7152024471456278,0.005555555555555556,0.14821379111126534,0.999,8/18,14.64%,PDGFRA;GLI2;GLI3;RARB;SALL1;TGFB2;TNF;NIPBL
prerank,positive regulation of cytokine production (GO:0001819),0.5560374333768383,1.7141220287521697,0.0,0.14865567005539168,0.999,48/292,9.53%,RORA;RUNX1;GLMN;NR1H4;CYP1B1;C3;ZBP1;IL23R;ADIPOQ;SULF1;LBP;RFTN1;CCBE1;IL16;CD276;TLR2;IRF7;LACC1;CD40;IL1R1;STOML2;XCL1;BATF;TSLP;STAT3;MDK;AIF1;PRKD2;LGALS9;PLA2R1;NOD1;PAEP;CREBBP;EIF2AK2;HPSE;TLR7;ARNT;IRF1;RAB7B;TIRAP;TMEM106A;MAPK11;CD14;LPL;ANXA1;WNT5A;CRCP;IL7
prerank,reverse cholesterol transport (GO:0043691),0.7997371583528998,1.7139948454465954,0.0015060240963855422,0.1473055994714512,0.999,4/13,4.34%,ABCA1;LIPC;APOE;ABCG1
prerank,skeletal system development (GO:0001501),0.5835301305074312,1.7137000837927607,0.0,0.14647821979312223,0.999,35/148,10.51%,COL1A2;COL1A1;TRPS1;SULF1;ITGB8;PAX1;MMP14;SH3PXD2B;GLI2;CDH11;COL11A2;DEAF1;COL13A1;PAPSS2;SOX5;CHD7;CMKLR1;ANKRD11;VCAN;EXT1;SUFU;FRZB;FBN1;BMP1;ADAMTS4;PRELP;SPEF2;CREB3L2;MMP16;TGFBR1;TRIP11;WNT5A;BMP5;TBX3;FGFR1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.7524447788962169,1.7135925527596687,0.0070028011204481795,0.14528932279918408,0.999,10/18,12.92%,IL34;TNFRSF21;PTN;MDK;NF1;PTPRZ1;TENM4;CXCR4;DRD3;OPALIN
prerank,response to sterol (GO:0036314),0.8254051533697223,1.7134598924547242,0.001567398119122257,0.14416443552995076,0.999,4/11,9.03%,RORA;SMAD2;ABCA2;TGFBR1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6371873456492982,1.7092212243614346,0.00591016548463357,0.15046462469050287,0.999,20/51,17.65%,IL34;EDN3;CXCL12;PTN;CMKLR1;XCL1;MDK;CCR1;AIF1;LGALS9;CCL5;CXCL10;PLA2G7;PTK2;CALR;VEGFC;IL6R;CREB3;MAPK1;ANO6
prerank,regulation of chemotaxis (GO:0050920),0.6748110448807341,1.7076819196284756,0.003875968992248062,0.151712061296892,0.999,10/30,13.33%,PDGFRA;MYCBP2;PDGFRB;ZSWIM6;TREM2;AIF1;CXCR4;PTPN2;ZSWIM8;ZSWIM4
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6367955663273364,1.7066254075411067,0.0036319612590799033,0.1523754853535996,0.999,8/43,6.27%,NR1H4;ADIPOQ;LBP;TNFAIP3;IRAK3;LGALS9;ILRUN;PTPN6
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.6434125583169125,1.7057833805932605,0.003708281829419036,0.15252997133643525,0.999,8/41,6.27%,NR1H4;ADIPOQ;LBP;TNFAIP3;IRAK3;LGALS9;ILRUN;PTPN6
prerank,alcohol catabolic process (GO:0046164),0.8266968302639367,1.704029058611906,0.011093502377179081,0.15450342591200208,0.999,3/10,8.44%,CEL;APOE;SRD5A3
prerank,cellular response to organic substance (GO:0071310),0.580221848831957,1.7018388653882879,0.0,0.1573185479606239,1.0,33/116,12.75%,NR1H4;CYP1B1;IBSP;IL1RL2;ROBO2;GHR;PTPN7;LRRK2;SLIT3;DPYSL3;CASP1;STAT3;IGFBP5;PTPN13;ACVR1;CCL5;SFRP1;PTPN6;PTPN18;PID1;CXCR4;TGFBR1;CYP1A1;RPS6KB1;ACVR1B;CCL2;PTPN23;PTPN9;PTPN2;ACVR2A;RHOA;TNF;ACVR1C
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.6449545652236239,1.7003167384350015,0.002372479240806643,0.15897459131331124,1.0,19/43,13.23%,CBLB;SH3KBP1;EGFR;ERRFI1;PTPN3;EGF;CDC42;RAB7A;EPS15L1;CBL;GRB2;MVP;PTPRJ;PTPN2;SOCS5;ZGPAT;SPRY2;EPS15;BTC
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.7886277268977684,1.699890885987359,0.014925373134328358,0.15834104589356268,1.0,5/13,10.77%,MDFIC;APOD;SUFU;SP100;NUP153
prerank,regulation of interleukin-2 production (GO:0032663),0.6341598626498464,1.6971469823747545,0.006172839506172839,0.16210345774019155,1.0,8/43,5.00%,RUNX1;GLMN;VSIG4;TNFAIP3;STOML2;XCL1;NAV3;PRKD2
prerank,regulation of interleukin-17 production (GO:0032660),0.6810901311991403,1.6962002806220657,0.005221932114882507,0.16253016889230149,1.0,3/31,0.90%,NR1H4;IL23R;RFTN1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.7417945447453644,1.6957820060414588,0.011816838995568686,0.16189097039873218,1.0,3/17,6.17%,RUNX1;CREB3L1;TGFB3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5382438385731645,-1.6949422866415795,0.007434944237918215,0.3307622656079961,1.0,8/25,4.33%,DMD;ATP1B3;ATP1B1;ACTN2;ANK2;SLC6A9;WNK4;WNK3
prerank,cellular sodium ion homeostasis (GO:0006883),-0.6173403960161148,-1.692671448932265,0.008670520231213872,0.32513735038611635,1.0,4/15,1.45%,ATP1A2;ATP1B3;SLC12A2;ATP1B1
prerank,regulation of response to external stimulus (GO:0032101),0.5785776303683827,1.6918307706260611,0.0,0.1681986456727552,1.0,27/121,9.14%,CASP4;ZBP1;IL1RL2;PDGFRA;SBNO2;PTGES;BCL6;LACC1;IL1R1;GATA6;JAK2;XCL1;BIRC3;CASP1;TREM2;CASP12;CD36;PIK3AP1;IRF1;ADAMTS12;TIRAP;CELF1;AREL1;PSMA6;ANXA1;CXCR4;WNT5A
prerank,regulation of striated muscle contraction (GO:0006942),-0.5151341316916763,-1.6916579435536678,0.00392156862745098,0.3176839606266503,1.0,5/27,5.11%,DMD;ATP1A2;ANK2;CALM1;SLC8A3
prerank,inflammatory response (GO:0006954),0.5532564638634189,1.6915842685073392,0.0,0.16727893314240846,1.0,37/195,12.69%,CCL11;SCUBE1;HP;HPR;CXCL5;CCL7;OLR1;CXCL1;HSPG2;CRP;CMKLR1;TLR2;CD40;XCL1;REL;STAT3;CCR1;AIF1;PTGDR;LGALS9;ADM;NOD1;HRH4;CCL5;CXCL10;PXK;CD14;ANXA1;CXCR4;HRH1;LOXL3;CCL2;TNFRSF1A;TNFRSF4;PJA2;TNF;TPST1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.798750128869454,1.6914520504190134,0.016,0.16613531543520424,1.0,5/12,10.88%,ADIPOQ;CBLB;APOD;CBL;PTPRJ
prerank,skeletal system morphogenesis (GO:0048705),0.6301160579386076,1.6909633807683708,0.0036809815950920245,0.16576014587299692,1.0,10/42,10.51%,MMP13;PDGFRA;FBN2;SFRP4;ANKRD11;HOXB3;LRP6;SPEF2;TGFBR1;FGFR1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.79641404335612,1.688530576935018,0.0078003120124804995,0.16932137812656964,1.0,3/12,2.90%,IL23R;IL1R1;XCL1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5354311787903012,-1.6884365495370026,0.011673151750972763,0.31631664543379473,1.0,13/25,22.90%,MINK1;SHANK3;SHISA6;CACNG2;SHANK1;CACNG7;SHISA7;RELN;NLGN1;ADRB2;MEF2C;SHISA9;CACNG8
prerank,action potential (GO:0001508),-0.4696299532612304,-1.6881162028494074,0.0,0.3070744623623355,1.0,25/44,32.22%,DMD;AKAP6;KCND2;SCN2A;KCNJ2;GNA11;GNA14;SCN8A;ANK3;CLN3;SCN9A;SLC4A3;KCNQ1;GPER1;MYH14;CACNA1I;KCNE4;SCN3B;SCN3A;YWHAH;KCNMB2;CHRNA4;KCNH2;KCNB1;SCN5A
prerank,muscle cell differentiation (GO:0042692),0.6692233781801608,1.6878838900213464,0.00903225806451613,0.16899484121561367,1.0,6/32,2.70%,RORA;GLMN;TBX18;MRTFA;FBXO40;GATA6
prerank,cellular response to fatty acid (GO:0071398),0.790922715673819,1.687218077414779,0.012759170653907496,0.1690344265735537,1.0,4/12,8.76%,NR1H4;IRS1;PID1;LPL
prerank,eosinophil migration (GO:0072677),0.7709611535875058,1.680608817681596,0.007564296520423601,0.18009806383718907,1.0,3/14,5.67%,CCL11;CCL7;CCL5
prerank,eosinophil chemotaxis (GO:0048245),0.7709611535875058,1.680608817681596,0.007564296520423601,0.18009806383718907,1.0,3/14,5.67%,CCL11;CCL7;CCL5
prerank,blood vessel morphogenesis (GO:0048514),0.6135915178653977,1.6804771315806075,0.0034883720930232558,0.17890661331198338,1.0,11/54,5.41%,COL4A1;GLMN;CYP1B1;ITGB8;CCBE1;LAMA1;NRP1;SHH;ADM;NF1;CCM2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.833745380563203,1.6798625768321247,0.008156606851549755,0.17871479655235423,1.0,4/10,10.71%,RUNX1;RUNX3;SH3RF1;CBFB
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.8053544983915654,1.6795020338607636,0.019877675840978593,0.17799869448790553,1.0,1/11,0.03%,MMP3
prerank,regulation of blood coagulation (GO:0030193),0.6829025180546887,1.6792742748487595,0.00788436268068331,0.17699159812914744,1.0,6/27,6.67%,FAP;KNG1;SERPINE2;APOE;APOH;HPSE
prerank,negative regulation of immune effector process (GO:0002698),-0.6230455443115537,-1.67866497525382,0.031055900621118012,0.323037248550127,1.0,7/13,19.06%,CD47;CD55;GRN;RPS19;HAVCR2;RC3H1;FER
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.6345907703348005,1.6782925631920504,0.003745318352059925,0.17758184000708496,1.0,15/40,14.44%,COL1A1;TCF7L2;SNAI1;SMAD2;JAG1;MDK;TGFB3;TGFBR1;TGFB1I1;WWTR1;PDPN;TGFB2;GCNT2;SMAD3;SMAD4
prerank,response to tumor necrosis factor (GO:0034612),0.5747488153014934,1.6777461486942549,0.0010845986984815619,0.17724558308451793,1.0,25/91,17.14%,CCL11;CCL7;ADIPOQ;TNFRSF21;ZFP36L1;ZFP36L2;CD40;JAK2;XCL1;CCL5;SFRP1;ADAMTS12;PID1;CCL2;ERBIN;NFE2L2;CASP8;ADAMTS7;TANK;YBX3;CX3CL1;RIPK1;GGT7;BAG4;AKT1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.5386393977684045,1.6735509290298578,0.0,0.18440243669678077,1.0,134/532,16.79%,PSMA7;RORA;MMP3;CCL11;COL1A2;MMP2;CXCL5;CCL7;IL34;IL23R;MAP3K14;IL1RL2;CXCL1;LBP;OSMR;ZEB1;MID1;YAP1;CXCL12;TEC;GHR;TNFSF11;JAK1;IL16;BCL6;NUMBL;STAT1;GAB2;IRF7;CD40;PLVAP;TIMP1;IL1R1;IRS1;PRTN3;JAK2;XCL1;UGCG;BIRC3;BATF;CASP1;TSLP;IRAK3;STAT3;FSCN1;CCR1;CUL1;CAMK2D;BCL2;CEBPD;NOD1;LIMS1;TRIM21;CD36;CCL5;RALA;TNFRSF12A;PTPRZ1;STAT5A;PTPN6;CXCL10;CDC42;IL3RA;ICAM1;IRAK2;IRF1;SKP1;IFNAR2;PYDC1;CANX;SDC1;MSN;TRIM8;CBL;GRB2;LMNB1;POU2F1;PSMB8;LCP1;PSMA6;SP100;ANXA1;FOXO3;IP6K2;IL7;IRAK4;PELI3;OASL;JUNB;EDA2R;GREM2;LIFR;BRWD1;CCL2;TNFRSF1A;PTPRJ;SOCS5;YWHAZ;EDA;TNFRSF4;VAV1;FBXW11;TNF;FGF2;PSMF1;COMMD7;TRAF2;SPI1;TALDO1;PIK3R1;ARF1;IL20RB;IRF9;SRC;CDKN1B;SMAD4;CX3CL1;IL22;RIPK1;IL6R;PSMA8;FCGR1A;HIF1A;PSMD2;STAT5B;PSMD12;SQSTM1;PSMD11;PELI2;TRAF3IP2;SMARCA4;TRAF5;BAG4;PSMD14
prerank,regulation of epidermal cell differentiation (GO:0045604),0.7073730038357989,1.6715625627881205,0.0070126227208976155,0.18694925594732364,1.0,6/21,7.12%,RUNX1;ZFP36L1;SFRP4;ERRFI1;CTSK;CTSL
prerank,transition metal ion homeostasis (GO:0055076),0.6673537096982848,1.6695754260192588,0.016774193548387096,0.19003067170772986,1.0,3/28,2.42%,SLC39A14;HEPH;CP
prerank,positive regulation of T cell differentiation (GO:0045582),0.6429553690882164,1.6689080235683216,0.006180469715698393,0.18996065190975678,1.0,7/36,4.42%,IL23R;GLI2;GLI3;BCL6;ZMIZ1;MDK;SHH
prerank,response to interleukin-1 (GO:0070555),0.5852229530139567,1.6684184608264006,0.0022727272727272726,0.18955883488729444,1.0,21/73,15.90%,CCL11;CCL7;CD40;IL1R1;XCL1;PRKCA;IRAK3;LGALS9;CCL5;SFRP1;IRAK2;ADAMTS12;MAPK11;ANXA1;CCL2;ADAMTS7;TANK;SRC;CX3CL1;HIF1A;RBMX
prerank,phospholipid homeostasis (GO:0055091),0.7943817336167179,1.6679742210357045,0.011111111111111112,0.18914769485687175,1.0,4/11,11.52%,ABCA1;ABCG1;TLCD2;RCN3
prerank,vasoconstriction (GO:0042310),0.7857290021503245,1.6657085095396138,0.01610305958132045,0.1924791132999993,1.0,3/11,2.89%,EDN3;CRP;EDNRA
prerank,phosphate ion homeostasis (GO:0055062),0.823296024985838,1.662775104075214,0.01584786053882726,0.19782747810062565,1.0,2/10,1.64%,ENPP1;SFRP4
prerank,sterol homeostasis (GO:0055092),0.6002098319168494,1.6624534866706167,0.003416856492027335,0.19707159315738468,1.0,12/65,9.98%,RORA;CYP7B1;ABCA1;LIPC;APOE;ABCA2;ABCG1;LIMA1;EPHX2;SOAT1;LPL;NPC2
prerank,cholesterol homeostasis (GO:0042632),0.6018265200422328,1.6620841107606792,0.003436426116838488,0.19648336885629572,1.0,12/64,9.98%,RORA;CYP7B1;ABCA1;LIPC;APOE;ABCA2;ABCG1;LIMA1;EPHX2;SOAT1;LPL;NPC2
prerank,organic anion transport (GO:0015711),-0.4175248678688916,-1.661352155557156,0.0,0.3611514819850585,1.0,18/76,10.82%,ABCC4;SLC4A10;ABCG2;SLC26A7;LRRC8D;SLCO1C1;SLC22A6;SLCO3A1;SLC39A8;CA2;SLC52A1;SLC25A42;SLC25A4;SLCO2A1;ABCC6;CA4;SLC4A8;SLC4A3
prerank,negative regulation of cell development (GO:0010721),0.6678008447319725,1.6611888031989157,0.014248704663212436,0.19699950986152906,1.0,6/25,12.44%,CCL11;FBN1;PCM1;FBXW7;TNF;GSK3B
prerank,synaptic vesicle cycle (GO:0099504),-0.48600030125340343,-1.6611724764049618,0.0,0.3511595324368093,1.0,10/30,19.82%,SNAP25;PCLO;SYNDIG1;SYT7;CPLX1;RIMS1;SNAPIN;DNAJC5;PIP5K1C;NLGN1
prerank,toxin transport (GO:1901998),0.8184473646721087,1.6608164522929483,0.007911392405063292,0.19644232097809125,1.0,2/10,0.71%,ANTXR1;ANTXR2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.7916338117919133,1.660782795887857,0.010852713178294573,0.19511944559660555,1.0,4/11,9.14%,WNT2;FZD1;LRP6;WNT5A
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7410213075241112,1.660004308627911,0.015536723163841809,0.19549658912850051,1.0,3/16,1.92%,LTBP3;SOX5;PTN
prerank,presynaptic endocytosis (GO:0140238),0.6937184556768611,1.6591624515386993,0.011019283746556474,0.19594757407241165,1.0,5/24,8.40%,CEL;STON2;OPHN1;CANX;SYT2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6665675795771252,-1.6587494966009306,0.035623409669211195,0.3477535757818476,1.0,4/11,7.90%,TJP1;TJP2;RAPGEF2;RAPGEF6
prerank,cholesterol transport (GO:0030301),0.6317045803202049,1.657557260366705,0.006105006105006105,0.19782133832036083,1.0,14/45,13.62%,CEL;ABCA1;LIPC;APOE;ABCG1;LIMA1;CD36;VPS4A;SOAT1;NPC2;OSBPL5;RELCH;ABCG4;MSR1
prerank,regulation of establishment of planar polarity (GO:0090175),0.5717336184352056,1.6568476111311803,0.004366812227074236,0.19810799923568723,1.0,24/88,16.79%,PSMA7;ROR2;CLTC;PRICKLE2;SMURF2;FZD1;CDC42;PRICKLE1;ARHGEF19;PSMB8;PSMA6;WNT5A;NPHP3;RHOA;PSMF1;DACT1;RAC1;AP2A2;PSMA8;SMURF1;PSMD2;PSMD12;PSMD11;PSMD14
prerank,regulation of T cell migration (GO:2000404),0.7154006686454379,1.6561258448621827,0.02097902097902098,0.1983413780738175,1.0,6/18,6.32%,APOD;CXCL12;SPN;AIF1;CCL5;CXCL10
prerank,positive regulation of T cell migration (GO:2000406),0.7131587580601726,1.6550817577964214,0.019178082191780823,0.199292416765796,1.0,8/20,11.96%,CXCL12;SPN;XCL1;AIF1;CCL5;CXCL10;WNT5A;RHOA
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5994216622130759,1.6530044038254301,0.0035046728971962616,0.20252434627218768,1.0,15/56,9.80%,LBP;TLR2;LACC1;ALPK1;CTSS;NOD1;CD36;LY96;CTSK;TLR7;IRAK2;CTSL;CD14;IRAK4;CTSB
prerank,negative regulation of interleukin-10 production (GO:0032693),0.7318767059791953,1.651206601851255,0.013177159590043924,0.20521551059787477,1.0,2/16,1.15%,IL23R;TNFRSF21
prerank,bicellular tight junction assembly (GO:0070830),-0.45870459570369637,-1.6506990554187702,0.0056179775280898875,0.361563143111025,1.0,16/46,21.14%,OCLN;PECAM1;CLDN5;ESAM;CDH5;RAMP2;APC;PARD3;PATJ;CLDN11;CLDN14;CLDN1;PARD6G;AFDN;RAB13;MPP7
prerank,xenobiotic transport (GO:0042908),-0.5751474880535845,-1.650683248800419,0.020338983050847456,0.35186669575553753,1.0,6/17,9.83%,ABCG2;SLC47A1;SLC7A5;SLC22A4;SLC22A18;ABCA3
prerank,negative regulation of intracellular protein transport (GO:0090317),0.7024052447480799,1.6501621462683613,0.017150395778364115,0.20606697725053033,1.0,7/22,10.58%,ADIPOQ;MDFIC;APOD;LRRK2;SUFU;SP100;LMAN1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.7281927457743912,1.6492455191055455,0.019637462235649546,0.2069752108179389,1.0,4/15,5.07%,FAP;LRP1;FSCN1;DDR2
prerank,positive regulation of protein maturation (GO:1903319),0.7819319122460304,1.6478902195415719,0.01529051987767584,0.20880524257089197,1.0,2/11,1.01%,CCBE1;NKD2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7214297260456657,1.6469245609112322,0.018544935805991442,0.20958267555782306,1.0,3/16,3.66%,APOD;ADCY7;TREM2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6826844538968886,1.6441976918609456,0.015363128491620111,0.2143970637567338,1.0,5/22,5.67%,CYP1B1;MGAT5;GHR;TSLP;CCL5
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7685488237689524,1.64113756681828,0.013846153846153847,0.21993186283692823,1.0,3/14,4.31%,IL23R;TNFSF11;CCR1
prerank,positive regulation of cell development (GO:0010720),0.6446871828323404,1.6406479782003351,0.01303780964797914,0.21981161868449509,1.0,5/31,7.23%,PDE3A;ADIPOQ;NUMBL;NKX6-1;SERPINF1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.5567375723210498,1.6399648028557066,0.0021164021164021165,0.2199418154056149,1.0,33/112,15.51%,LTBP2;COL1A2;COL3A1;PDE3A;WNT2;ZFP36L1;ITGB5;SOX5;ZMIZ1;ZFP36L2;XCL1;SMAD2;USP9X;ACVR1;LIMS1;SFRP1;TGFB3;CBL;TGFBR1;WNT5A;SMAD5;PTK2;TGFB2;GCNT2;TGFBRAP1;RHOA;SMAD3;SRC;ARHGEF18;SMAD4;LRRC32;SMAD1;SMURF1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6643761651961615,1.639557566446832,0.016736401673640166,0.21950413482131348,1.0,4/25,5.00%,RUNX1;GLMN;STOML2;PRKD2
prerank,regulation of T cell differentiation (GO:0045580),0.6454427152022046,1.6388325547034583,0.014705882352941176,0.21969930028255483,1.0,7/33,10.71%,RUNX1;ZMIZ1;MDK;IL7;PRDM1;TCF7;CBFB
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6837691054548514,1.6366471626536991,0.019444444444444445,0.22359361524649732,1.0,1/22,0.01%,PSMA7
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.6268855885123323,-1.636046006613328,0.017699115044247787,0.38364340782929385,1.0,9/13,22.16%,SLC4A10;SHISA6;CLN3;GRIK2;SHISA7;SYP;SYNGR1;SLC8A2;SHISA9
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.5657896366276532,1.6338468720422512,0.0032822757111597373,0.22850575194623418,1.0,22/85,16.79%,PSMA7;ROR2;CLTC;PRICKLE2;SMURF2;FZD1;CDC42;PRICKLE1;ARHGEF19;PSMB8;PSMA6;WNT5A;RHOA;PSMF1;RAC1;AP2A2;PSMA8;SMURF1;PSMD2;PSMD12;PSMD11;PSMD14
prerank,eye development (GO:0001654),0.5966856752927512,1.633614673760388,0.0057405281285878304,0.2275941868046185,1.0,11/54,5.29%,COL5A2;SH3PXD2B;FBN2;LAMA1;COL5A1;MEIS2;CACNA1C;SIPA1L3;MEIS1;FBN1;PBX3
prerank,bone morphogenesis (GO:0060349),0.7431644208809222,1.63050917500713,0.017001545595054096,0.23360046673728085,1.0,3/14,6.00%,MMP13;SFRP4;LRP6
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7555421103907654,1.6299409884751463,0.010670731707317074,0.23371570235116934,1.0,2/13,2.90%,IL23R;XCL1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7182346777595062,1.6291145832140494,0.008784773060029283,0.2343715835277475,1.0,3/16,5.70%,RORA;ADIPOQ;FOXK2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5576108896554753,1.6280944543692242,0.0021231422505307855,0.23532295739030346,1.0,28/108,10.71%,RUNX1;SULF1;MDFIC;LRP1;NKD2;SFRP4;KREMEN1;TLR2;LRRK2;TNFAIP3;TLE1;TAX1BP3;FRZB;ATP6AP2;SFRP1;CDK14;FAM53B;NXN;MDFI;GSKIP;TERT;ITGA3;CSNK2A1;SALL1;SFRP5;WLS;DISC1;CBFB
prerank,negative regulation of lipid storage (GO:0010888),0.689774258304626,1.6269914337220517,0.02097902097902098,0.23676145663522577,1.0,7/19,12.29%,ABCA1;CRP;TREM2;ABCG1;PPARG;PTPN2;TNF
prerank,regulation of acrosome reaction (GO:0060046),-0.67657549563927,-1.6262309988067611,0.023054755043227664,0.40509626194449627,1.0,2/10,7.25%,PLCB1;GLRA1
prerank,epithelial cell migration (GO:0010631),0.6302737695353944,1.6248875384372972,0.009791921664626682,0.24044659007587205,1.0,6/37,3.21%,FAP;CYP1B1;ZEB2;STAT1;NRP1;FSTL1
prerank,adenine nucleotide transport (GO:0051503),-0.5924922775958399,-1.6237781199012975,0.03785488958990536,0.4026772687883389,1.0,5/17,8.93%,ABCC4;LRRC8D;SLC25A42;SLC25A4;ABCC6
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4652942436375836,-1.623264641657336,0.010869565217391304,0.3945826111171373,1.0,15/40,21.36%,UNC13C;SNAP25;UNC13B;PCLO;SYT7;CPLX1;RIMS1;SNAPIN;DNAJC5;STX3;STX2;SNPH;PIP5K1C;RIMS2;BLOC1S6
prerank,regulation of chromatin organization (GO:1902275),-0.6036629176608261,-1.622430301082481,0.017804154302670624,0.3875387921345619,1.0,7/14,19.60%,MLLT3;HNRNPU;TLK1;IGF2;SSRP1;METTL4;SETD1A
prerank,regulation of cytokine production (GO:0001817),0.5419939267665194,1.6222231079686726,0.0,0.24602805085372842,1.0,25/126,12.29%,GLMN;IGF2BP1;ZBP1;DTX4;IGF2BP2;BCL6;CD276;CRP;IRF7;SNAI2;CCN4;BATF;TREM2;LGALS9;PLA2R1;TRIM21;EIF2AK2;MAST2;GPNMB;ANXA1;GAPDH;PLD4;CASP8;ATP2B1;TNF
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5941355034292661,1.6216422901585805,0.008393285371702638,0.2459689210792796,1.0,10/49,8.14%,ADIPOQ;LBP;TLR2;STAT3;PRKD2;LGALS9;NOD1;TLR7;TIRAP;CD14
prerank,regulation of interleukin-8 production (GO:0032677),0.5655643090684583,1.621550395327477,0.00562429696287964,0.24469034105793758,1.0,13/69,8.96%,ADIPOQ;LBP;BCL3;CRP;TLR2;STAT3;PRKD2;LGALS9;NOD1;TLR7;TIRAP;CD14;ANXA1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.6664105960709416,1.6213472678492775,0.019736842105263157,0.2437493879421003,1.0,8/26,7.18%,TLR2;IRF7;BIRC3;FLOT2;IRAK3;TREM2;CD36;IRF1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.7787932837834437,1.621152645063046,0.025974025974025976,0.24278967273889404,1.0,2/10,3.66%,C3;TREM2
prerank,ATP transport (GO:0015867),-0.6975515077795923,-1.6208840629866705,0.017369727047146403,0.3835521931101428,1.0,7/10,30.04%,CD47;SLC25A42;SLC25A4;ABCC6;SLC17A9;SLC25A17;SLC25A24
prerank,embryonic skeletal system development (GO:0048706),0.6330534974014927,1.6207518572997335,0.008793969849246231,0.24219543298953744,1.0,6/35,4.05%,COL1A1;SULF1;PDGFRA;DEAF1;WNT9A;HOXB3
prerank,positive regulation of reproductive process (GO:2000243),0.6429471398060537,1.6204850867445486,0.010309278350515464,0.24147883085143684,1.0,6/31,10.18%,PDE3A;SYDE1;LHFPL2;SMURF2;INHBB;ACVR1B
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.7023073786499989,1.6202361243376093,0.015691868758915834,0.2407996126535381,1.0,6/17,8.59%,CXCL12;CCR1;AIF1;CCL5;CXCL10;PLA2G7
prerank,aorta development (GO:0035904),0.7415346134914319,1.6195346465645044,0.027496382054992764,0.24134730250836278,1.0,7/14,8.15%,LRP1;ROBO2;PDGFRB;TBX2;JAG1;PKD2;ADAMTS9
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5346068930005541,1.6190382578563647,0.002053388090349076,0.24108060271931553,1.0,31/151,12.55%,ROR2;CCL11;ROR1;CCL7;PDGFRA;TNFSF11;PDGFRB;XCL1;PRKCA;NRP1;EGFR;TREM2;APOE;CCR1;PRKD2;LGALS9;CD36;CCL5;ICAM1;TIRAP;ANGPT1;FBXW7;GPNMB;MAP2K1;CCL2;BMPER;GCNT2;SPRY2;TNF;FGF2;NTRK3
prerank,positive regulation of bone resorption (GO:0045780),0.7678899543236487,1.618845801030847,0.022151898734177215,0.24023711583669322,1.0,3/11,3.05%,SPP1;TNFSF11;PRKCA
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.616439643963323,1.6156214077534197,0.011961722488038277,0.2467896756514368,1.0,16/39,13.23%,SH3KBP1;EGFR;ERRFI1;PTPN3;EGF;CDC42;PTPN18;EPS15L1;CBL;GRB2;MVP;PTPRJ;PTPN2;SPRY2;EPS15;BTC
prerank,intracellular lipid transport (GO:0032365),-0.5300031291158366,-1.615237907363092,0.017421602787456445,0.3922801201559998,1.0,3/21,1.29%,PRKAG2;PRKAA2;CERT1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6454930612228387,1.6134523074085885,0.020463847203274217,0.25058437365982855,1.0,9/27,8.81%,SNAI1;SNAI2;SPRED1;KMT5A;SPRED2;PLA2R1;ATM;EEF1E1;ATR
prerank,cellular response to mechanical stimulus (GO:0071260),0.6047568524344967,1.6131910452840137,0.0035169988276670576,0.24983220181532423,1.0,12/46,12.25%,MAP3K14;SLC9A1;CASP8AP2;CD40;CASP1;MAP2K4;PIEZO2;TLR7;IRF1;TNFRSF1A;CASP8;MAP3K2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.5276587100401686,1.6126773615250953,0.0,0.24972832232025513,1.0,57/208,17.47%,RORA;NR1H4;ROR1;ADIPOQ;MAP3K14;TRIML2;NEK6;TNIP1;STAT1;ALPK1;CD40;TNFAIP3;BIRC3;CFLAR;CASP1;REL;TLE1;TREM2;LITAF;IKBKE;SLC20A1;UNC5CL;LGALS9;NOD1;TRIM21;VAPA;TIRAP;TRIM13;TMEM106A;TRIM8;WNT5A;IRAK4;WLS;EDA2R;CXXC5;GAPDH;TNFRSF1A;CASP8;ANKRD17;RHOA;TNF;AKAP13;TANK;TRAF2;SPHK2;CX3CL1;TIFA;RIPK1;SQSTM1;PELI2;RBCK1;TRAF3IP2;LAMTOR5;TRAF5;BRD4;MAP3K3;DDX1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.544561548322775,1.612369782830612,0.005313496280552604,0.2492012252462316,1.0,30/114,16.79%,PSMA7;MAP3K14;TNFSF11;STAT1;CD40;PLVAP;JAK2;BIRC3;LIMS1;TNFRSF12A;PYDC1;PSMB8;PSMA6;FOXO3;EDA2R;TNFRSF1A;EDA;TNFRSF4;TNF;PSMF1;COMMD7;TRAF2;RIPK1;PSMA8;PSMD2;PSMD12;PSMD11;TRAF5;BAG4;PSMD14
prerank,nerve growth factor signaling pathway (GO:0038180),-0.6668537811726374,-1.6123093942620523,0.021505376344086023,0.39192585635273947,1.0,6/10,27.28%,KIDINS220;RAPGEF2;RAP1A;BDNF;MAGI2;NTF3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5898162270850434,1.612018747651182,0.008215962441314555,0.24874649642639265,1.0,13/55,8.32%,DCN;CEMIP;LUM;HSPG2;BGN;SLC9A1;GPC6;VCAN;CEMIP2;PRELP;HPSE;SDC1;SDC2
prerank,embryonic eye morphogenesis (GO:0048048),0.7672543446890644,1.6098649775098128,0.0243161094224924,0.25258270798415855,1.0,4/11,6.00%,FBN2;TBX2;FBN1;LRP6
prerank,negative regulation of cellular catabolic process (GO:0031330),0.5789705739533826,1.6088003725766316,0.004555808656036446,0.2538561385209362,1.0,12/63,5.70%,HP;DAP;EIF4G2;TIMP1;EIF4G3;NELL1;KLHL22;TREM2;STAT3;PTPN3;BCL2;FOXK2
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7358556078912551,1.6087640202867035,0.017804154302670624,0.2525860455493228,1.0,4/15,4.34%,LIPC;APOE;PLTP;ABCG1
prerank,regulation of adaptive immune response (GO:0002819),0.6924153491115936,1.6085462022480468,0.032904148783977114,0.25174796618905965,1.0,5/18,7.18%,IRF7;ADCY7;AHR;SASH3;IRF1
prerank,mesonephros development (GO:0001823),-0.6427885492610675,-1.6058812139559988,0.017543859649122806,0.4022793433367121,1.0,4/11,4.86%,ZBTB16;BMP4;FGF1;OSR1
prerank,regulation of chemokine production (GO:0032642),0.6240773162323977,1.6047015722554556,0.01734820322180917,0.26015817952875253,1.0,14/36,15.68%,TLR2;SNAI2;TSLP;TREM2;AIF1;LGALS9;EIF2AK2;TLR7;LPL;WNT5A;IL7;TNF;IL6R;HIF1A
prerank,dorsal/ventral pattern formation (GO:0009953),0.6964761057994837,1.6045723263112868,0.02653631284916201,0.2591115987054938,1.0,6/20,6.54%,GLI2;SHH;AIDA;ACVR1;SFRP1;MDFI
prerank,dopaminergic neuron differentiation (GO:0071542),0.6871351624890808,1.6045239535887803,0.03221288515406162,0.2578352393184356,1.0,3/19,6.00%,WNT2;SHH;LRP6
prerank,regulation of transmembrane transport (GO:0034762),-0.47203792368154146,-1.6043951726776877,0.02304147465437788,0.3984373193508357,1.0,9/31,7.30%,OCLN;SLC2A1;WWP2;ACTB;KCNJ2;KCNJ3;PRKCB;KCNJ13;KCNJ10
prerank,cell proliferation in forebrain (GO:0021846),0.7726408657226764,1.6041274992185657,0.03333333333333333,0.2575035007795219,1.0,4/10,12.59%,NUMBL;PCM1;CEP120;NUMB
prerank,regulation of mitotic spindle organization (GO:0060236),0.6368433372308678,1.6040985020030778,0.007407407407407408,0.2562116400315172,1.0,11/35,10.99%,CLTC;PARP3;CHMP4B;DYNC1H1;RAE1;PLK1;GPSM2;BORA;EML3;TPX2;GNAI1
prerank,negative regulation of proteolysis (GO:0045861),0.6351315494929581,1.6034277584224246,0.019975031210986267,0.2564710600084057,1.0,10/34,8.36%,KNG1;SERPINE2;LRRK2;TIMP1;DNAJC1;PTPN3;TRIM21;PLAT;BAG6;GAS1
prerank,regulation of muscle contraction (GO:0006937),-0.5065116911352241,-1.6033562712365876,0.03065134099616858,0.39341630486366735,1.0,5/26,1.98%,PLCE1;ATP1A2;CHRM2;CAV1;KCNB2
prerank,cellular response to sterol (GO:0036315),0.7413827794971981,1.6028435703363615,0.02252252252252252,0.2565548997665043,1.0,5/13,11.03%,RORA;INSIG2;LRP6;GRAMD1A;GRAMD1C
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7396400355890049,1.6016843802187928,0.022658610271903322,0.25811844709196247,1.0,3/13,4.42%,COL4A1;NRP1;SHH
prerank,negative regulation of peptidase activity (GO:0010466),0.6014811965019273,1.6015808865770946,0.004750593824228029,0.2570934744562187,1.0,11/47,11.22%,KNG1;LRP1;SERPING1;FETUB;SERPINE2;TIMP1;SERPINH1;SERPINF1;SERPINA2;GAPDH;VTN
prerank,melanocyte differentiation (GO:0030318),0.7695493752922498,1.6002246656687862,0.02564102564102564,0.25936615165524696,1.0,4/11,5.49%,ENPP1;LRMDA;MITF;SLC24A5
prerank,positive regulation of lipid storage (GO:0010884),0.6674758535606539,1.5974258154760612,0.02247191011235955,0.2651537676196535,1.0,6/21,8.76%,C3;PLIN2;IKBKE;OSBPL11;VSTM2A;LPL
prerank,bicarbonate transport (GO:0015701),-0.5118755708251244,-1.5972896733525574,0.004329004329004329,0.40340966073838347,1.0,12/25,24.46%,SLC4A10;SLC26A7;SLC39A8;CA2;CA4;SLC4A8;SLC4A3;CYB5R1;SLC26A6;CYB5R4;CYB5RL;CFTR
prerank,regulation of osteoclast differentiation (GO:0045670),0.6340336396858135,1.5957417732821477,0.022106631989596878,0.26816041828129883,1.0,6/33,4.45%,IL23R;TNFSF11;LRRC17;MAFB;CCR1;FBN1
prerank,negative regulation of hemostasis (GO:1900047),0.7506825716340222,1.5954798272085893,0.02472952086553323,0.26745156563997213,1.0,5/12,11.22%,KNG1;SERPINE2;APOE;APOH;VTN
prerank,regulation of mononuclear cell migration (GO:0071675),0.6640613598856961,1.595269153248317,0.0286493860845839,0.2666283297117089,1.0,9/23,12.29%,IL34;CMKLR1;MDK;AIF1;CCL5;MSN;BMP5;PTK2;TNF
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.710192301140228,1.595183390797342,0.03418803418803419,0.26552629595045274,1.0,10/18,15.26%,YAP1;JAK1;STAT1;JAK2;STAT3;CBL;SPI1;SRC;SMAD4;IL6R
prerank,establishment of protein localization to extracellular region (GO:0035592),0.6053906993083228,1.5938477992602218,0.019329896907216496,0.2678560830417451,1.0,11/39,13.50%,LTBP2;ABCA1;ARFGAP3;STEAP3;RAB8B;MIA3;CANX;COPG1;TMEM167A;RCN3;RAB10
prerank,embryonic digit morphogenesis (GO:0042733),0.7050682501196782,1.593788446571473,0.02346041055718475,0.2667388742852946,1.0,8/18,10.21%,GLI3;TBX2;SHH;CREBBP;HDAC1;SALL1;WDPCP;TBX3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7477484300798,1.5931630247910662,0.031055900621118012,0.26685271646215564,1.0,5/11,5.67%,TNFSF11;JAK1;PRKCA;BLK;CCL5
prerank,negative regulation of cell junction assembly (GO:1901889),0.6603117768649178,1.5930793182675156,0.022106631989596878,0.2657708940453178,1.0,14/25,19.84%,DLC1;APOD;ROBO2;TLR2;SLIT1;PTEN;TNF;ARHGAP6;SRC;PHLDB2;ITGB1BP1;ACVRL1;BCAS3;CORO1C
prerank,response to organic cyclic compound (GO:0014070),0.5962076819837938,1.5919016422003547,0.009378663540445486,0.26719992905258205,1.0,18/52,15.91%,CYP1B1;SPP1;LRRK2;STAT3;IGFBP5;ABCA2;CYP27B1;CCL5;SFRP1;GLDC;ANXA1;CYP1A1;DRD3;CCL2;TNF;STAT5B;GGT7;BGLAP
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5331203040388235,1.5918772748848233,0.003194888178913738,0.2659850172469417,1.0,26/112,15.12%,NR1H4;ADIPOQ;LBP;SPN;TLR2;TNFAIP3;JAK2;IRAK3;STAT3;ARFGEF2;LGALS9;ILRUN;LY96;PTPN6;TIRAP;TMEM106A;CD14;LPL;WNT5A;DICER1;PTPRJ;MC1R;SPHK2;PSEN1;CX3CL1;RIPK1
prerank,artery morphogenesis (GO:0048844),0.6391064543796907,1.5910923590227362,0.021573604060913704,0.26670849332765606,1.0,11/30,11.44%,LRP1;PDGFRB;NRP1;TBX2;JAG1;PKD2;NF1;ADAMTS9;HOXA1;TGFBR1;TGFB2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.536659249498985,-1.590949666386916,0.03460207612456748,0.4147731899848378,1.0,9/18,24.07%,COX16;PET100;COX18;COX14;COX17;TIMM21;BCS1L;SCO1;COA3
prerank,fatty acid transmembrane transport (GO:1902001),-0.5452148981412555,-1.5900567127022573,0.03169014084507042,0.40959936099947725,1.0,5/19,10.23%,PRKAG2;PRKAA2;SLC2A1;ABCD3;SLC27A1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6810783985987487,1.5898376278096855,0.019746121297602257,0.2686260865490885,1.0,6/21,5.97%,ADIPOQ;LRP1;TREM2;APOE;PLTP;PPARG
prerank,regulation of stem cell differentiation (GO:2000736),0.5575429847784442,1.5897926788083845,0.010893246187363835,0.26745537831553867,1.0,10/89,6.20%,PSMA7;RUNX1;KMT2A;PDGFRA;YAP1;PTN;ZFP36L2;JAG1;TCF12;EIF2AK2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.6322000019875709,1.5895230087857795,0.02102496714848883,0.2669001059739945,1.0,8/33,6.17%,ADIPOQ;APOD;TNFAIP3;IGFBP5;PTEN;AIF1;PPARG;TGFB3
prerank,positive regulation of transporter activity (GO:0032411),0.7369322212989117,1.5894362833430946,0.022488755622188907,0.2658964215986167,1.0,3/13,5.13%,KMT2A;ADIPOQ;TRPC6
prerank,response to lipid (GO:0033993),0.5441887961573412,1.5885939543939283,0.004259850905218318,0.2668601221260445,1.0,22/105,11.09%,IL23R;SPP1;LBP;ASXL1;GATA6;JAK2;RXRG;IRAK3;STAT3;ABCA2;ABCG1;LGALS9;CYP27B1;CD36;PPARG;LY96;TIRAP;ANXA1;FOXO3;HMGB2;ERBIN;TMEM161A
prerank,purine ribonucleotide transport (GO:0015868),-0.5933942660219951,-1.5884895731544997,0.036923076923076927,0.4060755630494329,1.0,5/16,8.93%,ABCC4;LRRC8D;SLC25A42;SLC25A4;ABCC6
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7417513462026811,1.5870082117332194,0.03115264797507788,0.2696314275925762,1.0,2/12,3.81%,RUNX1;BLK
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6793037230939807,1.587005776805352,0.02601156069364162,0.2683888864515966,1.0,6/18,13.74%,RUNX1;FSCN1;DDR2;EMILIN1;PDPN;SMAD3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.727224962664165,1.5866324041217352,0.03240058910162003,0.2680014304097486,1.0,4/14,9.14%,CCL7;XCL1;CCL5;WNT5A
prerank,hyaluronan catabolic process (GO:0030214),0.6773744760426773,1.5852178162403334,0.03571428571428571,0.2704636141564748,1.0,3/18,5.03%,CEMIP;SLC9A1;CEMIP2
prerank,membrane assembly (GO:0071709),0.6197376226721937,1.5851446586719629,0.02038216560509554,0.26944323803454623,1.0,8/34,6.56%,CEL;RFTN1;UGCG;FLOT2;CHMP4B;TLCD2;PTEN;VPS4A
prerank,lipoprotein transport (GO:0042953),0.7969530776409032,1.5838285430098722,0.025848142164781908,0.27141426395185664,1.0,5/10,7.08%,LRP1;VMP1;CD36;PPARG;MIA3
prerank,negative regulation of cell differentiation (GO:0045596),0.5225179143419398,1.5831059713468905,0.0010183299389002036,0.271945301847325,1.0,44/181,12.65%,RORA;ABCA1;ENPP1;ADIPOQ;COL5A2;YAP1;COL5A1;ASXL1;TNN;MEIS2;CRP;ZFP36L2;SNAI2;ZFPM2;SPRED1;WNT9A;SUFU;EGFR;MEIS1;JAG1;ABCG1;SHH;E2F1;SPRED2;PTEN;CDK6;SFRP1;PPARG;RUNX1T1;ADAMTS12;TRIO;TGFBR1;WNT5A;BMP5;TBX3;WWTR1;NEPRO;NPHP3;LDLRAD4;NBR1;CALR;SPRY2;TNF;ADAMTS7
prerank,regulation of keratinocyte differentiation (GO:0045616),0.6536719582590905,1.5821806303188128,0.02710027100271003,0.27304891531561476,1.0,6/24,7.12%,RUNX1;ZFP36L1;ERRFI1;CYP27B1;CTSK;CTSL
prerank,cellular response to lipid (GO:0071396),0.5199193383498029,1.5820799871307805,0.0,0.27215382011634714,1.0,34/191,11.96%,RORA;NR1H4;CXCL5;WNT2;SPP1;CXCL1;LBP;SBNO2;NRIP1;IRS1;TNFAIP3;WNT9A;CASP1;EGFR;MGST1;ADCY2;NUGGC;ATM;SFRP1;LY96;CD68;CXCL10;AHR;PID1;CD14;MSN;LPL;WNT5A;UBE2L3;HMGB2;CCL2;GNAI1;LCOR;RHOA
prerank,regulation of hemopoiesis (GO:1903706),0.7688535848520975,1.5808026912847484,0.03605015673981191,0.2741277130639645,1.0,4/10,5.85%,RUNX1;PTN;MAFB;CREBBP
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7662783765260872,1.5804081746384506,0.01910828025477707,0.2738099613082019,1.0,5/11,6.26%,NOS1AP;CACNA2D1;CACNB1;CAMK2D;SESTD1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6847944894661412,1.5802154649313307,0.03851640513552068,0.27305838219333955,1.0,4/18,4.23%,EDN3;PTN;XCL1;MDK
prerank,negative regulation of defense response (GO:0031348),0.552148394310623,1.5800515049877832,0.008908685968819599,0.2722640986515458,1.0,10/77,5.97%,RORA;NR1H4;ADIPOQ;TNFAIP3;IRAK3;APOE;ILRUN;MVK;TRIM21;PPARG
prerank,sulfur compound transport (GO:0072348),-0.489326160889791,-1.5795283803764173,0.025423728813559324,0.42560389967120543,1.0,8/27,10.23%,SLC13A4;ABCG2;SLC6A6;SLC26A7;LRRC8D;SLC5A6;SLC25A26;SLC27A1
prerank,endothelial cell migration (GO:0043542),0.6128328387534465,1.5783722220138052,0.015037593984962405,0.2754613143864529,1.0,8/37,6.84%,FAP;CYP1B1;STAT1;EGR3;NRP1;FSTL1;MYH9;PLXND1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5616599074959105,1.5775956540903575,0.015730337078651686,0.27618285791689867,1.0,18/70,16.79%,PSMA7;RUNX1;KMT2A;YAP1;TCF12;EIF2AK2;PSMB8;PSMA6;CBFB;PSMF1;PSMA8;ITCH;PSMD2;PRKDC;PSMD12;PSMD11;TCF3;PSMD14
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.701495332584013,1.5769344997224575,0.027220630372492838,0.276734489854364,1.0,2/16,2.90%,IL23R;XCL1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.7317552482011597,1.5757957197085222,0.03939393939393939,0.27849254819431773,1.0,6/13,9.83%,JAK1;STAT1;JAK2;STAT3;CANX;OASL
prerank,negative regulation of B cell proliferation (GO:0030889),0.7571553592058629,1.5741099622443464,0.021671826625386997,0.281516051265831,1.0,3/11,5.91%,TNFRSF21;BLK;ATM
prerank,regulation of protein autophosphorylation (GO:0031952),0.6153941818017412,1.5738217912519068,0.022443890274314215,0.2810203891766432,1.0,11/36,10.65%,ENPP1;EPHA7;ADIPOQ;TNKS1BP1;ERRFI1;RAP2A;TOM1L1;RASSF2;GPNMB;PPP2R5A;MVP
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.5119111601739895,1.573718441707213,0.0030272452068617556,0.28010283437723993,1.0,44/214,12.57%,ROR2;CCL11;ROR1;EPHA7;CCL7;ADIPOQ;PDGFRA;FBLN1;TNIP1;PDGFRB;XCL1;PRKCA;SPRED1;NRP1;EGFR;TREM2;APOE;CCR1;SPRED2;PTEN;PRKD2;LGALS9;CD36;CCL5;PTPN6;EMILIN1;ICAM1;PTPN1;TIRAP;ANGPT1;FBXW7;GPNMB;MAP2K1;CNKSR3;CCL2;PTPN2;YWHAZ;BMPER;GCNT2;SPRY2;TNF;FGF2;NTRK3;DUSP26
prerank,dopamine metabolic process (GO:0042417),-0.5538152515807747,-1.573397585199251,0.020618556701030927,0.43657720965928676,1.0,5/18,4.47%,SNCAIP;MOXD1;PRKN;MAOA;MAOB
prerank,positive regulation of calcium ion import (GO:0090280),0.7446841160056438,1.5732484717766375,0.023809523809523808,0.28011527060172575,1.0,4/12,13.14%,CXCL12;PDGFRB;CCL2;SPHK2
prerank,positive regulation of chemokine production (GO:0032722),0.5924486925800876,1.572574283362776,0.018050541516245487,0.2804595781365139,1.0,14/44,15.68%,ADIPOQ;TLR2;TSLP;AIF1;LGALS9;EIF2AK2;TLR7;TIRAP;LPL;WNT5A;IL7;TNF;IL6R;HIF1A
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.5686128335367039,-1.5720159499016233,0.048701298701298704,0.4326196172117094,1.0,7/16,12.49%,ST6GALNAC3;ST8SIA4;ST3GAL5;ST8SIA6;B4GALT6;ST8SIA2;ST6GALNAC5
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6901796801273443,1.5717974931573273,0.03784570596797671,0.28125178514765575,1.0,10/18,22.34%,MDFIC;APOD;SUFU;ILRUN;GSK3B;CTNNA1;LATS2;MFHAS1;LATS1;POLR1A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.5572841655114531,1.569899242968924,0.016816143497757848,0.285269490724314,1.0,19/73,16.79%,PSMA7;RUNX1;KMT2A;YAP1;TCF12;EIF2AK2;PSMB8;PSMA6;CBFB;PSMF1;SPI1;PSMA8;ITCH;PSMD2;PRKDC;PSMD12;PSMD11;TCF3;PSMD14
prerank,regulation of neurogenesis (GO:0050767),0.5658551550886415,1.5685619781805882,0.013793103448275862,0.28764438506454026,1.0,10/55,12.59%,CCL11;YAP1;NUMBL;PCM1;SERPINF1;BHLHE40;HEYL;HMGB2;TNF;NUMB
prerank,cholesterol efflux (GO:0033344),0.6762578780104354,1.5685274593977607,0.023709902370990237,0.2865313965123418,1.0,6/20,13.37%,ABCA1;APOE;ABCG1;SOAT1;NPC2;ABCG4
prerank,regulation of cation channel activity (GO:2001257),-0.3687582704282455,-1.5683310268638122,0.0,0.43597282391638814,1.0,23/89,11.80%,DMD;FGF12;CACNB2;CACNB4;FGF14;LRRC7;ACTN2;DLG2;ANK2;MINK1;CALM1;SLMAP;SHISA6;GRIA2;GRIA1;CACNG2;AHNAK;ANK3;SHANK1;PDE4D;APP;GRIN2B;CAMK2B
prerank,regulation of necroptotic process (GO:0060544),0.6484556678502889,1.5675606871365113,0.027359781121751026,0.28790187510673265,1.0,10/23,15.12%,ZBP1;BIRC3;FLOT2;CFLAR;OGT;CDC37;MLKL;CASP8;YBX3;RIPK1
prerank,regulation of macrophage differentiation (GO:0045649),0.7010835078488753,1.567498363829578,0.035398230088495575,0.28687267599484306,1.0,6/15,15.12%,IL34;ADIPOQ;PRKCA;PTPN2;CASP8;RIPK1
prerank,basement membrane organization (GO:0071711),0.7235668869795455,1.5661731629871625,0.02706766917293233,0.2891643779740125,1.0,6/14,8.73%,COL4A1;LAMB1;NID1;FLRT2;CTSS;PXDN
prerank,respiratory chain complex IV assembly (GO:0008535),-0.5157377923618841,-1.5658974476989138,0.026615969581749048,0.4362666995528434,1.0,11/21,26.57%,COX16;PET100;COX18;COX10;COX14;COX17;TIMM21;BCS1L;SCO1;COA3;COA6
prerank,positive regulation of synapse assembly (GO:0051965),-0.4813306548427757,-1.5641295184835218,0.016260162601626018,0.4341573722780389,1.0,19/27,29.70%,NRXN1;GRID2;IL1RAPL1;AGRN;CLSTN3;SYNDIG1;CUX2;LRRC4B;CLSTN1;SEMA4D;PTPRD;BDNF;EPHB1;NLGN1;VSTM5;SEMA4A;SLITRK2;CLSTN2;NLGN2
prerank,osteoclast differentiation (GO:0030316),0.6614594559446286,1.563999602340133,0.027472527472527472,0.2936185960925568,1.0,5/22,3.66%,SBNO2;TNFSF11;FARP2;GAB2;TREM2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7743127292376489,1.5636488117509233,0.01594896331738437,0.2932931366931224,1.0,5/10,7.37%,GHR;JAK2;STAT3;STAT5A;PTPN1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.706854795503542,1.5633852864233757,0.023494860499265784,0.2926807344806153,1.0,3/15,4.42%,IL23R;GLI3;SHH
prerank,odontogenesis (GO:0042476),0.6112153490023498,1.5623920131984665,0.016331658291457288,0.2939644195713875,1.0,9/35,11.51%,COL1A2;GLI2;LAMB1;ANKRD11;LRP6;TGFB3;HDAC1;TGFB2;EDA
prerank,lipoprotein localization (GO:0044872),0.7606413134918669,1.5618415555553913,0.03930817610062893,0.2942898617338328,1.0,5/11,7.08%,LRP1;VMP1;CD36;PPARG;MIA3
prerank,synaptic vesicle recycling (GO:0036465),0.6230792019772856,1.560847165918531,0.026455026455026454,0.2956344974108049,1.0,5/31,8.40%,CEL;STON2;OPHN1;CANX;SYT2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.72965175520055,1.5588687765364668,0.03479576399394856,0.2996633576971596,1.0,1/12,0.45%,IL23R
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5577411324052499,1.558546722090044,0.014806378132118452,0.2992405651777073,1.0,23/73,17.60%,CASP4;DLC1;DAP;CASP8AP2;JAK2;CFLAR;CASP1;BBC3;CASP12;IFT57;NOD1;PPARG;HSPE1;CASP8;TNF;TRAF2;SMAD3;BCL2L13;RIPK1;CYCS;AIFM1;HSPD1;EIF2AK3
prerank,bone development (GO:0060348),0.5988725072391299,1.5581533028133299,0.03229813664596273,0.29904728340901066,1.0,5/39,1.94%,MMP13;SULF1;SH3PXD2B;SFRP4;LRRC17
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6189118468307186,-1.557638057148994,0.038356164383561646,0.4461556570105887,1.0,5/11,12.33%,KCND3;ATP1B1;KCNJ2;KCNJ3;KCNQ1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5722673742885226,1.5564769183842706,0.0170316301703163,0.3021622840818046,1.0,16/50,15.58%,RORA;GLI3;KCTD21;SUFU;STK36;SHH;CREBBP;SFRP1;GAS1;ZIC1;IFT81;HERC4;RAB34;DLG5;SMO;MOSMO
prerank,chondroitin sulfate catabolic process (GO:0030207),0.7263089482802929,1.5561935346856182,0.04141104294478527,0.3017386729279426,1.0,3/13,2.84%,DCN;BGN;VCAN
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.5479535524279934,1.5561707076366824,0.00683371298405467,0.30061987715782335,1.0,21/74,14.44%,COL1A1;SNAI1;SPRED1;SMAD2;MDK;SPRED2;PTEN;SFRP1;TGFB3;TGFBR1;BMP5;TGFB1I1;WWTR1;PDPN;TGFB2;GCNT2;LDLRAD4;SPRY2;SMAD3;PHLDB2;SMAD4
prerank,vasodilation (GO:0042311),-0.5821726310142395,-1.5559458848096646,0.027692307692307693,0.444215758277792,1.0,6/13,21.73%,NOS3;KLF2;SOD1;GPER1;SOD2;ADRB2
prerank,secretion (GO:0046903),-0.5919986633775605,-1.5558712754617223,0.03625377643504532,0.43723895250908384,1.0,6/14,11.13%,FBLN5;SLC22A6;NPR1;SLC22A4;TPD52;RIMS1
prerank,regulation of tissue remodeling (GO:0034103),0.6723206680084466,1.5553238636594,0.035346097201767304,0.30159711657738897,1.0,5/18,8.49%,RUNX1;THBS4;MDK;DDR2;GPNMB
prerank,regulation of monocyte differentiation (GO:0045655),0.7245761264947459,1.5552465306000298,0.03627760252365931,0.3006459604582924,1.0,4/14,5.86%,IL34;ZFP36L1;IRF7;CDK6
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.7563492473004657,1.555220334845478,0.03577235772357724,0.2995443426796016,1.0,2/10,7.77%,LBP;TIRAP
prerank,cardiac muscle cell action potential (GO:0086001),-0.46343742946712607,-1.5547450125985995,0.030042918454935622,0.4331916478535501,1.0,7/30,4.05%,DMD;ATP1A2;FGF12;KCND3;ATP1B1;ANK2;KCNJ2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6928958183273993,1.554535636598044,0.04160688665710186,0.30027864361112866,1.0,5/17,8.66%,SULF1;SFRP4;FSTL1;CASK;ITGA3
prerank,neurotrophin signaling pathway (GO:0038179),-0.5085129352359598,-1.5540364613191007,0.03389830508474576,0.42825258156749724,1.0,9/21,14.90%,SORT1;KIDINS220;NTRK2;RAPGEF2;ZFYVE27;CASP3;DDIT4;RAP1A;BDNF
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.6524270676005635,1.5534547975244999,0.028112449799196786,0.3018999220367299,1.0,5/22,10.71%,RUNX1;BCL6;MDK;IRF1;CBFB
prerank,negative regulation of complement activation (GO:0045916),0.76684611702171,1.553373572553879,0.04153354632587859,0.30094653168408253,1.0,2/10,1.02%,VSIG4;SERPING1
prerank,negative regulation of coagulation (GO:0050819),0.70865467371636,1.552329784825802,0.03167420814479638,0.3027471994924486,1.0,5/14,11.22%,KNG1;SERPINE2;APOE;APOH;VTN
prerank,cellular response to interleukin-7 (GO:0098761),0.6809802797569698,1.550394453754405,0.03571428571428571,0.30578337131333694,1.0,9/17,16.59%,JAK1;IRS1;TSLP;STAT3;STAT5A;IL7;BRWD1;STAT5B;SMARCA4
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6809802797569698,1.550394453754405,0.03571428571428571,0.30578337131333694,1.0,9/17,16.59%,JAK1;IRS1;TSLP;STAT3;STAT5A;IL7;BRWD1;STAT5B;SMARCA4
prerank,positive regulation of cholesterol transport (GO:0032376),0.6282558319182068,1.5486111500272925,0.02509907529722589,0.3095238385150722,1.0,6/27,5.97%,ADIPOQ;LRP1;TREM2;APOE;PLTP;PPARG
prerank,iron ion transmembrane transport (GO:0034755),0.7401877533160288,1.548530274277635,0.047692307692307694,0.3085750557410473,1.0,2/10,2.99%,SLC39A14;SLC11A2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.7058453398129864,1.548418471384839,0.03576751117734724,0.30769435624454966,1.0,8/14,15.86%,GHR;JAK2;STAT3;STAT5A;PTPN1;PTK2;PIK3R1;STAT5B
prerank,anion transport (GO:0006820),-0.4575577971433812,-1.5478785361605791,0.018867924528301886,0.43988608298107323,1.0,7/33,7.65%,SLC13A4;ABCG2;SLC13A3;SLC26A7;LRRC8D;SLC22A6;VDAC1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.5815093066657976,1.5477022052296905,0.02784503631961259,0.3084801500961602,1.0,12/45,9.83%,MID1;JAK1;STAT1;IRF7;JAK2;CAMK2D;TRIM21;ICAM1;IRF1;TRIM8;SP100;OASL
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.6035271982111469,-1.546864169542736,0.030985915492957747,0.4362284829243581,1.0,4/12,3.53%,PCGF5;HNRNPU;YTHDC1;SMCHD1
prerank,heart process (GO:0003015),-0.5754979171380132,-1.545819420901481,0.04487179487179487,0.4328652024777145,1.0,5/14,19.70%,SGCD;SGCZ;ACE;SOD1;PPCS
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.5164156858872676,1.5457894658947784,0.003083247687564234,0.312533658251943,1.0,44/152,17.00%,PSMA7;COL1A1;ZEB2;SULF1;SFRP4;LYPD6;TLR2;LRRK2;TNFAIP3;EGFR;SMURF2;UBR5;EGF;ATP6AP2;SFRP1;FAM53B;GSKIP;CCAR2;TERT;DKK2;LRRK1;PSMB8;PSMA6;CSNK2A1;SALL1;TBL1X;WLS;DISC1;CSNK1G2;RUVBL1;ZBED3;PSMF1;DACT1;TRPM4;PTK7;PSMA8;DEPDC1B;PSMD2;PSMD12;PSMD11;TNKS2;SMARCA4;PSMD14;CSNK1D
prerank,myeloid leukocyte differentiation (GO:0002573),0.5542914221883994,1.5456324174697726,0.014925373134328358,0.31179137862241213,1.0,13/65,6.39%,RUNX1;SBNO2;TNFSF11;FARP2;GAB2;PRTN3;BATF;TREM2;MYH9;E2F1;LGALS9;PPARG;CDC42
prerank,regulation of cholesterol efflux (GO:0010874),0.6227447433535183,1.5452204469233175,0.02766798418972332,0.31168566687510874,1.0,8/30,5.97%,ADIPOQ;LRP1;TREM2;APOE;ABCA2;PLTP;SHH;PPARG
prerank,heart contraction (GO:0060047),-0.41870152305587566,-1.5451186016733847,0.016483516483516484,0.4287403053309937,1.0,5/41,1.45%,DMD;ATP1A2;SGCD;SGCZ;ATP1B1
prerank,regulation of platelet activation (GO:0010543),0.6527048035231481,1.544422942448222,0.04189944134078212,0.3126698978588532,1.0,5/21,3.81%,PDGFRA;TEC;PRKCA;APOE;BLK
prerank,iron ion transport (GO:0006826),0.5675503048164416,1.544129403375749,0.02926829268292683,0.31235291702160783,1.0,14/47,18.00%,SLC39A14;HEPH;CLTC;CP;SLC11A2;STEAP3;ATP6V1F;ATP6V1H;IREB2;ATP6V1G2;TTYH1;ATP6V1G1;ATP6V1D;REP15
prerank,NIK/NF-kappaB signaling (GO:0038061),0.5411133879153246,1.5440102914841696,0.022222222222222223,0.31150690703259265,1.0,22/72,17.74%,PSMA7;MAP3K14;BIRC3;REL;CUL1;SKP1;TIRAP;PSMB8;PSMA6;DICER1;FBXW11;PSMF1;NFKB2;TRAF2;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14;AKT1;PSMB1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.5497860870244765,-1.5439693185055154,0.03333333333333333,0.4260381313405934,1.0,10/17,31.18%,CAV1;OSR1;KLF7;AJAP1;APOLD1;PRKX;DSPP;CEACAM1;DLL1;SOX9
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.7311343711409579,1.5430738677757951,0.04404567699836868,0.31302530552905367,1.0,2/11,2.01%,CREB3L1;CREB3L3
prerank,positive regulation of cell death (GO:0010942),0.5553039947387602,1.5427238377321248,0.020737327188940093,0.3127805617994842,1.0,9/59,9.14%,MMP3;HP;HPR;LRP1;LRRK2;CD36;TRIM13;CELF1;WNT5A
prerank,lipid homeostasis (GO:0055088),0.5641105589071905,1.5392169705251904,0.019721577726218097,0.32105745495334115,1.0,16/57,14.14%,ABCA1;TREM2;APOE;USF1;ABCA2;ABCG1;TLCD2;PPARG;ADCK1;ACOX1;FBXW7;RCN3;ZBTB20;ORMDL3;ACOX3;ABHD8
prerank,macrophage activation involved in immune response (GO:0002281),0.7171484097723276,1.5391803725322333,0.043740573152337855,0.32001658203793415,1.0,3/13,3.66%,LBP;SBNO2;TREM2
prerank,regulation of neuroinflammatory response (GO:0150077),0.6588006745735538,1.5388576507957918,0.04499274310595065,0.31974219316756536,1.0,2/19,3.66%,MMP3;TREM2
prerank,epithelial tube morphogenesis (GO:0060562),0.6127136944874991,1.5386076436721805,0.027989821882951654,0.3193243057052666,1.0,7/32,5.41%,COL4A1;GLI2;SHH;PRKD2;PKD2;ACVR1;CCM2
prerank,monocyte chemotaxis (GO:0002548),0.6141780687527875,1.537671911339096,0.02577319587628866,0.3206449876144196,1.0,7/32,10.36%,CCL11;CCL7;TNFSF11;XCL1;CCL5;ANXA1;CCL2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6744017270089452,1.5374529453668677,0.033946251768033946,0.3200788291321663,1.0,9/17,11.22%,PDGFRB;CCN4;NRP1;IGFBP5;MDK;AIF1;CCL5;ADAMTS1;VTN
prerank,regulation of cellular metabolic process (GO:0031323),0.5705869642074127,1.536204607380264,0.03106332138590203,0.32244173163617806,1.0,13/45,13.96%,CYP1B1;NCOR2;ABCA2;ABCG1;TBC1D16;PID1;PANK2;SSH1;NPC2;ARF4;KIF16B;ARF1;MKLN1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.625486004089753,1.5358594527320684,0.03342245989304813,0.32226403438758033,1.0,7/28,5.67%,NR1H4;C3;ADIPOQ;NOS1AP;JAK2;MITF;CCL5
prerank,regulation of steroid biosynthetic process (GO:0050810),0.7197408402714497,1.5357831365704235,0.047987616099071206,0.32130515476187493,1.0,1/11,0.10%,NR1H4
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.711665583606325,1.534739034423017,0.048484848484848485,0.3230587612638329,1.0,5/12,12.29%,POU5F1;NCOR2;PPARG;TERT;TNF
prerank,epidermis development (GO:0008544),0.5660199022496617,1.5345553151281688,0.021101992966002344,0.3223734219447733,1.0,10/56,10.01%,COL7A1;EMP1;GATA6;FGF7;UGCG;FLOT2;SVEP1;HDAC1;ATP2A2;EDA2R
prerank,negative regulation of reproductive process (GO:2000242),0.6860819415127578,1.5326070750162673,0.03818953323903819,0.32640582016454606,1.0,5/17,12.75%,SULF1;TIMP1;PAEP;CALR;ACVR1C
prerank,lamellipodium assembly (GO:0030032),-0.47719267523801073,-1.5324716322678462,0.043478260869565216,0.454951307697084,1.0,11/26,14.21%,ABLIM1;KIT;CDH13;ABLIM3;S1PR1;CCDC88A;PTPRO;ARHGEF6;VCL;PARVB;DMTN
prerank,hyaluronan metabolic process (GO:0030212),0.6351232953010809,1.5322554531367534,0.038028169014084505,0.326249228333814,1.0,3/23,5.03%,CEMIP;SLC9A1;CEMIP2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.6477821207041103,1.5320595318835397,0.04477611940298507,0.3255599905641948,1.0,5/21,2.84%,DCN;CHSY3;BGN;CHST13;VCAN
prerank,regulation of cell size (GO:0008361),0.6427419013105067,1.5318148834002718,0.029085872576177285,0.3250539381547893,1.0,11/23,16.76%,PRR16;VAV2;VAV3;PTEN;RPTOR;MSN;RHOA;VAV1;RAC1;LAMTOR5;PLEK
prerank,positive regulation of acute inflammatory response (GO:0002675),0.7005708615747102,1.5312839892242769,0.04216867469879518,0.3253464585530125,1.0,2/14,2.01%,OSMR;CREB3L3
prerank,dendritic cell differentiation (GO:0097028),0.6400262427163519,1.5307267465223267,0.042028985507246375,0.3256543665174352,1.0,5/22,5.04%,PRTN3;BATF;TREM2;BLK;LGALS9
prerank,positive regulation of viral life cycle (GO:1903902),0.630934366298421,1.5306649251539854,0.0456989247311828,0.32470978447630494,1.0,14/22,25.84%,LGALS9;VPS4A;FMR1;CHMP2B;DDB1;TYRO3;TMPRSS2;LGALS1;KPNA2;TRIM11;TSG101;P4HB;AXL;CHMP3
prerank,positive regulation of T cell activation (GO:0050870),0.5488576053245718,1.5306337555465759,0.01726121979286536,0.3237129004561248,1.0,14/62,10.36%,IL23R;TNFSF11;CD276;ZMIZ1;FLOT2;MDK;NCK1;AIF1;LGALS9;NCK2;CCL5;ANXA1;IL7;CCL2
prerank,regulation of stem cell proliferation (GO:0072091),0.6758240251682273,1.5300444829604256,0.039660056657223795,0.32429154917558484,1.0,6/17,10.06%,FBLN1;YAP1;ZFP36L1;EIF2AK2;TERT;HMGB2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7038579131334639,1.5290937144926244,0.052316890881913304,0.32574409973339596,1.0,2/14,0.60%,CREB3L1;SULF1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6251146471520299,1.5280133863717051,0.042953020134228186,0.3273953945020626,1.0,6/24,11.09%,CXCL12;SNAI1;SNAI2;BCL2;CCAR2;TMEM161A
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.5163741079100425,1.5279420761007383,0.006289308176100629,0.326498217960236,1.0,30/124,16.12%,PSMA7;ROR2;CLTC;TCF7L2;SFRP4;PRICKLE2;FRZB;SMURF2;FZD1;SFRP1;CDC42;PRICKLE1;TNRC6B;ARHGEF19;PSMB8;PSMA6;WNT5A;SFRP5;PPP3CA;PLCB3;MOV10;RHOA;PSMF1;RAC1;AP2A2;PSMA8;SMURF1;PSMD2;PSMD12;PSMD11
prerank,protein secretion (GO:0009306),0.5526740097550656,1.5272808390230415,0.02372479240806643,0.3271346062901886,1.0,12/56,11.52%,LTBP2;ABCA1;ARFGAP3;STEAP3;RAB8B;MIA3;CANX;COPG1;ANXA1;WLS;TMEM167A;RCN3
prerank,regulation of trophoblast cell migration (GO:1901163),0.701815147382023,1.5263743438415749,0.05014749262536873,0.32837918167219626,1.0,7/14,14.20%,SYDE1;TIMP1;SMURF2;ACVR1B;CALR;ACVR1C;YTHDF3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.4375634284088186,-1.525926959199163,0.02564102564102564,0.4682935991031386,1.0,12/39,9.96%,DMD;FGF12;FGF14;SLMAP;FXYD5;WNK4;WNK3;OSR1;GPD1L;HECW1;ANK3;FXYD6
prerank,plasma membrane invagination (GO:0099024),0.6178419265402684,1.5255950716677622,0.03359173126614987,0.3294570454627852,1.0,12/29,15.63%,DOCK1;MYH9;AIF1;CD36;CDC42;SPIRE1;SNX18;SNX33;SNX9;RHOA;MSR1;FCGR1A
prerank,negative regulation of bone remodeling (GO:0046851),0.7244005925590329,1.525157360864529,0.05196850393700787,0.32952282686496226,1.0,6/11,17.17%,TNFAIP3;SFRP1;TMEM119;UBASH3B;P2RX7;GPR137
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.704221099459539,1.5244124105959913,0.0695266272189349,0.3304994188746554,1.0,4/14,4.99%,ADIPOQ;LRP1;IGFBP5;AIF1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6917171905703512,1.5228798291647803,0.0669710806697108,0.3334397595005515,1.0,6/13,8.81%,SPRED1;SPRED2;PLA2R1;ATM;EEF1E1;ATR
prerank,cellular defense response (GO:0006968),0.5842497248337387,1.5221575404006251,0.029484029484029485,0.3344072155965655,1.0,4/40,5.98%,IL1RL2;LBP;SPN;LY96
prerank,manganese ion transport (GO:0006828),0.7039175340659869,1.5220350171922874,0.05069124423963134,0.33366650026472583,1.0,3/14,5.13%,SLC39A14;SLC11A2;TRPC6
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.5279400465322615,1.5219803893309949,0.019933554817275746,0.33275201273180216,1.0,16/88,7.60%,IGF2BP1;KNG1;IGF2BP2;SERPINE2;SYNCRIP;DNAJC1;NELL1;APOE;ILF3;IGFBP5;EIF2AK2;PLAT;BAG6;CAPRIN1;GIGYF2;SAMD4A
prerank,camera-type eye morphogenesis (GO:0048593),0.7287299978029756,1.5213043672000204,0.05825242718446602,0.3335178538356321,1.0,4/10,6.00%,TENM3;TBX2;NF1;LRP6
prerank,negative regulation of angiogenesis (GO:0016525),0.5380946870370513,1.521206252958992,0.015102481121898598,0.33268529219880794,1.0,22/84,12.29%,COL4A2;DCN;CREB3L1;SULF1;HSPG2;SPARC;THBS4;STAT1;THBS2;SPRED1;APOH;PPARG;CXCL10;EMILIN1;SERPINF1;ADAMTS1;ADAMTS9;SEMA3E;TGFB2;PTPRM;SPRY2;TNF
prerank,negative regulation of cell population proliferation (GO:0008285),0.4939949876580071,1.5205863087382012,0.001002004008016032,0.33328596337566946,1.0,61/351,11.44%,ROR2;GLMN;FAP;CYP1B1;COL18A1;DLC1;RUNX3;CXCL1;IGFBP7;APOD;FBLN1;TNN;SFRP4;TNFAIP3;GATA6;JAK2;NELL1;WNT9A;CDKN2B;TREM2;FRZB;IGFBP5;E2F1;ALDH1A2;PTEN;AIF1;PKD2;NF1;MORC3;CYP27B1;NCK2;NF2;STRN;CDK6;SFRP1;PPARG;TGFB3;EIF2AK2;PTPN6;PDS5B;PINX1;IRF1;ADAMTS1;CDK10;EEF1E1;FRK;CELF1;BTG1;GPNMB;MAP2K1;WNT5A;SFRP5;BMP5;TGFB1I1;TBX3;RERG;PTPRJ;KLF10;PTPN2;PDPN;TGFB2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5888604677390351,1.5200246558436423,0.03178484107579462,0.33381097679695937,1.0,15/36,20.64%,CASP4;ZBP1;CASP1;TSLP;CXCR4;WNT5A;IL7;TRIM44;UBE2K;RIPK1;HIF1A;CD300LF;IRGM;TRIM6;PARP14
prerank,vasculogenesis (GO:0001570),0.6026299704920736,1.519225647292351,0.045859872611464965,0.33505180907688314,1.0,7/32,5.41%,GLMN;ITGB8;PDGFRB;SPRED1;SHH;ADM;CCM2
prerank,regulation of B cell differentiation (GO:0045577),0.6649920013662259,1.5187108601193817,0.05588235294117647,0.3354965196166367,1.0,4/17,5.95%,MMP14;ZFP36L1;ZFP36L2;SFRP1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.5055910230658017,1.5186158577607882,0.004098360655737705,0.3347161393124983,1.0,46/158,17.47%,ROR1;ADIPOQ;MAP3K14;TRIML2;NEK6;ALPK1;CD40;BIRC3;CFLAR;CASP1;REL;LITAF;IKBKE;SLC20A1;UNC5CL;LGALS9;NOD1;TRIM21;VAPA;TIRAP;TRIM13;TMEM106A;TRIM8;IRAK4;WLS;EDA2R;CXXC5;GAPDH;TNFRSF1A;CASP8;ANKRD17;RHOA;TNF;AKAP13;TRAF2;CX3CL1;TIFA;RIPK1;PELI2;RBCK1;TRAF3IP2;LAMTOR5;TRAF5;BRD4;MAP3K3;DDX1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6056954418044751,1.5186078843999835,0.03367875647668394,0.3336763691104372,1.0,7/27,9.14%,WNT2;PDGFRA;E2F1;DDR2;CDK6;S100A6;WNT5A
prerank,negative regulation of inflammatory response (GO:0050728),0.501932778037811,1.5185550250901085,0.004106776180698152,0.3328262906453516,1.0,21/182,6.53%,RORA;MC5R;NR1H4;ADIPOQ;IAPP;GPR176;GPR39;TNFAIP3;ADCY7;TREM2;APOE;RXFP2;MDK;MYH9;ADCY2;PTGDR;ADM;MVK;ADCYAP1R1;PPARG;GLP2R
prerank,digestive tract development (GO:0048565),0.598560139419736,1.517673103983633,0.049479166666666664,0.334210917211618,1.0,12/32,15.46%,GLI2;CLMP;GLI3;RARB;GATA6;EPHB3;SALL1;TGFB2;TNF;NPY;NIPBL;SMO
prerank,B cell proliferation (GO:0042100),0.6550594967380823,1.5164187182827509,0.059880239520958084,0.33649373474534117,1.0,6/17,17.09%,CD40;BCL2;MS4A1;CTPS1;PTPRC;HSPD1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6437035753628507,-1.5162230710036453,0.04935064935064935,0.4921366518037339,1.0,3/10,11.35%,BMP6;NEXMIF;NOTCH4
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5774217589448838,1.5160659439068735,0.026022304832713755,0.3363685864907751,1.0,8/40,10.16%,LBP;CRP;TLR2;RNASE7;MPEG1;TIRAP;HMGB2;GBP7
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5362760942093289,1.5143661700871631,0.023411371237458192,0.3397284800356327,1.0,15/68,13.14%,LBP;IL16;TLR2;TSLP;STAT3;AIF1;LGALS9;TLR7;RAB7B;TIRAP;TMEM106A;LPL;WNT5A;TNF;SPHK2
prerank,cellular protein catabolic process (GO:0044257),0.5412627913208691,1.514244678373087,0.02304147465437788,0.33902150603753195,1.0,18/59,15.12%,FAP;CLTC;MYLIP;CTSS;SIAH2;CTSK;CTSL;ADAMTS12;RAB7A;CAPN2;PSMA6;CTSB;CASP8;CTSC;ADAMTS7;CTSW;AP2A2;RIPK1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.5208098509960688,1.5141773880763993,0.014130434782608696,0.33817067243004945,1.0,16/95,10.36%,CXCL5;CXCL1;LBP;SBNO2;TLR2;TNFAIP3;CASP1;NUGGC;LY96;CD68;CXCL10;TIRAP;CD14;WNT5A;HMGB2;CCL2
prerank,sulfate transport (GO:0008272),-0.5543759574430455,-1.5140337100552166,0.07033639143730887,0.4924043392135726,1.0,3/14,1.78%,SLC13A4;SLC26A7;SLC26A2
prerank,cytoskeleton organization (GO:0007010),0.5083432312690035,1.5138662982025968,0.005279831045406547,0.33782811327028145,1.0,29/114,14.73%,CCL11;CCL7;KRT25;PALLD;RND3;SH3KBP1;FMNL2;MAST4;TNFAIP3;SIPA1L3;MARK1;APOE;FMNL3;MDK;RHOD;FGD4;ABI2;MAST2;WDPCP;BRWD1;CCL2;PDZD8;ZMYM4;FGD6;RHOA;CFAP410;WTIP;RANBP9;RAC1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6844444702821383,1.513837128471893,0.0547112462006079,0.3368513833031478,1.0,5/15,8.76%,PLIN2;TREM2;OSBPL11;PPARG;LPL
prerank,regulation of axon guidance (GO:1902667),0.7370617565348104,1.5130398527139526,0.0732899022801303,0.3379929660790381,1.0,5/10,13.33%,MYCBP2;NRP1;ZSWIM6;ZSWIM8;ZSWIM4
prerank,lipoprotein biosynthetic process (GO:0042158),0.7222218506320127,1.5127528235016998,0.06583072100313479,0.3376883494540275,1.0,6/11,16.47%,WIPI1;UGCG;APOE;ATG7;WDR45;PIK3C3
prerank,postreplication repair (GO:0006301),-0.41757950416138534,-1.5120503972462103,0.005291005291005291,0.49178420515966553,1.0,32/45,35.18%,WDR33;UBE2A;MSH2;UBE2V2;UBC;UBE2B;UBE2N;POLD3;PCNA;NSMCE1;FAAP20;RFC3;UBA52;POLH;PARP10;USP10;POLD2;RPA2;UBE2V1;PRIMPOL;BRCA1;PCLAF;RFC4;ZBTB1;POLD4;RFC2;DTL;RPA3;POLK;USP43;SPRTN;RFC5
prerank,response to molecule of bacterial origin (GO:0002237),0.5314286999647985,1.5109349759073458,0.021181716833890748,0.3415535227281078,1.0,15/69,15.89%,IL23R;LBP;TNFAIP3;JAK2;IRAK3;LGALS9;CYP27B1;LY96;TIRAP;CD14;HMGB2;ERBIN;C4B;TRIB1;GGT7
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6145757905509548,1.5104877820651499,0.046296296296296294,0.34174466851536567,1.0,5/27,2.84%,DCN;CHSY3;BGN;CHST13;VCAN
prerank,hematopoietic stem cell proliferation (GO:0071425),0.7203454651233603,1.5102432700170059,0.06269592476489028,0.34136047731406105,1.0,2/11,1.08%,RUNX1;ETV6
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5045078387940304,1.5101406588957846,0.007376185458377239,0.340621587089837,1.0,35/128,15.51%,RUNX2;LTBP2;COL1A2;COL3A1;ITGB5;ZMIZ1;SMAD2;USP9X;SMURF2;ACVR1;HIVEP1;TGFB3;INHBB;RNF111;CBL;TGFBR1;SMAD5;BMP5;TGFB1I1;ACVR1B;PTK2;TGFB2;GCNT2;TGFBRAP1;ACVR2A;RHOA;ACVR1C;SMAD3;BMP7;SRC;ARHGEF18;SMAD4;LRRC32;SMAD1;SMURF1
prerank,synaptic vesicle endocytosis (GO:0048488),0.5996890669114936,1.5091292977718735,0.047865459249676584,0.3423480392560428,1.0,8/33,10.49%,CEL;STON2;ITSN1;OPHN1;DNAJC6;CANX;SYT2;GAK
prerank,regulation of focal adhesion assembly (GO:0051893),0.5591824546141042,1.508588946420699,0.027777777777777776,0.34277008107118595,1.0,23/54,18.77%,DLC1;GPM6B;APOD;MAP4K4;SLC9A1;PEAK1;NRP1;PTEN;LIMS1;SFRP1;EFNA5;PTPRJ;PTK2;RHOA;ARHGAP6;SRC;PHLDB2;RAC1;ITGB1BP1;ACVRL1;PTPRA;BCAS3;COL16A1
prerank,steroid catabolic process (GO:0006706),0.7373790592063103,1.507727832027951,0.051036682615629984,0.34399179017289633,1.0,3/10,8.79%,SPP1;CYP27B1;HSD11B1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.6352388041132483,1.5073620724903312,0.044755244755244755,0.34397459682165116,1.0,3/23,5.04%,NR1H4;XCL1;LGALS9
prerank,cellular response to interleukin-1 (GO:0071347),0.5003509266264247,1.5071560990646755,0.004162330905306972,0.34346934727265654,1.0,36/143,17.74%,PSMA7;CCL11;CCL7;CD40;IL1R1;XCL1;IRAK3;CUL1;NOD1;CCL5;SFRP1;IRAK2;ADAMTS12;SKP1;MAPK11;PSMB8;PSMA6;IRAK4;PELI3;CCL2;FBXW11;PSMF1;ADAMTS7;TANK;CX3CL1;PSMA8;HIF1A;PSMD2;RBMX;PSMD12;SQSTM1;PSMD11;PELI2;PSMD14;MAP3K3;PSMB1
prerank,negative regulation of protein polymerization (GO:0032272),-0.4743144083940271,-1.506811973855159,0.0411522633744856,0.5014528414933399,1.0,14/27,23.29%,MAP2;EML2;KANK3;CDH5;HIP1R;TWF2;KANK4;STMN2;PFN1;SLIT2;TWF1;TUBB4A;STMN1;SSH3
prerank,retinol metabolic process (GO:0042572),0.6867406079335041,1.5061894727689438,0.05325443786982249,0.345040912151623,1.0,4/14,9.08%,CYP1B1;RDH12;RDH10;CYP1A1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.540959042140089,1.5060512246324753,0.015367727771679473,0.3444511017363066,1.0,19/75,11.91%,COL4A2;DCN;SULF1;HSPG2;SPARC;THBS4;STAT1;THBS2;SPRED1;APOH;PPARG;CXCL10;EMILIN1;SERPINF1;ADAMTS1;SEMA3E;TGFB2;PTPRM;SPRY2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6627434228545739,1.505835844934807,0.060085836909871244,0.342979215099977,1.0,10/16,19.84%,DLC1;APOD;PTEN;ARHGAP6;SRC;PHLDB2;ITGB1BP1;ACVRL1;BCAS3;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6627434228545739,1.505835844934807,0.060085836909871244,0.342979215099977,1.0,10/16,19.84%,DLC1;APOD;PTEN;ARHGAP6;SRC;PHLDB2;ITGB1BP1;ACVRL1;BCAS3;CORO1C
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.6207274045089681,1.5056421087148446,0.04032258064516129,0.34243048392096415,1.0,15/25,19.61%,STAT1;STAT3;ARNT;MAPK11;FOXO3;HMGB2;ACVR1B;ACVR2A;BRD1;HIF1A;STAT5B;PRKDC;ETS1;INHBA;MED1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.7089006386506872,1.5041206714066881,0.05582137161084529,0.3455223115251524,1.0,5/13,10.04%,FBN2;FSTL1;FBN1;LTBP1;GREM2
prerank,positive regulation of chemotaxis (GO:0050921),0.5723187751576966,1.5039690781895065,0.03799019607843137,0.3449307634980556,1.0,12/43,12.55%,EDN3;PTN;PDGFRB;XCL1;NRP1;TREM2;MDK;AIF1;PRKD2;DSCAM;FGF2;NTRK3
prerank,negative regulation of endopeptidase activity (GO:0010951),0.5560576345628772,1.5022043520581392,0.03411764705882353,0.3485097996679844,1.0,10/47,11.22%,KNG1;SERPING1;FETUB;SERPINE2;TIMP1;SERPINH1;SERPINF1;SERPINA2;GAPDH;VTN
prerank,neuromuscular process controlling balance (GO:0050885),-0.5766624109329987,-1.5007227658949023,0.054285714285714284,0.5143289403126903,1.0,4/12,9.93%,PCDH15;NRXN1;SHANK1;CLN3
prerank,actin filament depolymerization (GO:0030042),-0.6093852433814266,-1.4995372991631644,0.06940874035989718,0.5112753185553781,1.0,7/11,25.67%,GSN;MICAL3;TWF2;MICAL1;CFL1;TWF1;WDR1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.5506912709809529,1.499393018125098,0.03368176538908246,0.35512172624036564,1.0,19/54,16.30%,CASP4;ADIPOQ;TNFAIP3;BIRC3;CFLAR;CASP1;PYDC1;PELI3;TNFRSF1A;PTPN2;CASP8;TNF;NLRP2B;UBE2K;TRAF2;RIPK1;CCDC3;RBCK1;TRAIP
prerank,sodium ion transport (GO:0006814),-0.36601367684571334,-1.4993409346731998,0.011494252873563218,0.505216073578397,1.0,17/85,11.47%,ATP1A2;ATP1B3;SLC12A2;SLC6A6;SLC24A2;ATP1B1;SLC6A9;SCN2A;SLC6A1;SLC6A12;SLC8A3;SLC9B2;SLC5A6;SCN8A;SLC4A8;SCN9A;SLC5A5
prerank,regulation of B cell apoptotic process (GO:0002902),0.6873433514459434,1.4990224622877109,0.07109737248840804,0.3550494458988658,1.0,5/12,13.03%,BCL6;BLK;NOC2L;FNIP1;ORMDL3
prerank,retinoid metabolic process (GO:0001523),0.5319087689936035,1.4987605500587857,0.017937219730941704,0.35471919550024605,1.0,12/71,9.08%,CYP1B1;LRP1;HSPG2;GPC6;APOE;ALDH1A2;RDH12;SDC1;RDH10;SDC2;LPL;CYP1A1
prerank,cellular response to organic cyclic compound (GO:0071407),0.5018919731236928,1.4985626249776123,0.008273009307135471,0.354320570808083,1.0,26/141,12.90%,RORA;NR1H4;CYP1B1;PDE3A;SPP1;PDXP;ZFP36L1;NRIP1;LRRK2;EGFR;IGFBP5;ADCY2;PKD2;CCL5;SFRP1;AHR;MSN;CYP1A1;UBE2L3;HRH1;SSH1;CCL2;GNAI1;LCOR;TNF;P2RX7
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.63799523770526,1.4984682531635098,0.06536856745479833,0.3535797323938309,1.0,5/20,12.48%,CREB3L1;SULF1;PRKD2;SPRY2;FGF2
prerank,cellular response to inorganic substance (GO:0071241),0.6418267337670834,1.498121027242554,0.040446304044630406,0.3535912686780057,1.0,5/21,14.28%,MMP3;DDX11;TIMELESS;ATRX;FMR1
prerank,endocrine system development (GO:0035270),0.6316686647501357,1.4978681627422141,0.058333333333333334,0.35321956552067657,1.0,6/21,9.20%,GLI2;MDK;NF1;FOXE1;TGFBR1;SALL1
prerank,negative regulation of platelet activation (GO:0010544),0.6656712916094849,1.4976658223413788,0.06784660766961652,0.352794970755217,1.0,4/16,8.25%,PDGFRA;SERPINE2;APOE;ADAMTS18
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6195606626780426,1.4974565406665967,0.042091836734693876,0.3524391627742854,1.0,7/27,8.76%,ABCA1;ADIPOQ;CRP;ABCG1;CD36;PPARG;LPL
prerank,negative regulation of protein processing (GO:0010955),0.7107343132320232,1.4973017752405673,0.07451564828614009,0.35190690464898383,1.0,3/12,8.36%,SERPINE2;LRRK2;GAS1
prerank,acute-phase response (GO:0006953),0.7064009316800213,1.4960126286601234,0.06220095693779904,0.3542995170714625,1.0,4/12,15.26%,LBP;CRP;IL22;IL6R
prerank,positive regulation of inflammatory response (GO:0050729),0.5183870649555975,1.4951164547329585,0.01829924650161464,0.35567982586387864,1.0,25/86,19.00%,ZBP1;LBP;OSMR;TNIP1;IL16;CREB3L3;TLR2;CCN4;TSLP;MDK;TLR7;PLA2G7;LPL;WNT5A;TNFRSF1A;NFKBIZ;TNF;ABCC1;CX3CL1;RIPK1;SNX4;ETS1;AGT;NFKBIA;IL17RA
prerank,Notch signaling pathway (GO:0007219),0.5341738867539141,1.4947870702646702,0.02306805074971165,0.3555739573087225,1.0,20/59,15.59%,DTX4;SNAI1;STAT1;SNAI2;MAML3;JAG1;MDK;CREBBP;GMDS;MIB1;PLXND1;HEYL;MAML2;DTX2;GALNT11;MAML1;PSEN1;DTX3L;PSENEN;ITCH
prerank,regulation of response to interferon-gamma (GO:0060330),0.6864064241711951,1.4945036650336117,0.04915514592933948,0.3553178282893979,1.0,5/14,11.00%,JAK1;STAT1;JAK2;CDC37;PTPN2
prerank,intracellular sterol transport (GO:0032366),0.6729701587143156,1.4920694953049272,0.0747800586510264,0.3608731737787597,1.0,5/13,11.20%,ABCA1;ABCG1;VPS4A;NPC2;RELCH
prerank,connective tissue development (GO:0061448),0.5896602255528577,1.4918859387442631,0.03625,0.3603575342277446,1.0,8/35,9.08%,SULF1;ITGB8;SH3PXD2B;COL11A2;SOX5;ARID5B;CREB3L2;TRIP11
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6692433944671579,1.4916276723435644,0.06485671191553545,0.3600423285792982,1.0,6/16,11.09%,CXCL12;SNAI1;SNAI2;CCAR2;FBH1;TMEM161A
prerank,cellular response to leucine starvation (GO:1990253),-0.6373549599587174,-1.4913100232686014,0.06382978723404255,0.5251561888704404,1.0,6/10,17.67%,SESN2;GCN1;SESN3;RRAGB;IMPACT;RRAGD
prerank,relaxation of muscle (GO:0090075),-0.5630714633847123,-1.488309156766069,0.05235602094240838,0.528519645227917,1.0,4/13,4.05%,ATP1A2;ATP1B1;GSN;KCNJ2
prerank,regulation of cellular senescence (GO:2000772),0.6063523625452066,1.4881414417531995,0.045112781954887216,0.36849998801291156,1.0,14/28,21.87%,NEK6;NUAK1;AKT3;CDK6;EEF1E1;NEK4;TERT;YPEL3;CGAS;MAP3K3;FBXO5;HMGA2;YBX1;RSL1D1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.5057680778464264,-1.4874726794518538,0.03900709219858156,0.524544722814675,1.0,6/18,19.28%,FCHSD2;KIF1B;DTNA;TBC1D24;CHRNB1;ERC1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.7018531131464638,1.4867250773986176,0.06708268330733229,0.3715327065944193,1.0,4/11,15.12%,IL34;PRKCA;CASP8;RIPK1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4577034685847013,-1.486425872695244,0.05714285714285714,0.5215534754559379,1.0,10/29,15.71%,SORBS1;LDLR;SCARB1;LPGAT1;ELOVL5;CREBL2;SLC27A1;GPLD1;SLC45A3;MFSD2A
prerank,negative regulation of neurogenesis (GO:0050768),0.5839922725805685,1.486282660465973,0.044929396662387676,0.3717913552219217,1.0,7/34,12.29%,CCL11;PTN;PTEN;NF1;PCM1;RHOA;TNF
prerank,apical junction assembly (GO:0043297),-0.39930351732419656,-1.4861466217818633,0.01910828025477707,0.5161586779155367,1.0,16/53,19.16%,OCLN;PECAM1;CLDN5;ESAM;CDH5;RAMP2;APC;PARD3;VCL;PATJ;CLDN11;CLDN14;CLDN1;PARD6G;AFDN;RAB13
prerank,regulation of endothelial cell proliferation (GO:0001936),0.5131086380395603,1.4859855270613784,0.025081788440567066,0.371568401690492,1.0,25/88,12.48%,CCL11;SULF1;SPARC;THBS4;STAT1;EGR3;PRKCA;NRP1;APOE;NR2F2;AKT3;PRKD2;NF1;APOH;EGF;STAT5A;ARNT;AIMP1;ANGPT1;TGFBR1;WNT5A;HMGB2;PTPRM;VEGFC;FGF2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.582423243282135,1.4857586963162703,0.03612903225806452,0.3711211439243619,1.0,7/35,5.75%,CYP1B1;BCL3;GHR;JAK2;NF2;CCL5;EGF
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.600726132473951,1.4850808410630738,0.053475935828877004,0.3719535632217437,1.0,7/29,13.32%,RUNX1;YAP1;DNAAF4;CARM1;CBFB;UBA5;DDRGK1
prerank,regulation of cardiac conduction (GO:1903779),-0.39779969938487236,-1.484197515268577,0.014598540145985401,0.5165055039262892,1.0,20/54,20.53%,ATP1A2;ATP1B3;ATP1B1;ANK2;ITPR2;ATP2B4;ATP2B2;SLC8A3;ABCC9;NPR1;ITPR3;DMPK;FXYD6;ATP2A3;STIM1;FXYD1;TRPC1;SLC8A2;ACE2;TMEM65
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5202236902121389,1.484056487644373,0.022650056625141562,0.3738586497672709,1.0,17/69,15.12%,LBP;SPN;TLR2;JAK2;STAT3;ARFGEF2;LGALS9;LY96;TIRAP;TMEM106A;CD14;LPL;WNT5A;PTPRJ;SPHK2;PSEN1;RIPK1
prerank,dermatan sulfate metabolic process (GO:0030205),0.6915495680559106,1.4832477943597882,0.05530642750373692,0.37523701679446686,1.0,3/13,2.84%,DCN;BGN;VCAN
prerank,positive regulation of growth (GO:0045927),0.5309635557772882,1.4831294710651097,0.03793103448275862,0.3745395716384392,1.0,15/64,9.19%,RFTN1;MMP14;EIF4G2;KLHL22;EGFR;FXN;BCL2;PABIR1;INO80;SFRP1;CDC42;RPTOR;EXOSC4;TGFBR1;CSNK2A1
prerank,mitochondrial fission (GO:0000266),-0.5274151062817384,-1.482969597929295,0.07278481012658228,0.514204736270113,1.0,10/16,31.77%,DNM3;PRKN;GDAP1;DNM1L;DNM2;MTFR1L;MFF;MTFR2;OPA1;MTFP1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.7183240602692709,1.4828777602884196,0.08398133748055987,0.37316685789245213,1.0,2/10,2.06%,CLTC;MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.7183240602692709,1.4828777602884196,0.08398133748055987,0.37316685789245213,1.0,2/10,2.06%,CLTC;MYLIP
prerank,glycine metabolic process (GO:0006544),0.6948038417869306,1.4828534555951551,0.06269592476489028,0.3722510478755065,1.0,4/12,10.40%,SDSL;AMT;GLDC;GCAT
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.62575019894418,1.4823936509587783,0.05867014341590613,0.3726044257307777,1.0,8/24,18.91%,EPHA7;NF1;FBXW7;FOXO3;TGFB2;TNF;ATF4;PRNP
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4893661537289991,1.4821389778672587,0.009202453987730062,0.3723173007592145,1.0,32/161,12.58%,PSMA7;RBMS3;BICC1;NKD2;TCF7L2;TNN;SFRP4;KREMEN1;TBX18;GLI3;IGFBP4;SNAI2;TLE1;APOE;FRZB;MDK;SFRP1;LRP6;PRICKLE1;SIAH2;DKK2;PSMB8;PSMA6;WNT5A;HDAC1;SFRP5;WWTR1;NPHP3;DRAXIN;GSK3B;CSNK1A1;PSMF1
prerank,negative regulation of cell migration (GO:0030336),0.5000170377890604,1.4816940499202362,0.011603375527426161,0.3724843252773014,1.0,35/137,14.97%,CYP1B1;DLC1;COL3A1;ADIPOQ;SULF1;LRP1;TNN;TIMP1;DPYSL3;MITF;NAV3;IGFBP5;JAG1;SHH;PTEN;NF1;NF2;SFRP1;RAP2A;SRGAP1;EPHA1;MIA3;FOXO3;PTPRJ;PTPN23;LDLRAD4;CALR;FGF2;ACVR1C;DLG5;STK24;PHLDB2;RAC1;CX3CL1;TRIB1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5263458054603299,1.4814715319466203,0.031638418079096044,0.37209361370620225,1.0,15/66,8.41%,RUNX3;SULF1;SPARC;STAT1;SNAI2;CDKN2B;APOE;NR2F2;CASK;NF1;APOH;CDK6;SFRP1;AIMP1;FBXW7
prerank,positive regulation of MAPK cascade (GO:0043410),0.4809858786607702,1.4813863353295602,0.0010141987829614604,0.371332911185209,1.0,46/245,12.55%,ROR2;CCL11;ROR1;CCL7;IL34;PDGFRA;EDN3;MID1;IAPP;TAOK1;TNFSF11;LRRK2;CD40;PDGFRB;XCL1;PRKCA;NRP1;EGFR;TREM2;APOE;CCR1;PRKD2;LGALS9;CD36;CCL5;EGF;EIF2AK2;ICAM1;TAOK3;PIK3R5;TIRAP;ANGPT1;TMEM106A;FBXW7;GPNMB;MAP2K1;CCL2;FGFR1;PTPRJ;BMPER;TGFB2;GCNT2;SPRY2;TNF;FGF2;NTRK3
prerank,response to cholesterol (GO:0070723),0.6453950295053836,1.481287514564218,0.06804733727810651,0.3706165464558457,1.0,7/17,15.46%,SMAD2;ABCA2;LRP6;GRAMD1A;TGFBR1;GRAMD1C;SMO
prerank,positive regulation of macrophage migration (GO:1905523),0.6436886275421024,1.481251773923391,0.04929577464788732,0.3697483930137601,1.0,8/19,17.06%,IL34;CMKLR1;TREM2;MDK;CCL5;PTK2;CX3CL1;MAPK1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6998266631244694,1.4811776764737647,0.05743740795287187,0.3689998039175192,1.0,9/12,22.60%,NCOR2;SFRP1;PIAS2;HEYL;HDAC1;SMARCA4;ZBTB7A;FOXP1;NCOR1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6839902411827503,1.4810663822613526,0.08133971291866028,0.3683591711220975,1.0,4/13,5.75%,MGAT5;JAK2;TSLP;EGF
prerank,regulation of angiogenesis (GO:0045765),0.4920563224672205,1.4806672478300675,0.006103763987792472,0.3684775790253984,1.0,45/192,12.48%,RUNX1;CYP1B1;COL4A2;DCN;SULF1;ITGB8;HSPG2;SPARC;THBS4;ADAM12;STAT1;RHOJ;THBS2;CD40;TNFAIP3;GATA6;PRKCA;SPRED1;HK2;PRKD2;CEMIP2;NF1;ANGPTL4;APOH;SFRP1;PPARG;CXCL10;EPHA1;EMILIN1;PLXND1;SERPINF1;SASH1;ADAMTS1;BTG1;GPNMB;SP100;WNT5A;RNH1;SEMA3E;BMPER;TGFB2;PTPRM;SPRY2;VEGFC;FGF2
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.7251960103034135,1.4802648479962301,0.05547226386806597,0.36863518209745466,1.0,3/10,4.35%,ENPP1;ADIPOQ;ERRFI1
prerank,positive regulation of secretion (GO:0051047),-0.5933893677515325,-1.4799836417524357,0.059782608695652176,0.5174048168965169,1.0,3/11,11.60%,NPR1;GPLD1;ACSL3
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6364426749014535,1.4799007407529003,0.059154929577464786,0.36865431715697444,1.0,5/19,10.71%,RUNX1;IRAK2;WNT5A;LIFR;CBFB
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4959523455451955,1.4798201284536368,0.013771186440677966,0.36792086712634037,1.0,24/113,10.06%,CCL11;LAMB1;YAP1;TCF7L2;THBS4;PTN;JAML;LAMC1;EGR3;FGF7;PRKCA;NRP1;EGFR;MDK;AKT3;PRKD2;EGF;SFRP1;STAT5A;ARNT;TGFBR1;WNT5A;BMP5;HMGB2
prerank,Notch signaling involved in heart development (GO:0061314),0.7016819075240377,1.4796267340085696,0.059654631083202514,0.36748878298982385,1.0,5/11,11.10%,SNAI1;SNAI2;JAG1;HEYL;GALNT11
prerank,epithelial structure maintenance (GO:0010669),-0.5972968054080029,-1.479516056083715,0.06842105263157895,0.5128832630264124,1.0,2/11,3.81%,RBP4;CXADR
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6634981111549408,1.4793868636333274,0.06344827586206897,0.36718763001992055,1.0,9/16,14.77%,SEC16B;LRRK2;MIA3;VAPA;GBF1;SEC16A;TAPT1;DDRGK1;HSPA5
prerank,positive regulation of protein processing (GO:0010954),0.643575194927588,1.4789661948774744,0.061452513966480445,0.3674041599350163,1.0,4/19,6.24%,CCBE1;NKD2;MYH9;ENO1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.6920887530997526,1.4784377002513578,0.07761194029850746,0.3678809114494788,1.0,6/12,11.96%,CXCL12;SPN;AIF1;CCL5;CXCL10;RHOA
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5013531026724977,1.4782468757389557,0.007399577167019027,0.3674116322603953,1.0,35/129,17.00%,PSMA7;COL1A1;ZEB2;SFRP4;LYPD6;LRRK2;EGFR;SMURF2;UBR5;EGF;ATP6AP2;SFRP1;FAM53B;GSKIP;CCAR2;DKK2;LRRK1;PSMB8;PSMA6;TBL1X;WLS;CSNK1G2;RUVBL1;ZBED3;PSMF1;DACT1;TRPM4;PTK7;PSMA8;PSMD2;PSMD12;PSMD11;TNKS2;PSMD14;CSNK1D
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.6828267488380968,1.4778297055851848,0.07922272047832586,0.36761813931762516,1.0,8/13,21.11%,PIK3AP1;TLR7;IRAK2;IRAK4;PIK3R4;PIK3C3;UNC93B1;TNIP2
prerank,lymphocyte proliferation (GO:0046651),0.6150328862572544,1.4777775208329504,0.06318681318681318,0.3668381085733108,1.0,9/22,17.09%,CD40;ELF4;BCL2;MSN;MS4A1;CTPS1;TNFRSF4;PTPRC;HSPD1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3514282901381375,-1.4776654488814485,0.0,0.5128235016586927,1.0,48/87,29.53%,IMMP2L;COX16;NDUFS1;NDUFAF5;NDUFAF4;ECSIT;NDUFV2;NDUFA13;NDUFAF2;NDUFA6;DMAC2;PET100;COX18;NDUFA12;UQCC2;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;COX14;NDUFB7;NDUFS3;NDUFA1;COX17;NDUFC2;FOXRED1;TIMM21;SAMM50;BCS1L;SDHAF4;NDUFA10;SCO1;NDUFS2;UQCRFS1;LYRM7;TMEM126B;NDUFB11;SLC25A33;COA3;NUBPL;UQCC3;CHCHD4;SDHAF2;NDUFS5;NDUFAF8;TIMMDC1;NDUFV1;NDUFAF6
prerank,regulation of B cell proliferation (GO:0030888),0.5515183818581163,1.477522108469395,0.042735042735042736,0.3665483510118622,1.0,11/44,11.94%,TNFRSF21;CD40;VAV3;BLK;BCL2;ATM;AHR;SASH3;TIRAP;IL7;TNFRSF4
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5488311470671061,-1.477122324756815,0.0660377358490566,0.508700238928618,1.0,4/14,8.04%,KIT;SEMA7A;MAVS;CAMK4
prerank,regulation of DNA biosynthetic process (GO:2000278),0.588230627072906,1.4768338301012742,0.06422018348623854,0.3674753760931739,1.0,7/27,8.43%,ADIPOQ;PDGFRB;PRKD2;ATM;TOM1L1;PINX1;SMG6
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.7040625070144177,1.476766787619114,0.07301587301587302,0.36675564911093944,1.0,1/10,0.26%,HP
prerank,protein processing (GO:0016485),0.5106899426896864,1.4767361127384242,0.017316017316017316,0.3659086050541355,1.0,15/102,9.03%,CASP4;HP;HPR;MMP14;ADAM19;STOML2;CASP1;FXN;KLK2;CTSS;CPXM1;OMA1;CTSL;MMP16;OGT
prerank,endoderm development (GO:0007492),0.6908324066129296,1.4762821885174917,0.08630952380952381,0.36612601730703,1.0,3/13,3.00%,LAMC1;DUSP2;DUSP5
prerank,cellular response to nitrogen compound (GO:1901699),0.6374314106301391,1.4761052943262067,0.05722070844686648,0.3656475205034182,1.0,5/20,14.28%,NR1H4;DDX11;TIMELESS;ATRX;FMR1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6276741489338596,1.4760502236713497,0.07832167832167833,0.36486053929403184,1.0,4/20,4.96%,NR1H4;APOE;ABCA2;EPHX2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7039334974182464,1.4759256735956496,0.06172839506172839,0.36428335789463734,1.0,3/12,2.84%,DCN;BGN;VCAN
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5402670487167635,1.475642866966865,0.031578947368421054,0.36415021383970075,1.0,19/59,18.36%,MAP3K14;BCL3;TLR2;BIRC3;REL;LY96;TLR7;IRAK2;CD14;TNFRSF1A;TNF;TANK;TRAF2;TIFA;RIPK1;RELB;RBCK1;AKT1;NFKBIA
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6139146123479748,1.4755575657020885,0.05922865013774105,0.3634436003722525,1.0,8/25,14.06%,GLMN;NRP1;EGFR;CCL5;EGF;DSCAM;PSEN1;SRC
prerank,proteolysis (GO:0006508),0.48160147814865745,1.4728149055637427,0.0010070493454179255,0.369890532761127,1.0,55/252,15.14%,MMP3;FAP;CASP4;MMP2;OLR1;MMP14;ADAM19;PRTN3;CASP1;ANPEP;SUFU;CPQ;XPNPEP1;CTSD;CTSS;BMP1;CPXM1;HTRA3;CAPN5;PLAT;CTSK;LACTB;CTSL;ADAMTS12;CAPN2;NPEPPS;CPA6;CAPN15;ADAMTS9;MMP16;HTRA4;PSMA6;OGT;ENPEP;TBL1X;NLN;PGPEP1L;CTSB;PAPPA2;SENP6;CASP8;CTSC;MMP15;ADAMTS7;SPG7;SPPL3;DPP7;CTSW;LVRN;FBXO2;PSEN1;HTRA1;XPNPEP3;DPP8;PSENEN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5793779410381424,1.4725293963099981,0.05,0.36986033186304346,1.0,5/32,10.28%,CXCL5;CXCL1;RNASE7;CXCL10;GAPDH
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6458593602044642,1.472527790971047,0.08111888111888112,0.3689540946767751,1.0,2/18,1.07%,LBP;SBNO2
prerank,defense response to tumor cell (GO:0002357),0.7322170326391104,1.47107727061282,0.0629800307219662,0.37201677221455975,1.0,2/10,1.46%,RBMS3;DLEC1
prerank,regulation of calcium ion import (GO:0090279),0.6204747148055161,1.4709873581401425,0.0796221322537112,0.3713395359153061,1.0,9/21,21.38%,CXCL12;PDGFRB;PKD2;EGF;CCL2;SPHK2;PRNP;PSEN2;TRIM27
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.7284363623202403,1.4698660322731876,0.07570977917981073,0.373404517744237,1.0,2/10,2.74%,CYP1B1;SNAI2
prerank,positive regulation of response to external stimulus (GO:0032103),0.4973207889444216,1.4686208672219094,0.01050420168067227,0.37580999451392133,1.0,28/128,12.43%,ZBP1;TNIP1;PTN;IL16;TLR2;PDGFRB;CCN4;PRKCA;TSLP;TREM2;USF1;MDK;PUM1;AIF1;APOH;CCL5;LY96;TLR7;SASH1;PLA2G7;LPL;WNT5A;OASL;TNFRSF1A;ANKRD17;NFKBIZ;TNF;POLR3D
prerank,regulation of endopeptidase activity (GO:0052548),0.5306676769261189,1.4686156108067487,0.028735632183908046,0.3749027945129255,1.0,19/59,18.42%,KNG1;SERPING1;FETUB;SERPINE2;TIMP1;BIRC3;SERPINH1;SERPINF1;PSMB8;SERPINA2;HDAC1;GAPDH;VTN;SERPINB8;PSENEN;AKT1;PICALM;AGT;TIMP2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5223998645246694,-1.4677823554888678,0.07165109034267912,0.5321759447902193,1.0,6/15,17.80%,PIK3CB;HIP1R;BMP2K;WASL;DAB2;SNAP91
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5550324734816559,-1.4667989228290987,0.06629834254143646,0.5290057180105772,1.0,3/13,1.45%,ATP1A2;ATP1B3;ATP1B1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5662435010538216,1.4667639645408024,0.05105853051058531,0.3789184684563188,1.0,19/35,19.61%,ZFP36L1;STAT1;MAFB;STAT3;CDK6;ARNT;MAPK11;FOXO3;HMGB2;ACVR1B;ACVR2A;SPI1;BRD1;HIF1A;STAT5B;PRKDC;ETS1;INHBA;MED1
prerank,negative regulation of wound healing (GO:0061045),0.5910345204020461,1.4663401616477292,0.0707482993197279,0.37911138731577226,1.0,10/28,14.32%,KNG1;SERPINE2;APOE;CASK;PTEN;APOH;VTN;TNF;FGF2;PHLDB2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3725464191445546,-1.4662265410873927,0.02631578947368421,0.5248917434501177,1.0,23/57,22.90%,DLGAP1;LRRC7;ACTN2;DLG2;MINK1;SHISA6;DLGAP2;GRIA2;GRIA1;CACNG2;SHANK1;APP;GRIN2B;CAMK2B;LYNX1;CACNG7;SHISA7;RELN;NLGN1;NPTXR;MEF2C;SHISA9;CACNG8
prerank,hexose metabolic process (GO:0019318),0.5631575098188918,1.465855241975677,0.051533742331288344,0.37946095478630504,1.0,14/39,19.71%,ADIPOQ;APOD;AKR1A1;OMA1;GALK2;ADPGK;GALK1;KHK;CHST1;GAA;PMM2;SORD;CHST15;DCXR
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5831846138197055,1.4653925947549118,0.04935064935064935,0.3798112978869118,1.0,10/29,14.20%,ZBP1;PTPN6;IFNAR2;PTPN1;ABCE1;WNT5A;CDC37;PTPN2;UBE2K;YTHDF3
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6044413264670835,1.4649607795457582,0.06858710562414266,0.3800398934054066,1.0,6/24,8.59%,CXCL12;CCR1;AIF1;CCL5;CXCL10;PLA2G7
prerank,body fluid secretion (GO:0007589),-0.5362431367816732,-1.464911909851346,0.07120743034055728,0.5231960289175582,1.0,6/15,21.75%,NPR1;ERBB4;SLC22A4;GPAT4;SLC22A2;PRLR
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5830288772730883,1.4647734468805387,0.06777493606138107,0.3795707153573763,1.0,14/32,16.80%,DLC1;APOD;MAP4K4;JAG1;CASK;PTEN;NF2;SEMA3E;ARHGAP6;SRC;PHLDB2;ITGB1BP1;RASA1;ACVRL1
prerank,negative regulation of signal transduction (GO:0009968),0.47798913172441965,1.464739691642415,0.0,0.3787526102941505,1.0,64/249,15.60%,ENPP1;DCN;CREB3L1;ADIPOQ;SULF1;APOD;LRP1;MMP14;NKD2;ASXL1;SFRP4;GLI3;KCTD21;LRRK2;IRS1;TNFAIP3;SNAI2;SUFU;EGFR;TLE1;IRAK3;TAX1BP3;FRZB;IGFBP5;NCK1;PTEN;BCL2;ACVR1;PIP4K2A;CCL5;EGF;SFRP1;SIAH2;NXN;MDFI;EMILIN1;PTPN18;ADAMTS12;PTPN1;PID1;FBXW7;BRAP;CSNK2A1;CSNK2A2;SFRP5;BMP5;RPS6KB1;PTPRJ;PTPN2;SOCS5;CALR;SPRY2;TNF;NLRP2B;FGF2;UBASH3B;HERC4;DACT1;CX3CL1;TRIB1;SMPDL3B;EGFL7;MOSMO;NEDD4
prerank,negative regulation of cell motility (GO:2000146),0.49975736359388223,1.462065256422001,0.02572347266881029,0.38508368178173497,1.0,19/108,7.08%,CYP1B1;DLC1;ADIPOQ;SULF1;FBLN1;DPYSL3;MITF;NAV3;IGFBP5;JAG1;SHH;PTEN;NF1;NF2;SFRP1;RAP2A;SRGAP1;EPHA1;MIA3
prerank,cellular response to amyloid-beta (GO:1904646),0.5718836140158798,1.4617037344884989,0.061946902654867256,0.3852878736086,1.0,8/35,6.91%,CASP4;CACNA1A;LRP1;CACNA2D1;TREM2;CACNB1;CD36;ICAM1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.506375723353164,-1.4612708165718864,0.06418918918918919,0.5293195669353693,1.0,10/18,24.83%,DDX19B;NUP133;ZC3H11A;HHEX;POLDIP3;NUP93;SARNP;MCM3AP;ENY2;DDX25
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7013036715362237,1.4603229676459115,0.07898894154818326,0.38824413857355233,1.0,2/10,4.89%,GFPT2;HK2
prerank,generation of neurons (GO:0048699),0.48501545750674796,1.4595882128541935,0.006141248720573183,0.38937956021771025,1.0,34/190,12.48%,RUNX1;RUNX2;WNT2;RUNX3;YAP1;DNAAF4;LRP12;MDGA1;AUTS2;NRP1;NAV1;WNT9A;ADGRL3;MARK1;BHLHE22;USP9X;SHH;ACSL4;ASTN2;OPHN1;FZD1;CDK6;BHLHE40;HEYL;SH3RF1;MAP2K1;WNT5A;HMGB2;DISC1;FGFR1;NEUROD6;TGFB2;NIF3L1;FGF13
prerank,negative regulation of immune response (GO:0050777),0.4852239455086992,1.4591804418784255,0.012526096033402923,0.3895649458061979,1.0,18/154,6.53%,MC5R;COL3A1;IAPP;GPR176;GPR39;TNFAIP3;ADCY7;IRAK3;TREM2;RXFP2;MYH9;ADCY2;PTGDR;ADM;ILRUN;ADCYAP1R1;TRIM21;GLP2R
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6629925670555263,1.4584512335487148,0.0844062947067239,0.3907255757049549,1.0,5/15,12.29%,XCL1;IRAK3;TGFB3;TGFB2;TNF
prerank,chloride transport (GO:0006821),-0.35893316365464606,-1.4570333030268505,0.009523809523809525,0.5371758775489082,1.0,18/74,9.76%,SLC12A2;SLC4A10;SLC12A7;SLC26A7;GABRA2;GABRB1;GLRA3;GABRG3;SLC1A1;SLC12A6;SLC6A1;GABRA5;CLCN2;GLRA1;CLCN3;GABRB2;ANO3;SLC4A8
prerank,regulation of keratinocyte proliferation (GO:0010837),0.6040544295173877,1.456691420318522,0.07015130674002751,0.3946271360369129,1.0,5/22,4.28%,ZFP36L1;FGF7;SNAI2;MDK;CASK
prerank,regulation of signal transduction (GO:0009966),0.4768842226285834,1.4565703626190223,0.008171603677221655,0.394028394264106,1.0,37/190,11.29%,RORA;RUNX1;ADIPOQ;SULF1;MDFIC;IGFBP7;RGS16;LRRK2;TIMP1;IGFBP4;UGCG;TREM2;IGFBP5;NCK1;ACVR1;CD36;NCK2;CREBBP;DTNBP1;IRAK2;LLGL1;PTPN1;GSKIP;GAS1;ITGA3;BRAP;SP100;OGT;ZIC1;LIFR;TSPEAR;WWTR1;CBFB;PTPN2;SOCS5;GALNT11;IFT81
prerank,lamellipodium organization (GO:0097581),-0.4360860975101031,-1.4562922719764966,0.06167400881057269,0.5335805669121753,1.0,12/29,14.21%,ABLIM1;KIT;CDH13;ABLIM3;S1PR1;CCDC88A;PTPRO;ARHGEF6;WASF1;VCL;PARVB;DMTN
prerank,regulation of cholesterol storage (GO:0010885),0.6551290649542052,1.4560285067461507,0.07280832095096583,0.39454496770087083,1.0,5/15,8.76%,ABCA1;TREM2;ABCG1;PPARG;LPL
prerank,regulation of cell differentiation (GO:0045595),0.4814854221656449,1.456024735991268,0.01752577319587629,0.39363242789540376,1.0,25/148,11.01%,RUNX1;RUNX2;TRPS1;RUNX3;EDN3;ZFP36L1;BCL6;ST7;MAFB;SNAI2;FLOT2;MDK;NREP;SHH;CEBPD;NF1;CREBBP;CDK6;EIF2AK2;DDX17;FADS1;TGFBR1;FGFR1;CBFB;PTK2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5176841743443984,1.4558538815925468,0.046565774155995346,0.39329443779237677,1.0,13/63,9.53%,IL23R;CD276;CD40;VAV3;NCK1;BCL2;AIF1;NCK2;CCL5;SASH3;TIRAP;ANXA1;IL7
prerank,regulation of oxidoreductase activity (GO:0051341),0.6763396619650224,1.4553702117313019,0.0811232449297972,0.39377118636448305,1.0,1/13,0.26%,HP
prerank,cellular response to oxygen-containing compound (GO:1901701),0.47101308662712416,1.4553371013871568,0.0,0.3929377329300983,1.0,41/291,10.36%,RORA;MMP3;NR1H4;PDE3A;CXCL5;WNT2;CXCL1;LBP;PDGFRA;SBNO2;PDXP;ZFP36L1;NRIP1;TLR2;IRS1;TNFAIP3;WNT9A;CASP1;EGFR;IGFBP5;PKD2;NUGGC;CPEB1;ATM;SFRP1;LY96;CD68;CXCL10;AHR;PID1;CAPN2;RPTOR;TIRAP;CD14;RRAGC;LPL;WNT5A;IP6K2;SSH1;HMGB2;CCL2
prerank,sodium ion transmembrane transport (GO:0035725),-0.3496606540859848,-1.455190566715091,0.027777777777777776,0.5317679641658124,1.0,17/84,10.98%,ATP1A2;ATP1B3;SLC12A2;SLC6A6;SLC24A2;ATP1B1;SLC9A2;SLC6A9;SCN2A;SLC6A1;SLC6A12;SLC8A3;SCN8A;SLC4A8;SCN9A;SLC9A6;SLC9A7
prerank,regulation of establishment of cell polarity (GO:2000114),-0.5127318334565878,-1.4548208069394184,0.0673076923076923,0.5273325913889171,1.0,6/16,14.77%,KRIT1;CDH5;GSN;SHTN1;RACK1;RIPOR2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5072095935689985,1.454737358283475,0.03160270880361174,0.3936372850302453,1.0,17/73,15.12%,LBP;SPN;TLR2;JAK2;STAT3;ARFGEF2;LGALS9;LY96;TIRAP;TMEM106A;CD14;LPL;WNT5A;PTPRJ;SPHK2;PSEN1;RIPK1
prerank,tube closure (GO:0060606),0.5666236474362731,1.4545950579456701,0.05822784810126582,0.39315642784441657,1.0,6/31,6.41%,DLC1;DEAF1;MTHFR;MTHFD1L;LRP6;PRICKLE1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5527684192066155,1.4540589956702186,0.049689440993788817,0.3937277660529281,1.0,17/43,20.71%,RUNX2;FBN2;YAP1;CCN4;NELL1;DDR2;ACVR1;TMEM119;WWTR1;ACVR2A;BMP7;IL6R;FBXO5;LRP5;CTNNBIP1;BMPR1A;IL6ST
prerank,protein localization to kinetochore (GO:0034501),-0.5499262352633869,-1.4539987082104069,0.08708708708708708,0.5245276130741159,1.0,10/14,34.14%,RCC2;ZWILCH;IK;BUB3;CENPT;KNL1;TTK;ZW10;MTBP;SPDL1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6401557392731922,1.4539679427638892,0.0818452380952381,0.3931036056930987,1.0,6/16,10.88%,PDGFRA;PDGFRB;NRP1;PLAT;PTPN1;PTPRJ
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6065951472494457,-1.4533152793083903,0.08064516129032258,0.5213558781154739,1.0,6/10,22.19%,GABRA2;GABRG3;GABRA5;GABRB2;GABRG1;GABRE
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7087130892848397,1.45327003298794,0.08745874587458746,0.3932005696146625,1.0,6/10,12.96%,MPG;ASCC3;FTO;ALKBH5;ALKBH1;MGMT
prerank,DNA dealkylation (GO:0035510),0.7087130892848397,1.45327003298794,0.08745874587458746,0.3932005696146625,1.0,6/10,12.96%,MPG;ASCC3;FTO;ALKBH5;ALKBH1;MGMT
prerank,neural tube closure (GO:0001843),0.5589117544515981,1.4527662059584792,0.057571964956195244,0.39367349922026434,1.0,6/34,6.41%,DLC1;DEAF1;MTHFR;MTHFD1L;LRP6;PRICKLE1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5150301516914523,1.452451029133294,0.0327313769751693,0.39365660328019636,1.0,22/72,14.06%,ROR2;ROR1;DCN;PDGFRA;PDGFRB;JAK2;TREM2;CCL5;EGF;PTPN6;PIK3AP1;PIK3R5;CBL;FGFR1;PTK2;TGFB2;UNC5B;TNF;FGF2;NTRK3;PIK3R1;SRC
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5325933584356062,1.4523253709475394,0.05889281507656066,0.3931138249390299,1.0,25/51,22.90%,GAS7;MAP4K4;TAOK1;LRRK2;MAP1S;DTNBP1;TAOK3;DCLK1;TRIO;DICER1;DBN1;NRK;DBNL;SNX2;ANKRD27;BMP7;ALS2;CTTN;ATP7A;EPB41L3;NYAP1;PAK1;CNTNAP1;SNX1;PLXNB1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.5039423295329353,1.4519972850888783,0.03614457831325301,0.39312370102097877,1.0,24/87,15.51%,LTBP2;COL1A2;COL3A1;ITGB5;ZMIZ1;SMAD2;USP9X;ACVR1;TGFB3;CBL;TGFBR1;SMAD5;PTK2;TGFB2;GCNT2;TGFBRAP1;RHOA;SMAD3;SRC;ARHGEF18;SMAD4;LRRC32;SMAD1;SMURF1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.5015353816993607,-1.4516402302050186,0.04153354632587859,0.5215265645800461,1.0,8/17,20.66%,ALK;SORL1;GPLD1;BSCL2;PDE3B;MFSD2A;ADRA2A;PRKAA1
prerank,regulation of glucose metabolic process (GO:0010906),0.5608178224630651,1.451516129919474,0.05443037974683544,0.3935187246322529,1.0,4/34,5.70%,RORA;ADIPOQ;IRS1;FOXK2
prerank,regulation of catabolic process (GO:0009894),0.6261709070693778,1.4514421773023327,0.06872370266479663,0.3928303368435701,1.0,1/18,0.09%,FAP
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7242031928316919,1.451404448148172,0.08240887480190175,0.39203482662138095,1.0,3/10,4.98%,DCN;LRRK2;BCL2
prerank,cellular response to interleukin-6 (GO:0071354),0.6023674899230418,1.4512771654203307,0.06964520367936924,0.39156591820356823,1.0,12/26,15.26%,SBNO2;YAP1;JAK1;STAT1;JAK2;STAT3;PID1;CBL;SPI1;SRC;SMAD4;IL6R
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6894726984808439,1.4512589074591387,0.0864,0.39074707929549685,1.0,6/11,21.11%,RFTN1;COLEC12;CASP8;RIPK1;UNC93B1;TNIP2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6508318377739222,1.4508248845588476,0.07871720116618076,0.3911429991203181,1.0,3/15,2.84%,DCN;BGN;VCAN
prerank,glucose metabolic process (GO:0006006),0.5281364343467697,1.450766775481436,0.03699421965317919,0.3904288810745624,1.0,8/58,10.28%,SLC39A14;ADIPOQ;APOD;AKR1A1;OMA1;ENO1;ADPGK;GAPDH
prerank,copper ion transport (GO:0006825),0.7023825661260835,1.450654649699692,0.08103975535168195,0.38981557527174016,1.0,4/11,5.77%,STEAP4;SLC11A2;STEAP2;STEAP3
prerank,peptidyl-asparagine modification (GO:0018196),0.5727141268495016,1.4501851306998386,0.055341055341055344,0.3901837393979526,1.0,12/31,15.84%,MGAT5;B4GALNT2;ST6GAL1;DDOST;ALG5;UGGT2;STT3A;LMAN1;UBE2J1;NUDT14;TUSC3;RPN1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6325369809062487,1.4498667949900144,0.06725146198830409,0.3901388429230923,1.0,6/17,14.53%,MID1;TAOK1;EIF2AK2;TAOK3;TGFB2;PDCD10
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6716135746998817,1.449537169703259,0.07057057057057058,0.390161813345593,1.0,5/14,11.01%,IL34;CMKLR1;MDK;CCL5;PTK2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5292760188190618,1.4492172231878493,0.043580683156654886,0.39018693323110437,1.0,15/53,18.32%,MC5R;HTR1D;CCR1;HRH4;ANXA1;HRH1;CCL2;LPAR3;CALCRL;MC1R;HRH3;NPY;MC2R;AGT;HTR1B
prerank,cellular response to peptide (GO:1901653),0.5323041258347664,1.448807236181274,0.051643192488262914,0.3904163021099018,1.0,16/56,14.06%,CASP4;CACNA1A;LRP1;ZFP36L1;CACNA2D1;TREM2;CACNB1;NOD1;CD36;DDX11;ICAM1;TIMELESS;GSK3B;ABCC1;PSEN1;SRC
prerank,primary neural tube formation (GO:0014020),0.5695299987824463,1.4484510935043728,0.057692307692307696,0.39047212469319875,1.0,6/30,6.41%,DLC1;DEAF1;MTHFR;MTHFD1L;LRP6;PRICKLE1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5770592030094159,1.4483075236049228,0.057441253263707574,0.3899664971557627,1.0,12/30,15.84%,MGAT5;B4GALNT2;ST6GAL1;DDOST;ALG5;UGGT2;STT3A;LMAN1;UBE2J1;NUDT14;TUSC3;RPN1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6257506112476178,1.4479954366628998,0.07024793388429752,0.3898713502199839,1.0,6/20,5.67%,LRP1;PDGFRB;CCN4;NRP1;IGFBP5;CCL5
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6074077459021442,1.447677535850846,0.0739247311827957,0.38994803044512505,1.0,7/24,9.03%,TRPS1;SOX5;SNAI2;WNT9A;MDK;ADAMTS12;TGFBR1
prerank,oligosaccharide metabolic process (GO:0009311),-0.39922514463848424,-1.4463442421052146,0.01694915254237288,0.5323741890332806,1.0,8/46,3.39%,ST3GAL6;ST6GALNAC3;AMY1C;AMY1B;AMY1A;ST8SIA4;FUT9;ST3GAL4
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.6600218161210769,1.4458869150125329,0.07868383404864092,0.39397162371514677,1.0,4/15,5.97%,ADIPOQ;IRS1;ADM;PPARG
prerank,L-amino acid transport (GO:0015807),0.5808284612666157,1.445380074543775,0.08047493403693931,0.3944956717466453,1.0,3/28,1.81%,SLC7A2;SLC1A3;SLC38A3
prerank,cilium movement (GO:0003341),0.5321977400778207,1.4440077651269083,0.04733009708737864,0.3972954835602177,1.0,9/47,13.37%,TEKT4;CFAP251;DNAAF4;SPEF2;DNAH9;DNAH11;TTC29;ODAD1;DNAAF5
prerank,positive regulation of hormone secretion (GO:0046887),0.6474350367278396,1.4438280708987468,0.08683068017366136,0.3969074647448372,1.0,2/17,1.15%,SPP1;EDN3
prerank,negative regulation of ossification (GO:0030279),0.6007386270058093,1.4437311793841674,0.07537012113055182,0.3963273293283144,1.0,5/23,9.33%,ENPP1;MDK;CCR1;SFRP1;CHSY1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5586173209351556,1.4435839286723267,0.07231920199501247,0.3958507701165595,1.0,9/39,12.48%,COL4A1;GLI2;NRP1;SHH;PKD2;LRP6;SALL1;SEMA3E;FGF2
prerank,positive regulation of histone methylation (GO:0031062),0.604502219888309,1.4435719503849154,0.061598951507208385,0.3950363881052133,1.0,8/24,15.02%,KMT2A;AUTS2;PHF1;OGT;DNMT3B;RIF1;SMAD4;PAXIP1
prerank,actin filament bundle assembly (GO:0051017),0.5732926136016615,1.4435391585535695,0.05911949685534591,0.3942758178630634,1.0,11/33,8.76%,PDXP;MYO1B;DPYSL3;CALD1;FSCN1;LIMA1;BAIAP2;AIF1;RHOD;ADD2;LCP1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.6887247723943292,1.443315006896817,0.10252365930599369,0.3940446797362436,1.0,5/11,18.40%,TNFAIP3;TREM2;TIRAP;PJA2;MFHAS1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5192034629980695,1.4428513842936055,0.04982618771726535,0.3944942728597935,1.0,3/61,1.11%,PSMA7;NR1H4;NCOR2
prerank,macrophage activation (GO:0042116),0.5564899390101986,1.442841170631422,0.0688360450563204,0.39367883774215584,1.0,9/34,14.73%,LBP;SBNO2;JAK2;TREM2;AIF1;TMEM106A;CRTC3;TNF;CX3CL1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6919393705499691,1.4425986091229195,0.0887218045112782,0.3934894888752813,1.0,3/11,6.77%,PARP8;PARP3;PARP11
prerank,response to endoplasmic reticulum stress (GO:0034976),0.4894227123683093,1.442421801762666,0.023554603854389723,0.39312342674460166,1.0,25/107,14.77%,CASP4;CREB3L1;THBS4;GORASP2;CREB3L3;ERN2;PDIA3;BBC3;NCK1;ITPR1;BCL2;BAG6;ERLEC1;CREB3L2;NIBAN1;ATP2A2;SEC16A;UBA5;RCN3;GSK3B;TRAF2;PIK3R1;DDRGK1;TRIB3;HSPA5
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5901708405547722,1.4419971447231608,0.06797385620915032,0.39338754445819857,1.0,10/28,17.65%,CASP4;ERN2;BBC3;ITPR1;BCL2;BAG6;TRAF2;TRIB3;AIFM1;ATF4
prerank,sterol metabolic process (GO:0016125),0.5166139893972055,1.441896846410762,0.055872291904218926,0.3928744993572709,1.0,6/60,4.34%,CYP1B1;CYP7B1;ABCA1;INSIG2;APOE;ABCG1
prerank,intracellular cholesterol transport (GO:0032367),0.6448197495891201,1.4411046553566214,0.09183673469387756,0.3941017450101905,1.0,6/15,11.20%,ABCA1;ABCG1;LRP6;VPS4A;NPC2;RELCH
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4728583888474567,1.4406895533155395,0.0010111223458038423,0.39438790241541677,1.0,49/248,12.58%,PSMA7;RBMS3;COL1A1;ZEB2;BICC1;NKD2;TCF7L2;SFRP4;KREMEN1;GLI3;LYPD6;LRRK2;IGFBP4;SNAI2;EGFR;TLE1;APOE;FRZB;MDK;SMURF2;UBR5;EGF;ATP6AP2;SFRP1;LRP6;CDK14;PRICKLE1;SIAH2;FAM53B;GSKIP;CCAR2;DKK2;LRRK1;PSMB8;PSMA6;WNT5A;HDAC1;SFRP5;TBL1X;WLS;WWTR1;NPHP3;DRAXIN;CSNK1G2;RUVBL1;ZBED3;GSK3B;CSNK1A1;PSMF1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.36683421621590107,-1.440649417351865,0.017094017094017096,0.5450274306597057,1.0,19/63,9.76%,SLC12A2;SLC12A7;SLC20A2;SLC26A2;GABRA2;GABRB1;GLRA3;GABRG3;SLC1A1;SLC12A6;SLC6A1;GABRA5;SLC5A6;GLRA1;CLCN3;XPR1;GABRB2;ANO3;SLC4A8
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5816132908797804,1.439750970171495,0.06809078771695594,0.3962387586258308,1.0,9/27,9.78%,TNIP1;TLR2;IRAK3;CD36;LY96;IRAK2;TIRAP;CD14;IRAK4
prerank,defense response to virus (GO:0051607),0.49671575778592114,1.4395939412182883,0.02682403433476395,0.39582664914147997,1.0,25/100,16.09%,ZBP1;MAP3K14;STAT1;TLR2;IRF7;CD40;BCL2;SHFL;EIF2AK2;CXCL10;TLR7;IRF1;IFNAR2;ABCE1;EXOSC4;MLKL;OASL;SETD2;MOV10;ATG7;AKAP1;RNASE1;TRIM56;RTP4;CGAS
prerank,mesoderm formation (GO:0001707),0.6336503948740371,1.4387297774229018,0.09026798307475317,0.39723160335247965,1.0,4/17,8.66%,SNAI1;ITGA8;SMAD2;ITGA3
prerank,regulation of sensory perception of pain (GO:0051930),-0.5789614791063885,-1.4381598326391392,0.09018567639257294,0.547495640206554,1.0,8/11,33.84%,MGLL;ZFHX2;CCN3;TMEM100;ATPSCKMT;ACP3;SPX;F2R
prerank,regulation of fibroblast proliferation (GO:0048145),0.5393691278489914,1.4373558005623122,0.043478260869565216,0.4002740938459541,1.0,10/45,9.14%,WNT2;PDGFRA;E2F1;DDR2;NF1;MORC3;CDK6;SFRP1;S100A6;WNT5A
prerank,regulation of interleukin-10 production (GO:0032653),0.5389659739341601,1.4371679776838642,0.051533742331288344,0.399941137948518,1.0,6/44,5.04%,IL23R;TNFRSF21;XCL1;TSLP;STAT3;LGALS9
prerank,negative regulation of cell adhesion (GO:0007162),0.5070076001480812,1.4366213580873926,0.04161979752530934,0.40056564342487555,1.0,26/72,17.01%,CYP1B1;KNG1;FBLN1;SPN;B4GALNT2;SNAI2;PLXNC1;JAG1;MDK;NF2;PLXND1;MIA3;ARHGDIG;ANGPT1;PLXNA3;PTK2;DSCAM;GCNT2;RHOA;TGFBI;CX3CL1;ITGB1BP1;RASA1;ARHGDIA;ACVRL1;PTPRC
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.6832411448561442,1.436470846114988,0.0974124809741248,0.4001699969490982,1.0,3/11,8.59%,LIPC;ABCG1;PLA2G7
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5432466332132168,1.4363616255240053,0.04389086595492289,0.3996218713579659,1.0,12/49,12.81%,RUNX1;KMT2A;RBBP5;CNOT4;RAB7B;TNRC6B;HDAC1;HMGB2;CBFB;KMT2E;MOV10;KMT2B
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.51608038104084,-1.4360193702015165,0.09003215434083602,0.5487609283083323,1.0,8/16,23.69%,RANBP3L;PLCB1;AKIRIN1;IGFBP3;RIPOR2;BOC;MEF2C;MAPK14
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3963942860244235,-1.4358510112912328,0.04819277108433735,0.5441556539659014,1.0,15/44,16.50%,ATP1B3;ATP1B1;ACTN2;AKAP6;ANK2;WNK4;KCNJ2;WNK3;KCNJ3;KCNJ10;KCNQ1;KCNJ12;KCNN2;KCNN3;WNK2
prerank,response to lipopolysaccharide (GO:0032496),0.48126517366490473,1.4355119491151667,0.01993704092339979,0.40121019249813733,1.0,22/138,11.96%,CXCL5;IL23R;CXCL1;LBP;SBNO2;TNFAIP3;JAK2;CASP1;IRAK3;LGALS9;NUGGC;CYP27B1;LY96;CD68;CXCL10;TIRAP;CD14;WNT5A;HMGB2;CCL2;ERBIN;RHOA
prerank,response to axon injury (GO:0048678),0.6373645802009341,1.4343584961956901,0.08860759493670886,0.40348158522414973,1.0,4/18,4.38%,APOD;DPYSL3;TREM2;NREP
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.6238040332542041,1.4343500605666204,0.0700280112044818,0.402680356839036,1.0,5/19,11.01%,IL34;CMKLR1;MDK;CCL5;PTK2
prerank,cellular response to UV (GO:0034644),0.5029504515012577,1.4329545610918912,0.04484304932735426,0.405712057274743,1.0,20/76,21.00%,MMP3;MMP2;TIMP1;PPID;INO80;CREBBP;NOC2L;ATR;TMEM161A;MC1R;MFAP4;FMR1;NEDD4;USP28;DDB1;ATF4;RHBDD1;KDM1A;PRKCD;YY1
prerank,estrogen metabolic process (GO:0008210),0.648388663189073,1.4328174793569695,0.0748502994011976,0.4053044722996801,1.0,3/15,9.08%,CYP1B1;HSD17B8;CYP1A1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5626090503230688,1.432815897237891,0.07528230865746549,0.40448774681592387,1.0,9/33,13.40%,RUNX1;DNAAF4;KLK2;CARM1;CBFB;UBA5;CALR;DDRGK1;SAFB2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6277898669398737,1.4324655024776325,0.10534124629080119,0.40465452410686753,1.0,7/17,12.42%,STAT1;MAML3;CREBBP;PLXND1;HEYL;MAML2;MAML1
prerank,negative regulation of phagocytosis (GO:0050765),0.6290341933605823,1.4323711861439434,0.0917941585535466,0.40403350741971367,1.0,3/17,2.72%,ADIPOQ;TLR2;PRTN3
prerank,regulation of ossification (GO:0030278),0.5572154703778822,1.432128742314813,0.0670807453416149,0.4039290175119254,1.0,12/36,11.67%,ENPP1;PTN;MDK;DDR2;ACVR1;CYP27B1;SFRP1;LRP6;WNT5A;CHSY1;TGFB2;NBR1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5474552259688893,-1.432117699440581,0.07611548556430446,0.5510353359711665,1.0,3/13,3.36%,NR3C2;BMP4;ESR1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.552659105181801,-1.4320397660963433,0.10109289617486339,0.5460857085073667,1.0,4/12,11.13%,MAP2;EML2;CDH5;STMN2
prerank,placenta development (GO:0001890),0.6699098737979052,1.4319091451809165,0.08204334365325078,0.4037215298859676,1.0,4/12,11.01%,ADAM19;PPARG;E2F8;PTK2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.6207468782068151,1.4311748786308456,0.07366984993178717,0.4048545700618021,1.0,1/21,0.03%,MMP3
prerank,defense response to symbiont (GO:0140546),0.49803224237872723,1.4307171336720512,0.038419319429198684,0.405315577324041,1.0,24/92,17.01%,ZBP1;MAP3K14;STAT1;TLR2;IRF7;CD40;BCL2;SHFL;EIF2AK2;TLR7;IRF1;IFNAR2;ABCE1;EXOSC4;MLKL;OASL;SETD2;MOV10;ATG7;RNASE1;TRIM56;RTP4;CGAS;PTPRC
prerank,regulation of calcium-mediated signaling (GO:0050848),0.5881650976399649,1.4298384461778344,0.07537012113055182,0.40677185532191634,1.0,5/25,4.84%,CMKLR1;LRRK2;P2RX5;TREM2;ITPR1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.4772764851069323,-1.4291109869024647,0.056105610561056105,0.550361913109289,1.0,4/20,1.98%,PLCE1;CHRM2;CAV1;KCNB2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5649109488431557,1.4287400445857183,0.08463541666666667,0.4088193589946626,1.0,9/30,15.12%,IRF7;CD40;BIRC3;IKBKE;LY96;CD14;CASP8;TANK;RIPK1
prerank,regulation of interleukin-6 production (GO:0032675),0.48489201226320133,1.4286965766488056,0.043010752688172046,0.4081147523331548,1.0,17/96,9.14%,LBP;IL16;TLR2;TNFAIP3;TSLP;IRAK3;TREM2;STAT3;AIF1;LGALS9;PTPN6;TLR7;RAB7B;TIRAP;TMEM106A;LPL;WNT5A
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6056937273718688,1.4285331121583345,0.08379120879120878,0.4077276775902555,1.0,5/22,14.04%,ADIPOQ;FLOT2;GCNT2;TNF;BMP7
prerank,negative regulation of innate immune response (GO:0045824),0.549112714995321,1.4283815182091686,0.07644110275689223,0.4073380690257638,1.0,5/34,5.54%,VSIG4;SERPING1;TNFAIP3;IRAK3;TRIM21
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5752731084392876,1.4273592901899426,0.0907840440165062,0.4093579527509921,1.0,4/26,3.52%,ZFP36L1;ZFP36L2;SNAI2;EGFR
prerank,response to insulin (GO:0032868),0.4976022410299706,1.427280014724466,0.03858875413450937,0.4087797629006161,1.0,21/80,14.12%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;IRS1;INSIG2;USF1;CPEB1;PPARG;MYO5A;INHBB;RAB8B;DENND4C;OGT;RPS6KB1;GCK;KHK;ZBED3;PIK3R1;RAB10;TRIB3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5424991204895859,-1.426565409755383,0.07242339832869081,0.553474294227186,1.0,7/13,20.10%,SHANK3;ADCY1;APP;ZDHHC2;SHISA7;RELN;LGMN
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5700460960350948,1.4264943456945014,0.07611548556430446,0.4100568882983949,1.0,9/29,15.12%,IRF7;CD40;BIRC3;IKBKE;LY96;CD14;CASP8;TANK;RIPK1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5031071227400784,1.4262351553647605,0.038461538461538464,0.4099631874372066,1.0,28/71,21.55%,FAP;TNFAIP3;USP9X;CHMP4B;CTSS;OMA1;VPS4A;CTSK;BAG6;CTSL;ADAMTS12;CAPN2;PSMA6;CTSB;CASP8;CTSC;ADAMTS7;CTSW;UBE2W;PSMA8;ZYG11B;DDB1;MDM2;RHBDD1;ISG15;NR1D1;HM13;RPS27A
prerank,endothelial cell differentiation (GO:0045446),0.6730741143754342,1.4249796846838818,0.09501557632398754,0.4124869497793569,1.0,3/12,4.21%,SCUBE1;FSTL1;JAG1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5857222213999324,1.424910698291237,0.09090909090909091,0.4118567655228221,1.0,5/26,5.86%,ADIPOQ;LRRC17;MAFB;FBN1;CDK6
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5669594235235018,1.4247382106118478,0.07642487046632124,0.41149456862722056,1.0,11/29,17.65%,CXCL12;CCR1;AIF1;LGALS9;CCL5;CXCL10;PLA2G7;CALR;TNF;CREB3;ANO6
prerank,regulation of vasculature development (GO:1901342),0.5806783131071453,1.4243574344538175,0.0796812749003984,0.4117259955510296,1.0,8/26,12.48%,NF1;SFRP1;PLXND1;GPNMB;SP100;RNH1;BMPER;FGF2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5914460553808208,1.4240469560394584,0.08882907133243607,0.4118503281658301,1.0,12/25,22.90%,ADIPOQ;ATXN2;ABCA2;DLG4;PSEN1;ANKRD13B;NEU3;RAC1;PICALM;MTMR2;SDCBP;ITGB3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5312609250686244,1.4239602204407578,0.06900726392251816,0.4112723135586723,1.0,17/46,17.21%,ADIPOQ;FBLN1;TNIP1;SPRED1;SPRED2;PTEN;EMILIN1;PTPN1;CNKSR3;PTPN2;SPRY2;DUSP26;RANBP9;SMAD4;ITGB1BP1;PTPRC;DUSP6
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6001130801407665,1.4233953935581058,0.08411214953271028,0.41115480083653794,1.0,7/23,14.44%,ZEB2;CDKN2B;CREBBP;RNF111;TGFB1I1;GIPC1;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6001130801407665,1.4233953935581058,0.08411214953271028,0.41115480083653794,1.0,7/23,14.44%,ZEB2;CDKN2B;CREBBP;RNF111;TGFB1I1;GIPC1;SMAD4
prerank,cobalamin metabolic process (GO:0009235),0.6196648796220148,1.4233472353397965,0.10518518518518519,0.41050994746923425,1.0,3/17,7.43%,TCN1;MMAB;TCN2
prerank,diacylglycerol metabolic process (GO:0046339),-0.45371216268982184,-1.4231114720354094,0.07462686567164178,0.5587657593638767,1.0,9/23,19.59%,PLCE1;DGKB;DGKI;DGKA;LIPE;DGAT1;DGKG;DGKQ;PNPLA2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6816357473622108,1.4229481346294095,0.10381679389312977,0.41077431926585145,1.0,3/11,7.94%,JAK2;TAF7;TMEM106A
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6984486041706115,1.4227832322425185,0.10685805422647528,0.410417855363215,1.0,4/10,7.08%,TREM2;CD36;CD68;MIA3
prerank,Golgi localization (GO:0051645),0.6848772954407555,1.4225694446610715,0.11201298701298701,0.4102327405403896,1.0,5/11,14.53%,ARCN1;CDC42;COPG1;YWHAZ;PDCD10
prerank,tetrapyrrole metabolic process (GO:0033013),0.6093755056665866,1.4225020115901328,0.10315186246418338,0.40960648226203633,1.0,3/18,7.43%,TCN1;MMAB;TCN2
prerank,B cell receptor signaling pathway (GO:0050853),0.5534509931482681,1.4222328584978896,0.07672301690507152,0.4095398021767921,1.0,8/32,9.76%,RFTN1;TEC;VAV3;BLK;BCL2;SH2B2;LAT2;MS4A1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5603548511674352,-1.4222318511384187,0.1116751269035533,0.5563837577561683,1.0,6/11,15.49%,MLLT3;RSPO3;CSNK1E;WNT5B;DAB2;PLEKHA4
prerank,chloride transmembrane transport (GO:1902476),-0.3754006844901069,-1.422082598223453,0.02040816326530612,0.5519483486729626,1.0,15/48,9.76%,SLC12A2;SLC12A7;GABRA2;GABRB1;GLRA3;GABRG3;SLC1A1;SLC12A6;SLC6A1;GABRA5;GLRA1;CLCN3;GABRB2;ANO3;SLC4A8
prerank,regulation of bone mineralization (GO:0030500),0.5210059607365878,1.4215456786017509,0.0630952380952381,0.4105953903160927,1.0,17/55,14.55%,ENPP1;GPM6B;FBN2;PTN;NELL1;CCR1;DDR2;ACVR1;CYP27B1;TGFB3;TMEM119;NBR1;ATP2B1;ACVR2A;P2RX7;BMP7;TRPM4
prerank,positive regulation of biosynthetic process (GO:0009891),0.5435161858345127,1.4209644080845976,0.07116104868913857,0.41148610602827546,1.0,6/40,6.17%,RUNX1;CREB3L1;APOE;CD36;CCL5;TGFB3
prerank,central nervous system myelination (GO:0022010),0.6771968442270221,1.4209585308351438,0.10518518518518519,0.4107232655218492,1.0,4/11,7.14%,B4GALT5;ABCA2;PTEN;TENM4
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5658394213297312,1.4205804016615398,0.07593307593307594,0.41092652755378467,1.0,10/30,15.22%,DCN;CHSY3;BGN;CHST13;VCAN;CHSY1;CHST11;UGDH;IDS;CHPF2
prerank,positive regulation of signal transduction (GO:0009967),0.46319851427982417,1.4205538126705526,0.006036217303822937,0.4101949664714288,1.0,73/238,17.73%,SLC39A14;C3;ADIPOQ;SULF1;MGAT5;CCBE1;YAP1;ASXL1;TNFSF11;ZMIZ1;TLR2;LRRK2;IRS1;TNFAIP3;JAK2;PRKCA;NRP1;TSLP;MAML3;TREM2;STAT3;STK36;JAG1;SHH;PTEN;PRKD2;PKD2;ASXL2;LIMS1;CYP27B1;CREBBP;ATP6AP2;SFRP1;LY96;DLG4;ARNT;SASH1;MAML2;TERT;TGFBR1;CSNK2A1;SALL1;IL7;DRD3;WLS;DISC1;LOXL3;TRIM44;NEPRO;PDE6H;VTN;TGFB2;MAML1;NTRK3;SNX5;PIK3R1;ITGA5;DACT1;RAB34;DLG5;SRC;PDCD10;CD63;SMO;HIF1A;DEPDC1B;ITGB1BP1;TSPAN14;SMARCA4;PTPRC;ING5;STX1B;GLI1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7007048757525107,1.419586650111325,0.09775641025641026,0.4112849688397715,1.0,1/10,0.48%,ADIPOQ
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7007048757525107,1.419586650111325,0.09775641025641026,0.4112849688397715,1.0,1/10,0.48%,ADIPOQ
prerank,neuron maturation (GO:0042551),0.6175556452038107,1.419482513484286,0.10526315789473684,0.41081670386160124,1.0,3/18,2.07%,C3;FARP2;B4GALT5
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5355413636318506,1.4192029730261386,0.0603448275862069,0.4108204714848516,1.0,15/40,22.19%,GLMN;PTEN;FBXW7;RAD23A;CSNK2A1;CSNK2A2;RAD23B;PTK2;RPL11;SMURF1;GNA12;XPO1;AXIN1;CLU;LATS1
prerank,presynapse assembly (GO:0099054),0.6312436835926378,1.419086760036222,0.09809663250366032,0.41034906026122914,1.0,4/16,9.14%,CEL;PTEN;FZD1;WNT5A
prerank,integrin-mediated signaling pathway (GO:0007229),0.5049170484474699,1.4188329444160312,0.039735099337748346,0.4102611559030951,1.0,28/73,21.28%,COL3A1;ITGB8;FBLN1;TEC;ITGB5;PTN;NRP1;DOCK1;MYH9;CCM2;CDC42;ADAMTS1;ITGA11;ITGBL1;PTK2;ERBIN;ITGA5;ADAM11;SRC;ITGB1BP1;PLEK;PTPRA;FERMT3;COL16A1;DST;ISG15;ADAM9;NME2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5914568768088482,1.4187644845825687,0.0681198910081744,0.4096790405588912,1.0,4/23,5.67%,CYP1B1;GHR;JAK2;CCL5
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3435915136968707,-1.418672838036117,0.0,0.5577558396065726,1.0,17/75,5.75%,ATP1A2;ATP1B3;SLC12A2;SLC24A2;SLC12A7;ATP1B1;SLC9A2;SLC39A10;SLC12A6;KCNJ2;KCNJ3;SLC6A1;ATP2B4;SLC8A3;KCNJ13;SLC39A8;ABCC9
prerank,embryonic limb morphogenesis (GO:0030326),0.5546993121919689,1.4185405028467988,0.093711467324291,0.4094890098616969,1.0,11/34,11.44%,GLI3;CACNA1C;TBX2;SHH;CREBBP;LRP6;HDAC1;SALL1;WDPCP;TBX3;TGFB2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4871280841779268,1.4185190972878876,0.03131749460043196,0.4087820839626289,1.0,26/100,13.29%,ROR2;ROR1;DCN;PDGFRA;PDGFRB;JAK2;EGFR;PIP5K1B;TREM2;PTPN13;PTEN;PIP4K2A;CCL5;EGF;PTPN6;PIK3AP1;PIK3R5;CBL;FGFR1;PTK2;TGFB2;UNC5B;TNF;FGF2;NTRK3;PIK3R1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.3661590900932109,-1.418097508418539,0.039735099337748346,0.5499187986868572,1.0,31/56,29.53%,NDUFS1;NDUFAF5;NDUFAF4;ECSIT;NDUFV2;NDUFA13;NDUFAF2;NDUFA6;DMAC2;NDUFA12;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;FOXRED1;TIMM21;BCS1L;NDUFA10;NDUFS2;TMEM126B;NDUFB11;NUBPL;NDUFS5;NDUFAF8;TIMMDC1;NDUFV1;NDUFAF6
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.3661590900932109,-1.418097508418539,0.039735099337748346,0.5499187986868572,1.0,31/56,29.53%,NDUFS1;NDUFAF5;NDUFAF4;ECSIT;NDUFV2;NDUFA13;NDUFAF2;NDUFA6;DMAC2;NDUFA12;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;FOXRED1;TIMM21;BCS1L;NDUFA10;NDUFS2;TMEM126B;NDUFB11;NUBPL;NDUFS5;NDUFAF8;TIMMDC1;NDUFV1;NDUFAF6
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4808918964777936,-1.417649897164106,0.09032258064516129,0.5467520844101487,1.0,5/20,4.05%,ATP1A2;ATP1B3;SLC12A2;ATP1B1;KCNJ2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.6080828873889573,1.417624541667141,0.09153952843273232,0.4104466910260311,1.0,6/19,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,secretory granule organization (GO:0033363),0.7004535471096041,1.4172869382729214,0.08179012345679013,0.4105504158196886,1.0,2/10,5.87%,ABCA1;DTNBP1
prerank,regulation of mast cell degranulation (GO:0043304),0.637200485619285,1.4172175522402646,0.10164424514200299,0.40995603395186153,1.0,6/14,14.81%,GAB2;BLK;LGALS9;UNC13D;SPHK2;FES
prerank,regulation of autophagosome assembly (GO:2000785),0.5649627673347599,1.4170696672388108,0.08207070707070707,0.40957697803103665,1.0,20/33,25.28%,LRRK2;CHMP4A;CHMP4B;TMEM39A;PIP4K2A;NPRL2;IFT88;RAB3GAP2;SMCR8;ADPRH;RAB3GAP1;SH3GLB1;MTMR3;SCFD1;MTM1;IFT20;RAB5A;TBC1D12;RALB;FEZ2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6379998307518668,1.4163208203445545,0.07971014492753623,0.4107738103403339,1.0,5/14,12.65%,SNAI2;WNT9A;ADAMTS12;TGFBR1;ADAMTS7
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.45613559928650377,1.4162661299731918,0.0,0.4101330333477115,1.0,126/476,18.64%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;KMT2A;RUNX3;CXXC1;SPP1;MDFIC;BCL3;GLI2;YAP1;DEAF1;TCF4;SNAI1;GLI3;STAT1;ZMIZ1;IRF7;GATA6;FGF7;MAFB;MITF;ZNF496;SMAD2;EGFR;APOE;STAT3;ELF4;ILF3;NR2F2;SHH;E2F1;MYBL1;SMARCC1;ACVR1;FOXK2;EGF;CREBBP;FZD1;SFRP1;PPARG;LRP6;YAF2;ZBTB48;TGFB3;AHR;FOXE1;GTF2H1;RNF111;IRF1;NEK4;CREB3L2;SP100;TGFBR1;MAP2K1;WNT5A;HDAC1;SALL1;FOXO3;TBL1X;ARID1B;SMAD5;TGFB1I1;HMGB2;ZIC1;TRIM44;TEAD1;KMT2E;RSF1;SP3;MED13;NIF3L1;MAP3K2;FBXW11;TNF;KLF6;FGF2;KMT2B;ELK1;NSD3;SNX5;BRPF1;CTCF;SMAD3;PSEN1;BMP7;EGR2;USP22;SMAD4;DTX3L;MMS19;NAA15;HIF1A;TRIM56;NPAS2;NSD1;POU3F3;ATF7IP;CLOCK;TCF3;SMARCA4;ACVRL1;ZFHX3;AKT1;ING5;CALCOCO1;THRAP3;PCBD2;BRD4;ATF4;PICALM;GLI1;ETS1;MAP3K12;RLF;RAI1;INHBA;BICRA;PAX8;AGT;SOX2;SETD3;HINFP;KAT6B
prerank,visual system development (GO:0150063),0.5443344721250469,1.416221888949022,0.057001239157372985,0.40952868950493754,1.0,7/37,8.25%,C3;SH3PXD2B;MEIS2;SIPA1L3;MEIS1;PBX3;ADAMTS18
prerank,defense response to Gram-negative bacterium (GO:0050829),0.5344609698099546,1.4158058628982766,0.0665024630541872,0.40985771836869944,1.0,6/42,10.06%,IL23R;LBP;TREM2;RNASE7;MPEG1;HMGB2
prerank,lipoprotein catabolic process (GO:0042159),0.6913617168373969,1.4155724598474637,0.09268292682926829,0.4096934869220293,1.0,6/11,16.48%,APOE;ABHD17C;CTSD;LYPLAL1;ABHD17B;LYPLA2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6590792879071312,1.4152256082126455,0.10675039246467818,0.40994761166025556,1.0,2/12,5.36%,IL23R;PAEP
prerank,sterol biosynthetic process (GO:0016126),-0.40805312521967546,-1.4146680512558467,0.06467661691542288,0.5508130816400184,1.0,17/33,26.50%,PRKAG2;LBR;MSMO1;INSIG1;ACAT2;SQLE;CYP51A1;DHCR24;IDI1;ACLY;LSS;HSD17B7;FDPS;EBP;FDFT1;NSDHL;TM7SF2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5246347438574227,1.4146136333338915,0.06880189798339265,0.41075114501375515,1.0,17/48,20.64%,ADIPOQ;SLIT3;IRAK3;TREM2;PADI2;PPARG;PYDC1;PELI3;PTPN2;NLRP2B;YTHDF3;CCDC3;TRAIP;PTPRC;STAT2;ISG15;PARP14
prerank,triglyceride catabolic process (GO:0019433),0.6100378323192699,1.414411777410559,0.08264462809917356,0.41053180742615286,1.0,3/19,12.66%,LIPC;LPL;FABP5
prerank,positive regulation of DNA replication (GO:0045740),0.6282224941323238,1.4135003035372886,0.08567415730337079,0.41220153925332703,1.0,5/16,5.80%,GLI2;DNA2;EGFR;EGF;BRPF3
prerank,regulation of programmed necrotic cell death (GO:0062098),0.6021427153535718,1.4134110957936872,0.081267217630854,0.411690811789861,1.0,8/20,15.12%,BIRC3;FLOT2;CFLAR;OGT;CDC37;MLKL;CASP8;RIPK1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5153908791870536,-1.4133043268714016,0.09206349206349207,0.5498318238221122,1.0,10/16,34.01%,PRKAG2;PPARGC1A;ACADL;ACADVL;TYSND1;MLYCD;NR4A3;SIRT4;SOX9;FABP3
prerank,cellular response to lipopolysaccharide (GO:0071222),0.483001052088879,1.4131408816241573,0.03336921420882669,0.4116704717032297,1.0,17/101,12.29%,CXCL5;CXCL1;LBP;SBNO2;TNFAIP3;CASP1;NUGGC;CCL5;LY96;CD68;CXCL10;CD14;WNT5A;HMGB2;CCL2;RHOA;TNF
prerank,relaxation of cardiac muscle (GO:0055119),-0.5478047294999915,-1.4130319299943566,0.0653950953678474,0.546017670873111,1.0,4/13,4.05%,ATP1A2;ATP1B1;GSN;KCNJ2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4955728343885843,1.4117171944139282,0.05672969966629588,0.41486263141919494,1.0,14/72,14.73%,ABCA1;DLC1;COL3A1;P2RY10;NRP1;APOE;OPHN1;ITGA3;KCTD10;AKAP13;ARHGEF18;ARHGAP35;PDCD10;RAC1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4641576374848125,1.411599053655528,0.017507723995880537,0.4144427420335759,1.0,56/170,21.38%,IGF2BP1;TRIML2;POU5F1;C1D;EDN3;AFF1;ZFP36L1;IGF2BP2;AFF2;NELL1;TREM2;APOE;CGGBP1;SHH;PRDM5;PRDM2;AIF1;TBC1D16;TRIM21;CDK6;AHR;HMG20B;FUBP1;PRDM1;TRIM44;MARF1;NFKBIZ;PRDM10;CTCF;YBX3;KIF16B;ARF1;PSEN1;MKLN1;MTMR9;TCF19;HIF1A;ADNP2;RASA1;PTPRC;ZNF445;MTMR3;STX1B;PRDM4;SOX2;HINFP;MTMR2;MTMR1;PIN1;HNRNPDL;GDNF;TRIM6;FOXP1;ZC3H12A;SIRPA;TRIM27
prerank,innate immune response (GO:0045087),0.46223871538979827,1.4111271233714406,0.00808080808080808,0.41495345174366693,1.0,41/217,16.15%,C3;IL23R;TRIML2;LBP;COLEC12;MASP1;CRP;TLR2;IRF7;ALPK1;CD40;REL;TREM2;BLK;CYP27B1;TRIM21;SHFL;RNASE7;PPARG;CXCL10;STYK1;PYDC1;TRIM13;FRK;TRIM8;SP100;IRAK4;SETD2;PTK2;POLR3A;ANKRD17;PJA2;MFAP4;COLEC11;SRC;AKAP1;FES;TIFA;TRIM56;RELB;YES1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.40304790026289133,-1.409903979936041,0.049723756906077346,0.5507983523144564,1.0,12/39,12.72%,TJP1;SNCAIP;EZR;HSP90AA1;TIE1;RAPGEF2;VPS11;RAP1A;ANKRA2;GFAP;RDX;PINK1
prerank,regulation of cell killing (GO:0031341),0.63693198409737,1.4097368167190016,0.10985915492957747,0.41790758987050136,1.0,5/16,14.73%,CFH;ICAM1;WNT5A;TGFB2;RAC1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.64631116092481,1.409641078940915,0.09347181008902077,0.41738099899266407,1.0,5/15,11.51%,GLI2;ANKRD11;LRP6;HDAC1;EDA
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4845090525083949,1.4096404333433732,0.043010752688172046,0.41662944808663366,1.0,28/95,15.52%,DCN;CEMIP;LUM;CHSY3;HSPG2;BGN;B4GALT5;CHST13;GPC6;VCAN;EXT1;ST3GAL3;EXT2;PRELP;ANGPT1;SDC1;HS2ST1;SDC2;CHSY1;CHST11;ST3GAL1;GCNT2;CHST1;UGDH;SLC35D2;CHPF2;B4GALT2;B4GALT7
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.6028703222130605,1.4089046727294785,0.0954356846473029,0.4178873780604281,1.0,3/21,4.80%,CREB3L1;LRRK2;NCK1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6509759530219681,1.4087571856517507,0.08370702541106129,0.4175327391847699,1.0,8/14,16.92%,SEC31A;SEC24D;SEC23A;SEC24A;MIA3;RAB1A;SEC13;TBC1D20
prerank,regulation of cell adhesion (GO:0030155),0.4746663196021271,1.4086549700832256,0.03008298755186722,0.41707297472337634,1.0,39/129,17.09%,IBSP;EPHA7;KNG1;FBLN1;CXCL12;SPN;PRKCA;PLXNC1;EPHB3;NUAK1;MDK;PRKD2;RHOD;CCL5;ATM;PLXND1;RSU1;MIA3;ARHGDIG;ANGPT1;PLXNA3;EFNA5;CXCR4;PPP3CA;PTPRJ;PTK2;DSCAM;PPP1CB;TNF;DUSP26;TGFBI;SRC;FES;ITGB1BP1;RASA1;ARHGDIA;CHRD;ACVRL1;ZFHX3
prerank,positive regulation of immune effector process (GO:0002699),0.5743070013677907,1.4086416005838547,0.0918918918918919,0.4163676491991266,1.0,5/27,11.83%,IL23R;LBP;LGALS9;PTPRJ;ANKRD17
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6510177909297825,1.4081292079036654,0.10283159463487332,0.41711985695627624,1.0,6/14,15.02%,KMT2A;AUTS2;KMT2E;DNMT3B;SMAD4;PAXIP1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.6172924692411881,1.408090963294704,0.09103840682788052,0.41648082904922196,1.0,6/17,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6808514212347467,1.4080305588710198,0.11496062992125984,0.4158932567147407,1.0,3/10,10.46%,FAP;EMILIN1;TNFRSF1A
prerank,regulation of T cell chemotaxis (GO:0010819),0.6816751421512208,1.407407645686397,0.11267605633802817,0.4167495637517314,1.0,4/11,9.14%,XCL1;CCL5;CXCL10;WNT5A
prerank,extracellular matrix assembly (GO:0085029),0.5911524258997256,1.4073783831068725,0.0912863070539419,0.4160873749586174,1.0,5/23,8.73%,LTBP3;GPM6B;LAMB1;EMILIN1;PXDN
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.6005875269964484,1.407235756569284,0.1038961038961039,0.41569928888777313,1.0,9/20,18.23%,RUNX2;SMAD5;NFE2L2;SMAD4;SMAD1;CREB3;HIF1A;ATF4;RBPJ
prerank,regulation of feeding behavior (GO:0060259),0.6689080107282829,1.4071409787488363,0.10151515151515152,0.41517513130578365,1.0,2/11,3.79%,QRFP;STAT3
prerank,kinetochore organization (GO:0051383),-0.5298463110109752,-1.407126346832874,0.10914454277286136,0.5545761825061962,1.0,10/13,41.57%,CENPC;POGZ;CENPT;CENPE;CENPH;NDC80;CENPF;DLGAP5;NUF2;CENPW
prerank,regulation of actin filament-based process (GO:0032970),0.5017255632447415,1.4069677178761728,0.05803571428571429,0.41490556719096666,1.0,13/70,8.60%,DLC1;GPM6B;LRP1;RND3;TAOK1;PDGFRB;RICTOR;FSCN1;BAIAP2;RHOD;CDK10;ARHGEF19;EFNA5
prerank,renal absorption (GO:0070293),-0.5877633461419511,-1.4067484745904117,0.11165048543689321,0.5511147162999556,1.0,4/10,12.33%,KLHL3;GSN;WNK4;KCNQ1
prerank,regulation of protein import into nucleus (GO:0042306),0.535539511330065,1.406703096315064,0.08787128712871287,0.41486582204230754,1.0,9/36,13.92%,MDFIC;APOD;SUFU;UBR5;BAG3;ZIC1;PIK3R1;SMAD3;PSEN1
prerank,nuclear membrane disassembly (GO:0051081),0.6432124071158847,1.4065541808199735,0.11746987951807229,0.41456896863992704,1.0,5/14,11.30%,NEK6;PRKCA;PLK1;NEK9;CCNB2
prerank,regulation of cell aging (GO:0090342),0.6772763412748677,1.4054407452283686,0.09774436090225563,0.41666872503357644,1.0,3/11,7.81%,NEK6;NUAK1;NEK4
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4989345017583821,1.4051041760526468,0.049773755656108594,0.4168358331001228,1.0,18/67,20.27%,PSMA7;ITGB5;PDIA3;CD36;PSMB8;PSMA6;CALR;PSMF1;PSMA8;FCGR1A;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;CYBB;PSMC6;TAP1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.47380518848746467,1.4047406045029138,0.039319872476089264,0.4170113032842279,1.0,13/116,6.53%,MC5R;IAPP;GPR176;GPR39;ADCY7;TREM2;RXFP2;MYH9;ADCY2;PTGDR;ADM;ADCYAP1R1;GLP2R
prerank,positive regulation of vasoconstriction (GO:0045907),-0.5438343452718875,-1.4047297375485832,0.08588957055214724,0.5527458565552344,1.0,4/13,16.39%,CAV1;ADRA1B;ADRA1A;TBXA2R
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5893954006306898,1.40450775556292,0.09153005464480875,0.41691106072995976,1.0,6/23,11.00%,JAK1;STAT1;JAK2;PPARG;CDC37;PTPN2
prerank,ceramide biosynthetic process (GO:0046513),-0.404145601554232,-1.4042614152009694,0.047619047619047616,0.5494751786028061,1.0,15/40,15.70%,ST6GALNAC3;ST8SIA4;ST3GAL5;CERS4;SGMS1;SPTLC2;SPTLC1;SGMS2;ST8SIA6;DEGS2;B4GALT6;ST8SIA2;ST6GALNAC5;ASAH2;SMPD2
prerank,response to glucocorticoid (GO:0051384),0.571944396159168,1.40411924819011,0.09659863945578231,0.417196348102922,1.0,6/26,12.29%,ZFP36L1;ZFP36L2;SLIT3;ANXA1;UBE2L3;TNF
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6248570056537247,1.4031607519927725,0.11946902654867257,0.41889762829558436,1.0,4/17,6.17%,ADIPOQ;PTEN;PPARG;TGFB3
prerank,regulation of osteoblast proliferation (GO:0033688),0.6240395832173283,1.4024664687183375,0.09393063583815028,0.41986973638306646,1.0,7/17,11.96%,TNN;NELL1;SFRP1;EIF2AK2;HPSE;TMEM119;RHOA
prerank,receptor catabolic process (GO:0032801),0.5820513388426611,1.4023184109532767,0.08090185676392574,0.41953993534188216,1.0,9/24,16.91%,CLTC;MYLIP;KIF16B;AP2A2;PIK3R4;SNX25;SMURF1;NEDD4;SH3GLB1
prerank,Golgi organization (GO:0007030),0.47663446721541314,1.4017313055001042,0.02685284640171858,0.4204349546904628,1.0,36/112,19.07%,SEC16B;VMP1;GORASP2;LRRK2;ATP8B1;STX6;RAB2A;PI4K2B;STX17;ATL2;CDC42;COG4;LMAN2L;GBF1;GOLGA8B;GOLGA5;TRIP11;SEC16A;GAK;LMAN1;SEC23IP;YWHAZ;CSNK1A1;TMED1;RAB1A;DYNC2H1;VCPIP1;PDCD10;LYSMD3;COG7;OBSL1;TBC1D20;CSNK1D;TMED5;BCAS3;TJAP1
prerank,negative regulation of bone mineralization (GO:0030502),0.6426892746818633,1.4017082325457813,0.12112259970457903,0.4197729677289179,1.0,2/13,4.31%,ENPP1;CCR1
prerank,regulation of nervous system development (GO:0051960),0.5377584271445226,1.4011281449260946,0.08375,0.4205939025297314,1.0,8/37,11.12%,YAP1;PTN;PTPRZ1;TENM4;BHLHE40;HEYL;HMGB2;NPHP3
prerank,bile acid and bile salt transport (GO:0015721),0.5792550067702011,1.4009894111092414,0.10719131614654002,0.42025984225899987,1.0,3/24,2.99%,NR1H4;ATP8B1;SLC10A6
prerank,positive regulation of cell adhesion (GO:0045785),0.4954543896518285,1.400479061753544,0.039149888143176735,0.4209575224235724,1.0,17/74,12.57%,IBSP;FBLN2;CXCL12;JAK2;PRKCA;MDK;PRKD2;RHOD;LIMS1;CCL5;ATM;RSU1;PPP3CA;PTPRJ;TGFB2;TNF;DUSP26
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.565423293527562,-1.4002881467054158,0.08401084010840108,0.5574128386019118,1.0,2/11,1.56%,CAV1;ACTN2
prerank,neuron differentiation (GO:0030182),0.4679467100268859,1.4001130344694723,0.01557632398753894,0.4212595360934057,1.0,24/165,12.13%,RUNX1;RUNX2;WNT2;RUNX3;GLI2;UGCG;WNT9A;TENM3;BHLHE22;SHH;ACSL4;PBX3;OPHN1;FZD1;LRP6;TENM4;MYO7A;TGFBR1;MAP2K1;WNT5A;NEUROD6;TGFB2;TDP2;NIF3L1
prerank,negative regulation of cartilage development (GO:0061037),0.6422011155383666,1.3992853723746639,0.08982035928143713,0.4227470601864753,1.0,5/13,12.65%,SNAI2;WNT9A;ADAMTS12;TGFBR1;ADAMTS7
prerank,diol metabolic process (GO:0034311),-0.48063264187173804,-1.3991006149302696,0.0781758957654723,0.5565524003107618,1.0,8/19,16.84%,NOS3;CALM1;HSP90AA1;DEGS2;PTS;SGPP1;ASAH2;NAAA
prerank,aorta morphogenesis (GO:0035909),0.6222455754632633,1.3990874288392225,0.11544011544011544,0.4225725691147065,1.0,6/17,9.18%,LRP1;PDGFRB;TBX2;JAG1;ADAMTS9;MYLK
prerank,renal system development (GO:0072001),0.5177028271329607,1.398831505573627,0.07244655581947744,0.4225488874935369,1.0,12/52,11.44%,SULF1;GLI2;TBX18;STAT1;ITGA8;IFT88;BAG6;TGFBR1;GREB1L;SALL1;NPHP3;TGFB2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5806836954530876,1.3970976100268675,0.09986130374479889,0.4264171826350273,1.0,6/22,8.81%,SPRED1;SPRED2;PLA2R1;ATM;EEF1E1;ATR
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5778366550549295,1.3956676053183381,0.09403973509933775,0.4295290145202777,1.0,9/26,13.23%,CBLB;ERRFI1;NCK2;EGF;CBL;FBXW7;SOCS5;ZGPAT;BTC
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5560066836787442,-1.3942321118285015,0.08310991957104558,0.5670305737489638,1.0,5/11,15.71%,LDLR;SCARB1;SLC27A1;GPLD1;MFSD2A
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5508704748399785,-1.3937303205610359,0.09749303621169916,0.56445643044959,1.0,7/11,29.64%,P3H2;P4HTM;EGLN2;EGLN3;CRTAP;P4HA3;P4HA1
prerank,membrane raft organization (GO:0031579),0.6398838246199207,1.3934369650839082,0.10245310245310245,0.43476248130148115,1.0,2/15,3.15%,RFTN1;FLOT2
prerank,negative regulation of macrophage activation (GO:0043031),-0.4891252991369915,-1.3932519841488875,0.0955223880597015,0.5613589454578986,1.0,4/16,5.87%,LRFN5;IL31RA;LDLR;CD200
prerank,ketone body metabolic process (GO:1902224),-0.568422708781482,-1.39288205946457,0.12987012987012986,0.5580654830748699,1.0,4/10,18.08%,BDH1;HMGCS2;HMGCLL1;HMGCL
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6360615934986172,1.3924662240811092,0.1346153846153846,0.43663521828229124,1.0,7/14,16.30%,ADIPOQ;PYDC1;PELI3;PTPN2;NLRP2B;CCDC3;TRAIP
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6847670675480623,1.3923630282342268,0.11488673139158576,0.4361999658464254,1.0,6/10,24.23%,CCL2;NFE2L2;HSPA5;EIF2AK3;ATF4;EIF2S1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.63502811450723,1.3923616689847451,0.12575757575757576,0.4354636237672467,1.0,2/14,5.36%,IL23R;PAEP
prerank,histone H3 deacetylation (GO:0070932),-0.5193654769444565,-1.3922161734179277,0.0856269113149847,0.5559671604336595,1.0,8/15,17.77%,SFPQ;HDAC4;HDAC9;PER1;SMARCAD1;PER2;SIRT7;HDAC3
prerank,regulation of amyloid-beta clearance (GO:1900221),0.6130499186418309,1.3921761560421346,0.10157367668097282,0.43524066785614063,1.0,5/16,12.29%,LRP1;TREM2;APOE;HDAC1;TNF
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6242636852369067,1.3921565415551196,0.11634756995581738,0.43457390464731277,1.0,4/14,11.83%,TLR2;PUM1;OASL;ANKRD17
prerank,androgen metabolic process (GO:0008209),0.6139048489919093,1.3919111738351648,0.11416184971098266,0.4345338179641256,1.0,3/18,8.44%,SPP1;SHH;SRD5A3
prerank,membrane repolarization during action potential (GO:0086011),-0.5221924764033256,-1.3904241989614348,0.1111111111111111,0.5570974732465314,1.0,4/13,12.33%,KCND3;ATP1B1;KCNJ2;KCNQ1
prerank,negative regulation of cytokine production (GO:0001818),0.458449810909895,1.3898746402999913,0.024896265560165973,0.4391838286286764,1.0,18/163,6.47%,NR1H4;IL23R;VSIG4;APOD;BCL3;TNFRSF21;CMKLR1;TNFAIP3;XCL1;ADCY7;NAV3;IRAK3;TREM2;IKBKE;LGALS9;ILRUN;PTPN6;INHBB
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.5489937836698069,1.3894332062370607,0.09218950064020487,0.4396213238499388,1.0,17/33,19.61%,STAT1;STAT3;ARNT;RAB7B;MAPK11;FOXO3;HMGB2;ACVR1B;ACVR2A;BRD1;FES;HIF1A;STAT5B;PRKDC;ETS1;INHBA;MED1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6702390207304227,1.3887842993934236,0.14492753623188406,0.4406974741917045,1.0,3/11,7.98%,CXCL12;IRF7;MERTK
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5811721974805094,1.3885773100425962,0.11261872455902307,0.4405431854299671,1.0,5/23,8.09%,ENPP1;GLI3;KCTD21;SUFU;GPR161
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5098514916630599,1.3884149128001697,0.0757396449704142,0.4402051813024973,1.0,14/55,17.74%,PSMA7;FBXL7;CUL1;PINX1;SKP1;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1
prerank,positive regulation of proteolysis (GO:0045862),0.5029276578817901,1.3879752331349753,0.05764705882352941,0.44062613666889017,1.0,15/55,13.06%,CCBE1;NKD2;TNIP1;APOE;PLK1;OGT;SNX33;SNX9;RCN3;CASP8;CLN6;CTSC;FBXW11;TNF;TANK
prerank,negative regulation of autophagosome assembly (GO:1902902),0.6465636470140206,1.3878775343037817,0.11160714285714286,0.44017520850571923,1.0,4/13,4.23%,LRRK2;CHMP4A;CHMP4B;TMEM39A
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.507282452258317,1.3863136192812593,0.06976744186046512,0.44380787463817734,1.0,13/53,17.05%,GLMN;DNAAF4;TREM2;APOE;OPHN1;FBXW7;RAD23A;RAD23B;PSMF1;DDRGK1;FMR1;PSMD14;GNA12
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6092281968513497,1.3842540158888323,0.10997067448680352,0.4487722484486343,1.0,6/17,11.10%,SNAI1;SNAI2;JAG1;ACVR1;HEYL;GALNT11
prerank,steroid metabolic process (GO:0008202),0.4887504567545694,1.3839910257966441,0.07238307349665925,0.44873807744907573,1.0,8/72,9.08%,CYP1B1;CYP7B1;DHRS4;SHH;CYP27B1;CYP2A6;HSD11B1;CYP1A1
prerank,positive regulation of neutrophil migration (GO:1902624),0.59856544015258,1.383688313419586,0.11173184357541899,0.44885602227871285,1.0,6/18,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.587720362620441,1.3835368713141074,0.11840228245363767,0.4485250662742823,1.0,3/19,3.88%,RUNX1;ZFPM2;TBX2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.6602679306379735,1.3833471478891806,0.11980830670926518,0.4482490681243284,1.0,5/12,11.30%,NEK6;PRKCA;PLK1;NEK9;CCNB2
prerank,phasic smooth muscle contraction (GO:0014821),0.6745973174436755,1.3828879786596384,0.13814756671899528,0.4487436868264079,1.0,2/10,3.32%,EDN3;HTR1D
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.42538647360107223,-1.3826773370372762,0.06072874493927125,0.5765332198168567,1.0,8/29,9.15%,TJP1;PRKN;KANK3;SHANK3;HIP1R;TWF2;KANK4;SHANK1
prerank,T cell activation involved in immune response (GO:0002286),0.6443369082978025,1.3824278394507858,0.11162079510703364,0.44927023771836,1.0,3/12,8.76%,MDK;ICAM1;LCP1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5350930510191381,1.3822232743226788,0.09351620947630923,0.44908315443193486,1.0,7/37,7.62%,MMP2;ADIPOQ;IGFBP5;PTEN;PPARG;TGFB3;ADAMTS1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.48040861065881035,1.3822212402705762,0.05326086956521739,0.4483498297881049,1.0,14/87,8.91%,PSMA7;ZFP36L1;ZFP36L2;CDKN2B;FBXL7;CUL1;PTEN;PKD2;CDK6;PINX1;SKP1;GPNMB;PSMB8;PSMA6
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5657459727584335,-1.3815859058335358,0.11666666666666667,0.5754563306254553,1.0,5/10,14.13%,CD34;RAPGEF2;KDR;RAP1A;TMEM100
prerank,outflow tract septum morphogenesis (GO:0003148),0.5804630672107295,1.381291187499944,0.09042553191489362,0.4501683854505273,1.0,7/24,5.19%,ROBO2;GATA6;ZFPM2;NRP1;TBX2;PARVA;ACVR1
prerank,cytoplasmic translation (GO:0002181),-0.32623243031389326,-1.381265184595576,0.010309278350515464,0.5720907203357326,1.0,41/91,21.75%,RPL34;RPL36;RPL8;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL22L1;EIF4A2;RPL32;RPL10;RPL15;RPS27;RPL35;DRG2;RPS16;RPL7A;RPS15;RPS29;RPL27;RPS13;EIF3M;RPS19;RPL41;RPLP1;RPL28;GSPT2;RPS17
prerank,chordate embryonic development (GO:0043009),0.5073337228921134,1.3811820104625716,0.08478513356562137,0.4497557238608894,1.0,11/55,10.51%,COL1A1;SULF1;DEAF1;CHD7;ALDH1A2;PKD2;TGFB3;TGFBR1;WNT5A;BMP5;FGFR1
prerank,carbohydrate derivative transport (GO:1901264),0.6054951849711155,1.3803353273253858,0.11190817790530846,0.4512348974081472,1.0,9/18,21.66%,LBP;SLC15A3;PLTP;ABCG1;NPC2;SLC29A1;CPTP;SLC15A2;SLC25A19
prerank,membrane lipid catabolic process (GO:0046466),0.6687336114505849,1.3798120128400009,0.14045801526717558,0.4519466511279533,1.0,1/10,0.18%,CYP1B1
prerank,regulation of establishment of protein localization (GO:0070201),0.6404571771605924,1.3796015238916273,0.12797619047619047,0.45176865658450177,1.0,5/13,18.88%,TREM2;CTSD;CEP120;SCFD1;GAPVD1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.37867590115136984,-1.379270623008709,0.03664921465968586,0.5738158272195854,1.0,25/39,33.61%,ERCC5;ERCC3;UBC;POLD3;CHD1L;PCNA;DDB2;GTF2H2;ERCC1;OGG1;GTF2H4;RFC3;UBA52;GTF2H3;FAN1;POLD2;RBX1;RPA2;PARP1;RFC4;NTHL1;POLD4;RFC2;RPA3;POLK
prerank,regulation of mRNA stability (GO:0043488),0.4645921738730463,1.3792191347338376,0.03441084462982273,0.4520433469425664,1.0,52/145,22.93%,PSMA7;IGF2BP1;ZFP36L1;IGF2BP2;ZFP36L2;PRKCA;E2F1;PUM1;TENT5A;METTL16;CARHSP1;GIGYF2;SAMD4A;CELF1;PSMB8;EXOSC4;PSMA6;DCP2;FTO;XRN1;YWHAZ;TNPO1;PSMF1;ANP32A;YTHDF3;FMR1;DCP1A;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;AKT1;RC3H2;THRAP3;PSMB1;AXIN2;PARN;NUP214;PSMC6;GDNF;EIF4G1;PRKCD;XPO1;RPS27A;YBX1;EXOSC5;ROCK2;PSMB4;YTHDF2;PSMB5;ROCK1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5768595483007731,1.379130894505764,0.11549295774647887,0.4515433602764064,1.0,2/21,7.19%,CEL;ACOX1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.550782410353426,1.3790620100645605,0.10286458333333333,0.45098721379848294,1.0,2/30,0.65%,COL3A1;P2RY10
prerank,regulation of mRNA catabolic process (GO:0061013),0.46210569525450845,1.3777678728045561,0.04105263157894737,0.4537800707160677,1.0,50/121,25.24%,PSMA7;IGF2BP1;ZFP36L1;IGF2BP2;ZFP36L2;PRKCA;PUM1;CARHSP1;SAMD4A;PSMB8;EXOSC4;PSMA6;DCP2;MOV10;XRN1;YWHAZ;TNPO1;PSMF1;ANP32A;YTHDF3;FMR1;DCP1A;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;AKT1;RC3H2;PSMB1;PARN;NUP214;PSMC6;EIF4G1;PRKCD;XPO1;ZC3H12A;RPS27A;EXOSC5;PSMB4;YTHDF2;PSMB5;PCID2;FXR2;PSMD4;ZC3H14;PSMD7;PSMD9;PSMA4;CNOT1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5830050569181451,1.3771191465204844,0.12256267409470752,0.4547918307920225,1.0,2/21,2.96%,EPHA7;BIRC3
prerank,regulation of MAP kinase activity (GO:0043405),0.4740459884001374,1.3768354333832382,0.06060606060606061,0.45490831865046366,1.0,24/92,15.69%,IL34;ADIPOQ;EDN3;TNFSF11;LRRK2;CD40;PDGFRB;EGFR;IRAK3;APOE;NF1;EGF;PTPN1;PIK3R5;FGFR1;PTPRJ;SPRY2;TNF;FGF2;BMP7;TRIB3;PDCD10;TRIB1;FGF18
prerank,cholesterol metabolic process (GO:0008203),0.49021396754765795,1.3766330178351105,0.07366071428571429,0.45471936954685566,1.0,7/68,7.56%,CEL;ABCA1;INSIG2;APOE;ABCG1;MVK;SOAT1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6537177362958604,1.3764465582243284,0.12405446293494705,0.454476988705262,1.0,5/13,11.57%,CBLB;ERRFI1;CBL;SOCS5;ZGPAT
prerank,retinal metabolic process (GO:0042574),0.6556165455924008,1.376422166391737,0.12042682926829268,0.4538282995369139,1.0,2/12,8.12%,CYP1B1;RDH10
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4775335500656511,1.3761808332149257,0.05652173913043478,0.45377256230322677,1.0,17/86,11.22%,EPHA7;IL23R;THBS4;TEC;GHR;FGF7;JAK2;NRP1;EGFR;TREM2;ACVR1;SFRP1;PTPN6;ANGPT1;EFNA5;PTPRJ;VTN
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4796726260314466,1.3758586604688876,0.0596529284164859,0.45391419176449715,1.0,15/87,8.60%,DLC1;GPM6B;PDGFRA;LRP1;RND3;TAOK1;PDGFRB;RICTOR;FSCN1;MDK;BAIAP2;RHOD;CDK10;ARHGEF19;EFNA5
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6532332394993762,1.3755319443150782,0.13924050632911392,0.45411719866055555,1.0,7/12,19.34%,APOBEC1;SETDB1;SETDB2;PPHLN1;RESF1;ATF7IP;TASOR
prerank,renal filtration (GO:0097205),0.6717911413907579,1.375447000093006,0.1274658573596358,0.45362753217367263,1.0,5/10,14.50%,SULF1;TBC1D8B;ITGA3;MYO1E;XPNPEP3
prerank,regulation of lymphocyte activation (GO:0051249),0.6431432203936063,1.3749620123359665,0.13435114503816795,0.45415635153515294,1.0,2/12,5.67%,DCAF15;CCL5
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4495421300430428,-1.3749604458423137,0.08896797153024912,0.5825668226244411,1.0,9/20,21.73%,ADRA1B;ADCY9;RAPGEF2;ADRA1A;PDE4D;ZDHHC21;ADRA2A;DRD2;ADRB2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6758471444117471,1.3749170874119074,0.13935681470137826,0.45355644128206263,1.0,3/10,5.97%,RARB;RXRG;PPARG
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6630530900034822,1.3744062758715587,0.1377049180327869,0.4543342986106342,1.0,2/10,7.40%,ENPP1;PID1
prerank,mammary gland development (GO:0030879),0.5926323912535525,1.374367104853316,0.11307901907356949,0.4537279316247975,1.0,5/21,10.21%,WNT2;GLI2;JAK2;TGFB3;TBX3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.45209227418661174,1.3741657358956125,0.023397761953204477,0.45356507430169285,1.0,35/186,12.58%,PSMA7;RBMS3;BICC1;LRP1;NKD2;TCF7L2;SFRP4;KREMEN1;GLI3;IGFBP4;SNAI2;TLE1;TAX1BP3;APOE;FRZB;MDK;SFRP1;LRP6;PRICKLE1;SIAH2;NXN;MDFI;DKK2;PSMB8;PSMA6;WNT5A;HDAC1;SFRP5;WWTR1;NPHP3;DRAXIN;RNF213;GSK3B;CSNK1A1;PSMF1
prerank,receptor signaling pathway via STAT (GO:0097696),0.5685229663858502,1.3740708945778686,0.10975609756097561,0.45310343188096064,1.0,8/25,10.36%,GHR;STAT1;JAK2;STAT3;PKD2;STAT5A;IFNAR2;CCL2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.46431544533924807,1.374037807702468,0.05425531914893617,0.45246972845904004,1.0,13/117,6.53%,MC5R;IAPP;GPR176;GPR39;ADCY7;TREM2;RXFP2;MYH9;ADCY2;PTGDR;ADM;ADCYAP1R1;GLP2R
prerank,wound healing (GO:0042060),0.4916600064805067,1.373882838276792,0.07593457943925233,0.4522037442438075,1.0,15/62,15.00%,COL3A1;PDGFRA;JAML;CFLAR;MYH9;NF1;HPSE;MIA3;TGFBR1;WNT5A;PPP3CA;TGFB2;FGF2;SMAD3;ANXA6
prerank,actin cytoskeleton reorganization (GO:0031532),0.4864010817039638,1.3737014025498258,0.07126436781609195,0.45202507822485877,1.0,23/63,14.62%,ANTXR1;SYDE1;FARP2;FGF7;AUTS2;NRP1;RICTOR;MYH9;PARVA;RALA;DTNBP1;RAP2A;PTPN1;PDLIM4;GRB2;S1PR2;ANXA1;CDC42BPA;NRK;RHOA;MICALL2;MKLN1;PTK7
prerank,positive regulation of rRNA processing (GO:2000234),-0.565551981320228,-1.3720236243177675,0.1356382978723404,0.5873636174360377,1.0,6/10,27.83%,RIOK1;WDR43;DIMT1;SIRT7;UTP15;TRMT112
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6516929788141113,1.372007562149965,0.1486697965571205,0.4559149709412528,1.0,6/12,14.79%,CHMP4A;CHMP4B;SEC63;SEC61A1;HSPA5;SEC61A2
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4591736969010325,-1.3718559028590924,0.1111111111111111,0.5835869909177577,1.0,5/20,10.35%,CHRM2;PLCB1;AGRN;GNA11;GRK2
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.44851444638981025,-1.3708760535825022,0.11307420494699646,0.58246594731301,1.0,10/22,19.40%,KANK3;GSN;HIP1R;TWF2;TMSB4X;KANK4;TMSB10;PFN1;SLIT2;TWF1
prerank,negative regulation of cellular protein localization (GO:1903828),0.5337649090120372,1.3708574050404037,0.1028858218318695,0.45832387448090783,1.0,13/34,18.70%,ADIPOQ;GPM6B;TAX1BP3;ILRUN;SNX33;GSK3B;SPI1;CTNNA1;LATS2;LEPROT;PICALM;MFHAS1;LEPROTL1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4965104095965001,1.3702256120752654,0.06521739130434782,0.45944203787422977,1.0,27/65,22.28%,PMEPA1;FBN2;SPRED1;SMAD2;FBN1;SMURF2;SPRED2;HTRA3;EMILIN1;WFIKKN1;HTRA4;TGFBR1;LTBP1;TGFB1I1;LDLRAD4;SPRY2;SKOR2;SMAD3;SNX25;SMURF1;NRROS;ZBTB7A;PIN1;ASPN;RPS27A;SNX6;IL17RD
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.34629116759614736,-1.3695909256326972,0.04310344827586207,0.5820148582389233,1.0,35/69,28.94%,COX5A;COX8A;NDUFS1;COX4I1;UQCRC2;NDUFV2;COX6C;COX6B1;NDUFA13;NDUFA6;COX6A1;NDUFA12;COX10;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;COX5B;UQCRB;NDUFA1;NDUFC2;NDUFA10;UQCRH;NDUFS2;UQCRFS1;NDUFB11;UQCC3;COA6;UQCR10;SDHAF2;UQCR11;NDUFS5;NDUFV1
prerank,regulation of actomyosin structure organization (GO:0110020),0.6398563175640422,1.368297685572654,0.12195121951219512,0.4639738491545991,1.0,6/13,14.73%,SLC9A1;ASAP3;ALMS1;CDC42;AKAP13;RAC1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.3297296086277084,-1.3681792818122542,0.012048192771084338,0.5820490078370847,1.0,38/91,20.27%,ARL6IP1;RPL34;SRP19;RPL36;RPL8;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL32;RPL10;RPL15;RPS27;RPL35;SRP9;RPS16;RPL7A;RPS15;RPS29;RPL27;RPS13;RPS19;RPL41;RPLP1;RPL28
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5114108019267297,1.3678733742194265,0.09036860879904875,0.46441232193636994,1.0,13/51,12.90%,IL16;JAK2;CASP1;STAT3;LGALS9;CD36;PYDC1;TMEM106A;LPL;WNT5A;CASP8;TNF;P2RX7
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5952356933390275,1.3674605867082723,0.11267605633802817,0.4648240467392699,1.0,9/18,15.68%,ITGB8;XCL1;LGALS9;LTBP1;TGFB2;SMAD3;SMAD4;LRRC32;HIF1A
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.46801944061905915,-1.3674091350906632,0.090625,0.5803173321503878,1.0,3/19,3.02%,TJP1;BMP6;NEXMIF
prerank,regulation of proteolysis (GO:0030162),0.508428010626392,1.3673863567834685,0.08896797153024912,0.46431091707578154,1.0,13/48,12.26%,KNG1;SERPINE2;DNAJC1;GSAP;SHH;PLK1;PLAT;BAG6;SPOP;OGT;CASP8;CLN6;FBXW11
prerank,response to growth factor (GO:0070848),0.513593184919699,1.3673758189343959,0.09529411764705882,0.46361589546386456,1.0,16/41,21.50%,IBSP;GATA6;ACVR1;SFRP1;TGFBR1;RPS6KB1;ACVR1B;ACVR2A;ACVR1C;STAT5B;ACVRL1;AKT1;SOX2;CPNE3;BMPR1A;EPHA2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.495524082673693,1.3673062491729437,0.0654627539503386,0.4630967435875345,1.0,16/62,13.10%,RUNX1;KMT2A;MEIS2;MAFB;MEIS1;RBBP5;CNOT4;CREBBP;CDK6;TNRC6B;HDAC1;CBFB;KMT2E;MOV10;KMT2B;SPI1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4816433201997962,1.366426436069501,0.06992230854605994,0.4646905925694575,1.0,18/70,20.27%,PSMA7;ITGB5;PDIA3;CD36;PSMB8;PSMA6;CALR;PSMF1;PSMA8;FCGR1A;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;CYBB;PSMC6;TAP1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.32628542123697996,-1.3663445690535578,0.010526315789473684,0.5796835549663449,1.0,37/87,20.27%,RPL34;SRP19;RPL36;RPL8;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL32;RPL10;RPL15;RPS27;RPL35;SRP9;RPS16;RPL7A;RPS15;RPS29;RPL27;RPS13;RPS19;RPL41;RPLP1;RPL28
prerank,replicative senescence (GO:0090399),0.6504262175919939,1.366259091076456,0.12440191387559808,0.4644957146520231,1.0,4/12,8.81%,PLA2R1;ATM;TERT;ATR
prerank,metanephric mesenchyme development (GO:0072075),0.6666562327838872,1.366011855475835,0.13023255813953488,0.4644523479235274,1.0,3/10,5.01%,STAT1;SHH;PKD2
prerank,glycogen metabolic process (GO:0005977),-0.4120724513574383,-1.3656959608944452,0.07883817427385892,0.577555222331577,1.0,6/27,6.91%,PRKAG2;CALM1;GBE1;PGM2L1;PYGM;PYGB
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4945929322585511,1.365544707242776,0.0777262180974478,0.4649788722292406,1.0,9/65,8.91%,PSMA7;FBXL7;CUL1;PABIR1;VPS4A;PINX1;SKP1;PSMB8;PSMA6
prerank,adherens junction organization (GO:0034332),-0.3785147200554455,-1.3647141178206679,0.055900621118012424,0.5765470838740349,1.0,13/48,10.31%,TJP1;CADM2;CDH13;CADM1;ACTB;CDH5;CTNND1;CDH10;RAMP2;CDH1;CDH4;VCL;CDH12
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5213778088872048,-1.3646153801698968,0.10144927536231885,0.5729228310926366,1.0,5/14,8.96%,DMD;ATP1B1;WNK4;WNK3;ANK3
prerank,negative regulation of cell communication (GO:0010648),0.5780578068257973,1.3645059898961343,0.10863509749303621,0.4670458800478152,1.0,6/21,12.88%,ADIPOQ;ACVR1;PTPN1;BRAP;SOCS5;UBASH3B
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5129231296247914,1.3642190831835699,0.09518072289156626,0.46710364706704094,1.0,10/46,5.97%,APOD;TCF7L2;STAT1;TNFAIP3;PDGFRB;CCN4;IGFBP5;AIF1;CCL5;PPARG
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5467836725359121,1.3634607107723113,0.12719891745602166,0.4683830192246301,1.0,11/24,22.90%,PRKD2;EMILIN1;ARNT;PTPN1;VTN;ITGA5;NEDD4;HIF1A;GRB10;TMEM204;ITGB3
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5604568998973953,-1.3626890961685092,0.12303664921465969,0.5745527950656212,1.0,2/10,3.04%,IL15;IL18
prerank,detection of visible light (GO:0009584),-0.48224916541083307,-1.362540395894311,0.12624584717607973,0.57107810079994,1.0,5/16,25.15%,ABCA4;GNA11;RP1;CACNA2D4;TULP1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.5739401287715631,1.3620219358368495,0.12691771269177127,0.4716225192355539,1.0,4/21,5.67%,IL34;CMKLR1;MDK;CCL5
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5858587240119961,1.3617920234379086,0.12343966712898752,0.47152507183379044,1.0,5/18,11.83%,BIRC3;PUM1;SEC14L1;OASL;ANKRD17
prerank,androgen receptor signaling pathway (GO:0030521),0.6568689200262088,1.3611605314904769,0.12618296529968454,0.4724170579476511,1.0,3/11,7.03%,PMEPA1;ZMIZ1;DDX17
prerank,negative regulation of potassium ion transport (GO:0043267),-0.5141512118735713,-1.360412095837704,0.0967741935483871,0.5737916256965832,1.0,2/13,1.56%,CAV1;ACTN2
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6463912668737242,1.3603696481693295,0.1494435612082671,0.4738001496697991,1.0,2/11,1.41%,IGF2BP1;IGF2BP2
prerank,T cell receptor signaling pathway (GO:0050852),0.45354866245375286,1.3603015881412126,0.04416403785488959,0.4732749971384007,1.0,30/138,17.74%,PSMA7;RFTN1;TNFRSF21;TEC;CD276;STOML2;CUL1;LCP2;KHDRBS1;NCK1;PRKD2;SKP1;PSMB8;PSMA6;PTPRJ;NFKBIZ;FBXW11;PSMF1;SPPL3;PIK3R1;PSMA8;PSMD2;PSMD12;PSMD11;RBCK1;EIF2B3;PSMD14;PTPRC;RC3H2;PSMB1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4924150715476461,1.3601110637828644,0.09195402298850575,0.4730873904635313,1.0,17/62,17.55%,CREB3L1;CXCL12;SNAI1;LRRK2;SNAI2;BCL2;ENO1;BCL2L2;NOC2L;CCAR2;TMEM161A;NFE2L2;YBX3;SRC;CREB3;AKT1;MDM2
prerank,thyroid hormone generation (GO:0006590),0.6581978603445666,1.3598100271038402,0.15822784810126583,0.4731863309413663,1.0,3/10,6.69%,CPQ;CTSK;FOXE1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6551605316984639,1.3594440331141702,0.1507293354943274,0.4733791260101466,1.0,3/10,5.04%,CXCL12;BLK;LGALS9
prerank,negative regulation of response to external stimulus (GO:0032102),0.46222368125755886,1.3588783362238595,0.04849137931034483,0.4743542548831352,1.0,12/105,5.97%,RORA;NR1H4;ADIPOQ;TNFAIP3;IRAK3;APOE;CASK;PTEN;ILRUN;MVK;TRIM21;PPARG
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.628548982001184,1.3582589610823266,0.13157894736842105,0.4753726121504142,1.0,1/14,0.33%,ENPP1
prerank,endomembrane system organization (GO:0010256),0.44545528632224585,1.3581372395969034,0.03790983606557377,0.4750296080517549,1.0,59/178,20.02%,SEC16B;SEC31A;VMP1;GORASP2;LRRK2;ATP8B1;RAB2A;ARFGEF2;TLCD2;HOOK2;PI4K2B;DNAJC13;STX17;WASHC4;ATL2;CDC42;VPS4A;COG4;MIA3;LMAN2L;VAPA;LEMD2;GBF1;AP3D1;GOLGA8B;GOLGA5;TRIP11;SEC16A;GAK;LMAN1;SNX33;SEC23IP;PLEKHF1;SNX10;CSNK1A1;TMED1;RAB1A;SEC61A1;DYNC2H1;TMCC1;LYSMD3;CHMP2B;SUN1;SQSTM1;ALS2;COG7;TOR1AIP2;OBSL1;TBC1D20;CSNK1D;EIF2AK3;SPTSSB;TMED5;SPTBN1;BCAS3;TJAP1;HOOK1;UBXN2A;WASHC5
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5518289272015036,1.3581214910836026,0.11197916666666667,0.4743577745868114,1.0,7/29,8.68%,COPA;COPZ2;COPZ1;COPB2;GOSR1;GOLGA5;COPG1
prerank,ethanol metabolic process (GO:0006067),-0.5401373415990386,-1.3580210348899637,0.12742382271468145,0.5768208471389781,1.0,5/12,20.01%,ALDH1A1;SULT1A1;ALDH2;ACSS1;ACSS2
prerank,positive regulation of cell motility (GO:2000147),0.44759684866862154,1.3578508712952142,0.022267206477732792,0.4743558769262548,1.0,28/205,6.61%,ROR2;CCL11;COL1A1;CCL7;CEMIP;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;MAP4K4;SNAI1;CCAR1;PDGFRB;SNAI2;PRKCA;EGFR;STAT3;MDK;CCR1;AIF1;ACVR1;RHOD;CARMIL1;CCL5;EGF;ATM;EPHA1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5161923242951846,-1.3576511317267015,0.12312312312312312,0.5741965145327481,1.0,7/13,26.51%,NAMPT;PARP16;NUDT12;NNMT;PARP10;NAXE;NAPRT
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.587127340088445,1.3575181589596685,0.12280701754385964,0.4745849600293912,1.0,1/18,0.16%,RAD51B
prerank,cell-matrix adhesion (GO:0007160),0.46677318907445947,1.3566827229340879,0.06587473002159827,0.4761543714513576,1.0,29/95,17.86%,DLC1;COL3A1;ITGB8;TNN;COL13A1;ITGB5;PEAK1;ITGA8;RHOD;HPSE;EMILIN1;ADAMTS12;L1CAM;ITGA11;ADAMTS9;TMEM8B;ITGBL1;ITGA3;VTN;NID2;MKLN1;SRC;RAC1;CD63;ITGA1;ITGB1BP1;CTTN;TESK2;FERMT3
prerank,response to hexose (GO:0009746),0.5572688878786846,1.3559693929959227,0.12121212121212122,0.4773759572621225,1.0,5/25,11.73%,ADIPOQ;TCF7L2;LPL;KHK;ZBED3
prerank,nitric oxide metabolic process (GO:0046209),0.6238853561474833,1.3557377910758113,0.13323572474377746,0.4772873418179122,1.0,1/14,0.18%,CYP1B1
prerank,vasculature development (GO:0001944),0.6005255456724374,1.3555658661377685,0.12406576980568013,0.477075827072646,1.0,4/16,8.41%,PDGFRA;PDGFRB;ERRFI1;FBXW7
prerank,regulation of cellular amine metabolic process (GO:0033238),0.5007365118958745,1.3551164499811588,0.09079903147699758,0.47753601712143295,1.0,11/50,17.74%,PSMA7;OAZ3;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5176112657638094,1.3550849099717126,0.11219512195121951,0.4769017916591452,1.0,15/39,16.53%,YAP1;ROBO2;ZMIZ1;MAML3;STAT3;JAG1;CREBBP;MAML2;NEPRO;TGFB2;MAML1;SRC;PDCD10;ITGB1BP1;TSPAN14
prerank,negative regulation of viral life cycle (GO:1903901),-0.4894410179846531,-1.3548599379936161,0.0990990990990991,0.5783890018019819,1.0,5/15,20.07%,GSN;LY6E;PPIA;BST2;MID2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4383993624594333,1.35475621790941,0.005025125628140704,0.4771292686803566,1.0,58/308,12.66%,GLMN;ABCA1;COL1A1;ADIPOQ;LBP;LRP1;PLAC8;SNAI1;GHR;SYDE1;SOX5;PTN;B4GALT5;CMKLR1;JAK2;BATF;NKX6-1;SMAD2;TREM2;APOE;DYNC1H1;MDK;SHH;SMURF2;PLA2R1;BMP1;ACVR1;CYP27B1;CD36;EGF;ALMS1;OMA1;TGFB3;EIF2AK2;ENO1;EHMT1;INHBB;TMEM119;SHLD3;TERT;CXCR4;TGFBR1;OGT;WNT5A;HCRT;TGFB1I1;ACVR1B;GAPDH;WWTR1;PDPN;TGFB2;GCNT2;ZBED3;TNF;FGF2;TAPT1;ELOVL6;FABP5
prerank,regulation of interferon-gamma production (GO:0032649),0.482210105360361,1.3547192378161943,0.07239819004524888,0.4765398442784487,1.0,8/71,8.14%,NR1H4;IL23R;CD276;IL1R1;XCL1;LGALS9;TLR7;CD14
prerank,defense response to bacterium (GO:0042742),0.461687548662325,1.3543209936158647,0.05190677966101695,0.4769211326624734,1.0,13/105,10.16%,IL23R;LBP;SPN;COLEC12;CRP;TLR2;TREM2;NOD1;RNASE7;MPEG1;TIRAP;HMGB2;GBP7
prerank,neuron migration (GO:0001764),0.5046434660609832,1.354094644120373,0.0971563981042654,0.47685218786329403,1.0,14/48,12.48%,DNAAF4;LRP12;MDGA1;AUTS2;NRP1;NAV1;ADGRL3;MARK1;USP9X;ASTN2;SH3RF1;DISC1;FGFR1;FGF13
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.6315106636112832,1.353635857852286,0.14666666666666667,0.47738237872865846,1.0,2/14,2.43%,CREB3L1;LRRK2
prerank,negative regulation of autophagy (GO:0010507),0.49316296177660035,1.3534299759666693,0.08266360505166476,0.47724684212543766,1.0,17/54,18.15%,DAP;EIF4G2;LRRK2;EIF4G3;KLHL22;TREM2;STAT3;BCL2;FOXK2;ATG7;SMCR8;WASHC1;MTMR9;AKT1;CTSA;CPTP;USP36
prerank,positive regulation of bone mineralization (GO:0030501),0.5290085016688467,1.3532593301372908,0.1076923076923077,0.4770066730399534,1.0,11/35,14.04%,GPM6B;FBN2;PTN;NELL1;ACVR1;TGFB3;TMEM119;ATP2B1;ACVR2A;P2RX7;BMP7
prerank,secondary alcohol metabolic process (GO:1902652),0.5146094926646522,1.3530178723364537,0.0959902794653706,0.47695748425322715,1.0,8/42,13.25%,ABCA1;APOE;ABCG1;SOAT1;IDH2;OSBPL5;CLN6;IDH3B
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.584903222867176,1.3525179296664485,0.14964028776978416,0.47766094889935895,1.0,4/18,7.78%,CMKLR1;BLK;BAG6;SH2B2
prerank,glucose import (GO:0046323),-0.5192970448968419,-1.3503648606695,0.13274336283185842,0.5876988491263366,1.0,3/13,10.23%,SLC2A1;SORT1;SLC27A1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5963435009838732,1.3502283360374625,0.14285714285714285,0.48324128816825757,1.0,4/18,8.41%,LRRC17;MAFB;FBN1;FBXW7
prerank,positive regulation of apoptotic process (GO:0043065),0.43883427146047793,1.350119932259717,0.008008008008008008,0.4828281946412353,1.0,89/293,22.27%,FAP;CYP1B1;DLC1;ZBP1;EPHA7;ADIPOQ;KNG1;IAPP;SFRP4;BCL6;CCAR1;VAV2;VAV3;KALRN;ITSN1;FRZB;E2F1;CTSD;NF1;PPID;FGD4;TNFRSF12A;ATM;OMA1;SFRP1;TGFB3;RASSF2;RRP1B;PHLDA1;AIFM2;EEF1E1;CCAR2;BTG1;ARHGEF19;SAP18;TRIO;TGFBR1;FOXO3;IP6K2;ARHGEF12;PREX1;TGFB2;CASP8;ATG7;VAV1;TNF;NLRP2B;AKAP13;ACVR1C;CALHM2;SPHK2;PSEN1;ARHGEF18;DAPK2;RIPK1;PSENEN;PAWR;SQSTM1;STK4;OLFM1;AIFM1;HSPD1;PTPA;DUSP6;LATS2;ING5;ANO6;ATF4;CLIP3;DDX20;PLEKHG2;PRNP;TLE5;GADD45A;HMGA2;NCSTN;UTP11;ARHGEF26;TIAM2;UBE2Z;MAP3K20;ZC3H12A;PSEN2;RPS27A;RARG;ARHGEF17;CLU;LATS1;ARHGEF1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5952840092046443,1.349074191169641,0.14903129657228018,0.4850110146001247,1.0,4/15,9.03%,PDGFRA;MTHFD1L;HOXA1;TGFBR1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6464969273339672,1.348496460101737,0.14696969696969697,0.4859098617679857,1.0,3/12,6.77%,PARP8;PARP3;PARP11
prerank,nitric oxide biosynthetic process (GO:0006809),0.6276343995212497,1.3480052080351153,0.14008941877794337,0.486476388238403,1.0,1/13,0.18%,CYP1B1
prerank,digestive tract morphogenesis (GO:0048546),0.6037103194041249,1.3476655744984445,0.14854517611026033,0.48665568642664964,1.0,2/14,3.57%,PDGFRA;EPHB3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.44909224861301533,1.3473858695713172,0.04564315352697095,0.48672488087835764,1.0,35/145,17.74%,PSMA7;RAD51B;DYNLL1;FBXL7;DYNC1H1;CUL1;TUBG1;ALMS1;PLK1;PCM1;HAUS3;PINX1;SKP1;CEP41;CNTRL;DCTN3;PSMB8;PSMA6;TPX2;PCNT;CEP72;PSMF1;ACTR1A;AKAP9;PSMA8;PSMD2;PSMD12;CEP192;PSMD11;PSMD14;CSNK1D;YWHAE;BRD4;CKAP5;PSMB1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5443078671426012,1.3470820949096103,0.11559139784946236,0.48681309844550746,1.0,7/29,11.91%,SPRED1;SPRED2;PTEN;SFRP1;BMP5;LDLRAD4;SPRY2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4697754040490057,1.3462762300892985,0.0737073707370737,0.4883333488235493,1.0,28/87,18.40%,ZFP36L1;FLRT2;EGR3;ZFP36L2;FGF7;SPRED1;GALNT3;SPRED2;CCL5;SFRP1;CBL;GRB2;GTF2F2;FRS2;NCBP2;CCL2;FGFR1;FGF2;GTF2F1;KIF16B;SETX;FGF18;ITGB1BP1;MAPK1;RBFOX2;POLR2L;POLR2K;DSTYK
prerank,Wnt signaling pathway (GO:0016055),0.46881461253837564,1.3460531705754195,0.0787139689578714,0.4882140415807665,1.0,21/92,12.56%,WNT2;TCF7L2;SFRP4;LRRK2;WNT9A;FRZB;CUL1;PTEN;STRN;FZD1;SFRP1;LRP6;NXN;SKP1;WNT5A;SFRP5;WLS;TCF7;CSNK1G2;GSK3B;CSNK1A1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.4953361596322272,1.346014372553136,0.09700598802395209,0.48758859662711523,1.0,12/53,17.74%,PSMA7;OAZ3;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PPM1K;PSMB1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.6277368456545415,1.3457664522166823,0.15432098765432098,0.4875853808040798,1.0,3/13,12.90%,ENPP1;TPST1;SULT4A1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5567833103796299,1.345275534019181,0.13447782546494993,0.48826924465331567,1.0,5/21,9.11%,ZFP36L1;ZFP36L2;LGALS9;EGF;MAP2K1
prerank,cellular response to growth factor stimulus (GO:0071363),0.44554993367238016,1.3452141310503778,0.04933196300102775,0.48773437208832715,1.0,36/151,14.44%,RUNX2;IBSP;PDE3A;WNT2;ZFP36L1;SOX5;EGR3;ZFP36L2;SNAI2;XCL1;NRP1;EGFR;PRKD2;ACVR1;LIMS1;CCL5;SFRP1;VSTM2A;ADAMTS12;GAS1;ANXA1;TGFBR1;WNT5A;RPS6KB1;ACVR1B;CCL2;ACVR2A;SPRY2;NTRK3;ADAMTS7;ACVR1C;GAREM1;SMAD3;ACAP2;BMP7;SMAD4
prerank,regulation of interleukin-4 production (GO:0032673),-0.45163637678368673,-1.3449532610550878,0.11940298507462686,0.6003202068873927,1.0,8/21,20.15%,PRKCZ;LEF1;SLC7A5;PRKCQ;SYK;ZFPM1;HAVCR2;FCER1G
prerank,organophosphate catabolic process (GO:0046434),0.6459222720331488,1.344895057965219,0.16901408450704225,0.48784953654209096,1.0,1/11,1.24%,PDXP
prerank,calcium ion homeostasis (GO:0055074),0.4665567110489473,1.3443516111725715,0.06337271750805586,0.4886587257035943,1.0,18/95,12.14%,CCL11;CCL7;EDN3;CXCL12;CD40;STOML2;CCR1;FAM20A;CYP27B1;SLC24A5;CCL5;ATP2A2;DRD3;SELENON;TMEM203;ATP2B1;CALR;TPCN2
prerank,histone lysine methylation (GO:0034968),0.5272954392837538,1.3443343011186881,0.11182519280205655,0.4880131913723974,1.0,10/33,15.80%,KMT2A;CXXC1;RBBP5;PRDM5;SETMAR;SETDB1;SETDB2;KMT2B;PAXIP1;WDR5B
prerank,muscle tissue morphogenesis (GO:0060415),-0.48231945375516233,-1.3439262839412427,0.142433234421365,0.5995830728456202,1.0,6/16,18.68%,TGFBR3;BMP4;PROX1;TBX1;HEY2;ZFPM1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4737754998373323,1.3438316424867178,0.0700985761226725,0.48874695701643334,1.0,26/79,20.69%,CREB3L1;SULF1;CASK;SMURF2;PPARG;HTRA3;EMILIN1;ADAMTS12;PTPN1;LEMD2;SMAD5;BMPER;ACVR2A;SPRY2;FGF2;SKOR2;SMAD4;SMAD1;SMURF1;NEDD4;CHRD;TRIM33;AGT;VWC2;SPRY4;BMPR1A
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.6342698797835522,1.3436877698349048,0.14330708661417324,0.48841607967026807,1.0,4/11,9.47%,ZMIZ1;SERTAD2;PADI2;ARID1B
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.45931326598781275,1.3432559961445147,0.05519480519480519,0.4888695698427752,1.0,26/108,17.60%,CASP4;DLC1;DAP;CASP8AP2;JAK2;CFLAR;CASP1;BBC3;CTSD;CASP12;IFT57;LGALS9;NOD1;PPARG;HSPE1;CASP8;TNF;ACVR1C;TRAF2;SMAD3;BCL2L13;RIPK1;CYCS;AIFM1;HSPD1;EIF2AK3
prerank,zinc ion transport (GO:0006829),0.5675982320961435,1.3428160194472376,0.13249651324965134,0.4893856340066678,1.0,1/21,0.13%,SLC39A14
prerank,regulation of innate immune response (GO:0045088),0.49072633445117353,1.342799627976921,0.09859154929577464,0.48874074814249113,1.0,15/57,12.43%,TNFAIP3;BIRC3;IRAK3;TREM2;TRIM21;CCL5;PTPN6;IRF1;IFNAR2;PTPN1;ABCE1;TIRAP;CDC37;CASP8;POLR3D
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5000326619278558,1.342626013184898,0.09429569266589057,0.4884985925263091,1.0,8/52,7.13%,CXXC1;SEC31A;ERN2;WIPI1;KDELR3;ARFGAP1;DDX11;YIF1A
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5338081568674721,1.3424767855243602,0.10763454317897372,0.4881949758606276,1.0,15/33,18.89%,STAT3;PPARG;TERT;FOXO3;TEAD1;TGFB2;TNF;FGF2;GNL3;SPI1;SMAD3;HIF1A;SMARCA4;ETS1;NR3C1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.57803634027377,1.3421912722073372,0.15384615384615385,0.4882717827231404,1.0,4/18,3.61%,VSIG4;TNFAIP3;XCL1;NAV3
prerank,actin filament bundle organization (GO:0061572),0.5333550761920588,1.340770884708276,0.1025,0.4914497935938412,1.0,10/33,8.76%,MYO1B;DPYSL3;CALD1;FSCN1;LIMA1;BAIAP2;AIF1;RHOD;ADD2;LCP1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4672413487770711,1.3406193485676448,0.07362637362637363,0.4911634513051387,1.0,13/85,5.95%,RUNX3;LAMB1;YAP1;DEAF1;ZFP36L1;TCF7L2;LAMC1;FGF7;CDKN2B;EGFR;LIMS1;CDK6;SFRP1
prerank,potassium ion transport (GO:0006813),-0.3061184940489156,-1.3404891258078782,0.0,0.6059753060094493,1.0,32/120,15.85%,ATP1A2;ATP1B3;KCNC2;SLC24A2;KCND3;SLC9A2;KCNB2;KCNK5;KCND2;KCNQ5;KCNH5;TMEM175;KCNH7;KCNJ2;KCNJ3;KCNK10;KCNJ13;ABCC9;KCNQ3;KCNQ4;KCNJ10;SLC9A6;KCNK2;SLC9A7;KCNQ1;LRRC38;KCNJ12;CCDC51;KCNN2;NALCN;KCNN3;KCNC1
prerank,homologous chromosome segregation (GO:0045143),-0.4471077277398903,-1.340181681447831,0.10702341137123746,0.6030420707743102,1.0,15/20,51.41%,CENPC;SIRT7;PTTG1;FMN2;PRDM9;MEI4;SGO1;MEIOB;ZCWPW1;IHO1;FANCD2;RNF212B;MEIKIN;ANKRD31;TERB2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5835480198258874,1.3396744996764698,0.14644351464435146,0.4930005505496638,1.0,4/18,15.88%,ZFP36L1;ZFP36L2;PRDM1;PRKDC
prerank,response to hydrogen peroxide (GO:0042542),0.5045315149650857,1.3393364422745588,0.12224938875305623,0.49319072560068,1.0,10/45,15.17%,CYP1B1;HP;TNFAIP3;FXN;ANXA1;NFE2L2;STK24;PDCD10;RIPK1;SETX
prerank,endothelial cell development (GO:0001885),0.5485989586443969,1.3390894789351828,0.1565934065934066,0.49320552955713115,1.0,2/25,0.19%,COL15A1;COL18A1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5479300656567309,1.3388747853486975,0.13066666666666665,0.49312440912928923,1.0,8/27,11.00%,ENPP1;IRS1;NCK1;PIP4K2A;PTPN1;PID1;RPS6KB1;PTPN2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.46971497722859895,1.3384482225728522,0.07298474945533769,0.4936966082728324,1.0,15/85,11.96%,ROR1;COL1A1;CEMIP;COL11A2;SNAI2;CRYM;COL11A1;PIEZO2;MYO7A;HOXA1;TPRN;TBL1X;TSPEAR;ALDH7A1;MYO3A
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5725127349486933,1.3381800568093996,0.16061452513966482,0.49377914402250445,1.0,5/19,14.90%,ENPP1;PAPSS2;TPST1;SULT4A1;SLC35B3
prerank,regulation of translational initiation (GO:0006446),0.4846580198208995,1.337760235364443,0.09395973154362416,0.4942918298951225,1.0,30/63,23.22%,EIF4G2;CTIF;EIF4G3;KHDRBS1;NCK1;NCK2;CCL5;EIF3H;EIF5B;EIF5;RPS6KB1;NCBP2;ALKBH1;EIF4EBP1;MTIF2;YTHDF3;FMR1;EIF1;KLHL25;DNAJC3;DDX1;EIF2AK3;ATF4;AGO2;EIF4G1;CSDE1;HABP4;EIF3E;YTHDF2;POLR2D
prerank,regulation of viral life cycle (GO:1903900),0.5710572214025571,1.337664852095173,0.13630229419703105,0.4938979861065889,1.0,11/21,25.13%,TRIML2;TRIM21;VPS4A;TYRO3;KPNA2;TRIM6;TRIM27;TRIM62;HS3ST5;TSG101;AXL
prerank,cellular response to BMP stimulus (GO:0071773),0.47584664285177475,1.3373849868062293,0.10854503464203233,0.49395431694386094,1.0,21/66,17.85%,RUNX2;SMAD2;USP9X;ACVR1;HIVEP1;SFRP1;TGFB3;VSTM2A;ADAMTS12;SMAD5;BMP5;TGFB2;ACVR2A;ADAMTS7;SMAD3;BMP7;SMAD4;SMAD1;SMURF1;ACVRL1;ZFYVE16
prerank,regulation of keratinocyte migration (GO:0051547),0.6320569502685872,1.3368160159634868,0.13771517996870108,0.494832186435762,1.0,4/12,10.79%,MAP4K4;FGF7;PTEN;MAPRE2
prerank,organelle organization (GO:0006996),0.43215018375317993,1.3368133652363223,0.004,0.49414870711213904,1.0,107/388,19.44%,CCL11;CCL7;KRT25;SEC16B;PALLD;SEC31A;VMP1;SH3KBP1;FMNL2;GORASP2;MAST4;PEX10;LRRK2;ATP8B1;TNFAIP3;STOML2;SIPA1L3;MARK1;RAB2A;APOE;CHMP4A;CHMP4B;FMNL3;MDK;PPRC1;IQCG;PKD2;PPID;VPS13C;FGD4;PI4K2B;STX17;ATL2;CDC42;VPS4A;ADCK1;COG4;MIA3;LMAN2L;RAB7A;VAPA;ABI2;TTC17;GBF1;MTX2;GOLGA8B;GOLGA5;MAST2;TERT;TRIP11;FAM161A;WDPCP;RAB32;SEC16A;BRWD1;CCL2;GAK;LMAN1;TTC29;PDZD8;ZMYM4;SEC23IP;FGD6;AGTPBP1;PEX19;PLEKHF1;EPS15;CSNK1A1;CFAP410;TMED1;CHMP7;RAB1A;RAB3GAP1;SEC61A1;DYNC2H1;RAB34;TMCC1;YTHDF3;WTIP;RANBP9;GABPB1;MTX1;SIRT3;PEX11A;LYSMD3;CYCS;CHMP2B;COG7;TOR1AIP2;OBSL1;TBC1D20;POLRMT;CSNK1D;PEX6;PITPNB;KIF9;EIF2AK3;ZFYVE16;SPTSSB;ATP7A;TMED5;BCAS3;TJAP1;CAMSAP1;GABPA;PEX12;TPM1
prerank,regulation of cell-cell adhesion (GO:0022407),0.5119510061750545,1.336752291150849,0.11866501854140915,0.4936058137576661,1.0,10/39,11.01%,EPHA7;B4GALNT2;MDGA1;FLOT2;TENM3;EPHB3;JAG1;NF2;EFNA5;PTK2
prerank,negative regulation of cell activation (GO:0050866),0.6162634997620615,1.3363626166168194,0.17298937784522003,0.49398587678562694,1.0,4/14,6.74%,PDGFRA;TREM2;APOE;EMILIN1
prerank,neuron remodeling (GO:0016322),0.6549932726648726,1.3359957899014054,0.1637239165329053,0.4942562181298219,1.0,2/10,1.83%,C3;FARP2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4658168708171992,1.335129871251412,0.08714596949891068,0.49511837640203393,1.0,15/78,7.74%,CLTC;SEC31A;DYNLL1;SEC24D;SEC23A;DYNC1H1;CTSD;SEC24A;KIF2A;CTSS;DCTN4;CTSL;RAB7A;CANX;DCTN3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4658168708171992,1.335129871251412,0.08714596949891068,0.49511837640203393,1.0,15/78,7.74%,CLTC;SEC31A;DYNLL1;SEC24D;SEC23A;DYNC1H1;CTSD;SEC24A;KIF2A;CTSS;DCTN4;CTSL;RAB7A;CANX;DCTN3
prerank,protein targeting to ER (GO:0045047),-0.3108139562607163,-1.335001567423639,0.01098901098901099,0.6147338479014464,1.0,48/99,24.63%,RPL34;SRP19;SPCS2;RPL36;RPL8;SRPRB;RPS4X;RPL18A;RPL19;RPL38;RPS21;RPL5;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;SPCS3;RPL32;RPL10;RPL15;RPS27;RPL35;SRP9;RPS16;RPL7A;RPS15;RPS29;RPL27;SEC61G;RPS13;RPS19;RPL41;RPLP1;RPL28;SGTA;RPS17;SPCS1;RPL23A;ZFAND2A;UBA52;ZFAND2B
prerank,mRNA 3'-end processing (GO:0031124),-0.33113768342210265,-1.3347666835790968,0.03125,0.6116660959300053,1.0,29/78,25.42%,CDC40;SRSF5;WDR33;CSTF2;PABPC1;RPRD2;U2AF2;RPRD1A;LEO1;APP;TUT1;SRSF7;SRSF9;RBM8A;CHTOP;CPSF2;MAGOH;ZC3H11A;EIF4A3;LSM11;SRSF3;CLP1;POLDIP3;CPSF4;SARNP;PAPOLB;DDX39B;DDX39A;THOC1
prerank,cellular iron ion homeostasis (GO:0006879),0.480668138917393,1.3347070058478332,0.10623556581986143,0.4955743811317801,1.0,8/55,7.29%,SLC39A14;HEPH;CP;SLC11A2;FXN;CUL1;ACO1;SKP1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.44293137287415074,-1.333800897976594,0.11231884057971014,0.6107888084475929,1.0,5/21,2.77%,DMD;ATP1A2;AKAP6;ANK2;CALM1
prerank,aerobic electron transport chain (GO:0019646),-0.34201393402282687,-1.3334559655337432,0.0625,0.6079040359829584,1.0,35/68,29.96%,COX5A;COX8A;NDUFS1;COX4I1;UQCRC2;NDUFV2;COX6C;COX6B1;NDUFA13;NDUFA6;COX6A1;NDUFA12;COX10;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;COX5B;UQCRB;NDUFA1;NDUFC2;NDUFA10;UQCRH;NDUFS2;UQCRFS1;NDUFB11;UQCC3;UQCR10;SDHAF2;UQCR11;NDUFS5;NDUFV1;SDHA
prerank,cellular response to superoxide (GO:0071451),-0.5753801846111508,-1.3334171000111465,0.16246498599439776,0.6042774317483878,1.0,6/10,22.69%,NOS3;SOD1;PRDX2;SOD3;SOD2;ADPRS
prerank,fatty acid elongation (GO:0030497),-0.5011881181685856,-1.3324976366816932,0.15142857142857144,0.6034101244717978,1.0,6/13,10.49%,TECR;ELOVL7;ELOVL5;HACD1;HACD3;HACD4
prerank,protein localization to condensed chromosome (GO:1903083),-0.519677204334374,-1.3323963551483566,0.1518624641833811,0.6000466666059393,1.0,9/12,39.44%,ZWILCH;IK;BUB3;KNL1;TTK;ZW10;MTBP;SPDL1;CDK1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.6523928438101217,1.3314136112310262,0.15517241379310345,0.5037248930396914,1.0,5/10,11.96%,OPHN1;RAP2A;CDC42;MSN;RHOA
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5307519387792593,-1.331286153121162,0.14328358208955225,0.5995576046858239,1.0,4/12,7.68%,SORBS1;PRKCZ;GKAP1;SORL1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.6311963241150784,1.3311371934000042,0.1484375,0.5038062171583698,1.0,5/12,11.46%,SDK2;STAT3;MYO7A;DSCAM;AGTPBP1
prerank,negative regulation of cellular process (GO:0048523),0.42844560597166076,1.3310044121035083,0.005,0.5034883977044349,1.0,81/521,11.44%,ROR2;GLMN;CYP1B1;COL18A1;DLC1;ENPP1;ADIPOQ;RUNX3;KNG1;CXCL1;IGFBP7;FBLN1;TNFRSF21;PPP1R9B;SPN;SFRP4;BCL6;TLR2;SLIT3;PRTN3;JAK2;CCN4;WNT9A;PLXNC1;CDKN2B;TREM2;SERTAD2;CHMP4B;FRZB;MDK;CASK;MYH9;SHH;MYBL1;NCK1;ALDH1A2;PTEN;BCL2;PKD2;VPS13C;CYP27B1;NCK2;NF2;STRN;CDK6;SFRP1;TGFB3;EIF2AK2;ENO1;PTPN6;PDS5B;EMILIN1;PLXND1;PINX1;MIA3;IRF1;ARHGDIG;ADAMTS1;CDK10;EEF1E1;ANGPT1;CCAR2;FRK;CELF1;BTG1;GPNMB;PLXNA3;SP100;MAP2K1;SFRP5;IP6K2;BMP5;TGFB1I1;ACVR1B;RERG;PTPRJ;KLF10;PTPN2;DSCAM;PDPN;TGFB2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4393751600646196,1.3306127291314787,0.04248704663212435,0.5038633623538677,1.0,36/163,17.74%,PSMA7;RFTN1;TNFRSF21;TEC;CD276;STOML2;VAV3;BLK;CUL1;LCP2;KHDRBS1;NCK1;BCL2;PRKD2;SKP1;SH2B2;PSMB8;PSMA6;LAT2;MS4A1;PTPRJ;NFKBIZ;FBXW11;PSMF1;SPPL3;PIK3R1;PSMA8;PSMD2;PSMD12;PSMD11;RBCK1;EIF2B3;PSMD14;PTPRC;RC3H2;PSMB1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5142656938836337,-1.330575283550231,0.13595166163141995,0.5979866847511628,1.0,4/13,7.68%,SORBS1;PRKCZ;GKAP1;SORL1
prerank,myofibril assembly (GO:0030239),0.4969755440136322,1.33025547715554,0.11386138613861387,0.5041619240386863,1.0,6/42,7.35%,PDGFRA;CSRP1;PDGFRB;CFLAR;FHOD3;TMOD1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.48880039326731173,-1.3298496717983983,0.12091503267973856,0.596622990237493,1.0,14/16,49.62%,CADM1;AP1G1;LAMP1;PVR;RAET1E;NECTIN2;RASGRP1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6033333641641685,1.3297316128387964,0.17418351477449456,0.5049057489338936,1.0,2/13,2.74%,SNAI1;SNAI2
prerank,regulation of RNA export from nucleus (GO:0046831),0.6363644287863842,1.3296160897390672,0.17917304747320062,0.5045450085500317,1.0,5/11,18.74%,KHDRBS1;SETD2;NCBP2;NUP153;IWS1
prerank,positive regulation of calcium ion transport (GO:0051928),0.5194664101565066,1.3294432987637934,0.1275,0.5043381717804126,1.0,11/36,13.14%,CXCL12;PDGFRB;P2RX5;CCR1;TRPC6;CCL5;MYLK;CCL2;ATP2B1;P2RX7;SPHK2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5434171948166623,1.3293180091178511,0.13172043010752688,0.5040027841245429,1.0,8/28,11.00%,ENPP1;IRS1;NCK1;PIP4K2A;PTPN1;PID1;RPS6KB1;PTPN2
prerank,negative regulation of cholesterol transport (GO:0032375),0.6530815722303123,1.3290056060224533,0.1642512077294686,0.5041937626260053,1.0,2/10,4.42%,ABCA2;SHH
prerank,negative regulation of MAP kinase activity (GO:0043407),0.4941743064618546,1.3286847735946057,0.1263408820023838,0.504391146314807,1.0,14/44,20.54%,ADIPOQ;IRAK3;APOE;AIDA;NF1;PTPN1;HIPK3;PTPRJ;SPRY2;BMP7;MAPK8IP1;AGT;SPRY4;PRKCD
prerank,zinc ion transmembrane transport (GO:0071577),0.5505670734918772,1.32849715226586,0.1331521739130435,0.5042478576867927,1.0,1/22,0.13%,SLC39A14
prerank,artery development (GO:0060840),0.5526027484344538,1.3284390032806495,0.13557046979865772,0.5037279960616263,1.0,6/23,9.03%,ROBO2;NRP1;PKD2;NF1;HOXA1;TGFBR1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.4792259919741928,-1.3279244109953066,0.14779874213836477,0.5986708345743237,1.0,8/16,29.16%,LDLR;SCARB1;SLC27A1;GPLD1;MFSD2A;PNPLA2;ABHD5;NR1H2
prerank,regulation of type I interferon production (GO:0032479),0.4627813412286064,1.327781281835121,0.06930693069306931,0.5048408276018592,1.0,27/84,20.62%,ZBP1;DTX4;IRF7;TNFAIP3;IKBKE;ILRUN;TRIM21;CREBBP;IRF1;TIRAP;CD14;CRCP;GAPDH;POLR3A;POLR3D;NFKB2;ITCH;TRIM56;PRKDC;CGAS;POLR2L;POLR2K;POLR3GL;PIN1;RNF135;POLR3K;ISG15
prerank,positive regulation of synaptic transmission (GO:0050806),-0.32554588904949733,-1.3277700900040903,0.03816793893129771,0.5956917208510256,1.0,26/72,20.84%,SLC24A2;NRXN1;PRKCZ;SHANK3;ADCY1;SLC8A3;CACNG2;CLSTN3;ADRA1A;KCTD13;GRIN2D;APP;GRIN2B;RIMS1;CACNG7;CLSTN1;GRIK2;ZDHHC2;LGI1;SHISA7;GPER1;RELN;SLC8A2;NLGN1;LGMN;RIMS2
prerank,"wound healing, spreading of cells (GO:0044319)",0.5391108153819042,1.3277598099154688,0.14342105263157895,0.5042265492068266,1.0,10/24,16.80%,COL5A1;MRTFA;ARHGAP24;LCP1;PDPN;RHOA;ITGA5;ARHGAP35;PDCD10;ACVRL1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5443390606105911,-1.327724170418769,0.15273775216138327,0.592322541996376,1.0,5/11,11.11%,ADIPOR2;CD34;NDNF;KDR;GATA2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5745181270174633,1.3276274825074212,0.15287517531556802,0.5039494808218017,1.0,4/18,6.56%,MMP14;ABCA2;PLK1;VPS4A
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.5555854476262607,1.3274316678915412,0.14767932489451477,0.5038544438179744,1.0,2/21,3.81%,RUNX1;BLK
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5487028483223975,1.3269410873395067,0.1349206349206349,0.5045428110968324,1.0,2/24,0.48%,KMT2A;ADIPOQ
prerank,regulation of lipase activity (GO:0060191),0.6171703946257989,1.326023383625616,0.1702127659574468,0.5063785121450263,1.0,3/13,11.96%,LIPC;LPL;RHOA
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6227812539254388,1.326003251291808,0.1735668789808917,0.505751240362928,1.0,7/12,22.60%,NCOR2;STAT3;TERT;TNF;BCDIN3D;ZC3H12A;NCOR1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6127974756376607,1.3251153729700087,0.1568627450980392,0.5074670363487367,1.0,5/13,13.10%,ZMIZ1;SERTAD2;PADI2;ARID1B;SPI1
prerank,genitalia development (GO:0048806),0.6434485500407544,1.3249762427458092,0.15311004784688995,0.50714693460138,1.0,4/12,10.21%,CHD7;SHH;WNT5A;TBX3
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.47010583277846657,-1.3248867708549386,0.12797619047619047,0.5972300839173664,1.0,8/17,16.35%,COX5A;COX8A;COX4I1;COX6C;COX6B1;COX6A1;COX10;COX5B
prerank,membrane lipid biosynthetic process (GO:0046467),-0.34818171813365606,-1.324744183035449,0.0547945205479452,0.5941924986611297,1.0,18/58,10.49%,CERT1;PPM1L;ACER2;ST3GAL4;CERS4;SGMS1;SPTLC2;SPTLC1;ELOVL7;SGMS2;ST8SIA6;ELOVL5;DEGS2;SPNS2;GBGT1;HACD1;HACD3;HACD4
prerank,mammary gland epithelium development (GO:0061180),0.5999096052809813,1.3246805158625945,0.17450682852807284,0.5072473044479661,1.0,2/14,2.75%,WNT2;JAK2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.6501466664638123,1.3245725819851752,0.17014446227929375,0.5068589580744474,1.0,5/10,14.11%,STOML2;INO80;E2F8;DBF4;ATRX
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.438650625283614,1.3245249884285313,0.0389344262295082,0.5063276146334464,1.0,43/184,17.74%,PSMA7;NEK6;PPP1R9B;ZFP36L1;DYNLL1;ZFP36L2;DYNC1H1;MAD2L1;CUL1;E2F1;TUBG1;INO80;ALMS1;PLK1;PTPN6;ANAPC11;PCM1;CDC27;HAUS3;SKP1;CEP41;CNTRL;DCTN3;PSMB8;PSMA6;TPX2;PCNT;CEP72;PSMF1;ACTR1A;AKAP9;CDC14A;PSMA8;PSMD2;PSMD12;CEP192;PSMD11;PSMD14;CSNK1D;YWHAE;DDB1;CKAP5;PSMB1
prerank,histone H3-K4 methylation (GO:0051568),0.5415700058281872,1.3240582116199906,0.15915119363395225,0.5069592472392521,1.0,9/26,15.80%,KMT2A;CXXC1;RBBP5;OGT;SETMAR;TET2;KMT2B;PAXIP1;WDR5B
prerank,positive regulation of cell migration (GO:0030335),0.43275967497636864,1.3239728372831867,0.02119071644803229,0.5065091351295177,1.0,49/253,12.59%,ROR2;CCL11;COL1A1;CCL7;CEMIP;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;MAP4K4;SNAI1;SYDE1;CCAR1;PDGFRB;SNAI2;CCN4;PRKCA;NRP1;EGFR;STAT3;DOCK1;MDK;CCR1;SMURF2;AIF1;DDR2;ACVR1;RHOD;CARMIL1;CCL5;EGF;ATM;EPHA1;MIA3;GPNMB;TGFBR1;MYLK;PPP3CA;ACVR1B;SEMA3E;PTK2;VTN;PDPN;TGFB2;GCNT2;SPRY2;NTRK3;NUMB
prerank,synaptic membrane adhesion (GO:0099560),-0.4888343232266699,-1.3238773295474267,0.16554054054054054,0.5933045090752824,1.0,6/14,13.91%,LRRC4C;LRFN5;NTNG1;SLITRK1;LRRC4B;PTPRD
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6102913775566634,1.3234096683842822,0.183206106870229,0.5073012589412987,1.0,5/13,17.56%,B4GALNT2;GFPT2;UAP1L1;AMDHD2;GNPDA2
prerank,lipid oxidation (GO:0034440),0.62223018304051,1.3230875586694992,0.17591125198098256,0.5074925357404044,1.0,3/12,8.59%,ADIPOQ;ACOX1;PLA2G7
prerank,ameboidal-type cell migration (GO:0001667),-0.3476666403311428,-1.322954055162589,0.07262569832402235,0.5923681146074872,1.0,25/51,26.72%,SEMA6A;SEMA3C;SEMA3D;GPC3;SEMA6D;SEMA7A;CCN3;ERBB4;TBX1;CENPV;ITGA4;SEMA4D;SEMA5A;AMOTL2;SEMA5B;SEMA3G;FAT2;RADIL;PKN3;SEMA6C;SEMA4B;SOX8;SEMA3B;SEMA4A;SEMA6B
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3847502255852008,-1.3227660107832444,0.1038961038961039,0.5895316652741093,1.0,9/32,11.80%,LRRC7;ACTN2;DLG2;SLC6A9;GRIA2;GRIA1;APP;GRIN2B;CAMK2B
prerank,establishment of epithelial cell polarity (GO:0090162),0.572459619090001,1.3226754961890559,0.14835164835164835,0.5079262708165649,1.0,7/19,11.96%,CYTH3;SIPA1L3;OPHN1;RAP2A;CDC42;MSN;RHOA
prerank,positive regulation of cell communication (GO:0010647),0.53165756744455,1.3222343787929831,0.1443850267379679,0.5084343504372505,1.0,7/28,12.29%,ADIPOQ;EDN3;DLG4;HCRT;WLS;PTPN23;TNF
prerank,spinal cord development (GO:0021510),0.6036280623759929,1.321705433692534,0.1800595238095238,0.5092682278502317,1.0,4/12,10.24%,GLI2;PKD2;NF1;LOXL3
prerank,cellular response to hypoxia (GO:0071456),0.44239399821035397,1.3215087101322778,0.0794148380355277,0.5091480262270037,1.0,13/126,8.91%,PSMA7;RORA;ZFP36L1;BACH1;GATA6;CPEB1;CREBBP;SFRP1;ARNT;NPEPPS;TERT;PSMB8;PSMA6
prerank,negative regulation of signaling (GO:0023057),0.544304644257157,1.3214604131590846,0.1476510067114094,0.5086213014717693,1.0,6/25,12.88%,ADIPOQ;ACVR1;PTPN1;BRAP;SOCS5;UBASH3B
prerank,nucleotide-sugar metabolic process (GO:0009225),0.612834565109565,1.3213065491790985,0.1671875,0.5084070575111991,1.0,3/12,6.07%,B4GALNT2;GFPT2;GMDS
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5579441583112978,1.32097207855039,0.14866760168302945,0.5086259314217444,1.0,1/21,0.16%,RAD51B
prerank,gland development (GO:0048732),0.48422854129744675,1.3206963942234062,0.10223266745005875,0.5087091518636303,1.0,16/59,10.21%,GLI2;PRKCSH;ARID5B;EPHB3;MDK;SHH;PHF2;PKD2;NF1;TGFB3;FOXE1;MSN;ANXA1;TGFBR1;SALL1;TBX3
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4432634368760802,1.3201427895756186,0.03722854188210962,0.50960024260025,1.0,42/173,13.45%,COL7A1;SEC16B;SEC31A;DYNLL1;SEC24D;SEC23A;COPA;PROS1;COPZ2;ARCN1;RAB2A;KDELR3;DYNC1H1;SEC24A;ARFGAP3;COPZ1;STX17;ARFGAP1;ATL2;COPB2;DCTN4;COG4;MIA3;YIF1A;LMAN2L;VAPA;DCTN3;GOSR1;GBF1;ERGIC1;COPG1;TRIP11;TRAPPC4;SEC16A;LMAN1;ARF4;ERGIC2;CTSC;KDELR2;TMED1;ACTR1A;RAB1A
prerank,regulation of vasculogenesis (GO:2001212),-0.4856636581506491,-1.3201062851458671,0.147239263803681,0.5937584781175197,1.0,6/14,14.26%,CD34;RAPGEF2;KDR;RAP1A;TMEM100;HEY2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.42928796558683724,-1.320005064577341,0.07835820895522388,0.5907733885291915,1.0,10/24,13.41%,TEK;KRIT1;CDH5;GAS6;NDNF;RAMP2;KDR;SCG2;GATA2;SEMA5A
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5733495073938496,1.3197649008929007,0.18093922651933703,0.5099794421419991,1.0,8/18,20.32%,EDN3;FXN;POR;TNF;SIRT3;ATP7A;AGT;GDNF
prerank,endoplasmic reticulum organization (GO:0007029),0.46381411210240736,1.3196215914329565,0.10367892976588629,0.5097142005167135,1.0,23/72,18.91%,SEC16B;SEC31A;LRRK2;TRAM2;ATL2;WDR83OS;MIA3;LMAN2L;VAPA;SEC16A;GAK;LMAN1;ZBED3;RAB10;SEC61A1;TMCC1;VCPIP1;ALDH3A2;TOR1AIP2;LPCAT3;EIF2AK3;SPTSSB;PRNP
prerank,regulation of receptor binding (GO:1900120),0.6391753357665428,1.3193845851565311,0.1712962962962963,0.5096638544755353,1.0,3/10,10.04%,ADIPOQ;ATP2A2;GREM2
prerank,regulation of myoblast fusion (GO:1901739),0.6347033361121511,1.3192283035850254,0.17076923076923076,0.5094209728291135,1.0,3/11,7.85%,CFLAR;CD53;EHD2
prerank,amino sugar metabolic process (GO:0006040),0.6489630761735458,1.3191530001425127,0.1617161716171617,0.5089425144139484,1.0,4/10,10.96%,B4GALNT2;ST6GAL1;GFPT2;ST3GAL1
prerank,ERBB2 signaling pathway (GO:0038128),0.5137843282823321,1.3186220485150861,0.1444723618090452,0.5097322724687916,1.0,10/31,14.06%,PRKCA;EGFR;EGF;PTPN18;GRB2;CDC37;ERBIN;BTC;PIK3R1;SRC
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.412555532215216,-1.3184694739985587,0.11646586345381527,0.5917299159743461,1.0,9/26,10.80%,PRKAG2;PRKAA2;ADIPOR2;ERLIN1;LPGAT1;ELOVL5;ADIPOR1;ACADL;ERLIN2
prerank,response to estradiol (GO:0032355),0.5267238899091384,1.3179354945521444,0.14602346805736635,0.5108429359181114,1.0,8/31,15.89%,NRIP1;EGFR;STAT3;SFRP1;ANXA1;LCOR;STAT5B;GGT7
prerank,regulation of myelination (GO:0031641),0.5450181334386712,1.3176569796356452,0.14835164835164835,0.5109011696312747,1.0,9/25,17.61%,TNFRSF21;PTN;PTPRZ1;TENM4;DICER1;EGR2;TPPP;EIF2AK3;NCMAP
prerank,positive regulation of innate immune response (GO:0045089),0.5281993377916763,1.317494467799601,0.1364795918367347,0.5106595785405741,1.0,7/30,13.10%,ZBP1;LBP;CCL5;WNT5A;POLR3D;UBE2K;SPI1
prerank,positive regulation of organelle assembly (GO:1902117),0.4978191941458904,1.3170691877696892,0.13365155131264916,0.5110738794717302,1.0,22/44,25.24%,ASAP1;FSCN1;DYNC1H1;PIP4K2A;GPSM2;SDC1;LCP1;RAB3GAP2;ENTR1;CEP120;TNF;TAPT1;RAB3GAP1;ARHGAP35;SH3GLB1;CAPG;CNOT2;SDC4;SDCBP;PDCD6IP;RALB;CNOT1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4589983873922283,1.3165247606423534,0.10141766630316248,0.5119124224723164,1.0,15/79,7.74%,CLTC;SEC31A;DYNLL1;SEC24D;SEC23A;DYNC1H1;CTSD;SEC24A;KIF2A;CTSS;DCTN4;CTSL;RAB7A;CANX;DCTN3
prerank,protein localization to cell periphery (GO:1990778),-0.29672375504045384,-1.3163520750065196,0.03773584905660377,0.5944043215959779,1.0,34/133,9.26%,KCNIP4;ATP1B3;TSPAN5;CACNB2;CAV1;BSG;ATP1B1;ACTN2;ANK2;KCNB2;CD81;LIN7A;EFR3B;TTC7B;DPP10;DPP6;C2CD5;EZR;GAS6;EHD4;SLMAP;RAMP1;RAPGEF2;WNK3;RAMP2;CDH1;RAB3C;ARL3;ZFYVE27;PACSIN1;MAP7;RAPGEF6;ANK3;INPP5K
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5342455139584465,1.3162706581780403,0.16120218579234974,0.5118966519908116,1.0,9/26,11.83%,EGFR;AIF1;CCND3;ADAMTS1;CDK10;RPTOR;ANXA1;KMT2E;ANKRD17
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5129856331918958,-1.3157935102338998,0.15426997245179064,0.5927414913694196,1.0,5/12,14.26%,ACTB;LAMA3;AHI1;LAMA5;SCRIB
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5295996156378757,-1.3151983400694012,0.15522388059701492,0.591163471882446,1.0,4/12,11.13%,UNC13C;UNC13B;SYT7;RIMS1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5540208184502168,1.3151857224099182,0.16759776536312848,0.5141740552798103,1.0,5/20,12.29%,LBP;CCL5;CD14;CCL2;TNF
prerank,negative regulation of protein metabolic process (GO:0051248),0.4869803660911497,1.3149834044889668,0.13157894736842105,0.5140557345187377,1.0,8/48,6.47%,IAPP;FLOT2;EGFR;IRAK3;TREM2;APOE;MAD2L1;INHBB
prerank,histone ubiquitination (GO:0016574),-0.4336192359402026,-1.3148695541403872,0.10740740740740741,0.5886660778611402,1.0,7/21,15.86%,HUWE1;CTR9;UBE2A;LEO1;UBE2B;UBE2N;PHC1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.5012455527814937,1.3145898146622261,0.14037267080745341,0.5144787455832117,1.0,16/40,20.69%,GPM6B;FBN2;PTN;NELL1;ACVR1;TGFB3;TMEM119;ATP2B1;ACVR2A;P2RX7;BMP7;ANO6;FBXO5;ADGRV1;ISG15;BMPR1A
prerank,response to organonitrogen compound (GO:0010243),0.5015205330309425,1.3144326882358668,0.12804097311139565,0.5142517472240818,1.0,7/38,11.52%,NR1H4;IRAK3;GLRB;ERLEC1;RRAGC;DRD3;RCN3
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.44593432582265036,1.3143961589255175,0.09615384615384616,0.5137052011910654,1.0,23/94,18.36%,PSMA7;IL1R1;IRAK3;CUL1;NOD1;IRAK2;SKP1;PSMB8;PSMA6;IRAK4;PELI3;FBXW11;PSMF1;PSMA8;PSMD2;PSMD12;SQSTM1;PSMD11;PELI2;PSMD14;MAP3K3;PSMB1;NFKBIA
prerank,arachidonic acid metabolic process (GO:0019369),0.5113348869397497,1.3143666920657897,0.149616368286445,0.5131352566243087,1.0,6/35,9.08%,CYP1B1;PTGES;EPHX2;CYP2A6;PTGES2;CYP1A1
prerank,potassium ion transmembrane transport (GO:0071805),-0.29889705370896474,-1.3137792423390715,0.0,0.5887170364869483,1.0,25/135,7.30%,ATP1A2;ATP1B3;SLC12A2;KCNC2;SLC24A2;SLC12A7;KCND3;ATP1B1;SLC9A2;KCNB2;KCNK5;KCND2;KCNQ5;KCNH5;TMEM175;KCNH7;SLC12A6;KCNJ2;KCNJ3;KCNK10;KCNJ13;ABCC9;KCNQ3;KCNQ4;KCNJ10
prerank,cell-cell junction organization (GO:0045216),-0.333856643938372,-1.3137119181769032,0.057692307692307696,0.5857009471034398,1.0,15/79,4.71%,TJP1;PKP4;TJP2;OCLN;CADM2;CDH13;LIMS2;CADM1;CLDN5;CDH5;CXADR;CTNND1;CDH10;CDH1;ARVCF
prerank,positive regulation of endocytosis (GO:0045807),0.4890459842856731,1.31331320032999,0.13746958637469586,0.5153128455745565,1.0,9/45,11.22%,C3;LRP1;TREM2;APOE;RAB21;CDC42;CBL;ANKFY1;VTN
prerank,regulation of platelet aggregation (GO:0090330),0.5826100934484041,1.3131031226206873,0.1661721068249258,0.5152148049244404,1.0,5/17,11.38%,SERPINE2;PRKCA;BLK;ADAMTS18;PDPN
prerank,RNA 3'-end processing (GO:0031123),-0.3334564062789683,-1.3121466655453626,0.018691588785046728,0.5870944796439171,1.0,26/69,25.42%,CDC40;SRSF5;WDR33;CSTF2;RPRD2;U2AF2;RPRD1A;TUT1;SRSF7;SRSF9;RBM8A;CHTOP;CPSF2;MAGOH;ZC3H11A;SUPV3L1;EIF4A3;SRSF3;CLP1;POLDIP3;TUT4;CPSF4;SARNP;DDX39B;DDX39A;THOC1
prerank,T cell activation (GO:0042110),0.46082086761967583,1.312046829060285,0.10079275198187995,0.5174635069713304,1.0,15/69,11.94%,JAML;CD276;CHD7;MDK;KIF13B;NCK1;NCK2;DDOST;MSN;LCP1;PPP3CA;CTPS1;PTPN2;CASP8;TNFRSF4
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6303729459848992,1.3115492990529076,0.1955128205128205,0.518114724152105,1.0,1/11,0.45%,IL23R
prerank,negative regulation of receptor binding (GO:1900121),0.6350078138927089,1.3114746356151041,0.1870967741935484,0.5176685797298913,1.0,2/10,9.67%,ADIPOQ;ATP2A2
prerank,tyrosine metabolic process (GO:0006570),-0.5421649404331899,-1.3110229747490505,0.14600550964187328,0.5871978580302265,1.0,6/11,37.45%,GSTZ1;FAH;THAP4;TYR;HGD;IL4I1
prerank,muscle cell migration (GO:0014812),0.629442410404279,1.3108435864079282,0.17445482866043613,0.5188022361885656,1.0,8/10,25.24%,THBS4;PLAT;ITGB1BP1;DDR1;MEGF10;ITGB3;ROCK1;AAMP
prerank,negative regulation of synaptic transmission (GO:0050805),0.556455311171395,1.31067358160858,0.14953271028037382,0.5186137403614423,1.0,5/23,9.77%,ADIPOQ;LRRK2;PTEN;STXBP1;DRD3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.363944776534745,-1.3103965838530378,0.09137055837563451,0.585630318999585,1.0,24/37,35.18%,ERCC5;ERCC3;UBC;POLD3;CHD1L;PCNA;DDB2;GTF2H2;ERCC1;GTF2H4;RFC3;UBA52;GTF2H3;POLD2;RBX1;RPA2;PARP1;RFC4;NTHL1;POLD4;RFC2;RPA3;POLK;RFC5
prerank,actomyosin structure organization (GO:0031032),-0.31933516970654624,-1.3094892317207887,0.08536585365853659,0.5851390450309392,1.0,10/75,3.95%,SORBS1;TJP1;PHACTR1;PGM5;ACTN2;FRMD5;EPB41;CIT;EPB41L5;TMOD3
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4908888964986583,-1.309122593635512,0.1572700296735905,0.5830840491978286,1.0,3/14,20.33%,MOXD1;ALDH9A1;SLC22A2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.45565237180311186,1.3089347332322592,0.08629989212513485,0.5226782570327595,1.0,36/95,22.30%,ZEB2;PMEPA1;SPRED1;SMAD2;CDKN2B;NREP;SMURF2;SPRED2;CREBBP;HTRA3;EMILIN1;RNF111;WFIKKN1;ITGA3;HTRA4;TGFBR1;TGFB1I1;LDLRAD4;SPRY2;SKOR2;GIPC1;SMAD3;SMAD4;SNX25;SMURF1;LATS2;TRIM33;ZBTB7A;PIN1;DKK3;ASPN;RPS27A;LATS1;SNX6;IL17RD;SDCBP
prerank,glucose transmembrane transport (GO:1904659),-0.44244251650568805,-1.3087915722585222,0.1262135922330097,0.5809286435934248,1.0,8/18,32.76%,SLC2A1;SORT1;SLC5A3;SLC2A8;SLC2A9;SLC45A1;SLC2A4;RAB4B
prerank,sensory perception of smell (GO:0007608),-0.5333230453643251,-1.308401729946837,0.16535433070866143,0.5790382761513924,1.0,4/11,19.93%,UBR3;BBS4;MKKS;DRD2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5483244377742998,1.3082177726000175,0.14172185430463577,0.5239948161569581,1.0,6/24,7.58%,SEC31A;SEC24D;SEC23A;PDIA3;SEC24A;CANX
prerank,myelin assembly (GO:0032288),0.6429409402592849,1.307255760972808,0.19516129032258064,0.5259716430786876,1.0,8/10,22.05%,ABCA2;PMP22;TENM4;DICER1;TPPP;NCMAP;EPB41L3;CNTNAP1
prerank,response to exogenous dsRNA (GO:0043330),0.5644404637078952,1.307059566132278,0.15474452554744525,0.5258445598677065,1.0,3/18,3.64%,RFTN1;COLEC12;IRAK3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.5402598660785682,-1.3070020338378139,0.18441558441558442,0.5800248345328178,1.0,4/10,20.66%,PRKAA2;DIP2B;MYOCD;PRKAA1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5723858294265438,1.3067533897875088,0.18037518037518038,0.5260429720284664,1.0,4/18,9.70%,ZFP36L1;ZFP36L2;ANXA1;UBE2L3
prerank,regulation of viral release from host cell (GO:1902186),0.5539008726726375,1.3061119347089605,0.14769647696476965,0.5271394509127902,1.0,13/21,28.11%,TRIM21;VPS4A;TRIM13;TRIM8;CHMP2B;DDB1;TRIM62;TRIM35;TRIM11;TSG101;CHMP3;TRIM26;PML
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5523705173871825,1.3060553821254814,0.16204986149584488,0.5266562518403824,1.0,11/20,23.43%,FMNL2;FMNL3;FHOD3;LLGL1;LCP1;TNF;PLEK;DLG1;ROCK2;ROCK1;STRIP1
prerank,regulation of actin filament depolymerization (GO:0030834),0.6237971049175893,1.305166700847879,0.18512898330804248,0.5284368144079772,1.0,4/12,16.76%,PDXP;LIMA1;PLEKHH2;PLEK
prerank,cation transport (GO:0006812),-0.2870240001307296,-1.3046520420508556,0.0,0.5832724275754815,1.0,29/167,11.47%,TRPM3;ATP1A2;SLC12A2;SLC47A1;SLC6A6;KCND3;ATP1B1;TRPM6;KCNB2;SLC6A9;KCNK5;SCN2A;SLC1A1;KCNJ2;KCNJ3;SLC8A3;KCNJ13;ABCC9;SLC9B2;SLC5A6;KCNQ4;KCNJ10;SCN8A;SLC22A4;SLC22A18;CLN3;SCN9A;SLC38A5;SLC5A5
prerank,chemical synaptic transmission (GO:0007268),-0.2703289081083973,-1.3045703419310837,0.0,0.5805201408492816,1.0,62/284,11.28%,UNC13C;FCHSD2;SNAP25;SYN3;SLC12A7;CACNB2;DLGAP1;CHRM2;UNC13B;CACNB4;KIF1B;SYNJ2BP;NRXN1;GRM7;GRM1;GRID2;HTR2C;RIT2;DLG2;GRIK4;GABRA2;MINK1;GABRB1;LIN7A;KCND2;GLRA3;GABRG3;CALM1;DTNA;SLC1A2;SLC1A1;ATXN3;PTCHD1;SLC12A6;SHISA6;SLC6A1;DLGAP2;GRIA2;PRKAR1A;GRM3;NOVA1;GABRA5;NRXN2;KCNQ3;GRIA1;HTR1F;CAMKK2;GLRA1;PRKAR2A;CAMK4;GABRB2;BSN;CACNA1E;CACNA1B;CPLX1;TBC1D24;GRIN2D;RPS6KA2;HTR7;GRIN2B;RIMS1;SNAPIN
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4582610883039116,1.3043893316086035,0.08629989212513485,0.5299251799019848,1.0,13/94,7.46%,CYP1B1;CASP4;ERN2;BBC3;IKBKE;CUL1;E2F1;ITPR1;BCL2;ATM;BAG6;BCL2L2;GSKIP
prerank,integrated stress response signaling (GO:0140467),0.5990317001883648,1.3041458442849923,0.19090909090909092,0.529911614555017,1.0,6/14,17.65%,OMA1;CCL2;NFE2L2;HSPA5;EIF2AK3;ATF4
prerank,protein-containing complex assembly (GO:0065003),0.4230115873533428,1.3041174591181948,0.033367037411526794,0.5293355206572858,1.0,70/259,17.95%,COL7A1;KMT2A;SEC16B;SH3PXD2B;SEC31A;YAP1;CXCL12;TCF7L2;FARP2;SEC24D;SLC9A1;LAMC1;SEC23A;SKAP2;LRRK2;CD40;STOML2;MITF;TLE1;FBXL7;RBBP5;WIPF1;CUL1;SEC24A;PPID;CREBBP;LLGL1;DLG4;KPNA3;ADD2;SKP1;TERT;HDAC1;TRAPPC4;SEC16A;TCF7;TNFRSF1A;LMAN1;TEAD1;SEC23IP;SNX9;RUVBL1;CASP8;DBNL;CTSC;TSPAN4;TNF;GSK3B;CSNK1A1;SPG7;P2RX7;TRAF2;RAB1A;RANBP9;CX3CL1;TUBGCP4;RIPK1;PPP6C;ITGB1BP1;TCF7L1;SMARCA4;SEC13;TBC1D20;CSNK1D;MDM2;ANO6;PICALM;FERMT3;SCFD1;CAPZA1
prerank,response to reactive oxygen species (GO:0000302),0.47486353489406796,1.3040325563707842,0.1313953488372093,0.5288946398246884,1.0,6/54,5.01%,HP;PDGFRA;APOD;EGFR;APOE;PKD2
prerank,regulation of macrophage cytokine production (GO:0010935),0.6074620283096803,1.3036215248829202,0.18646616541353384,0.5293277746075555,1.0,4/13,11.44%,IRAK3;TGFB3;WNT5A;TGFB2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5706995311485957,1.303301136745892,0.1924198250728863,0.5295641145949662,1.0,6/18,14.92%,KMT2A;EHMT1;SETMAR;SETD2;KMT2B;ASH1L
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4538267091672927,1.3028018236191605,0.11672278338945005,0.5302453963031424,1.0,21/76,18.77%,CCL11;PDXP;SYNPO;NRP1;DYNC1H1;NCK1;BAIAP2;NCK2;CARMIL1;CDC42;GPSM2;SNX9;NTRK3;P2RX7;CX3CL1;FES;CDC42EP1;PLEK;CTTN;CDC42EP4;BCAS3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.44871750814464856,1.3026814438707073,0.08983957219251337,0.529927277461438,1.0,23/101,14.53%,CEMIP;IL34;ADIPOQ;EDN3;TNFSF11;LRRK2;CD40;PDGFRB;EGFR;PKD2;EGF;CCND3;PIK3R5;RPTOR;MAP2K1;WNT5A;FGFR1;RHOA;TNF;FGF2;CALM2;SRC;PDCD10
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.5506236659316615,1.3024006645507018,0.17563739376770537,0.5299999265622937,1.0,3/19,2.74%,RUNX1;SNAI1;SNAI2
prerank,brain development (GO:0007420),0.4332550677366076,1.3020193458768137,0.07883817427385892,0.530394868918117,1.0,17/136,7.04%,COL4A1;EPHA7;APOD;HSPG2;ROBO2;ATXN1;MEIS2;MDGA1;AFF2;ADGRL3;MEIS1;MAP1S;PTEN;NF1;PBX3;SPEF2;BAG6
prerank,midbody abscission (GO:0061952),0.5800979120926221,1.3017537757077466,0.1871508379888268,0.5305261231756816,1.0,6/17,17.50%,CHMP4A;CHMP4B;VPS4A;CHMP7;CHMP2B;KIF20A
prerank,negative regulation of T cell differentiation (GO:0045581),0.6269411437683331,1.3009914162043696,0.21103896103896103,0.5320169264620779,1.0,3/10,7.18%,GLI3;MDK;IRF1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5818144017116383,1.2999786378485716,0.18523676880222842,0.5341289747930277,1.0,8/15,22.93%,SLC9A1;PRKCA;CAMK2D;AGT;IL6ST;PDE9A;ROCK2;ROCK1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.4565674488976494,1.2997676162820684,0.11847826086956521,0.5340538061479569,1.0,24/80,17.88%,COPA;COPZ2;ARCN1;KDELR3;KIF1C;ARFGAP3;KIF2A;COPZ1;ARFGAP1;COPB2;COG4;GBF1;ERGIC1;COPG1;ARF4;ERGIC2;KDELR2;RINT1;RAB1A;ERGIC3;COG7;KIF5A;PITPNB;SCFD1
prerank,monosaccharide transmembrane transport (GO:0015749),-0.46294236007549644,-1.2996428390202186,0.140625,0.591198568786157,1.0,5/16,20.89%,SLC5A3;SLC2A12;SLC45A3;SLC2A8;SLC2A9
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5150884855214959,1.2996276350460267,0.14766839378238342,0.5337915558012478,1.0,9/33,11.84%,DCN;APOE;NR2F2;PTEN;APOH;ADAMTS9;SP100;PTPN23;PTPRM
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.43408334425227024,-1.2992756492973818,0.14130434782608695,0.5892094770072253,1.0,8/19,15.91%,SYNJ2BP;LRRC7;DLG2;PARD3;PATJ;SCRIB;CLIC4;MTCL1
prerank,positive regulation of ossification (GO:0045778),0.5036248147916049,1.2985473733433575,0.14956736711990112,0.5360706343655828,1.0,13/39,14.04%,GPM6B;FBN2;PTN;NELL1;ACVR1;TGFB3;TMEM119;WNT5A;TGFB2;ATP2B1;ACVR2A;P2RX7;BMP7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.44190266900531816,1.297990723050989,0.09650053022269353,0.5368784995425392,1.0,25/109,17.06%,PSMA7;TEC;VAV2;GAB2;VAV3;MAP2K4;CUL1;LCP2;SKP1;GRB2;PSMB8;PSMA6;LAT2;PPP3CA;VAV1;FBXW11;PSMF1;PIK3R1;RAC1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;MAPK1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4688112961871667,-1.2969200474042102,0.14814814814814814,0.5927496791045217,1.0,15/17,51.66%,CADM1;AP1G1;LAMP1;PVR;RAET1E;NECTIN2;RASGRP1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,protein localization to synapse (GO:0035418),-0.5105753293826447,-1.2968581460659296,0.15714285714285714,0.5898974260367699,1.0,7/12,19.82%,NRXN1;PCLO;NRXN2;BSN;SHANK1;ZDHHC15;NLGN1
prerank,thymus development (GO:0048538),0.6038619630344494,1.2961010779267788,0.1875,0.5414885751522093,1.0,4/13,9.03%,EPHB3;SHH;FOXE1;TGFBR1
prerank,serine family amino acid catabolic process (GO:0009071),0.6314028073486715,1.2960798172736392,0.17721518987341772,0.5408883319177407,1.0,3/10,11.98%,AMT;GLDC;THNSL2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.48033698856601553,1.295822364528993,0.13532934131736526,0.5408791506575151,1.0,7/49,5.67%,IL23R;GHR;CD40;JAK2;TSLP;STAT3;CCL5
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.58372471309357,1.295747341215609,0.1889055472263868,0.5404220978721551,1.0,4/15,9.70%,ZFP36L1;ZFP36L2;ANXA1;UBE2L3
prerank,positive regulation of phosphorylation (GO:0042327),0.4234933343978789,1.2943429978524748,0.030456852791878174,0.5436321682966045,1.0,43/240,12.90%,ROR2;GLMN;ROR1;C3;EPHA7;IL34;ADIPOQ;PDGFRA;LRRK2;CD40;PDGFRB;FGF7;NRP1;EGFR;EPHB3;TREM2;DDR2;FAM20A;CCL5;EGF;CCND3;RAP2A;EPHA1;TMEM119;ARNT;PFKFB4;ANGPT1;MERTK;GPNMB;EFNA5;NIBAN1;FBH1;FGFR1;FNIP1;PTK2;DSCAM;ACVR2A;TNF;VEGFC;FGF2;NTRK3;ZBTB20;P2RX7
prerank,defense response to protozoan (GO:0042832),0.6122181396646167,1.2939685169668027,0.20241691842900303,0.543958203242833,1.0,3/12,10.16%,CD40;BATF;GBP7
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5297679553923208,-1.2938804847424945,0.18128654970760233,0.595373630644925,1.0,5/11,16.83%,NOS3;CALM1;HSP90AA1;PTS;DHFR
prerank,negative regulation of translation (GO:0017148),0.4513197460838257,1.293708307272438,0.11855104281009879,0.544019915750035,1.0,20/87,14.52%,IGF2BP1;IGF2BP2;SYNCRIP;ILF3;IGFBP5;PUM1;CPEB1;METTL16;EIF2AK2;CAPRIN1;GIGYF2;SAMD4A;CELF1;FTO;GAPDH;EIF4EBP1;CALR;YTHDF3;FMR1;CPEB4
prerank,cellular response to ATP (GO:0071318),0.5842195007302052,1.2936229955311525,0.17673048600883653,0.5435873407096777,1.0,5/14,21.68%,PDXP;SSH1;P2RX7;HSP90B1;P2RY12
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4496250697521637,1.2922985712885366,0.1141602634467618,0.5464977367915932,1.0,23/88,20.15%,PSMA7;FBXL7;CUL1;SKP1;FBXL18;FBXW7;PSMB8;PSMA6;FBXW11;PSMF1;FBXO2;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;FBXW4;FBXO31;AMN1;FBXO38;FBXL22;PSMC6
prerank,catecholamine metabolic process (GO:0006584),-0.468971882664616,-1.2919372932321236,0.13864306784660768,0.5979544099049929,1.0,5/14,19.93%,SNCAIP;PRKN;DDC;RNF180;DRD2
prerank,regulation of protein kinase A signaling (GO:0010738),0.558144222568601,1.2918838179728005,0.15112994350282485,0.5470007832024745,1.0,6/20,12.75%,ADIPOQ;IAPP;LRRK2;PRKAR1B;PJA2;MC1R
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.46407599520613235,1.2918289288819473,0.1353558926487748,0.5465241110167256,1.0,25/59,23.25%,LRRK2;PRKCA;CAMK2D;PRKD2;ACVR1;CDK10;HIPK4;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;HIPK3;ACVR1B;CDC42BPA;GSK3B;PRKDC;MAPK1;AKT1;MAP3K12;PRKCD;DYRK1A;MARK2;ROCK2;ROCK1;NLK
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4714224157117349,1.2917088769388625,0.13038548752834467,0.5462240392248472,1.0,18/64,12.44%,GPM6B;MAP4K4;SLC9A1;PEAK1;JAG1;CASK;NF1;CD36;NF2;CDK6;SFRP1;EPHA1;EFNA5;SEMA3E;PTK2;UTRN;RHOA;GSK3B
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.41404352570405817,1.2915658321608887,0.001,0.5459481392778582,1.0,160/807,14.46%,RUNX1;NR1H4;RUNX2;CREB3L1;ADIPOQ;TRPS1;RUNX3;ZEB2;POU5F1;MDFIC;BCL3;GLI2;ZEB1;SBNO2;ETV6;NCOR2;DAP;YAP1;DEAF1;TCF7L2;NRIP1;SNAI1;ATXN1;GLI3;BCL6;MEIS2;STAT1;ERN2;RARB;IRF7;ATP8B1;BACH1;GATA6;SNAI2;ZFPM2;XCL1;RCOR1;FHL2;DNAJB1;NKX6-1;PHC2;MITF;CRYM;ARID5B;SMAD2;NFIX;MIER2;SUFU;TLE1;MLIP;GLIS1;STAT3;CGGBP1;TBX2;USP9X;ILF3;NR2F2;ARID5A;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;KHDRBS1;PRDM2;PPID;LIMS1;TAF7;SCMH1;HIVEP1;RNF2;FOXK2;CREBBP;CBX8;SFRP1;PPARG;RUNX1T1;YAF2;PLK1;ETV5;ENO1;ZHX2;SFMBT1;MBD1;EHMT1;AHR;PRICKLE1;MDFI;TSHZ3;FOXE1;E2F8;NOC2L;IRF1;BHLHE40;HEYL;CCAR2;FRK;ZMYND15;POU2F1;SAP18;SP100;BAHD1;WNT5A;HDAC1;ZBTB5;SALL1;NONO;FOXO3;TBL1X;ZBTB38;DICER1;FOXP4;PRDM1;NR2F1;MTA2;HMGB2;CXXC5;TGIF2;TBX3;LOXL3;EID1;FNIP1;CBFB;GATAD2B;KLF10;ELK4;RSF1;ZGPAT;PHF21A;DNMT3B;CALR;TIMELESS;SP3;LCOR;TNFRSF4;SETDB2;FBXW11;TNF;KDM2A;NAB2;DUSP26;SKOR2;COMMD7;GLIS3;SPI1;RIF1;GATAD2A;CTCF;SMAD3;DACT1;PSEN1;KCNIP3;BMP7;TRIB3;DRAP1;CDKN1B;TFAP2C;SMAD4;MAFK
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.44291903645213665,1.2914424125542712,0.09503695881731784,0.5456162069249705,1.0,16/107,12.14%,CCL11;SLC39A14;CCL7;EDN3;CXCL12;CD40;STOML2;CCR1;SLC24A5;CCL5;ATP2A2;DRD3;TMEM203;ATP2B1;CALR;TPCN2
prerank,positive regulation of defense response (GO:0031349),0.4492623719297333,1.2913749584883318,0.11220043572984749,0.5451459622803351,1.0,24/89,19.00%,ZBP1;TNIP1;IL16;TLR2;CCN4;TSLP;MDK;CCL5;TLR7;PLA2G7;LPL;WNT5A;TNFRSF1A;NFKBIZ;TNF;POLR3D;ABCC1;CX3CL1;RIPK1;NPAS2;ETS1;AGT;NFKBIA;IL17RA
prerank,diterpenoid metabolic process (GO:0016101),0.4698423645600508,1.2911514138442972,0.15447154471544716,0.5450838467734179,1.0,10/55,11.18%,LRP1;HSPG2;GPC6;APOE;RDH12;SDC1;RDH10;SDC2;LPL;OPN1MW
prerank,cardiac muscle cell development (GO:0055013),0.548466667231829,1.2905190151067107,0.1623931623931624,0.5462143865169059,1.0,3/20,4.03%,PDGFRA;PDGFRB;FHOD3
prerank,canonical Wnt signaling pathway (GO:0060070),0.46392027182588746,1.2905140471764196,0.13468013468013468,0.5455697067893543,1.0,15/68,12.56%,WNT2;TCF7L2;SFRP4;LRRK2;WNT9A;FRZB;PTEN;FZD1;SFRP1;LRP6;WNT5A;SFRP5;TCF7;GSK3B;CSNK1A1
prerank,polarized epithelial cell differentiation (GO:0030859),0.590201317320713,1.2902105927898064,0.18731117824773413,0.5457780705995419,1.0,6/13,13.50%,OPHN1;RAP2A;CDC42;MSN;RHOA;RAB10
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5824154951982915,1.2896182849245097,0.1683599419448476,0.5466797783627415,1.0,5/16,15.02%,KMT2A;AUTS2;DNMT3B;SMAD4;PAXIP1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.5980773034274578,1.2894789021832442,0.1779788838612368,0.5463631948794176,1.0,2/14,3.64%,CMKLR1;IRAK3
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4131236805448311,1.289225787838437,0.0,0.5464062786603754,1.0,204/834,18.64%,RORA;RUNX1;NR1H4;RUNX2;DCN;KMT2A;WNT2;ZEB2;POU5F1;PLAC8;GLI2;SBNO2;YAP1;TCF7L2;TCF4;NRIP1;ASXL1;TNFSF11;TNIP1;MRTFA;GLI3;CREB3L3;SATB2;MEIS2;SLC9A1;STAT1;ZMIZ1;RARB;TLR2;IRF7;CD40;GATA6;ZFPM2;AUTS2;NPAS4;NKX6-1;RXRG;MITF;SMAD2;NFIX;CDKN2B;EGFR;REL;MAML3;MLIP;UBP1;GLIS1;USF1;STAT3;LITAF;MEIS1;HOXB3;ELF4;NR2F2;JAG1;PPRC1;SHH;E2F1;MYBL1;NCK1;PRDM2;PRKD2;PKD2;ACVR1;ASXL2;TAF7;TCF12;NCK2;HIVEP1;INO80;FOXK2;CREBBP;ATM;MACC1;PPARG;LRP6;TGFB3;EAPP;ETV5;CXCL10;AHR;MLXIP;E2F8;PLXND1;BCL11B;SUB1;DDX17;ARNT;RNF111;IRF1;PID1;RRP1B;HEYL;ACTR2;CRTC1;MAML2;TERT;HOXA1;POU2F1;OGT;WNT5A;HDAC1;SALL1;FOXO3;TBL1X;ZBTB38;SMAD5;BMP5;NR2F1;JUNB;HMGB2;PPP3CA;PELP1;TBX3;TNFRSF1A;WWTR1;TEAD1;KLF10;ARF4;ELK4;CRTC3;RSF1;TGFB2;NFE2L2;ZBED3;SP3;CDK7;ACVR2A;TET2;E2F3;MED13;TNF;ZSCAN21;HOXB2;KLF6;MAML1;GLYR1;FGF2;GNL3;MC1R;NKX2-8;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;PIK3R1;DDRGK1;GTF2F1;PRDM10;SMAD3;ATRX;EGR2;DRAP1;MYSM1;TFAP2C;SMAD4;GABPB1;CX3CL1;PAXIP1;RIPK1;SETX;SMAD1;RTRAF;CREB3L4;CREB3;CCNT1;HIF1A;STAT5B;PRKDC;RBMX;PTOV1;SQSTM1;SLC30A9;NPAS2;MAX;ITGB1BP1;CLOCK;TCF3;SMARCA4;SREBF1;ACVRL1;ZFHX3;TCERG1;CALCOCO1;THRAP3;BRD4;MZF1;ATF4;GLI1;ETS1;RLF;PRDM4;INHBA;PAX8;RBPJ;HDAC5;NR2C2;NFKBIA;SOX2;CDK9;SETD3;HINFP;KAT6B
prerank,regulation of mitotic cell cycle (GO:0007346),0.4271192396867581,1.2887946253138263,0.06141248720573183,0.5469552808290968,1.0,47/171,20.36%,PSMA7;NEK6;PDXP;MEIS2;PRKCA;MAD2L1;CUL1;PTPN3;PLK1;CKS1B;ANAPC11;CDC27;ASNS;SKP1;CDK10;GBF1;BORA;TMEM8B;BTG1;GAS1;PSMB8;TTC28;PSMA6;RPS6KB1;EIF4EBP1;PSMF1;MAEA;SMAD3;CDKN1B;USP22;PSMA8;PSMD2;PSMD12;PSMD11;RCC1;OBSL1;PSMD14;DDB1;MDM2;PSMB1;CDK9;FBXO5;PIN1;CDK13;PSMC6;ERCC2;UBE2E1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5927826899071051,1.2886951257185544,0.19461077844311378,0.546542070985627,1.0,6/14,11.96%,FSCN1;OPHN1;RAP2A;CDC42;MSN;RHOA
prerank,cell cycle G1/S phase transition (GO:0044843),0.4709946242086538,1.288566976853968,0.1359447004608295,0.5462782488326451,1.0,30/61,25.10%,CCNE2;CUL1;E2F1;KHDRBS1;ACVR1;CACUL1;CDK6;DBF4;RPS6KB1;ACVR1B;EIF4EBP1;CDK7;E2F3;CDKN1B;GSPT1;PPP6C;MAX;RCC1;LATS2;INHBA;HINFP;PLK2;CDC7;LATS1;CCNH;MNAT1;CDKN1A;NASP;CDC25A;BCAT1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4208331088001539,-1.2884263075592781,0.13818181818181818,0.6049597693612649,1.0,8/22,14.90%,KIDINS220;NTRK2;RAPGEF2;SH3GL2;WASF1;STMN2;RAP1A;BDNF
prerank,protein localization to membrane (GO:0072657),-0.2660108266389296,-1.2866093688705253,0.0625,0.6071053831412171,1.0,44/187,9.26%,KCNIP4;ATP1B3;TSPAN5;CACNB2;CAV1;SYNJ2BP;NRXN1;BSG;ATP1B1;LRRC7;ACTN2;DLG2;ANK2;KCNB2;CD81;LIN7A;EFR3B;TTC7B;DPP10;DPP6;C2CD5;SHANK3;EZR;GAS6;EHD4;SLMAP;RAMP1;CPE;AGRN;RAPGEF2;WNK3;RAMP2;CDH1;RAB3C;NRXN2;ARL3;ZFYVE27;PACSIN1;MAP7;RAPGEF6;FRMPD1;TM9SF1;ANK3;INPP5K
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.416555069399408,1.286429328859859,0.018036072144288578,0.5514399337910905,1.0,116/417,19.45%,RUNX2;CREB3L1;ADIPOQ;MDFIC;BCL3;ZEB1;SBNO2;NCOR2;DAP;DEAF1;TCF7L2;ATXN1;GLI3;BCL6;ERN2;ATP8B1;GATA6;ZFPM2;XCL1;RCOR1;PHC2;ARID5B;SMAD2;TLE1;TBX2;ILF3;NR2F2;ARID5A;KMT5A;SMURF2;MBD2;E2F1;PRDM5;KHDRBS1;LIMS1;TAF7;SCMH1;FOXK2;SFRP1;PPARG;RUNX1T1;YAF2;ENO1;ZHX2;SFMBT1;MBD1;EHMT1;AHR;PRICKLE1;TSHZ3;FOXE1;IRF1;BHLHE40;HEYL;CCAR2;ZMYND15;POU2F1;SAP18;BAHD1;WNT5A;HDAC1;SALL1;NONO;ZBTB38;HMGB2;TBX3;LOXL3;EID1;KLF10;RSF1;ZGPAT;CALR;TIMELESS;SP3;TNFRSF4;NIF3L1;SETDB2;FBXW11;TNF;COMMD7;SPI1;GATAD2A;CTCF;BMP7;TRIB3;CDKN1B;SMAD4;NIPBL;TSC22D4;PHC3;PATZ1;PHF12;L3MBTL3;POU3F3;ATF7IP;CLOCK;SMARCA4;MTA3;TRIM33;RBFOX2;MDM2;RCOR2;RBPJ;HDAC5;RBM15;SPEN;HINFP;SPINDOC;KAT6B;ZBTB7A;ARID4A;NR3C1;TLE5;THAP7;KDM1A;KAT7
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.41622105124427483,1.285750543872643,0.012036108324974924,0.5526223100412971,1.0,129/497,18.98%,RUNX2;IGF2BP1;ENPP1;CREB3L1;ADIPOQ;MDFIC;BCL3;ZEB1;SBNO2;NCOR2;DAP;DEAF1;IGF2BP2;TCF7L2;ATXN1;GLI3;BCL6;ERN2;SYNCRIP;ATP8B1;GATA6;ZFPM2;XCL1;RCOR1;PHC2;ARID5B;SMAD2;TLE1;TBX2;ILF3;IGFBP5;NR2F2;ARID5A;KMT5A;SMURF2;MBD2;E2F1;PRDM5;KHDRBS1;LIMS1;TAF7;SCMH1;FOXK2;SFRP1;PPARG;RUNX1T1;YAF2;EIF2AK2;ENO1;ZHX2;SFMBT1;MBD1;EHMT1;AHR;PRICKLE1;TSHZ3;FOXE1;IRF1;CAPRIN1;GIGYF2;BHLHE40;SAMD4A;HEYL;CCAR2;PDS5A;ZMYND15;POU2F1;SAP18;ATR;BAHD1;WNT5A;HDAC1;SALL1;NONO;ZBTB38;HMGB2;TBX3;LOXL3;GAPDH;EID1;KLF10;RSF1;ZGPAT;CALR;TIMELESS;SP3;TNFRSF4;SETDB2;FBXW11;TNF;GSK3B;COMMD7;SPI1;GATAD2A;CTCF;BMP7;TRIB3;CDKN1B;FMR1;SMAD4;NIPBL;TSC22D4;PHC3;PATZ1;PHF12;L3MBTL3;POU3F3;ATF7IP;CLOCK;SMARCA4;ACVRL1;MTA3;TRIM33;RBFOX2;MDM2;EIF2AK3;RCOR2;RBPJ;HDAC5;RBM15;SPEN;HINFP;SPINDOC;KAT6B;ZBTB7A;ARID4A;NR3C1;TLE5;WAPL
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4537435423892357,1.2857018034809782,0.12008733624454149,0.552121915868809,1.0,19/86,14.44%,ZEB2;SULF1;JAK2;SMAD2;CDKN2B;ACVR1;CREBBP;TGFB3;INHBB;RNF111;TGFBR1;BMP5;TGFB1I1;ACVR1B;TGFB2;ACVR2A;GIPC1;BMP7;SMAD4
prerank,limb morphogenesis (GO:0035108),0.5580536011738454,1.2854520357614698,0.19327731092436976,0.5521965603111438,1.0,8/20,17.75%,GLI3;SHH;LRP6;TBX3;TGFB2;IQCE;NIPBL;FBXW4
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5619784285029534,1.2853540531574037,0.1976911976911977,0.5517970109863775,1.0,7/16,16.85%,PARP3;SHLD3;SETMAR;RIF1;DTX3L;PRKDC;PNKP
prerank,negative regulation of chemokine production (GO:0032682),0.5800049809030691,1.2853434616996564,0.20657276995305165,0.5511785869987471,1.0,2/14,5.04%,APOD;LGALS9
prerank,regulation of pH (GO:0006885),0.6235097501443121,1.285168346792074,0.17115689381933438,0.5510007426744462,1.0,2/11,2.41%,SLC9A1;LACC1
prerank,peptidyl-threonine modification (GO:0018210),0.4551264298288528,1.28504107530916,0.14139110604332952,0.550726921846021,1.0,28/66,23.25%,LRRK2;PRKCA;GALNT3;CAMK2D;PRKD2;ACVR1;CDK10;HIPK4;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;HIPK3;ACVR1B;CDC42BPA;GALNTL6;GALNT11;GSK3B;PRKDC;MAPK1;AKT1;MAP3K12;PRKCD;DYRK1A;MARK2;ROCK2;ROCK1;NLK
prerank,negative regulation of catalytic activity (GO:0043086),0.5258001697962819,1.284735805990087,0.17479674796747968,0.5509183086779748,1.0,3/24,7.96%,HP;TIMP1;CCAR2
prerank,pinocytosis (GO:0006907),0.6250168111476181,1.284465096575105,0.20124804992199688,0.5510371183372539,1.0,5/10,16.49%,CARMIL1;SNX33;SNX5;RAB34;DOCK2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4769044549525083,1.284285621868957,0.16748166259168704,0.5508410649567008,1.0,7/44,11.14%,CCL11;NCK1;BAIAP2;NCK2;CARMIL1;SPIRE1;SNX9
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6056511814456398,1.2841813454895599,0.2006172839506173,0.5504763715790277,1.0,5/12,14.77%,KDELR3;INSIG2;KDELR2;TAPT1;HSPA5
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4366001251297251,1.2839378260161023,0.11434735706580366,0.5505234083016263,1.0,22/102,14.12%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;IRS1;ADCY7;INSIG2;USF1;ADCY2;CPEB1;PPARG;MYO5A;INHBB;RAB8B;DENND4C;PRKAR1B;RPS6KB1;GCK;PIK3R1;RAB10;SRC;TRIB3
prerank,autophagosome assembly (GO:0000045),0.4726333512936026,1.2826043273428596,0.14002333722287047,0.553504112820048,1.0,18/52,21.19%,VMP1;WIPI1;AMBRA1;STX17;ATG3;RAB7A;ATP2A2;ATG7;PACS2;RAB1A;ATG16L1;ATG16L2;SMURF1;WDR45;PIK3C3;IRGM;UBXN2A;BECN1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6338299024773575,1.281655247634975,0.18670886075949367,0.5555122168391567,1.0,3/10,9.14%,XCL1;CCL5;WNT5A
prerank,regulation of cell migration (GO:0030334),0.4161850123913881,1.2815713353925524,0.022,0.5550900547165024,1.0,59/382,9.23%,ROR2;CCL11;CYP1B1;DLC1;COL1A1;CCL7;CEMIP;ADIPOQ;SULF1;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;SERPINE2;MAP4K4;SNAI1;CCAR1;PDGFRB;FGF7;SNAI2;PRKCA;DPYSL3;MITF;PLXNC1;AMOTL1;EGFR;NAV3;STAT3;IGFBP5;JAG1;MDK;CCR1;SHH;KIF2A;PTEN;AIF1;NF1;ACVR1;RHOD;CARMIL1;NF2;CCL5;EGF;ATM;SFRP1;RAP2A;SRGAP1;EPHA1;PLXND1;MIA3;SASH1;IGSF10;GPNMB;PLXNA3;ANXA1;TGFBR1;MYLK;FOXO3
prerank,COPII vesicle coating (GO:0048208),0.46493364319199276,1.2813413149733075,0.1400462962962963,0.5537925907430273,1.0,17/61,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,vesicle coating (GO:0006901),0.46493364319199276,1.2813413149733075,0.1400462962962963,0.5537925907430273,1.0,17/61,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.46493364319199276,1.2813413149733075,0.1400462962962963,0.5537925907430273,1.0,17/61,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,negative regulation of immune system process (GO:0002683),0.5689811147570484,1.2812942972913062,0.2072463768115942,0.5532995391556307,1.0,1/16,0.36%,COL3A1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6138645248571765,1.2809247581704768,0.18445121951219512,0.5536656575701449,1.0,8/12,22.93%,FLOT2;APOE;ABCA2;RANBP9;PICALM;PRNP;ROCK2;ROCK1
prerank,hemopoiesis (GO:0030097),0.44037909222369426,1.2808743127745603,0.10474090407938258,0.5531596726552839,1.0,9/87,5.95%,RUNX1;RUNX2;KMT2A;RUNX3;ETV6;ZFP36L2;MEIS1;JAG1;SFRP1
prerank,cell-cell junction assembly (GO:0007043),-0.329487527954708,-1.2806724785320334,0.07092198581560284,0.6209517180101886,1.0,17/63,10.53%,TJP1;PKP4;CLDN5;ACTB;CDH5;GJB6;CTNND1;CDH10;RAMP2;ARVCF;GJB2;CLDN12;CD9;VCL;PATJ;CDH12;CLDN11
prerank,cytoplasmic sequestering of protein (GO:0051220),0.598132313707667,1.2800085213975083,0.18235294117647058,0.5547943589368076,1.0,5/13,9.91%,SUFU;NFKBIE;PKD2;MDFI;DBN1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5234638651023006,1.2799567806480003,0.17718120805369128,0.5542858736450478,1.0,6/25,11.60%,HK2;FOXK2;ENO1;ADPGK;GAPDH;GCK
prerank,cellular response to estradiol stimulus (GO:0071392),0.5592467501887167,1.2796777289710637,0.2,0.554422355247888,1.0,4/18,11.91%,NRIP1;EGFR;SFRP1;LCOR
prerank,secondary palate development (GO:0062009),0.5877777080055917,1.2794659742525984,0.2062314540059347,0.5543331599452955,1.0,7/14,14.65%,CHD7;SMAD2;TGFB3;WNT5A;TGFB2;SMAD4;LRRC32
prerank,glycogen biosynthetic process (GO:0005978),-0.5029216483691812,-1.2793607748645959,0.1826086956521739,0.6185542200024291,1.0,5/12,17.60%,GBE1;PGM2L1;PER2;PPP1R3C;UGP2
prerank,glucan biosynthetic process (GO:0009250),-0.5029216483691812,-1.2793607748645959,0.1826086956521739,0.6185542200024291,1.0,5/12,17.60%,GBE1;PGM2L1;PER2;PPP1R3C;UGP2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.43241505640001354,-1.2792061329014623,0.183206106870229,0.6159800488399939,1.0,11/19,21.07%,IL1RAPL1;CDKL5;CUX1;CUX2;CAMK2B;LRP8;CDKL3;PTPRD;RELN;DHX36;CUL7
prerank,post-translational protein modification (GO:0043687),0.4142345718919473,1.2786650073622225,0.03313253012048193,0.5558540605635797,1.0,84/332,20.15%,PSMA7;C3;ENAM;KNG1;SPP1;IGFBP7;LAMB1;LAMC1;FBXO40;CP;TIMP1;IGFBP4;VCAN;SPSB1;FSTL1;PRKCSH;KLHL22;RAB2A;APOE;FBXL7;RBBP5;CALU;IGFBP5;WSB2;DCAF10;CUL1;FBN1;FN3KRP;MIA3;KLHL13;SKP1;CKAP4;DCUN1D1;SDC2;FBXL18;FBXW7;FBXO30;CHML;PSMB8;UBE2F;PSMA6;MGAT4A;TNC;LTBP1;STT3A;SOCS5;DCAF11;NEURL2;FBXO7;FBXW11;PSMF1;KCTD7;RAB1A;FBXO2;COPS6;RABGGTB;PSMA8;HIF1A;FBXL19;PSMD2;PSMD12;KLHL25;PSMD11;OBSL1;PSMD14;DNAJC3;DDB1;PSMB1;FBXW4;ASB3;RHBDD1;FBXO31;HSP90B1;DCAF8;EVA1A;FAM20C;PDIA6;FBXO32;FBXL22;LGALS1;ASB6;SHISA5;RAB8A;PSMC6
prerank,sulfur compound catabolic process (GO:0044273),0.4956450130566825,1.2786222957155284,0.18536585365853658,0.5553608238941266,1.0,5/38,6.55%,DCN;LUM;BGN;VCAN;PRELP
prerank,lung development (GO:0030324),0.5022955404594631,1.2776066220653575,0.17352185089974292,0.5575319793946684,1.0,11/33,12.48%,GLI2;FGF7;ERRFI1;SHH;BAG6;ITGA3;LOXL3;NPHP3;PDPN;RCN3;FGF2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.4847335031103144,1.277547772346369,0.14981729598051158,0.5570684844238996,1.0,12/45,12.90%,JAK2;CASP1;STAT3;LGALS9;CD36;PYDC1;TMEM106A;LPL;WNT5A;CASP8;TNF;P2RX7
prerank,chromatin assembly (GO:0031497),0.4853631337653659,1.2773334395595635,0.171990171990172,0.5570131301729071,1.0,15/38,20.05%,POLE3;NOC2L;BAHD1;GRWD1;HMGB2;LIN54;RSF1;SPTY2D1;NAP1L3;CTCF;ATRX;ASF1A;KAT6B;NAP1L1;HMGA2
prerank,regulation of mast cell activation (GO:0033003),0.6199822178718826,1.2772644783187204,0.1935483870967742,0.5565700418443316,1.0,6/10,25.10%,MILR1;TSLP;CD300LF;PLSCR1;CRLF2;CD84
prerank,response to peptide hormone (GO:0043434),0.4909159107467366,1.2769101504868745,0.15384615384615385,0.5569461085167682,1.0,15/43,17.14%,ZFP36L1;STAT1;IRS1;STAT3;IGFBP5;STAT5A;ANXA1;OGT;GNAI1;KHK;ZBED3;SRC;STAT5B;EIF2B3;AKT1
prerank,regulation of phospholipase activity (GO:0010517),0.6064617692866265,1.276812983116379,0.22328548644338117,0.5565613969088479,1.0,2/10,10.51%,LRP1;FGFR1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4784409906565867,-1.276098284090564,0.17543859649122806,0.62195323604299,1.0,6/14,17.08%,CHKA;PCYT2;LPIN1;SLC27A1;SELENOI;CHKB
prerank,Fc receptor signaling pathway (GO:0038093),0.43432569317948727,1.2759551707348447,0.11652542372881355,0.5582888892928338,1.0,25/110,17.06%,PSMA7;TEC;VAV2;GAB2;VAV3;MAP2K4;CUL1;LCP2;SKP1;GRB2;PSMB8;PSMA6;LAT2;PPP3CA;VAV1;FBXW11;PSMF1;PIK3R1;RAC1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;MAPK1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5357923801086439,1.2756547571813965,0.1651376146788991,0.55844241613284,1.0,7/25,12.29%,CBLB;ERRFI1;PPARG;CBL;SOCS5;ZGPAT;TNF
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.504544311114788,1.2751130898566074,0.17557251908396945,0.5593843689140165,1.0,15/31,22.46%,ARRDC4;PTEN;PLK1;SKP1;ARRDC3;DCUN1D1;FBXW7;UBE2L3;RAB1A;TRIB3;DCUN1D5;PIN1;CDC14B;AXIN1;FZR1
prerank,respiratory system development (GO:0060541),0.5065871129844695,1.2743747093153133,0.158311345646438,0.5608350745427892,1.0,11/32,12.48%,GLI2;CHD7;FGF7;SHH;SPEF2;BAG6;ITGA3;LOXL3;NPHP3;PDPN;FGF2
prerank,RNA destabilization (GO:0050779),0.5624365301487062,1.2739824816452276,0.19635343618513323,0.5612571949486171,1.0,10/18,22.93%,PUM1;METTL16;GIGYF2;CELF1;FTO;YTHDF3;DXO;ROCK2;YTHDF2;ROCK1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5346505971499907,1.2730894202042886,0.1763888888888889,0.5631669285131152,1.0,6/21,17.16%,PLA1A;PLA2G12A;OSBPL5;PLA2G4A;PLA2G4E;LPCAT3
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5106436304753605,1.2722347970100545,0.18725617685305593,0.5648508020276386,1.0,8/29,10.36%,GHR;STAT1;JAK2;STAT3;PKD2;STAT5A;IFNAR2;CCL2
prerank,regulation of cell junction assembly (GO:1901888),0.5095515145455999,1.2720251416649133,0.18610747051114024,0.5647317066436184,1.0,3/27,2.74%,RUNX1;SNAI1;SNAI2
prerank,female gamete generation (GO:0007292),0.5165007647875421,1.2719215609329912,0.1820580474934037,0.5643895437168639,1.0,10/29,23.15%,PTN;USP9X;MDK;DIAPH2;MCM9;MARF1;PARN;GDF9;KMT2D;DMC1
prerank,vesicle transport along actin filament (GO:0030050),0.5494625234582344,1.2718770038949858,0.19448476052249636,0.5638713054246388,1.0,5/19,7.53%,MYO1B;MYO5A;MYO1D;MYO1H;MYO7A
prerank,cellular glucan metabolic process (GO:0006073),-0.5081086747492878,-1.271695564221799,0.2010178117048346,0.6313279598650963,1.0,3/11,5.04%,PRKAG2;GBE1;PYGM
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4071371205989227,1.2714331563895511,0.0,0.564424527407699,1.0,259/1082,18.48%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;DCN;KMT2A;WNT2;RUNX3;ZEB2;POU5F1;CXXC1;SPP1;MDFIC;BCL3;PLAC8;GLI2;SBNO2;YAP1;DEAF1;TCF7L2;TCF4;NRIP1;ASXL1;SNAI1;TNFSF11;TNIP1;MRTFA;GLI3;CREB3L3;SATB2;MEIS2;SLC9A1;STAT1;ZMIZ1;RARB;TLR2;IRF7;CD40;GATA6;FGF7;MAFB;ZFPM2;AUTS2;NPAS4;NKX6-1;RXRG;MITF;ZNF496;SMAD2;NFIX;CDKN2B;EGFR;REL;MAML3;MLIP;UBP1;GLIS1;APOE;USF1;STAT3;LITAF;MEIS1;SERTAD2;HOXB3;ELF4;ILF3;PADI2;NR2F2;JAG1;PPRC1;SHH;E2F1;MYBL1;NCK1;PRDM2;PRKD2;PKD2;SMARCC1;ACVR1;ASXL2;TAF7;TCF12;NCK2;HIVEP1;INO80;FOXK2;EGF;CREBBP;FZD1;ATM;MACC1;SFRP1;PPARG;LRP6;YAF2;ZBTB48;TGFB3;ETV5;CXCL10;AHR;FOXE1;MLXIP;E2F8;BCL11B;GTF2H1;DDX17;ARNT;RNF111;IRF1;PID1;RRP1B;RPTOR;NEK4;HEYL;CREB3L2;ACTR2;CRTC1;MAML2;HOXA1;POU2F1;SP100;TGFBR1;OGT;MAP2K1;WNT5A;HDAC1;SALL1;FOXO3;TBL1X;ZBTB38;ARID1B;SMAD5;BMP5;NR2F1;TGFB1I1;JUNB;HMGB2;PPP3CA;PELP1;ZIC1;TBX3;TNFRSF1A;WWTR1;TRIM44;TEAD1;KLF10;ARF4;KMT2E;ELK4;CRTC3;RSF1;NFE2L2;ZBED3;SP3;CDK7;ACVR2A;TET2;E2F3;MED13;NIF3L1;MAP3K2;FBXW11;TNF;ZSCAN21;HOXB2;KLF6;MAML1;GLYR1;FGF2;MC1R;NKX2-8;KMT2B;ELK1;NSD3;GLIS3;SNX5;FOXJ3;NFKB2;SPI1;BRPF1;PIK3R1;DDRGK1;GTF2F1;PRDM10;CTCF;SMAD3;PSEN1;BMP7;ATRX;EGR2;DRAP1;MYSM1;USP22;TFAP2C;SMAD4;ASF1A;DTX3L;GABPB1;MMS19;CX3CL1;NAA15;RIPK1;SETX;SMAD1;RTRAF;CREB3L4;CREB3;CCNT1;HIF1A;TRIM56;STAT5B;PRKDC;RBMX;PTOV1;SQSTM1;SLC30A9;NPAS2;NSD1;POU3F3;MAX;ITGB1BP1;ATF7IP;CLOCK;TCF3;SMARCA4;SREBF1;HMGN1;ACVRL1;ZFHX3;AKT1;ING5;TCERG1;CALCOCO1;THRAP3;PCBD2;BRD4;MZF1;EIF2AK3;ATF4;PICALM;ICE1;GLI1;ETS1;MAP3K12;RLF;PRDM4;RAI1;INHBA;BICRA;PAX8;AGT;RBPJ;HDAC5;NR2C2;NFKBIA;SOX2;CDK9;SETD3
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4566243678435766,1.2713778501883657,0.15081206496519722,0.5639512437214143,1.0,10/62,12.60%,COL3A1;P2RY10;MAP4K4;JAK2;AUTS2;GRB2;MAPRE2;ERBIN;VAV1;AKAP13
prerank,lytic vacuole organization (GO:0080171),0.4942347478864655,1.2706727998518157,0.1707920792079208,0.5652161973761967,1.0,7/32,14.50%,ABCA1;LRRK2;HOOK2;MYO7A;CLN6;TPCN2;GAA
prerank,transition metal ion transport (GO:0000041),0.4903322151511226,1.2706270606634509,0.17723156532988357,0.5646890065232094,1.0,9/35,18.03%,HEPH;CP;SLC11A2;TRPC6;SLC31A1;IREB2;SLC30A9;TTYH1;ATP7A
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.44701285114851763,1.2699902738864608,0.13616071428571427,0.5658077616352046,1.0,17/75,12.48%,CCL11;THBS4;EGR3;PRKCA;NRP1;MDK;AKT3;PRKD2;EGF;STAT5A;ARNT;TGFBR1;WNT5A;HMGB2;FGFR1;VEGFC;FGF2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.49319769912856604,-1.2698885450660269,0.19346049046321526,0.6336224873495445,1.0,4/12,14.43%,MAOA;HNMT;DDC;SMS
prerank,positive regulation of type I interferon production (GO:0032481),0.45371110260282504,1.2698354679509496,0.13392857142857142,0.5656174801683208,1.0,24/73,20.62%,ZBP1;STAT1;TLR2;IRF7;CREBBP;TLR7;IRF1;CD14;CRCP;SETD2;GAPDH;POLR3A;POLR3D;NFKB2;TRIM56;PRKDC;CGAS;HSPD1;POLR2L;POLR2K;POLR3GL;RNF135;POLR3K;ISG15
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.49997226689645213,1.2697939024582823,0.17852522639068563,0.5650812928128648,1.0,4/32,6.32%,CEMIP;XCL1;P2RX5;CXCL10
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4311625060621471,1.2694055938241642,0.08764519535374868,0.5655096835911497,1.0,21/140,13.03%,P2RY10;KNG1;PDGFRA;CACNA1A;IAPP;CMKLR1;CACNA2D1;EDNRA;CACNA1C;P2RX5;CCR1;PTGDR;CD36;S1PR3;DLG4;CXCR4;DRD3;LPAR3;LPAR2;P2RX7;SPPL3
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5957561494738627,1.2693019741765548,0.2027231467473525,0.5651578945554925,1.0,1/12,0.41%,IL34
prerank,positive regulation of neuron projection development (GO:0010976),0.4411371141606401,1.2692166363320827,0.11002178649237472,0.5647611745310192,1.0,20/85,15.17%,ROR2;ROR1;PTN;DPYSL3;TENM3;APOE;MDK;FZD1;CAPRIN1;WNT5A;BMP5;DBN1;DBNL;NTRK3;BMP7;ARHGAP35;PTK7;CX3CL1;FES;SETX
prerank,regulation of protein polymerization (GO:0032271),-0.3625977314837285,-1.2690656319251732,0.12105263157894737,0.6330653561152281,1.0,9/35,12.55%,FCHSD2;MAP2;ARHGAP18;ESAM;HSP90AA1;ARHGAP28;TTBK1;PRUNE1;PAK3
prerank,protein N-linked glycosylation (GO:0006487),0.4558341045471966,1.2686344855956935,0.1380897583429229,0.5657935735589296,1.0,19/66,15.84%,MGAT5;B4GALNT2;ST6GAL1;GFPT2;DDOST;ALG5;SRD5A3;MAN1C1;MGAT4A;UGGT2;STT3A;LMAN1;ST3GAL1;UBE2J1;NUDT14;TUSC3;PMM2;B4GALT7;RPN1
prerank,positive regulation of cell cycle (GO:0045787),0.4610915824387158,1.2685032230988555,0.1550925925925926,0.5655213330430438,1.0,17/62,14.31%,MEIS2;PRKCA;EGFR;PKD2;TRIM21;CCND3;LRP6;ASNS;RAD23A;RPS6KB1;TBX3;EIF4EBP1;TGFB2;CALR;ANKRD17;CDKN1B;USP22
prerank,embryonic organ morphogenesis (GO:0048562),0.47515773068099665,1.2683410173157574,0.15609756097560976,0.5653522209727502,1.0,6/42,6.69%,PDGFRA;FBN2;HOXB3;FBN1;ACVR1;FOXE1
prerank,positive regulation of exosomal secretion (GO:1903543),0.5726706282837284,1.2676803327841657,0.20029673590504452,0.5665090908506951,1.0,8/15,24.73%,VPS4A;RAB7A;SDC1;SMPD3;SDC4;SDCBP;PDCD6IP;TSG101
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.616361083282343,1.267485115882662,0.20930232558139536,0.5664210909651227,1.0,7/10,22.90%,PRKD2;ARNT;VTN;ITGA5;HIF1A;GRB10;ITGB3
prerank,regulation of cell cycle phase transition (GO:1901987),0.43618017520911406,1.267281606077831,0.13347685683530677,0.5663253393244486,1.0,34/91,25.19%,PSMA7;MAD2L1;CUL1;PLK1;ANAPC11;CDC27;SKP1;FBXW7;PSMB8;PSMA6;DBF4;PSMF1;CDKN1B;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;DDB1;PSMB1;FBXO5;PSMC6;ERCC2;UBE2E1;FZR1;PSMB4;PSMB5;ANAPC2;CDKN1A;PSMD4;PSMD7;PSMD9;PSMA4;CDC16
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.4650852822204984,-1.2665241699626386,0.1791044776119403,0.6373249228155102,1.0,6/15,14.90%,SORT1;NTRK2;ZFYVE27;CASP3;DDIT4;BDNF
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5790491244080213,1.2664926798463356,0.2015151515151515,0.5677902805212821,1.0,4/14,6.54%,SUFU;NFKBIE;PKD2;MDFI
prerank,negative regulation of protein phosphorylation (GO:0001933),0.424286608883287,1.265715447182041,0.09304703476482618,0.5692848250796558,1.0,46/150,17.28%,ENPP1;ADIPOQ;FBLN1;PMEPA1;LRRK2;SPRED1;ERRFI1;SPRED2;PTPN13;NCK1;PTEN;NF1;TAF7;NCK2;DTNBP1;SFRP1;LRP6;PTPN6;EPHA1;EMILIN1;PID1;RASSF2;GSKIP;PYDC1;NIBAN1;CNKSR3;MVP;WWTR1;IBTK;LDLRAD4;ZBED3;SPRY2;NLRP2B;NTRK3;UBASH3B;SMCR8;CALM2;TRIB3;TRIB1;RTRAF;SNX25;PRKDC;ITGB1BP1;PTPRC;AKT1;DNAJC3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.61493520587751,1.2652404870315046,0.23597359735973597,0.5699341801633058,1.0,3/10,4.80%,DNAJB1;BAG3;NCK1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4459920253935589,-1.26497663371363,0.1644295302013423,0.638688675281412,1.0,7/18,9.85%,PPP1R16B;YWHAB;ARPP19;PPP1R8;SH3RF2;INPP5K;URI1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5036186783439798,1.264756401962764,0.1797752808988764,0.57064991700906,1.0,12/32,24.24%,NR1H4;ATXN2;FOXO3;NOLC1;PICALM;RBM4B;PRKCD;SAMD8;ROCK1;PCIF1;METAP1;EIF2A
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.42099477752290365,1.2647160538268238,0.11356466876971609,0.5701221088485152,1.0,23/138,11.01%,ROR2;ROR1;EPHA7;PDGFRA;PTN;PDGFRB;JAK2;EGFR;EPHB3;BLK;LCP2;DDR2;NPR2;EPHA1;STYK1;MERTK;FRK;TRIO;FRS2;ACVR1B;LIFR;FGFR1;PTK2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5888799478286898,1.2641365770915594,0.21266968325791855,0.5710898158204111,1.0,3/12,7.62%,ADIPOQ;IGFBP5;ADAMTS1
prerank,mitotic cytokinetic process (GO:1902410),0.5453664170463086,1.2639955621696393,0.19586206896551725,0.5708285565261738,1.0,7/20,17.50%,CHMP4A;CHMP4B;VPS4A;RHOA;CHMP7;CHMP2B;KIF20A
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6023902380482757,1.2635146037629046,0.23343373493975902,0.5715176488071897,1.0,4/11,5.87%,GATA6;XCL1;LGALS9;ATP6AP2
prerank,positive regulation of vascular permeability (GO:0043117),-0.4887921933071824,-1.2634456617949876,0.16939890710382513,0.640270388504289,1.0,4/12,0.74%,TJP1;BMP6;TJP2;OCLN
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.36712867818726175,-1.2630757037220404,0.14215686274509803,0.6383972249830091,1.0,18/31,20.52%,EPHA4;TANC2;SRCIN1;SHANK3;ARHGAP44;CUX2;NGEF;PDLIM5;CAMK2B;LRP8;ZDHHC15;ABI3;KIF1A;RELN;DHX36;CFL1;NLGN1;PPFIA2
prerank,negative regulation of anoikis (GO:2000811),0.575192449417049,1.262979204896192,0.20967741935483872,0.5723356192768193,1.0,6/14,14.06%,SNAI2;TLE1;BCL2;PTK2;ITGA5;SRC
prerank,lipid phosphorylation (GO:0046834),-0.5251549244799714,-1.2626728504023093,0.18604651162790697,0.6365672814106115,1.0,5/10,16.74%,DGKB;DGKI;DGKA;DGKG;DGKQ
prerank,response to glucose (GO:0009749),0.47351704633019887,1.2626571671877234,0.16443361753958588,0.5725791365185691,1.0,9/46,12.61%,SLC39A14;ADIPOQ;TCF7L2;NKX6-1;LPL;GCK;KHK;ZBED3;ZBTB20
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.49312752928504133,1.2626159193318438,0.18637532133676094,0.5720448355480254,1.0,7/35,11.45%,CDH11;PCDHB6;PCDHB16;DCHS1;CDH6;CDH18;CDH24
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4519855641927788,1.2625534080096048,0.15529411764705883,0.5715957356529513,1.0,12/56,13.21%,RAD51B;EGFR;AIF1;CCND3;ANAPC11;CDC27;ADAMTS1;RPTOR;ANXA1;KMT2E;ANKRD17;NSMCE2
prerank,negative regulation of developmental growth (GO:0048640),-0.38098862114859144,-1.262440006765632,0.13100436681222707,0.6343850257630176,1.0,9/30,15.97%,MAP2;DCC;DIP2B;WWC2;ULK2;DUSP10;CDKL3;MAG;WWC1
prerank,positive regulation of cell cycle process (GO:0090068),0.43231152083616853,1.2623296337492826,0.1454940282301846,0.5715505187134605,1.0,22/91,14.53%,SVIL;EDN3;PDGFRB;DYNC1H1;MAD2L1;INO80;EGF;XRCC3;DDX11;CDC42;E2F8;GPSM2;DRD3;DBF4;OPN1MW;CSPP1;RHOA;CEP120;BTC;GIPC1;ATRX;CDC14A
prerank,apoptotic process (GO:0006915),0.4142007034152748,1.2623032076629035,0.06510681586978637,0.5709889124916232,1.0,29/203,9.31%,FAP;CASP4;DLC1;TNFRSF21;IAPP;DAP;KREMEN1;TLR2;JAK2;CFLAR;CASP1;BBC3;CASP12;IFT57;HK2;BCL2;MCM2;PAEP;AHR;YARS1;BAG6;IRF1;AIFM2;CD14;RRAGC;EFNA5;CXCR4;OGT;SFRP5
prerank,regulation of neuroblast proliferation (GO:1902692),0.5695171552689434,1.261637628756686,0.19676945668135096,0.5720689926977383,1.0,9/15,25.00%,PTN;LRRK2;NF1;DISC1;CX3CL1;KDM1A;SMARCD3;FZD3;VEGFA
prerank,visual perception (GO:0007601),0.4340673682658675,1.261495095738886,0.1385606874328679,0.5718337723684693,1.0,8/84,9.31%,COL18A1;COL1A1;RGS16;COL11A1;RDH12;MYO7A;RDH10;SFRP5
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5274597401639454,1.2612229603390606,0.18975069252077562,0.5719444926354105,1.0,5/23,6.94%,NOS1AP;CACNA2D1;CACNB1;CAMK2D;CBARP
prerank,membrane fusion (GO:0061025),-0.3681560184104302,-1.2611497028902077,0.10909090909090909,0.6351455740132075,1.0,11/33,16.82%,DNM3;MYOF;HUWE1;NSF;DYSF;GCA;HACE1;RIMS1;DNM1L;NAPA;DNM2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5188058277001482,1.2608599841635866,0.2102496714848883,0.5723521610203296,1.0,2/22,2.90%,IL23R;XCL1
prerank,fatty acid catabolic process (GO:0009062),0.4533084144843325,1.2605903869727495,0.16258351893095768,0.572492096402846,1.0,6/67,7.19%,CEL;ADIPOQ;EHHADH;AIG1;SLC27A2;ACOX1
prerank,protein localization to phagophore assembly site (GO:0034497),0.602331638906848,1.260426863985578,0.22617124394184168,0.5723018648341043,1.0,4/11,15.93%,WIPI1;STX17;PACS2;WDR45
prerank,COPII-coated vesicle budding (GO:0090114),0.4505099162513143,1.2594169612749,0.15296803652968036,0.5744629561925693,1.0,19/68,17.88%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC24A;MIA3;VAPA;TRAPPC4;SEC16A;LMAN1;SEC23IP;CTSC;RAB1A;PPP6C;SEC13;TBC1D20;CSNK1D;SCFD1
prerank,positive regulation of B cell activation (GO:0050871),0.46574723302899257,1.2593479951223934,0.16251482799525505,0.5740294034156385,1.0,12/50,15.02%,MMP14;SH3KBP1;CD40;VAV3;BCL2;SASH3;TIRAP;SHLD3;IL7;TNFRSF4;RIF1;PAXIP1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.45828197967414147,1.259200383619987,0.16745283018867924,0.5737617389011951,1.0,11/47,11.67%,MID1;MAP4K4;TAOK1;EGFR;LGALS9;RAP2A;EIF2AK2;TAOK3;MAP2K1;TGFB2;NBR1
prerank,sensory organ development (GO:0007423),0.46900694674990423,1.2590353026954348,0.15903614457831325,0.5735698509328049,1.0,9/51,8.25%,SH3PXD2B;MEIS2;CHD7;MAFB;SIPA1L3;MEIS1;PBX3;MYO7A;ADAMTS18
prerank,sensory perception of sound (GO:0007605),0.4397028067742268,1.258728497806941,0.13043478260869565,0.5737882013235112,1.0,14/88,11.96%,ROR1;COL1A1;CEMIP;COL11A2;SNAI2;CRYM;COL11A1;MYO7A;HOXA1;TPRN;TBL1X;TSPEAR;ALDH7A1;MYO3A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.45096111275581013,1.2586682219988523,0.1455981941309255,0.5733384913285412,1.0,18/67,14.73%,FBLN2;JAK2;NRP1;DOCK1;MDK;LIMS1;CD36;CARMIL1;CDK6;SFRP1;CDC42;EPHA1;RSU1;CALR;UTRN;GSK3B;RAC1;CX3CL1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.538779078954573,1.2586182596151765,0.20527045769764216,0.5728412520452318,1.0,6/21,11.96%,GPM6B;SLC9A1;PEAK1;EFNA5;PTK2;RHOA
prerank,neuron projection regeneration (GO:0031102),0.6220001177476783,1.257817649719442,0.2296875,0.5743996892460547,1.0,3/10,13.48%,PTN;NREP;RTN4RL1
prerank,early endosome to late endosome transport (GO:0045022),0.533519933535382,1.2578126491841382,0.20275862068965517,0.5737901894475278,1.0,10/20,21.89%,HOOK2;RAB7A;PTPN23;EEA1;ANKRD27;KIF16B;PIK3C3;HOOK1;BECN1;RAB5A
prerank,cellular zinc ion homeostasis (GO:0006882),0.5163713663755817,1.257318746110311,0.19973190348525469,0.5745169288076741,1.0,1/26,0.13%,SLC39A14
prerank,cellular response to virus (GO:0098586),0.4935218062643707,1.257227479296338,0.19816272965879264,0.5741193374881871,1.0,11/30,21.08%,LGALS9;CCL5;CXCL10;RRP1B;MAPK11;GBF1;ARF1;FMR1;HIF1A;IRGM;ZC3H12A
prerank,negative regulation of centrosome duplication (GO:0010826),-0.49404404314465744,-1.257072651277402,0.17679558011049723,0.6435173081328927,1.0,8/11,30.67%,TRIM37;MDM1;CDK5RAP2;KAT2A;CCNF;BRCA1;TMEM67;NPM1
prerank,pre-replicative complex assembly (GO:0036388),0.45074585335857376,1.256756244030322,0.15446224256292906,0.5747389146769426,1.0,12/64,17.74%,PSMA7;MCM2;MCM7;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1
prerank,regulation of endothelial cell migration (GO:0010594),0.43991484019563054,1.2566972538104162,0.13442622950819672,0.5742784176423041,1.0,23/85,12.48%,DCN;SPARC;PTN;RHOJ;PRKCA;NRP1;APOE;NR2F2;PRKD2;NF1;APOH;EGF;SASH1;ANGPT1;ADAMTS9;SP100;WNT5A;PTK2;BMPER;CALR;PTPRM;RIN2;FGF2
prerank,response to interferon-beta (GO:0035456),0.5353271583606601,1.25660974868051,0.19864864864864865,0.5739075207739048,1.0,9/22,20.38%,STAT1;IKBKE;SHFL;IRF1;IFNAR2;UBE2K;IRGM;PLSCR1;TRIM6
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6149900359799494,1.2558580834370978,0.23920265780730898,0.5752782971646457,1.0,3/10,7.08%,APOD;PADI2;MIA3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.47664960597938777,1.2557178068679082,0.17857142857142858,0.5750424908396661,1.0,11/37,13.72%,DYNLL1;IFT57;IFT88;PCM1;DYNC2LI1;TRIP11;WDR35;TNPO1;IFT172;IFT81;DYNC2H1
prerank,inner ear morphogenesis (GO:0042472),0.5308794935485569,1.255272228399185,0.2154696132596685,0.5756523241388224,1.0,7/22,18.17%,TBX18;CHD7;HOXA1;ZIC1;MYO3A;TTC39C;PAX8
prerank,epithelial to mesenchymal transition (GO:0001837),0.46624259094545073,1.2552554862887801,0.17689530685920576,0.5750756597205103,1.0,19/47,20.05%,SNAI1;SNAI2;LIMS1;DDX17;HEYL;TGFBR1;WNT5A;TBX3;LOXL3;FGFR1;TGFB2;GSK3B;DLG5;BMP7;HIF1A;OLFM1;RBPJ;TASOR;HMGA2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.47744915341457894,1.2547996451293595,0.16367980884109917,0.5757516256945697,1.0,13/42,14.73%,MAP4K4;NRP1;LIMS1;CD36;CDK6;SFRP1;EPHA1;PTPRJ;UTRN;RIN2;GSK3B;RAC1;CX3CL1
prerank,cellular response to ketone (GO:1901655),0.48312551834195216,1.2546628583965223,0.19035532994923857,0.5755021880239478,1.0,14/35,22.98%,SPP1;ADCY2;SFRP1;AHR;MSN;GNAI1;SPHK2;SRC;GNB1;NR3C1;PTGFR;ROCK2;NDOR1;KLF9
prerank,dendritic cell chemotaxis (GO:0002407),0.5825977587352792,1.2546221683682477,0.23520710059171598,0.5750295927366044,1.0,4/14,14.55%,CCR1;CCL5;CXCR4;TRPM4
prerank,regulation of defense response to virus by host (GO:0050691),0.49512585453544994,1.254288765982397,0.19477124183006536,0.5753997359872566,1.0,7/30,16.40%,IL23R;STAT1;TNFAIP3;TRIM44;DTX3L;CGAS;TRAF3IP2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.48190850393948903,-1.2539383730687659,0.20520231213872833,0.649729695046443,1.0,6/13,10.49%,TECR;ELOVL7;ELOVL5;HACD1;HACD3;HACD4
prerank,MAPK cascade (GO:0000165),0.4070348196136779,1.25372441533805,0.05527638190954774,0.5762946207900133,1.0,72/295,17.44%,PSMA7;PDGFRA;ZFP36L1;MAP4K4;TAOK1;PTPN7;RASA3;JAK1;LRRK2;ZFP36L2;PLVAP;IRS1;PDGFRB;FGF7;JAK2;DUSP5;SPRED1;EGFR;CUL1;ABHD17C;PTPN3;LGALS9;NF1;CCM2;CCL5;EGF;IL3RA;DLG4;SKP1;TAOK3;ANGPT1;MAPK11;GRB2;PSMB8;BRAP;PSMA6;MAP2K1;FRS2;CCL2;RALGDS;FGFR1;PTK2;NRK;PDE6D;PPP1CB;FBXW11;TNF;FGF13;FGF2;PSMF1;BTC;PIK3R1;RANBP9;RASAL1;ABHD17B;ZDHHC9;SETX;PSMA8;FNTB;FGF18;PSMD2;PSMD12;PSMD11;RGL1;SYNGAP1;RASA1;PSMD14;MAPK1;PTPRA;DUSP6;YWHAE;MAP3K3
prerank,maturation of 5.8S rRNA (GO:0000460),0.5555715876609303,1.2535678046423062,0.22561863173216884,0.5761517412408597,1.0,8/17,17.10%,C1D;MAK16;PES1;EXOSC4;MPHOSPH6;PRKDC;RPF1;MTREX
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5880682709341866,1.2530195060146352,0.22807017543859648,0.5770590740688718,1.0,3/12,3.78%,IAPP;TREM2;APOE
prerank,protein localization to mitochondrion (GO:0070585),0.6037010060120466,1.2528830379404228,0.2248427672955975,0.5768800444172966,1.0,6/11,20.62%,LRRK2;HK2;RALA;AKT1;MAIP1;ISG15
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5062388425527726,1.2522159685687404,0.21466666666666667,0.5779961726553673,1.0,4/26,12.24%,LBP;TLR2;TIRAP;PJA2
prerank,oogenesis (GO:0048477),0.5687676930290836,1.2519289556321358,0.22205663189269748,0.5781948557948339,1.0,3/15,12.09%,PTN;MDK;MARF1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.44140138231699166,1.2515980466372336,0.14333333333333334,0.5785169417737959,1.0,40/83,26.65%,BACH1;CCNE2;CUL1;E2F1;KHDRBS1;ACVR1;CACUL1;CDK6;CDK14;DBF4;RPS6KB1;ACVR1B;EIF4EBP1;CDK7;E2F3;CDKN1B;GSPT1;PPP6C;MAX;RCC1;LATS2;BRD4;INHBA;CDK16;FBXO5;HINFP;PLK2;CDC7;LATS1;CCNH;MNAT1;CDC6;CDKN1A;TYMS;NASP;CDC25A;BCAT1;TFDP1;CDK18;CDC34
prerank,regulation of cell population proliferation (GO:0042127),0.40275493979994037,1.251544724279357,0.007,0.5780585571900926,1.0,103/691,11.96%,ROR2;RUNX1;GLMN;CYP1B1;COL18A1;DLC1;CXCL5;IL34;WNT2;CXCL1;OSMR;IGFBP7;PDGFRA;EDN3;YAP1;PPP1R9B;ZFP36L1;TCF7L2;SFRP4;PTN;BCL6;MEIS2;STAT1;CCAR1;GAB2;TIMP1;IRS1;PDGFRB;PRTN3;FGF7;JAK2;WNT9A;TSLP;CDKN2B;EGFR;NUAK1;STAT3;MEIS1;TBX2;FRZB;FXN;JAG1;SHH;ALDH1A2;PTEN;BCL2;AIF1;PKD2;LIMS1;CYP27B1;NCK2;NF2;CACUL1;EGF;STRN;CDK6;SFRP1;STAT5A;TGFB3;EAPP;EIF2AK2;PTPN6;CXCL10;PDS5B;GLP2R;S1PR3;EPHA1;PINX1;IRF1;ADAMTS1;CDK10;EEF1E1;FRK;CELF1;BTG1;GPNMB;S1PR2;TGFBR1;MAP2K1;HDAC1;CSNK2A1;SFRP5;IL7;BMP5;TGFB1I1;JUNB;NOP2;HMGB2;LIFR;TBX3;RERG;FGFR1;WWTR1;PTPRJ;KLF10;PTPN2;PTK2;PDPN;TGFB2;GCNT2;CALR;TIMELESS;RHOA
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.537371176120463,1.2510248875607632,0.2055944055944056,0.5788786515378183,1.0,2/19,0.97%,DCN;CCBE1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.4706476145550688,1.2505605791526015,0.17064439140811455,0.579540318828546,1.0,13/49,14.77%,PMEPA1;IAPP;TREM2;AIDA;CDC42;PYDC1;LDLRAD4;GSK3B;NLRP2B;ANKRD27;DACT1;SRC;HSPA5
prerank,negative regulation of endothelial cell migration (GO:0010596),0.49308083816929654,1.2505550714742846,0.18513853904282115,0.578946135242864,1.0,10/36,12.48%,DCN;APOE;NR2F2;APOH;PPARG;ADAMTS9;SP100;PTPRM;TNF;FGF2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.49907778814072823,1.2500314667900907,0.19764397905759162,0.5798334106643052,1.0,10/30,17.22%,SFRP4;FSTL1;SMAD2;NREP;SMURF2;ITGA3;SMAD3;SMAD4;LATS2;TRIM33
prerank,sulfur compound biosynthetic process (GO:0044272),0.4297646859492949,1.2498364105425182,0.14589989350372737,0.5797098702001808,1.0,27/104,16.06%,DCN;LUM;CHSY3;BGN;PAPSS2;B4GALT5;CHST13;VCAN;MGST1;AKR1A1;ST3GAL3;METTL16;PRELP;ANGPT1;CHSY1;CHST11;GSTK1;ST3GAL1;CHST1;GGCT;UGDH;SLC35D2;SLC35B3;CHPF2;B4GALT2;GGT7;CNDP2
prerank,regulation of osteoblast differentiation (GO:0045667),0.4307830117785645,1.2495429132195333,0.14770240700218817,0.5798719645621713,1.0,17/82,11.90%,RUNX2;FBN2;YAP1;TNN;SNAI2;CCN4;NELL1;SUFU;DDR2;ACVR1;CDK6;PPARG;TMEM119;WWTR1;PTK2;NBR1;ACVR2A
prerank,regulation of ion transmembrane transport (GO:0034765),-0.36976150606679625,-1.2494146523959127,0.15942028985507245,0.6598100907992197,1.0,9/33,13.73%,AKAP6;WWP2;KCNJ2;WNK3;KCNJ3;KCNJ13;KCNJ10;KCNQ1;KCNJ12
prerank,synapse assembly (GO:0007416),0.44623379463395446,1.2493523538088933,0.16361556064073227,0.5797731992905468,1.0,16/67,12.66%,LGI2;SLITRK6;PCDHB6;PCDHB16;FARP1;SDK2;NPAS4;ADGRL3;PTEN;FZD1;PLXND1;WNT5A;DSCAM;DBNL;FGF13;SDK1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4454429766370982,1.2492611734634862,0.16439909297052155,0.5794197242435117,1.0,15/66,13.07%,IL34;EDN3;TNFSF11;LRRK2;CD40;PDGFRB;EGFR;EGF;SASH1;TAOK3;PIK3R5;FGFR1;TNF;FGF2;TRAF2
prerank,inhibitory synapse assembly (GO:1904862),0.5990758242185186,1.2490663636499653,0.23647604327666152,0.5793131126678699,1.0,4/11,12.48%,LGI2;NPAS4;WNT5A;FGF13
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.5200986521462522,-1.2483969413439133,0.24581005586592178,0.6565784935513752,1.0,3/10,11.09%,HDAC4;CBFA2T3;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),-0.5200986521462522,-1.2483969413439133,0.24581005586592178,0.6565784935513752,1.0,3/10,11.09%,HDAC4;CBFA2T3;GIT1
prerank,primary alcohol metabolic process (GO:0034308),0.514964274392583,1.2483347968004561,0.2002652519893899,0.5806702346020325,1.0,9/25,19.58%,CYP1B1;RDH12;RDH10;CYP1A1;ALDH3A2;PECR;ADH1A;DHRS3;GDPD3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.40547618910672883,1.2482485709196636,0.03610832497492478,0.5803031071389266,1.0,83/390,15.17%,ROR2;ROR1;SLC39A14;COL4A2;COL1A1;EPHA7;MMP2;SULF1;PDGFRA;GHR;FLRT2;VAV2;EFNA4;IRS1;PDGFRB;FGF7;JAK2;VAV3;SPRED1;NRP1;EGFR;KALRN;EPHB3;STAT3;BLK;ITSN1;GALNT3;DOCK1;LCP2;SPRED2;NCK1;ANKS1B;BAIAP2;PRKD2;DDR2;AP3S1;NCK2;PLAT;CDC42;EPHA1;STYK1;GIGYF2;SH2B2;ANGPT1;MERTK;ACTR2;MAPK11;FRK;SDC2;CBL;GRB2;EFNA5;GTF2F2;FRS2;NCBP2;BRK1;FGFR1;MVP;PTPRJ;PTPN2;PTK2;ATP6V1F;RHOA;SHB;VAV1;GSK3B;VEGFC;FGF2;NTRK3;UBASH3B;ATP6V1H;ABI1;PIK3R1;ATP6V1G2;GTF2F1;KIF16B;PSEN1;SRC;RAC1;AP2A2;FES;PSENEN;SETX
prerank,postsynaptic membrane organization (GO:0001941),0.5502586361038698,1.2482073666756233,0.20902255639097744,0.5798167189565586,1.0,3/17,7.01%,CEL;APOE;DLG4
prerank,regulation of kinase activity (GO:0043549),0.4251078476693819,1.2479480194518142,0.13591160220994475,0.5798852122252998,1.0,11/89,6.61%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;EGFR;EPHB3;TREM2;DDR2;NPRL2;EPHA1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5987766420491469,1.2474552427568575,0.22993827160493827,0.5805534981753647,1.0,7/10,25.76%,ST6GAL1;ST3GAL1;AMDHD2;GNPDA2;NPL;GNE;GNPDA1
prerank,ESCRT complex disassembly (GO:1904896),0.6135959767102832,1.2471738986162795,0.22756410256410256,0.5801173429674676,1.0,3/10,15.31%,VPS4A;CHMP7;CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),0.6135959767102832,1.2471738986162795,0.22756410256410256,0.5801173429674676,1.0,3/10,15.31%,VPS4A;CHMP7;CHMP2B
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5587906891131732,1.2471342169213038,0.21688500727802038,0.5796104151469851,1.0,6/17,20.05%,LTBP3;TERT;PTPRC;KDM1A;KAT7;HMGA2
prerank,heart morphogenesis (GO:0003007),0.46678803870183444,1.2466592767068219,0.16864608076009502,0.5802445562021361,1.0,10/50,11.44%,DLC1;FLRT2;CHD7;TBX2;ACVR1;HEYL;TGFBR1;TBX3;PTK2;TGFB2
prerank,ephrin receptor signaling pathway (GO:0048013),0.4368246766078539,1.246531508627251,0.16924778761061948,0.5799810751972637,1.0,24/82,16.40%,EPHA7;MMP2;VAV2;EFNA4;VAV3;KALRN;EPHB3;ITSN1;ANKS1B;NCK2;CDC42;EPHA1;ACTR2;SDC2;EFNA5;PTK2;RHOA;PSEN1;SRC;RAC1;AP2A2;PSENEN;YES1;RASA1
prerank,regulation of actin filament-based movement (GO:1903115),-0.530471327199871,-1.2464236035786682,0.23138297872340424,0.659685652167963,1.0,3/10,10.43%,PDE4B;ANK2;PDE4D
prerank,positive regulation of leukocyte activation (GO:0002696),0.5562176999504287,1.2463780099757784,0.20399429386590584,0.5798319045466251,1.0,7/18,22.65%,LBP;TSLP;WNT5A;HSPD1;TNIP2;CRLF2;IL33
prerank,T cell differentiation (GO:0030217),0.466210028760988,1.2447501835676418,0.19592875318066158,0.5836544747970103,1.0,9/40,13.10%,ZFP36L1;GLI3;CHD7;ZFP36L2;SHH;ANXA1;TCF7;PTPN2;SPI1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5174739042755866,1.2442656262039924,0.22074468085106383,0.5843049727567596,1.0,11/21,21.40%,ADAM19;PRTN3;MYH9;SPPL3;PSEN1;PSENEN;RBMX;NCSTN;ADAM9;PSEN2;HM13
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4140556277449464,1.2441605735948749,0.0849539406345957,0.5839942954839408,1.0,54/182,21.08%,RUNX1;RBMS3;CREB3L1;ITGB8;YAP1;APOBEC1;ATXN2;FLOT2;REL;APOE;CCR1;LGALS9;SFRP1;EMILIN1;SUB1;DLG4;CELF1;TERT;TNRC6B;FBXW7;MAP2K1;HDAC1;DICER1;SETDB1;MOV10;TGFB2;SETDB2;TNF;FGF2;SMCR8;SPI1;DDRGK1;MSR1;PSEN1;ANKRD13B;PDCD10;CCDC3;SMO;HIF1A;OLFM1;ACVRL1;PICALM;XDH;HINFP;TLE5;MTMR2;AGO2;TRIM6;FOXP1;PARP14;BMPR1A;YY1;VHL;ZC3H12A
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.588068631573446,1.2440972493974225,0.22993827160493827,0.58355522017947,1.0,2/11,3.66%,P2RX5;TREM2
prerank,negative regulation of blood pressure (GO:0045776),0.5832627020058299,1.2438292513645155,0.23238380809595202,0.5836399960334303,1.0,3/13,13.62%,ADIPOQ;DRD3;SCPEP1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5798536931209959,1.243802957144299,0.23088235294117648,0.5831131950124168,1.0,3/14,13.11%,EHHADH;ACOX1;ACOX3
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.269414599341042,-1.243800447854416,0.05555555555555555,0.6643343026680746,1.0,48/224,9.63%,UNC13C;SNAP25;SLC12A7;CACNB2;DLGAP1;CHRM2;UNC13B;CACNB4;SYNJ2BP;NRXN1;GRM7;GRM1;HTR2C;RIT2;DLG2;GRIK4;GABRA2;MINK1;GABRB1;KCND2;GLRA3;GABRG3;CALM1;DTNA;SLC1A2;SLC1A1;ATXN3;PTCHD1;SLC12A6;SLC6A1;GRIA2;PRKAR1A;GRM3;NOVA1;GABRA5;NRXN2;KCNQ3;GRIA1;HTR1F;CAMKK2;GLRA1;PRKAR2A;CAMK4;GABRB2;BSN;CACNA1E;CACNA1B;CPLX1
prerank,regulation of translation (GO:0006417),0.4137901061270078,1.2437979016328413,0.11008230452674897,0.5825268130016756,1.0,37/173,16.04%,IGF2BP1;PRR16;BCL3;IGF2BP2;EIF4G2;SYNCRIP;CTIF;ATXN2;EIF4G3;PLD1;ILF3;IGFBP5;SHFL;EIF2AK2;EIF3H;CAPRIN1;GIGYF2;SAMD4A;EIF5B;NIBAN1;EIF5;FOXO3;RPS6KB1;NCBP2;GAPDH;ALKBH1;NAT10;MTIF2;TRAP1;CALR;YTHDF3;FMR1;NOLC1;GSPT1;EIF1;PRKDC;KLHL25
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5973280933113015,1.2433825099895743,0.22015503875968992,0.5830825323657972,1.0,4/11,14.28%,STAT3;PUM1;WTIP;FMR1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.48268218611173663,1.2430394567180136,0.19672131147540983,0.5834294171517352,1.0,4/32,6.32%,CEMIP;XCL1;PKD2;CXCL10
prerank,regulation of potassium ion transport (GO:0043266),-0.3711262047797325,-1.2430082949073693,0.15486725663716813,0.6637483270471424,1.0,6/31,2.68%,KCNIP4;FHL1;ACTN2;ANK2;DPP10;DPP6
prerank,amino acid transport (GO:0006865),0.4598851771467358,1.242521833560945,0.19110576923076922,0.5841968246309039,1.0,8/49,11.38%,SLC7A2;SLC38A3;SLC25A47;SLC7A7;SLC38A4;SLC36A2;SLC7A8;PDPN
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3992892513622239,1.2417889681401075,0.014,0.5855917862429417,1.0,112/572,14.46%,RUNX1;NR1H4;TRPS1;RUNX3;ZEB2;POU5F1;GLI2;ZEB1;ETV6;NCOR2;YAP1;DEAF1;TCF7L2;NRIP1;SNAI1;ATXN1;GLI3;BCL6;MEIS2;STAT1;RARB;IRF7;BACH1;GATA6;SNAI2;ZFPM2;FHL2;DNAJB1;NKX6-1;MITF;CRYM;ARID5B;SMAD2;NFIX;MIER2;SUFU;MLIP;GLIS1;STAT3;CGGBP1;TBX2;USP9X;NR2F2;ARID5A;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;BAG3;PRDM2;PPID;TAF7;HIVEP1;RNF2;CREBBP;CBX8;PPARG;PLK1;ETV5;ENO1;ZHX2;MDFI;FOXE1;E2F8;NOC2L;BHLHE40;FRK;SP100;HDAC1;ZBTB5;SALL1;FOXO3;TBL1X;DICER1;FOXP4;PRDM1;NR2F1;MTA2;CXXC5;TGIF2;TBX3;EID1;FNIP1;CBFB;GATAD2B;KLF10;ELK4;ZGPAT;PHF21A;DNMT3B;CALR;LCOR;TNF;DUSP26;SKOR2;GLIS3;SPI1;RIF1;GATAD2A;CTCF;SMAD3;DACT1;PSEN1;KCNIP3;ATRX;TRIB3;DRAP1;TFAP2C;SMAD4;MAFK
prerank,regulation of DNA binding (GO:0051101),0.4702579997458776,1.2416123408579467,0.17633136094674556,0.5854730622720102,1.0,15/44,20.05%,BCL3;JAK2;E2F1;ILRUN;EGF;PPARG;MDFI;SP100;HMGB2;RSF1;SMO;NFKBIA;ZBTB7A;KDM1A;HMGA2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.4010519947032976,1.241022557632505,0.022022022022022022,0.5865115077483063,1.0,96/509,13.29%,ROR2;ROR1;DCN;ADIPOQ;MAP3K14;TRIML2;PDGFRA;NEK6;IAPP;TCF7L2;TNFSF11;NOS1AP;GAB2;TLR2;ALPK1;CD40;IRS1;PDGFRB;FGF7;JAK2;BIRC3;CFLAR;CASP1;EGFR;P2RX5;REL;TREM2;RICTOR;LITAF;BBC3;IKBKE;MIOS;SLC20A1;PUM1;UNC5CL;BCL2;PRKD2;LGALS9;NOD1;LIMS1;TRIM21;CCL5;EGF;STRN;EIF2AK2;PTPN6;PIK3AP1;HPSE;TLR7;SASH1;VAPA;PIK3R5;RPTOR;TIRAP;TRIM13;ANGPT1;TMEM106A;CD14;TRIM8;CBL;GRB2;RRAGC;TGFBR1;WNT5A;FRS2;IRAK4;OASL;WLS;EDA2R;CXXC5;GAPDH;TNFRSF1A;FGFR1;FNIP1;TRIM44;PTPRJ;PTK2;TGFB2;CASP8;GCNT2;ANKRD17;UNC5B;SPRY2;RHOA;VAV1;TNF;FGF2;NTRK3;AKAP13;MC1R;RASD2;TRAF2;SMCR8;SPHK2;BTC;PIK3R1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4541951964788541,-1.2408788122617356,0.19488817891373802,0.6668525989063868,1.0,6/15,14.55%,KCND3;ATP1B1;KCNJ2;KCNJ3;KCNQ1;KCNN2
prerank,positive regulation of transferase activity (GO:0051347),0.41259502675151116,1.2407100002228089,0.1275933609958506,0.586710882782809,1.0,18/142,8.41%,ROR2;ROR1;EPHA7;ADIPOQ;PDGFRA;PARM1;PDGFRB;ARRDC4;EGFR;EPHB3;TREM2;DDR2;PLK1;EPHA1;ARRDC3;MERTK;DCUN1D1;FBXW7
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4191417807210314,1.2401221375346287,0.12070759625390219,0.5877034314158681,1.0,30/136,16.25%,CYP1B1;DAP;TCF7L2;SFRP4;CMKLR1;TNFAIP3;XCL1;SUFU;IRAK3;NFKBIE;PKD2;TRIM21;RNF2;MDFI;IRAK2;BHLHE40;PYDC1;HEYL;SP100;SFRP5;ERBIN;TNFRSF4;NLRP2B;COMMD7;SPI1;BMP7;TRIB1;PAXIP1;ITCH;RBCK1
prerank,fatty acid metabolic process (GO:0006631),0.4233902829828228,1.2399693634284383,0.1289308176100629,0.5875136149989311,1.0,13/115,10.01%,CEL;ADIPOQ;LIPC;ACSL4;ACADSB;CD36;PPARG;SLC27A2;ACOX1;HSD17B8;LPL;CYP1A1;ACSF2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4866645182051878,1.2399677845784292,0.20448877805486285,0.5869235393862262,1.0,11/34,12.88%,DUSP2;DUSP5;PTPN13;PTPRZ1;PTPN6;PTPN18;PTPN1;PTPRJ;PTPN9;PTPN2;UBASH3B
prerank,stem cell development (GO:0048864),0.541935685042903,1.2392487824982954,0.2311111111111111,0.5882789684381556,1.0,5/16,17.01%,SNAI2;SHH;TAPT1;NOLC1;PTPRC
prerank,actin polymerization or depolymerization (GO:0008154),0.45714991596556676,1.2389045133628538,0.1806375442739079,0.5886294895038614,1.0,13/50,14.73%,GAS7;SVIL;JAK2;AIF1;ABI2;TTC17;SPIRE1;PREX1;VILL;ARHGAP6;MICALL2;ABI1;RAC1
prerank,positive regulation of macrophage activation (GO:0043032),0.5555585178864717,1.2387744737187658,0.2391304347826087,0.5884054447080046,1.0,3/17,9.14%,LBP;TREM2;WNT5A
prerank,regulation of hormone secretion (GO:0046883),0.557401356551019,1.2387679057373044,0.22140762463343108,0.5878261305950052,1.0,2/15,8.96%,EDN3;ANXA1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.42989092456208144,-1.2387157837554972,0.17525773195876287,0.6703422918995516,1.0,6/18,14.77%,TEK;KRIT1;CDH5;SHTN1;RACK1;RIPOR2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4377608812902686,1.2383276641768945,0.16798196166854565,0.5884181068843249,1.0,21/67,14.73%,SULF1;VAV2;VAV3;NRP1;DOCK1;NCK1;BAIAP2;PRKD2;NCK2;CDC42;MAPK11;BRK1;PTK2;RHOA;SHB;VAV1;VEGFC;ABI1;PIK3R1;SRC;RAC1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5947010730970923,1.238223685941861,0.25117739403453687,0.588077645827742,1.0,6/11,18.70%,GPM6B;TAX1BP3;SNX33;LEPROT;PICALM;LEPROTL1
prerank,regulation of cholesterol esterification (GO:0010872),0.5973696803788611,1.2380709788651796,0.23667711598746083,0.5879095399318917,1.0,3/10,4.34%,APOE;ABCA2;ABCG1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4549038735839937,1.2380616324101033,0.18706697459584296,0.5873494840239749,1.0,20/56,20.69%,PMEPA1;ACVR1;TGFB3;INHBB;EMILIN1;TGFBR1;BMP5;BMPER;TGFB2;LDLRAD4;ACVR2A;BMP7;SMAD4;SNX25;ACVRL1;INHBA;PIN1;GDF9;GDF11;BMPR1A
prerank,heart development (GO:0007507),0.4124979690391244,1.2378443532089372,0.12242798353909465,0.5873096584574639,1.0,26/150,12.60%,SCUBE1;DLC1;COL3A1;SH3PXD2B;GLI2;FLRT2;DNAAF4;CHD7;ZFPM2;CACNA1C;TBX2;SHH;FBN1;PTEN;PKD2;NF1;ACVR1;PDLIM4;TGFBR1;SALL1;BMP5;PTK2;TGFB2;CASP8;NTRK3;AKAP13
prerank,BMP signaling pathway (GO:0030509),0.4439689545727328,1.2371168794033576,0.1852704257767549,0.5886401662003056,1.0,21/62,20.88%,RUNX2;SMAD2;USP9X;ACVR1;HIVEP1;TGFB3;SMAD5;BMP5;TGFB2;ACVR2A;SMAD3;BMP7;SMAD4;SMAD1;SMURF1;CHRD;ACVRL1;ZFYVE16;GDF9;BMPR1A;RGMB
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.3236088851303167,-1.2369249794477164,0.125,0.672869976905324,1.0,9/54,4.59%,KCNIP4;CAV1;FHL1;AKAP6;WWP2;DPP10;DPP6;KCNJ2;KCNJ3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.5000603298466695,1.2368757256111669,0.21916010498687663,0.5887332508369467,1.0,2/27,0.63%,SLC7A2;SLC1A3
prerank,negative regulation of viral process (GO:0048525),0.44900754077906724,1.2365694178761324,0.189873417721519,0.5889355908442306,1.0,12/57,12.29%,TNIP1;STAT1;UBP1;ILF3;TRIM21;SHFL;CCL5;EIF2AK2;TRIM13;TRIM8;OASL;TNF
prerank,positive regulation of kinase activity (GO:0033674),0.41863508822192186,1.2365237840716876,0.1630901287553648,0.5884590529290873,1.0,15/107,7.98%,ROR2;ROR1;EPHA7;PDGFRA;JTB;PDGFRB;EGFR;EPHB3;TREM2;LCP2;DDR2;CACUL1;EPHA1;RASSF2;MERTK
prerank,organic hydroxy compound transport (GO:0015850),0.48283851185203297,1.2360448565568611,0.21119592875318066,0.589125715789992,1.0,6/36,11.69%,NR1H4;ATP8B1;SLC10A6;NPC2;SLC10A1;SLCO1B1
prerank,regulation of centrosome duplication (GO:0010824),0.4961252934292777,1.2358195097137106,0.20689655172413793,0.5891312648602244,1.0,8/29,15.31%,CEP295NL;CHMP4B;ALMS1;XRCC3;NAT10;CEP120;CENATAC;CHMP2B
prerank,cellular response to hydrogen peroxide (GO:0070301),0.4830281435672694,1.2357044836458189,0.21374045801526717,0.588853592914955,1.0,7/33,15.17%,CYP1B1;TNFAIP3;FXN;ANXA1;NFE2L2;RIPK1;SETX
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.45126178144061874,-1.2354912665369935,0.2108626198083067,0.6742092440764069,1.0,6/16,13.78%,PPP1R16B;AGTR1;GATA2;JCAD;FGFBP1;THBS1
prerank,fat cell differentiation (GO:0045444),0.45219879383055317,1.2353721124336225,0.18006795016987542,0.589112815780645,1.0,10/57,8.71%,ADIPOQ;STEAP4;TCF7L2;MAFB;TMEM120B;OSBPL11;PPARG;INHBB;PID1;PSMB8
prerank,regulation of vacuole organization (GO:0044088),0.5226381855881856,1.2352415619937824,0.2200557103064067,0.5888906173018124,1.0,13/20,27.83%,NPRL2;IFT88;ENO1;ADPRH;MTMR3;MTM1;IFT20;RAB5A;TBC1D12;ENO3;ANXA2;SCARB2;ENO2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.40332351912797665,-1.235030587759129,0.18214285714285713,0.6726132817416183,1.0,7/23,12.82%,HDAC7;CCN3;NMI;TMSB4X;ADIPOR1;C1QTNF3;CYLD
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.46789705479582466,1.2350293392449596,0.2103960396039604,0.5888303573201944,1.0,16/43,20.69%,MMP2;STAT1;PDGFRB;CCN4;IGFBP5;AIF1;CCL5;ADAMTS1;TNF;FGF2;CX3CL1;IL6R;AKT1;HTR1B;FOXP1;BMPR1A
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.48200898093903033,1.2350270330336233,0.2096569250317662,0.5882537376767927,1.0,11/35,11.84%,SULF1;SPARC;STAT1;APOE;NR2F2;NF1;APOH;PPARG;AIMP1;CCL2;PTPRM
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5613674662308453,1.234905805801216,0.23695976154992549,0.5879894641982694,1.0,3/15,6.56%,NEK6;PLK1;CDC27
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.2896833416524093,-1.2348124801233853,0.03125,0.6703806125660455,1.0,46/110,21.75%,RPL34;PPP2R1A;RPL36;RPL8;PABPC1;RPS4X;RPL18A;PYM1;RPL19;RPL38;RPS21;RPL5;UPF2;RPS10;RPLP0;RPL7;RPL13;RPS8;RPS23;RPL30;RPS12;UPF1;RPL13A;RPL35A;RPL29;RPL32;PNRC2;RPL10;RPL15;RPS27;RPL35;RPS16;RBM8A;RPL7A;RPS15;RPS29;MAGOH;RPL27;RPS13;RPS19;RPL41;RPLP1;RPL28;EIF4A3;GSPT2;RPS17
prerank,proton transmembrane transport (GO:1902600),0.47886152831146195,1.234159263854843,0.20802005012531327,0.5893733496397445,1.0,7/36,12.92%,HVCN1;SLC9A1;ATP5PO;DMAC2L;SLC36A2;ATP6V1F;ATP6V1H
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.4813331573954822,-1.233974814629622,0.20168067226890757,0.669870249203287,1.0,8/12,35.85%,PSAT1;CBS;SEPHS1;PHGDH;SEPHS2;CTH;GGT1;SERINC3
prerank,embryonic organ development (GO:0048568),0.4503871054219374,1.2333353699301373,0.1806674338319908,0.5910043797355942,1.0,13/61,12.29%,KMT2A;GLI2;COL13A1;GLI3;RARB;TBX2;TEAD3;PBX3;FOXE1;SALL1;TEAD1;TGFB2;TNF
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.36696543611108434,-1.233240039804723,0.18840579710144928,0.669033833320106,1.0,15/31,30.82%,GPHN;MOCS2;CYP51A1;DHRS11;LIAS;NFS1;LSS;PRLR;NOXRED1;FDFT1;PYCR2;STAR;MOCS3;PYCR3;GCH1
prerank,granulocyte differentiation (GO:0030851),-0.4233705193621045,-1.233140155184416,0.17843866171003717,0.6664564300366776,1.0,8/18,18.96%,LEF1;LBR;CBFA2T3;EP300;CDK4;TAL1;RXRA;DEK
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.41603101502904716,1.2329712564282889,0.13555787278415016,0.5914314959266352,1.0,35/138,18.89%,RORA;NR1H4;NCOR2;YAP1;RARB;RXRG;MAML3;TEAD3;TAF7;CREBBP;PPARG;GTF2H1;MAML2;HDAC1;TBL1X;GTF2F2;NR2F1;WWTR1;TEAD1;CDK7;E2F3;MAML1;GTF2F1;TAF4;NR6A1;MED26;NRBF2;TAF2;POLR2L;POLR2K;RBPJ;HDAC5;NR2C2;CDK9;NR3C1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5949069496914857,1.2327449675046158,0.23887973640856672,0.591484186088469,1.0,4/10,18.48%,KMT5A;EHMT1;SETD2;SETD3
prerank,regulation of cartilage development (GO:0061035),0.5432244016564207,1.2319699123750767,0.21207865168539325,0.5930629113530566,1.0,4/18,5.18%,TRPS1;SOX5;MDK;BMP1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.491393828091774,1.231730622824353,0.22278481012658227,0.593106834872767,1.0,14/30,22.60%,NCOR2;KLK2;SFRP1;PIAS2;HEYL;HDAC1;SAFB2;SMARCA4;ZBTB7A;KDM1A;FOXP1;RNF14;PKN1;NCOR1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5192189919738238,1.2302013986802478,0.23709902370990238,0.5966137081572492,1.0,9/20,18.23%,SNAI1;SNAI2;HEYL;TGFBR1;TBX3;TGFB2;OLFM1;ACVRL1;RBPJ
prerank,peptide catabolic process (GO:0043171),0.5211316232361688,1.2298659699157153,0.2523364485981308,0.5968471458404511,1.0,7/23,15.89%,ANPEP;CPQ;XPNPEP1;NPEPPS;ENPEP;LVRN;GGT7
prerank,protein localization to cell-cell junction (GO:0150105),-0.4564212046463362,-1.2296346146564832,0.19718309859154928,0.6736700960198102,1.0,5/15,6.66%,TJP1;TJP2;ACTB;CDH5;LSR
prerank,protein polymerization (GO:0051258),0.4464001566770794,1.229488913353376,0.19377162629757785,0.5972750395243293,1.0,20/55,20.38%,GAS7;JAK2;CHMP4A;CHMP4B;AIF1;TTC17;SPIRE1;PREX1;ARHGAP6;FGF13;MICALL2;UBE2K;RAC1;TPPP;CKAP5;MSRB1;PIN1;RNF135;WASHC5;TRIM6
prerank,protein localization to plasma membrane (GO:0072659),-0.27695112217929885,-1.2292525576051616,0.07407407407407407,0.6719792449124004,1.0,32/129,9.26%,KCNIP4;ATP1B3;TSPAN5;CACNB2;BSG;ATP1B1;ACTN2;ANK2;KCNB2;CD81;EFR3B;TTC7B;DPP10;DPP6;C2CD5;EZR;GAS6;EHD4;SLMAP;RAMP1;RAPGEF2;WNK3;RAMP2;CDH1;CCDC88A;RAB3C;ZFYVE27;PACSIN1;MAP7;RAPGEF6;ANK3;INPP5K
prerank,positive regulation of actin nucleation (GO:0051127),-0.5025842992854775,-1.2292254754184717,0.215633423180593,0.6692262545797765,1.0,4/11,8.61%,FCHSD2;GSN;NCKAP1;WASF1
prerank,negative regulation of MAPK cascade (GO:0043409),0.42557368189024447,1.2286856449818273,0.16813186813186815,0.598848352113726,1.0,29/87,21.21%,ADIPOQ;FBLN1;TNIP1;SPRED1;IRAK3;APOE;SPRED2;PTEN;NF1;EMILIN1;PTPN1;CNKSR3;PTPRJ;PTPN2;SPRY2;DUSP26;P2RX7;BMP7;RANBP9;SMAD4;ITGB1BP1;PTPRC;DUSP6;AGT;PIN1;SPRY4;DLG1;PRKCD;SIRPA
prerank,microtubule anchoring at centrosome (GO:0034454),0.5920687569996994,1.2283251251547236,0.25040387722132473,0.5992032499317859,1.0,5/10,22.49%,CEP19;PCM1;NIN;CCDC120;NINL
prerank,muscle contraction (GO:0006936),-0.27288771910451093,-1.2282827468873507,0.02127659574468085,0.6690648310300132,1.0,23/126,14.49%,SORBS1;DMD;ACTN2;MYOF;CALM1;DTNA;SNTA1;TMOD3;MYL6;SNTB1;SORBS3;GLRA1;BDKRB2;DYSF;ADRA1A;VCL;MYL9;MYOM1;LMOD1;KCNJ12;ACTA2;TPM2;ARHGEF11
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4208263461465052,1.2273860955834415,0.16720604099244876,0.6011983377255864,1.0,19/86,17.74%,PSMA7;BACH1;DNAJB1;BAG3;INO80;CREBBP;ARNT;PSMB8;PSMA6;NFE2L2;PSMF1;PSMA8;HIF1A;PSMD2;PSMD12;PSMD11;PSMD14;ATF4;PSMB1
prerank,dendritic cell migration (GO:0036336),0.5553908298620868,1.2267844798390284,0.2503556187766714,0.6022347726662723,1.0,6/16,22.13%,CCR1;CCL5;CXCR4;TRPM4;EPS8;TRPM2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.481346568292587,1.2267274212711543,0.20806241872561768,0.6017834744475695,1.0,11/34,19.09%,TNFAIP3;IRAK3;TREM2;LY96;RAB7B;CD14;NLRP2B;SMPDL3B;MFHAS1;CD300LF;TYRO3
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.46272195054219317,1.2261117639461103,0.21733821733821734,0.6028263005582096,1.0,14/46,14.73%,ANTXR1;LAMB1;LAMC1;PEAK1;ITGA8;NRP1;EPHB3;PARVA;EPHA1;LAMC3;RHOA;MICALL2;PIK3R1;RAC1
prerank,cochlea morphogenesis (GO:0090103),0.5945698427985288,1.2257802401501212,0.2701863354037267,0.6031426517549365,1.0,3/10,11.96%,TBX18;HOXA1;MYO3A
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.43828108043094344,-1.225654462238977,0.22153846153846155,0.6738108123583022,1.0,4/15,11.90%,ALDH4A1;GGACT;PRODH;CHAC2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4098638345588483,1.2256130830584318,0.12127440904419322,0.6029998231016792,1.0,56/166,23.36%,RORA;NR1H4;NCOR2;YAP1;RARB;RXRG;TAF1D;MAML3;TEAD3;TAF7;POLR1E;CREBBP;PPARG;GTF2H1;MAML2;HDAC1;TBL1X;GTF2F2;CRCP;NR2F1;WWTR1;TEAD1;RSF1;CDK7;E2F3;MAML1;GTF2F1;POLR1B;BRF1;TAF1A;TAF4;NR6A1;MED26;NRBF2;POLRMT;TAF2;POLR2L;POLR2K;RBPJ;HDAC5;NR2C2;CDK9;NR3C1;MED1;POLR1G;ERCC2;THRA;NR1D1;NR1D2;RARG;POLR1A;NCOR1;CCNH;THRB;POLR2D;MNAT1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.39548965022067895,-1.2253014898412293,0.17279411764705882,0.6720276178823941,1.0,11/25,22.56%,HNRNPU;LDB1;NELFB;WDR43;LEO1;EAF2;LARP7;NELFA;SUPT4H1;NELFE;ZMYND11
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.39542930984403724,-1.2252280120557912,0.1925925925925926,0.669496999380554,1.0,16/24,29.80%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;SEMA4D;SEMA5A;SEMA5B;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA6B;SEMA4G;SEMA3F
prerank,aortic valve morphogenesis (GO:0003180),0.4920321250865568,1.2246146352819658,0.2176696542893726,0.6052305110486255,1.0,7/30,7.87%,SNAI1;ROBO2;SLIT3;SNAI2;JAG1;EMILIN1;HEYL
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5606970551968921,1.2244989192451612,0.24246987951807228,0.6043760587332035,1.0,4/13,8.42%,JAK1;STAT3;STAT5A;GRB2
prerank,cellular response to interleukin-15 (GO:0071350),0.5606970551968921,1.2244989192451612,0.24246987951807228,0.6043760587332035,1.0,4/13,8.42%,JAK1;STAT3;STAT5A;GRB2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5251649067334339,1.224334374765637,0.23578363384188628,0.6042663486488453,1.0,4/19,9.84%,STAT1;IRF7;TLR7;SETD2
prerank,positive regulation of cellular process (GO:0048522),0.3946879721851536,1.2242627266511175,0.027,0.6038790815214358,1.0,107/565,14.73%,IBSP;HP;HPR;CXCL5;IL34;WNT2;LBP;OSMR;PDGFRA;LRP1;MMP14;EDN3;CXCL12;ZFP36L1;COLEC12;EIF4G2;PTN;MEIS2;CCAR1;GAB2;TLR2;TIMP1;IRS1;PDGFRB;PRTN3;FGF7;PRKCA;KLHL22;TSLP;EGFR;P2RX5;TREM2;MEIS1;TBX2;DYNC1H1;FXN;MDK;SHH;PTEN;BCL2;AIF1;PRKD2;RHOD;PABIR1;TRIM21;CD36;INO80;CACUL1;CCL5;EGF;ATM;SFRP1;LRP6;TGFB3;EAPP;PTPN6;CDC42;GLP2R;S1PR3;EPHA1;TENM4;RPTOR;TRIM13;MERTK;CELF1;S1PR2;RAD23A;EXOSC4;TGFBR1;FKBP1B;WNT5A;HDAC1;CSNK2A1;IL7;DICER1;BMP5;NOP2;PPP3CA;LIFR;TBX3;FGFR1;WWTR1;PTPRJ;PTK2;CSPP1;PDPN;TGFB2;GCNT2;CALR;ANKRD17;TNF;VEGFC;FGF2;NTRK3;DUSP26;P2RX7;BTC;DDRGK1;POFUT2;GAREM1;EGR2;CDKN1B;FMR1;PDCD10;TRPM4;RAC1;CX3CL1
prerank,negative regulation of protein catabolic process (GO:0042177),0.46359829461557356,1.2229929044309138,0.1980440097799511,0.6067224750401532,1.0,6/40,4.72%,TIMP1;NELL1;EGFR;IRAK3;MAD2L1;PTPN3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4349526225666844,1.2226851734654236,0.17097862767154107,0.6069652708264343,1.0,15/76,16.25%,CYP1B1;DAP;CMKLR1;TNFAIP3;IRAK3;TRIM21;IRAK2;PYDC1;ERBIN;NLRP2B;COMMD7;SPI1;BMP7;ITCH;RBCK1
prerank,cellular response to nutrient levels (GO:0031669),0.438888263397612,1.22265638870963,0.1956769055745165,0.6064845242734536,1.0,25/62,24.69%,LRRK2;WIPI1;CDKN2B;SFRP1;CD68;INHBB;LAMP2;RPTOR;RRAGC;FADS1;LPL;FNIP1;KLF10;ATG7;STK24;WDR45;SREBF1;EIF4G1;ZFYVE1;PDK4;CLEC16A;VPS41;BMPR2;RALB;XBP1
prerank,cellular response to hydroxyurea (GO:0072711),0.6002934752086705,1.2226118879937646,0.2539432176656151,0.6060264479605559,1.0,4/10,14.28%,DDX11;TIMELESS;ATRX;FMR1
prerank,organic acid transport (GO:0015849),0.4233951779594329,1.222417203688926,0.16721311475409836,0.6059621797435547,1.0,15/94,11.76%,NR1H4;SLC7A2;SLC38A3;ATP8B1;SLC10A6;SLC25A47;SLC7A7;SLC38A4;SLC13A5;SLC36A2;SLC7A8;SLC10A1;PDPN;SLCO1B1;SFXN5
prerank,transcription preinitiation complex assembly (GO:0070897),0.5719887269198436,1.222416156487314,0.24881889763779527,0.6053802330364233,1.0,3/12,7.00%,TAF7;POLR1E;BDP1
prerank,positive regulation of cell differentiation (GO:0045597),0.40195860846344356,1.222288275028075,0.10473313192346426,0.6051689110041706,1.0,62/237,19.37%,RUNX2;COL1A1;ZEB1;EDN3;FBN2;YAP1;ZFP36L1;TCF4;SNAI1;SOX5;PTN;CMKLR1;CCN4;NELL1;SMAD2;FRZB;MDK;DDR2;ACVR1;ASXL2;CD36;SFRP1;PPARG;TGFB3;CDC42;TMEM119;CARM1;HEYL;MAPK11;BTG1;LPL;TGFBR1;TGFB1I1;FGFR1;WWTR1;PDPN;TGFB2;GCNT2;ACVR2A;RHOA;RIN2;WDFY2;MSR1;SMAD3;BMP7;SMAD4;TRPM4;FES;IL6R;CTNNA1;TCF3;OLFM1;ACVRL1;AKT1;AAMDC;PAX8;AGT;FBXO5;AXIN2;LRP5;CTNNBIP1;VWC2
prerank,smoothened signaling pathway (GO:0007224),0.47636981370951215,1.2219761303638361,0.21373056994818654,0.6054334566213366,1.0,4/32,4.42%,GLI2;GLI3;STK36;SHH
prerank,regulation of Golgi organization (GO:1903358),0.5330055868953317,1.2218479449603097,0.24328147100424327,0.6052018378445134,1.0,8/17,17.54%,MYO5A;MAP2K1;CAMSAP2;AKAP9;PDCD10;ARMH3;MAPK1;RAB33B
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4392400957900052,1.2217112161891335,0.19252548131370328,0.6050050518891975,1.0,21/66,21.82%,TNFAIP3;JAK2;CASP1;STAT3;LGALS9;CD36;PYDC1;TMEM106A;LPL;WNT5A;CASP8;TNF;NLRP2B;P2RX7;CX3CL1;CPTP;PANX1;FOXP1;ZC3H12A;SIRPA;NLRP12
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.2559786276632802,-1.2211795080021994,0.0,0.6782614092990965,1.0,82/241,25.12%,ELAVL2;U2SURP;SRRM2;PSPC1;SFPQ;SNRNP70;DDX5;HNRNPU;YTHDC1;NOVA2;PRPF6;CDC40;SRSF5;SNRNP48;FRG1;WDR33;CSTF2;CWC22;SNRPN;PABPC1;NOVA1;AQR;HNRNPH3;ZCRB1;U2AF2;ISY1;PRPF38A;PRPF4;USP49;RALY;RBM5;CWF19L1;GCFC2;LSM6;SNRPC;PPIH;HNRNPA1;SNRPG;POLR2A;POLR2H;SRSF7;RBM19;POLR2G;PRPF40B;SRSF9;PPIL3;SNRNP27;POLR2F;RBM17;IK;PRPF19;CWC25;RBM8A;SART1;CPSF2;LSM5;HNRNPR;MAGOH;SNRPD3;HNRNPA3;POLR2E;HNRNPM;HNRNPA0;PRPF8;EIF4A3;SRSF3;CLP1;HNRNPL;CACTIN;DNAJC8;RAVER2;CPSF4;SF3B6;SF3B5;DDX39B;TXNL4A;PDCD7;DDX46;DDX39A;SF3A1;SF3A3;HNRNPD
prerank,neurotransmitter transport (GO:0006836),-0.29145140754919474,-1.2208621274825397,0.12264150943396226,0.6764818991940366,1.0,23/73,17.20%,ATP1A2;SNAP25;SYN3;UNC13B;NRXN1;GABRA2;GLUL;LIN7A;SLC1A2;SLC1A1;NRXN2;CPLX1;RIMS1;SNAPIN;DNAJC5;GAD1;SYN2;PTPRN2;LIN7C;SYNJ1;NAAA;SNPH;PPFIA1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5474905290502105,1.220802611432152,0.2246376811594203,0.6068689245157202,1.0,4/17,8.76%,LIPC;ANGPTL4;APOH;LPL
prerank,organic cation transport (GO:0015695),-0.4169777521330399,-1.220633098061985,0.20069204152249134,0.674382325220034,1.0,5/20,8.94%,SLC47A1;SLC25A42;SLC25A26;SLC22A4;SLC22A18
prerank,regulation of GTPase activity (GO:0043087),0.4048126093270287,1.2198674558016442,0.12654320987654322,0.6088665052439729,1.0,37/177,12.76%,CCL11;CCL7;RGS16;MAP4K4;VAV2;ARHGAP15;LRRK2;CD40;PRTN3;VAV3;XCL1;PLXNC1;EPHB3;ASAP3;NF1;LIMS1;FGD4;CCL5;SFRP1;EPHA1;PLXND1;RSU1;ZC3H15;RRP1B;PLXNA3;EFNA5;SNX18;RABGAP1;RAB3GAP2;CCL2;MAPRE2;PTK2;SNX9;FGD6;VAV1;GSK3B;RGS10
prerank,regulation of heart contraction (GO:0008016),-0.2922099626595321,-1.219722143251929,0.08450704225352113,0.674280269558867,1.0,20/90,14.38%,ATP1A2;ATP1B3;ATP1B1;ANK2;CELF2;CALM1;ITPR2;ATP2B4;ATP2B2;SLC8A3;ABCC9;NPR1;ITPR3;DMPK;FXYD6;PDE4D;KCNQ1;KCNJ12;ATP2A3;STIM1
prerank,protein palmitoylation (GO:0018345),-0.3562053114902687,-1.219653220758805,0.17167381974248927,0.671731416059956,1.0,10/30,16.77%,GLUL;ZDHHC13;ZDHHC21;ZDHHC17;ZDHHC14;SELENOK;ZDHHC5;ZDHHC15;PORCN;ZDHHC2
prerank,lipid droplet formation (GO:0140042),-0.5192728751817168,-1.219470302444455,0.23015873015873015,0.6695223923358065,1.0,5/10,25.62%,CDS2;BSCL2;SQLE;PLA2G4C;FITM2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5210854057643389,1.2194044503322705,0.24651810584958217,0.6095298620433315,1.0,9/21,22.46%,MAD2L1;PTEN;PLK1;SKP1;RAB1A;RPL11;FBXO5;CDC14B;FZR1
prerank,regulation of cellular component organization (GO:0051128),-0.2842934244365466,-1.2191628880374663,0.05405405405405406,0.667682773822361,1.0,41/135,18.86%,TJP1;SNCAIP;MLLT3;PLCE1;LTBP4;RIT2;CHPT1;CDH13;NRG3;HNRNPU;SPOCK1;HSP90AA1;PAK5;TFRC;HIP1R;RAPGEF2;RASGRP2;LAMTOR1;AGTR1;PACSIN1;URI1;FAM107A;RAP1A;ANKRA2;GFAP;HIP1;PINK1;SEMA4D;SSRP1;PACSIN3;ARHGEF11;TSC2;METTL4;WFDC1;STON1;EGLN2;PRKCQ;TAOK2;LAMTOR2;SOCS2;OGFR
prerank,regulation of ion transport (GO:0043269),-0.2971722944373681,-1.2180313579310451,0.09,0.6684773355149788,1.0,16/76,10.54%,WWP2;PRKN;NKAIN2;KCNJ2;KCNJ3;PER1;NKAIN3;NKAIN4;KCNJ13;CA2;SIK1;KCNJ10;NKAIN1;SYT7;ANK3;RAB11B
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4442234674639982,1.217586394600286,0.19767441860465115,0.6138220680300703,1.0,11/57,12.29%,IL23R;GHR;CD40;JAK2;TSLP;STAT3;NF2;CCL5;TNFRSF1A;PTPN2;TNF
prerank,kidney development (GO:0001822),0.44057704756492294,1.2175521498043793,0.19818799546998866,0.613307035411702,1.0,13/65,11.44%,SULF1;GLI2;ROBO2;ITGA8;SHH;NF1;IFT88;BAG6;TGFBR1;GREB1L;SALL1;NPHP3;TGFB2
prerank,neuron development (GO:0048666),0.4088642571973836,1.2174292149514032,0.1440329218106996,0.6130635781743972,1.0,19/141,7.73%,RUNX1;RUNX3;GPM6B;GLI2;LAMB1;PPP1R9B;LRP12;B4GALT5;ATXN10;UGCG;TENM3;APOE;BLK;PBX3;OPHN1;DTNBP1;TENM4;VAPA;L1CAM
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5713802468413886,1.2173135656464598,0.24256651017214398,0.6127786210719981,1.0,2/12,5.41%,CLTC;TAF7
prerank,P-body assembly (GO:0033962),0.5775554228232587,1.2168898284468455,0.26003210272873195,0.6133795052265294,1.0,2/12,4.11%,ATXN2;DYNC1H1
prerank,endodermal cell fate commitment (GO:0001711),0.5893957757968856,1.2167218393029735,0.25902668759811615,0.6132545373554479,1.0,1/10,0.60%,POU5F1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5510333733568917,1.215572651673966,0.2521489971346705,0.6152909904582613,1.0,4/15,8.24%,AP3B1;AP3S1;DTNBP1;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5510333733568917,1.215572651673966,0.2521489971346705,0.6152909904582613,1.0,4/15,8.24%,AP3B1;AP3S1;DTNBP1;AP3D1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4483259723745167,1.2150192243872548,0.21445783132530122,0.6162018996496627,1.0,12/50,12.29%,TLR2;EGFR;LGALS9;NOD1;LIMS1;EIF2AK2;TLR7;SASH1;CD14;TRIM44;RHOA;TNF
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4186259058484863,1.2147042511767014,0.185226019845645,0.6164900434739685,1.0,19/86,17.45%,CCL11;PDXP;SYNPO;NAV3;APOE;NCK1;BAIAP2;NCK2;CARMIL1;SNX9;PSEN1;AKAP9;RAC1;CX3CL1;FES;CDC42EP1;TOGARAM1;PLEK;CTTN
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5947437039808021,1.2145439950858838,0.26163723916532905,0.6163481755510185,1.0,3/10,10.79%,MAP4K4;FGF7;MAPRE2
prerank,mitochondrion localization (GO:0051646),0.5221765936966231,1.2141062922039718,0.2327823691460055,0.6169678395888091,1.0,4/19,11.73%,LRRK2;MARK1;TRAK1;ZBED3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.38840006536078153,1.2132812807041544,0.0,0.6185694226385126,1.0,376/1646,18.67%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;KMT2A;CREB3L1;ADIPOQ;SOHLH2;TRPS1;RUNX3;ZEB2;POU5F1;CXXC1;SPP1;MDFIC;PAX1;BCL3;GLI2;ZEB1;SBNO2;ETV6;NCOR2;DAP;YAP1;MED13L;DEAF1;TCF7L2;TCF4;SNAI1;TBX18;SOX5;ATXN1;PRRX1;GLI3;BCL6;CREB3L3;SATB2;MEIS2;BAZ1A;STAT1;EGR3;CCAR1;ERN2;CHD7;ZMIZ1;IRF7;ATP8B1;BRIP1;BACH1;GON4L;GATA6;FGF7;MAFB;SNAI2;ZFPM2;XCL1;RCOR1;NPAS4;BATF;NKX6-1;RXRG;PHC2;MITF;ZNF496;ARID5B;SMAD2;NFIX;SUFU;EGFR;ZIC4;REL;TLE1;PRRX2;BHLHE22;UBP1;GLIS1;APOE;USF1;STAT3;LITAF;MEIS1;TBX2;PKNOX2;TEAD3;ZBTB10;SOX21;HOXB3;ELF4;ILF3;NR2F2;ABCA2;ARID5A;TRAK1;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;CAMK2D;PHF1;PHF2;MYBL1;KHDRBS1;VGLL3;SP110;PRDM2;CEBPD;SMARCC1;CCNL1;BAZ2B;ACVR1;HIVEP2;PBX3;LIMS1;TAF7;SCMH1;SP140;TCF12;HIVEP1;FOXK2;EGF;CREBBP;FZD1;SFRP1;PPARG;LRP6;RUNX1T1;YAF2;CDK14;ZNF292;STAT5A;ZBTB48;TGFB3;ETV5;ENO1;ZHX2;SFMBT1;ZNF250;MBD1;EHMT1;AHR;PRICKLE1;PIAS2;TSHZ3;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;SUB1;ZBTB12;GTF2H1;DDX17;ARNT;RNF111;IRF1;NFE2L3;BHLHE40;TADA2B;CARM1;NEK4;HEYL;CREB3L2;CCAR2;EPC2;BTG1;ZMYND15;HOXA1;POU2F1;FADS1;ZFHX4;SAP18;SP100;BAHD1;TGFBR1;OGT;ZNF182;AHRR;MAP2K1;WNT5A;HDAC1;ZBTB5;SALL1;NONO;FOXO3;TBL1X;ZSCAN22;ZBTB38;ARID1B;SMAD5;FOXP4;UBE2L3;PRDM1;NR2F1;TGFB1I1;JUNB;NOP2;HMGB2;TGIF2;ZIC1;ACVR1B;TBX3;LOXL3;TCF7;BRWD1;NEUROD6;EID1;WWTR1;CBFB;TRIM44;TEAD1;FOXN2;KLF10;BBX;LIN54;CHD2;KMT2E;ELK4;RSF1;RUVBL1;NFE2L2;ZGPAT;SAFB;TGFBRAP1;CALR;TIMELESS;SP3;LCOR;TNFRSF4;SPTY2D1;ARID4B;E2F3;MED13;NIF3L1;SETDB2;MAP3K2;FBXW11;TNF;KDM2A;ZSCAN21;HOXB2;KLF6;NAB2;FGF2;ZBTB20;NKX2-8;SKOR2;KMT2B;ELK1;COMMD7;NSD3;GLIS3;SNX5;FOXJ3;NFKB2;SPI1;BRPF1;TFCP2L1;SAFB2;GATAD2A;CTCF;SMAD3;PSEN1;IRF9;BMP7;ATRX;EGR2;TRIB3;DRAP1;WTIP;CDKN1B;USP22;ZFP62;LCORL;HOXB5;TFAP2C;SMAD4;MAFK;DTX3L;NIPBL;MMS19;BAZ2A;NAA15;SMAD1;BNC2;TSC22D4;PHC3;SRCAP;CREB3L4;CREB3;PATZ1;NR6A1;CCNT1;HIF1A;MED26;TRIM56;PHF12;FBXL19;STAT5B;RELB;L3MBTL3;NPAS2;NUP35;NSD1;POU3F3;MAX;LIN9;NFXL1;ZKSCAN8;ATF7IP;CLOCK;TCF7L1;TCF3;SMARCA4;SREBF1;ACVRL1;ZNF18;MTA3;ZFHX3;HSPD1;BACH2;AKT1;HCFC2;TRIM33;NUCKS1;PHF20;ING5;CALCOCO1;THRAP3;RBFOX2;PCBD2;BRD4;ZNF445;MZF1;ZNF25;MDM2;NFE2L1;ATF4;RCOR2;PICALM;GLI1;ETS1;ZNF3;MAP3K12;RLF;RAI1;SALL3;POLR2L;LHX6;INHBA;ZSCAN29;POLR2K;BICRA;PAX8;ZBTB40;AGT;RBPJ;CDK16;ZBTB9;HDAC5;NR2C2;MXD4;SOX2;RBM15;SPEN;RBBP8;SETD3;FBXO5;HINFP;SPINDOC;KAT6B;ZBTB25;ZBTB7A
prerank,sister chromatid segregation (GO:0000819),0.48121743693677765,1.212963830272581,0.23924050632911392,0.6187943010744557,1.0,6/31,6.21%,KIFC1;SMC1A;KLHL22;TUBG1;INO80;PLK1
prerank,protein transport (GO:0015031),0.393614797314052,1.2129332597276261,0.08249496981891348,0.6183021443787098,1.0,83/332,18.76%,LTBP2;ABCA1;CLTC;LRP1;SEC31A;VMP1;COPA;AP4M1;COPZ2;STX6;AP3B1;ARRDC4;ARCN1;APOE;MYH9;ABCG1;ARFGAP3;TBC1D16;CD36;STEAP3;COPZ1;PPARG;STX17;RAB21;SNX8;STXBP1;LAMP2;TBC1D2B;COPB2;RABGAP1L;RAB8B;MIA3;LMAN2L;RAB7A;CANX;ARRDC3;AP3D1;TBC1D8B;COPG1;RABGAP1;RAB3GAP2;STXBP3;RAB32;WLS;TMEM167A;SNX33;ARF4;SEC23IP;SNX9;ATP6V1F;RCN3;CALCRL;ATP6V1H;TMED1;TBC1D1;ATP6V1G2;ADPRH;RAB1A;RAB10;ARF1;RAB34;TBC1D10B;NDC1;SNX15;STX11;CHMP2B;COG7;SNX4;ATP6V1G1;SEC13;CTSA;ATP6V1D;CTTN;RUFY1;STX1B;SCFD2;SCFD1;REP15;TVP23B;ARL5A;TMED5;SPTBN1;HSP90B1
prerank,regulation of receptor internalization (GO:0002090),0.47690821820186663,1.2122045743306287,0.236318407960199,0.6196634670530281,1.0,10/35,14.82%,SFRP4;ATXN2;EGF;DLG4;ANGPT1;ARF1;ANKRD13B;MKLN1;FMR1;CD63
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5694244282923261,1.2121025851074905,0.2393026941362916,0.61877660353279,1.0,6/12,23.22%,FBLN1;EFNA5;ITGB1BP1;CORO1C;SPRY4;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5694244282923261,1.2121025851074905,0.2393026941362916,0.61877660353279,1.0,6/12,23.22%,FBLN1;EFNA5;ITGB1BP1;CORO1C;SPRY4;AP1AR
prerank,mitotic sister chromatid segregation (GO:0000070),0.4213274367098975,1.2120822258066333,0.18349619978284473,0.6182516800107342,1.0,18/98,9.35%,KIFC1;EML4;SMC1A;KLHL22;CHMP4A;CHMP4B;NAA50;KMT5A;TUBG1;INO80;PLK1;PDS5B;VPS4A;PINX1;PDS5A;CSNK2A1;CSNK2A2;EML3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4995832325753583,1.211908379839787,0.236986301369863,0.6181266582982288,1.0,5/21,8.07%,SULF1;EXT1;EXT2;HPSE;HS2ST1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.40240087811228253,1.2117447548562437,0.15670103092783505,0.618022998971593,1.0,34/149,16.63%,ROR1;TRIML2;TNFSF11;TLR2;CD40;FLOT2;CFLAR;IRAK3;STAT3;PRKD2;LGALS9;NOD1;TRIM21;CD36;EIF2AK2;IRAK2;RAB7B;TIRAP;TRIM13;TRIM8;PSMA6;WNT5A;EDA2R;EDA;TNF;NFKB2;TRAF2;DDRGK1;CX3CL1;RIPK1;RBCK1;CLOCK;LAMTOR5;TRAF5
prerank,positive regulation of cell projection organization (GO:0031346),0.4085593951400417,1.2116143621340152,0.15256008359456635,0.6178063211158846,1.0,16/115,9.14%,ROR2;ROR1;ROBO2;PTN;DPYSL3;PLXNC1;TENM3;APOE;MDK;CARMIL1;FZD1;PLXND1;DLG4;CAPRIN1;PLXNA3;WNT5A
prerank,negative regulation of cellular component organization (GO:0051129),0.4328565558672368,1.2111986354550577,0.1977401129943503,0.6183635865777515,1.0,13/74,12.44%,FAP;NR1H4;IAPP;DNAJB1;IRAK3;AIDA;CARMIL1;CDC42;SNX33;DNAJB6;SPRY2;TNF;GSK3B
prerank,actin filament polymerization (GO:0030041),0.48787966390827053,1.2110448899616915,0.22797927461139897,0.6181967927096722,1.0,9/29,14.73%,GAS7;JAK2;AIF1;TTC17;SPIRE1;PREX1;ARHGAP6;MICALL2;RAC1
prerank,cellular component assembly (GO:0022607),0.3946203683215553,1.2109836149604747,0.1185929648241206,0.6177729484490787,1.0,52/253,15.18%,KMT2A;GPM6B;YAP1;MYO1B;VMP1;GORASP2;FLNC;LAMC1;SKAP2;RHOJ;CD40;DPYSL3;CALD1;MITF;FSCN1;WIPF1;PARVA;LIMA1;TLCD2;BAIAP2;AIF1;PPID;RHOD;OPHN1;LIMS1;CREBBP;FZD1;CDC42;LLGL1;DLG4;BAG6;KPNA3;NOC2L;ADD2;LCP1;WNT5A;TEAD1;SNX9;YWHAZ;FBLIM1;RHOA;TSPAN4;SPG7;TRAF2;AIF1L;YTHDF3;RANBP9;VCPIP1;PDCD10;RAC1;TUBGCP4;PAWR
prerank,ncRNA transcription (GO:0098781),0.561970504533653,1.2107016758441043,0.2601246105919003,0.6179243593023008,1.0,6/13,20.16%,SNAPC3;USPL1;GTF3A;BRF1;RPAP2;POLR1G
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5848650528692502,1.210024928932487,0.2588996763754045,0.6191049238005344,1.0,7/11,23.73%,SETDB1;SETDB2;PPHLN1;RESF1;ATF7IP;TASOR;MPHOSPH8
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5013324580505655,1.210015494767707,0.24191461836998707,0.6185516668439957,1.0,12/26,22.60%,NCOR2;SFRP1;PIAS2;HEYL;HDAC1;CALR;CLOCK;SMARCA4;ZBTB7A;FOXP1;CNOT2;NCOR1
prerank,regulation of nervous system process (GO:0031644),-0.4249024359786983,-1.2096240395997524,0.20945945945945946,0.6898149022065787,1.0,5/18,5.11%,DLGAP1;HTR2C;NOS3;DLGAP2;SLC8A3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5708393285890676,1.2095265956770562,0.2562111801242236,0.6192452338246304,1.0,6/13,25.50%,CBLB;KPNA3;NUP35;KPNA2;KPNB1;RGPD1
prerank,respiratory tube development (GO:0030323),0.4897084268536757,1.2093658467445312,0.2359249329758713,0.6190985488606051,1.0,9/28,12.48%,GLI2;FGF7;SHH;BAG6;ITGA3;LOXL3;NPHP3;PDPN;FGF2
prerank,regulation of mitochondrial fission (GO:0090140),0.5011936947777978,1.2091309883893908,0.23544973544973544,0.6191309991067022,1.0,5/24,8.71%,DCN;LRRK2;RALA;SPIRE1;INF2
prerank,regulation of insulin secretion (GO:0050796),0.4124457019338348,1.2084485442044435,0.18074866310160428,0.6203591291581065,1.0,14/101,6.47%,NR1H4;CACNA1A;TCF7L2;IRS1;RAPGEF4;PRKCA;CACNA1C;BLK;ACSL4;ITPR1;KCNA5;CCL5;SFRP1;INHBB
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.42364174649545466,1.2084197315012295,0.1888268156424581,0.619856658006512,1.0,20/80,15.88%,PRR16;BCL3;SLC2A13;PLD1;GSAP;ABCA2;ABCG1;SAMD4A;NIBAN1;RPS6KB1;NSMAF;TNFRSF1A;NAT10;TNF;SPHK2;SMPD3;YTHDF3;FMR1;SIRT3;PRKDC
prerank,cellular protein modification process (GO:0006464),0.3888793034403201,1.208295248226076,0.009,0.6196065370508667,1.0,269/983,21.18%,PSMA7;CCL11;CEL;C3;COL3A1;ENAM;RUNX3;KNG1;SPP1;PARP8;IGFBP7;NEK6;LAMB1;PARP3;PDXP;PLOD2;MAP4K4;TEC;TAOK1;PTPN7;JAK1;B4GALT5;LAMC1;PEAK1;ERN2;DUSP2;FBXO40;CP;LRRK2;WIPI1;TIMP1;IGFBP4;JAK2;VCAN;SPSB1;UGCG;DUSP5;PRKCA;FSTL1;PRKCSH;KLHL22;MARK1;NUAK1;IRAK3;RAB2A;APOE;FBXL7;STK36;RBBP5;CALU;ILF3;IGFBP5;WSB2;IKBKE;DCAF10;CUL1;AKT3;FBN1;CAMK2D;PTPN3;PTPN13;PTEN;PRKD2;ST3GAL3;ACVR1;MORC3;FAM20A;DDOST;CDK6;ATM;PTPRZ1;CDK14;EIF2AK2;PLK1;PLAT;PTPN6;ALG5;PPP4R1;DAPP1;ATG3;FN3KRP;PTPN18;MIA3;LOXL1;KLHL13;SKP1;TAOK3;PTPN1;DCLK1;CDK10;NEK4;MERTK;PXK;CKAP4;FRK;DCUN1D1;SDC2;MAST2;PRKAR1B;MAN2A1;FBXL18;FBXW7;FBXO30;CHML;PSMB8;UBE2F;PSMA6;ANXA1;TGFBR1;MAP2K1;CSNK2A1;MGAT4A;MAP4K5;TNC;HIPK3;UBE2L3;LTBP1;SSH1;PPP3CA;ACVR1B;CDC42BPA;CCL2;STT3A;PPP2R2A;FGFR1;PPP2R5A;PTPRJ;PTPN9;ST3GAL1;ARF4;SOCS5;DCAF11;YWHAZ;NEURL2;FBXO7;NRK;CSNK1G2;TGFB2;GMFB;GCNT2;PPP4R2;PTPRM;CDK7;ACVR2A;PHKA2;COQ8B;ATG7;PPP1CB;FBXW11;MMP15;MAML1;GSK3B;CSNK1A1;DUSP26;PSMF1;ACVR1C;ILKAP;KCTD7;SSH2;ADPRH;RAB1A;MAP3K6;FBXO2;MKNK1;CTTNBP2NL;STK24;DAPK2;ZDHHC6;SIRT3;COPS6;TRIB1;RABGGTB;PMM2;PIK3R4;PSMA8;TIMM50;B4GALT7;CCNT1;FNTB;HIF1A;PPP6C;PRKAB1;FBXL19;PSMD2;RPN1;PRKDC;GRK4;PSMD12;WDR45;COG7;KLHL25;PSMD11;PIGH;PIGT;YES1;STK4;FAM20B;TNKS2;PIK3C3;B3GNT9;OBSL1;PSMD14;ACVRL1;PTAR1;CSNK1D;PTPRC;PTPN5;MAPK1;PTPRA;AKT1;DUSP6;LATS2;DNAJC3;CDKL1;DDB1;MTMR3;TYK2;EIF2AK3;TESK2;PSMB1;FBXW4;MAP3K12;SIK3;FCGR3A;CDK16;FUT4;ASB3;RHBDD1;CDK9;SETD3;FBXO31;AGA;HSP90B1;DCAF8;PHEX;MTMR2;EVA1A;MTMR6;FAM20C;PDIA6;FBXO32;FBXL22;LGALS1;MAN2A2;MTM1;ASB6;UBL5;SHISA5;CDK13;CDC14B;DUSP11;RAB8A;PSMC6;PLK2;UBE2E1;PRKCD;COPS3;ISG15;PARP14;PARP4;BMPR1A;PDK4;DCAF4;USP25;MAP3K20;VHL;CDK12;DYRK1A;PIGK
prerank,lipid transport (GO:0006869),0.41546807765023275,1.2079314700054722,0.17818574514038876,0.6199862616279893,1.0,19/97,13.37%,NR1H4;ABCA1;LBP;ATP8B1;UGCG;SLC10A6;APOE;ABCA2;PLTP;ABCG1;CD36;NPC2;OSBPL5;SLC10A1;PEX19;SLCO1B1;FABP5;ABCA9;ABCG4
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4090824558752647,1.207621825784374,0.16771488469601678,0.6201900900941368,1.0,21/121,11.22%,IL34;IL23R;THBS4;TEC;GHR;CD40;FGF7;JAK2;NRP1;TSLP;TREM2;STAT3;ACVR1;CCL5;DLG4;PTPN1;ANGPT1;EFNA5;TNFRSF1A;PTPRJ;VTN
prerank,epithelium development (GO:0060429),0.41561767467015204,1.2076139242114758,0.1853448275862069,0.6196338160699615,1.0,18/107,11.81%,WNT2;STAT1;GATA6;SNAI2;JAK2;TBX2;ERRFI1;SHH;ALDH1A2;PKD2;PPARG;SALL1;CTSB;LOXL3;CNN3;GSTK1;RCN3;TIMELESS
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.41299939107350997,-1.2076129407776917,0.20068027210884354,0.6927517440238995,1.0,7/17,21.73%,ADRA1B;ADCY9;RAPGEF2;ADRA1A;ADRA2A;DRD2;ADRB2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.4907622848445262,1.2070311677788765,0.24740932642487046,0.6206476582845281,1.0,2/29,2.90%,IL23R;XCL1
prerank,establishment of spindle orientation (GO:0051294),0.48875691916559444,1.206915753800324,0.2506493506493506,0.6203819079893439,1.0,8/28,15.92%,MAD2L1;PLK1;GPSM2;LLGL1;INSC;FBXW11;NDEL1;MAP4
prerank,regulation of cell death (GO:0010941),0.40900525367821067,1.2068109517149705,0.193756727664155,0.6200940047591151,1.0,11/94,8.29%,HP;HPR;LRP1;LRRK2;CCN4;CHMP4B;NCK1;CD36;CCL5;TRIM13;CELF1
prerank,ion homeostasis (GO:0050801),-0.36651003984796304,-1.2060569581517995,0.18907563025210083,0.6945350147279045,1.0,7/30,10.82%,SLC4A10;FHL1;KLHL3;WNK4;WNK3;SLC4A8;SLC4A3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4089094124717555,1.205869858312222,0.17677824267782427,0.6220792828004856,1.0,28/122,14.28%,PRR16;BCL3;GLI2;TLR2;IRS1;PDGFRB;JAK2;DNA2;PLD1;EGFR;PRKD2;EGF;BRPF3;SAMD4A;NMD3;TMEM106A;NIBAN1;RPS6KB1;CCL2;SLC25A37;NAT10;TGFB2;GCK;FGF2;HSPH1;CTC1;YTHDF3;FMR1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.407280500092768,1.205738270571034,0.1824973319103522,0.6218525012634089,1.0,17/110,12.75%,MC5R;ABCA1;IAPP;ADCY7;ADGRL3;RXFP2;ADCY2;ADM;CXCL10;S1PR3;GPR161;S1PR2;DRD3;LPAR3;LPAR2;CALCRL;MC1R
prerank,positive regulation of programmed cell death (GO:0043068),0.39319056612321923,1.2051117996650371,0.0963855421686747,0.6229461937841464,1.0,80/272,22.27%,CYP1B1;ZBP1;KNG1;IAPP;SFRP4;BCL6;CCAR1;VAV2;LRRK2;VAV3;KALRN;ITSN1;FRZB;E2F1;CTSD;NF1;PPID;FGD4;TNFRSF12A;ATM;OMA1;SFRP1;TGFB3;RASSF2;RRP1B;PHLDA1;AIFM2;EEF1E1;CCAR2;ARHGEF19;SAP18;TRIO;FOXO3;IP6K2;ARHGEF12;PREX1;CASP8;ATG7;VAV1;TNF;NLRP2B;AKAP13;ACVR1C;CALHM2;SPHK2;PSEN1;ARHGEF18;DAPK2;RIPK1;PSENEN;PAWR;SQSTM1;STK4;OLFM1;AIFM1;HSPD1;PTPA;DUSP6;LATS2;ING5;ANO6;ATF4;CLIP3;DDX20;PLEKHG2;GADD45A;HMGA2;NCSTN;UTP11;ARHGEF26;TIAM2;UBE2Z;MAP3K20;PSEN2;RPS27A;RARG;ARHGEF17;CLU;LATS1;ARHGEF1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.343385832839015,-1.204782122538199,0.15428571428571428,0.6954387275706106,1.0,12/38,16.48%,FHL1;ACTN2;AKAP6;ANK2;KCNJ2;KCNJ3;KCNJ10;KCNQ1;KCNJ12;KCNN2;KCNN3;ADRA2A
prerank,macrophage differentiation (GO:0030225),-0.46442581598678523,-1.2045513327404556,0.21798365122615804,0.6934092513487338,1.0,3/13,2.29%,IL15;BMP4;IL31RA
prerank,negative regulation of gluconeogenesis (GO:0045721),0.5717808186142322,1.2041475281690917,0.27001569858712715,0.6249694295370076,1.0,1/11,0.48%,ADIPOQ
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4895992908467161,1.2038848846344068,0.23667100130039012,0.625086224758154,1.0,10/26,20.32%,NOS1AP;APOE;POR;CYP27B1;TERT;TNF;HIF1A;AKT1;ATP7A;GDNF
prerank,detection of mechanical stimulus (GO:0050982),0.5255124809244434,1.2038551028028064,0.2616033755274262,0.6245947940104979,1.0,6/19,18.83%,PIEZO2;PKD2;PTK2;PKD1L3;LHFPL5;PIEZO1
prerank,cellular response to reactive oxygen species (GO:0034614),0.43346637387310805,1.203748408992218,0.220023282887078,0.6242889383827547,1.0,6/59,5.01%,CYP1B1;PDGFRA;TNFAIP3;EGFR;FXN;PKD2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.43170284629959077,1.2036956005596824,0.21313364055299538,0.6238525237485952,1.0,17/66,11.83%,CDKN2B;EGFR;E2F1;PTEN;AIF1;PKD2;INO80;CDK6;CCND3;PTPN6;ADAMTS1;RPTOR;GPNMB;ANXA1;CCL2;KMT2E;ANKRD17
prerank,sphingolipid biosynthetic process (GO:0030148),-0.30342391805752356,-1.2036806698000577,0.13274336283185842,0.6931786376616828,1.0,22/71,16.43%,CERT1;PPM1L;ACER2;ST3GAL5;CERS4;SGMS1;SPTLC2;SPTLC1;ELOVL7;SGMS2;ELOVL5;DEGS2;SPNS2;B4GALT6;HACD1;HACD3;HACD4;ST6GALNAC5;SGPP1;ASAH2;SMPD2;PRKD1
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.34040338128694525,-1.2033008580408593,0.18055555555555555,0.6916522005234799,1.0,7/33,5.63%,GLUL;MTHFS;GCLC;ALDH4A1;GLUD1;SLC39A8;PRODH
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.44895126991531575,1.202833704494882,0.2398568019093079,0.625679459023396,1.0,11/47,11.80%,FBLN1;NRP1;DOCK1;MDK;LIMS1;CARMIL1;CDC42;EFNA5;PTK2;PDPN;CALR
prerank,epidermal cell differentiation (GO:0009913),0.45311911941888405,1.2018754620339618,0.23391089108910892,0.6276367356594605,1.0,13/41,21.50%,GATA6;UGCG;JAG1;ANXA1;WNT5A;HDAC1;GLI1;PIP5K1A;MED1;ERCC2;ADAM9;WNT16;EPHA2
prerank,amino acid import across plasma membrane (GO:0089718),0.5078064889412863,1.2016995849554788,0.22814207650273224,0.6275318959742295,1.0,2/24,0.63%,SLC7A2;SLC1A3
prerank,regulation of endocytic recycling (GO:2001135),-0.48739298104002127,-1.2015125724479778,0.2440318302387268,0.694015361979218,1.0,5/11,10.54%,INPP5F;ACTN2;ATP9A;SORL1;RAB11B
prerank,neurogenesis (GO:0022008),0.4551711978723563,1.2014020968055996,0.2388419782870929,0.6277286545785972,1.0,7/43,11.44%,WNT2;TRAK1;DCHS1;CDK6;ANXA1;CXCR4;TGFB2
prerank,polyol metabolic process (GO:0019751),-0.33497488890596067,-1.2010550251800378,0.17297297297297298,0.6927528429978927,1.0,23/46,25.34%,PLCE1;INPP4B;CALM1;PLCB4;ITPK1;INPP5D;PLCB1;IPPK;NUDT3;ISYNA1;SLC5A3;PPIP5K1;IP6K1;SYNJ1;INPP5A;IMPA2;ITPKB;NUDT11;OCRL;PLCD4;PLCH1;INPPL1;PPIP5K2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.5025268433167289,-1.2008802692211358,0.24653739612188366,0.6906007506619939,1.0,3/10,7.68%,RB1;HSP90AA1;SORL1
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3604973021883303,-1.2006585720876461,0.15639810426540285,0.6885829291506531,1.0,16/30,26.50%,LBR;MSMO1;INSIG1;ACAT2;SQLE;CYP51A1;DHCR24;IDI1;ACLY;LSS;HSD17B7;FDPS;EBP;FDFT1;NSDHL;TM7SF2
prerank,acylglycerol biosynthetic process (GO:0046463),-0.38908492895733704,-1.2005092712068455,0.19367588932806323,0.6863991824360179,1.0,6/23,14.31%,PLCE1;AGMO;LPGAT1;LPIN1;DGAT1;GPAT4
prerank,microglial cell activation (GO:0001774),0.49702671655962527,1.199479929693816,0.2695417789757412,0.6323105772473646,1.0,5/21,14.73%,JAK2;TREM2;AIF1;TNF;CX3CL1
prerank,positive regulation of vasculature development (GO:1904018),0.4150188927837894,1.1994674469313504,0.2100108813928183,0.6317667780856203,1.0,14/94,9.14%,RUNX1;CYP1B1;ITGB8;ADAM12;CD40;GATA6;PRKCA;HK2;PRKD2;ANGPTL4;EPHA1;SASH1;BTG1;WNT5A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.49512537664680834,1.1992518466045856,0.24789915966386555,0.6317711613144019,1.0,7/24,18.23%,CREB3L1;CREB3L3;NFE2L2;HSPA5;HIF1A;ATF4;RBPJ
prerank,neural crest cell migration (GO:0001755),-0.3446783451533251,-1.199207678999955,0.18636363636363637,0.6873914529771681,1.0,19/36,26.72%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;FN1;ERBB4;TBX1;SEMA4D;SEMA5A;SEMA5B;SEMA3G;RADIL;SEMA6C;SEMA4B;SOX8;SEMA3B;SEMA4A;SEMA6B
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5053940746059292,1.1989177147085381,0.2641509433962264,0.6320990901369761,1.0,4/22,4.56%,SLC9A1;PRKCA;MLIP;CAMK2D
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4430341995805245,1.1985813184092717,0.24076281287246723,0.632393911000951,1.0,6/48,8.14%,IL23R;CD276;IL1R1;LGALS9;TLR7;CD14
prerank,sensory perception of light stimulus (GO:0050953),0.4111886522498111,1.1985645115798675,0.20234291799787008,0.6318659327462647,1.0,8/87,9.31%,COL18A1;COL1A1;RGS16;COL11A1;RDH12;MYO7A;RDH10;SFRP5
prerank,neuromuscular junction development (GO:0007528),-0.3737017530922197,-1.1984757285351713,0.18532818532818532,0.6868871692158959,1.0,6/24,4.28%,UNC13C;GPHN;CACNB2;UNC13B;CACNB4;AGRN
prerank,ERBB signaling pathway (GO:0038127),0.42873854474916023,1.1983975613017295,0.20498301245753114,0.6316875476385801,1.0,17/64,14.06%,FAM83A;PRKCA;EGFR;NCK2;EGF;PTPN18;CBL;GRB2;CDC37;MVP;PTK2;ERBIN;BTC;PIK3R1;GAREM1;KIF16B;SRC
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.41806625352109417,1.1983825839582847,0.21076233183856502,0.6311593143755241,1.0,16/74,18.23%,PSMA7;BACH1;CREBBP;ARNT;PSMB8;PSMA6;NFE2L2;PSMF1;PSMA8;HIF1A;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;RBPJ
prerank,protein-DNA complex assembly (GO:0065004),0.40554744224471684,1.1982459559584349,0.18482905982905984,0.630940243145787,1.0,42/116,25.08%,PSMA7;TCF4;MCM2;GTF2H1;MCM7;PSMB8;PSMA6;RAD23B;GRWD1;HMGB2;RSF1;CDK7;SPTY2D1;PSMF1;NAP1L3;ATRX;ASF1A;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;DDB1;PSMB1;KAT6B;NAP1L1;PSMC6;ERCC2;RPS27A;RPA1;CCNH;PSMB4;PSMB5;DMC1;RAD51;MNAT1;CDC6;PSMD4;ORC4;PSMD7;PSMD9;PSMA4
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4625837983562512,1.198227339961681,0.22140221402214022,0.6304145669579081,1.0,10/37,21.21%,APOD;ADCY7;TREM2;STAT3;PLD4;TNF;HIF1A;IL17RA;ZC3H12A;SIRPA
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.44591184865890104,1.1982119213457245,0.2354988399071926,0.6298916890941515,1.0,22/54,21.92%,CD40;PRKCA;APOE;AKT3;PRKD2;NF1;PPARG;STAT5A;ANGPT1;FGFR1;TNF;FGF2;HIF1A;FGF18;ACVRL1;AKT1;ANGPT2;ETS1;GADD45A;ATP5F1A;EPHA2;RGCC
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.42958522146940453,1.1979493568043025,0.2304199772985244,0.630020493865684,1.0,17/70,13.29%,ANTXR1;LAMB1;LAMC1;PEAK1;ITGA8;NRP1;SIPA1L3;EPHB3;PARVA;OPHN1;EPHA1;ABI2;LAMC3;RHOA;MICALL2;SPI1;PIK3R1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.38223073738978247,1.1977129501272403,0.002,0.6300752901772083,1.0,408/1668,20.09%,RORA;RUNX1;NR1H4;RUNX2;DCN;KMT2A;CREB3L1;SOHLH2;WNT2;TRPS1;RUNX3;ZEB2;POU5F1;PAX1;PLAC8;GLI2;ZEB1;SBNO2;ETV6;NCOR2;YAP1;MED13L;DEAF1;TCF7L2;TCF4;NRIP1;ASXL1;SNAI1;TBX18;TNFSF11;SOX5;TNIP1;ATXN1;PRRX1;MRTFA;GLI3;BCL6;CREB3L3;SATB2;MEIS2;SLC9A1;BAZ1A;STAT1;EGR3;ZMIZ1;RARB;TLR2;IRF7;BRIP1;BACH1;CD40;GATA6;MAFB;SNAI2;ZFPM2;RCOR1;AUTS2;FHL2;NPAS4;BATF;DNAJB1;NKX6-1;RXRG;MITF;CRYM;ZNF496;ARID5B;SMAD2;NFIX;MIER2;SUFU;CDKN2B;EGFR;ZIC4;REL;MAML3;MLIP;PRRX2;BHLHE22;UBP1;GLIS1;APOE;USF1;STAT3;LITAF;CGGBP1;MEIS1;TBX2;PKNOX2;TEAD3;USP9X;ZBTB10;SOX21;HOXB3;ELF4;NR2F2;JAG1;PPRC1;ABCA2;ARID5A;TRAK1;SHH;KMT5A;SMURF2;MBD2;E2F1;PRDM5;CAMK2D;PHF2;MYBL1;VGLL3;NCK1;SP110;PRDM2;PTEN;CEBPD;PRKD2;PKD2;SMARCC1;CCNL1;BAZ2B;ACVR1;PPID;ASXL2;HIVEP2;PBX3;TAF7;SP140;TCF12;NCK2;HIVEP1;INO80;RNF2;FOXK2;CREBBP;ATM;CBX8;MACC1;PPARG;LRP6;ZNF292;STAT5A;ZBTB48;TGFB3;PLK1;ETV5;ENO1;ZHX2;ZNF250;CXCL10;AHR;PIAS2;MDFI;TSHZ3;FOXE1;ZNF260;MLXIP;E2F8;BCL11B;ZKSCAN1;SUB1;ZBTB12;GTF2H1;DDX17;ARNT;NOC2L;RNF111;IRF1;NFE2L3;PID1;BHLHE40;RRP1B;TADA2B;HEYL;CREB3L2;ACTR2;FRK;CRTC1;MAML2;EPC2;TNRC6B;HOXA1;POU2F1;ZFHX4;SAP18;SP100;OGT;ZNF182;AHRR;WNT5A;HDAC1;ZBTB5;SALL1;FOXO3;TBL1X;ZSCAN22;ZBTB38;ARID1B;DICER1;SMAD5;FOXP4;PRDM1;BMP5;NR2F1;MTA2;JUNB;NOP2;HMGB2;PPP3CA;PELP1;CXXC5;TGIF2;ZIC1;TBX3;TCF7;BRWD1;TNFRSF1A;NEUROD6;EID1;FNIP1;WWTR1;CBFB;TEAD1;GATAD2B;KLF10;ARF4;BBX;CHD2;MOV10;ELK4;CRTC3;RSF1;RUVBL1;NFE2L2;ZGPAT;PHF21A;DNMT3B;SAFB;ZBED3;CALR;SP3;CDK7;ACVR2A;LCOR;TET2;ARID4B;E2F3;MED13;TNF;KDM2A;ZSCAN21;HOXB2;KLF6;MAML1;GLYR1;FGF2;DUSP26;ZBTB20;MC1R;NKX2-8;SKOR2;ELK1;GLIS3;FOXJ3;NFKB2;SPI1;PIK3R1;TFCP2L1;DDRGK1;RIF1;SAFB2;GATAD2A;GTF2F1;PRDM10;CTCF;SMAD3;DACT1;PSEN1;KCNIP3;MED15;IRF9;ATRX;EGR2;TRIB3;DRAP1;MYSM1;ZFP62;LCORL;HOXB5;TFAP2C;SMAD4;MAFK;GABPB1;NIPBL;CX3CL1;RIPK1;SETX;SMAD1;RTRAF;SRCAP;CREB3L4;CREB3;PATZ1;NR6A1;CCNT1;HIF1A;MED26;PHF12;FBXL19;STAT5B;PRKDC;RBMX;PTOV1;SQSTM1;RELB;SLC30A9;NPAS2;NSD1;POU3F3;MAX;LIN9;ITGB1BP1;ZKSCAN8;CLOCK;TCF7L1;TCF3;SMARCA4;SREBF1;ACVRL1;ZNF18;MTA3;ZFHX3;HSPD1;BACH2;HCFC2;TRIM33;NUCKS1;PHF20;TCERG1;CALCOCO1;THRAP3;BRD4;ZNF445;MZF1;ZNF25;MDM2;NFE2L1;ATF4;RCOR2;GLI1;ETS1;ZNF3;RLF;PRDM4;RAI1;SALL3;LHX6;INHBA;ZSCAN29;PAX8;ZBTB40;RBPJ;DDX20;ZBTB9;HDAC5;NR2C2;NFKBIA;MXD4;SOX2;SPEN;RBBP8;CDK9;SETD3;RPAP2;HINFP;KAT6B;ZBTB25;ZBTB7A;BCAS3;ARID4A;NR3C1;TLE5;DVL2;BRMS1L;LRP5;THAP7;GADD45A;MGA;GABPA;STAT2;KDM1A;KAT7;MED12;MED1;AGO2;CCNL2;PCGF3;ELF2;CC2D1B;TMF1;RBAK;LAGE3;PIN1;CDK13;YEATS2;HMGA2;MXI1;ZNF367
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.438776331778422,-1.1976465346710894,0.22742474916387959,0.6868612445513484,1.0,4/16,2.77%,DMD;ATP1A2;ANK2;CALM1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.42478528915700886,1.1975568593289057,0.22972972972972974,0.6299263653516032,1.0,23/73,18.08%,MYO10;VAV2;VAV3;BLK;DOCK1;WIPF1;NCK1;BAIAP2;CDC42;ACTR2;GRB2;BRK1;PTK2;VAV1;ABI1;PIK3R1;SRC;RAC1;FCGR1A;WIPF2;YES1;MAPK1;FCGR3A
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4291185160408048,1.1974060478975597,0.20956719817767655,0.6298044044576683,1.0,7/65,8.34%,RORA;ZFP36L1;GATA6;CPEB1;SFRP1;NPEPPS;TERT
prerank,mitotic cell cycle phase transition (GO:0044772),0.3990601432381593,1.1972632407228487,0.1396534148827727,0.6295971301487631,1.0,58/203,18.90%,DYNLL1;CDKN2B;FBXL7;CHMP4B;DYNC1H1;CCNE2;CUL1;E2F1;KHDRBS1;TUBG1;ACVR1;CACUL1;ALMS1;CDK6;CCND3;CDK14;PLK1;PCM1;CDC27;HAUS3;SKP1;CEP41;CNTRL;PHLDA1;DCTN3;BORA;DBF4;RPS6KB1;PCNT;ACVR1B;PPP2R2A;EIF4EBP1;CCNB2;CDK7;CEP72;E2F3;PPP1CB;FBXW11;CCNI;CHMP7;PPME1;ACTR1A;AKAP9;CDKN1B;GSPT1;PPP6C;CEP192;MAX;RCC1;CSNK1D;LATS2;YWHAE;CKAP5;TAF2;INHBA;HINFP;EPS8;HAUS6
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3730298131808738,-1.1967700465598299,0.20909090909090908,0.6867864868975473,1.0,15/29,22.16%,SLC4A10;MCTP1;SHISA6;CLN3;APP;CAMK2B;GRIK2;ZDHHC2;SHISA7;SYP;NCDN;SYNGR1;SLC8A2;DRD2;SHISA9
prerank,positive regulation of defense response to virus by host (GO:0002230),0.49061836405975157,1.1964535834957652,0.28053691275167786,0.6311875622984822,1.0,8/24,21.08%,IL23R;STAT1;TRIM44;DTX3L;CGAS;TRAF3IP2;TRIM6;ZC3H12A
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3867655947990779,1.1961755140081556,0.12234580384226491,0.6313420500976169,1.0,52/234,16.63%,ROR1;WNT2;TRIML2;TNFSF11;TLR2;CD40;FLOT2;NKX6-1;CFLAR;ARID5B;IRAK3;STAT3;STK36;IKBKE;PPRC1;SHH;PTEN;PRKD2;LGALS9;DDR2;NOD1;TRIM21;CD36;FZD1;PPARG;LRP6;EIF2AK2;IRAK2;RAB7B;TIRAP;TRIM13;CRTC1;TRIM8;PSMA6;WNT5A;EDA2R;CRTC3;EDA;TNF;NFKB2;TRAF2;DDRGK1;SMAD3;CX3CL1;RIPK1;SMO;RBCK1;CLOCK;TCF3;SMARCA4;LAMTOR5;TRAF5
prerank,regulation of lipid catabolic process (GO:0050994),-0.4106430213294781,-1.196055558116783,0.20666666666666667,0.6861610465652946,1.0,6/19,22.92%,ALK;BSCL2;PDE3B;ADRA2A;PRKAA1;TYSND1
prerank,cellular response to insulin stimulus (GO:0032869),0.40108005984347894,1.1959281514693283,0.1650893796004206,0.6314678263310382,1.0,27/124,14.12%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;IRS1;INSIG2;USF1;BAIAP2;AP3S1;CPEB1;PPARG;MYO5A;INHBB;RAB8B;DENND4C;SH2B2;GRB2;RPS6KB1;PTPN2;ATP6V1F;GCK;GSK3B;ATP6V1H;PIK3R1;ATP6V1G2;RAB10;TRIB3
prerank,smooth muscle cell differentiation (GO:0051145),0.5707079626362599,1.1953982485814256,0.2674050632911392,0.6323558300036098,1.0,3/12,2.70%,TBX18;MRTFA;GATA6
prerank,actin crosslink formation (GO:0051764),0.5658752670183261,1.1943128002982262,0.2835820895522388,0.6347712754944652,1.0,4/12,8.76%,DPYSL3;BAIAP2;AIF1;LCP1
prerank,hexose transmembrane transport (GO:0008645),-0.38721776190976953,-1.193396201601847,0.22304832713754646,0.6912928210060103,1.0,7/21,25.00%,SLC2A1;SLC5A3;SLC2A12;SLC45A3;SLC2A8;SLC2A9;SLC45A1
prerank,regulation of dendritic spine development (GO:0060998),-0.40926157600856006,-1.1928435579350898,0.23344947735191637,0.690315910693318,1.0,11/19,22.05%,TANC2;CPEB3;SHANK3;GRIN3A;SHANK1;CAMK2B;LLPH;KIF1A;NLGN1;PPFIA2;MEF2C
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5826250459580913,1.1923571859879667,0.2863849765258216,0.6383309544811854,1.0,5/11,15.35%,DCAKD;SLC25A16;PANK2;COASY;PANK1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5826250459580913,1.1923571859879667,0.2863849765258216,0.6383309544811854,1.0,5/11,15.35%,DCAKD;SLC25A16;PANK2;COASY;PANK1
prerank,coenzyme A biosynthetic process (GO:0015937),0.5826250459580913,1.1923571859879667,0.2863849765258216,0.6383309544811854,1.0,5/11,15.35%,DCAKD;SLC25A16;PANK2;COASY;PANK1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.44401643573562233,1.191803893532976,0.24235294117647058,0.6392179892466189,1.0,7/48,7.06%,BCL3;IKBKE;E2F1;BCL2;ATM;BAG6;BCL2L2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4967475941234394,1.1913558266910875,0.26666666666666666,0.6398846802457997,1.0,5/24,8.23%,OLR1;TNIP1;CCL5;ICAM1;MSN
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5457169944550714,1.1912920723756968,0.27382753403933435,0.6394737442420775,1.0,3/14,4.55%,ZEB1;SPRED1;SPRED2
prerank,cellular response to interleukin-2 (GO:0071352),0.5733236637707619,1.1911364113522267,0.2698170731707317,0.6387458821263209,1.0,2/11,6.10%,JAK1;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5733236637707619,1.1911364113522267,0.2698170731707317,0.6387458821263209,1.0,2/11,6.10%,JAK1;STAT5A
prerank,positive regulation of protein polymerization (GO:0032273),0.41629033820748557,1.1905725319407967,0.24031890660592256,0.6396976337579467,1.0,15/65,18.41%,CCL11;NAV3;NCK1;BAIAP2;NCK2;CARMIL1;SNX9;AKAP9;RAC1;FES;CDC42EP1;TOGARAM1;CTTN;TPPP;CDC42EP4
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2866364540449125,-1.1902980157168885,0.11764705882352941,0.6946835604718432,1.0,33/84,23.77%,KHDRBS2;QKI;DDX5;CELF2;MBNL1;HNRNPU;YTHDC1;WTAP;NOVA2;TIA1;NCL;CWC22;NOVA1;RBFOX3;U2AF2;CIRBP;RBM5;LARP7;HNRNPA1;SRSF7;DAZAP1;SRSF9;RBM8A;SRRM4;MAGOH;NUP98;FXR1;SRSF3;HNRNPL;PCBP4;RBM3;ZC3H10;CELF6
prerank,regulation of melanin biosynthetic process (GO:0048021),0.5884678831539495,1.190256693875117,0.2825040128410915,0.6399879733469963,1.0,1/10,0.58%,ZEB2
prerank,immunoglobulin mediated immune response (GO:0016064),-0.4833192098006497,-1.1901930457846128,0.26902173913043476,0.6924020177622978,1.0,2/10,20.15%,CD81;FCER1G
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.4409613898761166,1.190049579021345,0.2493975903614458,0.6400148685489937,1.0,11/45,14.25%,ZFP36L1;BCL6;ZFP36L2;MAD2L1;PTPN3;TOM1L1;BTG1;GAS1;SMAD3;BMP7;CDKN1B
prerank,positive chemotaxis (GO:0050918),0.5212596672437652,1.189969036350051,0.2727272727272727,0.6396848117750837,1.0,6/17,14.73%,FGF7;NRP1;ANGPT1;GPNMB;PTPRJ;CX3CL1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3326284883134523,-1.1898609624574576,0.16883116883116883,0.6907811029404477,1.0,9/46,6.60%,ATP1A2;NRXN1;GRM7;GRM1;DGKI;SHANK3;GRM8;GRM3;CACNG2
prerank,regulation of cellular localization (GO:0060341),0.4422414801033982,1.1898249650426018,0.2493857493857494,0.639528203495812,1.0,8/46,8.60%,NR1H4;LRRK2;BLK;DYNC1H1;CAMK2D;UNC13D;GOSR1;EFNA5
prerank,response to hydroxyurea (GO:0072710),0.570954076929058,1.1893574498016268,0.2764976958525346,0.6402290968286553,1.0,5/11,19.45%,DDX11;TIMELESS;ATRX;FMR1;KAT7
prerank,miRNA metabolic process (GO:0010586),0.5077318963678537,1.1888774887285551,0.26912181303116145,0.6409648885659258,1.0,7/20,19.61%,DDX17;DICER1;SND1;TUT7;PARN;BCDIN3D;AGO2
prerank,cGMP-mediated signaling (GO:0019934),0.54818033091755,1.1887927941681629,0.28355957767722473,0.6406035661650413,1.0,3/13,5.55%,PDE3A;APOE;CD36
prerank,regulation of spindle assembly (GO:0090169),0.48766682070041467,1.1887097276586893,0.2540322580645161,0.6402681334042739,1.0,6/25,10.58%,CHMP4B;DYNC1H1;PLK1;GPSM2;EML3;SENP6
prerank,aortic valve development (GO:0003176),0.46711482601879284,1.1884863918128168,0.2371392722710163,0.6403198450886168,1.0,8/34,10.46%,SNAI1;ROBO2;SLIT3;SNAI2;JAG1;EMILIN1;HEYL;TNFRSF1A
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4656864799942025,1.1882734481805048,0.24751243781094528,0.6403480588463377,1.0,9/35,16.39%,DLC1;ARHGAP24;MAPKAP1;ITGA3;TGFB2;KCTD10;SPRY2;ARHGAP35;SYNGAP1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.46848852642114214,1.1876791410763972,0.24867021276595744,0.6413782316605894,1.0,11/30,23.74%,CXCL12;SNAI1;SNAI2;CCAR2;TMEM161A;MDM2;FBXO5;KDM1A;DYRK1A;CLU;THOC5
prerank,cholesterol biosynthetic process (GO:0006695),-0.3513386263540734,-1.187510247877514,0.17209302325581396,0.6949966865974982,1.0,16/31,26.50%,LBR;MSMO1;INSIG1;ACAT2;SQLE;CYP51A1;DHCR24;IDI1;ACLY;LSS;HSD17B7;FDPS;EBP;FDFT1;NSDHL;TM7SF2
prerank,cell chemotaxis (GO:0060326),0.4333066292019555,1.1873645764479646,0.22423556058890148,0.6416768657310314,1.0,7/60,4.50%,PDGFRA;CXCL12;EGR3;PDGFRB;NRP1;CCR1;PARVA
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5826016401575431,1.1873408226010551,0.2859399684044234,0.6411704669134443,1.0,1/10,0.38%,PDE3A
prerank,cellular calcium ion homeostasis (GO:0006874),0.40170800279690305,1.1872293039141326,0.18401682439537329,0.6408721874256265,1.0,22/133,12.64%,CCL11;CCL7;EDN3;CXCL12;CD40;STOML2;CCR1;CAMK2D;BCL2;TRPC6;SLC24A5;CCL5;FKBP1B;ATP2A2;DRD3;PDZD8;TMEM203;ATP2B1;CALR;TPCN2;MICU2;PACS2
prerank,prostanoid metabolic process (GO:0006692),0.554406837175708,1.1868807127195635,0.27896341463414637,0.6413246453863648,1.0,2/13,7.19%,PTGES;ACOX1
prerank,autophagosome organization (GO:1905037),0.43957607075061633,1.1865957285688358,0.24824355971896955,0.6415372043736071,1.0,16/50,21.19%,VMP1;WIPI1;AMBRA1;ATG3;RAB7A;ATP2A2;ATG7;PACS2;RAB1A;ATG16L1;ATG16L2;WDR45;PIK3C3;IRGM;UBXN2A;BECN1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.40961376684188283,1.186523885732797,0.20192307692307693,0.6411642288688449,1.0,27/100,17.55%,GLMN;NKD2;LRRK2;PABIR1;RNF144A;PLK1;PRICKLE1;BAG6;EIF3H;CCAR2;RAD23A;ARIH1;OGT;RAD23B;SOCS5;RNF19B;GSK3B;CSNK1A1;GIPC1;DDRGK1;TRIB3;RPL11;TRIB1;ZYG11B;CSNK1D;GNA12;MDM2
prerank,epithelial cell differentiation (GO:0030855),0.41314369493643793,1.1859498724865203,0.2164835164835165,0.6421569839407656,1.0,12/88,10.94%,SCUBE1;GATA6;FSTL1;JAG1;PPARG;E2F8;DEUP1;ANXA1;HDAC1;CTSB;CNN3;GSTK1
prerank,negative regulation of cellular senescence (GO:2000773),0.5502026001534023,1.1851434700459706,0.27165932452276065,0.643714279065758,1.0,7/13,21.73%,AKT3;CDK6;TERT;MAP3K3;FBXO5;HMGA2;YBX1
prerank,receptor clustering (GO:0043113),-0.36321263065125287,-1.184807565137058,0.19369369369369369,0.700021236756594,1.0,6/27,6.07%,SYNJ2BP;NRXN1;LRRC7;DLG2;AGRN;NRXN2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.4334639237674396,-1.1847072826206808,0.22258064516129034,0.6977975063696112,1.0,5/15,10.39%,ARL6IP1;REEP1;ZFYVE27;RAB18;TMEM170A
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4461615947423884,1.1846232774138452,0.2517814726840855,0.6445513650903849,1.0,16/43,18.89%,POU5F1;STAT3;PPARG;TERT;FOXO3;TEAD1;TGFB2;TNF;FGF2;GNL3;SPI1;SMAD3;HIF1A;SMARCA4;ETS1;NR3C1
prerank,regulation of cell communication (GO:0010646),0.45582761786265025,1.1845832001005825,0.27112232030264816,0.6440968154203855,1.0,6/35,8.96%,IGFBP7;TBX18;UGCG;CAMK2D;PTPN1;ANXA1
prerank,cell junction assembly (GO:0034329),0.40647692226890586,1.1839219961766532,0.21155943293347873,0.6452893364139561,1.0,25/100,12.66%,CDH11;VMP1;SLITRK6;PCDHB6;FLNC;PCDHB16;FARP1;SDK2;ADGRL3;FSCN1;PTEN;DCHS1;OPHN1;LIMS1;CDC42;CDH6;PLXND1;GJC1;DSCAM;CDH18;CDH24;DBNL;FBLIM1;RHOA;SDK1
prerank,cardiac myofibril assembly (GO:0055003),0.5427050844226528,1.1838555258779981,0.2763744427934621,0.6449079213138751,1.0,3/15,4.03%,PDGFRA;PDGFRB;FHOD3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4920876455606602,1.1837957060033388,0.29357798165137616,0.6445013806399882,1.0,8/24,14.73%,MAP4K4;NRP1;LIMS1;SFRP1;MAPRE2;PTPRJ;PIK3R1;RAC1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5482413935257648,1.1835200095181335,0.28088235294117647,0.6446908548409458,1.0,1/13,0.45%,IL23R
prerank,DNA geometric change (GO:0032392),0.4913429035190525,1.1835115797576745,0.2749003984063745,0.6441484960974146,1.0,6/24,10.37%,DNA2;ASCC3;DDX11;ANXA1;HMGB2;MCM9
prerank,lysine metabolic process (GO:0006553),0.5547558085072188,1.1829495010031812,0.27617602427921095,0.6445359326991548,1.0,6/12,21.44%,CRYM;DLST;ALDH7A1;HYKK;PIPOX;SLC25A21
prerank,lysine catabolic process (GO:0006554),0.5547558085072188,1.1829495010031812,0.27617602427921095,0.6445359326991548,1.0,6/12,21.44%,CRYM;DLST;ALDH7A1;HYKK;PIPOX;SLC25A21
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4931137568130478,1.1826824115180643,0.27114093959731544,0.6447194075663396,1.0,6/23,14.73%,THBS4;XCL1;MDK;TIRAP;DAPK2;RAC1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.42339026172291633,1.1820361128071333,0.2431818181818182,0.6459650567274715,1.0,20/65,18.20%,SH3KBP1;EGFR;ERRFI1;PTPN3;EGF;CDC42;EPS15L1;CBL;GRB2;MVP;PTPRJ;PTPN2;PDE6H;SPRY2;EPS15;BTC;NEU3;ITGA1;AKT1;AGT
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4070144589220962,1.1817792360871913,0.20948180815876516,0.6461116215982586,1.0,34/93,26.27%,SH3RF3;MID1;TAOK1;UNC5CL;EIF2AK2;SASH1;TAOK3;RASSF2;TIRAP;SH3RF1;EDA2R;TGFB2;PJA2;TRAF2;SPI1;PDCD10;RIPK1;TRAF5;MAPK8IP1;MFHAS1;XDH;GADD45A;DUSP15;ZC3H12A;WNT16;AXIN1;SDCBP;RELL1;TRAF3;SEMA3A;VEGFA;LTBR;MBIP;PYCARD
prerank,negative regulation of protein transport (GO:0051224),0.49570332499236575,1.1814759097226541,0.26865671641791045,0.6463047397222914,1.0,4/25,12.15%,ADIPOQ;APOE;DRD3;DPH3
prerank,positive regulation of double-strand break repair (GO:2000781),0.45268040905535717,1.1813287654208129,0.2459425717852684,0.646109276724518,1.0,14/39,18.04%,PARP3;DDX11;ACTR2;SHLD3;SPIRE1;SETMAR;TIMELESS;MGMT;RIF1;DTX3L;MMS19;PRKDC;PNKP;SLF2
prerank,positive regulation of behavior (GO:0048520),-0.48707785550871535,-1.1809024140914854,0.28150134048257375,0.7063632406205816,1.0,5/10,26.30%,SGIP1;CFAP20;NLGN1;MEF2C;NR4A3
prerank,cellular response to type I interferon (GO:0071357),0.4542923208835008,1.1808802198380963,0.26666666666666666,0.6461906215916553,1.0,9/41,9.83%,JAK1;STAT1;IRF7;IRF1;IFNAR2;PSMB8;SP100;IP6K2;OASL
prerank,type I interferon signaling pathway (GO:0060337),0.4542923208835008,1.1808802198380963,0.26666666666666666,0.6461906215916553,1.0,9/41,9.83%,JAK1;STAT1;IRF7;IRF1;IFNAR2;PSMB8;SP100;IP6K2;OASL
prerank,natural killer cell activation (GO:0030101),0.48893890153068187,1.1806143527573607,0.26180836707152494,0.6463838864207375,1.0,7/23,21.97%,ULBP1;ELF4;BAG6;CASP8;PTPRC;KAT7;NFIL3
prerank,histone mRNA catabolic process (GO:0071044),0.5303788675340352,1.1802588760833017,0.2887218045112782,0.6467808262811153,1.0,5/15,11.16%,ATM;ERI1;EXOSC4;DCP2;XRN1
prerank,synaptic vesicle localization (GO:0097479),-0.4646050570973304,-1.1801051207924425,0.2520775623268698,0.7060495381719674,1.0,7/13,19.82%,RAB27A;SYNDIG1;SNAPIN;TOR1A;SYNJ1;DNM2;NLGN1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3959413206352016,-1.179618322042264,0.21649484536082475,0.7049104379392621,1.0,5/20,3.68%,PRKCZ;CD81;MALT1;IL18;CD55
prerank,regulation of interleukin-13 production (GO:0032656),0.5430622288050441,1.1796177604286047,0.28287461773700306,0.6479098253517273,1.0,3/13,5.04%,TNFRSF21;TSLP;LGALS9
prerank,regulation of integrin activation (GO:0033623),0.5307743711627464,1.1793479797472803,0.2911010558069382,0.6480598569680232,1.0,6/15,21.94%,FARP2;FBLIM1;SRC;PLEK;PIEZO1;RAP1B
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.41910894067650517,1.1791188353218307,0.25675675675675674,0.6481078898536371,1.0,22/70,18.08%,MYO10;VAV2;VAV3;DOCK1;WIPF1;NCK1;BAIAP2;CDC42;ACTR2;GRB2;BRK1;PTK2;VAV1;ABI1;PIK3R1;SRC;RAC1;FCGR1A;WIPF2;YES1;MAPK1;FCGR3A
prerank,organophosphate ester transport (GO:0015748),-0.378982227715368,-1.1784123210071138,0.1953125,0.7056625968483757,1.0,6/24,9.97%,PITPNC1;LDLR;PITPNA;SCARB1;ABCA3;TNFAIP8L3
prerank,long-term synaptic potentiation (GO:0060291),-0.3985870490848339,-1.177704470219705,0.24087591240875914,0.7051152214287838,1.0,5/21,11.07%,SLC24A2;PRKCZ;SLC8A3;GRIN2D;GRIN2B
prerank,circulatory system development (GO:0072359),0.3968658336290206,1.1776613229062316,0.20732984293193718,0.6514928928143655,1.0,22/118,12.60%,COL3A1;SH3PXD2B;GLI2;HSPG2;DNAAF4;ZFPM2;CACNA1C;SHH;FBN1;PTEN;PKD2;NF1;ACVR1;NXN;PDLIM4;FBXW7;TGFBR1;SALL1;TGFB2;CASP8;NTRK3;AKAP13
prerank,negative regulation of protein depolymerization (GO:1901880),0.48230681950712423,1.1766754496483043,0.271523178807947,0.6536279012450454,1.0,7/24,13.76%,TAOK1;NAV3;LIMA1;TPX2;CAMSAP2;FGF13;PLEKHH2
prerank,canonical glycolysis (GO:0061621),0.48414794474439105,1.176041135012884,0.2804878048780488,0.6542236995479892,1.0,5/24,11.60%,HK2;FOXK2;ENO1;GAPDH;GCK
prerank,glucose catabolic process to pyruvate (GO:0061718),0.48414794474439105,1.176041135012884,0.2804878048780488,0.6542236995479892,1.0,5/24,11.60%,HK2;FOXK2;ENO1;GAPDH;GCK
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4936327715400054,-1.1759550584139637,0.2601626016260163,0.7076348522935336,1.0,5/10,29.16%,LPGAT1;ELOVL5;SLC45A3;MLXIPL;NR1H2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4638499222131547,1.175946552651117,0.2576530612244898,0.6539230399136239,1.0,2/33,0.87%,CEL;CACNA1A
prerank,positive regulation of B cell proliferation (GO:0030890),0.46932225621663937,1.17572473106023,0.283289817232376,0.6539597116040013,1.0,7/29,11.94%,CD40;VAV3;BCL2;SASH3;TIRAP;IL7;TNFRSF4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5026179507442321,1.1756034085714833,0.2809917355371901,0.653729537525403,1.0,4/20,12.59%,CLTC;PID1;PPP2R5A;NUMB
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.47143972308416293,1.1754857392923264,0.26273458445040215,0.653504111386631,1.0,8/26,20.99%,TNFAIP3;IRAK3;ILRUN;TRIM21;TRIB1;ITCH;TYRO3;LYAR
prerank,regulation of cell morphogenesis (GO:0022604),0.46531983113663866,1.175000341273083,0.2827496757457847,0.6542460339504625,1.0,8/30,14.24%,SPARC;FMNL2;EFNA5;PDZD8;ZMYM4;MOV10;PDPN;WTIP
prerank,negative regulation of hormone secretion (GO:0046888),-0.4841968978966309,-1.174960415104437,0.27371273712737126,0.7079531327937211,1.0,3/10,19.05%,RAB11FIP3;RAB11FIP1;GJA1
prerank,regulation of phosphate metabolic process (GO:0019220),0.5179557087551727,1.1743276780445435,0.28913963328631875,0.655478895481278,1.0,4/16,13.92%,SMG7;SMG6;MCM7;PSEN1
prerank,regulation of BMP signaling pathway (GO:0030510),0.4190845881793592,1.174315295117314,0.24336283185840707,0.6549449750943034,1.0,20/73,18.23%,SULF1;SFRP4;FSTL1;SMAD2;SMURF2;PPARG;HTRA3;LEMD2;ITGA3;SMAD5;BMPER;ACVR2A;SKOR2;SMAD4;SMAD1;SMURF1;CHRD;ACVRL1;TRIM33;RBPJ
prerank,glial cell development (GO:0021782),0.4772699499960422,1.1739345247135688,0.27344782034346105,0.6553521541532948,1.0,7/25,17.89%,TLR2;MDK;NF1;CDK6;EIF2B3;TPPP;NRROS
prerank,regulation of tube diameter (GO:0035296),-0.44714600552121825,-1.1739181906533434,0.2551928783382789,0.7058802196175856,1.0,7/13,23.37%,NOS3;GCLC;NPR1;AGTR1;ACE;ACE2;GCLM
prerank,vascular process in circulatory system (GO:0003018),-0.44714600552121825,-1.1739181906533434,0.2551928783382789,0.7058802196175856,1.0,7/13,23.37%,NOS3;GCLC;NPR1;AGTR1;ACE;ACE2;GCLM
prerank,maintenance of protein localization in organelle (GO:0072595),0.5092125527072016,1.173472167277955,0.2767475035663338,0.6560925908581565,1.0,7/19,17.14%,BCL3;HK2;MORC3;SKP1;TAPT1;HSPA5;AKT1
prerank,heterocycle biosynthetic process (GO:0018130),-0.4280144143665935,-1.1733235793482133,0.2326283987915408,0.7050605903273495,1.0,9/14,30.82%,GPHN;MOCS2;LIAS;NFS1;NOXRED1;PYCR2;MOCS3;PYCR3;GCH1
prerank,cardiac muscle contraction (GO:0060048),-0.3411080337414779,-1.1726952612353676,0.19811320754716982,0.7044649183447201,1.0,4/34,3.22%,DMD;ATP1A2;ATP1B1;GSN
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3912483209428992,-1.1726261385927803,0.25461254612546125,0.70223753926461,1.0,4/21,4.77%,PRKCH;CD81;SLC39A10;PRKCB
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.48199015650856325,1.1726078004673142,0.2830188679245283,0.6578258353196212,1.0,6/22,12.29%,TIMP1;APOE;PTPN3;SNX33;SNX9;TNF
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2853206032490053,-1.172360293262418,0.16,0.7004493450108623,1.0,21/75,12.55%,MAP2;DCC;CTNNA2;NTNG1;CNTN4;MINK1;ACTB;RB1;KLF7;SHTN1;DSCAML1;DCDC2;FGFR2;SLITRK1;PARD3;ANK3;MAP1A;APP;ZDHHC17;S100B;PAK3
prerank,myeloid cell differentiation (GO:0030099),0.43930722250790194,1.172300383682281,0.25690276110444177,0.6581325536436916,1.0,9/47,13.10%,RUNX1;JAK2;CDKN2B;TIRAP;UBA5;PTPN2;KMT2E;TET2;SPI1
prerank,regulation of response to biotic stimulus (GO:0002831),0.4763914855887615,1.1722937820629524,0.3033112582781457,0.65759432077451,1.0,8/28,14.73%,GATA6;BIRC3;TREM2;CD36;IRF1;TIRAP;CASP8;CX3CL1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4114706012198736,1.1722862081252654,0.2408026755852843,0.6570526762982889,1.0,21/88,18.04%,MMP3;SYNPO;PRKCA;VPS4A;EMILIN1;RAB7A;TIRAP;SDC1;BRK1;FNIP1;TNF;GSK3B;SMPD3;SMAD3;BMP7;CX3CL1;PLEK;SH3GLB1;TPPP;ICE1;SLF2
prerank,negative regulation of gene expression (GO:0010629),0.3824677942551643,1.1720513452321868,0.12084592145015106,0.6571156974418302,1.0,58/302,15.68%,RUNX1;RBMS3;IGF2BP1;CREB3L1;ITGB8;NCOR2;YAP1;IGF2BP2;SYNCRIP;ZFP36L2;FLOT2;REL;APOE;ILF3;IGFBP5;CCR1;PHF1;LGALS9;METTL16;SFRP1;EIF2AK2;PTBP3;EMILIN1;CAPRIN1;GIGYF2;SAMD4A;CELF1;TERT;TNRC6B;FBXW7;GPNMB;MAP2K1;DCP2;HDAC1;RNH1;DICER1;GAPDH;SETDB1;MOV10;TGFB2;ATP2B1;DNMT3B;CALR;SETDB2;TNF;FGF2;SMCR8;SPI1;DDRGK1;MSR1;PSEN1;FMR1;PPHLN1;PDCD10;DXO;CCDC3;SMO;HIF1A
prerank,anterior/posterior axis specification (GO:0009948),0.5274792983333668,1.1715820341238463,0.29411764705882354,0.6578077422411944,1.0,3/15,10.21%,SHH;WLS;TBX3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.40006510658045585,1.1714875189611116,0.200836820083682,0.6575078639163837,1.0,34/128,17.67%,DYNLL1;BACH1;CDKN2B;FBXL7;DYNC1H1;CUL1;KHDRBS1;TUBG1;ALMS1;CDK14;PLK1;PCM1;HAUS3;SKP1;CEP41;CNTRL;PHLDA1;DCTN3;BORA;PCNT;PPP2R2A;CCNB2;CDK7;CEP72;PPP1CB;FBXW11;PPME1;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;TAF2
prerank,negative regulation of macroautophagy (GO:0016242),0.4771638189984722,1.171259441083082,0.2913907284768212,0.6575100334202315,1.0,10/26,21.25%,LRRK2;CHMP4A;CHMP4B;TMEM39A;SMCR8;AKT1;SCFD1;USP36;MTM1;CLEC16A
prerank,cellular metal ion homeostasis (GO:0006875),0.3988737073581867,1.1712238746470378,0.24763903462749212,0.657065432065692,1.0,16/102,12.14%,CCL11;CCL7;EDN3;CXCL12;SLC9A1;CD40;STOML2;CCR1;SLC24A5;CCL5;ATP2A2;DRD3;TMEM203;ATP2B1;CALR;TPCN2
prerank,receptor-mediated endocytosis (GO:0006898),0.39411434612313856,1.170451818870111,0.22338204592901878,0.65853787871972,1.0,31/132,15.88%,HP;HPR;CLTC;LRP1;HSPG2;SPARC;COLEC12;MASP1;APOE;ADM;DNAJC6;CD36;DNAJC13;LRP6;CTSL;CANX;GPR107;GRB2;GAK;SNX9;CALR;CALCRL;TPCN2;EPS15;MSR1;HSPH1;COLEC11;AP2A2;NEDD4;FCGR1A;GRK4
prerank,zinc ion homeostasis (GO:0055069),0.47635864382825427,1.1701188591417604,0.28664921465968585,0.6588829265224876,1.0,1/28,0.13%,SLC39A14
prerank,mitotic metaphase plate congression (GO:0007080),0.4327974871503395,1.1693330411992748,0.246189917936694,0.6604320845505549,1.0,10/51,15.31%,KIFC1;EML4;CHMP4A;CHMP4B;VPS4A;PINX1;EML3;CHMP7;MAD1L1;CHMP2B
prerank,nucleosome organization (GO:0034728),0.42120503687431804,1.1689507632294687,0.24571428571428572,0.6608804881349667,1.0,18/55,20.23%,POLE3;SMARCC1;INO80;SETD2;GRWD1;HMGB2;LIN54;RSF1;SPTY2D1;NAP1L3;CTCF;ATRX;ASF1A;SRCAP;SMARCA4;KAT6B;NAP1L1;ARID2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5669703777344594,1.1688620304781752,0.30647709320695105,0.660010662991746,1.0,7/10,20.54%,NSMAF;TNFRSF1A;TNF;SPHK2;SMPD3;SIRT3;PRKCD
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5669703777344594,1.1688620304781752,0.30647709320695105,0.660010662991746,1.0,7/10,20.54%,NSMAF;TNFRSF1A;TNF;SPHK2;SMPD3;SIRT3;PRKCD
prerank,triglyceride biosynthetic process (GO:0019432),-0.38941199552401334,-1.1688253704221034,0.2426470588235294,0.7080404016099875,1.0,5/18,14.31%,AGMO;LPGAT1;LPIN1;DGAT1;GPAT4
prerank,regulation of Notch signaling pathway (GO:0008593),0.4157450500018752,1.1685699979524875,0.24354657687991021,0.6602263774721048,1.0,25/76,18.67%,MMP14;YAP1;ZMIZ1;EGFR;MAML3;STAT3;JAG1;EGF;CREBBP;LLGL1;MAML2;FBXW7;TSPEAR;NEPRO;GALNT11;TGFB2;MAML1;SRC;PDCD10;EGFL7;ITGB1BP1;TSPAN14;AKT1;RBPJ;ZBTB7A
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5641537627462009,1.1684287258005364,0.28683385579937304,0.6600364323444916,1.0,6/12,22.46%,PTEN;PLK1;SKP1;RAB1A;CDC14B;FZR1
prerank,ruffle organization (GO:0031529),0.5167947153201543,1.1681041484891197,0.28717201166180756,0.6603636837943117,1.0,9/16,22.69%,LIMA1;AIF1;CARMIL1;AIF1L;RAC1;PLEK;PIP5K1A;TPM1;ARFIP2
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4330652754398322,1.168070867745317,0.26633785450061653,0.65990163283913,1.0,10/41,14.73%,ADAM19;TNFSF11;JAK1;MDK;CCL5;PTPN23;GCNT2;TNF;BMP7;CX3CL1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.3228946004441031,-1.1680541242832794,0.1751412429378531,0.7078120705355335,1.0,26/42,35.18%,UBC;POLD3;PCNA;FAAP20;RFC3;UBA52;POLH;PARP10;USP10;POLD2;RPA2;PRIMPOL;PCLAF;POLE;RFC4;ZBTB1;CDKN2D;POLD4;RFC2;WRN;DTL;RPA3;POLK;USP43;SPRTN;RFC5
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.41375366702611693,1.1673976913884374,0.23991275899672845,0.6611325446992518,1.0,24/88,13.81%,CLTC;MYO1B;AP4M1;STEAP2;ARFGEF2;PUM1;RABIF;VPS13C;DNAJC6;TXNDC5;DTNBP1;MYO5A;LLGL1;EXOC4;GBF1;ACBD3;EXOC1;OSBPL5;CLINT1;EPS15;CCDC93;RAB10;KIF16B;ARF1
prerank,regulation of cellular component size (GO:0032535),0.4731171274210884,1.1667736060062532,0.2707253886010363,0.6621509080226586,1.0,11/30,18.74%,VAV2;VAV3;PTEN;RPTOR;MSN;VAV1;RAC1;PEX11A;LAMTOR5;PICALM;EPS8
prerank,cellular response to ionizing radiation (GO:0071479),0.4329846205402531,1.1666127466586549,0.2582619339045288,0.6619959134544323,1.0,16/47,21.02%,YAP1;TNKS1BP1;INO80;ATM;GRB2;ATR;TANK;NIPBL;CLOCK;NUCKS1;MDM2;RAD9A;SWI5;GADD45A;KDM1A;MAP3K20
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4098030284824329,1.166574912641305,0.24608501118568232,0.6615434010019406,1.0,17/69,13.29%,PDGFRA;ZFP36L1;GAB2;IRS1;PDGFRB;PTEN;NF1;PIK3R5;OGT;PLCL1;EXOC1;RPS6KB1;FGFR1;PLCB3;RHOA;PI4KA;PIK3R1
prerank,positive regulation of lyase activity (GO:0051349),0.5425338878453216,1.1665635709975515,0.31277533039647576,0.6610168343766902,1.0,3/14,5.10%,CACNA1C;FXN;NF1
prerank,positive regulation of signaling (GO:0023056),0.44786326379346014,1.1665071718407491,0.2727272727272727,0.6605905199445524,1.0,7/37,12.29%,ADIPOQ;EDN3;DLG4;HCRT;WLS;PTPN23;TNF
prerank,I-kappaB phosphorylation (GO:0007252),0.5710145927867952,1.166308489577573,0.2942097026604069,0.6605629392716926,1.0,2/10,6.73%,TLR2;TLR7
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5796308679304719,1.1660017573737773,0.29838709677419356,0.6608466072954022,1.0,4/10,18.30%,KMT2A;SPHK2;SMAD4;HDAC5
prerank,translesion synthesis (GO:0019985),-0.33127503122098817,-1.1659609001119133,0.1837837837837838,0.711679560562701,1.0,27/42,35.18%,RCHY1;UBC;POLD3;PCNA;UFD1;FAAP20;RFC3;NPLOC4;UBA52;POLH;PARP10;USP10;POLD2;RPA2;PRIMPOL;PCLAF;POLE2;RFC4;ZBTB1;POLD4;RFC2;DTL;RPA3;POLK;USP43;SPRTN;RFC5
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.46392872458556517,1.165841702849029,0.27466666666666667,0.6607282030648719,1.0,10/27,20.36%,EGFR;STAT3;PUM1;TNRC6B;MAP2K1;WTIP;FMR1;RIPK1;AGO2;EIF4G1
prerank,protein ADP-ribosylation (GO:0006471),0.46967492427327867,1.1653727957685742,0.2667509481668774,0.6614184591433352,1.0,8/28,20.64%,PARP8;PARP3;PARP11;ARF4;SIRT3;TNKS2;PARP14;PARP4
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.40242775604176645,1.1650837514974504,0.25686059275521406,0.6616660342837105,1.0,28/84,25.19%,PSMA7;MAD2L1;PLK1;ANAPC11;CDC27;PSMB8;PSMA6;PSMF1;PSMA8;PSMD2;PSMD12;PSMD11;PSMD14;PSMB1;FBXO5;FBXO31;PSMC6;UBE2E1;RPS27A;FZR1;PSMB4;PSMB5;ANAPC2;PSMD4;PSMD7;PSMD9;PSMA4;CDC16
prerank,platelet aggregation (GO:0070527),0.45530099917709593,1.165071509939083,0.2676767676767677,0.6611457956330693,1.0,15/33,24.04%,PDGFRA;CSRP1;MYH9;STXBP1;STXBP3;UBASH3B;GNAS;PLEK;FERMT3;TYRO3;ACTN1;FIBP;P2RY12;ITGB3;METAP1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3879334243370521,1.164880243851779,0.17959183673469387,0.6610672251959443,1.0,32/190,14.24%,RORA;NR1H4;PDE3A;ADIPOQ;TNIP1;STAT1;TNFAIP3;SPRED1;TLE1;TREM2;ITPR1;PTEN;BCL2;NF1;NPRL2;CGNL1;BCL2L2;NOC2L;SFRP5;OTUD3;DRD3;FNIP1;PTPRJ;CASP8;P2RX7;TANK;SPI1;DLG5;BMP7;SRC;TRIB3;WTIP
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.45205659884721083,-1.1647383595392602,0.2612359550561798,0.7127100191125261,1.0,2/12,5.03%,GSN;LY6E
prerank,DNA replication (GO:0006260),0.4023691218475079,1.1643869594782628,0.2288135593220339,0.6617954219945089,1.0,26/105,19.97%,RBMS1;BAZ1A;POLE3;BRIP1;DNA2;MCM2;NT5M;ATM;MCM7;ATR;DBF4;GRWD1;RNASEH2A;MCM9;TIMELESS;POLA2;REV1;RMI1;POLG;ATRIP;PNKP;ING5;RAD9A;RBBP8;KAT7;NAP1L1
prerank,lymphocyte differentiation (GO:0030098),-0.28575191268676237,-1.164090318345429,0.15454545454545454,0.7122391801634271,1.0,19/68,17.48%,KIT;HDAC4;HDAC9;TOX;GPR89B;GPR89A;VCAM1;TPD52;MSH2;JAG2;ITGA4;DNAJB9;BLNK;CEBPG;PIK3CD;NHEJ1;GPS2;LFNG;IKZF1
prerank,liver development (GO:0001889),0.45921729316263826,1.1634835594098685,0.2626903553299492,0.6637465502498844,1.0,9/32,12.77%,PRKCSH;ARID5B;PHF2;PKD2;NF1;E2F8;ANXA1;NPHP3;NKX2-8
prerank,positive regulation of type 2 immune response (GO:0002830),-0.439423721047252,-1.1634483486042857,0.2722063037249284,0.7114958872691464,1.0,3/14,3.04%,PRKCZ;CD81;IL18
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5624448020183456,1.1633077873316475,0.3042763157894737,0.6636929859647404,1.0,6/11,25.13%,BIRC3;CASP8;YBX3;RIPK1;FZD9;ARHGEF2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3479844686057947,-1.162614745122388,0.24313725490196078,0.7114365455763721,1.0,7/27,9.96%,FGF12;SLMAP;FXYD5;SNTA1;ATP2B4;GPD1L;FXYD6
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.40812402846382834,1.161972844146146,0.24044943820224718,0.6665811744182317,1.0,4/75,1.36%,SLC39A14;C3;RGS16;PPP1R9B
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.503085424395184,1.161744614482012,0.2759601706970128,0.666654877005831,1.0,6/19,21.08%,TNFAIP3;PYDC1;NLRP2B;CX3CL1;CPTP;ZC3H12A
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3974781006691619,1.1613860869707426,0.22376873661670235,0.6670536520061621,1.0,26/110,18.04%,MMP3;ABCA1;IAPP;FARP2;APOE;AIDA;CD36;EIF2AK2;CDC42;STXBP1;TIRAP;BRK1;FNIP1;FBLIM1;TNF;GSK3B;TRAF2;SRC;HSPA5;ATF7IP;SH3GLB1;KIF9;TPPP;STX1B;ICE1;SLF2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4566366457575262,-1.1612925949827706,0.28106508875739644,0.7128535768672173,1.0,4/13,14.26%,TMSB4X;SIN3A;PER2;HEY2
prerank,cellular response to pH (GO:0071467),0.5094886734547354,1.1612710678576168,0.29737609329446063,0.6668061168315915,1.0,2/17,2.09%,HVCN1;SLC9A1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.37889527650486776,1.1610987767965573,0.14543630892678033,0.6666957310739314,1.0,94/327,21.97%,RORA;RUNX3;POU5F1;CXXC1;SBNO2;ATXN1;CCAR1;CHD7;ZMIZ1;BACH1;GON4L;MAFB;SNAI2;MITF;SUFU;PRRX2;STAT3;SOX21;E2F1;PHF1;MYBL1;PRDM2;FOXK2;CREBBP;YAF2;AHR;BHLHE40;CARM1;CCAR2;BTG1;FADS1;TGFBR1;NONO;ZBTB38;UBE2L3;TGIF2;ACVR1B;TCF7;WWTR1;FOXN2;LIN54;TGFBRAP1;CALR;SP3;SPTY2D1;NIF3L1;ZSCAN21;NAB2;SKOR2;NSD3;NFKB2;SPI1;ATRX;DRAP1;WTIP;BAZ2A;BNC2;PATZ1;HIF1A;PHF12;NUP35;NSD1;NFXL1;CLOCK;TCF7L1;TCF3;ACVRL1;ZFHX3;HCFC2;MZF1;ATF4;NR2C2;SOX2;HINFP;KAT6B;NR3C1;TULP3;DVL2;THAP7;RPL6;KAT7;RBAK;HMGA2;NUP107;VHL;HINT1;MAGED1;NR1D2;RNF14;YBX1;ZNF423;RPS6KA4;CREM;NFIL3
prerank,negative regulation of TOR signaling (GO:0032007),-0.335331944616019,-1.1608892750058653,0.21608040201005024,0.7115480230105806,1.0,14/36,20.66%,PRKAA2;RNF152;NPRL3;DEPDC5;SESN2;SESN3;DDIT4;TSC1;SPAAR;TSC2;MINAR1;AKT1S1;TNFAIP8L1;PRKAA1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.4133150814584945,1.1606375494666505,0.2692307692307692,0.6674296196417056,1.0,22/71,18.08%,MYO10;VAV2;VAV3;DOCK1;WIPF1;NCK1;BAIAP2;CDC42;ACTR2;GRB2;BRK1;PTK2;VAV1;ABI1;PIK3R1;SRC;RAC1;FCGR1A;WIPF2;YES1;MAPK1;FCGR3A
prerank,DNA modification (GO:0006304),0.4908367756796679,1.1605189422754256,0.28843537414965986,0.6672217493026464,1.0,2/22,1.20%,PARP3;MPG
prerank,positive regulation of GTPase activity (GO:0043547),0.38586339310360435,1.1602812976350887,0.19817073170731708,0.6672836859999233,1.0,40/188,14.96%,CCL11;CCL7;RGS16;MAP4K4;SYDE1;CD40;PRTN3;ARHGAP24;XCL1;ARHGAP42;SIPA1L3;TAX1BP3;ASAP3;TBC1D16;NF1;LIMS1;CCL5;SFRP1;EPHA1;TBC1D2B;RABGAP1L;RSU1;ZC3H15;ARHGEF19;TBC1D8B;SNX18;RABGAP1;CCL2;MAPRE2;SNX9;GSK3B;NTRK3;RGS10;TBC1D1;ADPRH;RAB3GAP1;ARHGAP22;TBC1D10B;CX3CL1;SIPA1L2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5076184533307929,1.1600473314025928,0.2921511627906977,0.6673296341396067,1.0,4/18,14.08%,DLC1;ITGA3;KCTD10;ARHGAP35
prerank,positive regulation of exocytosis (GO:0045921),0.4469623465302501,1.1596515169067454,0.2770618556701031,0.667806616933798,1.0,17/35,27.57%,RAB2B;VPS4A;UNC13D;RAB7A;SDC1;RAB9A;RAB27B;SMPD3;RAB15;SDC4;RAB5A;SDCBP;PDCD6IP;TSG101;CLASP2;CLASP1;CADPS2
prerank,axon extension (GO:0048675),0.4824955364703478,1.1595792239341924,0.29579375848032563,0.6674546972435118,1.0,5/23,3.93%,SLIT3;SLIT1;AUTS2;NRP1;USP9X
prerank,peptidyl-tyrosine modification (GO:0018212),0.4137057604532582,1.1594213961750226,0.26143024618991795,0.6673427445681277,1.0,16/56,14.81%,PDGFRA;TEC;PDGFRB;JAK2;EGFR;BLK;DDR2;PTPN6;EPHA1;ABI2;FGFR1;PTK2;TPST1;ABI1;SRC;FES
prerank,positive regulation of angiogenesis (GO:0045766),0.396554623808778,1.1590129388266324,0.2532188841201717,0.6678818909162566,1.0,16/108,9.14%,RUNX1;CYP1B1;ITGB8;ADAM12;JAK1;CD40;GATA6;PRKCA;MDK;HK2;PRKD2;ANGPTL4;EPHA1;SASH1;BTG1;WNT5A
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.40391182865667663,1.1582120338943809,0.2513781697905182,0.6695052453049997,1.0,17/80,14.70%,CLTC;HEATR5A;STX6;TMEM87B;SNX8;RAB7A;RAB7B;GOSR1;GBF1;RAB9A;ANKFY1;LMAN1;DENND5A;SNX2;SNX5;TBC1D10B;WASHC1
prerank,phosphatidylserine metabolic process (GO:0006658),0.45603398558759783,1.1581124098135456,0.2868217054263566,0.6692238156796934,1.0,9/32,20.29%,PLA1A;PLA2G12A;OSBPL5;ABHD16A;PLA2G4A;PLA2G4E;LPCAT3;PTDSS2;PLSCR1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.28502910055510955,-1.1580158744675937,0.17272727272727273,0.7174065094514589,1.0,12/76,8.49%,PLCE1;CHRM2;GRM1;ACTN2;HTR2C;ADRA1B;ESR1;GPR4;GNA11;GNA14;AGTR1;ADRA1A
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5407162983071823,1.15794961133195,0.31643625192012287,0.6691091250858077,1.0,1/13,0.33%,ENPP1
prerank,phosphorylation (GO:0016310),0.3750566323042861,1.157935799736265,0.11623246492985972,0.6686025167461705,1.0,97/385,18.46%,CCL11;EPHA7;RUNX3;NEK6;MAP4K4;TEC;TAOK1;JAK1;PEAK1;ERN2;LRRK2;JAK2;PRKCA;MARK1;NUAK1;IRAK3;STAT3;STK36;ILF3;IKBKE;AKT3;CAMK2D;PRKD2;ACVR1;MORC3;FAM20A;CDK6;ATM;CDK14;EIF2AK2;PLK1;PPP4R1;DGKH;TAOK3;DCLK1;CDK10;NEK4;MERTK;PXK;FRK;MAST2;PRKAR1B;TGFBR1;MAP2K1;CSNK2A1;PANK2;MAP4K5;HIPK3;ACVR1B;CDC42BPA;CCL2;FGFR1;YWHAZ;NRK;CSNK1G2;TGFB2;GMFB;GK;CDK7;ACVR2A;COQ8B;MAML1;GSK3B;CSNK1A1;ACVR1C;PI4KA;SPHK2;MAP3K6;MKNK1;STK24;DAPK2;TRIB1;NADK;PIK3R4;CCNT1;PRKAB1;PRKDC;GRK4;STK4;FAM20B;ACVRL1;PNKP;CSNK1D;GNPTG;MAPK1;AKT1;LATS2;CDKL1;TYK2;EIF2AK3;TESK2;MAP3K12;SIK3;CDK16;GNPTAB;CDK9;POMK
prerank,nervous system development (GO:0007399),0.37399854702091856,1.1578691039801916,0.12012012012012012,0.6682336904782075,1.0,71/429,12.77%,IGF2BP1;WNT2;ZEB2;GPM6B;CXCL1;YAP1;SLITRK6;IGF2BP2;ROBO2;RBFOX1;PCDHB6;PTN;ATXN1;MYLIP;NUMBL;CHD7;PCDHB16;FARP1;ATXN10;HPCAL4;VCAN;SDK2;NELL1;NAV1;ADGRL3;ZIC4;P2RX5;KALRN;NAV3;STAT3;JAG1;MDK;GLRB;TRAK1;SHH;MAP1S;SERF1A;PMP22;ALDH1A2;PTEN;PKD2;DCHS1;NF1;OPHN1;GDA;PTPRZ1;PLXND1;DLG4;DCLK1;L1CAM;MERTK;SCD5;EFNA5;CXCR4;TGFBR1;WDPCP;ZIC1;ACVR1B;TBX3;WWTR1;TEAD1;DSCAM;ESS2;GMFB;DBNL;NAB2;FGF13;FGF2;SDK1;ACVR1C;SPG7
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.45012894790762387,1.1578540212400796,0.28756476683937826,0.6677360795612597,1.0,13/33,21.92%,EGFR;AIF1;CCND3;ADAMTS1;RPTOR;ANXA1;KMT2E;ANKRD17;DDRGK1;AKT1;GLI1;EIF4G1;RGCC
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4971066950520542,1.1578475765021676,0.2935528120713306,0.6672094423085198,1.0,4/20,10.36%,SFRP4;CD40;PLA2R1;CCL2
prerank,glycerolipid catabolic process (GO:0046503),-0.3974614494115398,-1.1571977782520246,0.2906574394463668,0.7172814613700521,1.0,6/19,17.01%,GPCPD1;MGLL;ABHD6;GDE1;GDPD1;ENPP6
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.23785433147706114,-1.1568313620470867,0.0,0.715927626921006,1.0,86/264,25.12%,ELAVL2;U2SURP;SRRM2;PSPC1;SFPQ;SNRNP70;DDX5;HNRNPU;YTHDC1;NOVA2;PRPF6;CDC40;SRSF5;SNRNP48;FRG1;WDR33;CSTF2;CWC22;SNRPN;PABPC1;NOVA1;AQR;HNRNPH3;ZCRB1;U2AF2;ISY1;PRPF38A;PRPF4;GEMIN2;USP49;RALY;RBM5;CWF19L1;GCFC2;LSM6;SNRPC;PPIH;DCPS;HNRNPA1;SNRPG;POLR2A;POLR2H;SRSF7;RBM19;POLR2G;PRPF40B;SRSF9;PPIL3;SNRNP27;POLR2F;RBM17;IK;SCNM1;PRPF19;CWC25;RBM8A;SART1;CPSF2;LSM5;HNRNPR;MAGOH;SNRPD3;HNRNPA3;POLR2E;HNRNPM;HNRNPA0;PRPF8;EIF4A3;SRSF3;CLP1;HNRNPL;CACTIN;DNAJC8;RAVER2;CPSF4;SNUPN;SF3B6;SF3B5;DDX39B;TXNL4A;PDCD7;DDX46;DDX39A;SF3A1;SF3A3;HNRNPD
prerank,positive regulation of hydrolase activity (GO:0051345),0.39007397659712173,1.1567959280181808,0.20435684647302904,0.6694319117733786,1.0,34/137,18.77%,CCL11;CCL7;RGS16;MAP4K4;CD40;PRTN3;XCL1;ASAP3;NF1;LIMS1;CCL5;SFRP1;RSU1;ZC3H15;SNX18;HMGB2;CCL2;MAPRE2;SNX9;RCN3;RHOA;GSK3B;RGS10;RAB3GAP1;CALM2;CX3CL1;MTMR9;NDEL1;ALS2;TBC1D20;DOCK10;PICALM;CCL15;BCAS3
prerank,regulation of interferon-alpha production (GO:0032647),0.4773441528840807,1.1567742544258233,0.2816711590296496,0.6689395036044201,1.0,4/23,9.84%,STAT1;IRF7;TLR7;SETD2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.49572472739190326,1.1567611880961857,0.3111111111111111,0.6684404519426392,1.0,4/19,9.53%,MMP14;ZMIZ1;MDK;IL7
prerank,response to iron ion (GO:0010039),0.5429237363911168,1.156653442797959,0.3166397415185784,0.6681999279958892,1.0,4/12,6.95%,SLC11A2;FXN;BCL2;ACO1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5502368722530324,1.1554198320430085,0.3066255778120185,0.6708865231070307,1.0,3/12,4.97%,B4GALT5;MYCBP2;PTEN
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.38527344589269635,1.1548417806852855,0.2295760082730093,0.6718534159921665,1.0,34/150,14.73%,PDGFRA;IAPP;TCF7L2;GAB2;IRS1;PDGFRB;FGF7;EGFR;RICTOR;EGF;STRN;PIK3AP1;HPSE;PIK3R5;ANGPT1;GRB2;TGFBR1;FRS2;FGFR1;PTPRJ;PTK2;GCNT2;SPRY2;VAV1;TNF;FGF2;MC1R;RASD2;BTC;PIK3R1;SRC;TRIB3;RAC1;CX3CL1
prerank,engulfment of apoptotic cell (GO:0043652),-0.4145741500385376,-1.1548029279974443,0.25,0.7192342500761157,1.0,5/15,20.76%,RHOBTB1;XKR4;THBS1;RHOG;RHOH
prerank,regulation of hippo signaling (GO:0035330),-0.4115908466868639,-1.1545322341340598,0.254071661237785,0.7177009275189622,1.0,9/17,23.69%,SCHIP1;CIT;MOB3B;WWC2;MARK3;WWC1;NEK8;MAP2K3;MAPK14
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4562850187161458,-1.1545007114339594,0.2884012539184953,0.7154245083178431,1.0,4/12,10.80%,ERLIN1;PIBF1;ACADL;ERLIN2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.48932208629027013,1.1544843493545858,0.31010928961748635,0.6722122633805973,1.0,4/20,12.59%,CLTC;PID1;PPP2R5A;NUMB
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.433642272534984,1.1544067839588457,0.2798053527980535,0.6718616144302693,1.0,13/45,14.06%,FAM83A;EGFR;NCK2;EGF;CBL;GRB2;PTK2;ERBIN;BTC;PIK3R1;GAREM1;KIF16B;SRC
prerank,calcium ion import across plasma membrane (GO:0098703),-0.41192715505731614,-1.1542251268959915,0.28253968253968254,0.7138126853867904,1.0,6/14,19.38%,SLC24A2;ATP2B4;SLC8A3;TRPV2;TRPV4;SLC8A2
prerank,regulation of gene expression (GO:0010468),0.3720428665978134,1.1541219104498421,0.033,0.6720865994872902,1.0,204/903,19.25%,RORA;RUNX1;GLMN;RBMS3;IGF2BP1;CREB3L1;TRIML2;RUNX3;POU5F1;CXXC1;ITGB8;SEC16B;C1D;SBNO2;EDN3;ADAM19;YAP1;AFF1;ZFP36L1;IGF2BP2;SFRP4;ATXN1;BCL6;NOS1AP;CD276;CCAR1;CRP;CHD7;TLR2;BACH1;GON4L;FGF7;MAFB;SNAI2;CCN4;AFF2;NELL1;FLOT2;MITF;SUFU;REL;TLE1;PRRX2;TREM2;APOE;STAT3;CGGBP1;SOX21;CCR1;SHH;E2F1;PRDM5;PHF1;MYBL1;UBR5;PUM1;PRDM2;EPHX2;AIF1;LGALS9;LIMS1;TRIM21;CD36;FOXK2;EGF;METTL16;CREBBP;CDK6;DTNBP1;ATM;SFRP1;YAF2;AHR;PTBP3;HMG20B;VSTM2A;EMILIN1;TMEM119;PID1;FUBP1;BHLHE40;RRP1B;CARM1;ANGPT1;CCAR2;MAPK11;MSN;CELF1;BTG1;TERT;TNRC6B;FBXW7;FADS1;TGFBR1;MAP2K1;WNT5A;HDAC1;NONO;ZBTB38;DICER1;UBE2L3;PRDM1;TGIF2;ACVR1B;TCF7;SETDB1;HNRNPH2;WWTR1;TRIM44;FOXN2;LIN54;MOV10;TGFB2;NFE2L2;CASP8;GCNT2;DNMT3B;TGFBRAP1;CALR;SP3;SPRY2;SPTY2D1;MARF1;SETDB2;NFKBIZ;TNF;ZSCAN21;NAB2;GSK3B;FGF2;NTRK3;SKOR2;NSD3;P2RX7;NFKB2;SMCR8;SPI1;DDRGK1;PRDM10;MSR1;CTCF;YBX3;SMAD3;PSEN1;BMP7;ATRX;DRAP1;WTIP;TFAP2C;RPL11;PDCD10;BAZ2A;SMAD1;BNC2;CCDC3;SMO;TCF19;PATZ1;HIF1A;FGF18;ADNP2;MED26;PRKAB1;PHF12;NUP35;NSD1;POU3F3;NFXL1;CLOCK;TCF7L1;TCF3;LAMTOR5;OLFM1;ACVRL1;PTPRC;MAPK1;ZFHX3;AKT1;HCFC2;CALCOCO1;MZF1;STX1B;EIF2AK3;ATF4;PICALM;ETS1;PRDM4;INHBA;USP36;RBPJ;HDAC5;NR2C2;SOX2;XDH;HINFP;KAT6B;NR3C1;TLE5;TULP3;DVL2;THAP7;MBNL2;SON;RPL6
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.35289322002006646,-1.153915795385828,0.23282442748091603,0.7122511363574211,1.0,5/30,4.39%,FLT1;MLLT3;KIT;BMP4;KDR
prerank,adipose tissue development (GO:0060612),0.5635159625531092,1.1538377332893148,0.3177004538577912,0.6722832731445717,1.0,2/11,3.37%,SH3PXD2B;ARID5B
prerank,regulation of primary metabolic process (GO:0080090),0.3868803342896919,1.1536015448738994,0.24476987447698745,0.6723892787769212,1.0,37/126,22.92%,PSMA7;NCOR2;APOE;MVK;CREBBP;PPARG;OAZ3;LACTB;CARM1;PSMB8;PSMA6;TBL1X;CHD9;PSMF1;ELOVL6;PSMA8;PRKAB1;PSMD2;PSMD12;RUBCNL;PSMD11;TGS1;SREBF1;PSMD14;PSMB1;ACACA;FASN;MED1;PSMC6;CERS2;NR1D1;NR1D2;ROCK2;NCOR1;SMARCD3;PSMB4;PSMB5
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4459191939822908,1.1530826676075008,0.28994082840236685,0.6731976508872617,1.0,9/40,14.82%,C3;SFRP4;EGF;RAB21;ANGPT1;CBL;VTN;FMR1;CD63
prerank,atrioventricular valve development (GO:0003171),0.5347507655477781,1.1530070719236278,0.29505813953488375,0.6728451580092366,1.0,4/14,11.44%,SLIT3;ACVR1;HEYL;TGFB2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.4116238539437618,1.1529350833447656,0.25863991081382387,0.6725063409440307,1.0,20/72,18.12%,FLRT2;FGF7;SPRED1;GALNT3;SPRED2;CBL;GRB2;GTF2F2;FRS2;NCBP2;FGFR1;FGF2;GTF2F1;KIF16B;SETX;FGF18;MAPK1;RBFOX2;POLR2L;POLR2K
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.45345781686965847,-1.1528506617460876,0.26878612716763006,0.7129251159603684,1.0,4/11,15.49%,TPK1;DCK;NT5C3A;SLC19A3
prerank,stress fiber assembly (GO:0043149),-0.4290438937530713,-1.152259245000136,0.24836601307189543,0.7098654211675486,1.0,2/15,0.40%,SORBS1;PHACTR1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4290438937530713,-1.152259245000136,0.24836601307189543,0.7098654211675486,1.0,2/15,0.40%,SORBS1;PHACTR1
prerank,regulation of dephosphorylation (GO:0035303),0.5131814508217405,1.152251361864675,0.30791788856304986,0.6737048561708188,1.0,8/15,19.50%,SMG7;SMG6;PPP1R16A;SRC;MTMR9;MTMR3;MTMR2;MTMR1
prerank,mRNA destabilization (GO:0061157),0.44830794504628596,1.152248254979932,0.2889447236180904,0.6731736416907127,1.0,18/38,25.24%,ZFP36L1;ZFP36L2;PUM1;METTL16;GIGYF2;CELF1;FTO;MOV10;YTHDF3;RC3H2;TUT7;ZC3H12A;ROCK2;YTHDF2;ROCK1;POLR2D;PLEKHN1;CNOT1
prerank,positive regulation of T cell proliferation (GO:0042102),0.4134497606723416,1.1518766967520955,0.26460071513706795,0.6736184802600377,1.0,7/55,8.96%,IL23R;CD276;NCK1;AIF1;NCK2;CCL5;ANXA1
prerank,regulation of MAPK cascade (GO:0043408),0.37965672729773825,1.1513759043419391,0.24020618556701032,0.674417092005505,1.0,23/157,12.90%,ROR2;ROR1;EPHA7;IAPP;MAP4K4;TAOK1;SPRED1;EGFR;NF1;EGF;ATP6AP2;PTPN6;TAOK3;TMEM106A;MAP2K1;FGFR1;PTPRJ;YWHAZ;NRK;NBR1;FGF2;NTRK3;P2RX7
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.462327890824407,1.1513487319056392,0.2955145118733509,0.6739584011261708,1.0,11/29,18.78%,TCF7L2;TLE1;RBBP5;CREBBP;TERT;HDAC1;TCF7;RUVBL1;TCF7L1;SMARCA4;AXIN2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.561399919698515,1.1510407004038743,0.3276661514683153,0.6742531308857784,1.0,1/10,0.34%,DCN
prerank,regulation of histone acetylation (GO:0035065),0.4535499294480521,1.150472011705695,0.2885572139303483,0.6752514038617009,1.0,10/33,19.16%,KMT2A;TAF7;NOC2L;TADA2B;GLYR1;SPI1;PAXIP1;HDAC5;IWS1;THAP7
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.35873051145843643,-1.1504385986468095,0.2606837606837607,0.712611650303702,1.0,5/27,2.77%,DMD;CACNB2;CACNB4;ANK2;CALM1
prerank,mRNA processing (GO:0006397),-0.2506691501524341,-1.1500231613247371,0.0,0.7114517739834515,1.0,100/287,25.12%,ELAVL2;U2SURP;SRRM2;PSPC1;SFPQ;SNRNP70;DDX5;HNRNPU;RNGTT;YTHDC1;NOVA2;PRPF6;CDC40;SRSF5;SNRNP48;FRG1;WDR33;CSTF2;PPARGC1A;CWC22;SNRPN;PABPC1;NOVA1;RPRD2;AQR;HNRNPH3;ZCRB1;U2AF2;ISY1;PRPF38A;PRPF4;GEMIN2;USP49;RPRD1A;ERCC3;RALY;RBM5;CWF19L1;GCFC2;LSM6;SNRPC;PPIH;HNRNPA1;SNRPG;POLR2A;POLR2H;SRSF7;RBM19;POLR2G;PRPF40B;SRSF9;PPIL3;SNRNP27;POLR2F;ERN1;RBM17;IK;PRPF19;CWC25;RBM8A;SART1;CHTOP;SRRM4;CPSF2;LSM5;HNRNPR;MAGOH;GTF2H2;ZC3H11A;SNRPD3;HNRNPA3;SUPT4H1;CMTR1;POLR2E;HNRNPM;HNRNPA0;PRPF8;EIF4A3;SRSF3;CLP1;HNRNPL;CACTIN;POLDIP3;GTF2H4;DNAJC8;RAVER2;CPSF4;SARNP;SF3B6;SF3B5;DDX39B;TXNL4A;PDCD7;DDX46;TBRG4;DDX39A;GTF2H3;SF3A1;SF3A3;HNRNPD
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5237371826011812,1.150020660473613,0.3242857142857143,0.6758792620085963,1.0,5/15,12.46%,TREM2;CD36;EIF2AK2;PYDC1;NLRP2B
prerank,microtubule nucleation (GO:0007020),0.5058190667410173,1.149907575872572,0.31332357247437775,0.6756584193240451,1.0,9/19,17.48%,TUBG1;TPX2;AKAP9;RANBP9;TUBGCP4;NDEL1;TUBG2;CSNK1D;TPPP
prerank,regulation of nuclear division (GO:0051783),0.48795163525192164,1.149841791141387,0.30376344086021506,0.6752932344041271,1.0,10/20,26.03%,PDXP;BORA;RCC1;OBSL1;FBXO5;PIN1;CDK13;PRMT5;CUL9;L3MBTL1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4132434913501212,-1.1496232085024223,0.27564102564102566,0.7102394511881333,1.0,4/17,1.15%,PRKAG2;PRKAA2;ADIPOR2;CAV1
prerank,regulation of aerobic respiration (GO:1903715),-0.4175421107262377,-1.1495582732917324,0.2781065088757396,0.7081242690921578,1.0,6/15,16.52%,COX7A2;CBFA2T3;PINK1;UQCC2;IDE;NOP53
prerank,positive regulation of filopodium assembly (GO:0051491),0.47634201556440814,1.149198479672007,0.31020408163265306,0.6764800071462348,1.0,6/24,6.39%,DPYSL3;NRP1;FSCN1;RALA;TGFB3;CDC42
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.38014388398098276,-1.148997325626634,0.24468085106382978,0.7074660281114122,1.0,4/20,4.84%,PRKAA2;RPS6KA5;DIP2B;PPARGC1A
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.46455486239364274,1.1482621936267217,0.3054054054054054,0.6784643148768766,1.0,10/27,25.49%,DTYMK;GUK1;CTPS1;AK2;AK8;TXNRD1;CTPS2;NME2;TYMS;NUDT13
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.34039298799682405,-1.1481632925863277,0.2660098522167488,0.7076545103556705,1.0,15/32,23.99%,ADGRB3;IL1RAPL1;CDKL5;CUX1;RAPGEF2;HECW1;CUX2;SEMA4D;CDKL3;PTPRD;CUL7;SARM1;HECW2;LZTS1;NEDD4L
prerank,positive regulation of cell growth (GO:0030307),0.396114428860022,1.1476538154138898,0.2727272727272727,0.679512069415365,1.0,19/96,11.62%,MMP14;EIF4G2;KLHL22;EGFR;FXN;BCL2;PABIR1;INO80;SFRP1;CDC42;RPTOR;L1CAM;SYT2;EXOSC4;TGFBR1;CSNK2A1;DBN1;TGFB2;DBNL
prerank,central nervous system development (GO:0007417),0.37324300537654465,1.1475765724759783,0.18309859154929578,0.6791733476091681,1.0,25/250,5.93%,COL4A1;C3;EPHA7;APOD;HSPG2;ROBO2;ATXN1;MEIS2;MDGA1;CHD7;HPCAL4;VCAN;AFF2;ADGRL3;ZIC4;STAT3;MEIS1;SHH;MAP1S;PTEN;PKD2;NF1;PBX3;ATP6AP2;PTPRZ1
prerank,carboxylic acid transport (GO:0046942),-0.3010672275239018,-1.1464828145390538,0.1888111888111888,0.7099680508066263,1.0,13/55,12.99%,SLC6A6;SLC13A3;SLC6A9;SLC7A5;SLC1A1;SLC6A12;SLC16A11;SLC16A1;CLN3;SLC16A9;SLC38A5;SLC16A4;SLC6A17
prerank,spindle assembly (GO:0051225),0.41061424660688217,1.14643787299446,0.27896512935883017,0.6816244580431885,1.0,17/67,17.00%,NEK6;KIFC1;SMC1A;KIF2A;INO80;HAUS3;STAG2;GOLGA8B;TPX2;STAG1;MAPRE2;RHOA;TUBGCP4;TOGARAM1;CEP192;RCC1;CSNK1D
prerank,negative regulation of viral release from host cell (GO:1902187),0.5281876563967923,1.1462168951885394,0.32608695652173914,0.6816251991141121,1.0,8/13,28.11%,TRIM21;TRIM13;TRIM8;TRIM35;TRIM11;CHMP3;TRIM26;PML
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4837819902909655,1.1461892876113278,0.3044654939106901,0.6811627351274108,1.0,15/22,27.15%,SLC2A13;GSAP;ABCA2;ABCG1;TNF;RANBP9;PICALM;IFNGR1;EFNA3;CLU;ROCK2;RELA;CHRNA7;EFNA1;GSK3A
prerank,nuclear membrane organization (GO:0071763),0.49936982050819306,1.145898333775542,0.32574679943101,0.6814303957776837,1.0,6/19,19.93%,CHMP4B;PLK1;VPS4A;CHMP7;TOR1AIP1;UBXN2A
prerank,regulation of amyloid fibril formation (GO:1905906),0.512112347927289,1.1451419824424727,0.32277526395173456,0.6828477605966391,1.0,3/15,3.78%,IAPP;TREM2;APOE
prerank,striated muscle tissue development (GO:0014706),-0.3467145812986109,-1.1451252985290281,0.22857142857142856,0.7114238546998913,1.0,8/29,7.19%,SGCD;PGM5;CAV1;SGCZ;RBP4;IGSF8;MYL6;NDUFV2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.41076398944458037,1.145112589827438,0.25597269624573377,0.6823854267050264,1.0,7/59,9.82%,CYP7B1;LIPC;ALDH1A2;SLC27A2;HSD17B8;LPL;OSBPL3
prerank,cranial nerve development (GO:0021545),0.547329944439219,1.1450062114508714,0.3328313253012048,0.6821172221195824,1.0,2/11,9.20%,CHD7;SALL1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.412387539320416,1.144864443048701,0.27304550758459745,0.6819525056600678,1.0,11/59,15.73%,RUNX2;TCF7L2;MITF;PTEN;TNRC6B;CBFB;MOV10;MED13;MED15;SETX;MED26
prerank,coenzyme A metabolic process (GO:0015936),0.5288678630595398,1.144454238671967,0.32653061224489793,0.6825097430496928,1.0,6/14,17.85%,DCAKD;SLC25A16;PANK2;COASY;PANK1;NUDT7
prerank,positive regulation of catalytic activity (GO:0043085),-0.32479670869331556,-1.1442146649139953,0.2358974358974359,0.7117655670857287,1.0,16/37,23.69%,CAV1;XRCC4;YWHAB;APH1A;MSH2;SLC5A3;IGF2;NHEJ1;FGFR4;SOD1;SSBP1;CHTOP;MAPK3;CIB1;MSH3;MAPK14
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.42801695775752746,1.1437477727411556,0.2699530516431925,0.6838772705656069,1.0,16/51,17.22%,FSTL1;FBN1;SMURF2;PPARG;HTRA3;LEMD2;SMAD5;GREM2;BMPER;ACVR2A;SKOR2;SMAD4;SMAD1;SMURF1;CHRD;TRIM33
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.47038498768330184,-1.1436204631562998,0.31016042780748665,0.7111530946333463,1.0,4/10,24.58%,PCGF5;IGF2;KDM1B;ZFP57
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3862973825062903,1.1431897186878968,0.24479166666666666,0.6848193090081371,1.0,36/140,16.70%,DLC1;SYDE1;VAV2;ARHGAP15;RHOJ;ARHGAP24;VAV3;ARHGAP32;KALRN;ITSN1;RHOD;OPHN1;FGD4;SRGAP1;CDC42;CGNL1;ARHGDIG;ARHGEF19;TRIO;ARHGEF12;PREX1;FAM13B;RHOA;VAV1;ARHGAP6;AKAP13;ARHGAP22;SRC;ARHGEF18;ARHGAP35;RAC1;RHOF;DEPDC1B;SQSTM1;ARHGAP9;ARHGDIA
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3935947965971841,-1.1427318286613206,0.28289473684210525,0.7116132398667929,1.0,5/18,4.77%,PRKAG2;OCLN;SLC2A1;C2CD5;PRKCB
prerank,protein prenylation (GO:0018342),0.5479517581656765,1.1424016449366963,0.33762057877813506,0.6863450127875851,1.0,4/10,16.88%,CHML;RABGGTB;FNTB;PTAR1
prerank,regulation of cellular component movement (GO:0051270),0.4215148154249405,1.1423912361617052,0.29156626506024097,0.6858335497475337,1.0,20/49,22.93%,MYCBP2;EGFR;ZSWIM6;EGF;CDK6;SP100;TGFBR1;PDPN;MEMO1;RHOA;ZSWIM8;BTC;ZSWIM4;FES;ETS1;ACTN1;PKN1;RAF1;ROCK2;ROCK1
prerank,regulation of synapse maturation (GO:0090128),-0.4624572487204365,-1.142072209927279,0.3018867924528302,0.7110720251314988,1.0,4/10,18.18%,NRXN1;ARHGEF15;CAMK2B;RELN
prerank,positive regulation of cellular component organization (GO:0051130),0.39289342226614354,1.1417579441114827,0.24786324786324787,0.6869930263012753,1.0,16/107,12.44%,MMP3;RUNX1;LRP1;TREM2;ASAP1;APOE;TGFB3;TIRAP;TGFBR1;BRK1;LMAN1;FNIP1;PTPN23;TGFB2;TNF;GSK3B
prerank,positive regulation of protein deacetylation (GO:0090312),-0.42519381963213976,-1.141707676918567,0.28012048192771083,0.7098841426016275,1.0,6/14,25.18%,SAP30BP;AKAP8;NNMT;CTBP1;APLNR;BRMS1
prerank,stabilization of membrane potential (GO:0030322),-0.3993476399345833,-1.1416497709394458,0.2721311475409836,0.7078444316873422,1.0,7/16,25.92%,KCNK5;KCNK10;KCNK2;KCNK13;KCNK6;CHCHD10;KCNK12
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5330406955815461,1.1414651869389372,0.3338533541341654,0.6872217790828963,1.0,3/12,14.04%,GCNT2;TNF;BMP7
prerank,cellular response to organonitrogen compound (GO:0071417),0.392723687406448,1.1413227604648357,0.27747551686615884,0.6870757013822792,1.0,14/99,9.92%,NR1H4;PDE3A;PDXP;ZFP36L1;IGFBP5;PKD2;CPEB1;SFRP1;AHR;CAPN2;RPTOR;RRAGC;HRH1;SSH1
prerank,transepithelial transport (GO:0070633),-0.4212836436403707,-1.1412378333711477,0.2948328267477204,0.7068123287668572,1.0,5/15,3.81%,SLC12A2;ABCG2;SLC1A2;SLC1A1;CXADR
prerank,regulation of calcium ion transport (GO:0051924),0.41708489851215225,1.1412003281159278,0.28987194412107103,0.6868395055975814,1.0,11/54,11.67%,IL16;CACNA2D1;CCR1;BCL2;PKD2;TRPC6;CCL5;EGF;EFHB;MYLK;ATP2B1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3890396220312708,1.1399460258392906,0.26545842217484006,0.6890400608306632,1.0,15/104,16.79%,PSMA7;CUL1;CREBBP;SKP1;PSMB8;PSMA6;FBXW11;PSMF1;SRC;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14
prerank,cellular response to lectin (GO:1990858),0.3890396220312708,1.1399460258392906,0.26545842217484006,0.6890400608306632,1.0,15/104,16.79%,PSMA7;CUL1;CREBBP;SKP1;PSMB8;PSMA6;FBXW11;PSMF1;SRC;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.46848949572515314,1.1396936815436463,0.30945945945945946,0.6891291259531495,1.0,10/23,22.19%,SMAD2;NREP;SMURF2;ITGA3;SMAD3;SMAD4;LATS2;TRIM33;DKK3;LATS1
prerank,second-messenger-mediated signaling (GO:0019932),0.4037260945138252,1.1396680662682321,0.2640883977900553,0.6886704900578121,1.0,16/82,14.55%,EDN3;PPP1R9B;TNFSF11;LRRK2;APOE;CCR1;RCAN2;CD36;CXCR4;SAMD14;LAT2;HRH1;RCAN3;TPCN2;NUDT4;TRPM4
prerank,protein targeting to lysosome (GO:0006622),0.4889442999449286,1.1394707024108148,0.30517711171662126,0.6886776739208983,1.0,7/20,18.32%,AP4M1;VPS4A;LAMP2;RAB7A;NEDD4;ZFYVE16;GNPTAB
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.3342441590060353,-1.1389543129006579,0.2553191489361702,0.7108985132340557,1.0,8/30,10.49%,ACSL1;TECR;ELOVL7;ELOVL5;ABCD3;HACD1;HACD3;HACD4
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.547741497954815,1.138945182214113,0.3333333333333333,0.6895116745823656,1.0,3/11,10.14%,ZFP36L1;ZC3H3;NCBP2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.343648857014081,-1.1389052811746925,0.25,0.7088544455501556,1.0,8/27,9.26%,TJP1;TMEFF2;PRKN;RHPN2;SHANK3;ARHGAP28;SHANK1;INPP5K
prerank,DNA alkylation (GO:0006305),0.49806645539115635,1.1386652879805708,0.33475783475783477,0.689152849079547,1.0,8/19,18.44%,EHMT1;KMT2E;DNMT3B;GATAD2A;ATRX;BAZ2A;ATF7IP;MTRR
prerank,DNA methylation or demethylation (GO:0044728),0.49806645539115635,1.1386652879805708,0.33475783475783477,0.689152849079547,1.0,8/19,18.44%,EHMT1;KMT2E;DNMT3B;GATAD2A;ATRX;BAZ2A;ATF7IP;MTRR
prerank,positive regulation of neuron death (GO:1901216),0.43472452211502255,1.138652059760794,0.29404617253948967,0.6886507221386745,1.0,10/46,18.91%,EPHA7;NF1;WNT5A;FOXO3;TGFB2;TNF;GSK3B;ATF4;PICALM;PRNP
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.40504282346254317,1.1384795852458223,0.29545454545454547,0.6885349287545329,1.0,22/66,21.08%,YAP1;UBR5;BAG3;PLK1;PINX1;NMD3;TERT;CCT8;ZIC1;WWTR1;ORMDL3;PIK3R1;SMAD3;PSEN1;CCT3;DTX3L;LAMTOR5;AKT1;EIF2AK3;KAT7;PRKCD;ZC3H12A
prerank,urogenital system development (GO:0001655),0.549340857177264,1.1381606019907737,0.32741935483870965,0.6888338998737842,1.0,3/11,8.96%,EPHB3;SHH;ANXA1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4483509384814266,-1.1380934103421045,0.29705882352941176,0.7090545904882323,1.0,6/12,27.89%,PPP3CB;GPLD1;PLA2G6;ANO1;CFTR;BAIAP3
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4189267037153548,1.137630408379567,0.2939150401836969,0.6896575636311149,1.0,14/55,19.71%,CYP1B1;PDGFRB;DHRS4;PID1;GRB2;ARF4;SPHK2;RAC1;RIPK1;AGT;XDH;CCN6;GADD45A;DCXR
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.40078665870399094,1.1375999080121864,0.2807991120976693,0.6892120049217217,1.0,20/74,15.12%,TCF7L2;TNFAIP3;SNAI2;CFLAR;BCL2;ACVR1;SIAH2;ICAM1;TERT;SH3RF1;TGFBR1;BMP5;PELI3;CASP8;UNC5B;TNF;GSK3B;TRAF2;SRC;RIPK1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.4141185936373835,1.137520435224941,0.2853907134767837,0.688867575734775,1.0,8/64,9.08%,CYP1B1;ACSL4;EPHX2;AIG1;SLC27A2;ACOX1;FADS1;CYP1A1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5325405674668051,1.1370014741815966,0.3179190751445087,0.6896608532887037,1.0,3/13,10.24%,SEC16B;TM9SF4;SEC16A
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.31937373715403783,-1.1367660533667345,0.22340425531914893,0.7105354337560408,1.0,7/38,4.59%,CACNB2;KCND3;CAV1;CTNNA3;ANK2;KCNJ2;KCNJ3
prerank,blood circulation (GO:0008015),0.4231468122153663,1.1364875716706202,0.28805620608899296,0.6904284258474898,1.0,5/49,2.14%,OLR1;SERPING1;EDN3;CXCL12;STAT1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3881965913030308,1.1361043476174577,0.27194860813704497,0.6908705206198527,1.0,15/105,16.79%,PSMA7;CUL1;CREBBP;SKP1;PSMB8;PSMA6;FBXW11;PSMF1;SRC;PSMA8;PSMD2;PSMD12;RELB;PSMD11;PSMD14
prerank,base conversion or substitution editing (GO:0016553),0.5439494104664512,1.1359831184620433,0.33996937212863704,0.6906575415167828,1.0,1/11,1.47%,APOBEC1
prerank,regulation of viral entry into host cell (GO:0046596),0.4505817050844021,1.1356806853796715,0.3233766233766234,0.6909467294763342,1.0,3/30,5.54%,TRIML2;LGALS9;TRIM21
prerank,heme catabolic process (GO:0042167),-0.4236624380708842,-1.1341937448374988,0.29780564263322884,0.7133908348553414,1.0,4/14,16.98%,ABCG2;BLVRB;BLVRA;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4236624380708842,-1.1341937448374988,0.29780564263322884,0.7133908348553414,1.0,4/14,16.98%,ABCG2;BLVRB;BLVRA;HMOX2
prerank,regulation of cell cycle (GO:0051726),0.3704796226636237,1.1340954942927683,0.21248741188318226,0.6945456849451386,1.0,48/271,14.53%,FAP;RUNX3;NEK6;PPP1R9B;TCF7L2;EIF4G2;GATA6;RASSF1;BIRC3;CDKN2B;STAT3;PUM1;PKD2;PES1;TRIM21;NF2;CDK6;ATM;SFRP1;LRP6;PLK1;CKS1B;IRF1;CDK10;GBF1;TMEM8B;RAD23A;TTC28;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;SND1;SETMAR;JUNB;TBX3;LIN54;CCNB2;TGFB2;CALR;ANKRD17;CDK7;NLRP2B;MAEA;SMAD3;BMP7;CDKN1B;CDC14A
prerank,telomere maintenance (GO:0000723),0.4207771670766461,1.1339897408120239,0.31170336037079954,0.6942792393021268,1.0,14/50,17.03%,PARP3;DNA2;XRCC3;ATM;ZBTB48;TERT;ATR;SP100;LTO1;NSMCE2;RIF1;CTC1;PRKDC;TEP1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.45519266107957357,1.1338467719867371,0.3228346456692913,0.6941216712625289,1.0,13/27,26.27%,TNFSF11;MDK;CCL2;RHOA;TNF;HSPD1;ETS1;SIRPA;CCDC88B;CYRIB;RELA;THY1;PYCARD
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.38183459460469643,1.1331506825627606,0.27035490605427975,0.6954283190881758,1.0,20/142,11.75%,KNG1;PDGFRA;CACNA1A;IAPP;CMKLR1;EDNRA;CACNA1C;CCR1;PTGDR;TRPC6;CD36;S1PR3;DLG4;CXCR4;FKBP1B;WNT5A;DRD3;LPAR3;ATP2B1;LPAR2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4031670338709494,1.133010717439922,0.2878612716763006,0.6952646170062816,1.0,12/60,16.43%,RUNX2;TCF7L2;PTEN;SUB1;TNRC6B;CBFB;MOV10;MED13;MED15;PAXIP1;MED26;ATF7IP
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.45576938094120667,1.132582346891246,0.3055198973042362,0.6958751598164185,1.0,12/29,21.63%,ARRDC4;PLK1;ARRDC3;DCUN1D1;FBXW7;UBE2L3;TRIB3;DTX3L;FBXO5;DCUN1D5;PIN1;AXIN1
prerank,positive regulation of cell population proliferation (GO:0008284),0.36604893758900114,1.1325501119400885,0.157,0.6954237898245668,1.0,70/423,12.55%,CXCL5;IL34;WNT2;OSMR;PDGFRA;LAMB1;EDN3;YAP1;TCF7L2;PTN;MEIS2;LAMC1;STAT1;CCAR1;GAB2;TIMP1;IRS1;PDGFRB;PRTN3;FGF7;CCN4;ZFPM2;TSLP;EGFR;MEIS1;TBX2;FXN;MDK;SHH;E2F1;PTEN;BCL2;AIF1;DDR2;CACUL1;CCL5;EGF;CDK6;SFRP1;TGFB3;EAPP;PTPN6;GLP2R;S1PR3;EPHA1;HPSE;TMEM119;PID1;TERT;S1PR2;S100A6;TGFBR1;WNT5A;HDAC1;CSNK2A1;IL7;BMP5;NOP2;LIFR;TBX3;FGFR1;WWTR1;PTK2;TGFB2;GCNT2;CALR;TNF;VEGFC;FGF2;NTRK3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3925985527163524,1.1319288472639821,0.2727272727272727,0.6964717472635037,1.0,35/104,22.28%,PMEPA1;SPRED1;SMAD2;SMURF2;SPRED2;ACVR1;PPARG;HTRA3;EMILIN1;LEMD2;WFIKKN1;HTRA4;TGFBR1;SMAD5;TGFB1I1;BMPER;LDLRAD4;ACVR2A;SPRY2;SKOR2;SMAD3;SMAD4;SMAD1;SNX25;SMURF1;CHRD;TRIM33;ZBTB7A;VWC2;PIN1;BMPR1A;ASPN;RPS27A;SNX6;IL17RD
prerank,histone H3 acetylation (GO:0043966),-0.3216515976487134,-1.1317914724524762,0.2535885167464115,0.7177920989692406,1.0,17/40,17.29%,LEF1;PHF14;LDB1;JADE1;PER1;BRCA2;DR1;TADA1;JADE2;WDR5;TAF6L;NAA60;JADE3;MAP3K7;KAT6A;TRIM16;SUPT7L
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.40124997755900665,1.1314583125199835,0.2781456953642384,0.6971425542432106,1.0,30/76,24.12%,NKD2;LRRK2;PTEN;PABIR1;RNF144A;PLK1;PRICKLE1;FBXW7;RAD23A;ARIH1;PTK2;SOCS5;RNF19B;GSK3B;CSNK1A1;DDRGK1;TRIB3;TRIB1;SMURF1;ZYG11B;CSNK1D;MDM2;ARIH2;FBXO22;RNF14;AXIN1;CLU;RNF144B;RNF217;PIAS1
prerank,lysosome organization (GO:0007040),0.43518773060650157,1.131422888172739,0.3011015911872705,0.6966928141745818,1.0,7/36,14.50%,ABCA1;LRRK2;HOOK2;MYO7A;CLN6;TPCN2;GAA
prerank,signal transduction in response to DNA damage (GO:0042770),0.42261009054513893,1.131224129955602,0.29009433962264153,0.6966749788863394,1.0,15/49,19.28%,BCL3;BRIP1;BATF;E2F1;ATM;GRB2;ATR;ATRX;PAXIP1;USP28;CLOCK;ATRIP;RAD9A;HINFP;GADD45A
prerank,proteoglycan metabolic process (GO:0006029),0.46531100798801694,1.1309226348467312,0.31057563587684067,0.696890568341468,1.0,7/26,16.27%,SULF1;CHST13;HPSE;ADAMTS12;CHST11;B4GALT7;FAM20B
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.4657817126747418,1.1308766536873847,0.33197278911564626,0.6964997704010398,1.0,3/26,2.62%,C3;ADIPOQ;IRS1
prerank,regulation of cytoskeleton organization (GO:0051493),0.3839944714332409,1.1305195272478834,0.2731137088204038,0.6969318385823184,1.0,22/108,14.73%,DLC1;GPM6B;LRP1;RND3;TAOK1;SYDE1;PDGFRB;RICTOR;FSCN1;BAIAP2;RHOD;CAPN2;CDK10;ARHGEF19;EFNA5;PTK2;RHOA;GSK3B;P2RX7;ARHGAP35;PHLDB2;RAC1
prerank,positive regulation of myelination (GO:0031643),0.5346274722813515,1.1305085956741052,0.3514774494556765,0.6964255624139314,1.0,5/11,17.61%,TENM4;DICER1;EGR2;TPPP;NCMAP
prerank,positive regulation of response to wounding (GO:1903036),0.46273902463453853,1.1304359135224902,0.31053351573187415,0.6960951559249028,1.0,6/24,11.22%,PTN;MDK;ANXA1;MYLK;PTK2;VTN
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.3307469357659809,-1.1300336766872912,0.22340425531914893,0.7206526807869847,1.0,16/38,23.60%,NDUFS1;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFAF1;NDUFB6;NDUFA11;NDUFA8;NDUFB7;NDUFS3;NDUFA1;NDUFC2;NDUFA10;NDUFS2;NDUFB11
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5457017329167799,1.1299690285192583,0.3317901234567901,0.696819709569249,1.0,3/10,14.60%,LIPC;PLA2G7;PLA2G4A
prerank,limb development (GO:0060173),0.45672348244883754,1.1290465538087096,0.33289473684210524,0.6987390134458933,1.0,3/28,2.22%,KREMEN1;GLI3;CHD7
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4014300765307751,1.1285178764855193,0.2994350282485876,0.6995854640207368,1.0,5/68,3.92%,ENPP1;TCN1;MMAB;MTHFR;MTHFD1L
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.3534697174555068,-1.1283332193749354,0.3,0.72331084644596,1.0,11/27,27.89%,CHKA;PCYT2;LPIN1;SLC27A1;SELENOI;PLA2G6;NAAA;CHKB;PLAAT3;PNPLA8;ETNPPL
prerank,regulation of ATP biosynthetic process (GO:2001169),0.5037787487010501,1.1277742895178007,0.3500717360114778,0.7009589843686584,1.0,5/16,13.14%,TREM2;ANTKMT;ENO1;PID1;SPHK2
prerank,nitrogen compound transport (GO:0071705),0.37874011415576636,1.127703991175784,0.2515592515592516,0.7006116616933671,1.0,21/141,11.87%,SLC7A2;TCN1;SLC15A3;SLC6A2;SLC38A3;ARRDC4;SLC25A47;SLC7A7;MYH9;SLC38A4;SEC14L1;MIA3;LMAN2L;RAB7A;TCN2;ARRDC3;SLC36A2;SLC7A8;PDPN;RCN3;CALCRL
prerank,positive regulation of dephosphorylation (GO:0035306),0.4563847486460886,1.1271023936809894,0.31895424836601305,0.7016414641177314,1.0,10/27,20.54%,DLC1;PPP2R5A;SPPL3;CALM2;SRC;MTMR9;PTPA;ANKLE2;PIN1;PRKCD
prerank,ventricular septum morphogenesis (GO:0060412),0.45408628213140867,1.1266639864602093,0.34585492227979275,0.7021619040641817,1.0,8/27,14.44%,ROBO2;SLIT3;ZFPM2;ACVR1;HEYL;TGFBR1;TGFB2;SMAD4
prerank,mitotic nuclear division (GO:0140014),0.40093873966723653,1.1266075796469193,0.3115124153498871,0.7017881604566938,1.0,18/71,16.65%,KIFC1;SMC1A;KLHL22;CHMP4B;KIF2A;TUBG1;INO80;PLK1;STAG2;TPX2;STAG1;RHOA;CHMP7;NDEL1;TOGARAM1;CEP192;TUBG2;NCAPG2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.49350101887386627,1.1266073078994796,0.33948863636363635,0.7012573070826721,1.0,13/18,27.15%,SLC2A13;GSAP;ABCA2;ABCG1;TNF;PICALM;IFNGR1;CLU;ROCK2;RELA;CHRNA7;EFNA1;GSK3A
prerank,positive regulation of binding (GO:0051099),0.3956561458719422,1.126388658710914,0.2949561403508772,0.7012779299026792,1.0,21/84,14.58%,LRP1;TCF7L2;LRRK2;APOE;TRIM21;EGF;PPARG;DDX11;ADD2;NMD3;TERT;HMGB2;VTN;DPH3;GSK3B;SPPL3;DACT1;PSEN1;TRIB3;RPL11;DTX3L
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.5047357391738021,1.126190226960172,0.3293943870014771,0.701248357817846,1.0,9/15,21.42%,NSMAF;TNFRSF1A;TNF;ORMDL3;SPHK2;SMPD3;SIRT3;PRKCD;SAMD8
prerank,aromatic amino acid family metabolic process (GO:0009072),0.534772154161555,1.1261760686281928,0.34810126582278483,0.7007468758073161,1.0,4/10,21.05%,PCBD1;KYAT1;ATP7A;QDPR
prerank,activation of protein kinase A activity (GO:0034199),-0.39331985383530393,-1.1259634693428264,0.28160919540229884,0.727846879056492,1.0,6/16,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,endosome organization (GO:0007032),0.4293156385928347,1.1259032333432053,0.315527950310559,0.7008996071180305,1.0,16/41,20.02%,ARFGEF2;HOOK2;PI4K2B;DNAJC13;WASHC4;SNX33;EEA1;PLEKHF1;SNX10;TMCC1;CHMP2B;SQSTM1;ALS2;HOOK1;CORO1C;WASHC5
prerank,peptidyl-lysine trimethylation (GO:0018023),0.46187098732878895,1.124870602875068,0.3324538258575198,0.7030071517309042,1.0,6/26,12.02%,KMT2A;ANTKMT;OGT;SETD2;VCPKMT;TET2
prerank,mRNA stabilization (GO:0048255),0.4375406741368156,1.1245082925056071,0.31533742331288345,0.7033441519783631,1.0,5/40,7.77%,IGF2BP1;SYNCRIP;E2F1;TENT5A;TIRAP
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.45835518330076425,1.1244155499709743,0.32075471698113206,0.703073256310519,1.0,3/25,6.32%,CEMIP;XCL1;CXCL10
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5475545820282063,1.1239883179048473,0.34316770186335405,0.7036179008406624,1.0,4/11,14.53%,CYP1B1;GSKIP;STK24;PDCD10
prerank,mitochondrial protein processing (GO:0034982),0.5365754718969803,1.1239519145915413,0.3660130718954248,0.7031691021874313,1.0,5/11,14.18%,STOML2;OMA1;PMPCB;SPG7;PMPCA
prerank,regulation of DNA replication (GO:0006275),0.42401791143214373,1.123763463134272,0.31939605110336816,0.7031528630968763,1.0,18/49,21.84%,GLI2;DNA2;EGFR;EGF;BRPF3;PDS5A;ATR;ZBTB38;ANKRD17;CTC1;ACVRL1;NUCKS1;GLI1;FBXO5;WAPL;KAT7;TERF1;RBBP6
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4892853974477372,1.1237343978231753,0.33918918918918917,0.7026843901110501,1.0,6/19,14.73%,MAP4K4;NRP1;LIMS1;SFRP1;PTPRJ;RAC1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.29955512297134684,-1.1236010337999496,0.2654320987654321,0.7322665013812768,1.0,12/47,10.96%,EXOC6;STXBP6;KIF13A;EXOC6B;GOPC;GGA1;VAMP4;PREPL;ARL3;NSF;ANK3;EXOC2
prerank,regulation of intracellular protein transport (GO:0033157),0.4467008683098368,1.1232849873781066,0.3111979166666667,0.7033042895087062,1.0,9/32,18.77%,ADIPOQ;PCM1;PTPN1;LCP1;PCNT;PDCD10;NDEL1;ICE1;BCAS3
prerank,regulation of protein localization (GO:0032880),0.41114795940652354,1.122281841620893,0.31285551763367464,0.7054081188552367,1.0,11/58,10.97%,TRIML2;STX6;CTSD;TRIM21;VPS4A;RABGAP1L;BORA;FBXW7;RAB9A;WDPCP;DNAJB6
prerank,fatty acid beta-oxidation (GO:0006635),0.4135286559149491,1.1221931178061992,0.30612244897959184,0.7051126234846529,1.0,5/51,7.19%,ADIPOQ;EHHADH;ETFA;SLC27A2;ACOX1
prerank,macrophage chemotaxis (GO:0048246),0.5414737227328583,1.1221926159292963,0.34108527131782945,0.7045860035695946,1.0,2/10,10.36%,CCL5;CCL2
prerank,cellular response to interferon-beta (GO:0035458),0.5160590664426599,1.121950384729528,0.34057971014492755,0.7047024214425903,1.0,5/14,20.38%,STAT1;IRF1;UBE2K;IRGM;TRIM6
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4142052749766103,-1.1218506080591553,0.323943661971831,0.7349190275133746,1.0,6/13,20.51%,CPEB3;PABPC1;TOB1;TNRC6C;POLR2G;ZFP36
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5453846270986644,1.1216483724085515,0.3366174055829228,0.7049461038950549,1.0,2/10,8.25%,SERPINE2;ADAMTS18
prerank,regulation of protein localization to nucleus (GO:1900180),0.42529250279745284,1.12139790227144,0.3265060240963855,0.7050857178669573,1.0,17/43,19.95%,YAP1;SHH;ILRUN;PLK1;WWTR1;GSK3B;ORMDL3;DTX3L;CTNNA1;BYSL;LAMTOR5;AKT1;LATS2;EIF2AK3;MFHAS1;KAT7;PIN1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4545452032791911,1.1213785438521766,0.3320363164721141,0.7046041209326837,1.0,11/28,22.12%,TREM2;PTEN;FBXW7;PTK2;CTSC;DDRGK1;FMR1;SMURF1;PSMC6;AXIN1;CLU
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5292512362419541,1.1211082722403378,0.3766617429837518,0.7048420020988515,1.0,4/13,8.76%,ABCA1;CD36;PPARG;LPL
prerank,response to laminar fluid shear stress (GO:0034616),0.5480676487692603,1.1209918034750639,0.3508500772797527,0.7046306382740217,1.0,1/10,0.25%,ABCA1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4301905978922459,1.1209398801588841,0.33126550868486354,0.7042454881417377,1.0,12/39,16.40%,FBLN1;MAP4K4;JAG1;CASK;NF2;EFNA5;SEMA3E;GCNT2;RHOA;CX3CL1;ITGB1BP1;RASA1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.47517538180976154,1.1201141181053154,0.33558863328822736,0.7057814333605923,1.0,13/23,21.63%,CEMIP;TNKS1BP1;EGF;PLK1;RPTOR;S1PR2;UBE2K;CALM2;BMP7;MAPK1;IRGM;TRIM6;AXIN1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.47900440120693333,1.1201124953841324,0.3602391629297459,0.7052578377912692,1.0,6/18,15.12%,NCOR2;EGFR;TERT;MAP2K1;TNF;RIPK1
prerank,cellular response to hormone stimulus (GO:0032870),0.397581181772625,1.1200048274885677,0.31425364758698093,0.7050164500150912,1.0,13/69,11.60%,ZFP36L1;ROBO2;GHR;SLIT3;STAT3;ARID5A;CTSS;SFRP1;CTSL;UBE2L3;CTSB;PELP1;GCK
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.44466485814592654,1.1199268624074157,0.32459425717852686,0.7046981033934131,1.0,8/30,15.12%,TNFAIP3;CFLAR;ICAM1;BMP5;CASP8;GSK3B;TRAF2;RIPK1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.4299028608357092,1.1194179501127253,0.3170731707317073,0.7054732258888803,1.0,4/41,8.61%,CYP1B1;ACOX1;SCD5;FADS1
prerank,response to alcohol (GO:0097305),0.45110149586711334,1.1193261075721812,0.35826771653543305,0.7051920999878755,1.0,5/27,9.77%,SLIT3;SMAD2;ABCA2;TGFBR1;DRD3
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.37557582199838413,-1.1192021018233151,0.3103448275862069,0.7401507421175814,1.0,9/20,28.61%,HSP90AA1;NDUFAF1;MKKS;PSMG3;HSP90AB1;HOPX;TMEM35A;HSPA1A;PTGES3L
prerank,protein polyubiquitination (GO:0000209),0.36502480043061997,1.11858347558313,0.22868605817452356,0.7066199317418506,1.0,91/297,23.20%,PSMA7;TRIML2;DCAF15;MYLIP;FBXO40;TNFAIP3;SPSB1;HECTD2;FBXL7;CUL1;SMURF2;UBR5;BCL2;TRIM21;RNF144A;ANAPC11;SIAH2;CDC27;SKP1;SASH1;SPOP;NPEPPS;TPP2;FBXL18;FBXW7;FBXO30;AREL1;PSMB8;ARIH1;PSMA6;UBE2L3;PELI3;CBFB;UBE2R2;UBE2J1;FBXO7;RNF213;RNF19B;FBXW11;PSMF1;UBE2K;TRAF2;UBE2W;FBXO2;DTX3L;PSMA8;SMURF1;ITCH;NEDD4;TRIM56;FBXL19;PSMD2;PSMD12;PSMD11;PELI2;RBCK1;TNKS2;TRAF3IP2;TRAF5;PSMD14;RC3H2;MDM2;PSMB1;FBXW4;FBXO31;ARIH2;FBXO32;FBXO38;FBXL22;RNF135;UBE2Q1;PSMC6;UBE2E1;TRIM6;IFI27;TRIM27;FBXO22;TRIM62;RPS27A;RUSC1;RNF14;RBBP6;UBE2L6;ZNRF2;FZR1;CHFR;PSMB4;PSMB5;ANKRD39;UBE3D;RNF144B
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5356527003472114,1.1180627628626199,0.3619344773790952,0.7074342357750895,1.0,2/11,3.66%,NOS1AP;TREM2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.4160344579326294,-1.1179065449118633,0.311046511627907,0.7417717884940711,1.0,3/14,3.04%,PRKCZ;MALT1;IL18
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3684257834891756,1.117786569982295,0.26557711950970375,0.707598612036277,1.0,32/198,13.52%,ENPP1;EPHA7;LGALS13;PDXP;TAOK1;LRRK2;INPP1;PPA1;DUSP5;STAT3;GFPT2;SLC20A1;HK2;EPHX2;PTEN;PIP4K2A;ITPKC;PFKFB4;LPL;IP6K2;PANK2;PPP3CA;PLD4;PLCB3;GCK;GK;THNSL2;DUSP28;PI4KA;NUDT14;SPHK2;NUDT4
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5349413499482505,1.1177708133350452,0.35348837209302325,0.7071069540356041,1.0,4/11,17.56%,GFPT2;UAP1L1;AMDHD2;GNPDA2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.36113533962352123,-1.1176256243485538,0.2867132867132867,0.7403488793251903,1.0,4/22,1.14%,DMD;PDE4B;CACNB2;CACNB4
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.48574603279674217,1.1175790353056265,0.34691011235955055,0.7070707402698037,1.0,7/19,17.56%,GFPT2;UAP1L1;GMPPB;UGDH;AMDHD2;PMM2;GNPDA2
prerank,negative regulation of organelle assembly (GO:1902116),0.43544885623933927,1.1172834394276276,0.3238213399503722,0.707289275641945,1.0,6/35,7.63%,YAP1;LRRK2;CHMP4A;CHMP4B;TMEM39A;CDK10
prerank,dendrite self-avoidance (GO:0070593),0.4994175321807378,1.117186935186514,0.35526315789473684,0.7070075086462477,1.0,2/16,1.57%,PALLD;TNN
prerank,muscle tissue development (GO:0060537),0.49738999873065937,1.1169202536391307,0.34277198211624443,0.7071843851988227,1.0,3/13,5.10%,CSRP1;SHH;NF1
prerank,inositol phosphate metabolic process (GO:0043647),-0.3093885440334916,-1.116879232341289,0.24607329842931938,0.7402478501296944,1.0,22/46,25.34%,PLCE1;INPP4B;CALM1;PLCB4;ITPK1;INPP5D;PLCB1;IPPK;NUDT3;ISYNA1;PPIP5K1;IP6K1;SYNJ1;INPP5A;IMPA2;ITPKB;NUDT11;OCRL;PLCD4;PLCH1;INPPL1;PPIP5K2
prerank,Golgi to endosome transport (GO:0006895),0.4996437169669482,1.1159639282108933,0.3546099290780142,0.7090632446595871,1.0,6/16,13.77%,WIPI1;AP4M1;VPS13C;GBF1;EPS15;KIF16B
prerank,positive regulation of cellular respiration (GO:1901857),-0.45083390993784256,-1.1159160260772003,0.31179775280898875,0.740848802758138,1.0,8/11,47.29%,PINK1;IFNAR1;ISCU;IL10RB;IFNLR1;IL4;PRELID1;VCP
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4759264558884815,1.115717730812143,0.3462603878116344,0.7091639687141846,1.0,5/20,5.86%,ZFP36L1;MEIS2;MAFB;MEIS1;CDK6
prerank,cellular senescence (GO:0090398),0.45277770490343416,1.1154530443957162,0.352112676056338,0.7093050862975767,1.0,10/27,20.54%,CDKN2B;TBX2;MAP2K1;TBX3;CALR;SPI1;NSMCE2;SMC5;HMGA2;PRKCD
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4329272038113072,-1.1152654721615833,0.32,0.7404655287299943,1.0,8/12,34.10%,WNK3;GPD1L;ANK3;SCN4B;SCN3B;PKP2;SCN5A;AHCYL1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.37619317475606745,1.1151658599397283,0.2897196261682243,0.709571283082502,1.0,40/132,21.38%,DCN;TRIML2;LRRK2;IRS1;APOE;TRIM21;NPRL2;ARNT;PFKFB4;PTPN1;MSN;TRIM8;FOXO3;SNX33;MOV10;SNX9;PLEKHF1;TNF;GSK3B;ZSWIM8;ZBTB20;P2RX7;ORMDL3;DACT1;PSEN1;DTX3L;DXO;ITCH;HIF1A;SH3GLB1;IRGM;PLK2;TRIM6;PRKCD;PHKG2;ADAM9;TPCN1;ZC3H12A;VPS35;TRIM27
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3801408888160712,-1.1150315577793941,0.28222996515679444,0.7390303959722471,1.0,5/20,2.77%,DMD;ATP1A2;ATP1B1;ANK2;CALM1
prerank,calcium-mediated signaling (GO:0019722),0.38468693756794264,1.114878923991328,0.296137339055794,0.7097816138546577,1.0,26/93,19.18%,PPP1R9B;TNFSF11;SLC9A1;LRRK2;CACNA1C;EGFR;CCR1;RCAN2;STIMATE;CXCR4;FKBP1B;SAMD14;ATP2A2;LAT2;PPP3CA;PTPRJ;RCAN3;TPCN2;P2RX7;NUDT4;TRPM4;MCTP2;PTPRC;EIF2AK3;PRNP;IRGM
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.31816669438343376,-1.1148783944738485,0.27472527472527475,0.737294026506371,1.0,13/39,13.78%,TEK;KRIT1;CDH5;GAS6;NDNF;RAMP2;KDR;SCG2;ITGA4;GATA2;SEMA5A;ECSCR;THBS1
prerank,B cell differentiation (GO:0030183),-0.3032264353917906,-1.1143841847669913,0.23636363636363636,0.7364586634765163,1.0,13/46,17.12%,KIT;HDAC4;HDAC9;VCAM1;TPD52;MSH2;ITGA4;DNAJB9;BLNK;CEBPG;NHEJ1;GPS2;IRF2BP2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5181746496001722,1.1140943798476701,0.36722306525037934,0.7112801193098023,1.0,4/13,12.48%,MDK;AKT3;FGFR1;FGF2
prerank,positive regulation of protein binding (GO:0032092),0.41343107123883815,1.1133963378147271,0.32779097387173395,0.7125346412787563,1.0,16/56,14.58%,LRP1;TCF7L2;LRRK2;APOE;TRIM21;ADD2;NMD3;TERT;VTN;GSK3B;SPPL3;DACT1;PSEN1;TRIB3;RPL11;DTX3L
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4641088192132526,1.11302944583795,0.32882273342354534,0.7129697392201964,1.0,4/22,12.44%,MGAT5;FKBP1B;TNF;GSK3B
prerank,negative regulation of response to stimulus (GO:0048585),0.4049538621635404,1.1128476580495377,0.32560834298957125,0.7129026454881483,1.0,20/60,22.12%,COL3A1;CASK;AKT3;ACVR1;VPS13C;CDK6;PTPN1;TERT;BRAP;SOCS5;UBASH3B;GGT7;LPCAT3;MAP3K3;FBXO5;TLE5;HMGA2;YBX1;NLRP12;CLU
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3744972315173221,1.112818036093161,0.2876712328767123,0.7124487413135694,1.0,27/118,14.32%,SPARC;FMNL2;BCL6;LRRK2;TNFAIP3;EPHB3;KIF13B;NF1;SFRP1;RAP2A;PLXND1;PID1;ABI2;SDC2;GPNMB;EFNA5;INF2;SP100;RNH1;PDZD8;ZMYM4;BMPER;GSK3B;FGF2;ARHGAP35;WTIP;PHLDB2
prerank,regulation of autophagy (GO:0010506),0.36646474332528617,1.112439443928867,0.25,0.7128844413004766,1.0,55/216,18.35%,DCN;TRIML2;DAP;EIF4G2;LRRK2;EIF4G3;KLHL22;DRAM1;TREM2;STAT3;RMC1;ITPR1;BCL2;PIP4K2A;TRIM21;FOXK2;ATM;NPRL2;EXOC4;RPTOR;TRIM8;FBXW7;RRAGC;CSNK2A2;FOXO3;EXOC1;EXOC7;GAPDH;PLEKHF1;TPCN2;GSK3B;DCAF12;ATP6V1H;SNX5;ORMDL3;SMCR8;ATP6V1G2;TRIB3;DAPK2;WASHC1;MTMR9;NEDD4;PRKAB1;LAMTOR5;ATP6V1G1;SREBF1;SH3GLB1;AKT1;CTSA;GPR137;ATP6V1D;MTMR3;CPTP;USP36;LAMTOR3
prerank,mesenchyme morphogenesis (GO:0072132),0.503660905270862,1.1122338233508455,0.3682008368200837,0.712901836361109,1.0,5/17,11.44%,SMAD2;TBX2;ACVR1;HEYL;TGFB2
prerank,peptide cross-linking (GO:0018149),0.4535760771291377,1.1119035395838777,0.34010840108401086,0.713206143948971,1.0,1/25,0.36%,COL3A1
prerank,regulation of membrane depolarization (GO:0003254),0.4797807424680531,1.111846811820387,0.359375,0.712843456655958,1.0,3/18,4.72%,LRRK2;CAMK2D;PTPN3
prerank,DNA-dependent DNA replication (GO:0006261),0.37447432206647546,1.1117717186113572,0.3012684989429176,0.7125043681125394,1.0,37/128,25.08%,PSMA7;BAZ1A;POLE3;DNA2;MCM2;MCM7;PSMB8;PSMA6;DBF4;PSMF1;POLA2;LRWD1;PSMA8;POLG;PSMD2;PSMD12;PSMD11;PSMD14;PNKP;PSMB1;PSMC6;RFC1;RPS27A;TWNK;CDC7;RPA1;PSMB4;PSMB5;RAD51;CDC6;DDX21;TEFM;PSMD4;ORC4;PSMD7;PSMD9;PSMA4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.43788229052069766,1.1117531995781096,0.3579617834394904,0.7120185272844227,1.0,12/37,14.04%,CEMIP;SPRED1;TNKS1BP1;SPRED2;EGF;PLK1;RPTOR;S1PR2;SPRY2;UBE2K;CALM2;BMP7
prerank,regulation of microtubule-based movement (GO:0060632),-0.43948050925735604,-1.1115456413933098,0.31767955801104975,0.7423540620452428,1.0,9/11,43.88%,MAP2;TTC21B;LAMP1;CFAP298;DRC1;CCDC65;IGBP1;HDAC6;HAP1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.39235139255563045,-1.1114488208169357,0.3041958041958042,0.7404804507741651,1.0,9/18,20.84%,NRXN1;PRKCZ;SHANK3;CUX2;SHANK1;RIMS1;RELN;NLGN1;RIMS2
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.3313210988491932,-1.1113011585831944,0.31336405529953915,0.7387518646861092,1.0,6/30,8.96%,KIF13A;GGA1;VAMP4;PREPL;NSF;ANK3
prerank,rRNA methylation (GO:0031167),0.473932980785714,1.1112300901452943,0.32816901408450705,0.7129453308782162,1.0,6/22,12.24%,METTL15;METTL16;MTERF4;NOP2;MRM1;MRM2
prerank,icosanoid metabolic process (GO:0006690),0.42159674564068933,1.111011770585596,0.34963325183374083,0.7129833982190155,1.0,6/40,14.60%,CYP1B1;DPEP2;FADS1;ABCC1;TBXAS1;PLA2G4A
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3928284894737843,1.110991285048956,0.3172645739910314,0.7125108827665407,1.0,21/78,18.76%,CLTC;LRP1;MMP14;NKD2;EGFR;TREM2;VPS4A;PID1;ITGA3;PPP2R5A;PTPN9;TNF;NUMB;KIF5B;PIK3R1;STAC3;SQSTM1;AKT1;PICALM;CLIP3;SPTBN1
prerank,"phototransduction, visible light (GO:0007603)",-0.4183281634751138,-1.1108984709991834,0.32371794871794873,0.7378442868133784,1.0,5/14,26.73%,ABCA4;GNA11;RP1;SAG;PDE6A
prerank,cilium-dependent cell motility (GO:0060285),0.45797971437966223,1.110840600765012,0.35020519835841313,0.7123942351070485,1.0,1/22,0.46%,TEKT4
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4731356350257213,1.1105520579308974,0.3633916554508748,0.7126008193619255,1.0,7/23,13.46%,CBLB;ERRFI1;CBL;MVP;SOCS5;ZGPAT;SH3BP5L
prerank,regulation of protein localization to cell surface (GO:2000008),0.4437336161111878,1.1104894710704627,0.3427835051546392,0.7122303071879021,1.0,8/33,12.29%,GPM6B;TM9SF4;TAX1BP3;ABCA2;EGF;GBF1;SNX33;TNF
prerank,regulation of isotype switching (GO:0045191),0.5032606272485288,1.1104104066622833,0.3387815750371471,0.7119054652850662,1.0,5/14,18.69%,PARP3;SHLD3;RIF1;PAXIP1;HMCES
prerank,negative regulation of viral genome replication (GO:0045071),0.4272528763149465,1.110260343800651,0.33540372670807456,0.7117866358744248,1.0,14/40,20.62%,TNIP1;ILF3;SHFL;CCL5;EIF2AK2;OASL;SETDB1;TNF;RESF1;TASOR;HMGA2;PLSCR1;TRIM6;ISG15
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5344607060082314,1.1100699039913011,0.35930047694753575,0.7117699363639812,1.0,6/10,25.00%,DISC1;CX3CL1;KDM1A;SMARCD3;FZD3;VEGFA
prerank,response to glucagon (GO:0033762),-0.37300789874092377,-1.1093637642999021,0.3022508038585209,0.7399260099514107,1.0,6/19,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5384222737500299,1.1091038391774306,0.3604294478527607,0.7137030919206576,1.0,3/10,15.12%,LRRK2;NFE2L2;RIPK1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.4355148892161863,-1.1090999541912492,0.32558139534883723,0.7385092526191622,1.0,4/12,31.18%,RBP4;TLR4;NOD2;SOX9
prerank,neuron cell-cell adhesion (GO:0007158),0.5048766794523809,1.1090052934307708,0.365296803652968,0.7134423098924696,1.0,2/14,5.08%,CEL;ASTN2
prerank,mitochondrion distribution (GO:0048311),0.5280237120544851,1.1087054928709017,0.3614088820826952,0.7137023866540692,1.0,2/12,4.41%,LRRK2;TRAK1
prerank,chromatin organization (GO:0006325),0.37472462612491664,1.1083900700827845,0.31048805815160957,0.7140077635336861,1.0,36/132,18.67%,SNAI1;SATB2;BAZ1A;PADI2;PHF1;SMARCC1;BAZ2B;INO80;DDX11;EHMT1;PWWP3A;TADA2B;HDAC1;SETD2;MTA2;HMGB2;BRWD1;SETDB1;RSF1;RUVBL1;SAFB;SETDB2;SPI1;LRWD1;ATRX;HMGN3;MYSM1;BAZ2A;TCF7L1;SMARCA4;HMGN1;HCFC2;NUCKS1;HDAC5;SOX2;ZBTB7A
prerank,regulation of macrophage migration (GO:1905521),-0.46166467391873595,-1.1081547052259075,0.34545454545454546,0.7390565162556051,1.0,3/10,5.87%,CD81;MTUS1;CD200
prerank,cortical cytoskeleton organization (GO:0030865),0.42112537414146767,1.1080402144584967,0.3478802992518703,0.7143686489307234,1.0,18/41,23.43%,RND3;FMNL2;FMNL3;FHOD3;RHOD;LLGL1;LCP1;RHOA;TNF;RAC1;RHOF;PLEK;EPB41L3;DLG1;RHOC;ROCK2;ROCK1;STRIP1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4293398212630908,1.107693718308965,0.3359173126614987,0.7147415204898103,1.0,16/35,21.63%,PMEPA1;YAP1;ZMIZ1;PADI2;UBR5;DDX17;SAFB;SRC;NEDD4;CALCOCO1;RBFOX2;NR3C1;MED1;TMF1;TADA3;RNF14
prerank,regulation of cellular respiration (GO:0043457),-0.3881605235670039,-1.1076526142031786,0.31761006289308175,0.7383462801800157,1.0,5/17,16.84%,PRDM16;CBFA2T3;IDE;NOP53;IFNAR1
prerank,muscle organ development (GO:0007517),0.41041271746833624,1.10763420533329,0.3241695303550974,0.7143831603851323,1.0,9/54,11.95%,LAMA2;COL6A3;EGR3;TCF12;CXCL10;FHL3;ITGA11;CHD2;UTRN
prerank,cell cycle G2/M phase transition (GO:0044839),0.37781728938629866,1.1074047326286982,0.29707112970711297,0.7144080303194267,1.0,33/129,17.67%,DYNLL1;CDKN2B;FBXL7;DYNC1H1;CUL1;KHDRBS1;TUBG1;ALMS1;CDK14;PLK1;PCM1;HAUS3;SKP1;CEP41;CNTRL;PHLDA1;DCTN3;BORA;PCNT;PPP2R2A;CCNB2;CDK7;CEP72;PPP1CB;FBXW11;PPME1;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;TAF2
prerank,DNA recombination (GO:0006310),0.42230429301823447,1.1073302685212698,0.32589838909541513,0.7140878612061442,1.0,4/37,10.03%,RAD51B;RAD52;XRCC3;FBH1
prerank,dendritic spine morphogenesis (GO:0060997),0.4998623372566025,1.1071022732212146,0.368575624082232,0.7141539846897658,1.0,4/15,7.01%,EPHB3;PTEN;CDC42;DLG4
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.44709727760126944,-1.1070083055870832,0.33707865168539325,0.7380095135572803,1.0,8/10,42.16%,WWP2;NDFIP2;CORO2B;NDFIP1;MAPT;SNX12;PPM1F;DNAJA1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.49689549115559817,1.106650737762382,0.3554301833568406,0.71478735255728,1.0,3/16,4.56%,SLC9A1;PRKCA;CAMK2D
prerank,import into cell (GO:0098657),0.43018285246918386,1.1062807336636367,0.33785450061652283,0.7152293699092315,1.0,5/41,3.66%,SLC39A14;SLC1A3;SLC11A2;SLC12A4;TREM2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.4005613195689845,-1.1060920250807895,0.32247557003257327,0.73847987069432,1.0,8/16,31.18%,ERLIN1;ACADL;ERLIN2;ACADVL;SIRT4;BRCA1;CEACAM1;SOX9
prerank,plasma membrane organization (GO:0007009),0.3994840372500041,1.10604174026682,0.32479627473806755,0.7153267392317688,1.0,17/61,18.76%,PLSCR5;COL5A1;UGCG;CHMP4A;MYH9;TLCD2;EHD2;CXCR4;SNX33;SNX9;BIN3;P2RX7;PLSCR4;ANXA6;ANO6;EPB41L3;SPTBN1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3653137907325899,1.1060324341460757,0.2842535787321063,0.7148380998376576,1.0,32/199,13.10%,NR1H4;ADIPOQ;PARP3;TBX18;TIMP1;SPRED1;EGFR;MDK;SHH;LAMA4;SPRED2;PTEN;ADM;PAEP;ADAMTS5;SFRP1;SFMBT1;ARRDC3;GPNMB;PLCL1;CHSY1;BMP5;ACOT13;PTPN23;LDLRAD4;ATP2B1;CALR;SPRY2;TNF;GSK3B;ACVR1C;SPI1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4120900333616606,-1.1060073742410428,0.32303370786516855,0.7366436804098224,1.0,7/15,30.07%,HNRNPA1;DHX36;MKNK2;PPIF;GSTO2;ATF3;HSF1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.5047851871275777,1.1059707611534937,0.36578171091445427,0.7144780668547466,1.0,2/15,5.97%,ADIPOQ;PPARG
prerank,actin filament network formation (GO:0051639),0.531629883712221,1.1057453530189718,0.3941267387944359,0.7145655391339396,1.0,4/11,8.76%,FHOD3;CARMIL1;SPIRE1;LCP1
prerank,microtubule bundle formation (GO:0001578),0.4097679041793385,1.105736734603569,0.33045622688039455,0.7140755711184519,1.0,9/42,17.61%,NAV1;MAP1S;NCKAP5;PLK1;NCKAP5L;TOGARAM1;TPPP;KIF20A;CFAP74
prerank,neuron projection development (GO:0031175),0.3692973814969633,1.1053004853771868,0.30093071354705275,0.7146584236612908,1.0,33/168,12.49%,GAS7;GPM6B;LAMB1;PPP1R9B;MAP4K4;TAOK1;LRP12;ATXN10;LRRK2;EPHB3;APOE;BLK;MAP1S;PTEN;OPHN1;DTNBP1;IFT88;CDC42;DLG4;TAOK3;VAPA;DCLK1;L1CAM;TRIO;DICER1;SAMD14;DBN1;NRK;DBNL;PTPRM;CAMSAP2;GSK3B;MICALL2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3606946453414152,1.1052402051022372,0.22937625754527163,0.7142988172197894,1.0,76/341,17.75%,PSMA7;RNF150;MYLIP;KCTD21;TNFAIP3;SPSB1;KLHL22;FBXL7;USP9X;MAD2L1;SMURF2;UBR4;CNOT4;APPBP2;RNF144A;PLK1;ANAPC11;SIAH2;MIB1;CDC27;VPS4A;TOM1L1;BAG6;RNF111;SPOP;TRIM13;CBL;FBXW7;AREL1;PSMB8;RAD23A;ARIH1;NTAN1;PSMA6;TBL1X;RAD23B;UBE2L3;TGFB1I1;VPS37C;UBE2R2;PTPN23;DCAF11;FBXO7;NFE2L2;RNF213;KCTD10;RNF19B;FBXW11;ZSWIM8;PSMF1;RNF149;UBE2K;MAEA;UBE2W;RNF11;DTX3L;PSMA8;SMURF1;ITCH;NEDD4;FBXL19;PSMD2;PSMD12;SQSTM1;KLHL25;PSMD11;RBCK1;CLOCK;PCNP;PSMD14;KCTD2;RC3H2;DDB1;MDM2;PSMB1;FBXW4
prerank,positive regulation of fat cell differentiation (GO:0045600),0.41577509675808705,1.1050203769582647,0.33616504854368934,0.714329360910583,1.0,15/47,19.13%,ZFP36L1;CMKLR1;FRZB;ASXL2;SFRP1;PPARG;VSTM2A;CARM1;LPL;WDFY2;BMP7;TRPM4;AKT1;AAMDC;LRP5
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3942446851902926,1.104682416389111,0.3202247191011236,0.7146371436251403,1.0,17/70,15.26%,CASP8AP2;JAK2;SIVA1;BAG3;BCL2;BCL2L2;ACVR1B;TNFRSF1A;TGFB2;CASP8;TNF;GSK3B;P2RX7;TRAF2;SMAD3;RIPK1;IL6R
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3603901663239318,1.1046515089052313,0.25425425425425424,0.7142179577843927,1.0,101/366,21.97%,RORA;RUNX3;POU5F1;CXXC1;SBNO2;ATXN1;CCAR1;CHD7;BACH1;GON4L;MAFB;SNAI2;ATXN2;MITF;SUFU;PRRX2;STAT3;SOX21;E2F1;PHF1;MYBL1;PRDM2;FOXK2;CREBBP;YAF2;AHR;TOM1L1;BHLHE40;CARM1;CCAR2;BTG1;FADS1;TGFBR1;NONO;FOXO3;ZBTB38;UBE2L3;TGIF2;ACVR1B;TCF7;WWTR1;FOXN2;LIN54;TGFBRAP1;CALR;SP3;ANKRD17;SPTY2D1;ZSCAN21;NAB2;SKOR2;NSD3;NFKB2;SPI1;ATRX;DRAP1;WTIP;BAZ2A;NOLC1;BNC2;PATZ1;HIF1A;PHF12;NUP35;NSD1;NFXL1;CLOCK;TCF7L1;TCF3;ACVRL1;ZFHX3;HCFC2;NUCKS1;MZF1;ATF4;NR2C2;SOX2;FBXO5;HINFP;KAT6B;NR3C1;TULP3;DVL2;THAP7;RPL6;KAT7;RBAK;HMGA2;RBM4B;NUP107;VHL;HINT1;MAGED1;NR1D2;RNF14;YBX1;ZNF423;RBBP6;RPS6KA4;CREM;NFIL3
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5011029244500277,1.10464285203316,0.37019969278033793,0.7137346883263398,1.0,3/13,15.60%,EMILIN1;PTPN1;NEDD4
prerank,regulation of lymphocyte migration (GO:2000401),0.5366360471822353,1.1045879108064405,0.3762541806020067,0.7133515984951644,1.0,3/10,8.23%,SPN;MIA3;MSN
prerank,cell-cell junction maintenance (GO:0045217),-0.4288062489852409,-1.1045336184807035,0.335978835978836,0.7385622436858027,1.0,1/11,0.05%,TJP1
prerank,heterochromatin organization (GO:0070828),0.5005233927628662,1.1040852454704058,0.3783783783783784,0.7140989803893836,1.0,5/14,12.13%,SNAI1;POLE3;BAHD1;SETDB1;SETDB2
prerank,gluconeogenesis (GO:0006094),0.4206356127667983,1.1038854362279187,0.353584447144593,0.7140396119015109,1.0,3/39,10.28%,SLC39A14;ENO1;GAPDH
prerank,calcium ion transmembrane transport (GO:0070588),0.38530423448076245,1.1037898385708296,0.3296582138919515,0.7137585759236503,1.0,22/86,18.80%,MCOLN2;CACNA1A;STOML2;CACNA2D1;CACNA1C;PKD2;TRPC6;SLC24A5;PMPCB;ATP2A2;ATP2B1;MICU2;SPG7;P2RX7;PMPCA;TRPM4;MCUR1;ORAI1;MAIP1;ANO6;TRPC4AP;MICU3
prerank,regulation of intracellular signal transduction (GO:1902531),0.3584501343435036,1.1034221511897058,0.209,0.7141695160311545,1.0,104/420,17.67%,DLC1;BCL3;MAP4K4;TAOK1;SYDE1;TNFSF11;VAV2;ARHGAP15;CMKLR1;RHOJ;LRRK2;BRIP1;ARHGAP24;VAV3;BIRC3;DNA2;SPRED1;ARHGAP32;EGFR;KALRN;PIP5K1B;NUAK1;TREM2;RICTOR;ITSN1;KMT5A;PTPN13;PTEN;PRKD2;RHOD;PIP4K2A;OPHN1;TAF7;FGD4;NF2;ATP6AP2;ATM;SRGAP1;CDC42;EHMT1;NOC2L;ARHGDIG;TAOK3;RASSF2;MAPKAP1;MAPK11;PRKAR1B;ARHGEF19;RRAGC;ATR;TRIO;WNT5A;HDAC1;CSNK2A1;CSNK2A2;TPX2;PRDM1;ARHGEF12;MTA2;NOP2;TTI1;PREX1;FAM13B;GNAI1;NRK;RCN3;RHOA;VAV1;PJA2;TNF;ARHGAP6;NTRK3;AKAP13;RASD2;TRAF2;BRPF1;SPHK2;GPAT3;ARHGAP22;RMI1;ARHGEF18;ARHGAP35;DAPK2;TAF4;RPL11;RAC1;BANP;RHOF;PRKAB1;DEPDC1B;SQSTM1;STK4;ARHGAP9;ATRIP;TRAF5;ARHGDIA;GNA12;MAPK1;AKT1;PHF20;ING5;MDM2;RAD9A;TAF2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4701791826916562,1.103282301343513,0.345679012345679,0.7140487132801209,1.0,2/24,2.43%,CREB3L1;LRRK2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.372042598874751,-1.1032507807542486,0.31543624161073824,0.7399795049265281,1.0,5/18,10.35%,CHRM2;PLCB1;AGRN;GNA11;GRK2
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.469703025029707,1.1030515242489745,0.36541143654114366,0.7141218830806735,1.0,1/20,0.48%,ADIPOQ
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.46639454905775424,1.1030435616913383,0.367911479944675,0.7136392478794896,1.0,4/21,12.48%,MMP2;IGFBP5;ADAMTS1;FGF2
prerank,regulation of postsynapse organization (GO:0099175),-0.33921510720818565,-1.1026451364253296,0.2869198312236287,0.7395335939880253,1.0,13/28,20.52%,EPHA4;TANC2;IL1RAPL1;SRCIN1;SHANK3;CDKL5;ARHGAP44;PDLIM5;ZDHHC15;ABI3;KIF1A;CFL1;PPFIA2
prerank,amyloid precursor protein metabolic process (GO:0042982),0.48624007152529003,1.102084012330513,0.365819209039548,0.7155186208972981,1.0,8/18,22.85%,ADAM19;APOE;ABCG1;PSEN1;PSENEN;NCSTN;PSEN2;TMCC2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.46993212738244267,1.1019982205203225,0.36941813261163736,0.7152189694417002,1.0,2/20,3.24%,C3;CASP1
prerank,establishment of spindle localization (GO:0051293),0.508258102458964,1.1015971946173637,0.39097744360902253,0.7157252083247057,1.0,7/14,27.10%,DYNC1H1;LLGL1;ZBED3;MAP4;KPNB1;CLASP2;CLASP1
prerank,cell junction organization (GO:0034330),0.3922954795345354,1.1011601671760647,0.3340782122905028,0.7163143216648662,1.0,20/71,14.48%,VMP1;FLNC;SDK2;PPFIBP2;OPHN1;LIMS1;TGFB3;CDC42;RAB8B;L1CAM;PPFIBP1;SEMA3E;TGFB2;FBLIM1;RHOA;SDK1;ELFN1;SMAD3;PSEN1;PPFIA4
prerank,positive regulation of gene expression (GO:0010628),0.3549356199916782,1.1010158455236243,0.227,0.7161796418642841,1.0,98/442,18.23%,GLMN;RBMS3;PRR16;ITGB8;SEC16B;BCL3;ADAM19;YAP1;SFRP4;NOS1AP;CRP;TLR2;FGF7;BATF;MITF;PLD1;EGFR;TAF1D;TLE1;TREM2;STAT3;E2F1;PHF2;UBR5;EPHX2;LGALS9;PLA2R1;LIMS1;CD36;POLR1E;EGF;DTNBP1;ATM;EIF2AK2;VSTM2A;EMILIN1;TMEM119;PID1;FUBP1;SAMD4A;ANGPT1;MAPK11;MSN;CELF1;TNRC6B;NIBAN1;TGFBR1;MAP2K1;WNT5A;RPS6KB1;GAPDH;NAT10;MOV10;NFE2L2;DNMT3B;SPRY2;TNF;GSK3B;FGF2;NTRK3;P2RX7;SPHK2;PIK3R1;DDRGK1;CTCF;SMAD3;PSEN1;POLR1B;BMP7;YTHDF3;FMR1;TAF1A;RPL11;PDCD10;RIPK1;SETX;SMAD1;SMO;HIF1A;FGF18;MED26;PRKAB1;PRKDC;POU3F3;LAMTOR5;OLFM1;MAPK1;AKT1;CALCOCO1;EIF2AK3;ATF4;ETS1;POLR2L;INHBA;PLXNB2;POLR2K;AGT;RBPJ
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5463199705043584,1.1010070978878288,0.3801261829652997,0.7156954381146973,1.0,3/10,10.36%,TLR2;JAK2;CCL2
prerank,positive regulation of transmembrane transport (GO:0034764),0.5161950580252316,1.1008965135918063,0.36459909228441756,0.7154866002210549,1.0,6/13,17.93%,C3;P2RX7;AZIN2;ANO6;ACSL5;CLIP3
prerank,determination of bilateral symmetry (GO:0009855),0.4540689134370819,1.1007778056710096,0.36797752808988765,0.715293145881474,1.0,5/24,11.12%,DNAAF4;PKD2;DNAH11;GALNT11;NPHP3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4265611362869222,1.10056412028227,0.34512195121951217,0.7152938391966172,1.0,10/38,15.12%,TNFAIP3;CFLAR;SFRP1;ICAM1;SP100;BMP5;CASP8;GSK3B;TRAF2;RIPK1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.428740200297244,1.1003662314059233,0.35544430538172717,0.7152507607373281,1.0,12/36,18.59%,BRIP1;DNA2;E2F1;ATM;ATR;SETMAR;TIMELESS;USP28;CLOCK;ATRIP;RAD9A;HINFP
prerank,inner dynein arm assembly (GO:0036159),0.5454259707438575,1.1003152051900538,0.37012987012987014,0.7148750312779484,1.0,2/10,13.37%,DNAAF4;DNAAF5
prerank,response to retinoic acid (GO:0032526),0.39922550998155826,1.1001616724949281,0.3453488372093023,0.7147671010887302,1.0,11/59,15.71%,WNT2;ASXL1;GATA6;WNT9A;RXRG;ATM;WNT5A;TMEM161A;PTK7;SETX;ADNP2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4644315573593875,-1.1001005252557097,0.3723404255319149,0.7424891789430104,1.0,4/10,12.44%,NFATC1;NFATC2;PPP3CB;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.4644315573593875,-1.1001005252557097,0.3723404255319149,0.7424891789430104,1.0,4/10,12.44%,NFATC1;NFATC2;PPP3CB;NFATC3
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3643630613869147,1.099943172065207,0.30635245901639346,0.714816136151599,1.0,40/166,18.10%,PRR16;ZEB2;BCL3;GLI2;NOS1AP;IRS1;PDGFRB;DNA2;PLD1;EGFR;PRKD2;PKD2;CD36;CCL5;EGF;BRPF3;ARNT;SAMD4A;NMD3;NIBAN1;RPS6KB1;SLC25A37;NAT10;PTPN2;GCK;TNF;FGF2;GIPC1;SMAD3;CTC1;YTHDF3;FMR1;HIF1A;PRKDC;SREBF1;AKT1;DDB1;GLI1;ATP7A;PLXNB2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.38098010778876484,-1.0998685319333923,0.3257328990228013,0.741051722149925,1.0,4/17,4.05%,ATP1A2;CACNB2;ANK2;KCNJ2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.37874992232358784,1.099152217918231,0.3402173913043478,0.7163054929197905,1.0,17/91,16.67%,SLC39A14;HEPH;CP;SLC11A2;FXN;CUL1;ACO1;SKP1;SLC22A17;SLC31A1;IREB2;ARF1;SMAD4;FRRS1;SLC39A6;SLC30A9;ATP6V1G1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.5435426037870668,1.0991483060341853,0.38801261829652994,0.7158106648445957,1.0,2/10,5.59%,PDXP;CARMIL1
prerank,potassium ion export across plasma membrane (GO:0097623),0.5147306140047271,1.0990466648499366,0.36560693641618497,0.7155644753939702,1.0,2/13,4.90%,KCNT2;KCNA5
prerank,positive regulation of cellular metabolic process (GO:0031325),0.37994073752997126,1.098533743253113,0.3304812834224599,0.7163325725907903,1.0,27/98,21.08%,ADIPOQ;SFRP4;PDGFRB;DHRS4;APOE;CCL5;EGF;PPARG;PID1;ANGPT1;GRB2;RAB1A;FMR1;CD63;RIPK1;AKT1;INHBA;PAX8;AGT;NFKBIA;XDH;ACACA;FASN;GADD45A;DCXR;EIF4G1;ZC3H12A
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5042046281343782,1.0984688550502437,0.3473684210526316,0.716012867340456,1.0,2/13,5.97%,POU5F1;PPARG
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.47311866422888027,1.0981608536416478,0.3746397694524496,0.7163332118919283,1.0,2/17,2.74%,SNAI1;SNAI2
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5238319867103629,1.0980376324136212,0.3869047619047619,0.716146486434369,1.0,5/12,13.25%,ACO1;ACO2;IDH2;IREB2;IDH3B
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.4340843779043436,1.0979928419971392,0.34889753566796367,0.7157713269922669,1.0,11/32,20.54%,DLC1;PDGFRB;PPP2R5A;DUSP26;SPPL3;CALM2;ITGA1;PTPA;ANKLE2;PIN1;PRKCD
prerank,negative regulation of cell aging (GO:0090344),0.4933069674124927,1.0979427210503396,0.36546762589928056,0.7153860166888184,1.0,7/16,21.73%,AKT3;CDK6;TERT;MAP3K3;FBXO5;HMGA2;YBX1
prerank,regulation of vasoconstriction (GO:0019229),-0.3443985554057277,-1.097058524760457,0.3026315789473684,0.7468351338614471,1.0,11/27,20.39%,CAV1;ADRA1B;BDKRB2;AGTR1;ADRA1A;ZDHHC21;PER2;ACE;TBXA2R;CHRM3;ACE2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4415825173128454,1.0970465732293007,0.3716577540106952,0.7171216315274389,1.0,4/26,6.56%,NEK6;PLK1;ANAPC11;CDC27
prerank,regulation of synapse assembly (GO:0051963),0.41023757615213124,1.0967666634481938,0.36114421930870083,0.71728731901835,1.0,6/46,3.57%,ROBO2;MDGA1;TLR2;SLIT1;GPC6;EPHB3
prerank,hepaticobiliary system development (GO:0061008),0.4673459967428029,1.0963147104977855,0.34540389972144847,0.7179498283030739,1.0,5/20,5.10%,PRKCSH;ARID5B;PHF2;PKD2;NF1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3901543527553723,1.096303406822191,0.3528748590755355,0.7174775065410006,1.0,26/73,23.73%,GLMN;TAF1D;CGGBP1;PHF1;PHF2;POLR1E;DNMT3B;SPI1;SPHK2;CTCF;POLR1B;TAF1A;TFAP2C;PPHLN1;POLR2L;POLR2K;HDAC5;TASOR;POLR1G;TRIM27;SUZ12;POLR1A;PPM1D;DDX21;BAZ1B;MPHOSPH8
prerank,regulation of cholesterol transport (GO:0032374),0.46540529962356214,1.0962982532948933,0.35555555555555557,0.7169959130820492,1.0,2/20,4.25%,LRP1;ABCA2
prerank,histone H3-K4 trimethylation (GO:0080182),0.5217303427821193,1.0960512042695156,0.3626707132018209,0.7171711485113842,1.0,3/11,12.02%,KMT2A;OGT;TET2
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.35359950523730943,-1.0957172449035524,0.30798479087452474,0.7485038580757876,1.0,9/25,22.10%,PRPSAP2;PAICS;PRPSAP1;ADK;GMPR;DCK;PRPS1;PRPS1L1;APRT
prerank,hexose biosynthetic process (GO:0019319),0.41154722922164433,1.09570736597679,0.35568862275449104,0.7175196270501016,1.0,7/42,18.57%,SLC39A14;ENO1;GAPDH;SLC25A10;ATF4;SORD;CHST15
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3586908061190192,-1.0955576046127937,0.29553264604810997,0.7467981322397227,1.0,9/21,21.95%,PPP1R16B;YWHAB;ARPP19;TIPRL;PPP1R8;FKBP1A;CRY2;MASTL;STYXL1
prerank,negative regulation of vascular permeability (GO:0043116),0.5174628374360778,1.0954907538341632,0.35248447204968947,0.7175619329548396,1.0,3/12,10.88%,PDE3A;ANGPT1;PTPRJ
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.48440844294574936,1.0950506290314783,0.3645680819912152,0.7181415960551336,1.0,6/16,16.13%,PIGW;PIGN;PIGL;PIGC;PIGP;PIGH
prerank,positive regulation of protein phosphorylation (GO:0001934),0.35675088652960085,1.094918830345867,0.2577733199598796,0.7179657691294586,1.0,102/348,22.52%,C3;CEMIP;IL34;ADIPOQ;THBS4;TEC;GHR;JTB;LRRK2;CD40;FGF7;JAK2;NRP1;TNKS1BP1;EGFR;TREM2;LCP2;PRKD2;DDR2;ACVR1;FAM20A;CACUL1;EGF;CCND3;RAP2A;TGFB3;PLK1;INHBB;TOM1L1;TMEM119;RASSF2;RPTOR;ANGPT1;GPNMB;S1PR2;EFNA5;NIBAN1;TGFBR1;BMP5;FBH1;FNIP1;PTPRJ;PTK2;SNX9;VTN;TGFB2;ACVR2A;SPRY2;TNF;VEGFC;FGF2;NTRK3;UBE2K;DDRGK1;ITGA5;WDFY2;CALM2;BMP7;SRC;AKAP9;FMR1;SMAD4;PDCD10;RAC1;CX3CL1;RIPK1;IL6R;FGF18;ALS2;STK4;PELI2;ACVRL1;CSNK1D;PTPRC;MAPK1;AKT1;CLIP3;INHBA;AGT;CDK9;AXIN2;PRNP;DVL2;IRGM;PIN1;GDF9;GDF11;EIF4G1;TRIM6;BMPR1A;MMD2;NPTN;AXIN1;VEGFB;PAK1;RPS6KA4;RAF1;LATS1;CSF1;SDCBP;ROCK2;CD80
prerank,carbohydrate homeostasis (GO:0033500),0.3817571546457996,1.0936605530281824,0.35625704622322435,0.7206564424713816,1.0,7/67,5.97%,ADIPOQ;TCF7L2;IRS1;USF1;STAT3;PYGL;PPARG
prerank,L-glutamate transmembrane transport (GO:0015813),0.5315906444979914,1.0933950252056766,0.38975155279503104,0.7208404200332552,1.0,1/10,0.63%,SLC1A3
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4602175376684021,1.0933571565452536,0.36693548387096775,0.7204310923668956,1.0,6/23,15.66%,MAD2L1;PLK1;GPSM2;INSC;FBXW11;NDEL1
prerank,keratan sulfate metabolic process (GO:0042339),0.44183885578014476,1.0933258702409747,0.35868187579214195,0.7200237386656646,1.0,10/31,15.44%,LUM;B4GALT5;ST3GAL3;PRELP;GALNS;ST3GAL1;CHST1;GNS;SLC35D2;B4GALT2
prerank,C4-dicarboxylate transport (GO:0015740),-0.39566282837489786,-1.0929962132003281,0.32621951219512196,0.7519185130738013,1.0,4/14,11.25%,LRRC8D;SLC1A2;SLC1A1;SLC25A12
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3807829533009315,-1.092973998874426,0.3465346534653465,0.7499277200271058,1.0,4/16,11.13%,SNCAIP;MCTP1;CPLX1;RIMS1
prerank,sympathetic nervous system development (GO:0048485),0.49812203730425697,1.0926108350873733,0.3733528550512445,0.7212922429201175,1.0,2/15,5.10%,NRP1;NF1
prerank,ganglioside biosynthetic process (GO:0001574),-0.39725202816728883,-1.092483339425108,0.30340557275541796,0.7492016614867928,1.0,7/15,12.49%,ST6GALNAC3;ST8SIA4;ST3GAL5;ST8SIA6;B4GALT6;ST8SIA2;ST6GALNAC5
prerank,positive regulation of interleukin-10 production (GO:0032733),0.43887650126876177,1.0919653568262875,0.3654353562005277,0.7223837743960486,1.0,4/30,5.04%,XCL1;TSLP;STAT3;LGALS9
prerank,cytosolic transport (GO:0016482),0.37717598031943667,1.0918186567596342,0.33620689655172414,0.7222579141544575,1.0,36/108,22.68%,CLTC;HEATR5A;AP4M1;STX6;TMEM87B;HOOK2;VPS13C;MYO1D;RAB7A;GOSR1;GBF1;RAB9A;ANKFY1;GAK;PTPN23;EEA1;DENND5A;SNX2;EPS15;SNX5;ANKRD27;KIF16B;TBC1D10B;WASHC1;PIK3C3;HOOK1;SYS1;BECN1;VPS35;TRIM27;SPAG9;GOSR2;RAB5A;SNX6;CORO7;SNX1
prerank,renal water homeostasis (GO:0003091),-0.3444323684111716,-1.0917893085104653,0.3176895306859206,0.7489655647355884,1.0,6/23,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3081217965256408,-1.0914375027617425,0.26288659793814434,0.747912818580697,1.0,18/39,27.43%,FGF12;FHL1;ANK2;WWP2;FXYD5;WNK3;GPD1L;FXYD6;CHRM3;SCN4B;FXYD1;NEDD4L;TCAF2;SCN3B;PPIF;CACNA1D;YWHAH;PHB2
prerank,O-glycan processing (GO:0016266),0.4039671129288798,1.09137849710088,0.3621683967704729,0.7228448145256829,1.0,7/54,11.10%,B4GALT5;ST6GAL1;GALNT3;ST3GAL3;GXYLT2;ST3GAL1;GALNT11
prerank,chromosome organization (GO:0051276),0.3713500353163314,1.090945151302151,0.35974304068522484,0.7234161605746879,1.0,35/99,23.70%,TCF7L2;POLE3;MTHFR;PADI2;PHF1;RAE1;EHMT1;PWWP3A;BAHD1;HDAC1;RAD23B;HMGB2;BRWD1;TOP2B;SAFB;LRWD1;HMGN3;COPS6;TCF7L1;SMARCA4;HMGN1;NUCKS1;DDB1;HDAC5;SOX2;ZBTB7A;AXIN2;HMGA2;COPS3;RPS27A;LATS1;ACTL6B;MSH6;DOT1L;HDAC8
prerank,neural crest cell differentiation (GO:0014033),0.4729259821501523,1.0908111487405505,0.3713450292397661,0.7232807274161136,1.0,4/18,14.87%,SNAI2;LRP6;TAPT1;NOLC1
prerank,positive regulation of viral process (GO:0048524),0.3951518431590219,1.0904678386567297,0.35555555555555557,0.7236244694481464,1.0,19/60,19.93%,MDFIC;TMEM39A;PPID;CCL5;VPS4A;RAB7A;RAD23A;GTF2F2;RSF1;STAU1;GTF2F1;CCNT1;TBC1D20;DDB1;POLR2L;POLR2K;CDK9;TYRO3;KPNA2
prerank,positive regulation of protein modification process (GO:0031401),0.359674832535584,1.090356478128497,0.32284263959390863,0.7233993741049426,1.0,46/203,17.93%,DLC1;C3;IL34;ADIPOQ;TAOK1;NOS1AP;LRRK2;CD40;FGF7;EGFR;TREM2;FAM20A;CCND3;RAP2A;TMEM119;ANGPT1;GPNMB;EFNA5;NIBAN1;FAM161A;RAB3GAP2;FBH1;PPP2R5A;FNIP1;PTK2;ACVR2A;ATG7;TNF;VEGFC;FGF2;NTRK3;SPPL3;RAB3GAP1;WDFY2;CALM2;FMR1;RAC1;RIPK1;FGF18;STK4;PELI2;CSNK1D;PTPA;AKT1;ANKLE2;CLIP3
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5314649417361135,1.090266120279622,0.39398496240601505,0.723111556661685,1.0,2/11,6.40%,XCL1;AHR
prerank,regulation of gene silencing by miRNA (GO:0060964),0.39203331360209537,1.090250815613221,0.35157159487776485,0.722660366016208,1.0,19/62,20.96%,POU5F1;STAT3;NUP37;PUM1;RAE1;PPARG;NUP153;WTIP;FMR1;NDC1;NUP35;NUP188;SEC13;POLR2L;POLR2K;NUP214;AGO2;EIF4G1;NUP107
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.501220507247732,1.0897271228060865,0.3668730650154799,0.7234644842634531,1.0,4/13,8.57%,NRP1;PLXNC1;PLXND1;PLXNA3
prerank,cellular response to glucagon stimulus (GO:0071377),-0.38153824551630106,-1.08933883195751,0.3198757763975155,0.7519564502582242,1.0,6/17,9.23%,ADCY5;ADCY9;ADCY1;PRKAR1A;PRKAR2A;ADCY4
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.48735622499669884,1.0892599213403318,0.4034090909090909,0.7240801963230213,1.0,5/16,18.70%,CHMP4A;CHMP4B;CHMP7;LEPROT;LEPROTL1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5149107420167459,1.0885828480470607,0.3808095952023988,0.7252419341293158,1.0,3/12,11.91%,DCN;ADAMTS12;SPRY2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3611801496747535,1.0880869080429882,0.3357438016528926,0.7259756381417043,1.0,20/152,12.75%,MC5R;ABCA1;IAPP;ADCY7;HTR1D;ADGRL3;RXFP2;ADCY2;ADM;ADCYAP1R1;CXCL10;GLP2R;S1PR3;GPR161;S1PR2;GNAI1;LPAR3;LPAR2;CALCRL;MC1R
prerank,regulation of protein neddylation (GO:2000434),-0.45067393756262075,-1.0880027548223599,0.3467741935483871,0.7535101046655186,1.0,4/10,8.10%,EPAS1;DCUN1D4;DCUN1D3;RPL5
prerank,pancreas development (GO:0031016),0.5134917200373935,1.0876630597947163,0.3891472868217054,0.7265081659343667,1.0,3/12,11.12%,TCF7L2;NKX6-1;NPHP3
prerank,amyloid-beta metabolic process (GO:0050435),-0.39310394289400813,-1.087572104371977,0.3353658536585366,0.7526239116295766,1.0,7/16,17.61%,BACE2;APH1A;APH1B;ABCA7;ACE;IDE;APEH
prerank,protein ubiquitination (GO:0016567),0.3517810092900423,1.0873304951805016,0.24573721163490472,0.7268008973802611,1.0,99/471,17.75%,PSMA7;TRIML2;SH3RF3;DTX4;DCAF15;PDZRN3;MYLIP;PEX10;FBXO40;MYCBP2;SPSB1;ARRDC4;KLHL22;HECTD2;FBXL7;USP9X;CUL1;SMURF2;UBR5;BCL2;TRIM21;CNOT4;RNF144A;PLK1;ANAPC11;SIAH2;MIB1;CDC27;ATG3;RNF111;KLHL13;SKP1;SASH1;SPOP;NPEPPS;TRIM13;TPP2;CBL;FBXL18;FBXW7;FBXO30;AREL1;PSMB8;ARIH1;BRAP;PSMA6;SH3RF1;DTX2;UBE2L3;PELI3;FBH1;CBFB;TRIM44;UBE2R2;EIPR1;UBE2J1;FBXO7;NFE2L2;RNF213;KCTD10;RNF19B;PJA2;FBXW11;RNF181;ZSWIM8;PSMF1;UBE2K;TRAF2;UBE2W;FBXO2;RNF11;USP22;VCPIP1;DTX3L;RNF141;PSMA8;SMURF1;ITCH;NEDD4;HIF1A;FBXL19;PSMD2;PRKDC;PSMD12;KLHL25;PSMD11;PELI2;RBCK1;TRAIP;TNKS2;PCNP;PSMD14;KLHL7;TRIM33;RC3H2;DDB1;MDM2;PSMB1;FBXW4
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4098670618775911,1.0871723395215134,0.3667083854818523,0.7266927298706737,1.0,9/40,12.55%,PDGFRA;PDGFRB;EDNRA;EGFR;FGFR1;LPAR2;ARHGAP6;FGF2;NTRK3
prerank,glutamate metabolic process (GO:0006536),-0.35587710191205435,-1.0870447919140003,0.3333333333333333,0.7520546453389112,1.0,5/19,5.63%,GLUL;MTHFS;GCLC;GLUD1;PRODH
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.3847245224680593,-1.086862951661209,0.35331230283911674,0.7505917630525841,1.0,9/17,34.14%,RB1;ZWILCH;IK;BUB3;KNL1;TTK;ZW10;MTBP;SPDL1
prerank,regulation of cell cycle process (GO:0010564),0.3752831447071381,1.085934429012894,0.33225806451612905,0.7293153022584525,1.0,39/104,24.43%,PDXP;CDKN2B;DYNC1H1;NUGGC;SFRP1;PLK1;CDC42;KLHL13;ZFYVE26;BORA;CSNK2A1;CSNK2A2;SND1;DBF4;SETD2;ENTR1;CALM2;MAD1L1;PIK3R4;FSD1;RCC1;PIK3C3;OBSL1;SH3GLB1;KIF20A;FBXO5;PIN1;CDK13;HMGA2;PLK2;MYO19;E4F1;BECN1;KIF11;YTHDF2;PRMT5;CALM3;TTL;CUL9
prerank,regulation of cellular response to stress (GO:0080135),0.3665490265993553,1.08586837528144,0.34249471458773784,0.7289815957968249,1.0,28/115,17.65%,NEK6;DNAJB1;NUAK1;NUP37;CAMK2D;BAG3;RAE1;CREBBP;ATM;RPTOR;AIFM2;NEK4;CCAR2;ATR;NUP153;DNAJB6;DNAJC7;GSK3B;HSPH1;NDC1;NPAS2;NUP35;NUP188;BAG4;SEC13;MAPK1;YWHAE;ATF4
prerank,cardiac conduction system development (GO:0003161),0.4354116396160405,1.0858225716470324,0.3557951482479784,0.7286031618553023,1.0,6/24,15.19%,TBX18;GATA6;SMAD5;MAML1;SMAD4;SMAD1
prerank,defense response to fungus (GO:0050832),0.47524316725169863,1.085088518139473,0.3815028901734104,0.7299680628362238,1.0,2/17,10.28%,RNASE7;GAPDH
prerank,protein modification by small protein removal (GO:0070646),0.35213882944060737,1.0844768998977472,0.3208502024291498,0.7310097152866035,1.0,50/252,16.12%,PSMA7;ASXL1;TNIP1;TNFAIP3;BIRC3;SMAD2;USP9X;SMURF2;BABAM2;OTULINL;PTEN;ASXL2;INO80;FOXK2;SIAH2;TADA2B;USP42;USP24;PSMB8;RAD23A;PSMA6;TGFBR1;OGT;RAD23B;USP12;OTUD3;USPL1;USP40;USP38;SENP6;USP3;RUVBL1;RHOA;PSMF1;TRAF2;SMAD3;MYSM1;USP22;VCPIP1;SMAD4;COPS6;RIPK1;SMAD1;PSMA8;STAMBPL1;HIF1A;PSMD2;PSMD12;USP28;PSMD11
prerank,oxoacid metabolic process (GO:0043436),0.43960386804953566,1.084288339265529,0.36671001300390116,0.73097266160909,1.0,2/27,2.97%,ENPP1;PPA1
prerank,maintenance of protein location in nucleus (GO:0051457),0.4705413042510048,1.0841242731189846,0.39088397790055246,0.7308808943225267,1.0,4/20,8.93%,BCL3;MORC3;SKP1;SP100
prerank,protein phosphorylation (GO:0006468),0.34870082252968665,1.084071871634099,0.26,0.730516310423186,1.0,110/479,17.81%,CCL11;RUNX3;PDGFRA;NEK6;MAP4K4;TEC;TAOK1;JAK1;MAST4;PEAK1;ERN2;TLR2;LRRK2;PDGFRB;JAK2;PRKCA;SMAD2;MARK1;EGFR;EPHB3;NUAK1;IRAK3;RICTOR;BLK;STK36;ILF3;IKBKE;AKT3;CAMK2D;PRKD2;DDR2;ACVR1;MORC3;FAM20A;CDK6;ATM;CDK14;EIF2AK2;PLK1;PTPN6;PPP4R1;EPHA1;TLR7;GTF2H1;TAOK3;DCLK1;CDK10;ABI2;HIPK4;NEK4;MERTK;PXK;FRK;MAST2;PRKAR1B;ATR;TGFBR1;MAP2K1;CSNK2A1;CSNK2A2;MAP4K5;HIPK3;RPS6KB1;ACVR1B;CDC42BPA;CCL2;FGFR1;PTK2;YWHAZ;NRK;CSNK1G2;TGFB2;GMFB;CDK7;ACVR2A;MYO3A;COQ8B;MAML1;GSK3B;CSNK1A1;ACVR1C;ABI1;MAP3K6;SRC;MKNK1;STK24;DAPK2;FES;TRIB1;VRK3;RIPK1;PIK3R4;CCNT1;PRKAB1;PRKDC;GRK4;STK4;FAM20B;ACVRL1;CSNK1D;MAPK1;AKT1;LATS2;CDKL1;MAP3K3;TYK2;EIF2AK3;TESK2;DCLK3;MAP3K12
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3539270242206323,1.083831547370079,0.273,0.7306229671492118,1.0,106/336,24.75%,RAD51B;BCL3;PARP3;YAP1;TAOK1;BCL6;POLE3;SUSD6;IRF7;BACH1;VAV3;SMC1A;BATF;RAD52;BLK;RBBP5;IKBKE;E2F1;PHF1;UBR5;BABAM2;BCL2;GNL1;INO80;XRCC3;ATM;DDX11;PDS5B;PWWP3A;GTF2H1;BCL2L2;LIG1;TAOK3;NEK4;GRB2;PDS5A;MCM7;ATR;RNF169;ZBTB38;FBH1;MCM9;ALKBH1;USP3;TIMELESS;POLI;MGMT;TANK;RIF1;PSEN1;FMR1;VCPIP1;ASF1A;DTX3L;NIPBL;MMS19;SETX;CHCHD6;PRKDC;USP28;CGAS;TRAIP;ATRIP;PNKP;MTREX;DDB1;RAD9A;SLF2;ZBTB40;RBBP8;FBXO31;HINFP;HMCES;EID3;GADD45A;MBD4;DCUN1D5;SMC5;FANCC;FOXP1;PARP4;YY1;ZC3H12A;EPHA2;PAK1;RBBP6;CDKN2AIP;ZRANB3;RPA1;SLX4;ENDOV;CBX5;RAD51;MNAT1;MSH6;DOT1L;BAZ1B;ETAA1;MACROD1;TRRAP;CDKN1A;TNFRSF1B;OARD1;TRIP12;BRAT1;FAM111A
prerank,histone H4-K16 acetylation (GO:0043984),0.46143206942242865,1.0836042882041677,0.38472418670438474,0.7307191023659418,1.0,3/19,9.03%,KMT2A;KANSL1;OGT
prerank,negative regulation of transport (GO:0051051),0.4022521146903936,1.083332247187115,0.35157159487776485,0.7308787105585413,1.0,8/51,10.82%,ADIPOQ;TLR2;PRTN3;PTEN;EGF;RAB7A;PXK;SNX33
prerank,regulation of interferon-beta production (GO:0032648),0.4088613453150559,1.0833277949079636,0.3752969121140142,0.7303955936161954,1.0,20/46,26.98%,TLR2;IRF7;REL;TLR7;IRF1;TIRAP;POLR3A;POLR3D;TRIM56;RELB;RNF135;ISG15;YY1;SIRPA;TRAF3;TLR3;NLRC3;PYCARD;PTPRS;DHX58
prerank,protein deubiquitination (GO:0016579),0.35161557301443663,1.0831243994669042,0.31648129423660265,0.730410219992228,1.0,47/242,16.12%,PSMA7;ASXL1;TNIP1;TNFAIP3;BIRC3;SMAD2;USP9X;SMURF2;BABAM2;OTULINL;PTEN;ASXL2;INO80;FOXK2;SIAH2;TADA2B;USP42;USP24;PSMB8;RAD23A;PSMA6;TGFBR1;OGT;RAD23B;USP12;OTUD3;USP40;USP38;USP3;RUVBL1;RHOA;PSMF1;TRAF2;SMAD3;MYSM1;USP22;VCPIP1;SMAD4;RIPK1;SMAD1;PSMA8;STAMBPL1;HIF1A;PSMD2;PSMD12;USP28;PSMD11
prerank,amino sugar biosynthetic process (GO:0046349),0.5086119458973855,1.0829582544324272,0.3767228177641654,0.7303082272227432,1.0,4/12,17.56%,GFPT2;UAP1L1;AMDHD2;GNPDA2
prerank,phospholipid translocation (GO:0045332),0.43351380601828415,1.0826927413131486,0.3675889328063241,0.7304725081695502,1.0,3/28,2.43%,ABCA1;PLSCR5;ATP8B1
prerank,nucleic acid metabolic process (GO:0090304),0.387179682631237,1.082498097255424,0.3633217993079585,0.7304705169306632,1.0,23/69,23.27%,ENPP1;ATXN2;DNA2;WDR74;GTF2F2;SETMAR;NCBP2;HNRNPH2;GTF2F1;MMS19;DXO;POLG;RBMX;RBFOX2;DDX1;POLR2L;POLR2K;KPNA2;DUSP11;DDX24;HNRNPC;POLR2D;PCBP1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.4232701138734791,1.082366220769354,0.3640897755610973,0.7302963927534485,1.0,8/36,15.68%,JAK2;NRP1;EGF;FBXW7;HDAC1;CCL2;BTC;HIF1A
prerank,regulation of filopodium assembly (GO:0051489),0.4144257289195525,1.0818722432761074,0.3644388398486759,0.7310335194482689,1.0,7/38,6.39%,MYO10;DPYSL3;NRP1;FSCN1;RALA;TGFB3;CDC42
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3520881423691766,-1.0811994794534858,0.33941605839416056,0.7624872960625778,1.0,11/21,27.26%,ERCC5;ERCC3;CHD1L;DDB2;GTF2H2;ERCC1;GTF2H4;GTF2H3;RBX1;RPA2;PARP1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3520881423691766,-1.0811994794534858,0.33941605839416056,0.7624872960625778,1.0,11/21,27.26%,ERCC5;ERCC3;CHD1L;DDB2;GTF2H2;ERCC1;GTF2H4;GTF2H3;RBX1;RPA2;PARP1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4532896725237357,1.0810590683120236,0.37751004016064255,0.7325528484234665,1.0,2/21,4.31%,ENPP1;CCR1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4458900064871892,1.0809469099823033,0.38154269972451793,0.7323419432068057,1.0,8/21,20.28%,STK36;SHH;SFRP1;RAB34;DLG5;SMO;GLI1;KIF7
prerank,heme biosynthetic process (GO:0006783),-0.3458670915558269,-1.0807905712500667,0.33584905660377357,0.761554451433299,1.0,7/22,14.86%,ABCG2;CPOX;FLVCR1;SLC25A38;UROS;COX10;ABCB10
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.32471724429854176,-1.0806755627513347,0.37142857142857144,0.7598354810282363,1.0,4/29,5.90%,TGFBR3;S1PR1;PROX1;FGFR2
prerank,positive regulation of developmental growth (GO:0048639),-0.2955558707684495,-1.0806056569112756,0.2642857142857143,0.7580395564797265,1.0,14/49,15.45%,CDKL5;SEMA7A;INSR;PLCB1;AGRN;ITSN2;SHTN1;TWF2;ZFYVE27;RIMS1;SEMA4D;BDNF;RNF157;PPIB
prerank,modulation by symbiont of host process (GO:0044003),0.5336642089414217,1.0802375444433485,0.4,0.7335884809702581,1.0,2/10,6.24%,TLR2;ENO1
prerank,negative regulation of interferon-beta production (GO:0032688),0.5284948970909209,1.080058411911479,0.40222575516693165,0.7335301928929149,1.0,7/10,26.89%,REL;RELB;YY1;SIRPA;NLRC3;PYCARD;PTPRS
prerank,positive regulation of neuron migration (GO:2001224),-0.42908893963657757,-1.0800123488376712,0.35656836461126007,0.7576528310402547,1.0,3/11,5.43%,SEMA6A;RAPGEF2;SHTN1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.40450653094499983,1.0798320050933754,0.39263803680981596,0.7336057081721225,1.0,11/46,17.95%,JAK1;JAK2;RALA;CDC42;MSN;LMNB1;LCP1;TALDO1;ARF1;TYK2;CAPZA1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.43662413962095603,1.0796598441186058,0.38562091503267976,0.7335742138130715,1.0,7/28,13.10%,CASP8AP2;BAG3;BCL2;TNFRSF1A;CASP8;TNF;SPI1
prerank,calcium ion import (GO:0070509),0.4403825690770167,1.0785249641353527,0.39233817701453105,0.735912344647075,1.0,8/28,18.80%,CACNA1A;CACNA1C;ATP2A2;MS4A1;MICU2;MCUR1;MAIP1;MICU3
prerank,rRNA pseudouridine synthesis (GO:0031118),0.518655367907639,1.0781613555107272,0.3875598086124402,0.7363105143837334,1.0,1/10,1.03%,RPUSD3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.37818931884342627,1.0779597134176062,0.3619361936193619,0.7363155731115418,1.0,22/75,20.54%,ADIPOQ;IRAK3;APOE;NR2F2;PTEN;NF1;LRP6;PLK1;PTPN1;PRKAR1B;PTPRJ;SPRY2;BMP7;CDKN1B;AKT1;LATS2;AGT;LRP5;GADD45A;PKIB;SPRY4;PRKCD
prerank,regulation of coagulation (GO:0050818),-0.43139690423255944,-1.0777838470551353,0.37971014492753624,0.7618426585623188,1.0,1/11,1.15%,CAV1
prerank,actin filament organization (GO:0007015),0.3595607368177737,1.0777290998075577,0.3408856848609681,0.7363794040326623,1.0,31/151,14.73%,SVIL;MYO1B;PPP1R9B;RND3;DPYSL3;FHOD3;BAIAP2;AIF1;RHOD;CARMIL1;MYO5A;CDC42;FAT1;MYO1D;CGNL1;MYO1H;TMOD1;MYO7A;ABI2;SPIRE1;LCP1;SAMD14;DBN1;VILL;ZBED3;RHOA;BIN3;ABI1;TPM4;MYO1E;RAC1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.437936485181652,1.0775773919479648,0.3944954128440367,0.7362689796663108,1.0,2/26,4.25%,CYP1B1;ABCA2
prerank,heart trabecula morphogenesis (GO:0061384),-0.36642010937516023,-1.0774872955827124,0.33221476510067116,0.7607164337851438,1.0,5/18,8.80%,TEK;TGFBR3;RBP4;S1PR1;ADGRG6
prerank,regulation of microtubule depolymerization (GO:0031114),0.43767349435726044,1.0773096075052426,0.39342105263157895,0.736479507513113,1.0,6/25,12.48%,TAOK1;NAV3;MAP1S;TPX2;CAMSAP2;FGF13
prerank,modulation by symbiont of entry into host (GO:0052372),0.4859364705477794,1.0762925104523193,0.4067796610169492,0.7385757815499061,1.0,7/16,21.59%,TRIML2;TRIM21;EXOC7;TRIM6;TRIM27;TRIM62;HS3ST5
prerank,negative regulation of hydrolase activity (GO:0051346),0.403247080625896,1.0762884740613887,0.3695652173913043,0.7380932940076962,1.0,4/49,7.54%,SLC39A14;LRRK2;PPP1R36;RRP1B
prerank,dephosphorylation (GO:0016311),0.3612873115689934,1.0760186840659243,0.3609100310237849,0.738282429846242,1.0,44/147,20.59%,PDXP;PTPN7;DUSP2;DUSP5;PTPN3;PTPN13;EPHX2;PTEN;PTPRZ1;PTPN6;PPP4R1;DAPP1;PTPN18;PTPN1;SSH1;PPP3CA;PPP2R2A;PPP2R5A;PTPRJ;PTPN9;PPP4R2;PTPRM;THNSL2;PPP1CB;FBXW11;DUSP28;DUSP26;ILKAP;SSH2;CTTNBP2NL;TIMM50;PPP6C;PNKP;PTPRC;PTPN5;PTPRA;DUSP6;MTMR3;MTMR2;MTMR6;MTM1;CDC14B;DUSP11;DUSP15
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.43043818453335064,1.0753518239268909,0.3795811518324607,0.7393767034644358,1.0,15/30,25.72%,ADIPOQ;PINX1;DCP2;NAT10;XRN1;CTC1;SRC;ACVRL1;HNRNPC;TERF1;BMPR2;CDKN1A;CERS1;NIBAN2;TERF2
prerank,cellular protein metabolic process (GO:0044267),0.34520028253926777,1.074458086903741,0.3033033033033033,0.7410797410029041,1.0,99/396,21.71%,C3;MMP2;ENAM;KNG1;SPP1;RPSA;RRBP1;IGFBP7;LAMB1;PLOD2;ASMT;TNIP1;LAMC1;CP;TIMP1;IGFBP4;GATA6;STOML2;VCAN;FSTL1;PRKCSH;RPL3L;APOE;CALU;IGFBP5;FBN1;OMA1;PLAT;SIAH2;ATG3;MIA3;PABPC4;CKAP4;SDC2;MGAT4A;MSRB3;TNC;UBE2L3;LTBP1;PAPPA2;CCDC59;ST3GAL1;GALNT11;RPL12;PPP4R2;MRPS18A;PHKA2;MMP15;SPG7;SPPL3;RPL22;RPL14;ADPRH;FBXO2;PCMT1;PSEN1;MRPS14;RPL11;RABGGTB;RIPK1;PSENEN;GSPT1;B4GALT7;RPN1;PRKDC;PIGH;YES1;SEC11A;MRPL55;L2HGDH;FDXR;DNAJC3;RPL36A;MSRB1;MRPL52;RPS9;HSP90B1;PHEX;EVA1A;RPL6;CSF2RA;FAM20C;PDIA6;RPLP2;AGO2;LGALS1;MRPS33;UBL5;SHISA5;NCSTN;EIF4G1;PARP4;ADORA2B;USP25;PSEN2;HM13;FBXO22;RPS27A;MXRA8
prerank,cellular response to gamma radiation (GO:0071480),0.46845476337659386,1.0736262715070741,0.3909348441926346,0.7426622204827595,1.0,6/17,21.02%,YAP1;ATM;ATR;MDM2;KDM1A;MAP3K20
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.45953963768668593,1.0735091681434228,0.37905604719764013,0.7424653209423111,1.0,1/18,0.45%,IL23R
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4599512246858407,1.0731782598272965,0.3931034482758621,0.7427765263811628,1.0,3/21,4.90%,NOS1AP;CACNA2D1;KCNA5
prerank,regulation of viral transcription (GO:0046782),0.4043733417794291,1.0729430859710876,0.37733499377334995,0.7428953075328004,1.0,15/39,23.95%,MDFIC;UBP1;TRIM21;TRIM13;GTF2F2;RSF1;GTF2F1;CCNT1;POLR2L;POLR2K;CDK9;TRIM27;TRIM62;POLR2D;TRIM11
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4666638127087122,1.0727305424033304,0.3902777777777778,0.74292171843802,1.0,3/18,8.45%,DCN;RALA;SPIRE1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.4690856461507153,1.0726045472849168,0.39598278335724535,0.7427312673549142,1.0,4/17,12.48%,SFRP4;NKX6-1;BTG1;FGF2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.41449859288877333,1.0724513005883995,0.38179519595448796,0.7425864367520196,1.0,6/34,13.14%,LACC1;XCL1;SASH3;WNT5A;TNFRSF4;SPHK2
prerank,neutrophil mediated immunity (GO:0002446),0.34674763658344065,1.0720203472940741,0.292,0.743139462057495,1.0,103/432,20.67%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;DYNLL1;HVCN1;TLR2;PRTN3;PLD1;ANPEP;MGST1;PADI2;DYNC1H1;CTSD;CD53;CTSS;PYGL;CD36;UBR4;DDOST;TXNDC5;ATP6AP2;DNAJC13;CD68;PTPN6;LAMP2;HPSE;SLC27A2;PDAP1;UNC13D;RAB7A;VAPA;ACTR2;PTGES2;CKAP4;FRK;CD14;CCT8;STXBP3;IRAK4;CTSB;NPC2;GALNS;MVP;PTPRJ;KMT2E;DBNL;RHOA;ATG7;CTSC;RAB37;FABP5;ORMDL3;KCMF1;DPP7;RAB10;PSEN1;GNS;GAA;RAC1;AP2A2;CD63;SLCO4C1;NEU1;RHOF;PSMD2;PSMD12;FGL2;PSMD11;SRP14;GGH;ARHGAP9;DOCK2;TSPAN14;PSMD14;PTPRC;MAPK1;CTSA;DNAJC3;ATP6V1D;ANO6;LAIR1;PSMB1;FCGR3B;LAMTOR3;TIMP2;AGA;IMPDH2;ATP11A;CPNE3;ADGRG3;CYBB;MGAM;HGSNAT;CYB5R3;AMPD3;CDK13;NCSTN;PRKCD;LCN2;TOM1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.41400214044027017,1.0714608088158963,0.3695090439276486,0.7440515144847181,1.0,8/34,13.23%,EDN3;PDGFRB;EGF;ANAPC11;CDC27;DRD3;NSMCE2;BTC
prerank,phospholipid catabolic process (GO:0009395),-0.3410177706825757,-1.0713765985823116,0.3707865168539326,0.7756753249104344,1.0,7/24,22.76%,GPCPD1;ENPP2;GDE1;GDPD1;ENPP6;SMPDL3A;PLA2G4C
prerank,negative regulation of kinase activity (GO:0033673),0.38327907356988167,1.0711520764122497,0.36914285714285716,0.744300084626462,1.0,20/62,17.14%,SPRED1;NF1;TAF7;DTNBP1;LRP6;NPRL2;EPHA1;GSKIP;PYDC1;PPP2R5A;WWTR1;UBASH3B;SMCR8;TRIB3;CDKN1B;TRIB1;RTRAF;ITGB1BP1;PTPRC;AKT1
prerank,regulation of cytokinesis (GO:0032465),0.37863107072093,1.0707916828107353,0.3741721854304636,0.7446752910573401,1.0,26/78,20.30%,SVIL;PDXP;PLK1;CDC42;VPS4A;E2F8;KLHL13;ZFYVE26;DRD3;SETD2;OPN1MW;CSPP1;RHOA;ENTR1;GIPC1;CALM2;CDC14A;PIK3R4;FSD1;PIK3C3;SH3GLB1;KIF20A;PIN1;CDC14B;PLK2;MYO19
prerank,cation transmembrane transport (GO:0098655),-0.29651694889471103,-1.0705742925102242,0.3431372549019608,0.7758798508945886,1.0,7/44,5.75%,TRPM3;ATP1A2;ATP1B1;TRPM6;SLC6A9;SLC7A5;ABCC9
prerank,microtubule polymerization (GO:0046785),0.4341231626382772,1.0702978006566977,0.40816326530612246,0.7453847517318405,1.0,12/28,19.95%,TUBG1;TPX2;FGF13;AKAP9;RANBP9;TUBGCP4;NDEL1;TUBG2;CSNK1D;TPPP;CKAP5;PIN1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.3843799133811368,-1.069979791428821,0.36507936507936506,0.7756526328558617,1.0,6/17,20.15%,PRKCZ;SLC7A5;PRKCQ;SYK;HAVCR2;FCER1G
prerank,proteasomal protein catabolic process (GO:0010498),0.35065835296735265,1.0695738600343392,0.36085626911314983,0.7466888182646997,1.0,43/201,17.74%,PSMA7;SPSB1;KLHL22;SMURF2;APPBP2;SIAH2;BAG6;ERLEC1;SPOP;TRIM13;FBXW7;AREL1;PSMB8;RAD23A;PSMA6;TBL1X;RAD23B;DCAF11;RCN3;NFE2L2;KCTD10;FBXW11;ZSWIM8;PSMF1;UBE2K;MAEA;UBE2W;PSMA8;SMURF1;ITCH;NEDD4;FBXL19;PSMD2;PSMD12;PSMD11;RBCK1;CLOCK;PCNP;PSMD14;KCTD2;DDB1;MDM2;PSMB1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5122959192642693,1.069406919649212,0.4062968515742129,0.7466033806664399,1.0,2/12,2.50%,GLI2;MYCBP2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3754527295620362,-1.0691964302645116,0.35668789808917195,0.7759309699280609,1.0,5/17,10.98%,SLC12A2;SLC9A2;SLC6A1;SLC9A6;SLC9A7
prerank,positive regulation of nuclear division (GO:0051785),0.4360568914097161,1.0687986233629416,0.3838926174496644,0.7475903700831468,1.0,5/25,13.23%,EDN3;PDGFRB;EGF;DRD3;BTC
prerank,negative regulation of developmental process (GO:0051093),-0.26796678094842574,-1.0687595628571436,0.2773109243697479,0.7751632066572793,1.0,15/69,9.72%,NFIB;DCC;BMP4;RAPGEF3;PRKN;HUWE1;NOS3;GAS6;CST3;TFRC;GRIN3A;KLF7;TBX1;ARHGEF15;IL17D
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3529252042950716,-1.0685676598040357,0.34,0.7736767446762484,1.0,8/23,12.06%,ACSL1;TECR;FAR2;ELOVL7;ELOVL5;HACD1;ACSL3;DGAT1
prerank,mitotic spindle organization (GO:0007052),0.357138510330392,1.0683695144808711,0.3481404958677686,0.7481647824395773,1.0,33/153,17.54%,NEK6;KIFC1;DYNLL1;TAOK1;EML4;SMC1A;CENPQ;DYNC1H1;MAD2L1;NUP37;CENPN;KIF2A;TUBG1;PLK1;GPSM2;NEK9;STAG2;TPX2;PCNT;STAG1;SPC25;CENPL;RHOA;MAD1L1;NDEL1;TOGARAM1;MAP4;CEP192;RCC1;TUBG2;SEC13;PTPA;CKAP5
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4367263682280659,1.0679096081898898,0.3761840324763194,0.7488050335606015,1.0,1/26,0.10%,NR1H4
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.32060030377734416,-1.0672225154343489,0.3308270676691729,0.7754618733101499,1.0,11/32,20.15%,CHPT1;CHKA;LPIN1;ABHD3;SLC27A1;PCYT1B;GPAT4;MFSD2A;CHKB;PCTP;PCYT1A
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.37145292826389953,-1.0671398565213057,0.3401360544217687,0.7736574270570171,1.0,7/18,23.40%,STT3B;OGA;SAMHD1;DERA;MANBA;FBXO44;FUCA1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.3768239593230349,-1.0670165802436506,0.35379061371841153,0.7720456578552776,1.0,7/17,19.45%,SNAP25;STX3;STX2;TOR1A;SYP;SYNGR1;SYNGR2
prerank,peroxisome organization (GO:0007031),0.4412710685404683,1.0669581627067273,0.39591836734693875,0.7506699264732294,1.0,2/25,2.13%,SEC16B;PEX10
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.4992988545308316,1.066892647974146,0.40214067278287463,0.7503376196789922,1.0,3/13,10.36%,TLR2;JAK2;CCL2
prerank,homeostasis of number of cells (GO:0048872),-0.42249534628156715,-1.066171319412768,0.3870967741935484,0.7725309261257176,1.0,3/12,6.10%,NOS3;CCN3;OCIAD1
prerank,keratan sulfate catabolic process (GO:0042340),0.5272681547201002,1.0656570620969699,0.4267515923566879,0.7528945752550553,1.0,4/11,14.06%,LUM;PRELP;GALNS;GNS
prerank,neutrophil degranulation (GO:0043312),0.34468434500141726,1.0654368728768342,0.308,0.7529698287821369,1.0,101/425,20.67%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;DYNLL1;HVCN1;TLR2;PRTN3;PLD1;ANPEP;MGST1;PADI2;DYNC1H1;CTSD;CD53;CTSS;PYGL;CD36;UBR4;DDOST;TXNDC5;ATP6AP2;DNAJC13;CD68;PTPN6;LAMP2;HPSE;SLC27A2;PDAP1;UNC13D;RAB7A;VAPA;ACTR2;PTGES2;CKAP4;FRK;CD14;CCT8;STXBP3;CTSB;NPC2;GALNS;MVP;PTPRJ;DBNL;RHOA;ATG7;CTSC;RAB37;FABP5;ORMDL3;KCMF1;DPP7;RAB10;PSEN1;GNS;GAA;RAC1;AP2A2;CD63;SLCO4C1;NEU1;RHOF;PSMD2;PSMD12;FGL2;PSMD11;SRP14;GGH;ARHGAP9;DOCK2;TSPAN14;PSMD14;PTPRC;MAPK1;CTSA;DNAJC3;ATP6V1D;ANO6;LAIR1;PSMB1;FCGR3B;LAMTOR3;TIMP2;AGA;IMPDH2;ATP11A;CPNE3;ADGRG3;CYBB;MGAM;HGSNAT;CYB5R3;AMPD3;CDK13;NCSTN;PRKCD;LCN2;TOM1
prerank,positive regulation of blood coagulation (GO:0030194),0.4663743044114841,1.0646515982531635,0.42053445850914206,0.7543926292692691,1.0,3/17,6.67%,USF1;APOH;HPSE
prerank,multivesicular body assembly (GO:0036258),0.4325130928643891,1.0643400258906557,0.39295039164490864,0.7547167232811133,1.0,6/30,15.31%,CHMP4A;CHMP4B;VPS4A;VPS37C;CHMP7;CHMP2B
prerank,regulation of RNA metabolic process (GO:0051252),0.3883969610078906,1.0638990322991397,0.38039673278879815,0.755306220465665,1.0,9/59,10.49%,IGF2BP1;IGF2BP2;AFF2;MITF;PTBP3;RRP1B;CELF1;OASL;HNRNPH2
prerank,mesenchymal cell differentiation (GO:0048762),0.38697144708128217,1.0638856263697591,0.40115606936416187,0.7548430366025151,1.0,15/51,15.68%,SNAI1;SNAI2;LIMS1;LRP6;DDX17;HEYL;TGFBR1;WNT5A;LOXL3;FGFR1;TGFB2;GSK3B;DLG5;BMP7;HIF1A
prerank,protein trimerization (GO:0070206),0.4929720364466389,1.062982891134383,0.4008941877794337,0.7560803657799674,1.0,2/14,9.63%,STEAP4;MLKL
prerank,protein homotrimerization (GO:0070207),0.4929720364466389,1.062982891134383,0.4008941877794337,0.7560803657799674,1.0,2/14,9.63%,STEAP4;MLKL
prerank,ventricular septum development (GO:0003281),0.4098057964912081,1.0627261097482765,0.4076827757125155,0.7562473584044955,1.0,8/37,11.44%,ROBO2;SLIT3;ZFPM2;ACVR1;HEYL;TGFBR1;SALL1;TGFB2
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3802541508453571,-1.0626913700286487,0.3883495145631068,0.7803687848397707,1.0,3/18,5.98%,ATP1A2;CAV1;SLC43A2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.4183383472318995,1.0621054849645448,0.40436456996148906,0.7572490565329987,1.0,5/32,7.31%,TAOK1;BABAM2;ATM;PLK1;TAOK3
prerank,regulation of defense response to virus (GO:0050688),0.4755694279755108,1.0619417439690828,0.40916030534351144,0.7571362751081369,1.0,2/14,5.26%,TNFAIP3;ILRUN
prerank,regulation of stem cell population maintenance (GO:2000036),0.45930023986088514,1.0619339076853342,0.39747191011235955,0.756663045775781,1.0,2/18,4.42%,PTN;ZC3H13
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5171007075973979,1.0618171668987915,0.41707717569786534,0.7564575394398052,1.0,2/10,4.42%,STAT1;SHH
prerank,negative regulation of histone modification (GO:0031057),0.4844338914667035,1.0615339768119243,0.4235294117647059,0.7566769956652218,1.0,4/14,19.16%,TAF7;NOC2L;SPHK2;THAP7
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.47487708041846866,1.061366236639699,0.4156028368794326,0.7565974767677732,1.0,3/16,10.87%,KLK2;ADM;PLCB3
prerank,bile acid biosynthetic process (GO:0006699),0.43170610045054025,1.0612689254360548,0.403485254691689,0.75634720783485,1.0,3/24,9.82%,CYP7B1;SLC27A2;OSBPL3
prerank,neuron projection morphogenesis (GO:0048812),0.35665063530788227,1.061216188650288,0.378125,0.7559783425856647,1.0,24/137,11.62%,GAS7;SLITRK6;MAP4K4;TNN;TAOK1;FARP1;LRRK2;EPHB3;MAP1S;BAIAP2;PTEN;DTNBP1;CDC42;LLGL1;DLG4;TAOK3;DCLK1;SDC2;S100A6;TRIO;DICER1;DBN1;NRK;DBNL
prerank,neutrophil activation involved in immune response (GO:0002283),0.343357430369453,1.0610132021387824,0.32,0.7559605147463965,1.0,101/428,20.67%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;DYNLL1;HVCN1;TLR2;PRTN3;PLD1;ANPEP;MGST1;PADI2;DYNC1H1;CTSD;CD53;CTSS;PYGL;CD36;UBR4;DDOST;TXNDC5;ATP6AP2;DNAJC13;CD68;PTPN6;LAMP2;HPSE;SLC27A2;PDAP1;UNC13D;RAB7A;VAPA;ACTR2;PTGES2;CKAP4;FRK;CD14;CCT8;STXBP3;CTSB;NPC2;GALNS;MVP;PTPRJ;DBNL;RHOA;ATG7;CTSC;RAB37;FABP5;ORMDL3;KCMF1;DPP7;RAB10;PSEN1;GNS;GAA;RAC1;AP2A2;CD63;SLCO4C1;NEU1;RHOF;PSMD2;PSMD12;FGL2;PSMD11;SRP14;GGH;ARHGAP9;DOCK2;TSPAN14;PSMD14;PTPRC;MAPK1;CTSA;DNAJC3;ATP6V1D;ANO6;LAIR1;PSMB1;FCGR3B;LAMTOR3;TIMP2;AGA;IMPDH2;ATP11A;CPNE3;ADGRG3;CYBB;MGAM;HGSNAT;CYB5R3;AMPD3;CDK13;NCSTN;PRKCD;LCN2;TOM1
prerank,regulation of hydrolase activity (GO:0051336),0.37316304332267025,1.0607450722197214,0.38329519450800914,0.7561397709201617,1.0,21/71,16.35%,VAV2;ARHGAP15;VAV3;PLXNC1;EPHB3;NF1;FGD4;EPHA1;PLXND1;PLXNA3;EFNA5;RABGAP1;RAB3GAP2;PTK2;FGD6;VAV1;FBXW11;RAB3GAP1;TBC1D10B;ARHGAP9;ITGB1BP1
prerank,autophagy of peroxisome (GO:0030242),0.5073619421550499,1.0602302704760944,0.42900763358778626,0.7569148979811715,1.0,5/12,16.47%,ATM;NBR1;PIK3R4;SQSTM1;PIK3C3
prerank,sphingolipid catabolic process (GO:0030149),-0.38450383270797345,-1.0599616686664282,0.3864306784660767,0.7860342677531542,1.0,7/15,27.41%,ACER2;ENPP2;ASAH2;SMPD2;SMPDL3A;SPHK1;ASAH1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4631787619954342,1.0597905910620948,0.4174757281553398,0.7574935397085818,1.0,6/19,16.65%,SLIT3;ACVR1;HEYL;TGFB2;SMAD4;OLFM1
prerank,regulation of anoikis (GO:2000209),0.45819145196337574,1.0595978914027164,0.3997214484679666,0.7574794116059287,1.0,6/19,14.06%,SNAI2;TLE1;BCL2;PTK2;ITGA5;SRC
prerank,negative regulation of hippo signaling (GO:0035331),-0.4235396345449366,-1.0595795219689599,0.41317365269461076,0.7850961114358581,1.0,6/12,23.69%,CIT;WWC2;MARK3;WWC1;MAP2K3;MAPK14
prerank,polyamine metabolic process (GO:0006595),-0.41324394386178653,-1.0594993257307688,0.36363636363636365,0.7833558374748862,1.0,8/13,35.67%,DHPS;SMS;OAZ2;PAOX;SAT2;HDAC10;SRM;SAT1
prerank,Rho protein signal transduction (GO:0007266),0.39351621237200757,1.0593535015806512,0.4050925925925926,0.7575632460809153,1.0,15/53,18.74%,COL1A2;RHOJ;TAX1BP3;RHOD;CDC42;ARHGDIG;PDPN;RHOA;ARHGAP6;RTKN;CDC42EP1;ARHGDIA;GNA12;CDC42EP4;EPS8
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3721459209492535,1.0585852904835706,0.3975225225225225,0.7589306665809148,1.0,16/76,14.04%,BCL3;TLR2;EGFR;LGALS9;NOD1;LIMS1;EIF2AK2;TLR7;SASH1;RASSF2;CD14;TRIM44;RHOA;TNF;SPI1;BMP7
prerank,L-serine metabolic process (GO:0006563),-0.4535364769916379,-1.0581971974352349,0.41578947368421054,0.7850641881891274,1.0,5/10,36.08%,PSAT1;CBS;PHGDH;SERINC3;SHMT1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.46700722470657785,1.0581170656538539,0.4058394160583942,0.759598376519641,1.0,1/15,0.28%,C3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3111627582258,-1.058028580258913,0.39545454545454545,0.7835972192463789,1.0,12/34,16.62%,FLT1;GAB1;SEMA6A;VEGFD;RAMP2;KDR;HSPB1;NR4A1;ERN1;FLT4;PRKD1;PGF
prerank,protein kinase B signaling (GO:0043491),0.4415379282838284,1.0579712777785863,0.4095890410958904,0.7595043245814561,1.0,10/23,22.05%,ZFP36L1;PTEN;CCL5;CCL2;TNF;SETX;AKT1;TYRO3;EPHA2;THEM4
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.39210244109233283,1.0571451009074793,0.3927710843373494,0.76101041744786,1.0,12/46,17.37%,TCF7L2;KHDRBS1;UBR5;BAG3;NCBP2;ZIC1;GSK3B;PIK3R1;SMAD3;PSEN1;NEDD4;YWHAE
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3727390450250392,1.0571047687148862,0.3870967741935484,0.7606259892393048,1.0,28/78,26.05%,CDKN2B;EGFR;NR2F2;CCNE2;PTEN;PKD2;CCND3;PLK1;GTF2H1;CDC37;CCNB2;CDK7;CCNI;CDKN1B;CCNT1;AKT1;LATS2;SERTAD1;GADD45A;RGCC;LATS1;CCNH;MNAT1;CDC6;CDKN1A;CDC25A;BCCIP;CCNY
prerank,ncRNA catabolic process (GO:0034661),0.4230386426018281,1.056762746831826,0.40843214756258234,0.7609368790623895,1.0,8/28,18.91%,ERN2;POP1;EXOSC4;SND1;XRN1;ZCCHC8;MTREX;PARN
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.48197058633596424,1.056748676511616,0.4123867069486405,0.7604831613034211,1.0,2/13,4.42%,GLI2;SHH
prerank,regulation of protein kinase B signaling (GO:0051896),0.3495673044421974,1.0556191603890643,0.3940936863543788,0.7626938110104365,1.0,40/193,14.73%,PDGFRA;IAPP;TCF7L2;GAB2;IRS1;PDGFRB;FGF7;EGFR;RICTOR;PTEN;EGF;STRN;PIK3AP1;HPSE;PIK3R5;ANGPT1;GRB2;TGFBR1;SFRP5;FRS2;OTUD3;DRD3;FGFR1;PTPRJ;PTK2;RCN3;GCNT2;SPRY2;VAV1;TNF;FGF2;NTRK3;MC1R;RASD2;BTC;PIK3R1;SRC;TRIB3;RAC1;CX3CL1
prerank,modified amino acid transport (GO:0072337),0.4727647438313759,1.0556015282258724,0.4056047197640118,0.7622461257524908,1.0,3/15,11.38%,MGST1;SLC16A12;PDPN
prerank,positive regulation of cell junction assembly (GO:1901890),-0.2762156628370148,-1.055588533962753,0.3235294117647059,0.7883361323480075,1.0,16/56,14.90%,TEK;CAV1;NRXN1;GRID2;IL1RAPL1;CLDN5;CNTNAP2;KDR;CLSTN3;SYNDIG1;CUX2;LRRC4B;CLSTN1;TSC1;PTPRD;BDNF
prerank,negative regulation of RNA metabolic process (GO:0051253),0.45564114821730917,1.0554971678446678,0.4090909090909091,0.7619989048924027,1.0,4/18,12.29%,NCOR2;PTBP3;TERT;TNF
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3088009239354825,-1.0550316501733996,0.3613861386138614,0.787874371134452,1.0,7/34,12.33%,PDE4B;ATP1B1;ANK2;CALM1;ADRA1A;PDE4D;KCNQ1
prerank,early endosome to Golgi transport (GO:0034498),0.5010131522934056,1.0549517184735895,0.4059561128526646,0.7628559370797672,1.0,7/11,27.51%,SNX8;LMAN1;SNX2;SNX1;TRAPPC10;RBSN;RAB6A
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.488355798575702,1.0546494786341345,0.40062111801242234,0.7630768562764562,1.0,4/13,10.83%,TSLP;WNT5A;IL7;TRIM44
prerank,regulation of double-strand break repair (GO:2000779),0.40252500823812093,1.054604799601887,0.4019975031210986,0.7627029200027868,1.0,10/39,13.88%,UBR5;DDX11;ACTR2;SPIRE1;RNF169;SETD2;PPP4R2;TIMELESS;MGMT;PPP4C
prerank,cellular response to heat (GO:0034605),-0.3033882119620273,-1.0544885098029777,0.34594594594594597,0.7874822804986711,1.0,19/35,35.20%,HSP90AA1;FGF1;ATXN3;THBS1;TRPV4;HIKESHI;ANO1;DHX36;HTRA2;TCIM;HSP90AB1;IER5;HSPA1A;HSF1;HSBP1;HSPA1B;HMOX1;TPR;MAPT
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4106235488921289,1.05433591430212,0.40430925221799746,0.7628357714034161,1.0,7/33,14.25%,E2F1;PTEN;INO80;PTPN6;FBXW7;DDRGK1;CDKN1B
prerank,regulation of cellular response to heat (GO:1900034),0.36381052079746673,1.0539811046048662,0.3930131004366812,0.763197193341753,1.0,22/77,17.37%,DNAJB1;NUP37;CAMK2D;BAG3;RAE1;CREBBP;ATM;RPTOR;CCAR2;ATR;NUP153;DNAJB6;DNAJC7;GSK3B;HSPH1;NDC1;NUP35;NUP188;BAG4;SEC13;MAPK1;YWHAE
prerank,positive regulation of JNK cascade (GO:0046330),0.3710004370625518,1.0538609984089193,0.37699316628701596,0.7629987835325664,1.0,19/70,22.30%,SH3RF3;TAOK1;UNC5CL;TAOK3;RASSF2;TIRAP;SH3RF1;EDA2R;PJA2;TRAF2;RIPK1;TRAF5;MAPK8IP1;MFHAS1;GADD45A;DUSP15;WNT16;AXIN1;SDCBP
prerank,aminoglycan catabolic process (GO:0006026),0.421235568169292,1.0537784057837474,0.4141145139813582,0.7627116052548149,1.0,7/28,15.15%,HSPG2;GPC6;HPSE;SDC1;SDC2;GNS;IDS
prerank,regulation of protein acetylation (GO:1901983),0.5005936817589434,1.0536068106521934,0.43364197530864196,0.7626459005750615,1.0,3/12,12.44%,TAOK1;FAM161A;GSK3B
prerank,negative regulation of protein localization to membrane (GO:1905476),0.43569749153999127,1.0535340886952267,0.4090909090909091,0.7623292434586209,1.0,6/24,17.71%,CLTC;PID1;PPP2R5A;NUMB;ITGB1BP1;PICALM
prerank,axonogenesis (GO:0007409),0.34404214983986936,1.0521425524693537,0.3850806451612903,0.7652077403688194,1.0,37/237,11.28%,EPHA7;LAMA2;PALLD;GLI2;CXCL12;LAMA1;SLITRK6;ROBO2;SH3KBP1;B4GALT5;GAB2;SLIT3;SLIT1;EFNA4;AUTS2;PRKCA;NRP1;EPHB3;USP9X;SHH;MAP1S;BAIAP2;PTEN;OPHN1;EPHA1;LLGL1;L1CAM;GRB2;EFNA5;S100A6;CXCR4;WNT5A;FRS2;SEMA3E;PTK2;DSCAM;DRAXIN
prerank,positive regulation of cellular senescence (GO:2000774),0.5198660220109045,1.0519795243050019,0.43797856049004597,0.7651026981490783,1.0,4/10,20.05%,EEF1E1;YPEL3;CGAS;HMGA2
prerank,regulation of axon extension (GO:0030516),-0.28989515319333337,-1.0515647370312138,0.37433155080213903,0.7939001905083203,1.0,14/37,22.21%,MAP2;CDKL5;SEMA7A;DIP2B;SHTN1;TWF2;ZFYVE27;SIN3A;CDKL3;MAG;DNM2;SEMA3G;LIMK1;TRIM46
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5098098073444337,1.0515500307376056,0.42879019908116384,0.7656261365457792,1.0,2/10,7.11%,TAF7;NOC2L
prerank,protein localization to cell junction (GO:1902414),-0.3452694265827112,-1.051399439405831,0.3835125448028674,0.792417939160604,1.0,5/22,9.15%,TJP1;TJP2;PCLO;BSN;SHANK1
prerank,ureteric bud morphogenesis (GO:0060675),0.46841521224397253,1.0512889387597528,0.4216691068814056,0.7657433179909616,1.0,6/16,20.32%,SHH;PKD2;SALL1;FGF2;PAX8;GDNF
prerank,negative regulation of calcium ion transport (GO:0051926),-0.385687510095649,-1.0508437101260986,0.3883495145631068,0.7919206713725195,1.0,5/15,19.44%,ATP1A2;INPP5K;PACSIN3;ADRA2A;TMBIM6
prerank,negative regulation of DNA binding (GO:0043392),0.4286500426400811,1.0504262016915278,0.4139715394566624,0.7673787091095274,1.0,10/28,20.05%,JAK2;E2F1;ILRUN;MDFI;SP100;RSF1;SMO;NFKBIA;KDM1A;HMGA2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.41694995309292293,-1.0501455036591854,0.4024390243902439,0.7919525763713553,1.0,5/12,16.23%,SORBS1;INSR;IGF1;IGF2;DYRK2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4811075631377909,1.0500448067049388,0.4271137026239067,0.7678091735633636,1.0,5/14,16.31%,PINX1;TERT;ATR;ATRX;TNKS2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.42845906067815204,1.0499538059619091,0.39037433155080214,0.7675361974153655,1.0,5/26,6.39%,SLC9A1;SYNPO;ASAP3;ALMS1;CDC42
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4347972732702246,1.0499380644036267,0.43119266055045874,0.7670886079926091,1.0,8/25,14.55%,TBX18;NOS1AP;CACNA1C;CAMK2D;ATP2A2;FGF13;AKAP9;TRPM4
prerank,skeletal muscle organ development (GO:0060538),0.42261413936738923,1.0493951311116443,0.3956185567010309,0.7679565342280524,1.0,2/26,3.22%,SVIL;CFLAR
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.44179068006699995,1.0491740634541733,0.4116847826086957,0.767991238673375,1.0,10/20,25.67%,CELF1;TNRC6B;MOV10;WTIP;HELZ;AGO2;AGO1;NRDE2;CNOT1;CNOT7
prerank,membrane depolarization (GO:0051899),-0.30578897804988237,-1.0483852249920698,0.35148514851485146,0.7948959300530286,1.0,8/32,10.06%,CACNB4;CAV1;SCN2A;CACNG2;SCN8A;CACNA1E;CACNA1B;SCN9A
prerank,negative regulation of interleukin-8 production (GO:0032717),0.45638053994714334,1.0483679536017045,0.409288824383164,0.7694910806899052,1.0,2/17,8.96%,BCL3;ANXA1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4284171546024391,1.0469801294176069,0.4314516129032258,0.7723598480946744,1.0,2/26,2.07%,TNIP1;B4GALT5
prerank,regulation of viral genome replication (GO:0045069),0.38005799473804464,1.0468313293503348,0.41114982578397213,0.7722639678658773,1.0,11/56,12.29%,TNIP1;ILF3;TMEM39A;PPID;SHFL;CCL5;EIF2AK2;RAD23A;OASL;STAU1;TNF
prerank,regulation of chromosome segregation (GO:0051983),0.4627336233820347,1.0465065722289646,0.4398826979472141,0.7725517880905608,1.0,3/16,9.20%,PUM1;CSNK2A1;CSNK2A2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.39456104146155035,1.0464304026382623,0.4187725631768953,0.772229920947552,1.0,11/42,14.73%,FBLN2;JAK2;NF1;LIMS1;RSU1;PTK2;PDPN;GCNT2;RHOA;RAC1;CX3CL1
prerank,neuropeptide signaling pathway (GO:0007218),-0.2732205874502792,-1.0463410599394494,0.35507246376811596,0.7987243075876095,1.0,9/58,7.68%,SORCS1;GLRA3;SORT1;SORCS3;CPE;RAPGEF2;SORCS2;GLRA1;SORL1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.44295938357774783,1.0462778467607845,0.41863699582753827,0.7721381878689415,1.0,3/22,5.97%,ADIPOQ;APOE;PPARG
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.42270972324384615,1.0459935497930508,0.4364123159303882,0.7723194812599687,1.0,7/26,13.03%,SLC9A1;FHL2;EFHB;STIMATE;TNF;GSK3B;SPPL3
prerank,monoacylglycerol metabolic process (GO:0046462),-0.39813829106521315,-1.0457804750623327,0.4059701492537313,0.7983374658035687,1.0,3/13,12.06%,MGLL;ABHD6;DGAT1
prerank,transcription by RNA polymerase II (GO:0006366),0.3420188248438477,1.0452709045953474,0.40080160320641284,0.7735921425407828,1.0,96/305,24.31%,RORA;NR1H4;PAX1;NCOR2;YAP1;DEAF1;SOX5;PRRX1;RARB;RXRG;NFIX;MAML3;TEAD3;CEBPD;TAF7;CSTF1;CREBBP;PPARG;MBD1;TTF2;GTF2H1;NFE2L3;MAML2;SNAPC3;POU2F1;TRIP11;HDAC1;TBL1X;GTF2F2;NR2F1;SETD2;NCBP2;WWTR1;CBFB;ELL2;TEAD1;INTS1;CDK7;E2F3;MAML1;NKX2-8;GLIS3;GTF2F1;IRF9;DRAP1;TAF1A;TAF4;INTS4;SETX;NR6A1;CCNT1;MED26;RBMX;NRBF2;INTS14;MLLT1;ATF4;TAF2;ICE1;POLR2L;POLR2K;RBPJ;HDAC5;NR2C2;CDK9;RPAP2;IWS1;NR3C1;MED1;SNRPB;PMF1;CDK13;ERCC2;INTS8;THRA;CDK12;NR1D1;SNAPC5;NR1D2;RARG;PCF11;NFIC;NCOR1;CCNH;THRB;TCEA1;POLR2D;MNAT1;DDX21;CDC73;PCID2;TAF5;FIP1L1;CPSF3;TAF3;PPARD
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.501294774635537,1.0452358103511303,0.4432,0.7731793611941168,1.0,5/11,19.26%,STAT1;WNT5A;CHRD;LRP5;CTNNBIP1
prerank,protein dephosphorylation (GO:0006470),0.35175637743797533,1.0451857776475113,0.41468459152016546,0.7728006663979174,1.0,43/135,20.10%,PDXP;PTPN7;DUSP2;DUSP5;PTPN3;PTPN13;NCK1;PTEN;PTPRZ1;PTPN6;PPP4R1;DAPP1;PTPN18;PTPN1;SSH1;PPP3CA;PPP2R2A;PPP2R5A;PTPRJ;PTPN9;PTPN2;PPP4R2;PTPRM;PPP1CB;FBXW11;DUSP26;ILKAP;UBASH3B;SSH2;CTTNBP2NL;TIMM50;PPP6C;PTPRC;PTPN5;PTPRA;DUSP6;MTMR3;RPAP2;MTMR2;MTMR6;MTM1;CDC14B;DUSP11
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.3878836235911056,-1.0448751521834045,0.3987341772151899,0.7988567150228092,1.0,6/14,16.62%,GAB1;VEGFD;KDR;PIK3CD;FLT4;PGF
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4601895041832419,1.044828018217311,0.4117647058823529,0.7726539205801262,1.0,3/15,8.36%,ZFP36L1;ZFP36L2;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4601895041832419,1.044828018217311,0.4117647058823529,0.7726539205801262,1.0,3/15,8.36%,ZFP36L1;ZFP36L2;TNRC6B
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.39759643616024914,1.044681003441934,0.412484700122399,0.7725410644430084,1.0,5/39,7.08%,ADIPOQ;B4GALNT2;JAG1;NF2;MIA3
prerank,RNA biosynthetic process (GO:0032774),0.4159399532797904,1.0442828339134076,0.4030612244897959,0.7730258474844468,1.0,9/31,15.17%,TAF7;TTF2;TERT;RSF1;POLA2;SMN1;BRF1;TAF4;SETX
prerank,RNA export from nucleus (GO:0006405),-0.23889937130540584,-1.043343503800116,0.38666666666666666,0.8012274038570125,1.0,38/100,25.42%,YTHDC1;CDC40;SRSF5;WDR33;DDX19B;U2AF2;NUP133;UPF2;UPF1;SEH1L;POM121;HNRNPA1;SRSF7;SRSF9;RBM8A;NUP43;CHTOP;CPSF2;MAGOH;NUP210;NUP50;ZC3H11A;NUP98;HHEX;EIF4A3;SRSF3;POLDIP3;XPO5;NUP93;CPSF4;SARNP;MCM3AP;DDX39B;NUP88;NUP85;DDX39A;DDX25;THOC1
prerank,cellular response to drug (GO:0035690),-0.3299045840530618,-1.0431998942423881,0.40234375,0.7997063134105316,1.0,5/25,4.06%,PDE4B;PPM1E;GAS6;ACER2;TFRC
prerank,glucose homeostasis (GO:0042593),0.3586728304683342,1.0431962141281808,0.41150442477876104,0.7750986956108201,1.0,9/83,5.97%,ADIPOQ;TCF7L2;IRS1;USF1;STAT3;HK2;PYGL;FOXK2;PPARG
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.36787479209596524,1.0430963209889466,0.42219679633867274,0.7748546190765414,1.0,16/67,14.81%,PDGFRA;TEC;GHR;PDGFRB;JAK2;EGFR;BLK;DDR2;PTPN6;EPHA1;ABI2;FGFR1;PTK2;ABI1;SRC;FES
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.36634318974595076,1.0429945175661073,0.41125541125541126,0.774614705394703,1.0,22/85,17.55%,NKD2;LRRK2;TREM2;PABIR1;RNF144A;PLK1;PRICKLE1;BAG6;FBXW7;RAD23A;ARIH1;SOCS5;RNF19B;GSK3B;CSNK1A1;DDRGK1;TRIB3;FMR1;TRIB1;ZYG11B;CSNK1D;MDM2
prerank,regulation of peptidase activity (GO:0052547),-0.3544909716861107,-1.0429221528237396,0.4129692832764505,0.7985068853312347,1.0,6/19,12.83%,CAV1;CST3;NDUFA13;PSMA3;PINK1;MAPK12
prerank,regulation of metal ion transport (GO:0010959),0.46220003139938864,1.0425618995171628,0.44886363636363635,0.7751939438614766,1.0,3/16,4.98%,IL16;CACNA2D1;BCL2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4043498048791911,1.0423020890430628,0.42036553524804177,0.7753565472990311,1.0,6/35,6.40%,PDE3A;PDE7B;APOE;ADCY2;CD36;AHR
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2741753412533516,-1.0421962870720651,0.34375,0.7986327456126318,1.0,10/52,6.01%,KHDRBS2;DDX5;CELF2;MBNL1;HNRNPU;YTHDC1;WTAP;NOVA2;NOVA1;RBFOX3
prerank,spindle assembly checkpoint signaling (GO:0071173),0.44361995900570794,1.041164192145006,0.4341736694677871,0.7765779312651079,1.0,4/20,6.21%,KLHL22;MAD2L1;ATM;PLK1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.44361995900570794,1.041164192145006,0.4341736694677871,0.7765779312651079,1.0,4/20,6.21%,KLHL22;MAD2L1;ATM;PLK1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.44361995900570794,1.041164192145006,0.4341736694677871,0.7765779312651079,1.0,4/20,6.21%,KLHL22;MAD2L1;ATM;PLK1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.47853840391481656,1.0411074587887543,0.44360902255639095,0.776230922384176,1.0,5/14,16.35%,TIMP1;LIMS1;LOXL3;CD63;ITGB1BP1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5056595915337834,1.04105137434763,0.44240400667779634,0.7753962557535894,1.0,2/11,4.97%,INPP1;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5056595915337834,1.04105137434763,0.44240400667779634,0.7753962557535894,1.0,2/11,4.97%,INPP1;PTEN
prerank,regulation of cellular catabolic process (GO:0031329),0.371943488969975,1.0410280017031142,0.4287330316742081,0.7749579786610502,1.0,15/62,17.44%,LRRK2;DRAM1;RMC1;ITPR1;PIP4K2A;ATM;RPTOR;RRAGC;TPCN2;DCAF12;SMCR8;TRIB3;DAPK2;GPR137;MTMR3
prerank,positive regulation of phagocytosis (GO:0050766),0.3891172702113684,1.0405958633282373,0.4177671068427371,0.7755426850898604,1.0,15/47,21.54%,C3;TREM2;MERTK;CCL2;PTPRJ;CALR;TNF;C4B;DOCK2;PTPRC;ANO6;CD300LF;LYAR;SIRPA;C2
prerank,muscle filament sliding (GO:0030049),-0.2970268427739513,-1.040554805498443,0.35436893203883496,0.7994258521407016,1.0,3/38,4.34%,DMD;ACTN2;MYL6
prerank,actin-myosin filament sliding (GO:0033275),-0.2970268427739513,-1.040554805498443,0.35436893203883496,0.7994258521407016,1.0,3/38,4.34%,DMD;ACTN2;MYL6
prerank,cellular response to alcohol (GO:0097306),0.3881431625519286,1.040358360741612,0.4226044226044226,0.7755994878474237,1.0,11/42,15.47%,ADCY7;ADCY2;SFRP1;LRP6;AHR;GRAMD1A;GNAI1;GRAMD1C;SPHK2;SMO;CTNNA1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.43927030215747515,1.040205954172164,0.4412568306010929,0.7755044171319222,1.0,5/21,12.48%,TAOK1;NAV3;TPX2;CAMSAP2;FGF13
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.38323909360691094,1.0401391817235515,0.41843971631205673,0.7751876400953948,1.0,18/50,25.82%,CDKN2B;CCNE2;CCND3;GTF2H1;CDC37;CCNB2;CDK7;CCNI;CDKN1B;CCNT1;SERTAD1;GADD45A;CCNH;MNAT1;CDC6;CDKN1A;CDC25A;BCCIP
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.352667741060775,1.0400796551128548,0.4178154825026511,0.7748661617980559,1.0,26/125,17.54%,NEK6;DYNLL1;TAOK1;EML4;CENPQ;DYNC1H1;MAD2L1;NUP37;CENPN;KIF2A;TUBG1;PLK1;GPSM2;NEK9;SETD2;PCNT;SPC25;CENPL;MAD1L1;NDEL1;MAP4;RCC1;TUBG2;SEC13;PTPA;CKAP5
prerank,B cell mediated immunity (GO:0019724),-0.43045097764365137,-1.0400039449291472,0.4343163538873995,0.7990738735390419,1.0,6/10,49.20%,MSH2;FCER1G;CD27;TLR8;CARD9;SLA2
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.39495258144453194,1.0399202927160924,0.4368098159509202,0.774769179151083,1.0,15/42,21.21%,PPA1;YARS1;CARS2;AIMP1;EEF1E1;IARS2;TARS1;RARS2;RARS1;EARS2;GARS1;LARS2;NARS2;FARS2;NARS1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.46775096612424255,1.0398355933824999,0.4114114114114114,0.7744973520309109,1.0,2/16,2.45%,ZFP36L1;ZFP36L2
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.508398075962546,1.0397336454197335,0.4339622641509434,0.7742519327099703,1.0,6/10,27.69%,LRP6;BMP5;BMP7;PHACTR4;ARHGAP12;DLL4
prerank,magnesium ion transport (GO:0015693),0.4811862532446027,1.0396566161845486,0.41033434650455924,0.7739477221656604,1.0,7/12,22.98%,NIPAL2;NIPAL4;TUSC3;NIPA2;CNNM4;NIPA1;SLC41A1
prerank,endothelial cell proliferation (GO:0001935),-0.3694098062516265,-1.0395723586445882,0.4139194139194139,0.7983460564079734,1.0,3/17,3.63%,TEK;BMP4;CD34
prerank,regulation of apoptotic process (GO:0042981),0.33493812559947517,1.0390238798931617,0.3763763763763764,0.7749578102672903,1.0,145/676,18.40%,NR1H4;CYP1B1;ZBP1;KNG1;BCL3;IAPP;MAP4K4;SFRP4;BCL6;STAT1;EGR3;CCAR1;VAV2;GATA6;JAK2;VAV3;BIRC3;FHL2;FSTL1;CFLAR;CASP1;TSLP;EGFR;KALRN;ITSN1;FRZB;FXN;MAD2L1;SHH;E2F1;CTSD;BAG3;IFT57;BABAM2;BCL2;NF1;NUGGC;PPID;FGD4;ANGPTL4;NF2;TXNDC5;STEAP3;TNFRSF12A;CREBBP;ATM;OMA1;SFRP1;TGFB3;PLK1;PTPN6;CXCL10;SIAH2;ASNS;BCL2L2;RASSF2;RRP1B;PHLDA1;AIFM2;EEF1E1;ANGPT1;CCAR2;USP42;GAS1;CBL;ARHGEF19;AREL1;SAP18;TRIO;SH3RF1;ANXA1;WNT5A;HDAC1;FOXO3;IP6K2;IL7;HIPK3;CTSB;RPS6KB1;ARHGEF12;PREX1;TBX3;ARF4;PTK2;YWHAZ;PDPN;CASP8;CALR;SPRY2;ATG7;VAV1;TNF;GSK3B;NLRP2B;AKAP13;ANP32A;ACVR1C;CALHM2;MGMT;TRAF2;SPHK2;PIK3R1;DDRGK1;PSEN1;SRC;ARHGEF18;DAPK2;PDCD10;RTKN;CX3CL1;HSPA5;RABGGTB;NAA15;RIPK1;PSENEN;SETX;PAWR;ITCH;PRKDC;SQSTM1;POU3F3;STK4;RASA1;OLFM1;BAG4;ARHGDIA;AIFM1;HSPD1;PTPA;AKT1;DUSP6;LATS2;DNAJC3;ING5;ANO6;ATF4;ANKLE2;CLIP3;USP36;PAX8;AGT;DDX20;NFKBIA;RHBDD1;DSTYK
prerank,cellular response to estrogen stimulus (GO:0071391),0.4783997281390765,1.0388566702353215,0.41158059467918623,0.7748559946317156,1.0,3/14,10.09%,ARID5A;SFRP1;PELP1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5078739332981855,1.038454763955157,0.4552590266875981,0.7753467066669522,1.0,4/10,15.46%,DMGDH;ALDH7A1;COMT;SMOX
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.35892481652445474,-1.0383382274787605,0.3980263157894737,0.7997143220618642,1.0,11/20,28.50%,ACTN2;OSR1;GOPC;HECW1;ADRA2A;HECW2;NEDD4L;TCAF2;CASQ2;PLN;PRKCE
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4784195495197459,1.0383299064406037,0.4236526946107784,0.7751573021614766,1.0,7/14,21.31%,ADAM19;ABCG1;PSEN1;PSENEN;NCSTN;DYRK1A;PSEN2
prerank,DNA methylation (GO:0006306),0.43915683519819104,1.0382199768584406,0.453929539295393,0.7749415265046271,1.0,10/23,22.74%,EHMT1;KMT2E;DNMT3B;GATAD2A;ATRX;BAZ2A;ATF7IP;MTRR;N6AMT1;PPM1D
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3860877861440362,1.038189141766432,0.42992874109263657,0.7745341938741782,1.0,10/43,12.95%,ENPP1;IRS1;NCK1;PIP4K2A;PTPN1;PID1;OGT;RPS6KB1;PTPN2;SNX5
prerank,regulation of G0 to G1 transition (GO:0070316),0.4010341675004835,1.0381592163722957,0.42875,0.7741368560555176,1.0,16/38,26.01%,CDKN2B;E2F1;RNF2;YAF2;EHMT1;PHC3;MAX;RBBP8;MGA;SUZ12;CDC7;CBX5;RAD51;RYBP;TFDP1;RBBP7
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.5022700353071531,1.0375011430384513,0.44881889763779526,0.7752284445584142,1.0,4/10,19.43%,DNMT3B;RIF1;ATRX;KDM1A
prerank,substrate-dependent cell migration (GO:0006929),0.4735129907658669,1.037482468055185,0.42686567164179107,0.7747970457528364,1.0,9/14,24.13%,NRP1;OPHN1;ITGA11;VEGFC;ITGB1BP1;PTPRC;P2RY12;SDCBP;ITGA2
prerank,negative regulation of chemotaxis (GO:0050922),-0.3089668305854286,-1.0365974336042432,0.3404255319148936,0.8027768219949426,1.0,20/31,29.80%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;SEMA4D;SEMA5A;THBS1;SEMA5B;SLIT2;SEMA3G;SEMA6C;SEMA4B;SEMA3B;SEMA4A;CORO1B;SEMA6B;NOTCH1;SEMA4G;SEMA3F
prerank,positive regulation of developmental process (GO:0051094),0.34565514802479885,1.0363462673660981,0.43615934627170583,0.7770457135038159,1.0,34/164,15.02%,DCN;EDN3;SYDE1;SOX5;PTN;B4GALT5;APOE;MDK;SHH;SMURF2;BMP1;ACVR1;RALA;DLG4;TMEM119;SHLD3;SPIRE1;WNT5A;BMP5;ACVR1B;FGFR1;ZBED3;TNF;TAPT1;RIF1;PSEN1;DLG5;BMP7;SRC;FMR1;PHLDB2;TRPM4;ZDHHC6;PAXIP1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.35632740082935704,1.036266571369252,0.43174603174603177,0.7767614092249787,1.0,43/104,26.78%,CDKN2B;CCNE2;CCND3;LRP6;GTF2H1;RPTOR;MAP2K1;CDC37;CCNB2;CDK7;RHOA;CCNI;CALM2;SRC;TRIB3;CDKN1B;PDCD10;TRIB1;CCNT1;AKT1;LRP5;IRGM;SERTAD1;GADD45A;TELO2;HMGA2;CDK12;CCNH;MNAT1;CDC6;ETAA1;CALM3;RALB;CDKN1A;TSG101;CDC25A;CAB39;MAP2K2;THY1;BCCIP;PYCARD;PIH1D1;PPP2CA
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4250994016877029,1.036058342599511,0.428,0.7767934561384392,1.0,7/26,17.55%,MEIS2;PRKCA;ASNS;RPS6KB1;EIF4EBP1;USP22;MDM2
prerank,presynapse organization (GO:0099172),0.4990397662326099,1.0358546016830106,0.43423137876386686,0.7767775569261961,1.0,2/10,9.14%,FZD1;WNT5A
prerank,intracellular protein transport (GO:0006886),0.33890793268799957,1.0357378063386382,0.40483383685800606,0.7765770986894397,1.0,70/304,18.47%,LTBP2;CLTC;SEC31A;COPA;AP4M1;COPZ2;STX6;AP3B1;ARCN1;STAT3;TRAK1;KIF13B;BAG3;ARFGAP3;TBC1D16;COPZ1;STX17;RAB21;SNX8;PRICKLE1;FAM53B;STXBP1;LAMP2;TBC1D2B;COPB2;RABGAP1L;RAB7A;AP3D1;TBC1D8B;RABGAP1;CDC37;RAB3GAP2;STXBP3;RAB32;WLS;SEC16A;XPO7;LMAN1;NUP153;ARF4;SEC23IP;SNX9;TNPO1;CALR;E2F3;TMED1;TBC1D1;GIPC1;ADPRH;RAB1A;ARF1;EGR2;TBC1D10B;RPL11;SNX15;STX11;SMURF1;COG7;NUP188;SEC13;AKT1;CTSA;CTTN;STX1B;MAIP1;SCFD2;SCFD1;CLIP3;ARL5A;TMED5
prerank,striated muscle contraction (GO:0006941),-0.2673788160126208,-1.0356858227101164,0.3586206896551724,0.8033783625420994,1.0,4/53,3.33%,DMD;ATP1A2;ATP1B1;DTNA
prerank,RNA catabolic process (GO:0006401),0.386707380436795,1.0356525293663523,0.43614457831325304,0.776294413405662,1.0,12/46,17.10%,ZFP36L2;DNA2;METTL16;PABPC4;DCP2;RNASEH1;RNH1;SND1;RNASEH2A;DXO;SIDT2;MTREX
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4039432834716666,1.0355346364287439,0.4296675191815857,0.7760712196818835,1.0,6/33,7.94%,YAP1;TCF7L2;TNFAIP3;MDK;ICAM1;ANGPT1
prerank,regulation of mitochondrion organization (GO:0010821),0.37945801861186673,1.0355238096639607,0.42634730538922155,0.7756137589347922,1.0,15/47,21.29%,IAPP;LRRK2;TREM2;OMA1;PID1;FBXW7;INF2;CSNK2A2;GSK3B;SQSTM1;SREBF1;USP36;STAT2;MYO19;VPS35
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3720655293980836,1.0353779238415342,0.43211334120425027,0.7754603836105337,1.0,15/54,15.52%,HSPG2;GPC6;EXT1;EXT2;HPSE;SDC1;HS2ST1;SDC2;GCNT2;CLN6;UGDH;GNS;SLC35D2;IDS;B4GALT7
prerank,natural killer cell mediated immunity (GO:0002228),0.4762018324744196,1.0351984079867218,0.4540059347181009,0.7753932362805891,1.0,2/15,13.14%,ULBP1;KIF5B
prerank,organelle assembly (GO:0070925),0.3353467006107656,1.0350292373641385,0.3981945837512538,0.7753111080940206,1.0,82/384,17.08%,TEKT4;NEK6;SH3PXD2B;VMP1;DYNLL1;FARP2;GORASP2;WIPI1;CEP19;SYNPO;ATXN2;ASAP1;STK36;CHMP4A;CHMP4B;DYNC1H1;PARVA;AMBRA1;INO80;IFT88;PCM1;VPS4A;HAUS3;ATG3;RAB8B;RAB7A;TMOD1;CEP41;EXOC4;EHD2;ACTR2;GBF1;GOLGA8B;FAM161A;EXOC1;EXOC7;WDPCP;ATP2A2;PCNT;RAB32;WDR35;DISC1;VPS37C;MAPRE2;PTPN23;ARF4;GALNT11;NPHP3;IFT172;IFT81;DBNL;ATG7;PDE6D;UBAP2L;SNX10;CFAP410;PACS2;CPLANE1;CHMP7;RAB1A;DYNC2H1;ATG16L1;DZIP1L;YTHDF3;KIF27;CDC14A;ATG16L2;TUBGCP4;PATL1;CHMP2B;TTC39C;EXOC5;WDR45;EXOC3;NUDCD3;POC1B;RCC1;PIK3C3;WDR90;DHX29;CSNK1D;PRRC2C
prerank,response to ATP (GO:0033198),0.4486300169963868,1.035021833697552,0.4243281471004243,0.7748546099973432,1.0,5/18,21.68%,PDXP;SSH1;P2RX7;HSP90B1;P2RY12
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3968657910995082,1.0349062668023392,0.42839352428393523,0.7746475391557386,1.0,12/39,16.42%,MYO1B;TRAK1;MYO5A;MYO1D;MYO1H;MYO7A;FBXW11;KIF5B;RAB1A;MYO1E;NDEL1;CCDC186
prerank,epithelial cell-cell adhesion (GO:0090136),0.4910580575073274,1.034563533673994,0.4416,0.7750039322572821,1.0,2/11,1.76%,THBS4;ITGB5
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.4190113104317267,-1.0344612902499566,0.41397849462365593,0.8030453577969361,1.0,4/11,12.55%,CCT4;CCT5;LARP7;DKC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.4190113104317267,-1.0344612902499566,0.41397849462365593,0.8030453577969361,1.0,4/11,12.55%,CCT4;CCT5;LARP7;DKC1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.48299475214746845,1.034373927068507,0.4446064139941691,0.7750048892592006,1.0,3/13,10.24%,SEC16B;TM9SF4;SEC16A
prerank,keratan sulfate biosynthetic process (GO:0018146),0.43004797785350324,1.034279821295448,0.44030808729139925,0.7747392893363901,1.0,9/26,17.68%,LUM;B4GALT5;ST3GAL3;PRELP;ST3GAL1;CHST1;SLC35D2;B4GALT2;B4GALT4
prerank,regulation of RNA splicing (GO:0043484),-0.26145105670572505,-1.0340798670677038,0.36936936936936937,0.8022590160793585,1.0,24/69,21.42%,KHDRBS2;QKI;SNRNP70;MBNL1;YTHDC1;TIA1;CWC22;HNRNPH3;U2AF2;AHNAK;CLK1;LARP7;POLR2A;METTL4;ERN1;HNRNPLL;SRRM4;PRX;RPS13;FAM50A;TMBIM6;PTBP2;SRSF3;HNRNPL
prerank,sulfation (GO:0051923),-0.41085483548441454,-1.0338383623596037,0.4305555555555556,0.8009754662736392,1.0,2/11,6.17%,UST;SULT1A1
prerank,positive regulation of cytokinesis (GO:0032467),0.40134618889230744,1.0334821596733794,0.4282051282051282,0.7761649197856633,1.0,8/32,14.53%,SVIL;CDC42;DRD3;OPN1MW;CSPP1;RHOA;GIPC1;CDC14A
prerank,negative regulation of lipid metabolic process (GO:0045833),0.4309294190613155,1.0330644985196091,0.44680851063829785,0.7766807506158522,1.0,4/22,15.23%,APOD;PPP2R5A;TNF;CCDC3
prerank,regulation of intracellular pH (GO:0051453),-0.3000767405926734,-1.0328850744724805,0.37254901960784315,0.8017758172734168,1.0,11/34,10.98%,SLC4A10;SLC9A2;TMEM165;GPR89B;GPR89A;CA2;SLC4A8;CLN3;SLC9A6;SLC4A3;SLC9A7
prerank,actin filament-based transport (GO:0099515),0.43961987817590037,1.032770074804008,0.44702467343976776,0.7768886622460663,1.0,5/21,7.53%,MYO1B;MYO5A;MYO1D;MYO1H;MYO7A
prerank,ceramide metabolic process (GO:0006672),-0.2747767119608666,-1.0321777657466387,0.3825136612021858,0.8019732574527816,1.0,9/49,7.25%,ST6GALNAC3;ACER2;CERS4;SGMS1;PPP2R1A;SPTLC2;SPTLC1;SGMS2;DEGS2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.44151492084951344,1.0321725202836523,0.44992947813822287,0.7778778042279153,1.0,8/20,18.80%,STOML2;PMPCB;MICU2;SPG7;PMPCA;MCUR1;MAIP1;MICU3
prerank,positive regulation of translation (GO:0045727),0.35813957296094995,1.0319219980066194,0.42311886586695746,0.7780186075770755,1.0,14/94,14.28%,PRR16;BCL3;RPUSD3;PLD1;KHDRBS1;CCL5;TRUB2;SAMD4A;NIBAN1;RPS6KB1;NAT10;YBX3;YTHDF3;FMR1
prerank,sensory perception of pain (GO:0019233),0.4415352398306554,1.0314460358003048,0.44537815126050423,0.7786112237730181,1.0,3/21,12.90%,PTGES;CCL2;P2RX7
prerank,keratinocyte differentiation (GO:0030216),0.4086332791964451,1.0310692821416987,0.4364123159303882,0.779009349654625,1.0,9/29,21.50%,UGCG;JAG1;ANXA1;WNT5A;PIP5K1A;MED1;ADAM9;WNT16;EPHA2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.38662135627073885,1.0310201062209654,0.4315151515151515,0.7786498268666502,1.0,9/44,11.12%,ZFP36L1;ZFP36L2;PUM1;METTL16;GIGYF2;CELF1;TNRC6B;FTO;MOV10
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.2944956748222578,-1.0307237955265895,0.40703517587939697,0.8041288225651662,1.0,8/38,5.08%,CAV1;CD47;KLF2;HSP90AA1;INSR;CD34;KLF4;ATP2B4
prerank,bile acid metabolic process (GO:0008206),0.4172861742871754,1.0302699302391694,0.44026845637583895,0.7799665638266315,1.0,3/27,9.82%,CYP7B1;SLC27A2;OSBPL3
prerank,neural crest cell development (GO:0014032),-0.2823404938436186,-1.0301179854852094,0.4,0.8041152540163357,1.0,20/44,26.72%,SEMA6A;SEMA3C;SEMA3D;SEMA6D;SEMA7A;ERBB4;TBX1;SEMA4D;SEMA5A;SEMA5B;CDH2;SEMA3G;RADIL;SEMA6C;SEMA4B;SOX8;SEMA3B;SEMA4A;KBTBD8;SEMA6B
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3608916521498706,1.0296464021290177,0.426550598476605,0.7809564393550701,1.0,10/84,7.60%,IGF2BP1;IGF2BP2;SYNCRIP;APOE;ILF3;IGFBP5;EIF2AK2;CAPRIN1;GIGYF2;SAMD4A
prerank,monocyte differentiation (GO:0030224),-0.42714439705252105,-1.0289865902301238,0.4271604938271605,0.8054219595263635,1.0,3/10,2.29%,PIR;BMP4;IL31RA
prerank,positive regulation of response to stimulus (GO:0048584),0.39289346142845777,1.0289472786381473,0.4449877750611247,0.7820768752386972,1.0,12/40,22.52%,ADIPOQ;EEF1E1;WNT5A;SELENON;TGFB2;YPEL3;FMR1;CGAS;HMGA2;PRKCD;CDKN2AIP;CD80
prerank,protein localization to nucleus (GO:0034504),0.35370457406219685,1.028821349538832,0.43944265809217575,0.7819051924928642,1.0,26/102,19.56%,COL1A1;BCL3;STAT3;MORC3;PLK1;PRICKLE1;FAM53B;PINX1;SKP1;NUP153;TNPO1;CALR;E2F3;BMP7;RPL11;BANP;TOR1AIP2;NUP188;SEC13;AKT1;YWHAE;MDM2;TOR1AIP1;ZBTB7A;HEATR3;NUP214
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4655558906050698,1.0288061036442449,0.4536082474226804,0.7814605769783115,1.0,4/16,8.44%,SMC1A;NAA50;PDS5B;PDS5A
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.32636684350439227,-1.0279491618971257,0.37454545454545457,0.8065796082640758,1.0,6/22,8.92%,NCL;IPPK;WDR43;PHF8;PWP1;DHX33
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4666811342797055,1.0275855339468496,0.46153846153846156,0.7838926708525241,1.0,5/15,14.31%,RICTOR;CELF1;FGFR1;TGFB2;USP22
prerank,regulation of urine volume (GO:0035809),-0.4255436980164764,-1.027377080136061,0.41847826086956524,0.806435091133868,1.0,3/10,9.26%,NPR3;NPR1;INPP5K
prerank,primary miRNA processing (GO:0031053),0.4978379008879962,1.0272581080001442,0.45058626465661644,0.7842112566246945,1.0,3/10,15.19%,SMAD2;SMAD3;SMAD1
prerank,iron ion homeostasis (GO:0055072),0.370377608368175,1.0270858978578052,0.4232558139534884,0.784136600127367,1.0,11/58,14.51%,HEPH;CP;SLC11A2;FXN;CUL1;ACO1;SKP1;SLC22A17;IREB2;SMAD4;FRRS1
prerank,heterochromatin assembly (GO:0031507),0.44125888015058806,1.0268650548627232,0.43243243243243246,0.7841753607048753,1.0,7/20,20.05%,POLE3;MBD2;BAHD1;HDAC1;BAZ2A;ZNFX1;HMGA2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.323415905911775,-1.0267629963929896,0.4069767441860465,0.806276148823163,1.0,9/24,20.11%,ABCG2;CPOX;FLVCR1;SLC25A38;UROS;COX10;ABCB10;RSAD1;ALAS1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4845779520744051,1.0266449362273726,0.4523076923076923,0.7841787972647521,1.0,7/12,24.11%,CTSS;CTSL;CTSB;MED1;KLF9;THRB;CTSH
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.39648091234456384,-1.0264779299090199,0.4046242774566474,0.8051498375538504,1.0,8/13,35.63%,OGA;EXTL2;CHST3;RENBP;CHST7;NAGK;CHST2;CHST5
prerank,spliceosomal complex assembly (GO:0000245),-0.2750789808833919,-1.0263733094335366,0.41566265060240964,0.803586561714853,1.0,15/46,25.10%,CELF2;YTHDC1;PRPF6;SRSF5;RBM5;GCFC2;SNRPG;SRSF9;PRPF19;LUC7L3;DDX39B;CELF6;TXNL4A;SF3A1;SF3A3
prerank,regulation of biomineral tissue development (GO:0070167),0.41390462721788346,1.0262846503724912,0.43427835051546393,0.7845193237278529,1.0,3/26,5.42%,ENPP1;DDR2;CYP27B1
prerank,negative regulation of receptor internalization (GO:0002091),0.48038650593128956,1.0259001230986133,0.43993759750390016,0.7849342339721663,1.0,5/12,22.30%,ATXN2;DLG4;ANKRD13B;MTMR2;SDCBP
prerank,platelet degranulation (GO:0002576),0.35380026448292773,1.0255547667761318,0.44805876180482684,0.7852541231950664,1.0,14/118,6.60%,KNG1;SERPING1;SPARC;LHFPL2;TIMP1;PROS1;BLK;CD36;APOH;EGF;BRPF3;TGFB3;STXBP1;LAMP2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3968491361457512,-1.0253562276225228,0.44011976047904194,0.8045531002847026,1.0,5/13,16.23%,SORBS1;INSR;IGF1;IGF2;DYRK2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.28870913834781864,-1.0253267960409713,0.40625,0.8027761642065694,1.0,11/41,15.79%,ACTN2;AKAP6;ANK2;KCNJ2;KCNJ3;KCNJ10;ANK3;KCNQ1;KCNJ12;KCNN2;KCNN3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3238373667735109,-1.025253717873372,0.4172661870503597,0.8011395227553345,1.0,10/25,25.42%,LDB1;WDR43;ERCC6;EAF2;TSFM;SUPT4H1;CCNK;ZMYND11;DDX39B;THOC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5005321227915172,1.0252155644002914,0.45,0.784616804836791,1.0,2/10,5.88%,DNA2;XRCC3
prerank,t-circle formation (GO:0090656),0.5005321227915172,1.0252155644002914,0.45,0.784616804836791,1.0,2/10,5.88%,DNA2;XRCC3
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5005321227915172,1.0252155644002914,0.45,0.784616804836791,1.0,2/10,5.88%,DNA2;XRCC3
prerank,neural tube development (GO:0021915),0.4651325050948969,1.024922601380637,0.4623493975903614,0.7848294968234291,1.0,3/15,13.84%,ALDH1A2;PKD2;DACT1
prerank,regulation of rRNA processing (GO:2000232),-0.36898525122727377,-1.0248906368058606,0.39590443686006827,0.800273869129538,1.0,7/16,27.83%,RIOK1;WDR43;DIMT1;SIRT7;UTP15;NUDT16;TRMT112
prerank,negative regulation of response to wounding (GO:1903035),-0.3423190693481153,-1.0247757538145605,0.38562091503267976,0.7987777001091445,1.0,6/19,12.15%,EPHA4;INPP5F;CRK;AJAP1;GIT1;CD109
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4299093848977773,1.024756262991023,0.4308510638297872,0.7847265857512917,1.0,1/24,0.40%,CEMIP
prerank,negative regulation of histone acetylation (GO:0035067),0.4948767644927318,1.0246454891171708,0.4626865671641791,0.7844914574839746,1.0,4/11,19.16%,TAF7;NOC2L;SPI1;THAP7
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.25348971431656514,-1.0246121630457097,0.42990654205607476,0.7974322956336494,1.0,28/72,26.50%,ERCC5;COPS5;AQR;ISY1;ERCC6;ERCC3;UBC;COPS7B;EP300;UVSSA;POLD3;USP7;POLR2A;POLR2H;PCNA;POLR2G;POLR2F;PRPF19;GTF2H2;ERCC1;POLR2E;GTF2H4;RFC3;UBA52;GTF2H3;POLD2;RBX1;RPA2
prerank,RNA metabolic process (GO:0016070),0.3460137496932229,1.0240715039885873,0.44397905759162304,0.7853386960262285,1.0,45/127,23.27%,RBMS1;APOBEC1;ATXN1;SYNCRIP;ATXN2;SNRNP40;DDX17;WDR74;PABPC4;FTO;RNASEH1;GTF2F2;DICER1;SND1;DHX8;RNASEH2A;NCBP2;ALKBH1;HNRNPH2;PAPOLG;GTF2F1;RBM6;RNASE1;SETX;RBMX;HNRNPUL1;SIDT2;MTREX;RBFOX2;POLR2L;POLR2K;DDX20;RBM39;PARN;AGO2;LAGE3;DUSP11;RBMS2;DDX24;ZC3H12A;HNRNPC;RNASE3;RNASEH2B;POLR2D;PCBP1
prerank,positive regulation of protein kinase activity (GO:0045860),0.3437978499981536,1.0239791641462674,0.4626407369498465,0.7850696684258243,1.0,45/148,22.25%,IL34;IL23R;MAP4K4;TAOK1;JTB;LCP2;DDR2;CACUL1;CCL5;TOM1L1;DLG4;TAOK3;PTPN1;RASSF2;RPTOR;BORA;MAP2K1;TPX2;PTK2;SNX9;NRK;TGFB2;RHOA;TNF;NAB2;CALM2;SRC;PDCD10;IL6R;FCGR1A;ALS2;STK4;PTPRC;AGT;PRNP;IRGM;TELO2;HMGA2;PRKCD;MMD2;AXIN1;PAK1;MARK2;CLU;CSF1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4565663146342205,1.0238525581083402,0.4513788098693759,0.7848906711469881,1.0,3/17,5.97%,EGFR;PKD2;CCND3
prerank,glycerophospholipid metabolic process (GO:0006650),0.3589664805305196,1.0238523276445177,0.45302013422818793,0.784420210163188,1.0,19/75,19.58%,PLA1A;PDXP;PDGFRB;PIGW;CPNE7;PIGN;DGKH;PLA2G7;PIGL;PIGC;PLCB3;PLA2G4A;PIGP;PLA2G4E;PIGH;PLEK;PIP5K1A;CPNE3;GDPD3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3229866358801038,-1.0236100386568672,0.4048582995951417,0.7983426068022297,1.0,5/25,14.26%,RB1;IGF1;SIN3A;PER2;HEY2
prerank,apoptotic mitochondrial changes (GO:0008637),0.410564589489012,1.0234326262054332,0.4489528795811518,0.7849107421572112,1.0,13/32,22.86%,BBC3;HK2;BCL2;ATG3;AIFM2;CCAR2;GGCT;TIMM50;HSPD1;VPS35;THEM4;CLU;FZD9
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.4935202110522029,1.0233649980472734,0.47058823529411764,0.7845874182360424,1.0,6/11,17.60%,GHR;IRS1;GIGYF2;PIK3R1;AKT1;EIF2AK3
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3465381514946321,1.0232356093828037,0.475,0.7844189470472689,1.0,35/144,18.91%,CEMIP;SEC16B;TCF7L2;TM9SF4;BBC3;E2F1;UBR5;BAG3;BCL2;PCM1;NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;PCNT;ZIC1;SEC16A;YWHAZ;CASP8;GSK3B;MICALL2;PIK3R1;SMAD3;PSEN1;PDCD10;ITGB1BP1;SH3GLB1;YWHAE;LEPROT;ICE1;USP36;BCAS3;ARIH2;PRNP
prerank,positive regulation of peptidase activity (GO:0010952),-0.3477011390390562,-1.0229797206357185,0.4175084175084175,0.7983404514776691,1.0,7/20,13.22%,APH1A;NDUFA13;VSIR;APH1B;PINK1;MAPK12;GRN
prerank,2-oxoglutarate metabolic process (GO:0006103),0.464411513687048,1.022837455218343,0.4471299093655589,0.7848896073137903,1.0,3/13,16.99%,DLST;IDH2;L2HGDH
prerank,axon development (GO:0061564),-0.24599796210123334,-1.0225995345052363,0.3963963963963964,0.7976296699522842,1.0,24/78,17.87%,DCC;GRM7;CTNNA2;NTNG1;CNTN4;ACTB;KLF7;SHTN1;DSCAML1;FGFR2;SLITRK1;PARD3;ANK3;MAP1A;APP;ZDHHC17;S100B;PAK3;SEMA5A;PLP1;PLPPR4;DHFR;APBB1;TAOK2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.33256229443658825,1.0223842033344817,0.4494494494494494,0.7854001101716165,1.0,79/348,18.23%,RBMS3;ITGB8;SEC16B;ADAM19;YAP1;SFRP4;NOS1AP;CRP;TLR2;FGF7;MITF;TLE1;TREM2;STAT3;E2F1;UBR5;EPHX2;LGALS9;LIMS1;CD36;EGF;DTNBP1;ATM;VSTM2A;EMILIN1;TMEM119;PTPN1;PID1;FUBP1;ANGPT1;MAPK11;MSN;CELF1;TNRC6B;TGFBR1;MAP2K1;WNT5A;SETDB1;MOV10;NFE2L2;DNMT3B;SPRY2;SETDB2;TNF;GSK3B;FGF2;NTRK3;P2RX7;DDRGK1;CTCF;SMAD3;PSEN1;BMP7;FMR1;PPHLN1;RPL11;PDCD10;RESF1;DTX3L;CD63;SMAD1;SMO;ITCH;HIF1A;FGF18;MED26;PRKAB1;POU3F3;ATF7IP;LAMTOR5;OLFM1;MAPK1;AKT1;CALCOCO1;EIF2AK3;ATF4;ETS1;INHBA;RBPJ
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4024719373927661,1.0222996050681343,0.44806007509386736,0.7851127552065414,1.0,6/34,6.39%,NRP1;DOCK1;MDK;LIMS1;CARMIL1;CDC42
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.40320787868134,-1.022118389007148,0.42120343839541546,0.7971297962301979,1.0,3/12,6.19%,PODXL;PTPRO;PROM1
prerank,negative regulation of growth (GO:0045926),0.3434354510904904,1.0217787346197145,0.43868921775898523,0.7858573250388098,1.0,20/121,14.44%,ENPP1;PPP1R9B;BCL6;SLIT3;SERTAD2;FRZB;CYP27B1;SFRP1;ENO1;CCAR2;BTG1;IP6K2;ACVR1B;RERG;PTPRJ;TGFB2;SPHK2;SMAD3;CDKN1B;SMAD4
prerank,negative regulation of nuclear division (GO:0051784),-0.4104361630132319,-1.0215689674764583,0.42159383033419023,0.7968959282781781,1.0,2/11,1.76%,TOM1L2;BMP4
prerank,regulation of stress fiber assembly (GO:0051492),0.3622280362909355,1.021367511744124,0.46265328874024525,0.786294831795343,1.0,19/74,14.73%,DLC1;SLC9A1;NRP1;ASAP3;CARMIL1;NF2;ALMS1;SFRP1;TGFB3;CDC42;EPHA1;CGNL1;TGFBR1;RHOA;ARHGAP6;PIK3R1;ARHGEF18;PHLDB2;RAC1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.4261937826200515,-1.020835812371485,0.42780748663101603,0.7971226083220254,1.0,3/10,21.32%,VSIR;TLR4;NCKAP1L
prerank,cAMP-mediated signaling (GO:0019933),0.42003824854276633,1.0207842245832315,0.43191196698762035,0.787198434149056,1.0,4/24,6.40%,PDE3A;PDE7B;ADCY2;AHR
prerank,regulation of neuron projection development (GO:0010975),0.34213620456950367,1.0206720424746936,0.47579814624098865,0.7870028608152286,1.0,33/163,15.66%,ROR2;ROR1;PTN;MYLIP;LRRK2;DPYSL3;MARK1;TENM3;EPHB3;APOE;MDK;KIF13B;PTEN;FZD1;ABI2;WNT5A;DBN1;DISC1;GAK;PTPN9;DENND5A;FBXO7;CAMSAP2;GSK3B;NTRK3;RTN4RL1;PSEN1;ARHGAP35;PTK7;CX3CL1;FES;SETX;NDEL1
prerank,neuron fate commitment (GO:0048663),0.4640103726686145,1.0205492881083973,0.4464555052790347,0.7868148413388873,1.0,2/14,9.03%,SHH;TGFBR1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4995833416014297,1.0205168551856416,0.4512743628185907,0.7864191507672478,1.0,3/10,11.59%,MTHFR;MTHFD1L;MTHFD2L
prerank,positive regulation of vacuole organization (GO:0044090),0.49829329487447227,1.0204620926125436,0.4587301587301587,0.7860885179586594,1.0,7/10,26.81%,PIP4K2A;RAB3GAP2;RAB3GAP1;SH3GLB1;RALB;ANXA2;PIP4K2B
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3756365280177591,1.0203495223888976,0.45813953488372094,0.785893463345019,1.0,17/52,18.76%,LRP1;NKD2;EGFR;TREM2;GPSM2;ITGA3;PTPN9;GNAI1;TNF;KIF5B;PIK3R1;EPB41L2;STAC3;SQSTM1;AKT1;CLIP3;SPTBN1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.3740586288313222,-1.0201996598436964,0.408955223880597,0.7969752452176673,1.0,5/15,14.46%,CPEB3;PABPC1;TOB1;TNRC6C;POLR2G
prerank,ribosomal small subunit assembly (GO:0000028),0.45578647534195615,1.0199972785906293,0.45614035087719296,0.7862195810872992,1.0,1/16,0.80%,RPSA
prerank,regulation of lipid metabolic process (GO:0019216),0.35528920083597915,1.0198603681111147,0.44884488448844884,0.7860672555449244,1.0,11/88,10.57%,RORA;NCOR2;MVK;CREBBP;PPARG;LACTB;CARM1;TBL1X;PANK2;NPC2;CHD9
prerank,cellular protein localization (GO:0034613),0.33385937821462164,1.0198300551491992,0.46834170854271356,0.7856628531879019,1.0,68/285,18.78%,CLTC;SH3PXD2B;SEC31A;LRRK2;WIPI1;COPA;FGF7;AP4M1;COPZ2;STX6;AP3B1;EGFR;ARCN1;TM9SF4;ITSN1;ARFGAP3;TBC1D16;COPZ1;ARMCX3;STX17;RAP2A;RAB21;SNX8;STXBP1;TBC1D2B;COPB2;RABGAP1L;MYO7A;ANGPT1;AP3D1;TBC1D8B;RRAGC;RABGAP1;WNT5A;RAB3GAP2;STXBP3;RAB32;WLS;ARF4;SEC23IP;SNX9;PACS2;TMED1;TBC1D1;ADPRH;RAB1A;ARF1;TBC1D10B;NIPBL;CD63;SNX15;STX11;SMURF1;RTP4;WDR45;COG7;TM9SF2;SEC13;CTSA;CTTN;STX1B;SCFD2;SCFD1;LAMTOR3;ARL5A;TMED5;EPB41L3;AXIN2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.33299852247335954,-1.0197883794103497,0.42028985507246375,0.7963128714146819,1.0,7/20,23.26%,BICD1;YWHAB;GRK2;RNF157;MRAP2;RPGRIP1L;STMN1
prerank,nucleotide catabolic process (GO:0009166),-0.3675286444778534,-1.0197019762657809,0.4426229508196721,0.7948152782321789,1.0,6/16,18.00%,NT5E;NUDT3;SAMHD1;ITPA;DERA;NT5C
prerank,regulation of peptide hormone secretion (GO:0090276),0.3623053204545781,1.0195859030128407,0.43973214285714285,0.7857680077477309,1.0,12/67,13.20%,CACNA1A;CHD7;RAPGEF4;PRKCA;CACNA1C;ITPR1;KCNA5;CCL5;EIPR1;GCK;TNF;KCNS3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.42093657398233175,-1.0193407813065425,0.44751381215469616,0.7940323040620668,1.0,2/10,3.17%,PODXL;DPP4
prerank,peptidyl-serine phosphorylation (GO:0018105),0.33988200127120455,1.0193358197391917,0.47156153050672184,0.7858894298127767,1.0,49/153,23.25%,NEK6;MAST4;LRRK2;PRKCA;MARK1;RICTOR;IKBKE;AKT3;CAMK2D;PRKD2;MORC3;ATM;PLK1;HIPK4;MAST2;ATR;TGFBR1;CSNK2A1;CSNK2A2;HIPK3;RPS6KB1;CSNK1G2;GSK3B;CSNK1A1;MKNK1;VRK3;RIPK1;PRKDC;STK4;CSNK1D;MAPK1;AKT1;LATS2;EIF2AK3;DCLK3;MAP3K12;PLK2;PRKCD;DYRK1A;VRK2;PKN1;RPS6KA4;MARK2;CDC7;LATS1;ROCK2;ROCK1;RPS6KA3;NLK
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.34625228905083644,1.0182212934626138,0.4564755838641189,0.7879996926686517,1.0,32/113,22.34%,MMP3;ABCA1;ASAP1;FSCN1;CD36;ATM;GTF2H1;TIRAP;LCP1;ATR;BRK1;FNIP1;TNF;GSK3B;SRC;PLEK;SH3GLB1;DDB1;TPPP;ICE1;SLF2;PIEZO1;CAPG;PSMC6;ERCC2;EIF4G1;ISG15;TERF1;RHOC;RAP1B;CLU;RPA1
prerank,membrane protein proteolysis (GO:0033619),0.3886913196156766,1.018197688068651,0.4434782608695652,0.7875750920146524,1.0,12/37,21.40%,ADAM19;PRTN3;MYH9;SPPL3;PSEN1;PSENEN;RBMX;RHBDD1;NCSTN;ADAM9;PSEN2;HM13
prerank,focal adhesion assembly (GO:0048041),0.42605052976398183,1.017792848820596,0.44049247606019154,0.7880455219951746,1.0,3/21,5.21%,DLC1;PEAK1;RHOD
prerank,synaptic vesicle transport (GO:0048489),-0.41793975558227103,-1.0177285816529784,0.43041237113402064,0.7966381195631784,1.0,5/11,16.82%,RAB27A;SNAPIN;TOR1A;SYNJ1;DNM2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.48750462809294304,1.0176623395367757,0.4788732394366197,0.787869124284968,1.0,2/10,7.04%,CD40;BAG6
prerank,monocarboxylic acid transport (GO:0015718),0.3764365964428208,1.0174027587373988,0.45876887340301975,0.7879877312901997,1.0,5/51,6.45%,NR1H4;ATP8B1;SLC10A6;CD36;SLC16A12
prerank,negative regulation of viral transcription (GO:0032897),0.4648560203748165,1.0171600341208697,0.45904173106646057,0.7880874437290507,1.0,3/13,7.89%,UBP1;TRIM21;TRIM13
prerank,regulation of glucose import (GO:0046324),0.4071062392865179,1.0169787689837355,0.46895640686922063,0.7880358847549819,1.0,3/30,2.62%,ENPP1;ADIPOQ;IRS1
prerank,positive regulation of locomotion (GO:0040017),0.4175536049965756,1.016904212017187,0.463254593175853,0.7877493311415208,1.0,3/27,4.99%,PDGFRB;TREM2;AIF1
prerank,DNA strand elongation (GO:0022616),-0.35355341061916495,-1.0168148545984483,0.4212218649517685,0.7973920142541933,1.0,12/18,30.44%,MRE11;POLD3;GINS3;DCLRE1B;MCMDC2;RFC3;GINS4;RAD50;POLD2;GINS1;RFC4;MCM3
prerank,metanephros development (GO:0001656),0.4178802015670599,1.01658722822726,0.4454787234042553,0.7880187032933714,1.0,4/26,5.10%,ROBO2;SHH;PKD2;NF1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4413108436990951,1.0165324070696617,0.4481792717086835,0.7876793866250539,1.0,3/18,6.47%,IRS1;SFRP1;INHBB
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3742028577960571,1.0163879218389733,0.4470158343483557,0.7875419346843907,1.0,9/48,14.73%,CEMIP;XCL1;CAMK2D;CXCL10;FKBP1B;SELENON;UBASH3B;CALM2;CX3CL1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.39524206575172244,-1.0161687718783377,0.4233128834355828,0.7973776151964821,1.0,4/13,10.43%,CAV1;CALM1;ANK3;PDE4D
prerank,nucleotide biosynthetic process (GO:0009165),-0.35856426025689736,-1.0159512945004678,0.3896551724137931,0.7962532401373569,1.0,4/18,9.41%,PRPSAP2;ME1;NMNAT3;PRPSAP1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3923451931847959,-1.0158292000114129,0.415929203539823,0.7948860817408234,1.0,4/13,10.21%,NOS3;CALM1;HSP90AA1;PTS
prerank,positive regulation of mitochondrial translation (GO:0070131),0.47749600436452455,1.015812861875259,0.465592972181552,0.7884071514169243,1.0,2/14,6.91%,RPUSD3;TRUB2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.48712380206863926,1.0156997720335306,0.4755905511811024,0.7881941231246169,1.0,6/12,25.91%,MDK;MIA3;AKT1;FUT4;ASS1;PPARA
prerank,positive regulation of viral transcription (GO:0050434),0.42242868651703414,1.0154332733453117,0.44170096021947874,0.7883667024750632,1.0,8/25,18.45%,MDFIC;GTF2F2;RSF1;GTF2F1;CCNT1;POLR2L;POLR2K;CDK9
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3160548267275778,-1.0153043881918933,0.4375,0.7945626771140549,1.0,4/27,1.87%,PDE4B;CAV1;CTNNA3;ANK2
prerank,inositol lipid-mediated signaling (GO:0048017),0.37187040293319285,1.0147309956658648,0.4651711924439197,0.7894742214367213,1.0,13/50,13.29%,PDGFRA;GAB2;IRS1;PDGFRB;OGT;PLCL1;EXOC1;RPS6KB1;FGFR1;PLCB3;RHOA;PI4KA;PIK3R1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4308470106781737,1.0144580726707073,0.444141689373297,0.7896392286714625,1.0,5/22,14.55%,LACC1;WNT5A;TNF;SPHK2;TRPM4
prerank,termination of RNA polymerase I transcription (GO:0006363),0.40174020325293985,1.0144288958829162,0.4624203821656051,0.7892402502302729,1.0,13/30,23.36%,TAF1D;POLR1E;GTF2H1;CDK7;POLR1B;TAF1A;POLR2L;POLR2K;POLR1G;ERCC2;POLR1A;CCNH;MNAT1
prerank,cellular response to radiation (GO:0071478),0.38642155907900494,1.0143037340515642,0.4493116395494368,0.789077817467067,1.0,14/40,24.47%,TNKS1BP1;INO80;GRB2;OPN1MW;OPN1MW3;TANK;CLOCK;GPR88;RAD9A;SWI5;GADD45A;RRH;RAD51;CDKN1A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4886251389995341,1.0142754044668574,0.4864864864864865,0.7886784370129413,1.0,4/11,26.68%,NRP1;RAC1;PAK1;BCAR1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.43100128676949023,1.0140174954544294,0.46078431372549017,0.7888435239631758,1.0,7/21,18.54%,KLHL22;MAD2L1;ATM;PLK1;MAD1L1;TEX14;FBXO5
prerank,embryonic hemopoiesis (GO:0035162),0.4762029221246631,1.0140160515295515,0.46635367762128327,0.7883853847920791,1.0,1/12,0.42%,KMT2A
prerank,endothelial tube morphogenesis (GO:0061154),0.49614275014290743,1.0137707092599775,0.4697986577181208,0.7884983113521737,1.0,6/10,21.40%,PRKD2;CCM2;RHOA;ACVRL1;RBPJ;STARD13
prerank,anterograde axonal transport (GO:0008089),0.3929645808655748,1.0137287993781599,0.4533169533169533,0.78811937318034,1.0,8/37,9.93%,AP3B1;KIF1C;TRAK1;AP3S1;DTNBP1;RAB21;AP3D1;RAB27B
prerank,axonal transport (GO:0098930),0.3980523620095694,1.013629368460607,0.45510455104551045,0.787870773518518,1.0,7/36,12.26%,AP3B1;DYNC1H1;AP3S1;DTNBP1;RAB21;AP3D1;FBXW11
prerank,folic acid-containing compound metabolic process (GO:0006760),0.437486314786964,1.013046007867197,0.4530612244897959,0.7887106668523609,1.0,10/19,27.34%,MTHFR;MTHFD1L;MTHFD2L;GGH;MTRR;SLC19A1;ALDH1L2;MTHFD1;FOLR2;SLC25A32
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4130998071977779,1.0129036381706304,0.45806451612903226,0.7885881672979626,1.0,11/28,26.27%,SH3KBP1;TNFSF11;CCL2;PRKDC;HSPD1;TNIP2;SIRPA;CCDC88B;CYRIB;THY1;PYCARD
prerank,telomere organization (GO:0032200),0.38389377955027376,1.012858195293334,0.45138055222088835,0.7882202212001771,1.0,10/43,15.88%,PARP3;DNA2;ATM;TERT;ATR;SP100;LTO1;RIF1;CTC1;PRKDC
prerank,extracellular transport (GO:0006858),0.4764855901876941,1.0127721906506324,0.4626865671641791,0.7879452700966808,1.0,2/12,6.77%,DNAAF4;SPEF2
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4116546477698003,1.0123048292494339,0.4616384915474642,0.7885772463436116,1.0,8/25,21.74%,SULF1;SMAD2;ACVR2A;SMAD4;ACVRL1;RBPJ;BMPR1A;ZNF423
prerank,regulation of protein phosphorylation (GO:0001932),0.3326702250285042,1.012181646610176,0.46153846153846156,0.7884014261144099,1.0,69/256,21.81%,C3;EPHA7;IL34;ADIPOQ;FBLN1;LRRK2;CD40;FGF7;EGFR;TREM2;PTPN13;PTEN;FAM20A;CCND3;LRP6;RAP2A;TMEM119;PID1;ANGPT1;GPNMB;EFNA5;NIBAN1;FBH1;PPP2R5A;FNIP1;WWTR1;IBTK;PTK2;BMPER;ZBED3;ACVR2A;TNF;VEGFC;FGF2;NTRK3;WDFY2;BMP7;FMR1;RAC1;RIPK1;FGF18;PRKDC;NSD1;STK4;PELI2;CSNK1D;AKT1;BRD4;EIF2AK3;ATF4;CLIP3;PLXNB2;XDH;AXIN2;PRNP;DVL2;IRGM;STAT2;CORO1C;PIN1;SPTBN4;NDUFS4;ZC3H12A;SIRPA;NPTN;PPP2R5C;AXIN1;VEGFB;PAK1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.42088267104143623,1.011579081240113,0.4528301886792453,0.7893042421204546,1.0,4/22,12.52%,ALDH1A2;CYP27B1;CYP1A1;CYP2R1
prerank,protein-containing complex subunit organization (GO:0043933),0.3429353560247704,1.0114699906387086,0.46559139784946235,0.7891115206243318,1.0,25/109,17.95%,KMT2A;YAP1;LAMC1;SKAP2;CD40;MITF;WIPF1;PPID;CREBBP;LLGL1;DLG4;KPNA3;ADD2;TEAD1;SNX9;TSPAN4;SPG7;TRAF2;RANBP9;NDC1;TUBGCP4;NUP35;MDM2;PICALM;CAPZA1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.3769429803068145,1.0104178188216038,0.4618991793669402,0.7910561039428927,1.0,13/47,21.08%,CRP;PDGFRB;DHRS4;CD36;PID1;GRB2;RIPK1;AGT;XDH;GADD45A;DCXR;PRKCD;ZC3H12A
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3790474328218048,1.0103705691772435,0.47325581395348837,0.7906989324711832,1.0,15/48,17.75%,RHOJ;CD40;PRKCA;AKT3;PRKD2;STAT5A;ANGPT1;ANXA1;FGFR1;FGF2;HIF1A;FGF18;AKT1;MAP3K3;ETS1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.35602555408555786,1.0102335095613677,0.46420581655480986,0.7905515321899199,1.0,17/77,15.12%,TCF7L2;CFLAR;FXN;BCL2;ACVR1;SIAH2;BCL2L2;NOC2L;SH3RF1;TGFBR1;CSNK2A1;CSNK2A2;PELI3;TNF;SRC;CX3CL1;RIPK1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.45296407782315395,1.0100526164371735,0.4537177541729894,0.7905095146187994,1.0,3/15,6.99%,EGFR;EGF;PTPN18
prerank,regulation of multicellular organismal development (GO:2000026),0.41749530186640393,1.0099825889622787,0.4777327935222672,0.7902221957992709,1.0,7/25,17.21%,PTN;EHMT1;HPSE;BAG6;MYSM1;NIPBL;DUSP6
prerank,myoblast fusion (GO:0007520),0.4799719351699655,1.0092670187032124,0.4816,0.7913922067896323,1.0,4/12,9.87%,ADAM12;ADAMTS15;ADAMTS5;PTGFRN
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.40690164323401257,1.0092657982716369,0.4507978723404255,0.7909361897022464,1.0,8/28,16.85%,PARP3;ACTR2;SHLD3;SETMAR;RIF1;DTX3L;PRKDC;PNKP
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.284235194216949,-1.009098863183505,0.4362745098039216,0.8095834202396929,1.0,15/36,24.77%,MECOM;PRKN;EZR;PER1;SH3RF2;DUSP10;PINK1;CYLD;QARS1;GPS2;HDAC3;PPIA;ZMYND11;DUSP19;MEN1
prerank,cellular response to interleukin-12 (GO:0071349),0.3766920666901551,1.008165469030914,0.47368421052631576,0.7930325259219895,1.0,14/48,21.94%,JAK1;JAK2;RALA;CDC42;MSN;LMNB1;LCP1;TALDO1;ARF1;TYK2;CAPZA1;HNRNPDL;SIRPA;RAP1B
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.35817411756373074,-1.007972779213343,0.4166666666666667,0.81088697343172,1.0,4/17,8.61%,FCHSD2;CTNNA2;NCKAP1;WASF1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.37110434132606823,1.007948612011442,0.48383233532934133,0.7930662407817628,1.0,13/48,19.83%,PAPSS2;DCAKD;ADCY7;ADCY2;SLC25A16;NPR2;PANK2;SLC35B3;COASY;PANK1;AMPD2;IMPDH2;AMPD3
prerank,response to gamma radiation (GO:0010332),0.41133210458852815,1.007652847422122,0.4886515353805073,0.793285320886465,1.0,4/24,8.81%,YAP1;ATM;TRIM13;ATR
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.31369293720883507,-1.007487018872367,0.4349593495934959,0.8104192009501066,1.0,5/25,10.64%,CTNNA3;CXADR;CD200;VCAM1;ITGA4
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.39391110155650955,1.0074210388622553,0.44938271604938274,0.7933496343684926,1.0,7/35,14.73%,C3;RAB21;CBL;VTN;ARF1;MKLN1;RAC1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.4812253745356967,1.0073879268162045,0.4603658536585366,0.7929724949103777,1.0,3/11,11.44%,ZFPM2;JAG1;TGFB2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.43947761233506927,1.007204280334224,0.4463768115942029,0.7929393475622322,1.0,6/17,14.97%,PRKCA;CD36;LY96;SASH1;CX3CL1;TRIB1
prerank,vitamin D metabolic process (GO:0042359),0.46147707984889424,1.0071930386350216,0.4694189602446483,0.7925073299334121,1.0,3/13,12.52%,CYP27B1;CYP1A1;CYP2R1
prerank,smooth muscle tissue development (GO:0048745),0.47561910451254175,1.0071218663885197,0.46153846153846156,0.7922051606222841,1.0,4/10,15.46%,SHH;NF1;MYLK;SMO
prerank,triglyceride metabolic process (GO:0006641),0.3733127128166369,1.0070589188776116,0.477751756440281,0.7918826801856844,1.0,7/48,13.16%,LIPC;APOE;APOH;LPL;GK;FABP5;GPAT3
prerank,axon guidance (GO:0007411),0.33127729267042816,1.0069692593297872,0.47469635627530365,0.7916360859982227,1.0,33/201,11.84%,EPHA7;LAMA2;PALLD;GLI2;CXCL12;LAMA1;ROBO2;SH3KBP1;GAB2;SLIT3;SLIT1;EFNA4;PRKCA;NRP1;PLXNC1;EPHB3;SHH;OPHN1;EPHA1;PLXND1;L1CAM;GRB2;PLXNA3;EFNA5;CXCR4;WNT5A;FRS2;SEMA3E;PTK2;DSCAM;DRAXIN;PTPRM;UNC5B
prerank,translational elongation (GO:0006414),-0.2300038066588474,-1.006947114187934,0.40789473684210525,0.8101114174029951,1.0,48/101,31.25%,MRPS9;MRPS35;MRPS28;MRPS15;EEF1B2;MRPS24;MRPL13;MRPL10;MRPL21;MRPL39;GTPBP2;ERAL1;TSFM;RACK1;PTCD3;MRPL4;MRPS7;MRPS31;EEF1G;EEF1D;MRPL30;MRPL28;MRPS18C;MRPL22;MRPL40;GADD45GIP1;MRPL46;MRPS16;MRPS18B;MRPL58;MRPS22;MRPS6;MRPS25;MRPS12;MRPS34;MRPL44;EEF2;MRPL18;MRPL20;MRPL35;MRPL23;GFM1;MRPL42;MRPL43;MRPL54;MRPL34;MRPL2;MRPS10
prerank,regulation of lipid biosynthetic process (GO:0046890),0.4028338430673555,1.0069302837024308,0.48365122615803813,0.7912706748366733,1.0,3/32,3.78%,C3;ADIPOQ;APOE
prerank,regulation of mitotic nuclear division (GO:0007088),0.36951799717373596,1.0067720777173925,0.4719904648390942,0.7911702681149123,1.0,20/55,24.43%,EDN3;PDXP;PDGFRB;EGF;TOM1L1;BORA;DRD3;BTC;BMP7;RCC1;OBSL1;FBXO5;LRP5;PIN1;CDK13;RGCC;IL1A;PRMT5;PHIP;CUL9
prerank,positive regulation of protein secretion (GO:0050714),0.356964510442621,1.0063870326598743,0.46265328874024525,0.7915805811956739,1.0,14/69,11.60%,TCF7L2;TLR2;TREM2;BLK;ABCG1;ACSL4;PPID;TGFB3;FRMD4A;EXOC1;WLS;PTPN23;TGFB2;GCK
prerank,insulin secretion (GO:0030073),-0.34821383982211696,-1.0062047888565822,0.4750830564784053,0.8103020547358174,1.0,7/19,23.69%,SELENOT;RAB11B;PTPRN2;ADCYAP1;PTPRN;RIMS2;CYB5R4
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.32636776205643936,1.0061842288396097,0.5020120724346077,0.7915472112083558,1.0,61/259,16.55%,TEKT4;PPP1R9B;DYNLL1;MAP4K4;EMP1;CEP19;NRP1;ASAP1;FSCN1;STK36;PARVA;PMP22;AIF1;RHOD;OPHN1;FGD4;CARMIL1;RAP2A;IFT88;PCM1;RAB8B;CEP41;EXOC4;EHD2;ACTR2;GBF1;S1PR2;MYLK;FAM161A;EXOC1;EXOC7;WDPCP;PCNT;WDR35;DISC1;PTPN23;ARF4;GALNT11;NPHP3;FGD6;IFT172;IFT81;PDE6D;SNX10;CFAP410;CPLANE1;P2RX7;RAB1A;AIF1L;DYNC2H1;DZIP1L;KIF27;CDC14A;RAC1;TTC39C;EMP3;EXOC5;EXOC3;NUDCD3;POC1B;WDR90
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.38839042696334924,1.005914698210946,0.48692403486924035,0.7916874145487656,1.0,8/38,12.43%,PRKCA;PUM1;CCL5;LY96;SASH1;OASL;ANKRD17;POLR3D
prerank,regulation of cell growth (GO:0001558),0.32863111595310307,1.0058514763610285,0.4801627670396745,0.7913800528931335,1.0,31/204,11.44%,ENPP1;MMP14;PPP1R9B;EIF4G2;BCL6;SLIT3;KLHL22;EGFR;SERTAD2;FRZB;FXN;CAMK2D;BCL2;PABIR1;CYP27B1;INO80;SFRP1;ENO1;CDC42;RPTOR;CCAR2;BTG1;EXOSC4;TGFBR1;CSNK2A1;IP6K2;PAPPA2;ACVR1B;RERG;PTPRJ;TGFB2
prerank,regulation of protein secretion (GO:0050708),0.3403711174303258,1.0052780858076502,0.48163693599160545,0.792188266584067,1.0,23/119,13.20%,CACNA1A;DNAJC1;RAPGEF4;PRKCA;CACNA1C;TREM2;APOE;ABCG1;ITPR1;KCNA5;PPID;CCL5;TGFB3;FRMD4A;LLGL1;EXOC1;DRD3;EIPR1;TGFB2;GCK;DPH3;TNF;KCNS3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3113262352367284,-1.0049692112161657,0.45121951219512196,0.8118810970802254,1.0,12/26,20.84%,NRXN1;PRKCZ;SHANK3;SLC8A3;CUX2;SHANK1;APP;RIMS1;RELN;SLC8A2;NLGN1;RIMS2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.296657073800318,-1.0048410219184916,0.467005076142132,0.8105259392101328,1.0,8/36,5.32%,CAV1;NPR3;NOS3;CALM1;HSP90AA1;PIK3CB;ATP2B4;SCARB1
prerank,glycerol metabolic process (GO:0006071),0.48752982528389177,1.0047512739262883,0.47875816993464054,0.7929039419028933,1.0,2/10,11.60%,PDXP;GK
prerank,endochondral bone morphogenesis (GO:0060350),0.48778087228108535,1.0047359038496073,0.5,0.7924843127692106,1.0,2/11,7.02%,COL13A1;TMEM119
prerank,sphingolipid metabolic process (GO:0006665),-0.23720203817626775,-1.004677406403849,0.39655172413793105,0.8092468888333951,1.0,22/108,10.49%,ST6GALNAC3;CERT1;PPM1L;TECR;ACER2;CERS4;SGMS1;ESYT2;PPP2R1A;SPTLC2;ESYT1;SPTLC1;ELOVL7;SGMS2;ENPP2;ELOVL5;DEGS2;SPNS2;HACD1;HACD3;GAL3ST1;HACD4
prerank,T cell homeostasis (GO:0043029),-0.4058752258654366,-1.0045101731855701,0.4601990049751244,0.8079372805104329,1.0,7/10,37.47%,PPP2R3C;NCKAP1L;ZC3H8;JAK3;FAS;FADD;PMAIP1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.39018176082669853,-1.0040743264441514,0.42696629213483145,0.8073549289727153,1.0,3/12,15.14%,SNAP25;STX3;STX2
prerank,positive regulation of heart contraction (GO:0045823),0.44264856772852773,1.0039224851584299,0.4830508474576271,0.7938401125316783,1.0,5/19,14.55%,EDN3;ADM;ATP2A2;TGFB2;TRPM4
prerank,mesenchymal cell development (GO:0014031),0.4400936432440916,1.0037803719472487,0.4656934306569343,0.7937323015960508,1.0,4/18,14.87%,SNAI2;HEYL;TAPT1;NOLC1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.400074840810876,1.0036335868307211,0.4885786802030457,0.793574227515592,1.0,2/33,2.74%,CYP1B1;SNAI2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3998638229241555,1.0036212069493013,0.4635416666666667,0.7931487350371254,1.0,10/32,14.73%,AUTS2;FSCN1;CARMIL1;CDC42;ABI2;ACTR2;BRK1;PIK3R1;SRC;RAC1
prerank,alpha-amino acid metabolic process (GO:1901605),0.36968374236857504,1.0034440701683747,0.47686832740213525,0.7930777890657101,1.0,5/45,7.20%,ALDH18A1;ASPG;MTHFR;ASNS;KYAT1
prerank,positive regulation of RNA splicing (GO:0033120),-0.30874158223621523,-1.003048927691523,0.466403162055336,0.8083169835161914,1.0,13/29,27.78%,NCL;U2AF2;CIRBP;POLR2A;DAZAP1;ERN1;HNRNPLL;NUP98;RBM3;SLC38A2;ZPR1;SF3B4;HSPA1A
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.449180154297195,1.00291644533166,0.49008498583569404,0.7938140679503128,1.0,6/16,17.14%,NOS1AP;APOE;TERT;TNF;HIF1A;AKT1
prerank,intermediate filament organization (GO:0045109),-0.3504129604351841,-1.0027615180562002,0.45,0.807378028437,1.0,8/17,30.30%,GFAP;BFSP2;KLHL24;BFSP1;DSP;TCHH;PKP2;NEFL
prerank,positive regulation of establishment of protein localization (GO:1904951),0.4352167240496109,1.002724667572213,0.48142857142857143,0.7937919249030299,1.0,5/18,14.46%,TREM2;CCT8;CEP120;TNF;CCT3
prerank,lymphocyte mediated immunity (GO:0002449),0.47341942395564507,1.0024319814304146,0.4909090909090909,0.7939877204414678,1.0,2/12,5.33%,JAG1;GNL1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3818372965211435,-1.0023520283474858,0.43641618497109824,0.8067708013169725,1.0,6/13,22.43%,HNRNPU;NELFB;LARP7;NELFA;SUPT4H1;NELFE
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3716510550404826,-1.002173004812033,0.4507462686567164,0.8055319247332311,1.0,5/15,11.77%,LEF1;JUN;CHD1;EP300;SP1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3898071647541861,1.0021035884694631,0.4625158831003812,0.7942942301792028,1.0,5/33,7.60%,ZFP36L1;IRS1;PTEN;NF1;PIK3R5
prerank,acylglycerol metabolic process (GO:0006639),-0.28862044224853234,-1.0019460015949229,0.44495412844036697,0.80446444156773,1.0,8/37,12.43%,DGKB;CAV1;MGLL;DGKI;ABHD6;DGKA;DGAT1;DGKG
prerank,regulation of phosphorylation (GO:0042325),0.3413116862095803,1.0015668069473072,0.4883474576271186,0.7951074952673444,1.0,34/120,20.96%,GLMN;DYNLL1;NRP1;CDKN2B;EGFR;NUP37;RAE1;CCL5;EGF;MCM7;OGT;FNIP1;NUP153;PTK2;DSCAM;GCK;PSEN1;BMP7;CDKN1B;NDC1;HIF1A;NUP35;NUP188;SEC13;ANKLE2;INHBA;PLXNB2;ZBTB7A;STAT2;NUP214;CORO1C;PIN1;NDUFS4;NUP107
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3525467085193008,-1.001078370844501,0.4405144694533762,0.8050296861136234,1.0,6/16,19.56%,SFPQ;DDX5;SRSF9;RBM17;SCNM1;HNRNPM
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4060769212535768,1.000927809716883,0.48817802503477054,0.7960160628574121,1.0,7/26,15.59%,ALPK1;TNFAIP3;NOD1;IRAK2;CASP8;TIFA;ITCH
prerank,rRNA transcription (GO:0009303),0.43601368592765744,1.0007926630881943,0.481962481962482,0.7958435083298451,1.0,5/17,20.16%,POLR1E;GTF3A;BRF1;GTF3C4;POLR1G
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4577303526594052,1.0000449149504136,0.4947683109118087,0.7970558778052688,1.0,2/14,8.35%,ADIPOQ;PRKAR1B
prerank,positive regulation of TOR signaling (GO:0032008),0.3776931604664799,1.0000040649698445,0.4721549636803874,0.796703603506844,1.0,15/40,21.25%,KLHL22;TREM2;RICTOR;MIOS;RPTOR;RRAGC;FNIP1;SMCR8;LAMTOR5;SEC13;GPR137;SIK3;LAMTOR3;TELO2;CLEC16A
prerank,negative regulation of interleukin-6 production (GO:0032715),0.39693057149053473,0.9992157416595959,0.47137150466045274,0.7979589077993878,1.0,9/27,22.97%,TNFAIP3;IRAK3;PTPN6;TNF;CX3CL1;ZC3H12A;SIRPA;NLRP12;CD200R1
prerank,positive regulation of receptor internalization (GO:0002092),0.4290364691835392,0.9990790534341153,0.4934725848563969,0.7978123919955271,1.0,5/22,14.82%,SFRP4;EGF;ANGPT1;FMR1;CD63
prerank,DNA damage checkpoint signaling (GO:0000077),0.40663339230657575,0.998906716020125,0.5033025099075297,0.7977741510968128,1.0,10/28,21.02%,BRIP1;E2F1;ATM;ATR;USP28;CLOCK;ATRIP;RAD9A;HINFP;MAP3K20
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4492049068492947,0.9978181580521456,0.4681159420289855,0.7998144015757176,1.0,10/16,27.70%,ATM;PINX1;SMG6;TNKS2;TERF1;SLX4;SMG5;TERF2;HNRNPA2B1;TINF2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3399376328729526,0.9974850429149313,0.47624076029567053,0.8000903142402755,1.0,23/124,12.49%,GPM6B;LAMB1;PPP1R9B;LRP12;ATXN10;APOE;BLK;IQCG;LIMA1;PKD2;OPHN1;CARMIL1;DTNBP1;VAPA;L1CAM;TTC17;FAM161A;WDPCP;SAMD14;TTC29;PTPRM;GSK3B;MICALL2
prerank,regulation of cytoplasmic transport (GO:1903649),0.48338695994009917,0.9971629017825494,0.47716535433070867,0.8003630123616259,1.0,5/11,17.06%,LRRK2;DNAJC13;MAP2K1;SRC;MAPK1
prerank,protein methylation (GO:0006479),0.3813457279136354,0.9971315999049851,0.4690265486725664,0.7999876442496434,1.0,20/40,27.81%,EHMT1;CARM1;CAMKMT;VCPKMT;NSD3;PCMT1;GSPT1;NSD1;ETFBKMT;PRMT3;SETD3;SNRPB;ETF1;N6AMT1;EEF2KMT;PRMT5;FAM98A;METTL21A;RAB6A;EEF1AKMT3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4826921357358334,0.9970453422756328,0.49319213313161875,0.7997338338915211,1.0,3/11,11.44%,ACVR1;TGFBR1;TGFB2
prerank,dendritic spine organization (GO:0097061),0.4018668026677128,0.9967917812108025,0.48344370860927155,0.7998475558188718,1.0,10/26,19.20%,EPHB3;TREM2;PTEN;CDC42;DLG4;ITGA3;ARF1;DOCK10;PRNP;MTMR2
prerank,membrane lipid metabolic process (GO:0006643),0.41784512896886106,0.9966952241647646,0.4925575101488498,0.7996056908716183,1.0,1/22,0.18%,CYP1B1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.45271914579815165,0.996563148698726,0.4583963691376702,0.7994560962874085,1.0,3/15,7.85%,TREM2;CD53;EHD2
prerank,protein O-linked mannosylation (GO:0035269),-0.34844788341662114,-0.9964181196178267,0.4912891986062718,0.8158945175756331,1.0,1/18,0.12%,TMTC1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3472534470231437,0.9959652396619709,0.48577680525164113,0.8003515987387495,1.0,19/82,17.54%,DYNLL1;DYNC1H1;TUBG1;ALMS1;PLK1;PCM1;HAUS3;CEP41;CNTRL;DCTN3;TPX2;PCNT;CEP72;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5
prerank,negative regulation of heart contraction (GO:0045822),-0.3940730802368201,-0.9957081158291633,0.49066666666666664,0.81610506564805,1.0,3/11,10.43%,ATP1A2;GRK2;PDE4D
prerank,establishment of vesicle localization (GO:0051650),-0.345630984961392,-0.9948902989756698,0.4405144694533762,0.8166265447196853,1.0,8/18,23.10%,RAB27A;SNAPIN;TOR1A;SYNJ1;DNM2;TESK1;IKBKG;SYT11
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.23092338634351695,-0.9947427450788832,0.4666666666666667,0.8152964710394085,1.0,36/96,25.42%,YTHDC1;CDC40;SRSF5;WDR33;DDX19B;U2AF2;NUP133;UPF2;UPF1;SEH1L;POM121;SRSF7;SRSF9;RBM8A;NUP43;CHTOP;CPSF2;MAGOH;NUP210;NUP50;ZC3H11A;NUP98;HHEX;EIF4A3;SRSF3;POLDIP3;NUP93;CPSF4;SARNP;MCM3AP;DDX39B;NUP88;NUP85;DDX39A;DDX25;THOC1
prerank,response to thyroid hormone (GO:0097066),0.4652354061597204,0.994288217773301,0.49242424242424243,0.8035618917906365,1.0,7/13,24.11%,CTSS;CTSL;CTSB;MED1;KLF9;THRB;CTSH
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.3106078595810903,-0.9935138081717985,0.4765625,0.817002865289867,1.0,10/27,23.91%,SYT7;PPP3CB;RIMS1;VAMP7;SDF4;RIMS2;SYT12;SYT11;SYT13;SYT3
prerank,protein targeting to mitochondrion (GO:0006626),-0.25698003707284856,-0.9933128356162731,0.4647887323943662,0.8158724503098482,1.0,23/52,27.20%,IMMP2L;HSP90AA1;DNAJC19;BCAP31;GRPEL2;NDUFA13;DNAJC15;TIMM17B;GDAP1;TOMM20;TIMM21;SAMM50;IMMP1L;TIMM22;TOMM70;TIMM8B;ROMO1;TOMM5;TOMM40;DNLZ;CHCHD4;MFF;TIMM9
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4695605742694249,0.9932345535787964,0.5077399380804953,0.8054319593116985,1.0,2/13,5.88%,MAD2L1;XRCC3
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.3568324442252172,-0.9930476327020872,0.46735395189003437,0.8148478816900911,1.0,3/16,4.33%,KCNC2;NOS3;NDNF
prerank,regulation of multicellular organism growth (GO:0040014),0.4450044848742397,0.9930084862159427,0.48703170028818443,0.8055005118352548,1.0,2/15,6.10%,GHR;STAT5A
prerank,negative regulation of type I interferon production (GO:0032480),0.3737402479534469,0.9929155333657953,0.4777227722772277,0.8052430042575528,1.0,12/40,22.02%,TNFAIP3;REL;IKBKE;ILRUN;ITCH;RELB;PIN1;RNF135;ISG15;YY1;SIRPA;UBE2L6
prerank,regulation of pseudopodium assembly (GO:0031272),0.4913383078617743,0.9929031382068616,0.48973143759873616,0.8043675143666554,1.0,4/10,18.41%,CDC42;WASHC1;CDC42EP1;CDC42EP4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4913383078617743,0.9929031382068616,0.48973143759873616,0.8043675143666554,1.0,4/10,18.41%,CDC42;WASHC1;CDC42EP1;CDC42EP4
prerank,positive regulation of cell division (GO:0051781),0.37525949220144766,0.9927910502342632,0.4825,0.8041663754683088,1.0,9/38,14.53%,SVIL;SHH;CDC42;DRD3;OPN1MW;CSPP1;RHOA;GIPC1;CDC14A
prerank,male meiosis I (GO:0007141),0.44224822420671517,0.9927782754909836,0.47619047619047616,0.8037375017222291,1.0,3/16,12.98%,MYBL1;ZSCAN21;FOXJ3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.39904208830648347,0.9926525580423876,0.4946091644204852,0.8035795189456597,1.0,6/27,12.48%,PDGFRA;IRS1;PDGFRB;AMBRA1;PTK2;FGF2
prerank,cardiac muscle cell contraction (GO:0086003),0.4279501820579158,0.9922445139768717,0.4815340909090909,0.80400592658564,1.0,3/19,4.56%,CACNA2D1;CACNA1C;CAMK2D
prerank,regulation of neuron death (GO:1901214),-0.24270719319416398,-0.9920266313293826,0.4772727272727273,0.8158885929377669,1.0,26/82,22.18%,DCC;GRID2;PRKN;MAP3K5;CD34;RILPL1;PPARGC1A;BTBD10;CD200;SORL1;GRIN2B;TRIM2;DDIT4;TSC1;DHCR24;EGLN2;EPHB1;EGLN3;INPP5A;AKT1S1;NAE1;HTRA2;CHGA;SARM1;MEF2C;IKBKG
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3805619620787775,-0.991921984468323,0.4562841530054645,0.8144828568773963,1.0,4/12,12.90%,HNRNPU;NELFB;LARP7;NELFA
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.47137469521073755,0.9917607635887546,0.4774494556765163,0.8046703505142748,1.0,3/11,8.96%,BLK;LGALS9;ANXA1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.41932168200435793,-0.9914762487489082,0.47493403693931396,0.8140009556174456,1.0,3/10,7.06%,ATP1A2;OSR1;HECW1
prerank,receptor metabolic process (GO:0043112),0.3677034783639032,0.9913646901708879,0.47002398081534774,0.8051140453149127,1.0,16/53,18.00%,CLTC;LRP1;ARFGEF2;ADM;CD36;GRB2;CALCRL;KIF16B;PIK3R4;SNX25;SMURF1;NEDD4;GRK4;SH3GLB1;PICALM;REP15
prerank,Ras protein signal transduction (GO:0007265),0.3340192199082194,0.9909753737245853,0.5170984455958549,0.8054963929935872,1.0,37/137,18.74%,COL1A2;FARP2;RASSF1;PLD1;TAX1BP3;AIF1;NF1;RHOD;RAB42;RALA;RAP2A;GPSM2;ARHGDIG;ABI2;MAPK11;GRB2;BRAP;RERG;BRK1;SETDB1;RALGDS;PDPN;RIT1;DBNL;RHOA;ARHGAP6;FGF2;RTKN;RAC1;CDC42EP1;USP28;ARHGDIA;GNA12;CDC42EP4;GNB1;SHC2;EPS8
prerank,neuromuscular process (GO:0050905),0.44672372786556114,0.9908700575428707,0.48604992657856094,0.8052483656816594,1.0,4/16,11.46%,MYCBP2;HOXA1;UBA5;AGTPBP1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.40787793497479397,0.9903637241260087,0.4965893587994543,0.8059530325098593,1.0,8/24,14.73%,AUTS2;FSCN1;CDC42;ABI2;ACTR2;BRK1;PIK3R1;RAC1
prerank,organophosphate biosynthetic process (GO:0090407),-0.2846357064319646,-0.9899882158730282,0.4694835680751174,0.816290568521217,1.0,9/37,12.84%,GPHN;TPK1;MBOAT1;IPPK;PCYT2;PPIP5K1;AGPAT3;MOCS2;TPI1
prerank,retina homeostasis (GO:0001895),-0.3232139087519707,-0.9895859146801862,0.45195729537366547,0.8156587256420259,1.0,6/23,16.36%,ACTB;POTEF;HSPB1;WHRN;SOD1;BBS4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.40606835957508197,0.9895770687538055,0.4894179894179894,0.8072053440071231,1.0,7/24,17.01%,XCL1;ITPR1;PKD2;IBTK;FGF2;ANXA6;PTPRC
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.42547147729547913,0.9892855667406183,0.4986187845303867,0.807448200664584,1.0,7/22,18.07%,DYNLL1;CDKN2B;BMP7;CDKN1B;PLEK;ANKLE2;INHBA
prerank,energy reserve metabolic process (GO:0006112),-0.3376233782369251,-0.9886737816680075,0.46984126984126984,0.8163144239368352,1.0,3/19,5.04%,PRKAG2;GBE1;PYGM
prerank,response to acidic pH (GO:0010447),0.45612009609212634,0.9884969462672434,0.4878419452887538,0.8087280380192964,1.0,2/13,5.02%,SLC9A1;CTSS
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.36442350194038864,0.9882232078035799,0.49221556886227547,0.808853630842016,1.0,15/48,20.16%,ZMIZ1;TAF1D;SERTAD2;PADI2;PHF2;POLR1E;ARID1B;SPHK2;POLR1B;TAF1A;ASF1A;POLR2L;POLR2K;SERTAD1;POLR1G
prerank,response to zinc ion (GO:0010043),0.4009278458090596,0.9878210887538154,0.46963562753036436,0.8092924265739438,1.0,2/25,2.51%,HVCN1;PAM
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.3830791351194486,-0.9875977475618692,0.4537313432835821,0.8173641867985408,1.0,2/12,3.58%,IGF1R;INSR
prerank,negative regulation of cation channel activity (GO:2001258),0.40303822119464794,0.9872399982567444,0.49933774834437084,0.8101233347125503,1.0,7/26,14.28%,PKD2;CBARP;FKBP1B;KCNAB1;DRD3;CALM2;FMR1
prerank,cellular response to light stimulus (GO:0071482),0.3533740153455749,0.9871523603494109,0.4925544100801833,0.8098732590382549,1.0,20/66,24.87%,INO80;CREBBP;NOC2L;ATR;TMEM161A;OPN1MW;OPN1MW3;FMR1;NEDD4;USP28;GPR88;ATF4;RHBDD1;GNB1;KDM1A;PRKCD;YY1;RRH;EIF2S1;CDC25A
prerank,cellular response to hexose stimulus (GO:0071331),0.41326315214819553,0.9871215148370108,0.5048951048951049,0.8094967371102407,1.0,1/23,0.13%,SLC39A14
prerank,regulation of cilium assembly (GO:1902017),0.35371558872969855,0.9869976685751872,0.48761261261261263,0.8093163231848132,1.0,17/62,17.41%,YAP1;TBC1D16;IFT88;TBC1D2B;ATG3;DYNC2LI1;CDK10;RABGAP1;ENTR1;CEP120;TAPT1;TBC1D1;ARHGAP35;TBC1D10B;TBC1D19;TBC1D20;CDKL1
prerank,amino acid import (GO:0043090),-0.33692860316912066,-0.9869309142967769,0.4666666666666667,0.8175813990360304,1.0,7/21,11.55%,SLC47A1;SLC6A6;SLC7A5;SLC1A1;SLC6A1;SLC22A4;SLC25A38
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4081423521156438,0.9869075558986419,0.491869918699187,0.8090654059075016,1.0,7/23,21.82%,TNFAIP3;PYDC1;NLRP2B;CX3CL1;CPTP;ZC3H12A;NLRP12
prerank,homotypic cell-cell adhesion (GO:0034109),0.3770956320065087,0.9867131318017655,0.49056603773584906,0.8090632367334536,1.0,16/39,24.04%,PDGFRA;CSRP1;MYH9;STXBP1;STXBP3;UBASH3B;GNAS;PLEK;FERMT3;TYRO3;ACTN1;FIBP;P2RY12;MEGF10;ITGB3;METAP1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4140526159754793,-0.9862193677778612,0.49081364829396323,0.8178435340259562,1.0,4/10,6.69%,PDE4B;CACNB2;CALM1;NIPSNAP2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.45402220770568236,0.9860395584906463,0.4913294797687861,0.810054958414358,1.0,1/13,2.18%,CRP
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.36229347794015615,-0.9858832448582083,0.4631268436578171,0.8170530534611787,1.0,7/15,20.10%,FGF1;TMSB4X;HSPB1;SEMA5A;THBS1;PRKD1;LGMN
prerank,regulation of vesicle-mediated transport (GO:0060627),0.34321240175454953,0.9857954486779574,0.5207877461706784,0.8101632433968265,1.0,24/91,17.88%,STON2;LRRK2;NRP1;PLD1;OPHN1;RALA;DNAJC13;ARFGAP1;RAB21;RAB8B;PTPN1;GAS1;MAP2K1;RINT1;RAB10;SRC;FES;PTPRC;MAPK1;RUFY1;RAB33B;PICALM;ZFYVE16;SCFD1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3410350922751868,-0.9857212285599863,0.44299674267100975,0.8157867266120308,1.0,10/18,26.74%,DNAJC19;GRPEL2;DNAJC15;TIMM17B;TOMM20;TIMM21;TOMM70;ROMO1;TOMM40;DNLZ
prerank,regulation of organelle assembly (GO:1902115),0.3460856065183534,0.9854110826603958,0.4933184855233853,0.8105535967354981,1.0,20/72,17.44%,CEP295NL;ATXN2;TBC1D16;ALMS1;NPRL2;IFT88;TBC1D2B;ATG3;DYNC2LI1;MSN;RABGAP1;SENP6;TBC1D1;ADPRH;TBC1D10B;TBC1D19;TBC1D20;KIF9;CDKL1;MTMR3
prerank,positive regulation of autophagy (GO:0010508),0.3464965453823646,0.9848395638479354,0.5136612021857924,0.8113745240633781,1.0,12/81,13.03%,DCN;TRIML2;LRRK2;TRIM21;NPRL2;TRIM13;TRIM8;FOXO3;FBXO7;PLEKHF1;GSK3B;ORMDL3
prerank,nucleosome disassembly (GO:0006337),0.4469495832922332,0.9847223006784384,0.492816091954023,0.8107394465571142,1.0,5/14,22.80%,SMARCC1;GRWD1;SMARCA4;ARID2;SMARCD3
prerank,chromatin disassembly (GO:0031498),0.4469495832922332,0.9847223006784384,0.492816091954023,0.8107394465571142,1.0,5/14,22.80%,SMARCC1;GRWD1;SMARCA4;ARID2;SMARCD3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.43631861451265985,0.9845538929664086,0.5079365079365079,0.8106653976675607,1.0,3/18,11.12%,DNAAF4;SPEF2;NPHP3
prerank,positive regulation of phospholipase activity (GO:0010518),0.41694339306124595,0.9845110887643589,0.48801128349788436,0.8103088907913164,1.0,7/22,12.55%,PDGFRA;PDGFRB;CCL5;FGFR1;ARF4;FGF2;NTRK3
prerank,peptidyl-lysine methylation (GO:0018022),0.3973764564452333,0.9844906224930192,0.5067024128686327,0.8099153552848455,1.0,13/26,27.81%,ANTKMT;KMT5A;EHMT1;SETD2;VCPKMT;ETFBKMT;SETD3;N6AMT1;EEF2KMT;SETD7;SETD4;METTL21A;EEF1AKMT3
prerank,apical protein localization (GO:0045176),-0.41415844953385605,-0.9843768465541315,0.47191011235955055,0.8176502634892261,1.0,4/10,6.86%,MAL;ACTB;GOPC;SHROOM3
prerank,mRNA polyadenylation (GO:0006378),-0.31284246543073596,-0.9838508540539076,0.4653846153846154,0.8157106794645061,1.0,8/26,23.17%,WDR33;PABPC1;LEO1;APP;TUT1;CPSF2;CLP1;PAPOLB
prerank,RNA polyadenylation (GO:0043631),-0.31284246543073596,-0.9838508540539076,0.4653846153846154,0.8157106794645061,1.0,8/26,23.17%,WDR33;PABPC1;LEO1;APP;TUT1;CPSF2;CLP1;PAPOLB
prerank,chromatin remodeling (GO:0006338),0.33899362916056575,0.9837495400466579,0.5149253731343284,0.8111198413868668,1.0,30/100,22.80%,SATB2;BAZ1A;POLE3;MBD2;SMARCC1;BAZ2B;INO80;TADA2B;BAHD1;HDAC1;ARID1B;MTA2;GATAD2B;RSF1;RUVBL1;ATRX;MYSM1;BAZ2A;SRCAP;SMARCA4;HCFC2;HDAC5;ZBTB7A;MBD3;HMGA2;HNRNPC;PAK1;ACTL6B;CHD8;SMARCD3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3507120862606529,0.9833882692677322,0.47885714285714287,0.8114790466798941,1.0,15/63,15.12%,TCF7L2;CFLAR;ACVR1;TNFRSF12A;SIAH2;SH3RF1;SP100;TGFBR1;PELI3;FGFR1;CASP8;TNF;TRAF2;SRC;RIPK1
prerank,sensory perception of taste (GO:0050909),0.488813649040731,0.9833649289718557,0.5070422535211268,0.8110866491483453,1.0,2/10,16.22%,CD36;PKD1L3
prerank,positive regulation of interferon-beta production (GO:0032728),0.39458425954339327,0.983185171805143,0.48350253807106597,0.811050561218492,1.0,9/33,20.62%,TLR2;IRF7;TLR7;IRF1;POLR3A;POLR3D;TRIM56;RNF135;ISG15
prerank,activation of protein kinase activity (GO:0032147),0.33847198225712133,0.9829911793340942,0.5197860962566845,0.8110150786970014,1.0,20/106,13.07%,MAP4K4;TAOK1;GHR;JAK2;ADCY7;RICTOR;ADCY2;TOM1L1;TAOK3;TIRAP;MAPKAP1;ANGPT1;BORA;PRKAR1B;WNT5A;TPX2;NRK;TGFB2;NTRK3;TRAF2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3593200354734027,0.9828869922375598,0.49715585893060293,0.8108208273665948,1.0,22/56,23.85%,JTB;CHMP4B;PLK1;VPS4A;DCTN3;SPIRE1;SNX18;SNX33;SNX9;RHOA;BIN3;RTKN;RASA1;TTC19;KIF20A;SPTBN1;SON;RHOC;ROCK2;ROCK1;PDCD6IP;RAB35
prerank,negative regulation of phosphorylation (GO:0042326),0.34415905700911975,0.9825316684084942,0.5096153846153846,0.8111238507229035,1.0,24/85,21.21%,FBLN1;DYNLL1;LRRK2;CDKN2B;PTPN13;PTEN;LRP6;NPRL2;PID1;NIBAN1;WWTR1;IBTK;ZBED3;NTRK3;BMP7;CDKN1B;PRKDC;ANKLE2;INHBA;XDH;PRNP;CORO1C;ZC3H12A;SIRPA
prerank,positive regulation of secretion by cell (GO:1903532),0.34645956463977434,0.9823544840430867,0.515358361774744,0.8110787895318984,1.0,13/70,11.44%,EDN3;TREM2;RAB2B;ABCG1;PPID;DTNBP1;TGFB3;FRMD4A;UNC13D;RAB9A;EXOC1;RAB27B;TGFB2
prerank,positive regulation of nervous system development (GO:0051962),-0.27083331227830454,-0.9821051436572326,0.5080213903743316,0.8188113793131842,1.0,14/42,19.82%,NRXN1;GRID2;IL1RAPL1;CLSTN3;SYNDIG1;CUX2;LRRC4B;CLSTN1;PTPRD;BDNF;EPHB1;TRIM32;GPER1;NLGN1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4012488802235689,0.9820277951854713,0.5078534031413613,0.8113497396448167,1.0,11/27,23.02%,CUL1;CCM2;SKP1;MAPK11;FBXW11;MAPK1;KAT7;MAP3K20;TNIP2;RPS27A;MAP2K7
prerank,protein localization to chromosome (GO:0034502),0.3866830973511274,0.9816667783756113,0.5141800246609125,0.8117055404501189,1.0,12/34,18.98%,PARP3;PLK1;PINX1;LEMD2;ATR;MCM9;CHMP7;CTCF;ATRX;TNKS2;SLF2;WAPL
prerank,pulmonary valve development (GO:0003177),0.43195727484573393,0.9813276792858436,0.5148514851485149,0.8120113524290719,1.0,5/18,11.44%,ROBO2;JAG1;HEYL;TNFRSF1A;TGFB2
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.3477271012448887,-0.9809836947133805,0.4785276073619632,0.820119293138057,1.0,7/16,24.87%,COX7A2;PINK1;UQCC2;PDE12;SLC25A33;MLXIPL;PPIF
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3723692061441771,0.9809519594468579,0.5060975609756098,0.8124046995326812,1.0,6/43,7.31%,TAOK1;BABAM2;PABIR1;ATM;PLK1;TAOK3
prerank,regulation of protein localization to centrosome (GO:1904779),-0.41792222363895015,-0.980944451522111,0.5040650406504065,0.8185747557698778,1.0,2/10,4.50%,BICD1;APC
prerank,calcium ion import into cytosol (GO:1902656),-0.34355565466574783,-0.9807965864103654,0.45394736842105265,0.8172800936859022,1.0,6/15,19.38%,SLC24A2;ATP2B4;SLC8A3;TRPV2;TRPV4;SLC8A2
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.2901515616522742,-0.980666573082399,0.5045454545454545,0.8159925015908569,1.0,6/35,2.94%,SEMA6A;SEMA3C;SEMA3D;PLXNA4;SEMA6D;SEMA7A
prerank,microvillus organization (GO:0032528),-0.3752740990396838,-0.9799890013190375,0.48863636363636365,0.8161157662385882,1.0,6/13,11.64%,MINK1;EZR;FXYD5;RAPGEF2;RAPGEF6;RAP1A
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.39123619211742305,0.9795796173726564,0.5019059720457433,0.8149307200991905,1.0,4/28,8.41%,MMP14;EGFR;EGF;FBXW7
prerank,regulation of astrocyte differentiation (GO:0048710),0.4544144113205175,0.9795312385871393,0.49924585218702866,0.8145815611553987,1.0,1/12,1.44%,SERPINE2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.44104242456357196,0.9794699088884004,0.48672566371681414,0.8142580924621405,1.0,4/15,12.55%,CXCL12;IL16;VEGFC;NTRK3
prerank,myelin maintenance (GO:0043217),0.48347662775871414,0.979338447521598,0.5209003215434084,0.8140923521032597,1.0,4/10,22.12%,PTEN;CXCR4;EPB41L3;CLU
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4143579333195435,-0.9791006280362067,0.4826666666666667,0.8167397011395281,1.0,6/10,19.93%,SHANK3;APP;CAMK2B;SYP;SYNGR1;DRD2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.43304776828488134,0.9788888170504632,0.4933135215453195,0.8146199757040663,1.0,4/15,12.29%,APOE;SNX33;SNX9;TNF
prerank,glycine transport (GO:0015816),-0.4008431505210228,-0.9788270894282872,0.4641025641025641,0.8157955793564805,1.0,4/10,12.99%,SLC6A9;SLC38A5;SLC25A38;SLC6A17
prerank,mitotic DNA replication (GO:1902969),0.4722489356465305,0.9782901242370032,0.5062305295950156,0.815472647130619,1.0,2/10,7.30%,MCM2;LIG1
prerank,negative regulation of axonogenesis (GO:0050771),-0.2975643393587474,-0.9778675975456708,0.4875,0.8166459097680934,1.0,10/27,22.21%,MAP2;DCC;DIP2B;ULK2;CDKL3;MAG;LINGO1;SEMA3G;EFNB3;TRIM46
prerank,glycolipid biosynthetic process (GO:0009247),-0.27477471201697623,-0.9778360761856657,0.4852941176470588,0.8151001411073453,1.0,19/38,27.34%,ST3GAL4;ST3GAL5;ST8SIA6;B4GALT6;PGAP2;PIGB;GBGT1;ST6GALNAC5;PIGG;PIGF;DPM3;SCCPDH;ST8SIA3;PIGZ;PIGM;PIGU;PGAP3;PIGO;PIGA
prerank,cardiocyte differentiation (GO:0035051),0.48225685433314536,0.9778291748741869,0.5024154589371981,0.8160499950529451,1.0,3/10,12.60%,GATA6;TGFB2;AKAP13
prerank,nuclear membrane reassembly (GO:0031468),0.3593398136509957,0.9777627640964232,0.5148632580261593,0.815747918894011,1.0,18/54,20.96%,CHMP4A;CHMP4B;NUP37;VPS4A;LEMD2;PPP2R2A;CCNB2;CHMP7;NDC1;CHMP2B;NUP35;NUP188;RCC1;SEC13;ANKLE2;CC2D1B;UBXN2A;NUP107
prerank,aspartate family amino acid catabolic process (GO:0009068),0.42473398488192443,0.9777590169901722,0.5155807365439093,0.8153122139127681,1.0,7/19,21.44%,SDSL;CRYM;DLST;ALDH7A1;HYKK;PIPOX;SLC25A21
prerank,determination of left/right symmetry (GO:0007368),0.3811142516081069,0.9772511263355034,0.5104166666666666,0.8159564838925076,1.0,6/36,11.12%,DNAAF4;SHH;PKD2;DNAH11;GALNT11;NPHP3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.347309456238567,0.9771987718724043,0.5204419889502763,0.8156303204291114,1.0,14/68,22.05%,ENPP1;LRRK2;ACSF2;ACOT13;TPST1;SULT4A1;ENTPD7;ACOT9;AMPD2;AMPD3;PDE9A;HINT1;EPHA2;THEM4
prerank,peptide biosynthetic process (GO:0043043),-0.21400380490351398,-0.9767706745316326,0.5384615384615384,0.8161665734140114,1.0,53/153,22.53%,DMD;RPL34;RPL36;RPL8;RPS4X;COPS5;RPL18A;RPL19;RPL38;RPS21;MRPS15;RPL5;RPS10;RPLP0;RPL7;RPL13;MRPL13;RPS8;MRPL10;RPS23;RPL30;RPS12;RPL13A;RPL35A;RPL29;RPL32;DHPS;EIF4EBP2;RPL10;RPL15;RPS27;RPL35;RPS16;RPL7A;RPS15;MRPS7;RPS29;RPL27;RPS13;RPS19;ABCF1;RPL41;SARS1;RPLP1;MRPL28;WARS1;MRPS18C;RPL28;GSPT2;RPS17;MRPS16;MRPS18B;RPS6KB2
prerank,negative regulation by host of viral process (GO:0044793),0.4692533922631539,0.976519396752224,0.5007824726134585,0.8166547859980174,1.0,2/10,7.36%,CRP;VAPA
prerank,DNA double-strand break processing (GO:0000729),0.4299267261606648,0.9758537606079513,0.4950213371266003,0.8176333880227067,1.0,4/18,9.64%,DNA2;RAD52;ATM;SETMAR
prerank,protein localization to chromatin (GO:0071168),0.4245350690028634,0.9753836001669524,0.5151098901098901,0.8181637434141846,1.0,9/18,19.34%,PLK1;LEMD2;MCM9;CHMP7;LRWD1;PPHLN1;NIPBL;WAPL;TASOR
prerank,regulation of cell division (GO:0051302),0.3475717165304084,0.9753796211069787,0.5128205128205128,0.8177253535888237,1.0,20/72,21.19%,POU5F1;PDXP;SHH;PLK1;KLHL13;ZFYVE26;SETD2;CSPP1;INSC;ENTR1;CALM2;PIK3R4;FSD1;PIK3C3;SH3GLB1;KIF20A;PIN1;PLK2;MYO19;BECN1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3724160503883305,-0.9752974751025597,0.4890282131661442,0.8184923431545936,1.0,9/13,30.87%,GLRX3;NFU1;CIAO2A;YAE1;ISCA2;GLRX5;BOLA2;ISCA1;CIAO2B
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3762233425179399,0.9752037359115198,0.4987562189054726,0.8176855528769071,1.0,5/39,7.69%,TCF7L2;TNFSF11;BLK;ACSL4;AIMP1
prerank,cell-substrate junction assembly (GO:0007044),0.38227387529099366,0.9751748553218681,0.533498759305211,0.8172919893417059,1.0,4/33,5.21%,DLC1;LAMC1;PEAK1;RHOD
prerank,recombinational repair (GO:0000725),0.33915291988963875,0.9751189677526843,0.514626218851571,0.8169674586473588,1.0,17/77,18.69%,RAD51B;RAD52;INO80;XRCC3;MMS22L;ZFYVE26;FBH1;AP5Z1;MCM9;NSMCE2;RMI1;XRCC1;PSMD14;NUCKS1;HELQ;RBBP8;SWI5
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4761954577404628,0.9751010474771388,0.49836601307189543,0.8165591078256594,1.0,2/10,17.01%,LGALS9;PTPRC
prerank,endocytic recycling (GO:0032456),0.35939179684745687,0.9749178770538013,0.536928487690504,0.8165150155516624,1.0,14/50,16.56%,STX6;RAB7A;EHD2;VPS39;PTPN23;EIPR1;ENTR1;MICALL2;EPS15;CCDC93;ANKRD27;ACAP2;WASHC1;SNX4
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.29164557941715025,-0.9748572081443899,0.5265700483091788,0.8180327388615184,1.0,5/31,3.09%,SYNJ2BP;LRRC7;DLG2;LIN7A;EZR
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4243075957415351,0.9746544617376977,0.5064748201438849,0.816627999546419,1.0,8/18,19.20%,DNAJC13;RAB21;MSN;MAP2K1;PTPN23;SRC;MAPK1;MTMR2
prerank,skeletal muscle tissue development (GO:0007519),0.38154858688423315,0.9746287103515757,0.5094577553593947,0.8162366403511188,1.0,5/32,14.11%,SVIL;CFLAR;LEMD2;SELENON;EGR2
prerank,organic substance transport (GO:0071702),0.32880161528557095,0.9744010843494134,0.5168067226890757,0.8162973671245032,1.0,31/121,21.26%,ABCA1;TCN1;SLC6A2;ARRDC4;ABCA2;PLTP;MYH9;ABCG1;MIA3;LMAN2L;RAB7A;TCN2;ARRDC3;RCN3;PEX19;SLCO1B1;CALCRL;ABCA9;ABCG4;NDC1;CHMP2B;SNX4;RUFY1;HSP90B1;SLCO2B1;SLC50A1;TAP1;SLC18A2;TOM1;SLC19A1;MFSD12
prerank,response to progesterone (GO:0032570),0.43287594656138617,0.9733446911570401,0.5258019525801952,0.8181069796821633,1.0,5/18,14.47%,YAP1;TGFB3;TGFB2;SRC;CATSPER3
prerank,protein modification by small protein conjugation (GO:0032446),0.315639512234542,0.973112679101554,0.5915492957746479,0.818162178359141,1.0,95/361,21.72%,TRIML2;DTX4;DCAF15;PDZRN3;MYLIP;PEX10;MYCBP2;SPSB1;ARRDC4;FBXL7;USP9X;CUL1;SMURF2;NUP37;TRIM21;RAE1;CNOT4;RNF144A;PLK1;ANAPC11;PIAS2;MIB1;CDC27;ATG3;RNF111;KLHL13;SKP1;TRIM13;DCUN1D1;CBL;FBXW7;AREL1;ARIH1;UBE2F;BRAP;DTX2;UBE2L3;FBH1;NUP153;TRIM44;UBE2R2;UBA5;EIPR1;FBXO7;NFE2L2;RNF213;KCTD10;ATG7;PJA2;FBXW11;RNF181;ZSWIM8;UBE2K;NSMCE2;DDRGK1;UBE2W;FBXO2;EGR2;VCPIP1;TRPM4;DTX3L;NDC1;SMURF1;ITCH;NEDD4;HIF1A;PRKDC;KLHL25;NUP35;NUP188;TRAIP;PCNP;KLHL7;TRIM33;DDB1;MDM2;TRPC4AP;ARIH2;PEX12;UBR1;FBXO32;NUP214;DCUN1D5;RNF135;UBE2E1;TRIM6;ISG15;NUP107;UBE2Z;VHL;TRIM27;TRIM62;RPS27A;RNF14;TNFAIP1
prerank,embryonic heart tube development (GO:0035050),0.44792631226360624,0.9728338649328886,0.4970845481049563,0.8183006157102595,1.0,2/14,5.19%,TBX2;ACVR1
prerank,outer dynein arm assembly (GO:0036158),0.43749209323743177,0.9728077022620087,0.5144596651445966,0.8179138510593524,1.0,3/14,13.37%,DNAAF4;ODAD1;DNAAF5
prerank,aspartate family amino acid metabolic process (GO:0009066),0.42379854361706765,0.9727810910419138,0.5056818181818182,0.8175313893990339,1.0,3/18,6.93%,ASPG;MTHFR;ASNS
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4532788399362022,0.9725928550267915,0.5024077046548957,0.8174930835148698,1.0,2/13,12.95%,LRRK2;ENTPD7
prerank,protein autophosphorylation (GO:0046777),0.3201284575839946,0.9725439954219461,0.5427083333333333,0.817155594444037,1.0,34/157,17.81%,PDGFRA;NEK6;TEC;TAOK1;PEAK1;LRRK2;PDGFRB;JAK2;EGFR;EPHB3;CAMK2D;PRKD2;DDR2;ATM;EIF2AK2;EPHA1;TAOK3;ATR;ACVR1B;FGFR1;PTK2;MYO3A;GSK3B;SRC;MKNK1;STK24;DAPK2;FES;RIPK1;STK4;AKT1;MAP3K3;EIF2AK3;MAP3K12
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.39994389674816055,0.9724977488331626,0.5077519379844961,0.816806841004669,1.0,3/25,7.63%,YAP1;ARHGAP24;CDK10
prerank,response to ketone (GO:1901654),0.40502191255071884,0.97241073179753,0.5091145833333334,0.816539279264351,1.0,5/24,14.47%,YAP1;SLIT3;TGFB3;TGFB2;CATSPER3
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3427967890991747,0.9718952544925447,0.5205327413984462,0.8172290775798745,1.0,24/80,18.77%,AUTS2;DPYSL3;NRP1;FSCN1;RALA;TGFB3;CDC42;ABI2;ACTR2;BRK1;ENTR1;CEP120;TAPT1;P2RX7;PIK3R1;ARHGAP35;FMR1;WASHC1;RAC1;CDC42EP1;NDEL1;CDC42EP4;EPS8;BCAS3
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4434080791295565,0.9713688414671061,0.5248538011695907,0.8179048592688427,1.0,5/14,18.69%,XCL1;SHLD3;RIF1;PAXIP1;HMCES
prerank,modification-dependent protein catabolic process (GO:0019941),0.3217564421625113,0.9712197029826001,0.562753036437247,0.8177775036497361,1.0,55/193,22.68%,RNF150;MYLIP;KCTD21;SPSB1;FBXL7;MAD2L1;SMURF2;UBR4;CNOT4;RNF144A;PLK1;ANAPC11;SIAH2;MIB1;CDC27;BAG6;RNF111;CBL;AREL1;ARIH1;NTAN1;UBE2L3;UBE2R2;FBXO7;RNF213;KCTD10;RNF19B;PSMF1;RNF149;UBE2K;RNF11;DTX3L;SMURF1;ITCH;NEDD4;SQSTM1;KLHL25;PSMD11;PSMD14;RC3H2;DDB1;MDM2;FBXW4;TRPC4AP;ARIH2;UBE2E1;COPS3;ISG15;FBXO22;RPS27A;RNF14;RBBP6;UBE2L6;FZR1;CHFR
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3594555622143557,0.9710781722999727,0.5268176400476758,0.8171704616808898,1.0,15/51,17.78%,CHMP4A;CHMP4B;NUP37;VPS4A;LEMD2;PPP2R2A;CCNB2;CHMP7;NDC1;CHMP2B;NUP35;NUP188;RCC1;SEC13;ANKLE2
prerank,mitotic nuclear membrane organization (GO:0101024),0.3594555622143557,0.9710781722999727,0.5268176400476758,0.8171704616808898,1.0,15/51,17.78%,CHMP4A;CHMP4B;NUP37;VPS4A;LEMD2;PPP2R2A;CCNB2;CHMP7;NDC1;CHMP2B;NUP35;NUP188;RCC1;SEC13;ANKLE2
prerank,stress-activated MAPK cascade (GO:0051403),0.3496219108386327,0.9708145680519719,0.5253456221198156,0.817285365010566,1.0,9/61,7.99%,ZFP36L1;MAP2K4;CUL1;LGALS9;NOD1;CCM2;IRAK2;SKP1;MAPK11
prerank,glycoprotein metabolic process (GO:0009100),0.35176097175348864,0.9705535868475228,0.5046728971962616,0.8173852557514354,1.0,14/53,19.82%,TNIP1;B4GALT5;PRKCSH;HPSE;ADAMTS9;MAN2A1;MAN1C1;MGAT4A;FBXO2;B4GALT7;HIF1A;AGA;GANAB;MAN2A2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.38021402523362374,0.9698268431460785,0.5242346938775511,0.8184787281012373,1.0,14/32,24.58%,TAF1D;POLR1E;GTF2H1;CDK7;POLR1B;TAF1A;POLR2L;POLR2K;POLR1G;ERCC2;POLR1A;CCNH;MNAT1;RRN3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4353025008725394,0.9693200526388582,0.5057971014492754,0.8190670084040742,1.0,2/17,2.85%,NOS1AP;CACNA2D1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.4692680512355522,0.9690907012615045,0.49019607843137253,0.8190958595214531,1.0,3/10,13.14%,TSLP;LGALS9;SPHK2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3759087034579582,0.9689182244993947,0.4975186104218362,0.8190190333441714,1.0,11/37,23.22%,ATXN2;APOE;ABCA2;DLG4;TRAP1;ANKRD13B;MTMR2;SDCBP;NCOR1;ITGB3;AP1AR
prerank,exit from mitosis (GO:0010458),0.45563039566364455,0.9688237206324061,0.5162337662337663,0.8187690573181431,1.0,6/12,27.10%,CHMP4B;CHMP7;EPS8;CLASP2;CTDP1;CLASP1
prerank,DNA biosynthetic process (GO:0071897),-0.3394046611697268,-0.9686620480630747,0.49038461538461536,0.832922231148224,1.0,11/16,37.77%,POLD3;PPIA;RFC3;POLH;POLD2;POLE;CDKN2D;POLD4;WRN;POLL;SIRT1
prerank,regulation of protein kinase activity (GO:0045859),0.3283678755825378,0.9685807194574921,0.5396145610278372,0.8188414444036923,1.0,26/106,17.14%,JTB;SPRED1;LCP2;DDR2;NF1;TAF7;CACUL1;DTNBP1;LRP6;EPHA1;RASSF2;GSKIP;PYDC1;WWTR1;PTK2;SNX9;TNF;UBASH3B;SMCR8;TRIB3;TRIB1;RTRAF;ALS2;ITGB1BP1;PTPRC;AKT1
prerank,regulation of programmed cell death (GO:0043067),0.3248841187555025,0.9685782815027677,0.5584016393442623,0.8184067006005281,1.0,27/161,15.12%,BCL3;BCL6;STAT1;LRRK2;JAK2;BIRC3;CASP1;IFT57;NF2;STEAP3;CREBBP;ATM;OMA1;PTPN6;CXCL10;AIFM2;USP42;GAS1;CTSB;CALR;TNF;ANP32A;TRAF2;DAPK2;RTKN;RABGGTB;RIPK1
prerank,regulation of centrosome cycle (GO:0046605),0.41559909012427804,0.9685689329537057,0.5131761442441054,0.8179883466964017,1.0,4/21,15.31%,CHMP4B;XRCC3;NAT10;CHMP2B
prerank,dendrite morphogenesis (GO:0048813),0.37659343782808924,0.9685271572674768,0.5148883374689827,0.8176335499183592,1.0,7/35,8.32%,PTN;FARP1;EPHB3;PTEN;CDC42;DLG4;SDC2
prerank,transferrin transport (GO:0033572),0.3753772600432928,0.9682566478978293,0.51875808538163,0.8177568502018824,1.0,8/33,18.00%,CLTC;STEAP3;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1G1;ATP6V1D;REP15
prerank,mitotic spindle assembly (GO:0090307),0.36973009535451573,0.9681614976390053,0.5073891625615764,0.8175039705615215,1.0,9/42,16.03%,KIFC1;SMC1A;KIF2A;STAG2;TPX2;STAG1;RHOA;TOGARAM1;CEP192
prerank,multivesicular body organization (GO:0036257),0.39227010600723833,0.9681307052093451,0.5252918287937743,0.817125897481167,1.0,6/31,15.31%,CHMP4A;CHMP4B;VPS4A;VPS37C;CHMP7;CHMP2B
prerank,histone mRNA metabolic process (GO:0008334),0.3847433512323222,0.9681270474057181,0.5177398160315374,0.8166962088736088,1.0,6/27,11.16%,ATM;ERI1;EXOSC4;DCP2;NCBP2;XRN1
prerank,Rac protein signal transduction (GO:0016601),0.4196302635622615,0.9680720318157542,0.520336605890603,0.8163715136319392,1.0,6/18,14.73%,FARP2;AIF1;ABI2;BRK1;DBNL;RAC1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.37761972075253697,0.9678904129630843,0.5032765399737876,0.8163135553039326,1.0,9/34,15.39%,PDGFRA;IRS1;PDGFRB;AMBRA1;PTK2;FGF2;PIK3R1;WASHC1;PIK3R4
prerank,pyruvate metabolic process (GO:0006090),-0.25505631557594544,-0.9678590745780421,0.5533333333333333,0.8334097369341974,1.0,12/52,17.23%,BSG;ME3;ME1;SLC16A1;VDAC1;HAGH;LDHB;PFKM;TPI1;ALDOC;PGK1;LDHA
prerank,ATP synthesis coupled proton transport (GO:0015986),0.4190843989418076,0.9677121536378237,0.49230769230769234,0.8162392577598218,1.0,3/17,8.50%,STOML2;ATP5PO;DMAC2L
prerank,amino acid transmembrane transport (GO:0003333),-0.26803160678067817,-0.9676810608423336,0.517948717948718,0.8322171085072091,1.0,6/45,3.48%,SLC47A1;SLC6A6;LRRC8D;SLC38A9;SLC7A5;SLC38A11
prerank,negative regulation of telomere maintenance (GO:0032205),0.43944513077076025,0.967321011983572,0.5158045977011494,0.8166300392992364,1.0,8/15,25.72%,ATM;PINX1;SMG6;TNKS2;TERF1;SLX4;TERF2IP;TERF2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.4295052935324634,0.9673150606390651,0.5133531157270029,0.8162023101242122,1.0,5/16,18.25%,MDK;RHOA;TNF;ETS1;FUT4
prerank,negative regulation of leukocyte activation (GO:0002695),-0.36104946915024133,-0.9671899807028671,0.4748427672955975,0.83192963636313,1.0,6/15,18.69%,LRFN5;IL31RA;CD200;GRN;GPER1;HAVCR2
prerank,plasma membrane tubulation (GO:0097320),0.4533334841789505,0.966949884898082,0.511520737327189,0.8165102733034404,1.0,5/13,12.50%,CHMP4A;EHD2;SNX33;SNX9;BIN3
prerank,microvillus assembly (GO:0030033),-0.36408799348199256,-0.9667755549603197,0.47619047619047616,0.831384429657296,1.0,6/14,11.64%,MINK1;EZR;FXYD5;RAPGEF2;RAPGEF6;RAP1A
prerank,RNA transport (GO:0050658),0.33892945875331154,0.9667625477382433,0.5288788221970555,0.8164600331765518,1.0,24/71,26.82%,RFTN1;ZFP36L1;RBFOX1;ATXN2;RAE1;NCBP2;NUP153;FMR1;RTRAF;NUP188;SIDT2;CKAP5;SRSF2;NUP214;YBX1;SLU7;SRSF11;THOC5;RNPS1;THOC2;KIF5C;HNRNPA2B1;NUP155;SRSF1
prerank,regulation of developmental growth (GO:0048638),0.38463630672289356,0.9666231064073827,0.509641873278237,0.8163269687851895,1.0,9/29,17.45%,GHR;APOE;STAT5A;GSK3B;NIPBL;STAT5B;OLFM1;LATS2;CTTN
prerank,positive regulation of epithelial cell migration (GO:0010634),0.33362937742623633,0.966604792293175,0.5408052230685527,0.8159330112423381,1.0,25/92,18.77%,SPARC;MAP4K4;FGF7;PRKCA;NRP1;DOCK1;PRKD2;EGF;SASH1;ANGPT1;WNT5A;MAPRE2;TGFB2;CALR;RIN2;FGF2;SRC;RAC1;HIF1A;ITGB1BP1;AKT1;ETS1;INSL3;AGT;BCAS3
prerank,negative regulation of cell cycle (GO:0045786),0.33892965929544117,0.9665407287879365,0.5167037861915368,0.815627165234897,1.0,13/73,14.25%,RUNX3;MAD2L1;NR2F2;PTPN3;PTEN;CDK6;PLK1;BTG1;GAS1;NLRP2B;SMAD3;BMP7;CDKN1B
prerank,positive regulation of cation channel activity (GO:2001259),-0.2677441527655003,-0.9657469003332235,0.538961038961039,0.8324970022561532,1.0,7/40,8.96%,ACTN2;AKAP6;ANK2;SHANK3;CALM1;TMSB4X;ANK3
prerank,cell projection assembly (GO:0030031),0.4047251558127436,0.9655522923308292,0.5069637883008357,0.8172634405784838,1.0,3/22,6.39%,RHOJ;PARVA;CDC42
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.4099775726810014,0.9654534747400614,0.5239398084815321,0.8170328400731102,1.0,4/23,12.65%,EPHX2;FADS1;CYP1A1;ELOVL6
prerank,SNARE complex assembly (GO:0035493),-0.40765205111679625,-0.9651856136431886,0.5068493150684932,0.8323958821885944,1.0,3/10,14.95%,STXBP6;VAMP4;VAMP8
prerank,response to metal ion (GO:0010038),0.3401489680206392,0.9651759585071897,0.5276211950394588,0.8171722678786745,1.0,12/67,16.97%,SEC31A;HVCN1;PAM;SLC11A2;FXN;BCL2;PPP3CA;KHK;CALM2;NEDD4;HIF1A;TNNT2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.43508465305507743,0.9648183014460217,0.5273556231003039,0.8175148197490112,1.0,4/15,17.37%,TCF7L2;BAG3;GSK3B;YWHAE
prerank,establishment of mitotic spindle localization (GO:0040001),0.392046037983778,0.9646597856184941,0.5331599479843954,0.8174218880774801,1.0,6/28,15.66%,MAD2L1;PLK1;GPSM2;INSC;FBXW11;NDEL1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.35913925402854247,-0.9644060980847249,0.5117647058823529,0.8327518591650167,1.0,3/15,4.13%,TJP1;FGF1;KLF4
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.34344796090232654,0.9643434761383959,0.5357548240635641,0.8176401549043756,1.0,18/67,17.41%,MYO10;ATP8B1;PLD1;FSCN1;TBC1D16;IFT88;CDC42;TBC1D2B;ATG3;DYNC2LI1;RABGAP1;TBC1D1;FMR1;TBC1D10B;RAC1;TBC1D19;TBC1D20;CDKL1
prerank,cellular response to glucose starvation (GO:0042149),-0.27240274057537556,-0.9643297786353455,0.4731182795698925,0.8313483032786396,1.0,11/41,14.59%,PRKAG2;PRKAA2;NIM1K;SIK1;SIK2;SESN2;SESN3;IMPACT;HNRNPA1;MYBBP1A;PRKAG3
prerank,regulation of muscle cell differentiation (GO:0051147),-0.29413780889343805,-0.9640970282283398,0.5201612903225806,0.8303040246293975,1.0,16/31,31.49%,CTNNA2;HDAC9;FGFR2;MAPK12;IGF2;BNIP2;BOC;MYOCD;CDH2;MEF2C;MAPK14;SRF;CAMK1;PTBP1;ID2;CDON
prerank,carbohydrate biosynthetic process (GO:0016051),-0.31466161507242074,-0.9640732887478376,0.5018867924528302,0.8287538764964568,1.0,4/21,6.77%,ST3GAL6;FUT9;ST3GAL4;ST8SIA6
prerank,cilium organization (GO:0044782),0.3153078243736437,0.9639048190721539,0.5752032520325203,0.81815935685082,1.0,46/209,16.55%,TEKT4;DYNLL1;CEP19;ASAP1;STK36;PARVA;IQCG;PKD2;IFT88;PCM1;RAB8B;CEP41;EXOC4;TTC17;EHD2;ACTR2;GBF1;FAM161A;EXOC1;EXOC7;WDPCP;PCNT;WDR35;DISC1;TTC29;PTPN23;ARF4;GALNT11;NPHP3;IFT172;IFT81;PDE6D;SNX10;CFAP410;CPLANE1;RAB1A;DYNC2H1;DZIP1L;KIF27;CDC14A;TTC39C;EXOC5;EXOC3;NUDCD3;POC1B;WDR90
prerank,rRNA catabolic process (GO:0016075),0.42315467443653715,0.9636242511129561,0.5167883211678832,0.8183135449847799,1.0,3/16,11.16%,ERN2;EXOSC4;XRN1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.36604759147246785,0.9636083445412843,0.5335820895522388,0.8179189973135856,1.0,16/40,24.75%,DDX11;MMS22L;ATR;SETMAR;FBH1;MCM9;TIMELESS;EME2;ATRX;TRAIP;NUCKS1;CDK9;ZRANB3;RAD51;ETAA1;FAM111A
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4093915725735002,0.9635127731690663,0.5301724137931034,0.8176760246544812,1.0,8/21,22.53%,MITF;SUB1;MED13;PAXIP1;SETX;MED12;MED1;MED14
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4624360391061581,0.963389890990256,0.5124223602484472,0.8175069525488303,1.0,1/10,2.70%,GATA6
prerank,double-strand break repair (GO:0006302),0.3208141605555907,0.9622526035347179,0.5614754098360656,0.8194958481284775,1.0,34/158,17.49%,RAD51B;PARP3;BRIP1;DNA2;RAD52;TNKS1BP1;BABAM2;INO80;XRCC3;ATM;MMS22L;ZFYVE26;DCLRE1C;SETMAR;FBH1;HMGB2;AP5Z1;MCM9;TDP2;KDM2A;MDC1;NSMCE2;RIF1;EME2;RMI1;XRCC1;DTX3L;PAXIP1;SETX;PRKDC;PSMD14;NUCKS1;DDX1;HELQ
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4609573342512865,0.9621205722385751,0.5077160493827161,0.8193395146395724,1.0,3/10,13.23%,EGF;FBXW7;BTC
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4203379644086804,0.9616053335684102,0.5234604105571847,0.8199629398891392,1.0,4/17,9.04%,CACNA1C;GJD3;GJC1;FKBP1B
prerank,electron transport chain (GO:0022900),0.42264666218312985,0.9615853923645254,0.5292307692307693,0.8195687718536522,1.0,3/15,10.07%,ETFA;POR;SDHB
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.36389241941448136,-0.9611241826736913,0.5201149425287356,0.8349964437669228,1.0,5/13,14.35%,RNF152;DEPDC5;SESN2;SESN3;SPAAR
prerank,axonal fasciculation (GO:0007413),-0.38252318533283824,-0.9608003074496978,0.48546511627906974,0.8342383492150836,1.0,2/12,1.91%,EPHA4;CNTN4
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3278537115356508,0.9607194258497365,0.5488721804511278,0.8209696460693755,1.0,23/101,18.36%,PRR16;BCL3;PLD1;PLK1;SAMD4A;MSN;NIBAN1;OGT;RPS6KB1;NAT10;CASP8;CLN6;ATG7;FBXW11;DACT1;YTHDF3;FMR1;PRKDC;AKT1;INHBA;PLXNB2;AGT;NFKBIA
prerank,calcium ion transport (GO:0006816),0.32904596027187005,0.9606149207287383,0.5617154811715481,0.8207480911804682,1.0,11/113,5.67%,MCOLN2;CACNA1A;CACNA2D1;CACNA1C;CCR1;ITPR1;PKD2;TRPC6;CYP27B1;SLC24A5;CCL5
prerank,substantia nigra development (GO:0021762),0.3686827095858284,0.9604831726880364,0.5248138957816377,0.820575324488204,1.0,9/37,14.77%,DYNLL1;GNB4;PADI2;CDC42;MAPKAP1;SEC16A;RHOA;CALM2;HSPA5
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3621180226702647,0.9601828783573317,0.5095465393794749,0.8207505285778989,1.0,18/45,26.07%,ACVR1;TGFB3;INHBB;TGFBR1;BMP5;TGFB2;ACVR2A;BMP7;SMAD4;ACVRL1;INHBA;GDF9;GDF11;BMPR1A;SDCBP;BMPR2;GDF1;INHA
prerank,regulation of wound healing (GO:0061041),0.35576703119036523,0.9591139361949612,0.5103785103785103,0.8225568662476039,1.0,8/42,12.48%,TNFAIP3;CASK;TNFRSF12A;ANXA1;MYLK;PTK2;VTN;FGF2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.4215318117574251,0.9590304762490689,0.5049786628733998,0.8222977757776744,1.0,3/16,8.50%,STOML2;ATP5PO;DMAC2L
prerank,negative regulation of stem cell differentiation (GO:2000737),0.45491796938480816,0.9586683417003402,0.5196374622356495,0.8226053073727931,1.0,2/12,4.21%,ZFP36L2;JAG1
prerank,regulation of amyloid-beta formation (GO:1902003),0.3809376958897932,0.9583305865936849,0.5445544554455446,0.8228861495952265,1.0,21/34,27.92%,SLC2A13;APOE;GSAP;ABCA2;ABCG1;TNF;PICALM;PRNP;PIN1;IFNGR1;CLU;RTN2;ROCK2;ROCK1;RELA;BIN1;CHRNA7;EFNA1;GGA3;GSK3A;TMED10
prerank,glycogen catabolic process (GO:0005980),-0.35340178001746514,-0.9580973009173871,0.5251572327044025,0.8396348533280188,1.0,4/15,6.91%,CALM1;PGM2L1;PYGM;PYGB
prerank,cytosolic calcium ion transport (GO:0060401),0.3899913802427073,0.9580439377743425,0.5339425587467362,0.8230274091224661,1.0,8/28,18.80%,CACNA2D1;CACNA1C;ATP2A2;ATP2B1;MICU2;MCUR1;MAIP1;MICU3
prerank,protein K63-linked ubiquitination (GO:0070534),-0.26522302088028704,-0.9576189094306018,0.5114942528735632,0.8393588807660445,1.0,10/41,15.59%,RNF152;WWP2;PRKN;UBE2E3;HECTD1;UBE2V2;UBE2B;UBE2N;BFAR;PRPF19
prerank,error-free translesion synthesis (GO:0070987),-0.32330141262983114,-0.957343574886965,0.5247933884297521,0.8385057743375205,1.0,14/22,35.18%,RCHY1;UBC;PCNA;UFD1;RFC3;NPLOC4;UBA52;POLH;RPA2;RFC4;RFC2;RPA3;SPRTN;RFC5
prerank,activation of adenylate cyclase activity (GO:0007190),0.3653059909914373,0.9566055016975278,0.5186615186615187,0.8255899801696547,1.0,4/35,4.40%,EDNRA;ADCY7;RXFP2;ADCY2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3418487487643566,0.9563189589490618,0.5308219178082192,0.8257377279230502,1.0,8/57,12.44%,DCN;TREM2;BBC3;RALA;ADCK1;SPIRE1;FBXO7;GSK3B
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4120639734429063,0.9562854282797084,0.5492957746478874,0.8253698578807233,1.0,6/20,18.25%,CAMK2D;BCL2;ATP2A2;PACS2;PSEN1;THADA
prerank,regulation of sprouting angiogenesis (GO:1903670),0.37487833186439096,0.9560601239482291,0.5115979381443299,0.8254123810567153,1.0,10/33,15.69%,CREB3L1;JAK1;RHOJ;CEMIP2;ADAMTS9;BMPER;FGF2;ITGA5;SMAD1;FGF18
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4444027339196604,0.9558475020536337,0.5225505443234837,0.8253867397854983,1.0,3/12,9.95%,CEP19;PCM1;NIN
prerank,response to cAMP (GO:0051591),0.3732563864042268,0.9545909189009226,0.529335071707953,0.8276003941952993,1.0,5/37,6.40%,ZFP36L1;STAT1;IGFBP5;PKD2;AHR
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4246652202595089,0.9544978309400561,0.5488505747126436,0.8273416250509638,1.0,3/17,5.33%,STAT3;JAG1;GNL1
prerank,regulation of superoxide anion generation (GO:0032928),0.4388567591229515,0.953802372395783,0.5244956772334294,0.8283625156000776,1.0,1/14,2.18%,CRP
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3914790721543945,-0.9536332509133212,0.5042492917847026,0.8464262080719748,1.0,2/10,6.15%,CSGALNACT1;DSEL
prerank,neuron projection fasciculation (GO:0106030),-0.4044488013566601,-0.953453075537881,0.5027624309392266,0.8453193215514715,1.0,2/10,1.91%,EPHA4;CNTN4
prerank,peptidyl-serine modification (GO:0018209),0.3178239476234661,0.9532144382399624,0.5841073271413829,0.8291875046782836,1.0,37/166,17.81%,NEK6;MAST4;LRRK2;PRKCA;MARK1;RICTOR;GALNT3;IKBKE;AKT3;CAMK2D;PRKD2;MORC3;ATM;PLK1;HIPK4;MAST2;ATR;TGFBR1;CSNK2A1;CSNK2A2;HIPK3;RPS6KB1;CSNK1G2;GSK3B;CSNK1A1;MKNK1;POGLUT3;VRK3;PRKDC;STK4;CSNK1D;MAPK1;AKT1;LATS2;EIF2AK3;DCLK3;MAP3K12
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3350952479839664,0.9531007455777354,0.5453551912568306,0.8289935776477035,1.0,9/72,8.93%,BCL3;BATF;TNKS1BP1;E2F1;CNOT4;ATM;E2F8;CARM1;SP100
prerank,fatty acid transport (GO:0015908),0.41899052445478374,0.9525519142099222,0.527007299270073,0.8296799571589166,1.0,4/17,12.66%,APOE;CD36;PPARG;FABP5
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3460555558900543,0.9518208501390505,0.5528169014084507,0.8307701691017252,1.0,19/54,24.01%,MAK16;RPL3L;PES1;NOC2L;WDR74;NOP2;NIP7;GTF3A;LTO1;RPL14;RPL11;NOP16;RPF1;HEATR3;RPL6;PAK1IP1;RSL1D1;MDN1;PPAN
prerank,mRNA modification (GO:0016556),0.4032357986856665,0.9517810579370692,0.5379310344827586,0.8304144106059158,1.0,4/22,9.72%,ZC3H13;METTL16;TRUB2;PUS3
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2560886670069162,-0.9516956859670688,0.5428571428571428,0.8482887699945936,1.0,11/48,16.74%,DGKB;DDHD1;GPD1L;DGKA;SLC27A1;AGPAT3;ACP6;DGKG;GPAT4;PLA2G6;DGKQ
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3533428557081265,0.9512934684312798,0.5492788461538461,0.8309996750580215,1.0,4/47,4.25%,ADIPOQ;SNAI1;SNAI2;ABCA2
prerank,DNA metabolic process (GO:0006259),0.31337524208810824,0.9509801995250937,0.6092648539778449,0.8312012210703804,1.0,74/270,23.59%,RAD51B;PARP3;MPG;TCF7L2;POLE3;BACH1;SMC1A;DNA2;RAD52;MCM2;INO80;XRCC3;ATM;PDS5B;PWWP3A;GTF2H1;LIG1;TERT;PDS5A;MCM7;ATR;SP100;RNASEH1;SETMAR;DBF4;RNASEH2A;HMGB2;ALKBH1;USP3;TOP2B;TIMELESS;LTO1;POLI;POLA2;MGMT;RIF1;LRWD1;CTC1;XRCC1;ASF1A;MMS19;POLG;PRKDC;ATRIP;PNKP;DDB1;ZNF445;RAD9A;RBBP8;HINFP;AXIN2;EID3;GADD45A;MBD4;KPNA2;FANCC;NEIL1;PARP4;TOP3B;RFC1;RPS27A;TERF1;ZRANB3;CDC7;RPA1;SLX4;ENDOV;DMC1;RAD51;MNAT1;CDC6;MSH6;DDX21;DOT1L
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3391538278700981,-0.9502839204959587,0.5239616613418531,0.8503472749032938,1.0,6/16,25.96%,NCL;CIRBP;DAZAP1;NUP98;RBM3;SF3B4
prerank,regulation of actin filament polymerization (GO:0030833),0.33615386275694953,0.9502699663579164,0.5346756152125279,0.8322313002385395,1.0,17/69,20.54%,CCL11;NCK1;BAIAP2;NCK2;CARMIL1;DBN1;SSH1;SNX9;DBNL;SSH2;CDC42EP1;RASA1;CTTN;CDC42EP4;PLEKHG2;WASHC5;PRKCD
prerank,protein kinase A signaling (GO:0010737),-0.37916964131142455,-0.9500646603364045,0.5130434782608696,0.8493064182591945,1.0,4/12,19.16%,EZR;RDX;MYOM1;RAB13
prerank,positive regulation of ERAD pathway (GO:1904294),-0.35507220525587196,-0.9500540829323961,0.5121212121212121,0.8477137617338436,1.0,3/13,7.27%,CAV1;ATXN3;BCAP31
prerank,protein-DNA complex disassembly (GO:0032986),0.42181232465983237,0.9499779449330801,0.532656023222061,0.8323579038891826,1.0,5/16,22.80%,SMARCC1;GRWD1;SMARCA4;ARID2;SMARCD3
prerank,establishment of protein localization to membrane (GO:0090150),0.3371180000667831,0.9499160228835335,0.5574516496018203,0.8320448642785859,1.0,13/66,16.83%,RFTN1;GORASP2;EGFR;ATG3;SEC63;RAB3GAP2;VPS37C;RAB10;RAB3GAP1;ZDHHC6;ZDHHC9;RTP4;ZDHHC3
prerank,catecholamine biosynthetic process (GO:0042423),-0.38088527509373504,-0.9498960252363927,0.5395894428152492,0.8464775510432704,1.0,2/11,12.12%,MOXD1;DDC
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4612270728380154,0.9497893100019308,0.5285935085007728,0.8318695264494338,1.0,3/10,19.61%,TERT;DICER1;AGO2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.33218714684447126,-0.949497784622943,0.5328947368421053,0.8459385014228804,1.0,7/18,22.90%,NRXN1;SHANK3;CACNG2;CACNG7;RELN;NLGN1;CACNG8
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.44352088858256117,0.9489849833616404,0.5384615384615384,0.8331041318837953,1.0,2/13,11.55%,LRRK2;NFE2L2
prerank,cyclooxygenase pathway (GO:0019371),0.4621478296369923,0.9489833456285884,0.5448504983388704,0.8326736408116595,1.0,3/10,13.69%,PTGES;PTGES2;TBXAS1
prerank,"phagocytosis, engulfment (GO:0006911)",0.36933086053304415,0.9485642866608226,0.5427509293680297,0.8331043102020893,1.0,8/36,15.63%,DOCK1;MYH9;AIF1;CD36;CDC42;MSR1;RAC1;FCGR1A
prerank,filopodium assembly (GO:0046847),0.4170104083650683,0.9483235266317088,0.5273264401772526,0.8331641767407751,1.0,4/16,11.23%,PPP1R9B;FGD4;S1PR2;FGD6
prerank,negative regulation of JUN kinase activity (GO:0043508),0.45907516163008366,0.9481060061565302,0.5529953917050692,0.8331974270706933,1.0,3/10,17.77%,AIDA;HIPK3;MAPK8IP1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.45865731197987447,0.948072140506615,0.5377503852080123,0.8328320093036863,1.0,4/11,21.08%,ANXA1;SOCS5;RC3H2;ZC3H12A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3968140047617836,0.9479106011329089,0.55858310626703,0.8327242771055626,1.0,3/22,5.01%,VMP1;SLC9A1;PKD2
prerank,lipid translocation (GO:0034204),0.40250508278797315,0.9477309877118872,0.5321477428180574,0.8326702122487109,1.0,2/21,2.43%,ABCA1;ATP8B1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.34983677236955185,0.947639499590462,0.5481569560047562,0.8324195817401403,1.0,20/51,24.18%,ATM;PINX1;SMG6;ATR;CCT8;DCP2;NAT10;XRN1;CTC1;SRC;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB;HNRNPC;TERF1;MAP2K7;SMG5
prerank,mRNA export from nucleus (GO:0006406),-0.21869728970022087,-0.9474826480899455,0.625,0.8495188110467619,1.0,37/102,25.42%,YTHDC1;CDC40;SRSF5;WDR33;DDX19B;U2AF2;NUP133;UPF2;UPF1;SEH1L;POM121;SRSF7;SRSF9;RBM8A;NUP43;CHTOP;CPSF2;MAGOH;NUP210;NUP50;ZC3H11A;NUP98;HHEX;EIF4A3;SRSF3;POLDIP3;NUP93;CPSF4;SARNP;MCM3AP;DDX39B;ENY2;NUP88;NUP85;DDX39A;DDX25;THOC1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.45919799245095727,0.9467972339599697,0.5338345864661654,0.8337450774576973,1.0,2/11,5.62%,BCL3;NF2
prerank,transcription by RNA polymerase I (GO:0006360),0.36709315467429393,0.946672144716748,0.5513784461152882,0.8335693285953276,1.0,14/34,24.58%,TAF1D;POLR1E;GTF2H1;CDK7;POLR1B;TAF1A;POLR2L;POLR2K;POLR1G;ERCC2;POLR1A;CCNH;MNAT1;RRN3
prerank,acidic amino acid transport (GO:0015800),-0.335763724590259,-0.9465307732959162,0.5094339622641509,0.8503173348546501,1.0,5/17,4.88%,SLC6A6;LRRC8D;SLC1A2;SLC1A1;SLC6A1
prerank,response to estrogen (GO:0043627),0.3739746953839082,0.946462941067204,0.5628205128205128,0.8335641494628453,1.0,5/31,10.09%,RBBP5;ARID5A;CYP27B1;SFRP1;PELP1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.43864166062584486,0.9464059527794226,0.5415335463258786,0.8332479939803584,1.0,5/13,21.15%,APOE;CYP27B1;BMP5;PLEK;DKK3
prerank,positive regulation of intracellular transport (GO:0032388),0.3671091350295965,0.9458413709848054,0.5422885572139303,0.8339899079296715,1.0,11/38,18.77%,DYNC1H1;PCM1;EHD2;PCNT;EIPR1;PDCD10;NEDD4;PLA2G4E;TBC1D20;ICE1;BCAS3
prerank,regulation of protein targeting to membrane (GO:0090313),0.3875811878451608,0.9455598404719555,0.5396618985695709,0.8341239994175333,1.0,1/28,0.40%,CEMIP
prerank,development of primary male sexual characteristics (GO:0046546),0.3637585762235465,0.9453174995307759,0.5360696517412935,0.8341866641431352,1.0,6/34,14.39%,LHFPL2;GATA6;WNT5A;TGFB2;ADAM21;TFAP2C
prerank,fatty acid oxidation (GO:0019395),0.34395916746617006,0.9452778901086994,0.5411899313501144,0.8338265061580121,1.0,12/57,20.42%,ADIPOQ;EHHADH;SLC27A2;ACOX1;ALDH3A2;ECHS1;DECR1;PECR;HACL1;AUH;ADH5;ECHDC2
prerank,aminoglycan biosynthetic process (GO:0006023),0.3501687155154456,0.9452420501142799,0.5475330926594465,0.8334814904720225,1.0,12/49,16.66%,HSPG2;GPC6;EXT1;EXT2;SDC1;HS2ST1;SDC2;GCNT2;UGDH;SLC35D2;B4GALT7;B3GNT9
prerank,negative regulation of cilium assembly (GO:1902018),0.4493595282510152,0.9451786780633536,0.5454545454545454,0.8331726833675066,1.0,2/12,7.63%,YAP1;CDK10
prerank,negative regulation of cell growth (GO:0030308),0.3178253410448735,0.9451580744217053,0.5760755508919203,0.8327825142574082,1.0,21/121,14.44%,ENPP1;PPP1R9B;BCL6;SLIT3;SERTAD2;FRZB;CYP27B1;SFRP1;ENO1;CCAR2;BTG1;IP6K2;ACVR1B;RERG;PTPRJ;TGFB2;FGF13;SPHK2;SMAD3;CDKN1B;SMAD4
prerank,transport across blood-brain barrier (GO:0150104),0.3307792071650228,0.9447866610088854,0.5726775956284152,0.8331169592114754,1.0,9/83,6.45%,SLC7A2;SLC1A3;LRP1;SLC38A3;SLC2A13;SLC28A2;ABCA2;CD36;SLC16A12
prerank,inositol phosphate catabolic process (GO:0071545),0.4539641897794711,0.9439640961274814,0.5336617405582923,0.8343538838430155,1.0,2/12,4.97%,INPP1;PTEN
prerank,acylglycerol catabolic process (GO:0046464),0.3781948506686254,0.9439259241630266,0.5498721227621484,0.8340131679923024,1.0,5/30,16.48%,LIPC;LPL;ABHD16A;FABP5;LYPLA2
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.37589495351027225,-0.9437491823331635,0.5294117647058824,0.8543022692043443,1.0,5/11,27.23%,NOTCH4;TNRC6C;ZFP36;AGO3;AGO4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.37589495351027225,-0.9437491823331635,0.5294117647058824,0.8543022692043443,1.0,5/11,27.23%,NOTCH4;TNRC6C;ZFP36;AGO3;AGO4
prerank,regulation of gluconeogenesis (GO:0006111),0.37530167045369073,0.943453472261069,0.5455746367239102,0.8345384116778777,1.0,6/27,17.41%,ADIPOQ;OGT;PTPN2;GCK;SDHAF3;DDB1
prerank,methylguanosine-cap decapping (GO:0110156),0.45829631344630084,0.9431306571151037,0.5481366459627329,0.8347466942973156,1.0,4/10,15.07%,EDC4;DCP2;DCP1A;PATL1
prerank,regulation of activated T cell proliferation (GO:0046006),0.37316781255434794,0.9428921941898043,0.5673202614379085,0.8347850761388727,1.0,2/30,5.04%,IL23R;LGALS9
prerank,JNK cascade (GO:0007254),-0.26846402141011577,-0.9428159486936953,0.56353591160221,0.8551013036906875,1.0,17/40,26.65%,MINK1;TAB3;MAP3K5;ARHGEF6;CRKL;UBC;UBE2N;MAPK9;GPS2;MAP3K7;MAPK10;IRAK1;IKBKG;UBA52;MAP3K11;NOD2;UBE2V1
prerank,peptidyl-proline modification (GO:0018208),-0.30329611699490333,-0.9425019858146395,0.551440329218107,0.8542897717323426,1.0,8/25,15.45%,FKBP5;PPIG;P3H2;PPIH;PPIL2;PPIL3;FKBP1A;PPIB
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4246526217874491,0.9422124524850165,0.5550660792951542,0.8357564778146597,1.0,6/17,18.77%,NRP1;BAIAP2;CDC42;NTRK3;FES;BCAS3
prerank,cellular response to acid chemical (GO:0071229),-0.3010396532989033,-0.9419309635741427,0.549800796812749,0.8540953436789501,1.0,12/27,20.44%,CPEB3;SLC38A9;KLF2;LAMTOR1;GLRA1;SESN2;RRAGB;SPAAR;RRAGD;GLRA2;LAMTOR2;RRAGA
prerank,mesonephric tubule development (GO:0072164),0.42872235059255237,0.9418626216253844,0.5507462686567164,0.8360514564760392,1.0,4/15,14.04%,ROBO2;PKD2;SALL1;BMP7
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.28224277109926665,-0.9417747458974041,0.5198019801980198,0.852911238141264,1.0,9/32,16.23%,FHIT;DDX5;PPP1R13B;HIPK1;MSH2;EP300;DDIT4;MYBBP1A;DYRK2
prerank,cell differentiation in spinal cord (GO:0021515),-0.39384119941359497,-0.9417435777017863,0.5483870967741935,0.8514187118675423,1.0,3/10,6.00%,MDGA2;SOX13;SOX6
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3528175144402458,0.9414682605056283,0.5413625304136253,0.8364332053393079,1.0,7/43,12.13%,TBX2;SHH;PKD2;ACVR1;TBX3;NPHP3;SETDB2
prerank,cellular response to retinoic acid (GO:0071300),0.35720471461062286,0.9413858216432793,0.5509950248756219,0.8361686650976118,1.0,7/42,15.71%,WNT2;WNT9A;ATM;WNT5A;PTK7;SETX;ADNP2
prerank,autophagy of nucleus (GO:0044804),0.4185267011135003,0.9410663315808021,0.5407303370786517,0.836385950789819,1.0,4/16,15.93%,WIPI1;ATG3;ATG7;WDR45
prerank,chromosome condensation (GO:0030261),0.36504049581484815,0.9409838020366079,0.5422885572139303,0.8361164686539733,1.0,11/36,21.09%,ERN2;KMT5A;PLK1;CSNK2A1;CSNK2A2;NCAPD2;NCAPG2;AIFM1;NCAPG;TENT4A;SMC4
prerank,regulation of microtubule polymerization (GO:0031113),-0.267720125166522,-0.9403124619682693,0.5440414507772021,0.8534353025032766,1.0,4/40,3.01%,MAP2;OCLN;EML2;CDH5
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4435625345694343,0.939727734209243,0.5474452554744526,0.8382190671564972,1.0,3/13,7.40%,TREM2;ENO1;PID1
prerank,negative regulation of apoptotic process (GO:0043066),0.30326398234647706,0.939691895856287,0.685370741482966,0.8378730593040056,1.0,88/444,17.37%,NR1H4;BCL3;YAP1;MAP4K4;EGR3;GATA6;SNAI2;BIRC3;PRKCA;FHL2;FSTL1;CFLAR;TSLP;EGFR;TLE1;TREM2;APOE;FXN;MAD2L1;MDK;SHH;BAG3;BABAM2;BCL2;NUGGC;ANGPTL4;APOH;TXNDC5;PTPRZ1;SFRP1;TGFB3;PLK1;SIAH2;ASNS;BCL2L2;ANGPT1;MERTK;CBL;AREL1;SH3RF1;ANXA1;WNT5A;HDAC1;CSNK2A1;CSNK2A2;IL7;HIPK3;RPS6KB1;TBX3;CCL2;FNIP1;DNAJB6;ARF4;PTK2;YWHAZ;PDPN;RNF213;UNC5B;SPRY2;TNF;GSK3B;MGMT;PIK3R1;DDRGK1;ITGA5;MAEA;PSEN1;SRC;CPEB4;PDCD10;CX3CL1;HSPA5;NAA15;RIPK1;SETX;ITCH;PRKDC;SQSTM1;POU3F3;RASA1;LAMTOR5;BAG4;ARHGDIA;MAPK1;HSPD1;AKT1;DNAJC3;YWHAE
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3283478944457606,0.9395892721785578,0.5726970033296337,0.8376319907688478,1.0,17/80,18.37%,EPHA7;CASP1;CTSD;NOD1;SIAH2;SH3RF1;CSNK2A1;FNIP1;DNAJB6;TNF;ACVR1C;SRC;CYCS;LAMTOR5;AKT1;YWHAE;SOX2
prerank,lipid modification (GO:0030258),-0.27673352863680706,-0.9395212514203615,0.5528846153846154,0.8538999229399162,1.0,9/37,16.74%,DGKB;MBOAT1;DGKI;DGKA;DGKG;SGPP1;PORCN;PLPPR4;DGKQ
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.4414427525109513,0.9392814845666718,0.5666666666666667,0.8378302018554824,1.0,5/12,21.84%,DPYSL3;CTPS1;DPYD;CTPS2;UMPS
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3279317738391764,0.938530945395259,0.5911602209944752,0.8389564993117092,1.0,18/86,16.70%,DLC1;JAK2;OPHN1;ARFGAP1;DENND4C;MAPKAP1;GRB2;OGT;ERBIN;TGFB2;SPRY2;VAV1;AKAP13;ARHGEF18;PDCD10;SQSTM1;SYNGAP1;ARHGDIA
prerank,neuron projection extension (GO:1990138),0.3690550181335121,0.9385032356332628,0.5481852315394243,0.8385794944107482,1.0,4/32,3.93%,TNN;AUTS2;NRP1;USP9X
prerank,positive regulation of heart rate (GO:0010460),0.4175576344764957,0.9377979478477437,0.5416058394160584,0.839538829888989,1.0,4/17,14.55%,EDN3;ADM;ATP2A2;TRPM4
prerank,protein O-linked glycosylation (GO:0006493),0.32253241488163487,0.9376858411459759,0.5942184154175589,0.8393580308944655,1.0,18/96,16.87%,PLOD2;B4GALT5;ST6GAL1;GALNT3;TRAK1;ST3GAL3;GXYLT2;OGT;SLC35C1;GALNTL6;ST3GAL1;GALNT11;TET2;POFUT2;POGLUT3;TMTC4;CRPPA;C1GALT1
prerank,regulation of embryonic development (GO:0045995),0.3622801394855822,0.9373572012098325,0.549618320610687,0.8395746660588608,1.0,10/34,18.34%,B4GALT5;EHMT1;BAG6;WDPCP;NPHP3;ZBED3;PHLDB2;NIPBL;PHLDB1;NR2C2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4527823649139699,0.9373218496902295,0.552099533437014,0.8392210415368577,1.0,9/11,33.21%,TRAP1;COA8;SLC18A2;MPV17L;PPARA;ABCD2;PARK7;ABCB7;FYN
prerank,epiboly involved in wound healing (GO:0090505),0.4171082234238008,0.9372782228448538,0.564179104477612,0.8388750685988352,1.0,6/16,14.53%,MRTFA;LCP1;PDPN;RHOA;ARHGAP35;PDCD10
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3654952296624514,0.937202189579574,0.5792682926829268,0.838593473135724,1.0,15/38,19.96%,LRRK2;NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;LMAN1;MICALL2;BAG4;SREBF1;SH3GLB1;LEPROT;USP36;ARIH2;UBL5
prerank,synapse organization (GO:0050808),0.31734425994120563,0.9368967301916885,0.615546218487395,0.8387892458434125,1.0,25/125,14.73%,SLITRK6;PDZRN3;PCDHB6;PCDHB16;FARP1;LRRK2;GPC6;SDK2;ADGRL3;CACNB1;PPFIBP2;PTEN;C1QB;CDC42;PLXND1;L1CAM;PPFIBP1;SEMA3E;DSCAM;DBNL;SDK1;ELFN1;PSEN1;PPFIA4;CX3CL1
prerank,regulation of inclusion body assembly (GO:0090083),-0.3809731433544685,-0.9368620005434329,0.5698005698005698,0.8591184458723354,1.0,2/11,2.49%,SNCAIP;SACS
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.435851268045595,0.9367330224891159,0.5619469026548672,0.8386983001180367,1.0,2/14,9.18%,EDN3;ENPEP
prerank,negative chemotaxis (GO:0050919),0.3693212284134667,0.9365144000305782,0.532156368221942,0.8387233475940891,1.0,3/33,2.46%,EPHA7;SLIT3;SLIT1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.389728766585784,0.936345940810057,0.5387931034482759,0.8386444756470011,1.0,10/22,23.74%,EAPP;CCNT1;HMGN1;TCERG1;BRD4;KAT7;CDK13;CDK12;CDC73;THOC5
prerank,apoptotic cell clearance (GO:0043277),0.3744345104763491,0.9361086380569682,0.5517241379310345,0.838691850868352,1.0,4/30,8.96%,LRP1;TREM2;TXNDC5;ANXA1
prerank,melanosome transport (GO:0032402),0.40352866804058735,0.9359893232479727,0.527536231884058,0.8380841660524239,1.0,3/18,9.93%,MLPH;MYO5A;RAB27B
prerank,pigment granule transport (GO:0051904),0.40352866804058735,0.9359893232479727,0.527536231884058,0.8380841660524239,1.0,3/18,9.93%,MLPH;MYO5A;RAB27B
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.4108886059180627,0.9358863811610602,0.5800561797752809,0.8378658062643093,1.0,6/18,25.91%,MIA3;GPNMB;AKT1;PAG1;ASS1;PPARA
prerank,B cell activation involved in immune response (GO:0002312),0.42326919454331513,0.9357630437042498,0.5301391035548686,0.8376974105920931,1.0,1/13,3.16%,BATF
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3345133030280151,-0.9355684798814826,0.5563380281690141,0.8608094981806397,1.0,8/17,27.79%,HDAC4;CBFA2T3;GIT1;PDE12;MLXIPL;PPIF;PARP1;TIGAR
prerank,erythrocyte differentiation (GO:0030218),-0.262074009274879,-0.9351468338530152,0.5752688172043011,0.8603966777944663,1.0,15/44,21.32%,KIT;TGFBR3;FLVCR1;CASP3;SLC25A38;CEBPG;DMTN;ABCB10;TAL1;HSPA9;IKZF1;RPS19;ZFPM1;ALAS1;NCKAP1L
prerank,positive regulation of cartilage development (GO:0061036),0.4128747933309578,0.9346782374696282,0.5671428571428572,0.8393625163668155,1.0,3/17,5.18%,SOX5;MDK;BMP1
prerank,phospholipid metabolic process (GO:0006644),0.3323280723104367,0.9346348432382502,0.580387685290764,0.8390299627477222,1.0,6/71,8.76%,LGALS13;PDXP;ABCA2;PIP4K2A;FADS1;LPL
prerank,autonomic nervous system development (GO:0048483),0.41589489046803996,0.9345369839030641,0.545045045045045,0.8388001842797682,1.0,2/17,5.10%,NRP1;NF1
prerank,cAMP metabolic process (GO:0046058),-0.3464091517027225,-0.9339769143973599,0.5389048991354467,0.8616279423214092,1.0,5/13,10.43%,ADCY5;ADCY9;ADCY1;ADCY4;PDE4D
prerank,positive regulation of isotype switching (GO:0045830),0.4202501608940525,0.933915062821409,0.5633001422475107,0.8396146708951002,1.0,5/15,18.69%,CD40;SHLD3;RIF1;PAXIP1;HMCES
prerank,positive regulation of immune system process (GO:0002684),0.4145290061296037,0.932513900759047,0.5319465081723626,0.8419819612355508,1.0,4/16,11.44%,LGALS9;MIA3;ANXA1;TGFB2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.3381432236894232,-0.9322393936775484,0.54421768707483,0.8644055411546104,1.0,2/17,1.76%,ATP1A2;BMP4
prerank,amide transport (GO:0042886),0.37832206096928683,0.9321958505112025,0.5666666666666667,0.8421994310880727,1.0,2/26,4.28%,SLC14A2;PLTP
prerank,membrane depolarization during action potential (GO:0086010),-0.2948727458703753,-0.9321936252140972,0.5657894736842105,0.8629649194819057,1.0,5/26,10.06%,ATP1A2;SCN2A;KCNJ2;SCN8A;SCN9A
prerank,positive regulation of protein depolymerization (GO:1901881),0.45295434366094095,0.9316495494989958,0.5480916030534351,0.842887048578042,1.0,1/11,1.24%,PDXP
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3630051729613604,0.9316003683765733,0.5532994923857868,0.8425542386895324,1.0,15/36,26.01%,E2F1;RNF2;YAF2;EHMT1;PHC3;MAX;RBBP8;MGA;SUZ12;CDC7;CBX5;RAD51;RYBP;TFDP1;RBBP7
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.40986235915611363,0.9315879639275957,0.5661764705882353,0.8421572899763374,1.0,3/18,8.70%,POLE3;LIG1;MCM7
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4598844608920703,0.9315278358410733,0.5629860031104199,0.8418452901097248,1.0,2/10,5.04%,XCL1;LGALS9
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.32329014574254694,0.9314431036955546,0.5756578947368421,0.8415949230463902,1.0,12/90,9.38%,ADIPOQ;PLAC8;CMKLR1;JAK2;DYNC1H1;CD36;ALMS1;OMA1;EHMT1;CXCR4;OGT;HCRT
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.29565694411922805,-0.9313121006770941,0.5625,0.8636339981352514,1.0,9/26,21.38%,EPHA4;APH1A;VSIR;GRIN2B;APH1B;TTBK1;AIM2;USP50;PSME1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.3270467579087049,-0.9310897417404571,0.5420875420875421,0.8626259209006462,1.0,7/18,18.18%,RPS6KA5;ADCY1;EPHA5;CD200;LRP8;PRKD1;RELN
prerank,regulation of neuron migration (GO:2001222),0.37911727820098345,0.9308765595875268,0.580952380952381,0.8422754471155036,1.0,4/26,8.12%,COL3A1;TNN;MDK;IGSF10
prerank,vascular transport (GO:0010232),0.32607190537414416,0.9306526249347545,0.5912568306010929,0.8422804361805453,1.0,7/81,4.25%,SLC7A2;SLC1A3;LRP1;SLC38A3;SLC2A13;SLC28A2;ABCA2
prerank,ceramide transport (GO:0035627),0.44208603857963946,0.9305152021654621,0.5486443381180224,0.8421269542133146,1.0,2/12,4.28%,ABCA2;PLTP
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.40346631145337136,0.9304002616806116,0.544055944055944,0.8419283735160256,1.0,2/19,7.04%,BCL3;BAG6
prerank,ganglioside metabolic process (GO:0001573),-0.31068009844373545,-0.9303559833319892,0.5544554455445545,0.862898552784666,1.0,6/20,12.49%,ST6GALNAC3;ST8SIA4;ST3GAL5;ST8SIA6;ST8SIA2;ST6GALNAC5
prerank,sprouting angiogenesis (GO:0002040),0.3448665837107969,0.9302990632642306,0.5702479338842975,0.8417053214419291,1.0,12/51,12.48%,CCBE1;EGR3;NRP1;PARVA;E2F8;MIA3;ANGPT1;SEMA3E;BMPER;RNF213;VEGFC;FGF2
prerank,positive regulation of neuron differentiation (GO:0045666),0.36187946096057283,0.9301483410751191,0.5652724968314322,0.8415646894947509,1.0,5/40,11.96%,ZEB1;TCF4;HEYL;FGFR1;RHOA
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.4033878349366459,0.9301355837623565,0.5818713450292398,0.8411618178342115,1.0,3/18,5.95%,NF1;MORC3;SFRP1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.37519955487611484,0.9299098063726589,0.5737483085250338,0.8411950644259681,1.0,4/29,5.21%,PDGFRA;IRS1;PDGFRB;AMBRA1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.4098646894562966,0.9297308927634222,0.5443959243085881,0.8411503091878748,1.0,3/16,9.71%,IGFBP4;IGFBP5;BMP5
prerank,positive regulation of immunoglobulin production (GO:0002639),0.366219309279725,0.9295978227710926,0.5725490196078431,0.8409861414045738,1.0,8/31,18.69%,XCL1;SASH3;SHLD3;TNFRSF4;RIF1;PAXIP1;PTPRC;HMCES
prerank,alanine transport (GO:0032328),0.457941266332473,0.9294916067799038,0.559016393442623,0.8407708946996998,1.0,2/10,8.93%,SLC38A3;SLC36A2
prerank,nucleosome assembly (GO:0006334),0.364809840423483,0.9294196608116387,0.5856209150326798,0.8404887683354878,1.0,10/31,19.97%,GRWD1;HMGB2;RSF1;UBN1;SPTY2D1;NAP1L3;ATRX;ASF1A;KAT6B;NAP1L1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.32201910363104697,0.9285665402863699,0.6154672395273899,0.8417595852132186,1.0,23/98,18.91%,CEMIP;LRP1;NKD2;EGFR;TREM2;BBC3;E2F1;BCL2;ITGA3;PTPN9;YWHAZ;CASP8;TNF;KIF5B;PIK3R1;STAC3;SQSTM1;ITGB1BP1;AKT1;YWHAE;CLIP3;SPTBN1;PRNP
prerank,mitotic recombination (GO:0006312),0.4173627557844988,0.9284921179169691,0.5542347696879644,0.8414977129523054,1.0,7/15,23.20%,RAD52;XRCC3;NSMCE2;TEP1;SMC5;DMC1;RAD51
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3445011525110696,-0.9277050907731023,0.5488958990536278,0.8678582777934298,1.0,6/14,18.65%,KLF4;MEOX2;CARD10;THBS1;TBXA2R;MAP2K5
prerank,negative regulation of programmed cell death (GO:0043069),0.3004328036705647,0.9276318102381783,0.6820461384152458,0.8427360681676328,1.0,66/355,17.28%,NR1H4;BCL3;MAP4K4;EGR3;GATA6;BIRC3;FHL2;FSTL1;CFLAR;TSLP;EGFR;TREM2;FXN;MAD2L1;SHH;BAG3;BABAM2;BCL2;NUGGC;ANGPTL4;TXNDC5;SFRP1;PLK1;SIAH2;ASNS;BCL2L2;RAB7A;AIFM2;ANGPT1;CBL;AREL1;SH3RF1;ANXA1;WNT5A;HDAC1;IL7;HIPK3;RPS6KB1;TBX3;ARF4;PTK2;YWHAZ;PDPN;SPRY2;GSK3B;MGMT;PIK3R1;DDRGK1;PSEN1;SRC;PDCD10;CX3CL1;HSPA5;NAA15;RIPK1;SETX;ITCH;PRKDC;SQSTM1;POU3F3;RASA1;BAG4;ARHGDIA;HSPD1;AKT1;DNAJC3
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3987263609182899,0.92754091741896,0.550471063257066,0.8420624395115425,1.0,8/20,26.03%,ACADSB;HIBCH;ECHS1;BCKDHB;AUH;HIBADH;BCAT1;SLC25A44
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3987263609182899,0.92754091741896,0.550471063257066,0.8420624395115425,1.0,8/20,26.03%,ACADSB;HIBCH;ECHS1;BCKDHB;AUH;HIBADH;BCAT1;SLC25A44
prerank,protein insertion into membrane (GO:0051205),0.3683970234664512,0.9273942108586126,0.5669700910273082,0.8419658771369288,1.0,8/32,18.91%,EGFR;TRAM2;WDR83OS;VAPA;ALDH3A2;RTP4;MAIP1;PRNP
prerank,long-chain fatty acid transport (GO:0015909),-0.2752655623945036,-0.9273024495432252,0.537117903930131,0.8672412268567401,1.0,6/30,11.60%,PRKAG2;PRKAA2;ACSL1;ABCD3;SLC27A1;ACSL3
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.32051913614641836,-0.9271679667883678,0.5694915254237288,0.8659660822793562,1.0,6/18,11.60%,ACSL1;TECR;ELOVL7;ELOVL5;HACD1;ACSL3
prerank,purine nucleotide metabolic process (GO:0006163),-0.2933741444272194,-0.9271389130035839,0.569620253164557,0.864497128516907,1.0,5/24,9.41%,FHIT;PRPSAP2;NT5E;ITPA;PRPSAP1
prerank,neutral amino acid transport (GO:0015804),-0.28743449594275644,-0.9270312653359726,0.5783132530120482,0.8631912409842628,1.0,8/28,15.87%,SLC6A6;SLC6A9;SLC7A5;SLC1A1;SLC43A2;SLC38A5;SLC6A17;SLC6A7
prerank,cytoplasmic translational initiation (GO:0002183),0.41434650381491966,0.9269557848626223,0.5648414985590778,0.8424073603254392,1.0,6/17,20.36%,EIF4A1;EIF5;EIF2B3;DHX29;MCTS1;EIF4G1
prerank,cellular amide metabolic process (GO:0043603),0.31975270714813375,0.9269065123193533,0.6156351791530945,0.8420949357696039,1.0,26/102,22.76%,DNPEP;ST6GAL1;MTHFR;MTHFD1L;ABCA2;CPXM1;NLN;PANK2;ACSF2;NSMAF;ACOT13;ST3GAL1;MTHFD2L;ORMDL3;SMPD3;ACOT9;SGPL1;PLA2G4E;ATF4;MTRR;PCCA;SLC19A1;ALDH1L2;THEM4;AEBP1;GNE
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.41807097342259103,0.9267426796606414,0.5703812316715543,0.8420158376118705,1.0,5/15,21.08%,POP1;RNASEH1;DICER1;ZC3H12B;ZC3H12A
prerank,folic acid metabolic process (GO:0046655),0.4053068535606369,0.9261878233761699,0.5319727891156463,0.842691572187339,1.0,9/18,27.34%,MTHFR;MTHFD1L;MTHFD2L;MTRR;SLC19A1;ALDH1L2;MTHFD1;FOLR2;SLC25A32
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3680849931325697,-0.9261151634034217,0.5281899109792285,0.8639843186930356,1.0,7/11,33.01%,NDUFA13;TIMM22;TOMM70;TIMM8B;ROMO1;TIMM9;TIMM10
prerank,stem cell differentiation (GO:0048863),0.358860596855535,0.9257724133192566,0.5819070904645477,0.8431099103603792,1.0,8/39,11.44%,BATF;SOX21;SHH;PUM1;SFRP1;LRP6;SETD2;TGFB2
prerank,mitochondrial translational elongation (GO:0070125),-0.21969738114836457,-0.9252870856324439,0.611764705882353,0.8645253601845772,1.0,45/88,33.37%,MRPS9;MRPS35;MRPS28;MRPS15;MRPS24;MRPL13;MRPL10;MRPL21;MRPL39;ERAL1;TSFM;PTCD3;MRPL4;MRPS7;MRPS31;MRPL30;MRPL28;MRPS18C;MRPL22;MRPL40;GADD45GIP1;MRPL46;MRPS16;MRPS18B;MRPL58;MRPS22;MRPS6;MRPS25;MRPS12;MRPS34;MRPL44;MRPL18;MRPL20;MRPL35;MRPL23;GFM1;MRPL42;MRPL43;MRPL54;MRPL34;MRPL2;MRPS10;TUFM;MRPL16;MRPL11
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.34054577391843777,0.9246529549067277,0.5799522673031027,0.8449217929537257,1.0,11/53,11.09%,SPRED1;EGFR;SPRED2;BABAM2;PLA2R1;ATM;EEF1E1;CCAR2;ATR;FBH1;TMEM161A
prerank,regulation of mitochondrial translation (GO:0070129),0.40153115882937235,0.9242711830101324,0.596931659693166,0.8452052816622784,1.0,3/21,10.43%,RPUSD3;TRUB2;ALKBH1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.44171269307150707,0.9239025438332875,0.5793528505392912,0.8454945914694896,1.0,2/11,8.15%,CREB3L1;ADAMTS9
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.3883464287155444,-0.9238370813836356,0.5512048192771084,0.8667071610869388,1.0,2/10,8.96%,CAV1;ANK3
prerank,regulation of membrane repolarization (GO:0060306),-0.3520365322269594,-0.9236283939625906,0.5402298850574713,0.8656266322657654,1.0,3/13,4.05%,CAV1;AKAP6;KCNJ2
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.3336423249943359,-0.922693679592337,0.5328947368421053,0.8663797541747801,1.0,4/16,6.91%,CALM1;PGM2L1;PYGM;PYGB
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.43455567332487244,0.9217606366274614,0.5618153364632238,0.8488247470217042,1.0,4/12,13.03%,SLC9A1;STIMATE;TNF;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.43455567332487244,0.9217606366274614,0.5618153364632238,0.8488247470217042,1.0,4/12,13.03%,SLC9A1;STIMATE;TNF;SPPL3
prerank,protein homotetramerization (GO:0051289),-0.2516959035235273,-0.9216656380860484,0.5789473684210527,0.8673742819895406,1.0,20/49,28.77%,KCNJ2;SAMHD1;UPB1;ALDH9A1;GOLGA2;KCNJ12;GBP5;SSBP1;HCN1;SOD2;CBR4;GLS;USP16;APIP;CRYZ;PKD2L1;CTH;TRPA1;CBY1;HSD17B10
prerank,cellular response to oxidative stress (GO:0034599),0.3111868943985127,0.9215824136664349,0.6321353065539113,0.8487278908418567,1.0,29/118,21.45%,PDGFRA;LRRK2;RAD52;EGFR;AIF1;PKD2;PLA2R1;ETV5;ARNT;FOXO3;TMEM161A;NFE2L2;GPX8;TXNRD1;TXNRD2;SETX;CYCS;HIF1A;ADNP2;MAPK1;AKT1;ATF4;CYBB;TPM1;FANCC;PRKCD;ZC3H12A;WNT16;VRK2
prerank,protein heterotetramerization (GO:0051290),0.4314134979961688,0.9214271536262933,0.5733532934131736,0.8486153953196115,1.0,2/13,8.54%,PKD2;HSD17B8
prerank,histone acetylation (GO:0016573),-0.23222692842138407,-0.9213990089873608,0.6271186440677966,0.8664640867938013,1.0,23/69,17.75%,LEF1;JADE1;PER1;ACTL6A;PHF20L1;BRCA2;DR1;TADA1;JADE2;WDR5;EP300;TAF6;TAF6L;HAT1;NAA60;JADE3;MAP3K7;KAT6A;KAT5;TRIM16;EPC1;SUPT7L;APBB1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3941055016247029,0.9208418613718928,0.6011004126547456,0.849322884418417,1.0,3/21,11.70%,TNFAIP3;GPNMB;LST1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.23036317706404852,-0.9205351768146084,0.6637168141592921,0.8671488339738822,1.0,25/69,30.55%,STT3B;ERLIN1;EDEM2;JKAMP;UBXN4;UBE4A;DNAJC18;DNAJB9;ERLIN2;DERL1;ANKZF1;WFS1;RNF185;UFD1;YOD1;SGTA;FBXO44;RNF5;NPLOC4;UBQLN2;DNAJB2;ECPAS;TMEM67;UBE2J2;TMEM129
prerank,cellular response to copper ion (GO:0071280),-0.32722061604466707,-0.9204294026625416,0.56875,0.865862386765663,1.0,13/16,49.30%,MT2A;HSF1;AQP1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;SNCA;MT3
prerank,non-motile cilium assembly (GO:1905515),0.36670661262877235,0.9203949186790749,0.5625806451612904,0.8497664888283412,1.0,6/30,17.00%,IFT57;IFT88;PCM1;DISC1;TOGARAM1;CSNK1D
prerank,regulation of endocytosis (GO:0030100),0.32973961352309533,0.9200288283709471,0.6152099886492622,0.8500682437411028,1.0,6/61,7.37%,STON2;LRP1;APOE;OPHN1;ARFGAP1;PTPN1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.366593723674374,0.9199757956995976,0.5761843790012804,0.8497389917925116,1.0,6/31,15.09%,STXBP1;CBARP;SYT2;STXBP3;RAB3GAP1;DOC2B
prerank,excitatory postsynaptic potential (GO:0060079),0.4053103353105627,0.9198110322041962,0.5722713864306784,0.8496450085931495,1.0,8/19,23.06%,LRRK2;NPAS4;GSK3B;RAB3GAP1;AKT1;GRIN2A;NPFF;MAPK8IP2
prerank,positive regulation of hemostasis (GO:1900048),0.4506794684447605,0.919790347127233,0.5654853620955316,0.8488422197608488,1.0,2/10,6.67%,APOH;HPSE
prerank,positive regulation of coagulation (GO:0050820),0.4506794684447605,0.919790347127233,0.5654853620955316,0.8488422197608488,1.0,2/10,6.67%,APOH;HPSE
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3086910923066256,0.9197627092051439,0.6542443064182195,0.8484919801633184,1.0,22/159,11.84%,PALLD;CDH11;ROBO2;PCDHB6;JAML;PCDHB16;MILR1;GPC6;SDK2;ADGRL3;TENM3;DCHS1;ACVR1;CDH6;ICAM1;TENM4;L1CAM;DSCAM;TGFB2;CDH18;CDH24;PTPRM
prerank,cellular response to fluid shear stress (GO:0071498),-0.3522910047918858,-0.9196606731711179,0.5855855855855856,0.8662523017489778,1.0,7/12,24.49%,KLF2;SREBF2;KLF4;HDAC3;MAP2K5;MEF2C;MAPK7
prerank,response to muscle stretch (GO:0035994),-0.34321696719236744,-0.9195513865590769,0.5792682926829268,0.8650032547222226,1.0,2/15,3.22%,DMD;GSN
prerank,replication fork processing (GO:0031297),0.34855930764773113,0.919415438872188,0.5779141104294478,0.8487434413426765,1.0,15/38,24.75%,DNA2;DDX11;MMS22L;ATR;SETMAR;FBH1;EME2;ATRX;TRAIP;NUCKS1;CDK9;ZRANB3;RAD51;ETAA1;FAM111A
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3262486606811057,0.9187994312516256,0.5915032679738562,0.8495280289502946,1.0,27/78,24.12%,NKD2;LRRK2;PABIR1;RNF144A;PLK1;PRICKLE1;RAD23A;ARIH1;SOCS5;NFE2L2;RNF19B;GSK3B;CSNK1A1;DDRGK1;TRIB3;TRIB1;ZYG11B;CSNK1D;MDM2;ARIH2;FBXO22;RNF14;CLU;FZR1;RNF144B;RNF217;PIAS1
prerank,regulation of phagocytosis (GO:0050764),0.3399247725475551,0.9187459345862036,0.5876777251184834,0.8492138133153545,1.0,7/53,12.29%,ADIPOQ;TLR2;PRTN3;TREM2;MERTK;CALR;TNF
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3702347533170916,0.9186661716046496,0.5865771812080537,0.848940779898917,1.0,5/28,11.58%,LACC1;TNFAIP3;NOD1;IRAK2;CASP8
prerank,"transcription, DNA-templated (GO:0006351)",0.3018618974235588,0.9184163419562205,0.665650406504065,0.8490150033622869,1.0,71/207,24.69%,PAX1;BCL3;DEAF1;SOX5;NFIX;E2F1;CEBPD;TAF7;MBD1;TTF2;GTF2H1;NFE2L3;SNAPC3;RRAGC;TRIP11;FOXO3;GTF2F2;CRCP;HIPK3;NCBP2;GTF3A;CBFB;POLR3A;RSF1;CDK7;NKX2-8;GLIS3;SMN1;GTF2F1;IRF9;DRAP1;BRF1;TAF1A;TAF4;MMS19;BAZ2A;SETX;CCNT1;GTF3C4;RBMX;MLLT1;POLRMT;ATF4;TAF2;POLR2L;POLR2K;PAX8;CDK9;IWS1;POLR3GL;PMF1;ERCC2;POLR3K;THRA;TWNK;NFIC;CCNH;THRB;TCEA1;FUBP3;POLR2D;MNAT1;DDX21;PRMT5;CDC73;TAF5;RNPS1;TAF3;TEFM;RNMT;XBP1
prerank,sphingosine metabolic process (GO:0006670),-0.31879023352472,-0.9183846336866287,0.5838509316770186,0.8663609839209911,1.0,6/17,16.84%,ACER2;SPTLC2;SPTLC1;SGPP1;ASAH2;NAAA
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4137152502206851,0.9181687397715043,0.5775862068965517,0.8490770553524595,1.0,2/16,13.14%,ULBP1;KIF5B
prerank,negative regulation of cell division (GO:0051782),0.4323152185608783,0.918088321836278,0.56,0.8488049971112015,1.0,2/11,6.82%,VPS4A;E2F8
prerank,glucan catabolic process (GO:0009251),-0.33816091973023543,-0.9170898931974705,0.565625,0.867994375489844,1.0,4/15,6.91%,CALM1;PGM2L1;PYGM;PYGB
prerank,regulation of autophagosome maturation (GO:1901096),0.42878534154712533,0.9169287236322102,0.5683890577507599,0.8506896067321433,1.0,4/13,21.25%,TMEM39A;SMCR8;IRGM;CLEC16A
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.37739236970626144,0.9165356443458571,0.5706666666666667,0.8510341271857828,1.0,7/26,17.14%,NOS1AP;PKD2;CD36;TMEM106A;TNF;SMAD3;AKT1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2726685046525448,-0.9159651274907568,0.5865384615384616,0.8692602187569224,1.0,6/30,7.73%,CAV1;INPP5F;PRKCZ;SRCIN1;PPP2R1A;PIBF1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.31248993523107277,0.915737513087586,0.6189967982924226,0.8521083071575382,1.0,20/95,18.69%,RAD51B;RAD52;MCM2;INO80;XRCC3;MMS22L;ZFYVE26;MCM7;FBH1;AP5Z1;MCM9;NSMCE2;RMI1;XRCC1;NIPBL;PSMD14;NUCKS1;HELQ;RBBP8;SWI5
prerank,sarcomere organization (GO:0045214),0.36837725590217585,0.9146572241870364,0.5685483870967742,0.8537662477647905,1.0,2/27,4.03%,CSRP1;FHOD3
prerank,sodium-independent organic anion transport (GO:0043252),-0.3726063926805278,-0.9143362360754791,0.5765765765765766,0.8717015588731625,1.0,3/10,8.27%,SLCO1C1;SLCO3A1;SLCO2A1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.37356801447536253,0.9143229331771141,0.5737051792828686,0.8540107383967381,1.0,5/25,13.14%,LACC1;XCL1;WNT5A;TRAF2;SPHK2
prerank,cilium assembly (GO:0060271),0.29551118380176994,0.9142672411286726,0.7028112449799196,0.8536953613310464,1.0,64/296,17.61%,TEKT4;DYNLL1;CEP19;ASAP1;STK36;DYNC1H1;PARVA;IFT57;TUBG1;ALMS1;IFT88;PLK1;PCM1;HAUS3;RAB8B;CEP41;EXOC4;DYNC2LI1;CNTRL;DCTN3;EHD2;ACTR2;GBF1;TRIP11;FAM161A;EXOC1;EXOC7;WDPCP;PCNT;WDR35;DISC1;PTPN23;ARF4;GALNT11;NPHP3;TNPO1;IFT172;IFT81;CEP72;PDE6D;SNX10;CFAP410;CPLANE1;ACTR1A;RAB1A;DYNC2H1;DZIP1L;AKAP9;KIF27;CDC14A;TTC39C;EXOC5;TOGARAM1;CEP192;EXOC3;NUDCD3;POC1B;WDR90;CSNK1D;SPATA6;YWHAE;ATP6V1D;CKAP5;CFAP74
prerank,macrophage migration (GO:1905517),0.42462686306527503,0.913471156276845,0.584070796460177,0.854820350210696,1.0,2/13,10.36%,CCL5;CCL2
prerank,positive regulation of viral genome replication (GO:0045070),0.36498591375683254,0.913450900928049,0.5721784776902887,0.8544381372581793,1.0,6/29,11.48%,TMEM39A;PPID;CCL5;RAD23A;TOP2B;STAU1
prerank,protein oxidation (GO:0018158),0.4440200959677807,0.9133384523883615,0.5830670926517572,0.8542218337082196,1.0,2/11,10.24%,LOXL1;LOXL3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4097020439097625,0.9124772158481563,0.5659025787965616,0.8554316456746941,1.0,2/15,5.42%,SFRP4;CYP27B1
prerank,regulation of T cell activation (GO:0050863),0.35163644617251943,0.9122235641654208,0.621301775147929,0.855518749732429,1.0,12/42,26.27%,TNFSF11;CCL5;GPNMB;CCL2;HSPD1;PAG1;SIRPA;CCDC88B;CYRIB;TNFRSF1B;THY1;PYCARD
prerank,fatty acid biosynthetic process (GO:0006633),0.3287889517585375,0.9122046053676528,0.6124293785310735,0.8551289297698436,1.0,8/63,9.08%,LIPC;EPHX2;HACD2;SCD5;HSD17B8;FADS1;LPL;CYP1A1
prerank,intestinal absorption (GO:0050892),0.4234049378544067,0.9121419830862877,0.5751937984496124,0.8548381169895876,1.0,2/13,5.55%,UGCG;CD36
prerank,positive regulation of endothelial cell migration (GO:0010595),0.32071929090448253,0.9118587837721518,0.6208791208791209,0.8549519044264894,1.0,34/84,25.43%,SPARC;CD40;PRKCA;NRP1;AKT3;PRKD2;EGF;STAT5A;SASH1;ANGPT1;WNT5A;FGFR1;CALR;RIN2;FGF2;RAC1;HIF1A;FGF18;ITGB1BP1;AKT1;ETS1;AGT;BCAS3;ATP5F1A;FOXP1;ZC3H12A;ROCK2;ITGB3;GPI;BMPR2;VEGFA;AAMP;PLPP3;PDPK1
prerank,response to interleukin-6 (GO:0070741),0.44498753659795864,0.9113731899035868,0.6006339144215531,0.8554656967907468,1.0,2/10,7.40%,SBNO2;PID1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.415875357735276,0.9110460700880658,0.5726872246696035,0.8557090400391947,1.0,4/15,18.54%,MAD2L1;RPL11;DTX3L;FBXO5
prerank,regulation of neuron differentiation (GO:0045664),0.32134932785031994,0.9104723428925481,0.6190476190476191,0.8563733555263675,1.0,16/76,19.61%,ZEB1;TCF4;LRRK2;NREP;HEYL;FGFR1;NEPRO;CALR;RHOA;BMP7;MOSMO;TCF3;ZFHX3;SOX2;VWC2;MED1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4058840564244872,0.9104069155069652,0.5892857142857143,0.8560871399169871,1.0,3/16,9.03%,ARHGAP24;AUTS2;OGT
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.29692943666257154,0.9103588386236519,0.7306532663316583,0.8557517863120462,1.0,62/306,19.97%,RPSA;RRBP1;RBMS1;BCL3;ASMT;EIF4G2;TNIP1;B4GALT5;POLE3;BRIP1;DNA2;EXT1;RPL3L;APOE;E2F1;MCM2;EXT2;NT5M;ATM;PABPC4;TERT;RRAGC;MCM7;ATR;DBF4;GRWD1;RNASEH2A;MCM9;POLR3A;RPL12;MRPS18A;TIMELESS;EEFSEC;POLA2;NKX2-8;RPL22;RPL14;REV1;RMI1;MRPS14;RPL11;MMS19;BAZ2A;GSPT1;ATRIP;MRPL55;ING5;RPL36A;RAD9A;MRPL52;POLR2L;RPS9;INHBA;POLR2K;PAX8;RBBP8;RPL6;KAT7;RPLP2;AGO2;MRPS33;NAP1L1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.37414790711862317,-0.9101820135638671,0.5683646112600537,0.8801705338427968,1.0,4/10,14.45%,HDAC4;PIAS3;UBA2;PIAS4
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4533175522474587,0.909734038495023,0.5799373040752351,0.856545327061813,1.0,6/10,30.06%,PIH1D2;RUVBL1;PIH1D1;RUVBL2;ZNHIT6;NUFIP1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.3620241328505306,0.9096464399181915,0.5969773299748111,0.8562983436853926,1.0,9/32,15.68%,TREM2;ENO1;ARNT;PFKFB4;PID1;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,T cell mediated immunity (GO:0002456),0.4142159199840799,0.9089710250088097,0.5827123695976155,0.8571561389595087,1.0,2/13,5.33%,JAG1;GNL1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3042833129811609,0.9089297526859094,0.6629098360655737,0.8568179290079401,1.0,35/148,18.96%,BRIP1;DNA2;NUAK1;RICTOR;KMT5A;PIP4K2A;TAF7;ATM;EHMT1;NOC2L;MAPKAP1;MAPK11;ATR;HDAC1;CSNK2A1;CSNK2A2;TPX2;PRDM1;MTA2;NOP2;BRPF1;RMI1;TAF4;RPL11;BANP;PRKAB1;ATRIP;AKT1;PHF20;ING5;MDM2;RAD9A;TAF2;RBBP8;MBD3
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3398374558327908,-0.9085863732278395,0.5632183908045977,0.8823855807872245,1.0,5/14,19.13%,MALT1;CARD10;CARD14;MAP3K7;IRAK1
prerank,T cell migration (GO:0072678),-0.3462770664055665,-0.9083265010444882,0.5705882352941176,0.8814910466789989,1.0,2/13,4.04%,SLC12A2;S1PR1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.39160568551154085,0.9082234095083271,0.5775862068965517,0.8577582909140425,1.0,3/20,5.97%,EGFR;PKD2;CCND3
prerank,pulmonary valve morphogenesis (GO:0003184),0.4046911431829588,0.9081754128238574,0.5754985754985755,0.8574280804855027,1.0,4/17,11.44%,ROBO2;JAG1;HEYL;TGFB2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.353059315073471,0.9081199607000545,0.6018396846254928,0.8571076434575672,1.0,3/31,9.03%,PDGFRA;HOXB3;TGFBR1
prerank,prostaglandin biosynthetic process (GO:0001516),0.3928271850365069,0.9080807232128557,0.5991189427312775,0.85675370700118,1.0,4/18,14.60%,PTGES;PTGES2;TBXAS1;PLA2G4A
prerank,regulation of protein dephosphorylation (GO:0035304),0.3468124515098761,0.9077191599531277,0.5894206549118388,0.8569686633950857,1.0,13/37,20.54%,DLC1;PPP2R5A;PPP1R2;SPPL3;PPP1R16A;CALM2;PTPA;ANKLE2;MFHAS1;HSP90B1;PIN1;PPP6R2;PRKCD
prerank,ear morphogenesis (GO:0042471),0.38888646094321194,0.9074121740229388,0.5938375350140056,0.8571069126140916,1.0,5/20,18.17%,CHD7;HOXA1;ZIC1;NIPBL;PAX8
prerank,Rap protein signal transduction (GO:0032486),-0.36643449344687384,-0.9074033811289344,0.5584415584415584,0.8821721954063956,1.0,3/10,11.64%,RAPGEF3;RAPGEF2;RAP1A
prerank,negative regulation of binding (GO:0051100),0.3223897627938072,0.907190993803332,0.6255411255411255,0.8571010424728117,1.0,25/81,20.54%,LRRK2;JAK2;E2F1;ILRUN;DDX11;MDFI;EFHB;SP100;DISC1;RSF1;PEX19;GSK3B;GTF2F1;DACT1;SMO;ITGB1BP1;AKT1;NFKBIA;TLE5;WAPL;CTNNBIP1;KDM1A;PIN1;HMGA2;PRKCD
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.24316334541263995,-0.9071808290349747,0.6612021857923497,0.881201761242431,1.0,10/46,16.74%,DGKB;DDHD1;GPD1L;DGKA;SLC27A1;AGPAT3;ACP6;DGKG;GPAT4;DGKQ
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4151767935879847,0.9069037831626686,0.6030534351145038,0.857241078146743,1.0,6/13,20.69%,ZFPM2;TBX2;FGF2;GLI1;RBPJ;BMPR1A
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3579552581270118,0.90670813554483,0.5923076923076923,0.8571865388130706,1.0,4/33,6.70%,IAPP;FXN;OMA1;ADCK1
prerank,regulation of response to stress (GO:0080134),-0.3780473377914202,-0.9064494620378627,0.5912596401028277,0.8813942578202851,1.0,8/10,44.05%,CORO2B;SLC38A2;MLC1;STOX1;OPRM1;DYRK3;ADCY8;CRHBP
prerank,positive regulation of protein metabolic process (GO:0051247),0.309064045271231,0.9062104039621101,0.650319829424307,0.8577021963198965,1.0,37/110,22.52%,IL23R;TNFAIP3;APOE;ABCA2;SMURF2;PAEP;OAZ3;RAB7A;AREL1;WNT5A;CSNK2A1;SLC25A37;ATG7;TNF;GSK3B;RAB1A;DACT1;PSEN1;CDKN1B;RANBP9;SMURF1;ITCH;NEDD4;AKT1;DDB1;INHBA;AGT;NFKBIA;TNFSF12;PLK2;EIF4G1;AXIN1;CLU;CSF1;FZR1;ROCK2;CD80
prerank,neuronal action potential (GO:0019228),-0.30116972808949727,-0.9061859130426797,0.5903614457831325,0.88054477511023,1.0,9/22,27.42%,SCN2A;SCN8A;ANK3;SCN9A;GPER1;MYH14;CACNA1I;SCN3A;KCNMB2
prerank,regulation of protein transport (GO:0051223),0.3691469083058909,0.9059688214591484,0.5847347994825356,0.8577456025617604,1.0,8/27,18.88%,DNAJC1;LLGL1;PTPN1;LCP1;TNF;NDEL1;SCFD1;GAPVD1
prerank,nucleic acid-templated transcription (GO:0097659),0.3443632672723271,0.905900192148041,0.6227106227106227,0.8574452308266725,1.0,11/42,18.17%,BCL3;E2F1;TERT;RRAGC;POLR3A;NKX2-8;MMS19;BAZ2A;POLR2L;POLR2K;PAX8
prerank,cellular response to glucose stimulus (GO:0071333),0.3573255089983235,0.9054965352368863,0.5992115637319316,0.8577812980233033,1.0,1/30,0.13%,SLC39A14
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.40525011336548955,0.9054467415854871,0.5960960960960962,0.8574643761420877,1.0,2/15,3.52%,TEC;EGFR
prerank,regulation of lipid kinase activity (GO:0043550),-0.3583433358620403,-0.9050884846817373,0.5773480662983426,0.8816563794302894,1.0,2/11,3.11%,PIK3R3;RB1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.33834928023094235,-0.9049033465371384,0.5680473372781065,0.8806291859223847,1.0,5/13,24.29%,PRR5L;CNOT8;UPF1;RC3H1;ZC3HAV1
prerank,myotube differentiation (GO:0014902),0.4041078912899558,0.9048957246548374,0.6008902077151336,0.8580716317713147,1.0,3/17,5.90%,ADAM12;ADAMTS15;ADAMTS5
prerank,regulation of lysosomal lumen pH (GO:0035751),0.43022815454872687,0.9047736322921677,0.5862595419847328,0.8578957624637736,1.0,3/12,11.74%,LRRK2;ATP6AP2;CLN6
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3805422055295221,0.9043043979894829,0.6044568245125348,0.8583945085887075,1.0,5/22,8.49%,TNKS1BP1;RAP2A;TOM1L1;RASSF2;GPNMB
prerank,polyol biosynthetic process (GO:0046173),0.40299675985898714,0.9039891448655885,0.5950920245398773,0.8585900362095237,1.0,5/16,12.52%,CYP27B1;ITPKC;IP6K2;FGF2;CYP2R1
prerank,establishment of melanosome localization (GO:0032401),0.3866023835237941,0.9039218494053357,0.5685131195335277,0.8583065618035217,1.0,3/19,9.93%,MLPH;MYO5A;RAB27B
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.29240310818153836,0.903684454319597,0.745,0.8583327125545973,1.0,67/314,20.36%,PSMA7;SPSB1;KLHL22;FBXL7;MAD2L1;CUL1;SMURF2;APPBP2;PLK1;ANAPC11;SIAH2;CDC27;BAG6;SKP1;SPOP;TRIM13;FBXL18;FBXW7;AREL1;PSMB8;RAD23A;PSMA6;TBL1X;RAD23B;DCAF11;UBE2J1;NFE2L2;KCTD10;FBXW11;DCAF12;ZSWIM8;PSMF1;UBE2K;MAEA;UBE2W;FBXO2;RHBDD2;HSPA5;PSMA8;SMURF1;ITCH;NEDD4;FBXL19;PSMD2;PSMD12;PSMD11;RBCK1;CLOCK;PCNP;PSMD14;KCTD2;FAM8A1;DDB1;MDM2;PSMB1;FBXW4;FBXO5;FBXO31;HSP90B1;LTN1;AMN1;UBR1;FBXO38;FBXL22;UBXN2A;PSMC6;UBE2E1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.24286015730297073,-0.9035038113829952,0.6172839506172839,0.8823856706382319,1.0,23/47,27.20%,ATP5MG;TMEM11;ATP5PD;ATP5PF;LETM1;NDUFA13;MTX3;IMMT;HSPA9;ATP5F1D;MICOS13;ATP5ME;SAMM50;APOO;TIMM22;APOOL;TOMM70;TIMM8B;ROMO1;MICOS10;UQCC3;ATP5MC2;TIMM9
prerank,protein localization to cell surface (GO:0034394),-0.2855377021967101,-0.9033245437700205,0.6576576576576577,0.8813142614961574,1.0,12/26,26.62%,ANK2;FBLN5;GGA1;VCL;PTPRK;FGF10;WNT11;PIGU;UNC50;RIC3;PRRT1;PTPRU
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3355319316465378,0.9028404102698433,0.6179906542056075,0.8594841956274707,1.0,21/51,23.87%,SYNPO;NRP1;CARMIL1;NF2;SFRP1;TGFB3;CDC42;EPHA1;TGFBR1;RHOA;RAC1;CX3CL1;ITGB1BP1;PLEK;TPM1;PAK1;RHOC;RGCC;ROCK2;LPAR1;PXN
prerank,positive regulation of immune response (GO:0050778),0.3237560862787129,0.9025286076770981,0.6284403669724771,0.8596487529551451,1.0,7/64,13.14%,IL23R;LGALS9;CCL5;SASH3;TGFB2;POLR3D;SPHK2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3767230467201224,0.9023530343304584,0.6058981233243967,0.8595554853200609,1.0,6/25,14.77%,DNAJB1;HSPE1;GAK;DNAJC7;SDF2;HSPA5
prerank,cellular response to leucine (GO:0071233),0.44413169020759324,0.902006282470342,0.5954692556634305,0.8593775869264301,1.0,2/10,7.66%,KLHL22;RPTOR
prerank,response to leucine (GO:0043201),0.44413169020759324,0.902006282470342,0.5954692556634305,0.8593775869264301,1.0,2/10,7.66%,KLHL22;RPTOR
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.37757890877542477,0.9016845974828278,0.5786593707250342,0.8595797594454287,1.0,1/23,0.48%,ADIPOQ
prerank,myoblast differentiation (GO:0045445),0.4122061284981481,0.9014431734422667,0.5797317436661699,0.8596293037492666,1.0,4/14,8.05%,TCF7L2;JAG1;DDX17;SDC1
prerank,regulation of cellular pH (GO:0030641),0.3587961495019201,0.9010473293972985,0.5860284605433377,0.8599368299499783,1.0,5/29,10.22%,SLC9A1;LACC1;TM9SF4;SLC9A8;SLC4A7
prerank,vesicle transport along microtubule (GO:0047496),0.3809743994238532,0.9010449788157135,0.611336032388664,0.8595273287703941,1.0,8/23,17.19%,DYNC1H1;KIF1C;TRAK1;FBXW11;KIF5B;RAB1A;NDEL1;KIF5A
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3376520572162713,0.9001935570842932,0.6127098321342925,0.8607091017139603,1.0,23/47,29.52%,ATXN2;APOE;FOXO3;SSH1;NOLC1;AKT1;INHBA;AGT;NFKBIA;RBM4B;EIF4G1;VPS35;CSF1;PCIF1;METAP1;EIF2A;NR1H3;PUM3;CYFIP1;WDR91;GEMIN5;NFKB1;EIF4E
prerank,central nervous system neuron differentiation (GO:0021953),0.35773193043095414,0.8990475354607315,0.61003861003861,0.8623373277628958,1.0,6/33,11.46%,WNT2;MDGA1;OPHN1;LRP6;DRAXIN;AGTPBP1
prerank,protein acetylation (GO:0006473),0.3604363169283438,0.8990348579896755,0.5931758530183727,0.8619429612503225,1.0,8/30,18.30%,NAA50;CREBBP;NAT9;NAT10;NAA15;CLOCK;ING5;AANAT
prerank,negative regulation of locomotion (GO:0040013),0.4150202701187994,0.898822687326213,0.5885093167701864,0.8619250376704636,1.0,1/12,1.00%,FBLN1
prerank,embryonic appendage morphogenesis (GO:0035113),0.42984304047632743,0.8985761467957909,0.598159509202454,0.861957118477389,1.0,4/12,17.75%,SHH;LRP6;TGFB2;FBXW4
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4020995349167845,0.8983692116629075,0.566813509544787,0.861929408583482,1.0,4/16,18.30%,NAA50;CREBBP;NAA15;AANAT
prerank,regulation of JNK cascade (GO:0046328),0.30590709777761144,0.8983296865849383,0.6502673796791444,0.8615878910755677,1.0,29/101,23.06%,SH3RF3;MAP4K4;TAOK1;EGFR;UNC5CL;AIDA;RAP2A;TAOK3;RASSF2;TIRAP;SH3RF1;EDA2R;PJA2;TRAF2;DACT1;RIPK1;ITCH;TRAF5;MAPK8IP1;MFHAS1;GADD45A;DUSP15;WNT16;SIRPA;AXIN1;SDCBP;MAPK8IP3;NCOR1;MAPK8IP2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.36697257284947304,-0.898258455863332,0.5779036827195467,0.8925084822418334,1.0,2/10,6.00%,ZBTB16;SOX6
prerank,protein localization to organelle (GO:0033365),0.30659051389658476,0.8980435979992178,0.6886792452830188,0.8617115987756282,1.0,37/133,21.74%,COL1A1;LRRK2;TRAM2;CD68;LAMP2;WDR83OS;VAPA;GBF1;WDR35;GAK;CALR;SNX10;DDRGK1;BMP7;RPL11;DCP1A;ALDH3A2;BANP;COG7;OBSL1;CSNK1D;YWHAE;ATP6V1D;DDX1;RAB33B;MDM2;TOR1AIP1;ZBTB7A;PRNP;TULP3;SYS1;LAMP5;ISG15;IFT20;VPS35;YBX1;ZNF423
prerank,leukotriene metabolic process (GO:0006691),0.3899796319675201,0.8977345519385492,0.6242857142857143,0.8618708946850631,1.0,3/19,14.60%,DPEP2;ABCC1;PLA2G4A
prerank,tRNA aminoacylation (GO:0043039),0.34943929520140127,0.8976759018986189,0.6281725888324873,0.8615597181755142,1.0,10/37,16.17%,PPA1;YARS1;AIMP1;EEF1E1;IARS2;TARS1;RARS2;RARS1;GARS1;LARS2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.33914683752207186,0.8975845976820862,0.6125461254612546,0.8613011263802477,1.0,14/42,22.61%,MBD2;SMARCC1;INO80;HDAC1;ARID1B;MTA2;GATAD2B;SPTY2D1;SRCAP;SMARCA4;MBD3;HNRNPC;ACTL6B;CHD8
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.41618802840845925,0.896814045984712,0.5957767722473605,0.8622912107073804,1.0,1/12,4.98%,BCL2
prerank,negative regulation of insulin secretion (GO:0046676),0.3961087780110713,0.896552727684725,0.6058823529411764,0.8623747428606992,1.0,3/17,6.47%,IRS1;SFRP1;INHBB
prerank,organonitrogen compound catabolic process (GO:1901565),0.3302347338112525,0.8963433133229618,0.6262975778546713,0.8623527949626802,1.0,11/57,15.09%,LIPC;ANPEP;CPQ;NPEPPS;PLA2G7;ENPEP;CLN6;LVRN;AMDHD2;PLA2G4A;SGPL1
prerank,phagosome-lysosome fusion (GO:0090385),0.4454073387798066,0.8961429130594153,0.6009933774834437,0.8623216011228053,1.0,3/10,13.84%,RAB7A;RAB7B;RAB34
prerank,protein lipidation (GO:0006497),0.3218266135584997,0.8961152361088959,0.6198830409356725,0.8619677129791948,1.0,15/59,16.83%,WIPI1;UGCG;PIGW;PIGN;PIGL;PIGC;ATG7;HHAT;PIGP;ZDHHC6;ZDHHC9;WDR45;PIGH;PIK3C3;ZDHHC3
prerank,DNA catabolic process (GO:0006308),0.4365995616804328,0.895987530711632,0.6146645865834633,0.8617934762859228,1.0,2/11,10.03%,SETMAR;FBH1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.232453101146534,-0.8956856529669448,0.6546762589928058,0.897122816934631,1.0,19/54,26.37%,RNF152;PRKN;KLHL3;UBE2E3;UBE2A;UBE3A;RFFL;HACE1;UBE2B;BFAR;SKP2;TRIM32;UBE2D1;KBTBD7;RNF5;NEDD4L;RNF126;RBX1;RNF115
prerank,entry into host (GO:0044409),0.41800010243257524,0.8956505381420923,0.5981873111782477,0.861995882869318,1.0,4/13,14.06%,CBL;GRB2;CXCR4;SRC
prerank,long-term memory (GO:0007616),-0.30587851280180617,-0.895385467082198,0.6086956521739131,0.8962773200362325,1.0,5/19,9.15%,CPEB3;LDLR;RASGRF1;CAMK4;SHANK1
prerank,regulation of epithelial cell migration (GO:0010632),0.3316731380833037,0.8953505774377635,0.6325301204819277,0.8621455219945124,1.0,10/51,15.68%,PTN;RHOJ;DOCK1;SASH1;PTPN23;PTK2;BMPER;TGFB2;SRC;HIF1A
prerank,blood vessel diameter maintenance (GO:0097746),0.35537432840167543,0.894960241772549,0.6181592039800995,0.8624405030436332,1.0,3/34,2.89%,EDN3;CRP;EDNRA
prerank,blood vessel endothelial cell migration (GO:0043534),0.37394541542445936,0.8947950945410639,0.6061452513966481,0.8623315423911291,1.0,4/22,7.08%,EGR3;NRP1;MYH9;MIA3
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.372102188253668,0.894672946013071,0.6032171581769437,0.8621415055319883,1.0,2/24,2.62%,ENPP1;IRS1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.36199833313563895,-0.8946328508270894,0.6061452513966481,0.8964665626946247,1.0,7/11,28.08%,UQCRC2;UQCRB;UQCRH;UQCRFS1;UQCC3;UQCR10;UQCR11
prerank,transcription by RNA polymerase III (GO:0006383),0.3607044333798018,0.8945860074096731,0.5978975032851511,0.861890429036703,1.0,11/27,21.36%,SNAPC3;CRCP;GTF3A;BRF1;GTF3C4;ICE1;POLR2L;POLR2K;POLR3GL;POLR3K;SNAPC5
prerank,gonad development (GO:0008406),0.33650359214551745,0.8937797888750604,0.6104368932038835,0.8629459762212673,1.0,10/41,21.01%,GATA6;NR2F2;WNT5A;SALL1;TGFB2;ADAM21;TFAP2C;INHBA;NUP107;CSDE1
prerank,selective autophagy (GO:0061912),0.3294304393904493,0.8935171684369707,0.6331018518518519,0.8630141587009954,1.0,11/56,13.32%,DYNLL1;DYNC1H1;AMBRA1;ATM;IFT88;RAB7A;PCNT;WDFY3;UBA5;NBR1;DDRGK1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.35304334249264446,-0.8932770964277328,0.5718654434250765,0.8981764470429177,1.0,4/12,15.94%,RAB27A;SLC5A3;TLR4;ZNF205
prerank,regulation of protein kinase C signaling (GO:0090036),0.4096435238043963,0.8931602952692272,0.5835866261398176,0.863233653771042,1.0,4/14,13.14%,CD40;WNT5A;MC1R;SPHK2
prerank,V(D)J recombination (GO:0033151),0.4243946231940823,0.8926513402141315,0.6087662337662337,0.8637322737161296,1.0,4/11,16.54%,LIG1;HMGB2;PRKDC;TCF3
prerank,metal ion export (GO:0070839),0.34997515467768153,0.8924076455497849,0.6090225563909775,0.8637427887873902,1.0,3/31,4.90%,KCNT2;SLC9A1;KCNA5
prerank,cellular response to zinc ion (GO:0071294),0.4036121195032837,0.8922853145612593,0.5959302325581395,0.8635619189057754,1.0,1/15,1.99%,HVCN1
prerank,regulation of exit from mitosis (GO:0007096),0.34327521841102465,0.8922216528008812,0.628140703517588,0.8632712925355345,1.0,4/38,6.56%,PPP1R9B;MAD2L1;ANAPC11;CDC27
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.2605629445846038,-0.8921862554545001,0.6787564766839378,0.8991616244008309,1.0,7/36,8.96%,KIF13A;RILPL1;GGA1;VAMP4;PREPL;NSF;ANK3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3490252188169867,0.8914453782114132,0.6169405815423514,0.8642902551174161,1.0,9/35,16.70%,PDGFRA;NRP1;MDK;BAIAP2;CDC42;SEMA3E;NTRK3;FES;ARHGDIA
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4197145256418413,0.8914353166374736,0.5875190258751902,0.8639032818263492,1.0,1/11,4.98%,BCL2
prerank,rRNA modification (GO:0000154),-0.292770740329416,-0.8910188489008424,0.6105263157894737,0.9003589068075756,1.0,12/21,31.06%,ZCCHC4;TFB1M;DKC1;DIMT1;GAR1;NOP10;TSR3;THUMPD1;TRMT112;FBL;NHP2;TFB2M
prerank,linoleic acid metabolic process (GO:0043651),-0.3135104792136729,-0.8907360268859404,0.5815602836879432,0.8994945329999543,1.0,2/17,7.04%,ACSL1;ELOVL5
prerank,mitotic chromosome condensation (GO:0007076),0.36271440915685715,0.8905248499514863,0.608,0.8651753420583993,1.0,9/26,21.09%,KMT5A;PLK1;CSNK2A1;CSNK2A2;NCAPD2;NCAPG2;NCAPG;TENT4A;SMC4
prerank,positive regulation of chromosome organization (GO:2001252),-0.32065596357505016,-0.8899104117059091,0.6214285714285714,0.8998503941479576,1.0,4/15,8.31%,RAD21;MRE11;PPP1R10;RTEL1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.2803299504101756,-0.8893387652419742,0.6176470588235294,0.8996092499101697,1.0,5/24,11.39%,LPGAT1;SERAC1;ABCA3;SLC27A1;CDS2
prerank,positive regulation of transport (GO:0051050),0.31013749427647797,0.8892778458118162,0.6673984632272228,0.8670440999407073,1.0,13/85,15.09%,KMT2A;LRP1;TREM2;APOE;DYNC1H1;MERTK;ANXA1;CALR;TNF;GSK3B;KCTD7;FMR1;DOC2B
prerank,receptor internalization (GO:0031623),0.3366134008128485,0.8891685764917198,0.642594859241126,0.8668370600645022,1.0,7/44,11.87%,CLTC;LRP1;ADM;CD36;GRB2;DRD3;CALCRL
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.37096106159134806,0.8888152448876375,0.6251673360107095,0.867053711159093,1.0,7/23,15.68%,EGF;ARNT;PFKFB4;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4067975951871539,0.8888012805489449,0.6015037593984962,0.8666658638072617,1.0,6/15,17.00%,SFRP4;SFRP1;NPHP3;RNF213;DACT1;CSNK1D
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3546573612860241,0.8887925749198153,0.5921052631578947,0.8658652281141288,1.0,5/29,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,CENP-A containing chromatin organization (GO:0061641),0.3546573612860241,0.8887925749198153,0.5921052631578947,0.8658652281141288,1.0,5/29,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,cardiac muscle tissue development (GO:0048738),0.3308325753712034,0.8886131004915842,0.6383495145631068,0.8657705699314047,1.0,11/50,15.19%,TBX18;GATA6;TBX2;ADAMTS9;SMAD5;BMP5;MAML1;AKAP13;BMP7;SMAD4;SMAD1
prerank,barbed-end actin filament capping (GO:0051016),0.39096219422731715,0.8884337222464718,0.6122159090909091,0.8652767155901271,1.0,7/18,19.06%,SVIL;ADD2;VILL;ADD3;CAPZA1;EPS8;CAPG
prerank,actin filament capping (GO:0051693),0.39096219422731715,0.8884337222464718,0.6122159090909091,0.8652767155901271,1.0,7/18,19.06%,SVIL;ADD2;VILL;ADD3;CAPZA1;EPS8;CAPG
prerank,regulation of phospholipase C activity (GO:1900274),0.401178192948547,0.8883166863402658,0.6079881656804734,0.8650876525406401,1.0,5/15,12.55%,PDGFRA;PDGFRB;FGFR1;FGF2;NTRK3
prerank,mitochondrial membrane organization (GO:0007006),-0.26482844998939675,-0.8876489517947032,0.6342592592592593,0.9020769671048854,1.0,13/32,20.64%,SLC25A4;RCC1L;BCL2L1;TMEM11;MFN1;MTX3;IMMT;BNIP3;HSPA9;MICOS13;SAMM50;APOO;APOOL
prerank,positive regulation of neurogenesis (GO:0050769),0.3128604448436555,0.8875306682760487,0.6279594137542277,0.8661202094726436,1.0,22/68,22.90%,ROBO2;NUMBL;PLXNC1;PLXND1;SERPINF1;CAPRIN1;PLXNA3;DISC1;RHOA;NUMB;CX3CL1;ARHGDIA;OBSL1;PLXNB2;SPEN;KDM1A;NAP1L1;TIAM2;NPTN;SMARCD3;FZD3;PLXNB1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.36811199197345545,-0.8872628815266409,0.6059782608695652,0.9014810048637059,1.0,5/10,33.30%,TXN2;CBS;CTH;ADO;MPST
prerank,myotube cell development (GO:0014904),-0.37733411791346666,-0.8872121098044505,0.628808864265928,0.9000809775389348,1.0,3/10,15.63%,CAV2;IGF1;SKI
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3294664922411559,0.8870627498908817,0.6445221445221445,0.8665690096325636,1.0,17/52,19.96%,BBC3;E2F1;BCL2;NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;YWHAZ;CASP8;MICALL2;SH3GLB1;YWHAE;LEPROT;USP36;ARIH2;UBL5
prerank,metal ion transport (GO:0030001),0.31022520339399734,0.8864176812065245,0.6717391304347826,0.8673384414153905,1.0,13/86,13.92%,CACNA1A;CACNA2D1;CACNA1C;CCR1;ITPR1;PKD2;CYP27B1;CCL5;NIPAL2;CALCRL;NIPAL4;TUSC3;PSEN1
prerank,plasma membrane repair (GO:0001778),-0.34288849598410376,-0.8862997750758733,0.6272189349112426,0.9007788596118003,1.0,3/13,8.42%,MYOF;DYSF;SYT7
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3690459880401228,-0.886108704028663,0.6064139941690962,0.8997254359942697,1.0,3/10,7.73%,INPP5F;PPP2R1A;PIBF1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2827080215273151,-0.8860077980252399,0.624,0.8984180833056266,1.0,3/24,2.77%,DMD;AKAP6;CALM1
prerank,smooth muscle contraction (GO:0006939),0.4069678901336038,0.8859088859316896,0.589041095890411,0.8678232371280741,1.0,6/14,22.93%,EDNRA;MYLK;TPCN2;SMTN;ROCK2;ROCK1
prerank,nuclear body organization (GO:0030575),0.4212153735715442,0.8856315130914358,0.5964125560538116,0.867904236264179,1.0,4/12,22.31%,AFF2;USPL1;ETS1;HABP4
prerank,cellular response to starvation (GO:0009267),0.2967212755999324,0.885514687317656,0.7135470527404343,0.8677264704358841,1.0,45/147,21.25%,DAP;LRRK2;WIPI1;NUAK1;MIOS;SFRP1;NPRL2;EIF2AK2;INHBB;LAMP2;ASNS;RPTOR;RRAGC;FADS1;FOXO3;KPTN;FNIP1;KLF10;ATP6V1F;ATG7;ATP6V1H;ATP6V1G2;STK24;CPEB4;HSPA5;PIK3R4;WDR45;PIK3C3;LAMTOR5;ATP6V1G1;SREBF1;SEC13;SH3GLB1;MAPK1;ATP6V1D;MTMR3;EIF2AK3;ATF4;LAMTOR3;TBL2;ZFYVE1;PDK4;ZC3H12A;BECN1;CLEC16A
prerank,myeloid dendritic cell activation (GO:0001773),0.4136064446753057,0.8854962271498761,0.6055045871559633,0.8673473904150495,1.0,1/12,3.16%,BATF
prerank,negative regulation of JNK cascade (GO:0046329),-0.2642264401398661,-0.8854586242103423,0.6292682926829268,0.898171252794045,1.0,12/31,24.77%,MECOM;PRKN;PER1;SH3RF2;DUSP10;PINK1;CYLD;GPS2;HDAC3;ZMYND11;DUSP19;MEN1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35110182128530787,0.885011788254855,0.6162790697674418,0.867818805153919,1.0,6/28,13.92%,UBR5;BAG3;ZIC1;PIK3R1;SMAD3;PSEN1
prerank,positive regulation of cyclase activity (GO:0031281),0.41279901783298556,0.8847160404998445,0.6257396449704142,0.8679825675758567,1.0,2/14,5.10%,CACNA1C;NF1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.30465998601397426,0.8842569374295202,0.6755037115588547,0.8684120448777379,1.0,12/107,9.38%,CEL;ADIPOQ;CACNA1A;LRRK2;NPAS4;PTEN;OPHN1;DLGAP3;DLG4;PXK;KCNMB4;HCRT
prerank,N-glycan processing (GO:0006491),0.3756692642335314,0.8841590462025496,0.6159527326440177,0.8681722112911446,1.0,7/18,19.82%,PRKCSH;MAN2A1;MAN1C1;MGAT4A;GNPTAB;GANAB;MAN2A2
prerank,protein localization to cilium (GO:0061512),-0.26064378699363944,-0.884069864612434,0.6666666666666666,0.8999127184579675,1.0,12/32,25.15%,BBS9;INVS;TTC21B;ARL3;TCTN1;TCTN2;BBS4;TULP2;NPHP4;ARL6;IFT122;TULP1
prerank,modulation by host of symbiont process (GO:0051851),-0.2656751835995395,-0.8838619291459177,0.6651982378854625,0.8989096800975133,1.0,7/31,11.77%,LEF1;SAP30BP;JUN;INPP5K;CHD1;EP300;SP1
prerank,phospholipid transport (GO:0015914),0.3260659708293868,0.8836366005665879,0.6564344746162928,0.8687084023828573,1.0,5/52,4.34%,ABCA1;ATP8B1;APOE;PLTP;ABCG1
prerank,regulation of neuron apoptotic process (GO:0043523),0.3070757017106222,0.8836072665441176,0.6926360725720384,0.8683595863907636,1.0,13/96,12.29%,EPHA7;TREM2;APOE;MDK;BCL2;NF1;PTPRZ1;TGFB3;FOXO3;CCL2;TGFB2;UNC5B;TNF
prerank,positive regulation of organelle organization (GO:0010638),0.34617453407122833,0.8835640866012605,0.6122994652406417,0.8680330915481171,1.0,9/32,15.09%,TREM2;ANXA1;RAB3GAP2;LMAN1;GSK3B;P2RX7;SMCR8;RAB3GAP1;DOC2B
prerank,response to amino acid (GO:0043200),-0.2654849161332909,-0.883549927849503,0.6595744680851063,0.8981192252143148,1.0,13/31,20.44%,CPEB3;SLC38A9;GLRA3;LAMTOR1;GLRA1;SESN2;RRAGB;SPAAR;RRAGD;GLRA2;LAMTOR2;TMBIM6;RRAGA
prerank,striated muscle cell development (GO:0055002),-0.32016108756600153,-0.8835098935789634,0.6395348837209303,0.896723271152162,1.0,2/14,3.95%,PGM5;TMOD3
prerank,Golgi inheritance (GO:0048313),0.4291675092152585,0.8833346867880141,0.6198738170347003,0.8680381020125802,1.0,4/11,14.53%,GBF1;YWHAZ;VCPIP1;PDCD10
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3742125108964461,0.8827286213043605,0.6217687074829932,0.868308332909011,1.0,5/23,11.58%,BBC3;E2F1;BCL2;YWHAZ;CASP8
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3742125108964461,0.8827286213043605,0.6217687074829932,0.868308332909011,1.0,5/23,11.58%,BBC3;E2F1;BCL2;YWHAZ;CASP8
prerank,fibrinolysis (GO:0042730),0.40427256190382965,0.8815874388212821,0.6288659793814433,0.8699377744298322,1.0,1/13,6.23%,PLAT
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.264767875207515,-0.8812413826029495,0.6521739130434783,0.9002491295519522,1.0,11/32,13.78%,HDAC7;HDAC9;KLF4;KDR;MEOX2;CARD10;GATA2;JCAD;FGFBP1;FOXC2;THBS1
prerank,macroautophagy (GO:0016236),0.3004882956329895,0.8811412448382844,0.6779303062302007,0.870327803143683,1.0,29/118,18.27%,DYNLL1;WIPI1;CHMP4A;CHMP4B;AMBRA1;ILRUN;PIP4K2A;STX17;VPS4A;LAMP2;ATG3;VPS39;TOMM7;CSNK2A1;CSNK2A2;VPS37C;NBR1;ATG7;ATG16L1;SRC;CHMP2B;PIK3R4;PRKAB1;SQSTM1;RUBCNL;PIK3C3;MTMR3;LIX1L;TOMM22
prerank,regulation of lamellipodium organization (GO:1902743),0.406492374355328,0.881012740094604,0.6242424242424243,0.8701715240265637,1.0,4/14,14.73%,CARMIL1;CDC42;PDPN;RAC1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.37686692169358205,0.8807581786751246,0.6134800550206327,0.87023318978394,1.0,1/19,2.62%,IRS1
prerank,regulated exocytosis (GO:0045055),0.29399352125797007,0.8802310471905873,0.7105263157894737,0.8707721130305545,1.0,16/173,6.60%,KNG1;SERPING1;SPARC;LHFPL2;TIMP1;PROS1;STEAP2;BLK;MYH9;CD36;APOH;EGF;BRPF3;TGFB3;STXBP1;LAMP2
prerank,regulation of DNA repair (GO:0006282),-0.2446785680126469,-0.8796618925510744,0.6703910614525139,0.9022333823332408,1.0,14/44,18.96%,EYA2;EYA1;EYA4;SMCHD1;ERCC6;UBE2V2;UBE2N;CEBPG;USP1;PCNA;SIRT7;FGF10;BABAM1;DEK
prerank,chemical homeostasis (GO:0048878),0.3199323027725709,0.8790555633084703,0.6624129930394431,0.8724661264907239,1.0,11/61,14.14%,TREM2;USF1;TLCD2;PPARG;ADCK1;ACOX1;FBXW7;SLC4A7;ZBTB20;ACOX3;ABHD8
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.22724563862410826,-0.8786172053147842,0.7480916030534351,0.9032040990246051,1.0,20/62,22.43%,MLLT3;ELOC;CTR9;NELFB;ERCC3;LEO1;EAF2;POLR2A;POLR2H;NELFA;SSRP1;POLR2G;POLR2F;GTF2H2;SUPT4H1;POLR2E;ELOB;CCNK;GTF2H4;NELFE
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.27731082697461856,-0.8782955445750298,0.6388888888888888,0.9025068474499344,1.0,8/23,22.66%,HSP90AA1;NDUFA13;COX18;SAMM50;TIMM22;TOMM70;TIMM8B;ROMO1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.38940550104856475,0.877984381474915,0.6114285714285714,0.8739919904422487,1.0,7/15,25.49%,COL11A1;PIEZO2;TMEM120A;LHFPL5;ADGRV1;PDZD7;TMC1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.32349032935589317,0.8778046032998927,0.6525323910482921,0.8739009668165366,1.0,14/52,18.76%,LRP1;NKD2;EGFR;TREM2;ITGA3;PTPN9;TNF;KIF5B;PIK3R1;STAC3;SQSTM1;AKT1;CLIP3;SPTBN1
prerank,positive regulation of mRNA processing (GO:0050685),-0.28580126788225957,-0.8776378367235408,0.6567164179104478,0.902493276212878,1.0,8/21,25.96%,NCL;CIRBP;LEO1;DAZAP1;DHX36;NUP98;RBM3;SF3B4
prerank,NAD biosynthetic process (GO:0009435),-0.2991312808788954,-0.8768282776118688,0.6180555555555556,0.9028551195658051,1.0,9/20,28.03%,NAMPT;NMNAT3;PARP16;NUDT12;NNMT;PARP10;NAXE;NAPRT;KYNU
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3667753269415634,0.8767623883416839,0.6391184573002755,0.8753909842539116,1.0,14/24,30.92%,PHF1;DNMT3B;SPI1;PPHLN1;TASOR;TRIM27;SUZ12;PPM1D;MPHOSPH8;RBBP7;DNMT3A;EZH2;BMI1;JARID2
prerank,protein destabilization (GO:0031648),0.3499033267805862,0.8764693745918029,0.6519480519480519,0.8754966252002683,1.0,13/32,24.11%,SERF1A;TRIM21;CREBBP;PLK1;RAD23A;FBXW11;MDM2;PRNP;IRGM;SERF2;NR1D1;CDC73;CTSH
prerank,icosanoid secretion (GO:0032309),-0.3340483818413265,-0.876415696885793,0.6297376093294461,0.902395905549493,1.0,4/12,19.93%,ABCC4;BDKRB2;ACE;DRD2
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2666808926061876,-0.876070271570507,0.6666666666666666,0.9017106594191684,1.0,13/31,21.48%,ATXN3;STAMBP;USP8;USP7;CYLD;SPATA2;OTUD1;BABAM1;OTUD7A;YOD1;OTUD4;USP50;USP16
prerank,amyloid fibril formation (GO:1990000),0.32392668511708966,0.8757495979951487,0.6650943396226415,0.8763455953443074,1.0,6/51,6.45%,HSPG2;IAPP;USP9X;SERF1A;CD36;SIAH2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.41287031097209803,0.8755030874351576,0.6264705882352941,0.8763628541588931,1.0,2/13,13.14%,GAB2;SPHK2
prerank,GTP metabolic process (GO:0046039),0.3984811898400794,0.8752944023034718,0.6028481012658228,0.8763283663890487,1.0,4/15,23.82%,LRRK2;ENTPD7;IMPDH2;IMPDH1
prerank,microtubule-based transport (GO:0099111),0.41230664599149314,0.8752894780368325,0.6067073170731707,0.8759300674013717,1.0,2/12,6.77%,DNAAF4;SPEF2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.34961570990022045,0.8749382558559179,0.6276041666666666,0.8761580183934562,1.0,10/29,25.79%,SMAD2;PUM1;DICER1;SMAD3;SMAD1;TUT7;AGO2;SNIP1;AGO1;HNRNPA2B1
prerank,cell junction maintenance (GO:0034331),0.3985675755151321,0.8747236793583298,0.6274509803921569,0.8761146689144701,1.0,1/14,2.72%,PRTN3
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.37076455103289474,0.8746247400593637,0.6270491803278688,0.875870505689069,1.0,6/21,21.63%,FZD1;LRP6;GSK3B;CSNK1A1;DVL2;AXIN1
prerank,activation of protein kinase B activity (GO:0032148),-0.26216365436753813,-0.874327164985709,0.6923076923076923,0.9041408885823503,1.0,5/29,4.70%,IL18;GAS6;INSR;FGF1;CCDC88A
prerank,positive regulation of cell aging (GO:0090343),0.4205128628568338,0.874178631351608,0.6295180722891566,0.8762534729655534,1.0,4/11,20.05%,EEF1E1;YPEL3;CGAS;HMGA2
prerank,photoreceptor cell development (GO:0042461),0.39204977510428884,0.8732306228619945,0.6087591240875913,0.877496023062147,1.0,2/14,7.53%,CDHR1;MYO7A
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3686247840802579,0.8730743275063471,0.6298342541436464,0.8769784791089604,1.0,3/20,10.94%,MGST1;AKR1A1;GSTK1
prerank,glutathione derivative metabolic process (GO:1901685),0.3686247840802579,0.8730743275063471,0.6298342541436464,0.8769784791089604,1.0,3/20,10.94%,MGST1;AKR1A1;GSTK1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3425392988798237,-0.8729054820061931,0.6253521126760564,0.9058432185635559,1.0,2/13,2.73%,SOX13;HNRNPU
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3403827069433338,0.8725097113727758,0.6557177615571776,0.8775587243314398,1.0,4/40,7.40%,LRRK2;STOML2;BCL2;PID1
prerank,histone H4 deacetylation (GO:0070933),-0.36853511142338463,-0.8721679348296377,0.6569920844327177,0.9060066925053385,1.0,3/10,5.95%,HDAC4;HDAC9;SMARCAD1
prerank,mitochondrion disassembly (GO:0061726),0.3454873838282162,0.8720491670140059,0.6547770700636942,0.8779617561522421,1.0,12/34,23.32%,WIPI1;AMBRA1;CTSK;ATG3;FBXO7;ATG7;WDR45;SQSTM1;FUNDC2;BECN1;MARK2;ATG2B
prerank,skeletal muscle contraction (GO:0003009),0.3734410083520927,0.8719493862491426,0.6346704871060171,0.8777354720133982,1.0,3/19,14.95%,CCDC78;TNNC1;STAC3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3495294499283951,-0.8709225867495608,0.6363636363636364,0.907304462425908,1.0,2/11,8.04%,MAVS;CAMK4
prerank,negative regulation of DNA replication (GO:0008156),0.4079251650302454,0.8708394186108926,0.6216617210682492,0.8793009634759448,1.0,5/13,23.37%,PDS5A;ATR;WAPL;TERF1;CDC6
prerank,neurotransmitter uptake (GO:0001504),0.4077625345364055,0.8707787964574328,0.601823708206687,0.8789997344741117,1.0,1/12,0.63%,SLC1A3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.35910900502495924,-0.8705160732640151,0.6272965879265092,0.9067561568860772,1.0,3/10,12.55%,CCT4;CCT5;DKC1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.27092179477108735,-0.8702625011656111,0.6784313725490196,0.9058572832402005,1.0,10/27,20.24%,PRKN;UBE2E3;UBE2A;CDC23;UBE2B;ANAPC1;ANAPC4;ANAPC5;ANAPC13;CDC26
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.27408922848913875,-0.8698971089161087,0.720754716981132,0.9052134554786347,1.0,14/25,37.47%,TNFSF10;PINK1;BNIP3;DNM1L;GPER1;BID;TP53;PPIF;MFF;BIK;PDCD5;BMF;HRK;PMAIP1
prerank,regulation of cell development (GO:0060284),0.341728952933467,0.8698482620166553,0.6422136422136422,0.8802529335021925,1.0,7/36,17.14%,YAP1;BHLHE40;HEYL;HMGB2;CX3CL1;CLOCK;AKT1
prerank,positive regulation of chromatin organization (GO:1905269),-0.3522147734687172,-0.8696433493753858,0.6314285714285715,0.9042702451792974,1.0,4/12,16.59%,UBE2N;SIN3A;H3-3A;TAL1
prerank,positive regulation of metabolic process (GO:0009893),0.29665680228111685,0.869525808204405,0.6788008565310493,0.8804016430024217,1.0,28/103,21.99%,ADIPOQ;PLAC8;CMKLR1;JAK2;DYNC1H1;CD36;ALMS1;OMA1;EHMT1;CXCR4;OGT;HCRT;TNF;ELOVL6;FABP5;GNAS;PRKAB1;DECR1;ACACA;FASN;KDM1A;IL4R;LCN2;THRA;GRB10;DIO2;FABP4;CNOT3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.33285567805486593,0.86948279902191,0.6593673965936739,0.8800758264306412,1.0,9/37,14.52%,BAG6;EIF3H;CCAR2;OGT;CSNK2A1;CSNK2A2;GIPC1;DDRGK1;RPL11
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.34282720884427903,-0.8694538383104319,0.6293103448275862,0.9032563425293164,1.0,4/11,22.05%,GPER1;DHX36;MYOCD;MEF2C
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3897491368223511,0.8694459462902935,0.6217391304347826,0.8797267664397603,1.0,6/17,22.86%,BBC3;BCL2;GGCT;TIMM50;CLU;FZD9
prerank,regulation of glycolytic process (GO:0006110),-0.22390542193617574,-0.8693869086647454,0.7837837837837838,0.901972261310274,1.0,12/68,11.30%,PRKAG2;PRKAA2;HDAC4;INSR;NUP133;CBFA2T3;IGF1;SEH1L;POM121;APP;GIT1;EP300
prerank,nuclear export (GO:0051168),-0.21033743659819695,-0.8691838124667649,0.7551020408163265,0.9009368235767206,1.0,28/80,25.42%,RANBP3L;MALT1;CDC40;SRSF5;U2AF2;DESI1;STRADB;POM121;HNRNPA1;SRSF7;SRSF9;RBM8A;CHTOP;MAGOH;ZC3H11A;EIF4A3;SRSF3;CSE1L;POLDIP3;XPO5;PHAX;SARNP;XPO6;NUTF2;DDX39B;DDX39A;XPO4;THOC1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3332307753090784,0.8691250901282424,0.641318124207858,0.8798486853396248,1.0,8/38,14.54%,CENPQ;CENPN;RSF1;CENPL;RUVBL1;UBN1;ATRX;ASF1A
prerank,anterior/posterior pattern specification (GO:0009952),0.31713668102980974,0.8689252935333315,0.6568047337278107,0.8798255962607774,1.0,7/53,9.97%,SMAD2;HOXB3;ATP6AP2;BHLHE40;HEYL;TGFBR1;WLS
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3362719435754149,0.8687486374957442,0.6514215080346106,0.8797127156224539,1.0,9/36,14.52%,OPHN1;BAG6;EIF3H;CCAR2;OGT;PSMF1;GIPC1;DDRGK1;RPL11
prerank,sphingoid metabolic process (GO:0046519),-0.3349033109239707,-0.8684314688186057,0.6,0.9011282847922986,1.0,5/12,24.73%,DEGS2;SGPP1;ASAH2;NAAA;SPHK1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.38486758770441143,0.8684011887471622,0.6329113924050633,0.879908733983361,1.0,5/18,14.28%,LRRK2;DTNBP1;GSK3B;RAB3GAP1;FMR1
prerank,TOR signaling (GO:0031929),0.34737480184987224,0.8680332464333019,0.6464516129032258,0.8801355783528648,1.0,6/26,11.23%,RICTOR;RPTOR;MAPKAP1;RPS6KB1;FNIP1;EIF4EBP1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.21802000366012858,-0.8678150265755619,0.7431192660550459,0.9010305513464612,1.0,21/70,23.12%,CHPT1;MBOAT1;CHKA;ENPP2;LPCAT2;LPIN1;ABHD3;ABCA3;SLC27A1;GPLD1;PCYT1B;GPAT4;PLA2G6;MFSD2A;CHKB;DBI;PCTP;PCYT1A;PLA2G4C;PLAAT3;TMEM86B
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3389835677219498,-0.8670272796277685,0.6480446927374302,0.9013212687819018,1.0,4/12,12.96%,CCT4;CCT5;DKC1;GNL3L
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3821789551344085,0.8668975780220864,0.6412742382271468,0.8817141231008014,1.0,4/16,14.88%,NCBP2;SFSWAP;SRSF12;SNRNP200
prerank,response to interleukin-4 (GO:0070670),0.42602026588099495,0.8668676550739323,0.6360708534621579,0.8813541682978039,1.0,2/10,10.26%,XCL1;TCF7
prerank,protein mannosylation (GO:0035268),-0.2890727721303203,-0.8666716226796354,0.6923076923076923,0.9006705829111533,1.0,1/22,0.12%,TMTC1
prerank,heart looping (GO:0001947),0.32922706382915284,0.8666136228364162,0.6484472049689441,0.8813989467217488,1.0,7/39,15.46%,TBX2;SHH;PKD2;TBX3;NPHP3;SETDB2;SMO
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2991403104611507,-0.8664836664349675,0.6480836236933798,0.8996246618590639,1.0,7/20,15.45%,FKBP5;PPIG;PPIH;PPIL2;PPIL3;FKBP1A;PPIB
prerank,mitochondrion morphogenesis (GO:0070584),-0.34836733970231093,-0.8664706614222332,0.6526610644257703,0.8982210533659966,1.0,7/11,27.02%,WASF1;DNM1L;SUPV3L1;SLIRP;MYH14;NUBPL;MFF
prerank,clathrin-dependent endocytosis (GO:0072583),0.35734005470795605,0.8660757384392336,0.6383265856950068,0.8819351220036403,1.0,6/26,10.49%,CLTC;ITSN1;DNAJC6;CANX;GPR107;GAK
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3548674334403774,0.8659256895100631,0.6348167539267016,0.8818061685836726,1.0,9/27,17.14%,MARK1;TREM2;PTEN;DISC1;FBXO7;GSK3B;PSEN1;NDEL1;AKT1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3886169820550817,0.8653551303707556,0.6103896103896104,0.8823922634020941,1.0,4/15,13.84%,ACVR1;ACVR1B;ACVR2A;DACT1
prerank,cellular response to interleukin-4 (GO:0071353),0.4260425511654997,0.8653078955263575,0.6235679214402619,0.8820651342775061,1.0,2/10,10.26%,XCL1;TCF7
prerank,activation of GTPase activity (GO:0090630),0.30058241652398154,0.865050307753843,0.7041484716157205,0.8821244627003327,1.0,18/89,14.96%,SYDE1;ARHGAP24;ARHGAP42;SIPA1L3;TAX1BP3;TBC1D16;EPHA1;TBC1D2B;RABGAP1L;ARHGEF19;TBC1D8B;RABGAP1;NTRK3;TBC1D1;ADPRH;ARHGAP22;TBC1D10B;SIPA1L2
prerank,protein localization to Golgi apparatus (GO:0034067),0.35282650671870264,0.8640162260628886,0.6357702349869452,0.883494668724978,1.0,16/27,28.61%,VPS13C;GBF1;GAK;COG7;OBSL1;CSNK1D;RAB33B;ARL5A;SYS1;IFT20;ARL5C;ARFRP1;RAB6A;TMED10;OPTN;RIPOR1
prerank,sphingosine biosynthetic process (GO:0046512),-0.3381377947835329,-0.8637637876531994,0.6815789473684211,0.9013733210906222,1.0,3/11,5.15%,ACER2;SPTLC2;SPTLC1
prerank,sphingoid biosynthetic process (GO:0046520),-0.3381377947835329,-0.8637637876531994,0.6815789473684211,0.9013733210906222,1.0,3/11,5.15%,ACER2;SPTLC2;SPTLC1
prerank,pseudouridine synthesis (GO:0001522),0.39479314487474815,0.8635142062715113,0.6394453004622496,0.8839573309974543,1.0,3/13,9.72%,PUS7L;TRUB2;PUS3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.37770442993837217,0.8630445785740684,0.6240928882438317,0.8843695552053882,1.0,4/17,12.48%,EGR3;NRP1;MIA3;FGF2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.35332567967138034,0.8627943111881475,0.6371191135734072,0.8843791311691341,1.0,7/24,19.95%,NCKAP5;KIF2A;FGF13;NCKAP5L;TPPP;CKAP5;PIN1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.37876747004556033,0.8625527004204693,0.6375358166189111,0.8844073783989431,1.0,5/16,16.89%,DPYSL3;NT5M;TET2;DPYD;NT5C1A
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3075593802769543,0.8619259831262782,0.7177777777777777,0.8850993711350277,1.0,11/80,9.70%,LRRK2;MYCBP2;BIRC3;ARRDC4;PLK1;PRICKLE1;ARRDC3;ANGPT1;DCUN1D1;FBXW7;UBE2L3
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3411239923842612,0.861586274882693,0.6466165413533834,0.8852737679264112,1.0,13/33,21.92%,APOE;PPARG;RHOA;TNF;FGF2;PDCD10;ITGB1BP1;ACVRL1;ANGPT2;HDAC5;GADD45A;STARD13;RGCC
prerank,clathrin coat assembly (GO:0048268),0.3887887306776387,0.8613368228540973,0.6341463414634146,0.8853015681555598,1.0,1/15,0.64%,CLTC
prerank,glycolytic process (GO:0006096),0.3461307404094006,0.8611443422902793,0.6552162849872774,0.885225391950851,1.0,4/28,11.60%,HK2;ENO1;GAPDH;GCK
prerank,negative regulation of stress fiber assembly (GO:0051497),0.35620004975687963,0.8609091561178658,0.6483825597749648,0.8852121865415851,1.0,6/24,14.32%,DLC1;CGNL1;ARHGAP6;PIK3R1;ARHGEF18;PHLDB2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.37248554256084887,0.8608970053331151,0.6562054208273894,0.8848287430988718,1.0,3/18,13.29%,NCK1;BAG6;PIK3R1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3937102294140393,0.8603878994158755,0.6401869158878505,0.8852751899674294,1.0,4/13,17.75%,MDK;RHOA;TNF;ETS1
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3094555973010462,-0.8603421135862873,0.6528662420382165,0.9072247710931766,1.0,5/17,10.72%,CLDN5;CDH5;ADD1;VCL;ZDHHC21
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.22113301376832759,-0.8602241826116165,0.7596899224806202,0.906049791102285,1.0,17/57,21.02%,CYFIP2;MALT1;MAP3K5;TNFSF10;BCAP31;NDUFA13;GRIN2B;PERP;TTBK1;GRAMD4;GPER1;SOX7;SYK;AIM2;LGMN;HTRA2;USP50
prerank,calcium import into the mitochondrion (GO:0036444),0.4231409888659801,0.8599951123258275,0.6417445482866043,0.8855630285065891,1.0,4/10,18.80%,MICU2;MCUR1;MAIP1;MICU3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3608073455796471,0.8598859042027239,0.6507503410641201,0.8853441248215717,1.0,5/24,16.09%,PDE3A;PRKAR1B;GNAI1;RASD2;CGAS
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.23182802264616842,-0.8597229932307986,0.7804878048780488,0.9057157275375982,1.0,8/57,6.50%,CHRM2;ADCY5;GRM7;ADCY9;GRM8;AKAP12;ADCY1;HTR1F
prerank,gastrulation (GO:0007369),0.3815770132421912,0.8593620851431402,0.6335766423357664,0.8858431885866862,1.0,5/15,19.34%,SMAD2;NPHP3;UGDH;LRP5;TASOR
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.39241564437905335,0.8590279072301211,0.6275115919629057,0.8860077047357053,1.0,2/12,12.29%,TREM2;TNF
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.36960061340314077,0.8590099513753855,0.6221590909090909,0.8856370212319962,1.0,6/19,14.06%,PINX1;DCP2;NAT10;XRN1;CTC1;SRC
prerank,regulation of cytoplasmic translation (GO:2000765),0.38967094987090034,0.8589822317713717,0.6418816388467374,0.8852801375835851,1.0,4/14,14.52%,CPEB1;YBX3;FMR1;CPEB4
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.302722547755383,0.8584402175769185,0.682648401826484,0.8858284392296145,1.0,15/72,14.83%,IAPP;TAOK1;NAV3;TREM2;APOE;LIMA1;EMILIN1;TPX2;SSH1;CAMSAP2;FGF13;SSH2;PLEKHH2;SMAD4;PFDN1
prerank,regulation of neutrophil migration (GO:1902622),-0.3619109149447298,-0.8584092357821238,0.6346153846153846,0.907079487962353,1.0,4/10,21.32%,RHOG;MPP1;RHOH;NCKAP1L
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3715367607204605,0.8582170065428927,0.6435643564356436,0.8858159476655222,1.0,4/19,15.31%,CHMP4B;PLK1;EML3;CHMP2B
prerank,protein deacetylation (GO:0006476),0.329969885434759,0.8578902066408218,0.6716604244694132,0.8859680490853347,1.0,12/41,19.11%,RCOR1;MIER2;PRDM5;HDAC1;TBL1X;MTA2;SIRT3;BAZ2A;MTA3;RCOR2;HDAC5;BRMS1L
prerank,protein autoubiquitination (GO:0051865),0.31543227635754145,0.8578549602121358,0.6670493685419059,0.8856209307193621,1.0,13/61,15.59%,SH3RF3;TRIM21;CNOT4;TRIM13;SH3RF1;RNF213;RNF19B;RNF181;TRAF2;RNF11;DTX3L;RNF141;ITCH
prerank,protein acylation (GO:0043543),-0.24184677152579298,-0.8574612813256576,0.7004830917874396,0.9077072395229507,1.0,12/38,16.77%,GLUL;ZDHHC13;ZDHHC21;EP300;ZDHHC17;ZDHHC14;SELENOK;ZDHHC5;KAT6A;ZDHHC15;PORCN;ZDHHC2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.34634770970315226,0.8573778940423155,0.6583769633507853,0.8860119886635848,1.0,10/27,24.17%,POP1;RNASEH1;DICER1;XRN1;RNASE1;PARN;ZC3H12B;ZC3H12A;PCF11;CPSF3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.39337923688131304,0.8563901937713149,0.6552748885586924,0.8873193928002533,1.0,1/15,1.62%,ASMT
prerank,mitochondrial translational termination (GO:0070126),-0.20819765821960057,-0.856100126429787,0.8157894736842105,0.9092557423713234,1.0,41/88,31.25%,MRPS9;MRPS35;MRPS28;MRPS15;MRPS24;MRPL13;MRPL10;MRPL21;MRPL39;ERAL1;MTRF1;PTCD3;MRPL4;MRPS7;MRPS31;MRPL30;MRPL28;MRPS18C;MRPL22;MRPL40;GADD45GIP1;MRPL46;MRPS16;MRPS18B;MRPL58;MRPS22;MRPS6;MRPS25;MRPS12;MRPS34;MRPL44;MRPL18;MRPL20;MRPL35;MRPL23;MRPL42;MRPL43;MRPL54;MRPL34;MRPL2;MRPS10
prerank,protein targeting (GO:0006605),0.29221376133637905,0.8560892089897809,0.7444794952681388,0.8874390693784272,1.0,26/118,19.53%,LTBP2;AP4M1;TRAK1;KIF13B;LAMP2;ATG3;TOMM7;SEC63;CDC37;VPS37C;FBXO7;PEX19;TIMM17A;GIPC1;SEC61A1;RPL11;ZDHHC6;ZDHHC9;RTP4;SRP14;ZDHHC3;PEX6;TOMM22;PEX12;HACL1;TIMM23
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.313810893270467,0.8557324480988334,0.6732101616628176,0.8876590133206076,1.0,13/57,20.09%,TAOK1;BABAM2;ATM;PLK1;TAOK3;MDC1;RINT1;EME2;PRKDC;RAD9A;FBXO31;HMGA2;CDC14B
prerank,microtubule depolymerization (GO:0007019),0.3774926934024019,0.8550110342154872,0.6407624633431085,0.8884529989145904,1.0,4/17,17.54%,NCKAP5;KIF2A;NCKAP5L;CKAP5
prerank,DNA replication initiation (GO:0006270),0.33010920034286073,0.8547907835525509,0.6646115906288532,0.8884352062194989,1.0,6/37,13.99%,POLE3;MCM2;MCM7;DBF4;POLA2;LRWD1
prerank,protein import into nucleus (GO:0006606),0.30577261371337366,0.8545334232763985,0.6872852233676976,0.8884756332413698,1.0,16/66,20.96%,CBLB;STAT3;PRICKLE1;FAM53B;KPNA3;NUP153;TNPO1;E2F3;NUP35;NUP188;SEC13;AKT1;HEATR3;NUP214;KPNA2;NUP107
prerank,mRNA methylation (GO:0080009),0.3884196612848039,0.8543072898802406,0.6608695652173913,0.8884744684924734,1.0,5/15,23.59%,ZC3H13;METTL16;TRMT61B;TRMT61A;PCIF1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3777468072801553,0.8542983273851167,0.6385714285714286,0.888087015666395,1.0,2/17,9.77%,NOS1AP;KCNAB1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3637562898165031,0.853792209726735,0.6382978723404256,0.8885390317987472,1.0,9/21,25.67%,TNKS1BP1;CNOT4;SAMD4A;TUT7;PARN;CNOT2;CNOT3;CNOT1;CNOT7
prerank,leukocyte tethering or rolling (GO:0050901),0.37723603246345394,0.8537767631206,0.6462395543175488,0.8881643492175899,1.0,3/17,12.29%,SPN;ADD2;TNF
prerank,regulation of protein catabolic process (GO:0042176),0.29487800681253024,0.8537539955398787,0.7228786251342643,0.8877964571298417,1.0,24/99,17.55%,TNFAIP3;EGFR;IRAK3;MAD2L1;SMURF2;OAZ3;RAB7A;AREL1;WNT5A;CSNK2A1;ATG7;TNF;GSK3B;DACT1;CENATAC;AZIN2;CDKN1B;BANP;SMURF1;ITCH;NEDD4;CTSA;DDB1;MDM2
prerank,cellular glucose homeostasis (GO:0001678),0.325086797299588,0.8535348322687963,0.6675031367628608,0.8877744097549182,1.0,8/41,17.25%,SLC39A14;HK2;FOXK2;GCK;ZBTB20;PIK3R1;HIF1A;NUCKS1
prerank,homocysteine metabolic process (GO:0050667),0.4102495732605933,0.8533888195464243,0.6482649842271293,0.8876248302986038,1.0,1/11,3.82%,MTHFR
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3476584322616248,0.8532523274468949,0.6566970091027308,0.8874265970906766,1.0,5/26,12.48%,XCL1;ITPR1;PKD2;IBTK;FGF2
prerank,nuclear migration (GO:0007097),0.3930673683044231,0.8528946657551035,0.6369230769230769,0.8876600802722263,1.0,4/13,12.26%,DYNC1H1;PCM1;CEP120;FBXW11
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.33309695893383895,-0.8521885560968783,0.640117994100295,0.9162274438953881,1.0,2/12,1.54%,CAV1;CTNNA3
prerank,proteoglycan biosynthetic process (GO:0030166),0.33634278403454254,0.8518198704999337,0.6861219195849546,0.8890990922132387,1.0,7/31,16.27%,CHST13;EXT1;EXT2;CHST11;UGDH;B4GALT7;FAM20B
prerank,neuron apoptotic process (GO:0051402),0.3722835439462768,0.8512965642953852,0.6780626780626781,0.8895972894003982,1.0,3/19,10.28%,TNFRSF21;BCL2;GAPDH
prerank,ncRNA metabolic process (GO:0034660),0.32741815664344137,0.8511418670964392,0.6670934699103713,0.8894389566485367,1.0,8/37,19.61%,DDX17;DICER1;DTD1;ZCCHC8;TUT7;PARN;BCDIN3D;AGO2
prerank,cardiac ventricle development (GO:0003231),-0.2851546544970291,-0.8509329752882066,0.6607142857142857,0.9174067403282062,1.0,5/20,14.26%,MATR3;HECTD1;MDM4;PDE2A;HEY2
prerank,cytoplasmic microtubule organization (GO:0031122),0.3111971804181048,0.8508933116435541,0.6928406466512702,0.8894768594052748,1.0,18/54,23.08%,DYNC1H1;HOOK2;PCM1;RHOA;CAMSAP2;FIGN;FIGNL2;TUBGCP4;FSD1;TPPP;CLIP3;CAMSAP1;HOOK1;DST;DLG1;CCDC88B;CLIP4;KPNB1
prerank,anion transmembrane transport (GO:0098656),0.30769849550714246,0.8508158366596512,0.7131696428571429,0.8892071791295612,1.0,2/67,0.63%,SLC7A2;SLC1A3
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.2331941665990067,-0.850635841469923,0.7724867724867724,0.916504647674391,1.0,18/45,27.83%,BMP4;DDX5;RIOK1;U2AF2;WDR43;POLR2A;DIMT1;ERN1;HNRNPLL;SIRT7;ZC3H18;SUPV3L1;UTP15;TP53;SLC38A2;ZPR1;HSPA1A;TRMT112
prerank,retrograde axonal transport (GO:0008090),0.3848252427285139,0.8504400638733857,0.6452554744525547,0.8894337278496157,1.0,6/16,20.40%,DYNC1H1;KIF1C;FBXW11;KIF5B;KIF5A;DST
prerank,determination of heart left/right asymmetry (GO:0061371),0.31988527516708437,0.850260280119316,0.6744186046511628,0.8893390418148595,1.0,7/42,15.46%,TBX2;SHH;PKD2;TBX3;NPHP3;SETDB2;SMO
prerank,neutrophil activation (GO:0042119),0.40039763413925905,0.8500094657223554,0.6582466567607727,0.8893608770108046,1.0,3/12,11.07%,CCL5;PREX1;KMT2E
prerank,regulation of presynapse organization (GO:0099174),0.3696491269056448,0.8493425825419627,0.6433666191155493,0.8896673804356723,1.0,2/18,2.81%,MDGA1;GPC6
prerank,regulation of presynapse assembly (GO:1905606),0.3696491269056448,0.8493425825419627,0.6433666191155493,0.8896673804356723,1.0,2/18,2.81%,MDGA1;GPC6
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.34850370395045227,0.849288506919883,0.6719160104986877,0.8893699564966122,1.0,6/25,18.70%,CHMP4A;CHMP4B;CHMP7;CHMP2B;LEPROT;LEPROTL1
prerank,mRNA splice site selection (GO:0006376),-0.2550062870220799,-0.8488443880723403,0.7162162162162162,0.9188387654017673,1.0,7/30,15.71%,CELF2;YTHDC1;SRSF5;ISY1;SNRPC;SRSF9;LUC7L3
prerank,negative regulation of endocytosis (GO:0045806),-0.27543559619323177,-0.8486207236860985,0.7269076305220884,0.9178484677647567,1.0,14/24,39.35%,CAV1;MCTP1;ABCA7;PACSIN3;PRKD1;RUBCN;SYT11;LRSAM1;NR1H2;SCAMP5;ARF6;LILRB1;UNC119;EPHA3
prerank,mononuclear cell differentiation (GO:1903131),0.3516198786912588,0.8484190754316213,0.6610644257703081,0.8903796741732681,1.0,4/24,5.97%,TREM2;BLK;MYH9;PPARG
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3223970718330671,-0.8483776503684193,0.6723646723646723,0.9169629871599255,1.0,2/13,5.48%,PALM;GRM3
prerank,cellular respiration (GO:0045333),-0.2311465999004494,-0.8476628881348095,0.73224043715847,0.9170074424355641,1.0,20/41,29.96%,ME3;NDUFS1;PPARGC1A;UQCRC2;COX10;ETFRF1;ATP5F1D;UQCRB;ETFB;SDHAF4;UQCRH;UQCRFS1;LYRM7;MTFR1L;MTLN;NR4A3;UQCR10;MTFR2;SLC25A14;SDHA
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3877253369814786,0.847295058250157,0.6480117820324006,0.8918216310498912,1.0,2/14,5.04%,XCL1;LGALS9
prerank,response to X-ray (GO:0010165),0.3870355792951763,0.847209672142957,0.6536144578313253,0.8915583881386351,1.0,5/14,17.25%,ATM;ANXA1;IKBIP;NIPBL;NUCKS1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3759387545190134,0.8470714381090663,0.6552217453505007,0.8914023129357646,1.0,1/17,1.20%,MPG
prerank,establishment of skin barrier (GO:0061436),0.3786012126697324,0.8467945081705313,0.6436950146627566,0.8910577081347978,1.0,1/15,2.95%,UGCG
prerank,regulation of water loss via skin (GO:0033561),0.3786012126697324,0.8467945081705313,0.6436950146627566,0.8910577081347978,1.0,1/15,2.95%,UGCG
prerank,positive regulation of translational initiation (GO:0045948),0.37172774258321306,0.8464348339314814,0.6643258426966292,0.8912666998144735,1.0,7/18,23.22%,KHDRBS1;CCL5;RPS6KB1;YTHDF3;HABP4;YTHDF2;POLR2D
prerank,peptide hormone secretion (GO:0030072),0.3455530303886155,0.8458330921555044,0.6631299734748011,0.8918855921933604,1.0,3/26,13.45%,EDN3;ANXA1;RAB1A
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3728218486358897,0.8454864338908334,0.6759124087591241,0.8920648467562424,1.0,2/16,11.70%,AHR;LST1
prerank,positive regulation of integrin activation (GO:0033625),0.4071764640495234,0.8452891422609424,0.6433021806853583,0.8920110518978003,1.0,5/11,21.94%,SRC;PLEK;PIEZO1;P2RY12;RAP1B
prerank,negative regulation of cyclase activity (GO:0031280),-0.31747303012760364,-0.8452404459743277,0.6838905775075987,0.920680816123909,1.0,2/14,5.48%,PALM;GRM3
prerank,response to chemokine (GO:1990868),0.3939240816384795,0.8452268187002532,0.6702954898911353,0.8917181416303114,1.0,4/13,21.08%,CXCL12;RHOA;LRCH1;ZC3H12A
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3775329512114803,0.8452238495433152,0.6681547619047619,0.8913271376272343,1.0,6/16,20.32%,SHH;PKD2;SALL1;FGF2;PAX8;GDNF
prerank,hippo signaling (GO:0035329),0.3469259819004998,0.8451831894437292,0.6876640419947506,0.8909924646020553,1.0,12/26,22.19%,YAP1;AMOTL1;TEAD3;DCHS1;WWTR1;TEAD1;STK4;LATS2;YWHAE;DVL2;LATS1;SAV1
prerank,regulation of protein localization to membrane (GO:1905475),0.33839716708111417,0.8451641386467389,0.6679586563307494,0.8906266986781558,1.0,3/28,6.56%,MMP14;GPC6;VPS4A
prerank,aggrephagy (GO:0035973),0.3461433668108339,0.8442877479579245,0.6680053547523427,0.8917168757425717,1.0,5/27,10.21%,DYNLL1;DYNC1H1;IFT88;PCNT;WDFY3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.27777743506254204,-0.8440162205702606,0.6857142857142857,0.9217333397447881,1.0,3/20,11.30%,RB1;IGF1;EP300
prerank,regulation of protein export from nucleus (GO:0046825),0.35219249758176085,0.8433594170699551,0.6689750692520776,0.8928728996986641,1.0,4/23,12.44%,TCF7L2;BAG3;SP100;GSK3B
prerank,retinoic acid metabolic process (GO:0042573),0.38253953250656064,0.843345438818477,0.648936170212766,0.892500879217629,1.0,3/14,18.23%,ALDH1A2;SCPEP1;ADH1A
prerank,DNA repair (GO:0006281),0.2760439988259386,0.8428186952791551,0.8405650857719476,0.8929979439815297,1.0,65/284,20.79%,RAD51B;PARP3;MPG;BRIP1;BACH1;SMC1A;DNA2;RAD52;TNKS1BP1;ASCC3;BABAM2;INO80;XRCC3;ATM;PDS5B;PWWP3A;GTF2H1;LIG1;DCLRE1C;PDS5A;RAD23A;ATR;FTO;RAD23B;SETD2;RNASEH2A;FBH1;ALKBH5;ALKBH1;USP3;TIMELESS;TDP2;POLI;MC1R;MGMT;MDC1;EME2;XRCC1;VCPIP1;ASF1A;DTX3L;MMS19;SETX;PRKDC;SLC30A9;TRAIP;ATRIP;PNKP;NUCKS1;DDB1;DDX1;RAD9A;RBBP8;HINFP;EID3;GADD45A;MBD4;KPNA2;HMGA2;ERCC2;TENT4A;FANCC;NEIL1;PARP4;FANCE
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3178395253825515,0.8424314638937128,0.6813186813186813,0.8932326493369758,1.0,14/41,20.96%,LACC1;NUP37;RAE1;OGT;NUP153;GCK;NDC1;HIF1A;NUP35;NUP188;SEC13;ZBTB7A;NUP214;NUP107
prerank,regulation of receptor recycling (GO:0001919),-0.30038372783388956,-0.8415957525935084,0.655786350148368,0.9252349074509083,1.0,4/16,14.26%,INPP5F;LAMTOR1;NSF;SCRIB
prerank,nucleus organization (GO:0006997),0.31867779644224326,0.8414011060068496,0.7251461988304093,0.894534769902118,1.0,11/47,18.15%,CHMP4A;CHMP4B;VPS4A;LEMD2;CHMP7;NDC1;CHMP2B;SUN1;NUP35;PITPNB;USP36
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3269598152721622,0.8404533862568947,0.6892583120204604,0.8952714679088446,1.0,10/32,20.96%,NUP37;XPOT;RAE1;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107
prerank,tRNA export from nucleus (GO:0006409),0.3269598152721622,0.8404533862568947,0.6892583120204604,0.8952714679088446,1.0,10/32,20.96%,NUP37;XPOT;RAE1;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.364664407555348,0.8400873804487854,0.6559766763848397,0.8954757487158798,1.0,3/17,4.34%,APOE;ABCA2;ABCG1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3096054817706549,0.8400223520900366,0.7141190198366394,0.8951834434721989,1.0,5/59,3.46%,PALLD;ROBO2;PCDHB6;SDK2;TENM3
prerank,negative regulation of protein secretion (GO:0050709),0.3227891941825523,0.8398996915056883,0.6947890818858561,0.894977414724014,1.0,6/38,12.15%,IRS1;APOE;SFRP1;INHBB;DRD3;DPH3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.34950687493241916,0.8397324047181791,0.6860622462787551,0.8948421620597891,1.0,10/24,22.66%,PINX1;DCP2;NAT10;XRN1;CTC1;SRC;TNKS2;HNRNPC;TERF1;SLX4
prerank,regulation of axon regeneration (GO:0048679),-0.32290439284603756,-0.8386613979144887,0.6534090909090909,0.9297595465247489,1.0,2/12,1.20%,EPHA4;INPP5F
prerank,activation of phospholipase C activity (GO:0007202),0.33395079467763583,0.8385937393394849,0.6842800528401585,0.8962756843761137,1.0,4/29,12.45%,EDNRA;EGFR;LPAR2;ARHGAP6
prerank,regulation of transport (GO:0051049),-0.24719581313791994,-0.8382292042680447,0.7345971563981043,0.9291964543412998,1.0,4/36,2.95%,ICA1;PRKN;EPB41;ACTB
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.38860440242903294,0.8381851245470349,0.6765140324963073,0.8965355842145544,1.0,4/14,21.92%,CD40;CCL2;ANO6;RGCC
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2813329430304719,0.838154434215956,0.7597883597883598,0.8961923893750591,1.0,30/109,19.90%,PDGFRB;PIGW;PIP5K1B;PTPN13;PTEN;PIP4K2A;PI4K2B;PIK3R5;PLA2G12A;FIG4;PLCB3;FGF2;PI4KA;PIK3R1;SACM1L;ARF1;PLA2G4A;MTMR9;PIK3R4;PLA2G4E;PIK3C3;PLEK;MTMR3;RUFY1;PIP5K1A;PLEKHA2;MTMR2;MTMR6;MTMR1;MTM1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3606636761796162,0.837935266452423,0.675561797752809,0.8961517005556127,1.0,5/22,15.60%,VPS4A;TOM1L1;VPS37C;PTPN23;NEDD4
prerank,cell cycle checkpoint signaling (GO:0000075),-0.3217797112958432,-0.8377004592207803,0.685131195335277,0.9288104808049576,1.0,3/12,14.69%,ZWINT;NABP1;ZWILCH
prerank,regulation of exosomal secretion (GO:1903541),0.36310452020196066,0.8369363173903422,0.6661931818181818,0.8973360301980502,1.0,9/19,25.84%,VPS4A;RAB7A;SDC1;SMPD3;SDC4;SDCBP;PDCD6IP;TSG101;CHMP3
prerank,positive regulation of glucose import (GO:0046326),0.3577206647067983,0.8368136853099224,0.6765119549929677,0.8971396167986515,1.0,2/21,2.62%,ADIPOQ;IRS1
prerank,negative regulation of cell cycle process (GO:0010948),0.2989031609943234,0.8367877875459878,0.7059496567505721,0.8967854832485505,1.0,23/61,26.01%,E2F1;RNF2;YAF2;EHMT1;VPS4A;TOM1L1;E2F8;BMP7;PHC3;MAX;RBBP8;FBXO5;WAPL;MGA;TERF1;SUZ12;CDC7;CBX5;RAD51;RYBP;TERF2;TFDP1;RBBP7
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.32331170445483837,0.8366808138329426,0.718192627824019,0.8965669398937928,1.0,10/38,18.91%,IL34;NCK2;DLG4;PTPN1;MVP;SH3BP5L;FCGR1A;PTPRC;AGT;PRNP
prerank,telomere maintenance via recombination (GO:0000722),0.39617308167492093,0.83636971257866,0.6579754601226994,0.8966974516801128,1.0,5/11,23.20%,XRCC3;NSMCE2;TEP1;SMC5;RAD51
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2787148581341475,0.8362716006149002,0.7691500524658972,0.8964570639967566,1.0,35/119,19.98%,PIGW;PIP5K1B;PTPN13;PTEN;PIP4K2A;PI4K2B;PIGN;ITPKC;PIK3R5;TTC7A;IP6K2;PIGL;FIG4;PIGC;SOCS5;FGF2;PI4KA;PIK3R1;SACM1L;ARF1;PIGP;EFR3A;MTMR9;PIK3R4;PIGH;PIK3C3;MTMR3;RUFY1;PIP5K1A;PLEKHA2;MTMR2;MTMR6;MTMR1;MTM1;MPPE1
prerank,positive regulation of protein acetylation (GO:1901985),-0.3323282629404657,-0.8361886517661368,0.6536312849162011,0.93048252713714,1.0,3/12,4.66%,PRKAA2;RAPGEF3;DIP2B
prerank,inorganic cation transmembrane transport (GO:0098662),0.27447217262882295,0.835642469358744,0.8493427704752275,0.8971049374687853,1.0,16/268,5.83%,MCOLN2;SLC39A14;SLC1A3;CACNA1A;SLC6A2;HVCN1;SLC9A1;SLC11A2;CACNA1C;ATP5PO;KCNF1;KCNA5;PKD2;TRPC6;SLC24A5;SCN7A
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.36696342747277155,0.8352090230965785,0.6642754662840746,0.8974290461698203,1.0,5/17,17.13%,PDGFRB;CALM2;ITGA1;PTPRC;PTPA
prerank,carbohydrate catabolic process (GO:0016052),0.3211933072030078,0.835036563030299,0.6959706959706959,0.8973218339580189,1.0,13/38,25.93%,HK2;ENO1;GAPDH;GCK;NEU3;NEU1;MAN2C1;GPI;PFKFB1;MAN2B1;ENO3;PFKFB2;PGM1
prerank,positive regulation of phosphatase activity (GO:0010922),0.34979462653567794,0.834846953607763,0.6684931506849315,0.8972578906464812,1.0,6/21,17.13%,PDGFRB;CALM2;MTMR9;ITGA1;PLEK;PTPA
prerank,nucleotide metabolic process (GO:0009117),-0.2643705079166877,-0.8341815237700261,0.7254901960784313,0.9329777741337966,1.0,3/23,7.23%,FHIT;ME1;NMNAT3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.30535775929549314,0.8336529355711487,0.6979785969084423,0.8987786206716399,1.0,17/52,23.22%,TNKS1BP1;EDC4;CNOT4;SAMD4A;EXOSC4;DCP2;DCP1A;PATL1;LSM7;RC3H2;TUT7;PARN;CNOT2;CNOT3;EXOSC5;PATL2;POLR2D
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2985903065929009,0.83352716500559,0.727683615819209,0.8985936700997765,1.0,24/68,24.17%,TAF1D;POLR1E;CSTF1;TTF2;GTF2H1;NCBP2;CDK7;SMN1;POLR1B;TAF1A;SETX;POLR2L;POLR2K;SNRPB;POLR1G;ERCC2;POLR3K;PCF11;POLR1A;CCNH;MNAT1;PRMT5;FIP1L1;CPSF3
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.24079688653422554,-0.8331986427298564,0.7592592592592593,0.9334348767109104,1.0,17/36,26.62%,RB1;SGMS1;MADD;TPD52L1;NR4A2;CYLD;QARS1;BDNF;ASAH2;CRADD;BCL2L12;TMBIM6;PPIA;STYXL1;TRAF1;MAZ;TRIM39
prerank,cellular response to osmotic stress (GO:0071470),0.35670118184166033,0.8331410667549036,0.6768377253814147,0.8988288294815844,1.0,4/21,13.71%,ZFP36L1;PKD2;MYLK;YBX3
prerank,regulation of axonogenesis (GO:0050770),0.30514361786485045,0.8328683665924371,0.7142857142857143,0.8988860003083451,1.0,10/51,14.08%,ROBO2;PLXNC1;EPHB3;KIF13B;PTEN;PLXND1;PLXNA3;RHOA;GSK3B;ARHGAP35
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.33693210773360066,0.8328143629497874,0.6824769433465085,0.898580084548992,1.0,12/27,28.11%,NAA50;CREBBP;BAG6;RUVBL1;PHF20;KAT6B;KAT7;TRRAP;MORF4L2;MORF4L1;MRGBP;RUVBL2
prerank,peptidyl-lysine acetylation (GO:0018394),0.39743558101911636,0.8326884628700608,0.6676783004552352,0.8984027226914569,1.0,2/10,7.04%,CREBBP;BAG6
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3650715847284481,0.8324751548004624,0.6638054363376252,0.8983398465609647,1.0,6/18,12.48%,MDK;AKT3;PPARG;CCL2;FGFR1;FGF2
prerank,morphogenesis of an epithelium (GO:0002009),-0.25776362640828787,-0.8324513278338148,0.7785977859778598,0.9334105246983783,1.0,6/25,9.23%,ACTB;LAMA3;FGFR2;AHI1;LAMA5;VCL
prerank,regulation of cell projection organization (GO:0031344),0.38245657628177915,0.8322306850094204,0.653179190751445,0.8983491787978432,1.0,3/13,11.91%,TREM2;MOV10;SPRY2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.33618499701364124,-0.8320331782867246,0.6734177215189874,0.9328156314550545,1.0,4/10,23.55%,ESR1;PSMC3;PSMC4;TP53
prerank,prostanoid biosynthetic process (GO:0046457),0.37203917390559804,0.8312687989773165,0.6590909090909091,0.8995097603809379,1.0,3/15,14.60%,PTGES;TBXAS1;PLA2G4A
prerank,ureteric bud development (GO:0001657),0.36513027760000977,0.8308964967460405,0.6806966618287373,0.8997370805157119,1.0,4/17,14.04%,ROBO2;PKD2;SALL1;BMP7
prerank,cAMP biosynthetic process (GO:0006171),0.4002142290342482,0.8308458711451302,0.6714975845410628,0.8994347289235562,1.0,2/10,4.40%,ADCY7;ADCY2
prerank,cellular response to misfolded protein (GO:0071218),-0.27707098256410134,-0.8307791597880151,0.7044673539518901,0.9339203925345564,1.0,9/20,24.85%,ATXN3;DNAJC18;DERL1;TOR1A;RNF185;UFD1;KLHL15;RNF5;RNF126
prerank,apoptotic nuclear changes (GO:0030262),0.34813445689851985,0.8307267974335153,0.6513513513513514,0.8992256954093184,1.0,4/24,12.75%,ERN2;DICER1;HMGB2;ACVR1C
prerank,DNA duplex unwinding (GO:0032508),0.30912067477839567,0.8307248097872535,0.7298578199052133,0.898834397067896,1.0,8/50,10.37%,ASCC3;MCM2;DDX11;GTF2H1;MCM7;ANXA1;RAD23B;MCM9
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.32273976024066986,-0.8303934962037944,0.6607669616519174,0.9332241401090323,1.0,2/12,3.11%,RAD21;RB1
prerank,cell projection organization (GO:0030030),0.3298575032117282,0.8303832194803802,0.7028795811518325,0.8989945678260295,1.0,8/30,23.38%,RHOJ;PARVA;CDC42;RAC1;PLEK;CAPG;P2RY12;ITGB1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.33433896928626544,0.8301145459217095,0.6954314720812182,0.8990254776792683,1.0,9/29,19.14%,ACSL4;HACD2;SCD5;HSD17B8;HSD17B12;ELOVL6;ACSL5;ACACA;FASN
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.3260213832819315,-0.8298708970934398,0.6878980891719745,0.9328637141010288,1.0,2/13,1.76%,BMP6;BMP4
prerank,somite development (GO:0061053),0.397881934050733,0.8298232563687655,0.6698564593301436,0.8990983399377365,1.0,3/11,15.46%,SHH;LOXL3;SMO
prerank,negative regulation of cell projection organization (GO:0031345),0.31400199466510215,0.8296718769651232,0.7132616487455197,0.8989349958331936,1.0,9/48,13.48%,MYLIP;DPYSL3;APOE;PTEN;GAK;PTPN9;DENND5A;SPRY2;RTN4RL1
prerank,protein heterooligomerization (GO:0051291),0.36687799296109225,0.8295205845420073,0.6856330014224751,0.8987651013934678,1.0,3/17,8.54%,TMEM120B;PKD2;HSD17B8
prerank,positive regulation of ATPase activity (GO:0032781),0.3175647835449373,0.8292866513099458,0.7146401985111662,0.8987376308072612,1.0,3/41,3.17%,VMP1;DYNLL1;DNAJB1
prerank,purine-containing compound salvage (GO:0043101),-0.3260527804639067,-0.8291660161321259,0.6782608695652174,0.9327893740080959,1.0,4/12,22.10%,ADK;GMPR;DCK;APRT
prerank,UV protection (GO:0009650),-0.33743120036962054,-0.8286871658107071,0.6628571428571428,0.9323457622842217,1.0,2/10,6.43%,ERCC5;CAT
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3506790976441739,0.82844174738095,0.6840696117804551,0.8996789298261115,1.0,9/21,27.89%,CGNL1;MAPKAP1;TGFB2;SPRY2;SYNGAP1;SPRY4;CYRIB;ARHGAP12;SPRY1
prerank,positive regulation of protein import (GO:1904591),0.32625328772481105,0.8283510035259829,0.6991037131882202,0.8994452101665495,1.0,6/30,13.92%,UBR5;BAG3;ZIC1;PIK3R1;SMAD3;PSEN1
prerank,mRNA metabolic process (GO:0016071),-0.19407460846889138,-0.8281808252933477,0.8658536585365854,0.9319487305203877,1.0,37/90,27.78%,SFPQ;DDX5;SRSF5;PPARGC1A;CNOT10;U2AF2;GEMIN2;RIDA;LSM6;PCBP3;SNRPG;SRSF7;SRSF9;NUDT12;ERN1;SRRM4;LSM5;HNRNPR;SNRPD3;RNASE4;SUPT4H1;HNRNPA0;PRPF8;ZFP36;LSM11;AGO3;TP53;TBRG4;SF3A1;SF3A3;LSM10;SF3B4;NUDT16;NUDT16L1;AGO4;U2AF1;HSPA1A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.34307288250512813,0.8281153732515404,0.687248322147651,0.8994299508359822,1.0,6/25,17.14%,NOS1AP;PKD2;CD36;TNF;SMAD3;AKT1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.36178546619282315,0.8278063619243076,0.6957123098201936,0.899536251903589,1.0,3/20,9.55%,PUM1;TERT;DICER1
prerank,striated muscle cell differentiation (GO:0051146),-0.2965489208588481,-0.8275822049182284,0.7051282051282052,0.9317236824416544,1.0,8/16,28.40%,SORT1;SIK1;SKI;MYOCD;MEF2C;MTLN;KDM6B;CBY1
prerank,protein deneddylation (GO:0000338),-0.3451209641052614,-0.8267939650189334,0.6856435643564357,0.9318516338727396,1.0,3/10,16.01%,COPS5;COPS7B;TOR1A
prerank,rRNA 3'-end processing (GO:0031125),-0.33868377317135995,-0.8267205111984094,0.6902439024390243,0.930587531846605,1.0,5/10,22.00%,EXOSC7;RPS21;EXOSC8;EXOSC3;EXOSC10
prerank,ncRNA export from nucleus (GO:0097064),0.3156058439384515,0.8267135387391102,0.705,0.9009294974275314,1.0,11/36,20.96%,NUP37;XPOT;RAE1;NCBP2;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107
prerank,phospholipid biosynthetic process (GO:0008654),-0.2272521455928319,-0.8262850073010061,0.7872340425531915,0.9300297546526232,1.0,7/36,11.79%,MBOAT1;SGMS1;PCYT2;SGMS2;CLN3;AGPAT3;HDHD5
prerank,cellular component maintenance (GO:0043954),-0.32979306326749974,-0.8260887750576514,0.7076502732240437,0.9290443679355584,1.0,2/12,3.58%,IGF1R;INSR
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.22607130564192943,-0.8252906438199583,0.78,0.9291993923353811,1.0,5/41,5.90%,TGFBR3;BMP4;CPE;PROX1;FGFR2
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.27974034085338767,-0.8252636604628013,0.6933797909407665,0.9278517536544828,1.0,6/19,15.74%,PRKN;SREBF2;CAMKK2;VDAC1;PINK1;DNM1L
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.38398458940265456,0.825137052306595,0.6587887740029542,0.903080871413128,1.0,3/12,12.29%,TIRAP;LPL;TNF
prerank,vitamin transport (GO:0051180),0.333854090594936,0.824917458222074,0.7043010752688172,0.9030347098939858,1.0,3/29,11.38%,TCN1;TCN2;PDPN
prerank,axonemal dynein complex assembly (GO:0070286),0.331687062582962,0.8248756235780059,0.6902536715620827,0.9027063609869048,1.0,4/27,13.37%,DNAAF4;TTC12;ODAD1;DNAAF5
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2822454030451506,-0.8241915920412723,0.7474402730375427,0.9284941170597151,1.0,6/18,23.86%,WDR43;PHF8;DHX33;SIRT7;UTP15;MAF1
prerank,melanosome localization (GO:0032400),0.34712868985841894,0.82398507781304,0.6875891583452212,0.9037377319391294,1.0,3/21,9.93%,MLPH;MYO5A;RAB27B
prerank,regulation of synapse organization (GO:0050807),0.33909773596085596,0.8231660771685185,0.718421052631579,0.9046296576840205,1.0,8/26,15.60%,MDGA1;ABHD17C;WNT5A;YWHAZ;TNF;ARHGAP22;ABHD17B;NEDD4
prerank,positive regulation of embryonic development (GO:0040019),0.34898254932873307,0.8230407592273993,0.689900426742532,0.9044439711355925,1.0,3/19,11.73%,B4GALT5;TENM4;ZBED3
prerank,lysosome localization (GO:0032418),0.3212067807551274,0.8228452620017768,0.726932668329177,0.9043640418913033,1.0,6/37,15.66%,BORCS6;MILR1;MYH9;KIF5B;RAB34;NDEL1
prerank,cell part morphogenesis (GO:0032990),-0.3112901558290332,-0.8227816555370562,0.695906432748538,0.9298485445318431,1.0,7/13,27.02%,WASF1;DNM1L;SUPV3L1;SLIRP;MYH14;NUBPL;MFF
prerank,protein homooligomerization (GO:0051260),-0.1876673358081188,-0.8227740448602282,0.9615384615384616,0.9284739530355514,1.0,32/114,23.54%,KCNC2;GLRA3;EHD4;SLC1A2;KCNJ2;ATL3;SAMHD1;UPB1;DISP1;LETM1;AQP11;GSDMD;ALDH9A1;GOLGA2;EHD3;PRMT1;KCNJ12;GBP5;SSBP1;POLQ;HCN1;SOD2;NACC2;PRMT8;CBR4;GLS;USP16;APIP;VSTM5;G3BP2;MIF;CRYZ
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2716508950972553,-0.8226044228395808,0.7360594795539034,0.9274065597371797,1.0,18/23,49.62%,CADM1;PIK3R6;AP1G1;LAMP1;PVR;RAET1E;NECTIN2;RASGRP1;LILRB1;ARRB2;SLAMF6;CD226;IL12A;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,regulation of leukocyte activation (GO:0002694),-0.3064528422862368,-0.8212281219157487,0.6848484848484848,0.9287093512093807,1.0,5/14,22.86%,CD200;MYO18A;SHPK;GPER1;MIF
prerank,positive regulation of DNA metabolic process (GO:0051054),0.2952545056903533,0.8207892689894817,0.7350620067643743,0.9072617625013764,1.0,6/61,5.00%,PARP3;PDGFRB;EGFR;USP9X;BABAM2;PRKD2
prerank,chromatin remodeling at centromere (GO:0031055),0.32504334868539153,0.8206990129943211,0.693717277486911,0.9070237533919141,1.0,5/31,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3352175509669605,0.8205844058743162,0.6770428015564203,0.9067988007146818,1.0,1/27,0.65%,P2RY10
prerank,RNA interference (GO:0016246),0.3677340778734274,0.8205600169650155,0.6954674220963173,0.90644338413414,1.0,3/17,9.55%,CELF1;TERT;DICER1
prerank,indolalkylamine catabolic process (GO:0046218),0.39393660848355316,0.8191211701875187,0.6550632911392406,0.90836828196004,1.0,1/10,7.20%,KYAT1
prerank,histone exchange (GO:0043486),0.316289743676118,0.8190672874358603,0.7007575757575758,0.908061171584616,1.0,7/37,15.43%,CENPQ;CENPN;RSF1;CENPL;RUVBL1;SPTY2D1;SRCAP
prerank,amide biosynthetic process (GO:0043604),0.30342613636672167,0.8181728061518277,0.7285886610373945,0.9090304675794386,1.0,3/47,2.51%,ASMT;CERS6;PAM
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.34429942018114634,0.8173075137034937,0.6931818181818182,0.9100197055342122,1.0,3/21,6.15%,ADCY7;ADCY2;NPR2
prerank,cellular response to cAMP (GO:0071320),0.3274650493065116,0.8169643879569194,0.704635761589404,0.910183402063978,1.0,4/30,6.40%,ZFP36L1;IGFBP5;PKD2;AHR
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.2822453580418565,-0.8169476630775293,0.753125,0.9354532818354261,1.0,5/18,12.69%,EZR;HSP90AA1;VPS11;RDX;FAF1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3468850363412561,0.8163905284757212,0.7168262653898769,0.9107162706396875,1.0,3/20,6.21%,NR2F2;PTEN;PLK1
prerank,glutathione metabolic process (GO:0006749),-0.23568084604430936,-0.816228118917103,0.8045977011494253,0.9353574832718868,1.0,11/38,23.37%,GCLC;HAGH;GSTZ1;CHAC2;ETHE1;GSTA3;GSR;SOD1;CTNS;GSTM5;GCLM
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4002099850413716,0.8161926061749649,0.6863354037267081,0.9106450500593907,1.0,5/10,24.21%,CBARP;DRD3;FMR1;GNB5;CALM3
prerank,positive regulation of histone modification (GO:0031058),-0.23972175475408092,-0.8154735018926405,0.7655502392344498,0.9353987961308114,1.0,9/33,19.61%,RPS6KA5;PPARGC1A;SAP30BP;AKAP8;UBE2N;CHTOP;TET1;CTBP1;MAPK3
prerank,response to UV (GO:0009411),0.28101352684427444,0.8154158172770755,0.775599128540305,0.9114707772330776,1.0,22/95,21.00%,BCL3;EGFR;USF1;INO80;CREBBP;NOC2L;CCAR2;ATR;TMEM161A;MC1R;REV1;MFAP4;FMR1;NEDD4;USP28;AKT1;ATF4;RHBDD1;KDM1A;ERCC2;PRKCD;YY1
prerank,histone H4-K8 acetylation (GO:0043982),-0.30002280592383707,-0.815350779041551,0.6963696369636964,0.932838044585897,1.0,5/15,13.96%,JADE1;KANSL2;JADE2;WDR5;JADE3
prerank,histone H4-K5 acetylation (GO:0043981),-0.30002280592383707,-0.815350779041551,0.6963696369636964,0.932838044585897,1.0,5/15,13.96%,JADE1;KANSL2;JADE2;WDR5;JADE3
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2806365316277579,0.8151778235776522,0.7679738562091504,0.9114469409430073,1.0,26/94,22.62%,DYNLL1;DYNC1H1;TUBG1;ALMS1;PLK1;PCM1;HAUS3;CEP41;CNTRL;DCTN3;PCNT;CEP72;ACTR1A;AKAP9;CEP192;CSNK1D;YWHAE;CKAP5;IQCB1;HAUS6;CEP162;HAUS5;RAB3IP;CC2D2A;NINL;C2CD3
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.31919676921993717,-0.814949142831061,0.7217847769028871,0.9321646405665635,1.0,5/12,31.91%,LFNG;MFNG;DOCK11;DLL1;PTK2B
prerank,response to interferon-alpha (GO:0035455),-0.28959449370626567,-0.8149468887599136,0.7174603174603175,0.930793888281005,1.0,6/16,21.84%,GAS6;ADAR;IFNAR1;RO60;BST2;PDE12
prerank,stress granule assembly (GO:0034063),0.3518082069837669,0.8147949749525321,0.6890982503364738,0.9116299542385593,1.0,8/20,24.23%,ATXN2;DYNC1H1;UBAP2L;YTHDF3;PRRC2C;CSDE1;YTHDF2;EIF2S1
prerank,necroptotic process (GO:0070266),0.36415729852971107,0.8147545403930635,0.6691842900302115,0.9113001478629011,1.0,4/16,15.12%,LY96;CD14;MLKL;RIPK1
prerank,nucleotide-excision repair (GO:0006289),-0.18969975811185336,-0.8142171388698469,0.9264705882352942,0.9307442120059441,1.0,42/101,29.31%,ERCC5;ATXN3;COPS5;AQR;ISY1;BRCA2;ERCC6;ERCC3;UBC;COPS7B;HUS1;EP300;UVSSA;POLD3;USP7;POLR2A;POLR2H;CHD1L;PCNA;POLR2G;DDB2;POLR2F;PRPF19;GTF2H2;ERCC1;POLR2E;OGG1;GTF2H4;RFC3;TP53;UBA52;GTF2H3;FAN1;POLD2;CETN2;RBX1;RPA2;PARP1;LIG4;XPC;POLE;RFC4
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.31263110626842067,0.8137326845164634,0.7151664611590629,0.9124912044620613,1.0,8/37,17.10%,PABPC4;RNASEH1;SND1;RNASEH2A;ENTPD7;ENTPD6;SIDT2;MTREX
prerank,prostaglandin metabolic process (GO:0006693),0.33163210851963276,0.8136983264934922,0.7222222222222222,0.9121494195700794,1.0,4/26,14.60%,PTGES;ACOX1;TBXAS1;PLA2G4A
prerank,Golgi to lysosome transport (GO:0090160),0.3940525288855057,0.8135230226054891,0.6924265842349304,0.9120240870358012,1.0,3/11,10.49%,AP4M1;ANKFY1;GAK
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.331818973981106,0.813438793794834,0.7158034528552457,0.9117677274315937,1.0,11/26,24.21%,PKD2;CBARP;FKBP1B;DRD3;CALM2;FMR1;YWHAE;THADA;GSTM2;GNB5;CALM3
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3746797083088418,0.8122564806963455,0.6885496183206107,0.9131887784506416,1.0,1/14,2.62%,IRS1
prerank,positive regulation of macroautophagy (GO:0016239),0.29936631686706755,0.8122043054154923,0.7430972388955582,0.9128697049249344,1.0,7/48,13.51%,DCN;BAG3;PIP4K2A;TRIM13;RAB3GAP2;SMCR8;RAB3GAP1
prerank,melanosome organization (GO:0032438),0.33085807521943805,0.8106828846317288,0.7237851662404092,0.9148265467890799,1.0,4/26,9.89%,AP3B1;DTNBP1;AP3D1;RAB32
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.263365535187711,-0.8103800526315027,0.7822878228782287,0.9362468765202866,1.0,12/22,28.70%,ERCC3;UBC;CHD1L;DDB2;GTF2H2;GTF2H4;UBA52;GTF2H3;CETN2;RBX1;PARP1;XPC
prerank,establishment of protein localization to organelle (GO:0072594),0.2888985605400856,0.8103245521832562,0.7645714285714286,0.9149854342986917,1.0,18/72,20.96%,STAT3;HK2;RALA;CD68;PRICKLE1;FAM53B;LAMP2;NUP153;TNPO1;PEX19;E2F3;NUP188;SEC13;AKT1;HEATR3;NUP214;LAMP5;NUP107
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2922225943174004,0.8101441697571288,0.7741203178206584,0.9148622799164718,1.0,17/72,22.34%,ENPP1;DNA2;EDC4;GTF2H1;DICER1;SETMAR;FBH1;DCP1A;RNASE1;DXO;DDB1;DDX1;ERCC2;ZC3H12A;RFC1;RPS27A;RPA1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2932053179150759,0.8100922257919465,0.7364787111622555,0.91454654709912,1.0,13/60,19.69%,PARM1;PDGFRB;PRKD2;ATM;ATR;CCT8;FGF2;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB
prerank,tRNA transport (GO:0051031),0.3111443669365553,0.8100327072668474,0.7162849872773537,0.9142477570699193,1.0,11/35,21.73%,NUP37;XPOT;RAE1;NUP153;NDC1;NUP35;NUP188;SEC13;NUP214;NUP107;YBX1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3833813058965443,0.8098884142416799,0.6787330316742082,0.9140663135612749,1.0,1/12,2.62%,IRS1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.3268907363784769,0.8091464976457202,0.7325728770595691,0.9147503313427732,1.0,10/30,24.86%,DNAJB1;HSPE1;GAK;DNAJC7;SDF2;HSPA5;HSPA13;DNAJB14;ST13;UGGT1
prerank,regulation of intracellular transport (GO:0032386),0.314754745334623,0.8090762480797411,0.7438725490196079,0.9144641068810231,1.0,6/38,8.76%,LRRK2;ANTKMT;DYNC1H1;PTPN1;GAS1;LCP1
prerank,protein insertion into ER membrane (GO:0045048),0.31471082959372,0.808453741552288,0.7329974811083123,0.915026486507705,1.0,5/37,7.67%,TRAM2;WDR83OS;BAG6;VAPA;EMC7
prerank,GPI anchor biosynthetic process (GO:0006506),0.31848289310996786,0.8080981930928051,0.7220026350461133,0.9151694211738677,1.0,9/30,21.18%,PIGW;PIGN;PIGL;PIGC;PIGP;PIGH;PIGT;MPPE1;PIGK
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3336061340661014,-0.8080957892878982,0.7236842105263158,0.9377273179498559,1.0,3/10,33.75%,CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3336061340661014,-0.8080957892878982,0.7236842105263158,0.9377273179498559,1.0,3/10,33.75%,CACNA2D4;TULP1;CNGB1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3447222814226635,0.8080107335443586,0.710455764075067,0.9149105161985279,1.0,2/22,3.00%,DUSP2;DUSP5
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3133096494501882,0.8076691658652542,0.7275064267352185,0.915067812766954,1.0,10/35,20.46%,PDGFRB;NUAK1;FKBP1B;PPP1R2;GSK3B;CALM2;ITGA1;PTPA;HSP90B1;PPP6R2
prerank,isotype switching (GO:0045190),0.39848733737293784,0.8074296394412606,0.7128712871287128,0.9150146690379626,1.0,4/10,25.96%,BATF;HSPD1;MSH6;RNF8
prerank,regulation of JUN kinase activity (GO:0043506),0.3197830623948654,0.8070842579255221,0.7292746113989638,0.9151333270749357,1.0,8/33,19.09%,AIDA;SASH1;TAOK3;HIPK3;TNF;TRAF2;MAPK8IP1;DVL2
prerank,regulation of transposition (GO:0010528),0.37615457147552606,0.80675464090455,0.6870229007633588,0.9152405254969361,1.0,1/13,4.62%,MYBL1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2978271325266557,0.8062404816967677,0.7578947368421053,0.9156773146784599,1.0,6/52,11.59%,ALDH18A1;MTHFR;MTHFD1L;DLST;IDH2;MTHFD2L
prerank,endocardial cushion morphogenesis (GO:0003203),0.360810094757135,0.8060807308814579,0.7111111111111111,0.9155262301264846,1.0,4/18,11.44%,TBX2;ACVR1;HEYL;TGFB2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.33527194805083405,0.8059534296515858,0.7096336499321574,0.9153098307202524,1.0,2/23,2.43%,SLC9A1;LRRK2
prerank,positive regulation of dendritic spine development (GO:0060999),0.3459376259711799,0.8051556853787633,0.7043596730245232,0.9161066909598609,1.0,7/20,14.28%,APOE;CAPRIN1;DBN1;DBNL;PSEN1;DLG5;FMR1
prerank,ERAD pathway (GO:0036503),-0.19463302524762266,-0.8045721342228426,0.9325842696629213,0.9426568557063326,1.0,26/83,26.81%,PRKN;STT3B;ATXN3;ERLIN1;JKAMP;UBXN4;UBE4A;DNAJC18;DNAJB9;ERLIN2;DERL1;ANKZF1;TOR1A;WFS1;UBXN6;RNF185;UFD1;YOD1;SGTA;FBXO44;RNF5;NPLOC4;RNF139;UBQLN2;CCDC47;DNAJB2
prerank,cristae formation (GO:0042407),-0.24840543396397755,-0.8045699985089353,0.8221343873517787,0.9412841499542436,1.0,11/27,20.64%,ATP5MG;ATP5PD;ATP5PF;LETM1;IMMT;ATP5F1D;MICOS13;ATP5ME;SAMM50;APOO;APOOL
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.38676566466750995,0.8044707849271455,0.6902086677367576,0.916710194536762,1.0,2/11,9.77%,ADM;DRD3
prerank,carboxylic acid metabolic process (GO:0019752),-0.23423992773811222,-0.8041364331073273,0.813953488372093,0.9406633961541772,1.0,7/33,15.75%,DDO;SLC2A1;GLUD1;CSGALNACT1;CARNMT1;CYB5A;LIAS
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3077087055819131,0.8037263503931176,0.7565947242206235,0.9174778909829322,1.0,18/44,23.87%,NRP1;CARMIL1;NF2;SFRP1;TGFB3;CDC42;EPHA1;TGFBR1;RHOA;RAC1;ITGB1BP1;TPM1;PAK1;RHOC;RGCC;ROCK2;LPAR1;PXN
prerank,negative regulation of transposition (GO:0010529),0.3608959418440741,0.8034895182717479,0.6977777777777778,0.9174339414344764,1.0,3/16,17.80%,MYBL1;MOV10;TUT7
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.32236574258658346,-0.8033643047717343,0.6920980926430518,0.9406500826311098,1.0,3/11,12.55%,CCT4;CCT5;DKC1
prerank,positive regulation of wound healing (GO:0090303),0.30732320743930047,0.8033494325290843,0.7403726708074534,0.9172598557891313,1.0,6/36,11.22%,APOH;HPSE;ANXA1;MYLK;PTK2;VTN
prerank,icosanoid biosynthetic process (GO:0046456),0.3868593879404812,0.8032714329930442,0.6975308641975309,0.9169875682858551,1.0,2/10,14.60%,FADS1;PLA2G4A
prerank,regulation of secretion (GO:0051046),-0.3100853403225329,-0.8024541195838731,0.7314814814814815,0.9409500298515814,1.0,7/13,22.37%,GPLD1;ACSL3;KCNQ1;FGF10;OAS2;ERBB3;OPRK1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3200355708111702,0.802405913259109,0.7334200260078023,0.9178852070692405,1.0,7/31,13.84%,CDKN2B;PTEN;PKD2;CDK6;GPNMB;CCL2;DACT1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.37374620193539254,0.802209779864356,0.718796992481203,0.9177889821318009,1.0,4/13,14.77%,NCK1;PTPN1;DDRGK1;HSPA5
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.38380749926061913,0.8021550166982878,0.6926677067082684,0.9174759625201859,1.0,1/10,3.11%,NELL1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.37930674797111724,0.8021081878640709,0.6889580093312597,0.9167773327384823,1.0,5/11,24.21%,PKD2;FKBP1B;CALM2;GSTM2;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.37930674797111724,0.8021081878640709,0.6889580093312597,0.9167773327384823,1.0,5/11,24.21%,PKD2;FKBP1B;CALM2;GSTM2;CALM3
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.23253664934314264,-0.801938845212037,0.8211009174311926,0.9405003605589275,1.0,7/34,11.07%,GRID2;GABRA2;GABRG3;GABRA5;GLRA1;GRIN2D;GRIN2B
prerank,regulation of lamellipodium assembly (GO:0010591),0.31244206132542446,0.8015640703300043,0.7146529562982005,0.9172000196336516,1.0,8/34,14.73%,AUTS2;FSCN1;CDC42;ABI2;ACTR2;BRK1;PIK3R1;RAC1
prerank,response to muramyl dipeptide (GO:0032495),0.37771655648388613,0.8015262793191918,0.6944024205748865,0.9168587115458041,1.0,2/12,11.01%,NOD1;ERBIN
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3169426299529812,0.8014680595884702,0.7551282051282051,0.9165471847888986,1.0,9/35,22.34%,MPG;LIG1;XRCC1;POLG;PNKP;MBD4;NEIL1;RFC1;RPA1
prerank,regulation of exocytosis (GO:0017157),0.2967568592501403,0.8013427200985892,0.7463768115942029,0.9163555727709912,1.0,8/46,9.93%,RAB2B;RALA;RAB21;UNC13D;RAB8B;ANXA1;RAB9A;RAB27B
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.35045284403221183,0.8013403952405357,0.7105978260869565,0.9159717238290062,1.0,11/19,26.61%,FLOT2;APOE;PICALM;PRNP;PIN1;CLU;RTN2;ROCK1;BIN1;CHRNA7;GGA3
prerank,protein hydroxylation (GO:0018126),0.362007141883554,0.8012812321336104,0.7243401759530792,0.9156765625921743,1.0,1/15,1.48%,PLOD2
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.2939508868373735,-0.8008969216932157,0.7466666666666667,0.9409618948127094,1.0,6/16,15.61%,IGF1R;INSR;CLN3;UPF1;MTRF1;BNIP3
prerank,meiosis I (GO:0007127),0.3325763907614293,0.8007707772951654,0.7194630872483222,0.9160549118375727,1.0,3/23,12.98%,MYBL1;ZSCAN21;FOXJ3
prerank,peptidyl-amino acid modification (GO:0018193),0.3929392648311978,0.8006580109687714,0.7179080824088748,0.9158443577839562,1.0,5/10,27.13%,FKBP10;ATP7A;METAP1;TTLL4;METAP1D
prerank,ion transport (GO:0006811),0.27533429308046004,0.8005288285671516,0.8048780487804879,0.9156426339797653,1.0,14/111,10.09%,SLC1A3;SLC15A3;SLC9A1;SLC12A4;PIEZO2;GLRB;SLC20A1;TRPC6;VDAC2;SLC24A5;SLC9A8;SLC36A2;LASP1;SLC15A1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.2939398924930123,-0.8003479615500981,0.7366771159874608,0.9405526629880044,1.0,3/15,7.43%,PRKCH;IL18;AGTR1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.33626750647766496,0.7999796031672202,0.7305061559507524,0.9160330572816087,1.0,3/22,5.93%,LRRK2;MDK;PTPRZ1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2766478737361594,0.7994332541354516,0.7767094017094017,0.9164711280564423,1.0,27/93,22.19%,TNKS1BP1;EGFR;NCK1;PTEN;PRKD2;NCK2;RASSF2;RPTOR;CNKSR3;FNIP1;SPRY2;TNF;NLRP2B;NTRK3;AKAP9;PDCD10;NSD1;STK4;AKT1;IRGM;EIF4G1;SPTBN4;TRIM6;AXIN1;PAK1;RAF1;LATS1
prerank,autophagosome maturation (GO:0097352),0.3192884590707039,0.7992139813300712,0.7229987293519695,0.9164033304624866,1.0,4/32,9.67%,VMP1;STX17;LAMP2;ATP2A2
prerank,regulation of regulated secretory pathway (GO:1903305),0.313087066261118,0.798733372757452,0.727735368956743,0.9167044044988978,1.0,5/34,12.44%,LRRK2;DTNBP1;UNC13D;SYT2;GSK3B
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.2781968616182039,-0.7983920767017735,0.7907801418439716,0.9425711779627831,1.0,6/19,18.65%,SLCO1C1;KLF2;KLF4;APP;WFS1;MAP2K5
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3792965812377812,0.798339670096974,0.6883942766295708,0.9168994614564029,1.0,2/12,13.29%,PTPN1;PIK3R1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.37672515804279716,0.7982581994613478,0.6848484848484848,0.9166408449276817,1.0,2/12,8.70%,MCM2;MCM7
prerank,glycoprotein biosynthetic process (GO:0009101),0.2811106139580013,0.7978453245815252,0.788546255506608,0.9168853658390138,1.0,16/79,18.25%,TNIP1;B4GALT5;CHST13;ST3GAL3;DDOST;ALG5;TMEM106A;CHST11;GCNT2;PMM2;B4GALT7;COG7;FAM20B;B3GNT9;ATP7A;FUT4
prerank,negative regulation of ion transport (GO:0043271),0.3267942668978893,0.7977130873545014,0.7177747625508819,0.9166782789211965,1.0,5/24,18.32%,GPM6B;PXK;HRH3;NEDD4;HTR1B
prerank,covalent chromatin modification (GO:0016569),0.36625690028899205,0.7970936464757243,0.7326283987915407,0.9172264018762745,1.0,2/14,9.16%,MBD2;HDAC1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.30242816940623063,0.796599386800034,0.7328339575530587,0.9175715986676642,1.0,5/37,7.14%,JAML;TENM3;DCHS1;ICAM1;TENM4
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.29691248299092354,0.7965069205436799,0.7541966426858513,0.9173287451559248,1.0,6/46,10.88%,ADIPOQ;LAMA4;ADAMTS5;ARRDC3;PLCL1;ACOT13
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3738811199796788,0.7964215231886451,0.7028301886792453,0.9170671581297554,1.0,6/12,23.08%,ABCA2;H6PD;SREBF1;LPCAT3;SEC14L2;KPNB1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.28460883584634045,0.7962396840218154,0.7858744394618834,0.9169503487808348,1.0,12/76,13.06%,TNIP1;LRRK2;MYCBP2;BIRC3;PRICKLE1;ANGPT1;DCUN1D1;FBXW7;UBE2L3;GNL3;RASD2;TANK
prerank,regulation of protein binding (GO:0043393),0.2735493195962817,0.795887551625635,0.8073298429319372,0.9170877968714457,1.0,29/114,20.54%,LRP1;TCF7L2;LRRK2;TRIM21;PLK1;DDX11;EFHB;ADD2;NMD3;TERT;DISC1;VTN;GSK3B;SPPL3;GTF2F1;DACT1;PSEN1;TRIB3;RPL11;DTX3L;STK4;ITGB1BP1;AKT1;HDAC5;TLE5;CTNNBIP1;KDM1A;PIN1;PRKCD
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.31515889121301816,0.7956373928779669,0.7567917205692108,0.9170884311805415,1.0,9/31,20.69%,ZFPM2;TGFBR1;TNNC1;TGFB2;SMAD4;TNNT2;RBPJ;TPM1;BMPR1A
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3007963140901433,0.7956285921676702,0.7511848341232228,0.916713518016166,1.0,7/48,7.26%,NRP1;DOCK1;MDK;LIMS1;CARMIL1;CDC42;CAPRIN1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.2906495740573454,-0.7953888683135024,0.7225609756097561,0.9464926885486317,1.0,7/15,19.93%,SYN3;ADRA1A;CNTNAP4;CLN3;USP46;NLGN1;DRD2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.23996009363404822,-0.7948085438904328,0.8015267175572519,0.94615117832465,1.0,5/29,13.47%,DDO;ALDH4A1;PRODH;GSTZ1;FAH
prerank,positive regulation of phospholipid transport (GO:2001140),0.3980609675442419,0.7946474215493522,0.6945288753799392,0.9177970961579188,1.0,1/10,3.78%,APOE
prerank,regulation of microtubule nucleation (GO:0010968),-0.33285087339870756,-0.7946269425653986,0.7029972752043597,0.9450804613668535,1.0,2/10,11.09%,EML2;GIT1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.29899983831970645,0.7945513013903316,0.7624242424242424,0.9175754698460027,1.0,15/44,25.00%,SIAH2;SH3RF1;CSNK2A1;FNIP1;DNAJB6;TNF;SRC;LAMTOR5;AKT1;YWHAE;CAST;RAF1;RPS6KA3;PCID2;VEGFA
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3191984449221714,0.7945255739424857,0.7348284960422163,0.9172248566966335,1.0,6/31,12.44%,BBC3;E2F1;BCL2;YWHAZ;CASP8;GSK3B
prerank,tRNA wobble uridine modification (GO:0002098),-0.2991682956242302,-0.7943043829428205,0.7532051282051282,0.9443076985157738,1.0,2/14,4.38%,ALKBH8;TRMT9B
prerank,mitochondrial transport (GO:0006839),-0.21209203093921758,-0.7942700176326606,0.8421052631578947,0.9430071476176362,1.0,22/53,27.20%,HSP90AA1;FLVCR1;DNAJC19;BCAP31;SLC25A4;BCL2L1;COX18;TIMM17B;GDAP1;ABCB10;BNIP3;TOMM20;STARD3;BCS1L;TIMM22;TOMM70;TIMM8B;TOMM5;TOMM40;PPIF;MFF;TIMM9
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.28482512373947133,-0.7942540628920692,0.7676470588235295,0.94168627183578,1.0,3/16,3.36%,DDX5;PPARGC1B;ESR1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.372446298401473,0.7939478358469648,0.7025641025641025,0.9177333278982529,1.0,3/11,15.12%,EGFR;MAP2K1;RIPK1
prerank,endocardial cushion development (GO:0003197),0.3428808459132061,0.7937773831475465,0.7148648648648649,0.9176114857085439,1.0,4/21,11.44%,TBX2;ACVR1;HEYL;TGFB2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.2501777171890133,-0.7935927442283645,0.7978723404255319,0.9415636215372534,1.0,3/23,5.90%,TGFBR3;PROX1;FGFR2
prerank,embryonic axis specification (GO:0000578),0.3524628564049105,0.7933041823636141,0.7250361794500724,0.9179753564987418,1.0,2/15,10.21%,SMAD2;TBX3
prerank,regulation of cellular protein localization (GO:1903827),0.30031591331475976,0.7927273314927215,0.7567567567567568,0.9184443150596605,1.0,11/45,15.66%,GPC6;ABCA2;SHH;EGF;PTPN1;GBF1;LCP1;SETD2;CEP72;VCPIP1;NDEL1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3795582028201887,0.792572007813487,0.6838006230529595,0.9182872118394225,1.0,3/10,17.06%,MAP2K1;NBR1;MAPK1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.36364774783121634,0.7921833596798376,0.7028985507246377,0.9185026589507844,1.0,4/15,19.00%,STAT3;TNF;HIF1A;IL17RA
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3941535522600185,0.7917244867265496,0.7275590551181103,0.9188193351270795,1.0,2/10,5.95%,BATF;SFRP1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.30032969034441137,-0.7917133387735859,0.7248520710059172,0.9433963364448125,1.0,5/14,22.93%,CSTF2;TUT1;ERN1;CPSF2;CPSF4
prerank,signal transduction by p53 class mediator (GO:0072331),0.3185864045411907,0.7915460593565788,0.7254658385093168,0.9187131695957325,1.0,2/30,3.16%,BCL3;BATF
prerank,autophagy of mitochondrion (GO:0000422),0.3060723787453107,0.791313355396398,0.7407407407407407,0.9186528386315853,1.0,12/38,23.32%,WIPI1;AMBRA1;CTSK;ATG3;FBXO7;ATG7;WDR45;SQSTM1;FUNDC2;BECN1;MARK2;ATG2B
prerank,positive regulation of dendrite development (GO:1900006),0.38692864480288436,0.7909669156238582,0.7192429022082019,0.9187831568297314,1.0,3/10,14.04%,PTN;BMP5;BMP7
prerank,atrial septum morphogenesis (GO:0060413),0.3923591205814897,0.7904682552329133,0.7181528662420382,0.9191256708883966,1.0,2/10,11.44%,ACVR1;TGFB2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3192252245004048,0.7899130855387598,0.75,0.9195396337045165,1.0,11/30,19.96%,NPEPPS;FBXW7;TOMM7;CSNK2A2;UBE2L3;MICALL2;SH3GLB1;LEPROT;USP36;ARIH2;UBL5
prerank,positive regulation of cellular protein localization (GO:1903829),0.2802186432771404,0.7898026369488576,0.7853170189098999,0.9193300996028008,1.0,16/69,17.60%,YAP1;CENPQ;TM9SF4;PLK1;WWTR1;SNX33;ENTR1;TNF;GSK3B;GNL3;ORMDL3;DDRGK1;DTX3L;LAMTOR5;AKT1;EIF2AK3
prerank,mitotic cytokinesis (GO:0000281),0.29549682910326786,0.7895905374674855,0.7626321974148061,0.9192653706237457,1.0,17/47,23.85%,JTB;CHMP4B;PLK1;SNX18;SNX33;SNX9;RTKN;RASA1;TTC19;KIF20A;SPTBN1;SON;RHOC;ROCK2;ROCK1;PDCD6IP;RAB35
prerank,response to purine-containing compound (GO:0014074),0.3487780192955357,0.7891276919527361,0.7464589235127479,0.9195474072795374,1.0,4/17,22.13%,STAT1;P2RX7;NDUFS4;TRPM2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3562459681722177,0.7890591138504995,0.7218259629101283,0.9192537284187347,1.0,4/14,17.47%,TSEN2;TRPT1;RTRAF;DDX1
prerank,regulation of histone modification (GO:0031056),-0.29789831965718194,-0.7881518820202046,0.7896174863387978,0.9482020505307223,1.0,5/13,18.42%,AKAP8;UBE2N;IGF2;NNMT;MYOCD
prerank,histone deacetylation (GO:0016575),0.3032782939428096,0.7880246470211696,0.7639751552795031,0.9203519496951239,1.0,12/43,19.11%,RCOR1;MIER2;PRDM5;HDAC1;TBL1X;MTA2;ELK4;BAZ2A;MTA3;RCOR2;HDAC5;BRMS1L
prerank,protein alkylation (GO:0008213),0.3359849744636938,0.7879493883213199,0.7372159090909091,0.9200735136476483,1.0,11/22,27.43%,CAMKMT;VCPKMT;PCMT1;GSPT1;ETFBKMT;PRMT3;SNRPB;ETF1;EEF2KMT;FAM98A;METTL21A
prerank,negative regulation of biosynthetic process (GO:0009890),0.3524893025817091,0.7876971905681186,0.7374631268436578,0.9200605511149155,1.0,4/16,20.52%,EMILIN1;TRAP1;COA8;SLC18A2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3347056532764825,0.7876519670555179,0.7278911564625851,0.9197471459359837,1.0,6/20,15.68%,ZMIZ1;DCUN1D1;TGFBR1;WASHC1;ITCH;HIF1A
prerank,tryptophan metabolic process (GO:0006568),0.3741653817118377,0.7875207825685148,0.7046875,0.9195407756739403,1.0,2/11,18.03%,KYAT1;ATP7A
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.33393087908093916,0.7871957740372107,0.7478510028653295,0.919605865777935,1.0,9/22,25.00%,SASH1;PJA2;SPI1;MFHAS1;XDH;GADD45A;ZC3H12A;RELL1;VEGFA
prerank,regulation of myotube differentiation (GO:0010830),0.32494616893255174,0.7865336640392598,0.7490092470277411,0.9201622483992771,1.0,7/24,18.87%,MMP14;TMEM119;HDAC1;MAML1;HDAC5;PIEZO1;ATP11A
prerank,GPI anchor metabolic process (GO:0006505),0.31829214085932483,0.786063241269193,0.7568681318681318,0.9204751463308533,1.0,6/26,16.13%,PIGW;PIGN;PIGL;PIGC;PIGP;PIGH
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.32300966952063953,-0.7860086344748226,0.7375,0.950400120377682,1.0,6/10,31.06%,APC;RCC2;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,positive regulation of telomerase activity (GO:0051973),-0.2268604924915073,-0.7859764363050517,0.8226600985221675,0.9490913909054306,1.0,10/33,22.46%,HSP90AA1;KLF4;CCT4;DKC1;PRKCQ;HMBOX1;MAPK3;NVL;HSP90AB1;TNKS
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3355617976544779,0.7851307588597929,0.7186147186147186,0.9214451997239271,1.0,5/18,13.84%,APOE;ABCA2;MSN;CTSC;DACT1
prerank,organelle transport along microtubule (GO:0072384),0.31550532337559967,0.784765496288096,0.752851711026616,0.9215781611772902,1.0,8/31,15.66%,TRAK1;MAP1S;CDC42;COPG1;FBXW11;KIF5B;RAB1A;NDEL1
prerank,regulation of monooxygenase activity (GO:0032768),0.3255170507548808,0.7845328273552227,0.7406417112299465,0.9215272754353263,1.0,4/23,9.94%,NOS1AP;EGFR;POR;CYGB
prerank,spermatid development (GO:0007286),0.30238645910902817,0.78441801320856,0.7396745932415519,0.9213173726228141,1.0,3/32,8.47%,IQCG;ACRBP;ZMYND15
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.3281222744020417,0.7839995618852251,0.7428571428571429,0.9215345940579426,1.0,8/25,23.06%,LRRK2;NPAS4;GSK3B;RAB3GAP1;AKT1;GRIN2A;NPFF;MAPK8IP2
prerank,calcium ion transport into cytosol (GO:0060402),0.33476392461274795,0.7835913383837367,0.7468879668049793,0.9217355306607028,1.0,3/21,9.76%,CACNA2D1;CACNA1C;MS4A1
prerank,positive regulation of axon extension (GO:0045773),0.3307520954609512,0.7835883108655671,0.7290575916230366,0.9213571975938728,1.0,5/22,11.62%,NRP1;L1CAM;DBN1;DSCAM;DBNL
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.28527345076556676,-0.7835387556664368,0.7641196013289037,0.9517298188859108,1.0,3/15,9.42%,PRKN;BCL2L1;IGF1
prerank,glycosphingolipid metabolic process (GO:0006687),0.2950781181168583,0.7834570732673808,0.7564575645756457,0.921157029229861,1.0,10/42,17.90%,UGCG;ABCA2;B4GALNT1;CLN6;SMPD3;NEU3;GALC;NEU1;CTSA;CPTP
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2851740387896988,0.7833418323493762,0.7854671280276817,0.9209494076718953,1.0,20/57,23.00%,PES1;NOC2L;WDR74;NOP14;NIP7;GTF3A;LTO1;DDX31;RPL14;RPL11;NOP16;BYSL;TGS1;HEATR3;PAK1IP1;RIOK2;XPO1;DHX37;NOM1;RRP36
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.34068975087584413,0.7832027579251253,0.743801652892562,0.920758459127651,1.0,3/18,12.29%,SPN;ADD2;TNF
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.24892860872154549,-0.7831693577492969,0.8038461538461539,0.950944258030495,1.0,12/25,32.52%,PRPF6;PRPF4;GEMIN2;PRPF8;TXNL4A;SF3A3;SF3B4;LSM1;SRSF10;BCAS2;MPHOSPH10;WDR83
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3239471328704411,0.7825099497451748,0.7334254143646409,0.9213555858336719,1.0,1/23,0.98%,MMP14
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.3857022422648674,0.7823660658741948,0.7303543913713405,0.9211650499977347,1.0,1/10,3.36%,ETFA
prerank,protein localization to lysosome (GO:0061462),0.3205038882502077,0.7823169935681887,0.7649402390438247,0.9208609978941096,1.0,7/28,17.85%,AP4M1;VPS4A;RAB7A;KPTN;NEDD4;LAMTOR5;ZFYVE16
prerank,myelination in peripheral nervous system (GO:0022011),-0.3010038953784928,-0.7821672675971566,0.7582089552238805,0.951231194594041,1.0,6/13,17.70%,ARHGEF10;PARD3;ADGRG6;SOD1;SKI;PRX
prerank,membrane organization (GO:0061024),0.2563850137682241,0.7820455526546518,0.8868686868686869,0.9208617509903912,1.0,47/227,19.09%,CLTC;STON2;SH3KBP1;EGFR;ITSN1;CHMP4A;CHMP4B;RABIF;TLCD2;DNAJC6;EGF;VPS4A;VAPA;EPS15L1;LEMD2;ACTR2;AP3D1;CBL;SYT2;GRB2;WNT5A;GAK;SNX9;AGFG1;EPS15;CHMP7;BTC;TMCC1;AZIN2;AP2A2;STX11;CHMP2B;TIMM50;SUN1;RTP4;TOR1AIP2;REPS1;SH3GLB1;LPCAT3;CTTN;KIF20A;PICALM;CPTP;TOR1AIP1;SPTBN1;GAPVD1;DVL2
prerank,negative regulation of lyase activity (GO:0051350),-0.27511951721442096,-0.7817107492589512,0.7704402515723271,0.9505818296426692,1.0,2/16,5.48%,PALM;GRM3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3518392989209128,0.78116593741505,0.7414285714285714,0.9217154084414234,1.0,3/16,11.00%,BCL3;NF2;PTPN2
prerank,regulation of mitochondrial fusion (GO:0010635),0.3804986735822662,0.781002910930993,0.7475728155339806,0.9215626017497857,1.0,4/11,14.63%,OMA1;ADCK1;PID1;ZDHHC6
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.24816681424438566,-0.7808034416671612,0.8087649402390438,0.9507314386277859,1.0,15/24,35.18%,UBC;POLD3;PCNA;RFC3;UBA52;POLD2;RPA2;LIG4;POLE;RFC4;POLD4;RFC2;RPA3;POLK;RFC5
prerank,response to steroid hormone (GO:0048545),0.3163001645355589,0.7807847315219132,0.7596899224806202,0.9215229854888961,1.0,6/31,14.47%,YAP1;ABCA2;TGFB3;UBE2L3;TGFB2;CATSPER3
prerank,insulin receptor signaling pathway (GO:0008286),0.2770144669983387,0.7802603764872189,0.7961275626423691,0.9219325203186864,1.0,12/69,13.35%,SLC39A14;IRS1;BAIAP2;AP3S1;SH2B2;GRB2;PTPN2;ATP6V1F;GSK3B;ATP6V1H;PIK3R1;ATP6V1G2
prerank,phagolysosome assembly (GO:0001845),0.37343885833787693,0.7801420113410455,0.7313664596273292,0.9217030940910607,1.0,3/12,13.84%,RAB7A;RAB7B;RAB34
prerank,response to copper ion (GO:0046688),-0.26248215173052286,-0.780028117017485,0.8127208480565371,0.9506503738503983,1.0,14/20,45.67%,MT2A;ATP5F1D;HSF1;ATP7B;AQP1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;SNCA
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.364308653705916,0.7799473883129997,0.7252252252252253,0.9215804610620194,1.0,3/13,7.90%,CACNA1C;KCNA5;GJC1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.27614962276261634,-0.7798691945216988,0.7837837837837838,0.9495723141748207,1.0,8/17,24.49%,SFPQ;HSPB1;SOD1;SOD2;NME5;PPIA;HTRA2;MAPK7
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2925709943111136,0.779476645538903,0.773109243697479,0.9218951201211288,1.0,4/44,9.82%,CYP7B1;INSIG2;SLC27A2;OSBPL3
prerank,negative regulation of neuron death (GO:1901215),0.2710095530006736,0.7793610341017994,0.8298800436205016,0.9216811493416887,1.0,26/93,22.97%,LRRK2;APOE;CHMP4A;CHMP4B;MDK;BCL2;PTPRZ1;TGFB3;GPNMB;CCL2;FBXO7;UNC5B;GSK3B;TRAF2;CPEB4;RASA1;AKT1;ATF4;TYRO3;GDNF;EIF4G1;VPS35;CSF1;SNX6;FZD9;CD200R1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.27131884469326284,-0.7787078273732642,0.7896551724137931,0.9500874529025941,1.0,5/17,13.07%,NTRK2;RTN1;SORL1;IGF1;ABCA7
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.3153604930880187,0.7786390987973391,0.7572944297082228,0.9223086119428742,1.0,9/26,20.32%,SNAI2;BCL2;TERT;FGFR1;UNC5B;TNF;AKT1;INHBA;GDNF
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3089497027484401,0.7786037589388424,0.7448453608247423,0.9219785433715167,1.0,7/32,18.59%,BACH1;E2F1;CDK14;BRD4;CDK16;FBXO5;HINFP
prerank,oligosaccharide biosynthetic process (GO:0009312),0.33622385425505813,0.7784575925913433,0.7493150684931507,0.9218131590735777,1.0,2/20,5.12%,B4GALNT2;ST3GAL3
prerank,atrial septum development (GO:0003283),-0.29576908865956997,-0.7783551327172487,0.7846153846153846,0.9493250377506446,1.0,4/13,18.68%,ANK2;MDM4;HEY2;ZFPM1
prerank,negative regulation of histone methylation (GO:0031061),0.3761199764540168,0.7782306157027172,0.7309562398703403,0.9217416421187703,1.0,3/10,19.43%,PHF1;DNMT3B;KDM1A
prerank,histone H2A monoubiquitination (GO:0035518),-0.2719621692620393,-0.7779005585847265,0.7647058823529411,0.948690363807908,1.0,2/17,1.99%,PCGF5;TRIM37
prerank,protein depolymerization (GO:0051261),-0.2441214354439867,-0.7774042079321669,0.8089887640449438,0.9481358598049263,1.0,11/27,25.67%,GSN;MICAL3;TWF2;STMN2;STMN3;MICAL1;CFL1;TWF1;KIF18A;STMN1;WDR1
prerank,positive regulation of dendrite extension (GO:1903861),-0.27306641503514095,-0.7763433001188214,0.805921052631579,0.9484831274102691,1.0,8/17,28.12%,ITSN2;RIMS1;RNF157;RIMS2;SYT3;NEDD4L;CPNE9;CPNE5
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3317589733493679,0.7763257699774774,0.7621023513139695,0.9240738439005616,1.0,6/21,12.46%,NCK1;PTEN;NCK2;RASSF2;CNKSR3;NLRP2B
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2986355598513862,-0.7762788243588035,0.7792207792207793,0.9472608047503195,1.0,4/14,14.60%,PAICS;ATIC;ADK;RFK
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2920824855425514,0.7760766430472106,0.7662178702570379,0.9240476537130307,1.0,12/42,20.23%,ACTR2;SHLD3;SETD2;FBH1;PPP4R2;TIMELESS;RIF1;PPP4C;MMS19;CGAS;KDM1A;ARID2
prerank,negative regulation of RNA splicing (GO:0033119),0.3353106975670659,0.7755584010237665,0.7397454031117398,0.9243858728194029,1.0,5/19,15.90%,PTBP3;SAP18;SFSWAP;SRSF12;RBMX
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.31154127971330875,0.7753331161343088,0.7431551499348109,0.9243129971611136,1.0,4/30,7.90%,CACNA2D1;CACNA1C;KCNA5;GJC1
prerank,tRNA wobble base modification (GO:0002097),-0.2877463737650924,-0.7752806496862542,0.7709677419354839,0.947541972458397,1.0,2/14,4.38%,ALKBH8;TRMT9B
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.32773512673200594,0.7750887709961949,0.7647849462365591,0.9242603152671119,1.0,4/23,10.06%,DICER1;SETMAR;FBH1;HMGB2
prerank,negative regulation of defense response to virus (GO:0050687),0.37434398017357373,0.7746144007675302,0.7252396166134185,0.9245418465918599,1.0,2/10,15.59%,ILRUN;ITCH
prerank,regulation of protein ubiquitination (GO:0031396),0.2701208852535577,0.7745534556936107,0.8328042328042328,0.9242518961921253,1.0,14/108,9.70%,LRRK2;MYCBP2;TNFAIP3;BIRC3;PRICKLE1;NXN;PINX1;SASH1;ANGPT1;DCUN1D1;FBXW7;TGFBR1;OGT;UBE2L3
prerank,regulation of dendrite extension (GO:1903859),-0.2674567505293489,-0.7744228845973584,0.7922535211267606,0.9474988537160849,1.0,8/18,28.12%,ITSN2;RIMS1;RNF157;RIMS2;SYT3;NEDD4L;CPNE9;CPNE5
prerank,purine-containing compound catabolic process (GO:0072523),0.3621925385823894,0.7743729941315821,0.725925925925926,0.9241163538349785,1.0,4/13,18.52%,GDA;DPYD;NT5C1A;XDH
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.30649001350661653,-0.7742054567081631,0.7527777777777778,0.9465100534064931,1.0,3/12,11.90%,GCLC;HAGH;CHAC2
prerank,positive regulation of DNA binding (GO:0043388),0.3043605544298479,0.7737538704687261,0.7569620253164557,0.924632946352589,1.0,4/31,10.06%,EGF;PPARG;PINX1;HMGB2
prerank,regulation of centriole replication (GO:0046599),0.3398343130271363,0.7737235155400517,0.7430249632892805,0.924295176243915,1.0,2/17,5.80%,CEP295NL;ALMS1
prerank,regulation of secretion by cell (GO:1903530),0.28310015685911183,0.7735754074601506,0.794392523364486,0.9241313296883633,1.0,11/54,16.28%,DNAJC1;RALA;RAB21;LLGL1;RAB8B;KCNMB4;ANXA1;HCRT;RAB10;FMR1;MCTP2
prerank,glutathione biosynthetic process (GO:0006750),-0.3109484879681409,-0.7735617916674606,0.7702702702702703,0.9462249186092471,1.0,3/11,11.90%,GCLC;HAGH;CHAC2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2918176150008534,0.7732106424092449,0.7723880597014925,0.9242562132428696,1.0,10/39,16.47%,PIP4K2A;PI4K2B;ITPKC;TTC7A;IP6K2;SOCS5;PI4KA;PIK3R1;EFR3A;PIK3C3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3246058962580105,0.7723083973434367,0.7780748663101604,0.9252096368913245,1.0,2/23,3.02%,SLC9A1;SLC12A4
prerank,carboxylic acid transmembrane transport (GO:1905039),0.2947593675558387,0.7722692535826184,0.7710396039603961,0.9248872283711009,1.0,10/40,21.44%,SLC38A3;SLC7A7;SLC38A4;SLC36A2;SLC7A8;ABCC1;SLC25A10;SLC19A1;SLC36A4;SLC25A21
prerank,glycerolipid metabolic process (GO:0046486),0.3621342039590817,0.7721177914750489,0.7381316998468607,0.9247330157756012,1.0,1/11,1.24%,PDXP
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.31921984677658616,0.7718095164431268,0.7577464788732394,0.924789802745432,1.0,5/24,15.59%,TNFAIP3;NOD1;IRAK2;CASP8;ITCH
prerank,cellular response to amino acid starvation (GO:0034198),0.2727953616838729,0.7714538961580787,0.8155555555555556,0.9248987184152375,1.0,19/71,18.35%,DAP;MIOS;NPRL2;EIF2AK2;RPTOR;RRAGC;KPTN;ATP6V1F;ATP6V1H;ATP6V1G2;LAMTOR5;ATP6V1G1;SEC13;SH3GLB1;MAPK1;ATP6V1D;EIF2AK3;ATF4;LAMTOR3
prerank,positive regulation of DNA recombination (GO:0045911),0.311025783365906,0.7709238615533446,0.7467700258397932,0.9252570488688948,1.0,9/27,20.29%,ACTR2;SHLD3;TIMELESS;RIF1;MMS19;PAXIP1;HMCES;ARID2;ERCC2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.31760062721877735,0.7708973004237454,0.7537826685006878,0.9249144259723577,1.0,10/24,26.49%,DNAAF4;APOE;CTSC;PSMD14;TMF1;LATS1;USP14;ATP5IF1;RHBDF1;EFNA1
prerank,protein stabilization (GO:0050821),0.25809533701327403,0.7708129619678442,0.8727087576374746,0.9246550437364108,1.0,35/168,17.09%,FLOT2;USP9X;PARVA;BAG3;PTEN;MORC3;RAB21;LAMP2;BAG6;RASSF2;FBXW7;CCT8;TBL1X;CDC37;OTUD3;SEC16A;GAPDH;TRIM44;PEX19;ZBED3;CALR;CDK7;PIK3R1;CCT3;COA8;RPL11;PDCD10;NAA15;MTMR9;COG7;STK4;ATF7IP;BAG4;PEX6;HSPD1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.3140779994457451,-0.7707243995009992,0.7576601671309192,0.9493600684003114,1.0,3/11,10.52%,FOLH1;ATG12;GPLD1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2150745450091652,-0.770638237906506,0.8602150537634409,0.9481505773435903,1.0,16/40,31.73%,PRKN;TNFSF10;BCL2L1;IGF1;PINK1;BNIP3;DNM1L;GPER1;BID;TP53;PPIF;MFF;PSMD10;BIK;PDCD5;OPA1
prerank,phagosome maturation (GO:0090382),0.29862017121212314,0.7704139988482055,0.7723270440251573,0.9248138430695726,1.0,8/35,17.43%,RAB7A;RAB32;ATP6V1F;ATP6V1H;ATP6V1G2;RAB34;ATP6V1G1;ATP6V1D
prerank,RNA processing (GO:0006396),0.2535715449426778,0.7699738720964586,0.8830769230769231,0.9250404105726409,1.0,38/176,21.08%,RBMS1;PPP1R9B;APOBEC1;TSEN2;ATXN1;SYNCRIP;SNRNP40;DDX17;CCAR2;PABPC4;CELF1;RRAGC;NONO;DICER1;DHX8;ALKBH5;NCBP2;PRPF18;SNRNP35;ZCCHC8;RNPC3;RBM6;SETX;HNRNPUL1;DHX15;TCERG1;TUT7;PRPF3;DDX20;RBM39;SRSF2;SON;SNRPB;DUSP11;TENT4A;RBMS2;SCAF11;CDK12
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3222812126231299,0.7695762877469428,0.7621621621621621,0.9251860156620743,1.0,3/22,6.21%,NR2F2;PTEN;PLK1
prerank,positive regulation of axonogenesis (GO:0050772),0.2911491919846742,0.7695691421308776,0.8014268727705113,0.9248187306586241,1.0,8/43,11.96%,ROBO2;PLXNC1;PLXND1;L1CAM;PLXNA3;DBN1;DBNL;RHOA
prerank,protein glycosylation (GO:0006486),0.25914267200408003,0.7692792334786124,0.8633993743482794,0.9248411592588045,1.0,21/125,16.66%,MGAT5;PLOD2;B4GALT5;GFPT2;TRAK1;ST3GAL3;DDOST;ALG5;OGT;MAN1C1;MGAT4A;STT3A;ST3GAL1;GCNT2;TET2;TUSC3;PMM2;B4GALT7;RPN1;COG7;B3GNT9
prerank,protein maturation (GO:0051604),0.2658388215760352,0.7688218794923103,0.834941050375134,0.9251051911271616,1.0,20/95,21.31%,MMP14;ADAM19;NAA50;CTSS;CPXM1;MMP16;OGT;LMF2;PSEN1;XPNPEP3;MMS19;NAA15;PSENEN;TSPAN14;HSPD1;AANAT;PHEX;NCSTN;PITRM1;PSEN2
prerank,myelination (GO:0042552),0.29036517614133966,0.7684177914089877,0.8011764705882353,0.9253070684697017,1.0,4/46,5.10%,TNFRSF21;B4GALT5;PMP22;NF1
prerank,protein localization to vacuole (GO:0072665),-0.29139527038923374,-0.7682298522636584,0.7873563218390804,0.9505273448448922,1.0,3/13,11.55%,CD81;LMBRD1;RNF128
prerank,steroid biosynthetic process (GO:0006694),0.2798355353374903,0.7680985391618796,0.8222222222222222,0.9253916011504685,1.0,5/56,9.82%,CYP7B1;INSIG2;SLC27A2;HSD11B1;OSBPL3
prerank,tRNA processing (GO:0008033),-0.19333567466505522,-0.7675398851345364,0.9568965517241379,0.9501738099532949,1.0,19/61,21.28%,RTCB;TRMT9B;CSTF2;DTWD2;TYW5;ELP5;FAM98B;TRDMT1;QTRT1;NSUN6;TRMT10A;LCMT2;PTCD1;CDKAL1;POP5;SARS1;TRMT10B;ADAT1;CLP1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3059510075406355,0.7675395207083712,0.7801778907242694,0.9253802654081512,1.0,13/31,24.54%,GTF2H1;GTF2F2;NCBP2;RAMAC;CDK7;GTF2F1;POLR2L;POLR2K;ERCC2;CCNH;POLR2D;MNAT1;RNMT
prerank,7-methylguanosine RNA capping (GO:0009452),0.3059510075406355,0.7675395207083712,0.7801778907242694,0.9253802654081512,1.0,13/31,24.54%,GTF2H1;GTF2F2;NCBP2;RAMAC;CDK7;GTF2F1;POLR2L;POLR2K;ERCC2;CCNH;POLR2D;MNAT1;RNMT
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.36121587118588083,0.7674452756688742,0.7253731343283583,0.9251475845460357,1.0,2/12,11.80%,ASXL1;CALR
prerank,acyl-CoA metabolic process (GO:0006637),0.2957702267350517,0.767218553743096,0.770935960591133,0.9250897481502393,1.0,8/35,18.59%,DLST;ACSF2;SUCLG2;ACOT13;ACOT9;SUCLA2;MCEE;ACACA
prerank,chromatin assembly or disassembly (GO:0006333),0.3687937434953769,0.7671334886367097,0.7563909774436091,0.9248271016607695,1.0,2/11,9.89%,NOC2L;MTA2
prerank,negative regulation of neuron differentiation (GO:0045665),0.31479618867134296,0.7662387408028303,0.7572178477690289,0.925664395484271,1.0,6/22,19.61%,NEPRO;CALR;GSK3B;BMP7;SOX2;MED1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.35011492253151427,0.7653330308091392,0.7414561664190193,0.9265184131068518,1.0,4/14,15.90%,SAP18;SFSWAP;SRSF12;RBMX
prerank,ribosomal subunit export from nucleus (GO:0000054),0.3571693749240014,0.7653036983930118,0.7290715372907154,0.9261801250328987,1.0,2/13,7.77%,ABCE1;NMD3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2780539784923929,0.7652478108667087,0.8043478260869565,0.9258876531063721,1.0,6/54,7.75%,TNKS1BP1;E2F1;CNOT4;ATM;E2F8;CARM1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3027641601642707,-0.7646934452890315,0.8011695906432749,0.9531588064403235,1.0,2/12,10.22%,CENPC;SEH1L
prerank,negative regulation of protein kinase activity (GO:0006469),0.2653512634924964,0.7643962428782008,0.8250539956803455,0.9266619110082819,1.0,25/88,19.84%,SPRED1;NF1;TAF7;DTNBP1;LRP6;EPHA1;PTPN1;GSKIP;PYDC1;MVP;WWTR1;DUSP26;UBASH3B;SMCR8;SH3BP5L;TRIB3;CDKN1B;TRIB1;RTRAF;ITGB1BP1;PTPRC;AKT1;LRP5;GADD45A;CORO1C
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3245655816885495,0.7642684597978274,0.7764060356652949,0.9264683510871254,1.0,1/19,3.78%,APOE
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.30414127074837044,0.7641196405842673,0.771838331160365,0.9262881803304774,1.0,9/32,19.69%,ATM;ATR;CCT8;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB
prerank,response to amino acid starvation (GO:1990928),0.269657693441104,0.7640004846859363,0.8213096559378469,0.9260767408705831,1.0,19/72,18.35%,DAP;MIOS;NPRL2;EIF2AK2;RPTOR;RRAGC;KPTN;ATP6V1F;ATP6V1H;ATP6V1G2;LAMTOR5;ATP6V1G1;SEC13;SH3GLB1;MAPK1;ATP6V1D;EIF2AK3;ATF4;LAMTOR3
prerank,macromolecule catabolic process (GO:0009057),0.3160090279954904,0.7639307577925777,0.7661290322580645,0.925803908413599,1.0,12/26,28.88%,CLN6;KIF16B;PIK3R4;SNX25;SMURF1;NEDD4;SH3GLB1;BECN1;CLN5;CLPX;PPT1;SIAH1
prerank,response to nutrient levels (GO:0031667),0.3370217256123246,0.7639061322203454,0.7396280400572246,0.9254619101361653,1.0,5/17,20.36%,CD68;RPTOR;RPS6KB1;ATF4;EIF4G1
prerank,negative regulation of metabolic process (GO:0009892),0.27690144305460224,0.7636276538966424,0.808584686774942,0.9254905122433954,1.0,6/54,10.88%,ADIPOQ;LAMA4;ADAMTS5;ARRDC3;PLCL1;ACOT13
prerank,regulation of response to oxidative stress (GO:1902882),-0.3063731652803091,-0.7630519451019275,0.7828571428571428,0.9543303269388932,1.0,2/11,2.89%,PRKN;MCTP1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3654511854116256,0.7628359077592353,0.7447154471544716,0.9261967127168954,1.0,3/11,12.48%,ITPKC;IP6K2;FGF2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2900258558057991,-0.7627448273133635,0.7754491017964071,0.9534815875159978,1.0,2/14,7.23%,ME1;NMNAT3
prerank,tRNA metabolic process (GO:0006399),0.33505328728675615,0.76225126915467,0.7574468085106383,0.9266251336103494,1.0,3/17,10.05%,TRPT1;POP1;DTD1
prerank,regulation of fibroblast migration (GO:0010762),0.31930995497017495,0.7614785352744743,0.7453083109919572,0.9272754640151623,1.0,7/20,19.84%,DDR2;PTK2;FGF2;RAC1;ITGB1BP1;GNA12;CORO1C
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.31861127610989587,0.7612693084804917,0.7639836289222374,0.927213432915613,1.0,3/23,4.89%,MYO10;KIF1C;HOOK2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3428579155036603,0.7611856358414106,0.7565982404692082,0.9269491525054799,1.0,5/16,23.20%,MCM2;MCM7;TWNK;RPA1;RAD51
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.367605554884033,0.7606115581057534,0.725705329153605,0.9273316878680948,1.0,3/10,19.94%,IRS1;AKT1;PTH1R
prerank,positive regulation of nervous system process (GO:0031646),0.32848842002297574,0.760520229941415,0.7606837606837606,0.9270885686003917,1.0,6/18,17.61%,TENM4;HCRT;DICER1;EGR2;TPPP;NCMAP
prerank,response to organophosphorus (GO:0046683),0.3453844908642514,0.7586070900818151,0.7704918032786885,0.9292682465467994,1.0,2/16,12.90%,STAT1;P2RX7
prerank,vesicle organization (GO:0016050),0.28679189037759795,0.7584286036544068,0.8023952095808383,0.9291454807465253,1.0,15/46,20.02%,ARFGEF2;HOOK2;PI4K2B;DNAJC13;WASHC4;SNX33;PLEKHF1;SNX10;EPS15;CHMP2B;SQSTM1;ALS2;ZFYVE16;HOOK1;WASHC5
prerank,peptide metabolic process (GO:0006518),0.2696700273055574,0.7579755563300571,0.8249721293199554,0.9293920587225653,1.0,11/75,13.92%,DNPEP;ANPEP;CPQ;CPXM1;NPEPPS;ENPEP;NLN;GSTK1;SPPL3;LVRN;PSEN1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.3145328549428023,-0.7577138931963262,0.7648514851485149,0.9595697663421521,1.0,5/11,13.07%,ITM2A;BACE2;NECAB1;ITM2C;ABCA7
prerank,negative regulation of neuron projection development (GO:0010977),0.2795779715223596,0.7569013814705183,0.8091428571428572,0.9304580132735809,1.0,9/56,13.48%,MYLIP;DPYSL3;APOE;PTEN;GAK;PTPN9;DENND5A;RHOA;RTN4RL1
prerank,lung epithelium development (GO:0060428),0.37073649879077475,0.7568161348775894,0.757527733755943,0.9302030326269207,1.0,2/10,11.52%,ERRFI1;RCN3
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3576499176174394,0.7568049192824112,0.7472,0.929843120274483,1.0,1/11,4.11%,PADI2
prerank,long-chain fatty acid import into cell (GO:0044539),0.37442191200824493,0.7567799795617516,0.7570093457943925,0.9295056654815085,1.0,3/10,9.84%,CD36;SLC27A2;RPS6KB1
prerank,regulation of supramolecular fiber organization (GO:1902903),0.31730032059166646,0.7567177133947459,0.7661064425770309,0.9292119799243088,1.0,4/22,12.60%,APOE;MAP1S;CAMSAP2;AKAP13
prerank,histone modification (GO:0016570),0.2590082244226767,0.7562917265975907,0.8588235294117647,0.9294378376985931,1.0,25/109,19.11%,RCOR1;MIER2;PADI2;NAA50;PRDM5;CREBBP;EHMT1;CARM1;HDAC1;TBL1X;MTA2;USP3;RUVBL1;NSD3;USP22;BAZ2A;NSD1;MTA3;PHF20;RCOR2;MAP3K12;USP36;HDAC5;KAT6B;BRMS1L
prerank,protein export from nucleus (GO:0006611),-0.24035236102995,-0.7559967563033719,0.8491379310344828,0.9607212550096859,1.0,9/27,25.07%,RANBP3L;DESI1;STRADB;CSE1L;XPO5;DUSP16;XPO6;NUTF2;XPO4
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.29847127219164954,0.7555045158333686,0.7727873183619551,0.930114138187327,1.0,5/30,14.06%,JAK2;GRB2;ERBIN;VAV1;SRC
prerank,mitochondrial fusion (GO:0008053),0.3330945279080986,0.7553419397799908,0.770745428973277,0.9299566376301963,1.0,3/18,12.77%,STOML2;MIGA2;SPG7
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.36377256690139775,0.7548649897134598,0.7183734939759037,0.930209784886636,1.0,2/11,16.22%,RTP4;PKD1L3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.31689506602716294,0.7548217947632758,0.7704918032786885,0.9298897857021866,1.0,7/23,20.32%,MDK;EGF;FGF2;SMO;PAX8;AGT;GDNF
prerank,central nervous system neuron development (GO:0021954),0.3435174350742056,0.754783856520136,0.740029542097489,0.9295671773106083,1.0,6/15,18.03%,B4GALT5;PTEN;ARHGAP35;NPY;LHX6;ATP7A
prerank,small GTPase mediated signal transduction (GO:0007264),0.25836895123140213,0.7544463470006497,0.8683651804670913,0.9296614029661036,1.0,22/103,16.29%,RASSF1;ARHGAP32;PLD1;NF1;NUCB2;RAB42;RALA;SIAH2;MAPK11;GRB2;RRAGC;BRAP;RERG;SETDB1;RALGDS;RIT1;RIN2;FGF2;ARHGEF18;RAC1;USP28;RGL1
prerank,protein modification process (GO:0036211),0.26687699071529947,0.7530028512036893,0.8504464285714286,0.9311626716187852,1.0,22/76,22.02%,PLOD2;PLAT;ATG3;UBE2L3;ST3GAL1;PPP4R2;PHKA2;MMP15;ADPRH;FBXO2;RABGGTB;B4GALT7;RPN1;PRKDC;PIGH;YES1;PHEX;UBL5;PARP4;USP25;FBXO22;UBE2L6
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3240367091154697,0.7526579632140799,0.7884615384615384,0.9308832722183021,1.0,6/20,15.68%,ARNT;PFKFB4;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,positive regulation of glycolytic process (GO:0045821),0.3240367091154697,0.7526579632140799,0.7884615384615384,0.9308832722183021,1.0,6/20,15.68%,ARNT;PFKFB4;ZBTB20;P2RX7;PSEN1;HIF1A
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.22913267933432518,-0.7522234195726161,0.8820960698689956,0.9646654533635829,1.0,14/29,28.70%,ERCC5;ERCC3;UBC;CHD1L;DDB2;GTF2H2;GTF2H4;UBA52;GTF2H3;CETN2;RBX1;RPA2;PARP1;XPC
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3472247746854603,0.7518607793419326,0.7720125786163522,0.9315921053758047,1.0,6/13,31.30%,SRD5A3;ALG11;ALG14;DPAGT1;ALG2;ALG8
prerank,programmed necrotic cell death (GO:0097300),0.3286254367338416,0.7512682926152079,0.7595870206489675,0.9320059212108928,1.0,4/18,15.12%,LY96;CD14;MLKL;RIPK1
prerank,regulation of dendrite development (GO:0050773),0.2904805015282449,0.7510838436010924,0.7946428571428571,0.9318801359524397,1.0,10/37,15.60%,PTN;MARK1;RAP2A;SDC2;BMP5;DBN1;CAMSAP2;GSK3B;BMP7;NEDD4
prerank,negative regulation of cellular component movement (GO:0051271),0.33692432064962335,0.750745171498555,0.7421758569299552,0.9319515469985189,1.0,2/15,8.93%,FBLN1;SP100
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.27841375658400813,0.7507358091084338,0.8232445520581114,0.9312159256286225,1.0,15/50,20.96%,NUP37;PUM1;RAE1;NUP153;FMR1;NDC1;NUP35;NUP188;SEC13;POLR2L;POLR2K;NUP214;AGO2;EIF4G1;NUP107
prerank,regulation of gene silencing by RNA (GO:0060966),0.27841375658400813,0.7507358091084338,0.8232445520581114,0.9312159256286225,1.0,15/50,20.96%,NUP37;PUM1;RAE1;NUP153;FMR1;NDC1;NUP35;NUP188;SEC13;POLR2L;POLR2K;NUP214;AGO2;EIF4G1;NUP107
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3656013145445632,0.7499111701773453,0.7698412698412699,0.9319208917587561,1.0,2/10,11.25%,ERLEC1;UBE2J1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3100831614189503,-0.749848035537733,0.8053333333333333,0.9667243004355572,1.0,1/10,1.76%,BMP4
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3224760462445295,0.7488550283260169,0.7902298850574713,0.9329361534304699,1.0,3/19,10.07%,EDN3;HRH1;PPP3CA
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.3523627637828724,0.7486518700054884,0.7524271844660194,0.9321019079937582,1.0,3/12,13.21%,ANAPC11;CDC27;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.3523627637828724,0.7486518700054884,0.7524271844660194,0.9321019079937582,1.0,3/12,13.21%,ANAPC11;CDC27;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.3523627637828724,0.7486518700054884,0.7524271844660194,0.9321019079937582,1.0,3/12,13.21%,ANAPC11;CDC27;NSMCE2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2969043549722161,0.7486457151108125,0.8012903225806451,0.9317361362794588,1.0,6/33,10.36%,CDKN2B;PTEN;PKD2;CDK6;GPNMB;CCL2
prerank,pore complex assembly (GO:0046931),-0.25717144034662487,-0.7485345554452588,0.8053691275167785,0.967222840142653,1.0,7/19,22.48%,PLEKHA7;ADAM10;TMEM170A;GSDMD;AFDN;NUP98;NUP93
prerank,negative regulation of protein modification process (GO:0031400),0.2622279977726512,0.74779688484961,0.8445652173913043,0.9324745868250627,1.0,23/79,21.21%,FBLN1;LRRK2;PTPN13;PTEN;LRP6;PID1;NIBAN1;WWTR1;IBTK;ZBED3;GSK3B;NTRK3;XRCC1;PRKDC;PNKP;PTPA;TPPP;MFHAS1;XDH;PRNP;CORO1C;ZC3H12A;SIRPA
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2123417125471297,-0.7472199718931574,0.9209039548022598,0.9676423901927905,1.0,10/38,23.03%,PRPF6;GEMIN2;SNRPC;SNRPG;PRPF19;SART1;SNRPD3;PRPF8;AAR2;SNUPN
prerank,diol biosynthetic process (GO:0034312),-0.26970217670901336,-0.7472112503498556,0.874251497005988,0.9663349862541827,1.0,3/15,5.15%,ACER2;SPTLC2;SPTLC1
prerank,peroxisomal membrane transport (GO:0015919),0.30236795199831024,0.746992349986572,0.8058902275769746,0.9331364451074278,1.0,6/27,19.40%,PEX10;RAB8B;PEX19;ALDH3A2;PEX6;PEX12
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.2950216711710859,0.746970650240022,0.7966963151207116,0.932795075222607,1.0,4/31,5.97%,TNN;SUFU;CDK6;PPARG
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.2730730084525474,-0.7463167681690142,0.8162650602409639,0.9662659934989335,1.0,2/16,2.73%,SOX13;HNRNPU
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3035336500678242,-0.7460820286698481,0.7861111111111111,0.9652643907715535,1.0,3/10,14.38%,HOMER2;SLC8B1;STIM1
prerank,regulation of organelle organization (GO:0033043),0.25755343817662035,0.7459335586456943,0.852017937219731,0.9338684914551475,1.0,15/80,17.54%,ZEB2;TAOK1;SYDE1;MYO5A;CAPN2;MSN;LMAN1;PTK2;CAMSAP2;AKAP9;PDCD10;SQSTM1;ARMH3;MAPK1;RAB33B
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.33764306755741946,0.7458094207265255,0.7866666666666666,0.9336704052623078,1.0,3/14,10.47%,NCK1;PPP3CA;PPP2R2A
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.2856955067794611,0.7455309344443608,0.8226190476190476,0.9336420995857707,1.0,10/41,18.91%,IL34;EGF;DLG4;PTPN1;FBXW7;BTC;SRC;FCGR1A;AGT;PRNP
prerank,phagosome acidification (GO:0090383),0.29770279377013403,0.7452846819875917,0.7967914438502673,0.9335975909434849,1.0,6/26,17.43%,RAB7A;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1G1;ATP6V1D
prerank,nucleoside catabolic process (GO:0009164),-0.30558932735176636,-0.7449627632271569,0.7942857142857143,0.9655273789868724,1.0,5/11,18.00%,NT5E;UPB1;NT5C3A;DERA;NT5C
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.25602556783669866,-0.744684112957116,0.8532423208191127,0.9645838463052154,1.0,5/19,20.48%,MAOB;CAT;SOD1;PRDX2;NOX1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.30336364314878167,0.7444782178226077,0.7708609271523179,0.934276079587188,1.0,5/25,14.52%,OPHN1;CSNK2A1;CSNK2A2;PSMF1;RPL11
prerank,brain morphogenesis (GO:0048854),0.3470216625006579,0.7443144198151272,0.7507552870090635,0.9341194880615143,1.0,3/12,12.26%,PTEN;SPEF2;FBXW11
prerank,pharyngeal system development (GO:0060037),0.33741196988783384,0.7441125355125291,0.7709251101321586,0.934005561830644,1.0,8/15,28.12%,TGFBR1;BMP5;TGFB2;BMP7;BMPR1A;BMPR2;HES1;PTCH1
prerank,intracellular pH reduction (GO:0051452),-0.2213316165123673,-0.7440303161366756,0.8878923766816144,0.9642058279701498,1.0,10/33,21.98%,DMXL2;GPR89B;GPR89A;CLCN3;ATP6V1B2;ATP6V1E1;ATP6V0B;DMXL1;ATP6V0E2;ATP6V0D1
prerank,regulation of protein modification process (GO:0031399),0.2739720491335412,0.7428139662600962,0.8212157330154947,0.9353294506558356,1.0,14/50,20.52%,SPRED1;ABCA2;SPRED2;CCAR2;FNIP1;PTK2;ATG7;PPP1R16A;PLXNB2;CDK9;STAT2;CORO1C;PIN1;NDUFS4
prerank,negative regulation of translational initiation (GO:0045947),0.3378439304397212,0.742668214657446,0.7691176470588236,0.9351410509817731,1.0,4/13,22.81%,EIF4EBP1;FMR1;AGO2;EIF3E
prerank,superoxide metabolic process (GO:0006801),0.29856544114088573,0.7425755071169096,0.8085381630012937,0.9348868389829186,1.0,5/29,19.23%,SH3PXD2B;PREX1;NRROS;ATP7A;CYBB
prerank,organelle fusion (GO:0048284),-0.2491604213792647,-0.7423103357073021,0.8703703703703703,0.9652116320937786,1.0,5/22,14.58%,MIGA1;VPS11;MFN1;USP30;GDAP1
prerank,response to light stimulus (GO:0009416),-0.18966395397347535,-0.7417922154007669,0.9366197183098591,0.9646449633573374,1.0,14/55,19.93%,ERCC5;UBE2A;CIRBP;ERCC6;ERCC3;UBE2B;UVSSA;USP1;DDB2;MAPK10;GTF2H2;TRIM32;CRY2;DRD2
prerank,N-terminal protein amino acid modification (GO:0031365),0.34404037352126204,0.7416378908934502,0.7856071964017991,0.9357019532041648,1.0,5/14,27.13%,NAA50;NAA15;AANAT;METAP1;METAP1D
prerank,positive regulation of TORC1 signaling (GO:1904263),0.3311362313451901,0.740805665743868,0.7847919655667145,0.9364052255505815,1.0,6/16,21.25%,KLHL22;LAMTOR5;GPR137;SIK3;TELO2;CLEC16A
prerank,error-prone translesion synthesis (GO:0042276),-0.24680881936417026,-0.7406343743537974,0.8546712802768166,0.9648755848093021,1.0,13/21,35.18%,UBC;PCNA;RFC3;UBA52;POLH;RPA2;PRIMPOL;POLE2;RFC4;RFC2;RPA3;POLK;RFC5
prerank,intracellular protein transmembrane transport (GO:0065002),0.2796207754527491,0.7405050238106311,0.8019441069258809,0.9364377913872587,1.0,13/42,19.53%,PEX10;SEC63;TIMM17A;SEC61A1;HSPA5;SEC61A2;TIMM50;AIFM1;PEX6;HSPD1;PEX12;TIMM23;TOMM40L
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2951824131001988,0.7404986335224163,0.8022813688212928,0.9360768042543228,1.0,8/32,17.53%,LRRK2;DTNBP1;KCNMB4;HCRT;GSK3B;FMR1;MCTP2;STX1B
prerank,mesoderm development (GO:0007498),0.32338799876394947,0.7403792818277328,0.7972602739726027,0.9358497842353867,1.0,3/18,10.21%,JAK2;MEST;TBX3
prerank,regulation of telomere maintenance (GO:0032204),-0.2366265831651974,-0.7388100478754158,0.8836206896551724,0.9661136962929621,1.0,7/26,18.27%,MRE11;PPP1R10;RTEL1;UPF1;USP7;ERCC1;DHX36
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.30470281480284356,-0.7387528653308261,0.8171428571428572,0.9648898869432802,1.0,4/10,15.17%,GALNT13;POGLUT1;POGLUT2;GALNT1
prerank,protein import into peroxisome matrix (GO:0016558),0.34571916775978084,0.7387124171891536,0.8,0.9376370666785605,1.0,1/12,2.13%,PEX10
prerank,nucleocytoplasmic transport (GO:0006913),0.2799919315809198,0.7379893651505243,0.8166259168704156,0.9381771682118312,1.0,9/40,20.95%,ATXN1;NCBP2;ANP32A;SMN1;BACH2;DDX20;SNRPB;NEMF;XPO1
prerank,pentose-phosphate shunt (GO:0006098),-0.3000141385062786,-0.7372011162807323,0.7914285714285715,0.9655549650661922,1.0,8/11,33.95%,RPIA;SHPK;DERA;RBKS;PGD;PGLS;PGM2;RPE
prerank,protein tetramerization (GO:0051262),-0.18968520230853944,-0.7371727292242595,0.9351851851851852,0.9643101835601874,1.0,23/67,28.77%,KCNJ2;SAMHD1;UPB1;GRIN2B;ALDH9A1;GOLGA2;KCNJ12;GBP5;SSBP1;KCNC1;HCN1;SOD2;CBR4;GLS;USP16;APIP;KCNC3;CRYZ;PKD2L1;CTH;TRPA1;CBY1;HSD17B10
prerank,ganglion development (GO:0061548),0.35762852613326596,0.7370107612637999,0.7519500780031201,0.9390782843346678,1.0,1/11,3.11%,NRP1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.35777313966488694,0.7368391843481185,0.7492063492063492,0.9389306819216153,1.0,3/10,18.94%,IRAK3;PTPRC;TLE5
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.31231822708113316,0.736022645553473,0.8068493150684931,0.9392164294480975,1.0,5/21,12.29%,SNAI2;BCL2;TERT;UNC5B;TNF
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.31231822708113316,0.736022645553473,0.8068493150684931,0.9392164294480975,1.0,5/21,12.29%,SNAI2;BCL2;TERT;UNC5B;TNF
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.35724262277215096,0.735877053616231,0.7712,0.939039948546434,1.0,4/10,26.50%,IFT88;ADGRV1;PDZD7;PLS1
prerank,regulation of cell motility (GO:2000145),0.24797840057535875,0.735826525022341,0.8916929547844374,0.938737995730521,1.0,21/121,18.10%,FBLN1;SERPINE2;FGF7;PLXNC1;AMOTL1;EGFR;KIF2A;EGF;CDK6;PLXND1;PLXNA3;MEMO1;RHOA;FGF2;BTC;RAC1;FES;FGF18;AKT1;DOCK10;PLXNB2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2696135050786421,-0.7351127043048314,0.8071895424836601,0.9655961083937744,1.0,3/15,11.23%,TIPIN;MRE11;HUS1
prerank,ribosomal small subunit biogenesis (GO:0042274),0.2835461795406544,0.7341008441183438,0.8384332925336597,0.940546277592968,1.0,2/39,3.70%,RPSA;NOL11
prerank,positive regulation of histone acetylation (GO:0035066),0.3034365902212232,0.7340465481378322,0.800266311584554,0.9402491991621963,1.0,10/23,28.11%,TADA2B;GLYR1;SPHK2;SMAD4;PAXIP1;KAT7;RPS6KA4;TADA2A;PIH1D1;RUVBL2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.3303188349471722,0.7335203777532151,0.7950937950937951,0.9405736361198278,1.0,4/15,17.47%,TSEN2;TRPT1;RTRAF;DDX1
prerank,sulfur amino acid metabolic process (GO:0000096),0.30781184300430253,0.7331507525738699,0.7989130434782609,0.9406542265442879,1.0,5/24,19.82%,MTHFR;AHCY;ADI1;MTRR;CDO1
prerank,UV-damage excision repair (GO:0070914),0.3521030082476355,0.7329488548571828,0.7784615384615384,0.9405302334531253,1.0,3/12,17.41%,INO80;MC1R;DDB1
prerank,regulation of macrophage activation (GO:0043030),0.2949981829729639,0.732128695456883,0.8058510638297872,0.9411919648193348,1.0,8/30,22.65%,LBP;WNT5A;PJA2;HSPD1;MFHAS1;ZC3H12A;TNIP2;IL33
prerank,positive regulation of protein catabolic process (GO:0045732),0.25459828470383383,0.7320660048667403,0.8674698795180723,0.9408944133476292,1.0,19/84,15.60%,TNFAIP3;APOE;SMURF2;OAZ3;RAB7A;MSN;AREL1;WNT5A;CSNK2A1;SNX33;SNX9;ATG7;TNF;GSK3B;DACT1;CDKN1B;SMURF1;ITCH;NEDD4
prerank,tRNA methylation (GO:0030488),-0.2069820970817388,-0.7313408672314631,0.8978494623655914,0.9692230039779283,1.0,14/34,29.44%,ALKBH8;TRMT1L;TRDMT1;NSUN6;TRMT10A;LCMT2;TRMT5;TRMT44;METTL6;TYW3;TRMT12;TRMT112;HSD17B10;TRMO
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.3465077087539485,0.7312380005015326,0.7911908646003263,0.941541435153964,1.0,3/10,9.04%,SESTD1;CBARP;FKBP1B
prerank,centromere complex assembly (GO:0034508),0.28466285451349904,0.7308639813636206,0.8092783505154639,0.9416455579977225,1.0,5/36,11.47%,CENPQ;CENPN;RSF1;CENPL;RUVBL1
prerank,megakaryocyte differentiation (GO:0030219),0.3542939625542314,0.7307197324453878,0.775,0.94145886015535,1.0,2/11,10.90%,CDKN2B;UBA5
prerank,positive regulation of catabolic process (GO:0009896),0.26316192793195764,0.7307025406929936,0.8537142857142858,0.9411115631673921,1.0,15/65,15.60%,TNFAIP3;SMURF2;OAZ3;RAB7A;AREL1;WNT5A;CSNK2A1;ATG7;TNF;GSK3B;DACT1;CDKN1B;SMURF1;ITCH;NEDD4
prerank,glycoprotein catabolic process (GO:0006516),0.31887833474280564,0.7305890545030025,0.7976710334788938,0.940885551396543,1.0,4/17,13.80%,CTSL;ADAMTS12;ADAMTS9;FBXO2
prerank,gas transport (GO:0015669),-0.3055483680649636,-0.7304226317896185,0.8159340659340659,0.969102872450481,1.0,2/10,11.58%,CA2;IPCEF1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.22846876603229122,-0.7292061320538589,0.8991935483870968,0.9693872637759539,1.0,14/24,30.96%,CIAPIN1;GLRX3;NFU1;CIAO2A;HSPA9;NFS1;ISCA2;GLRX5;BOLA2;ISCU;NUBPL;ISCA1;CIAO2B;CIAO3
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3258246514659729,0.7290405654727178,0.7956204379562044,0.942406104568659,1.0,6/15,25.67%,PTPN2;YTHDF3;STAT2;ISG15;YTHDF2;CNOT7
prerank,positive regulation of insulin secretion (GO:0032024),0.28340777572043496,0.7279466296979972,0.8174019607843137,0.9433961495868336,1.0,6/36,15.09%,TCF7L2;BLK;ACSL4;GCK;TRPM4;DOC2B
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.3018446084479594,-0.7275086159659924,0.7961956521739131,0.9702024900267898,1.0,4/10,23.55%,KAT5;TFAP4;RPS6KA6;TP53
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.28391274195886207,-0.7272946590517095,0.8265582655826558,0.9691797731017137,1.0,3/11,22.05%,SOX6;MYOCD;MEF2C
prerank,modulation by host of viral genome replication (GO:0044827),0.3348756458899085,0.726991800322709,0.7877428998505231,0.9442181212569082,1.0,6/13,21.37%,VAPA;FMR1;TBC1D20;NUCKS1;ZC3H12A;IFI27
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.338708950320831,0.726872488721893,0.8054298642533937,0.9439840457202253,1.0,3/13,12.29%,TM9SF4;SNX33;TNF
prerank,regulation of transferase activity (GO:0051338),0.32417417546136273,0.7268394571143356,0.8125937031484258,0.9436553722382552,1.0,3/17,8.43%,ATM;PINX1;SMG6
prerank,DNA packaging (GO:0006323),-0.2553572250119762,-0.7265967450436401,0.8205980066445183,0.9687407438809139,1.0,7/16,27.64%,HAT1;CDAN1;KAT6A;TP53;BANF1;H1-0;CHAF1A
prerank,mRNA catabolic process (GO:0006402),0.2734161644049129,0.7265254582999482,0.8081683168316832,0.9436923403260553,1.0,10/44,17.80%,ZFP36L2;METTL16;EXOSC4;DCP2;RNH1;DHX34;XRN1;DXO;THRAP3;TUT7
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.29511650073508844,0.7264283166130051,0.7905405405405406,0.9434319713224459,1.0,5/25,15.67%,OMA1;BAG6;UGGT2;UBE2W;ZYG11B
prerank,regulation of mRNA polyadenylation (GO:1900363),0.32677400625976927,0.7263226399206105,0.781524926686217,0.9431977702415792,1.0,5/17,18.45%,CPEB1;ZC3H3;NCBP2;CCNT1;CDK9
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.34174103997577465,0.7258131750439367,0.7875968992248062,0.9430999192804429,1.0,3/12,18.91%,FHL2;GSK3B;PRNP
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.34174103997577465,0.7258131750439367,0.7875968992248062,0.9430999192804429,1.0,3/12,18.91%,FHL2;GSK3B;PRNP
prerank,erythrocyte development (GO:0048821),-0.2949772345354267,-0.7255927452749816,0.832,0.9686628745291268,1.0,4/10,21.32%,DMTN;ABCB10;ALAS1;NCKAP1L
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3220179086861764,0.7251556348646592,0.7919655667144907,0.9435635455724293,1.0,4/17,13.64%,SPRED1;SPRED2;SPRY2;CALM2
prerank,negative regulation of protein binding (GO:0032091),0.2622430428179301,0.7250591525759659,0.8632286995515696,0.9433081220830049,1.0,16/71,20.54%,ADIPOQ;LRRK2;DDX11;EFHB;ATP2A2;DISC1;GSK3B;GTF2F1;DACT1;ITGB1BP1;AKT1;TLE5;CTNNBIP1;KDM1A;PIN1;PRKCD
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3030673720418525,0.7245208245046423,0.809775429326288,0.9436206072353203,1.0,3/25,8.07%,EXT1;EXT2;HS2ST1
prerank,negative regulation of transferase activity (GO:0051348),0.2929842370622354,0.7241412715571853,0.8142493638676844,0.9437228302906713,1.0,7/28,18.54%,NPRL2;PINX1;GSK3B;SRC;CDKN1B;DTX3L;FBXO5
prerank,B cell homeostasis (GO:0001782),0.35259549815138735,0.7238333414599022,0.79585326953748,0.9437512767765489,1.0,1/10,2.65%,TNFAIP3
prerank,in utero embryonic development (GO:0001701),0.29435673910375426,0.7232573240631063,0.8016304347826086,0.9441173799292143,1.0,3/25,9.03%,CHD7;TGFB3;TGFBR1
prerank,histone H2B ubiquitination (GO:0033523),-0.28942205591004544,-0.7230451016842712,0.8011049723756906,0.970538460314693,1.0,2/10,9.07%,CTR9;LEO1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2217767251791082,-0.7227876472951507,0.9078947368421053,0.96956883554838,1.0,6/27,13.69%,PER1;SIK1;FBXL3;USP2;MTA1;PER2
prerank,regulation of mRNA metabolic process (GO:1903311),0.3501612052529419,0.7226054998526221,0.7770800627943485,0.944548876267406,1.0,4/11,23.15%,SAFB;SAFB2;IWS1;CDK11B
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.25710650170037164,0.7224936956018672,0.8534675615212528,0.9443147543566375,1.0,23/73,25.32%,TNKS1BP1;EGFR;PRKD2;RPTOR;FNIP1;SPRY2;TNF;NTRK3;AKAP9;PDCD10;STK4;AKT1;IRGM;EIF4G1;TRIM6;AXIN1;PAK1;RAF1;LATS1;TERF2IP;VEGFA;BRAF;PFN2
prerank,ncRNA processing (GO:0034470),0.2369249480190308,0.722246138562553,0.9355168884339816,0.9442375247316769,1.0,48/200,22.01%,C1D;SMAD2;NOL11;PES1;TRPT1;POP1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;DICER1;NOP14;PELP1;PIH1D2;UTP3;RPL12;INTS1;ZCCHC8;MRM2;POP4;RPL22;RPL14;SMAD3;TEX10;RPL11;INTS4;NOLC1;SMAD1;WDR36;BYSL;RPF1;MTREX;HELQ;RPL36A;TUT7;RPS9;RPL6;RPLP2;AGO2;FARS2;UTP11;INTS8;LYAR;DHX37;BMS1;DDX10;EXOSC5
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.30377456947319165,0.7218576047425143,0.8189300411522634,0.9443341004650425,1.0,9/21,25.00%,MDK;DISC1;CX3CL1;KDM1A;NAP1L1;SMARCD3;FZD3;FZD9;VEGFA
prerank,cellular response to metal ion (GO:0071248),0.24262837706520365,0.7218389425018075,0.9135932560590094,0.9439918364097334,1.0,12/123,9.14%,HVCN1;LRRK2;ADCY7;EGFR;CAMK2D;PKD2;CPNE7;CPNE2;DLG4;SLC13A5;SYT2;WNT5A
prerank,protein localization to centrosome (GO:0071539),0.31260808885714503,0.7215389552181017,0.7976366322008862,0.9440085798450578,1.0,5/17,17.00%,PCM1;SNX10;CEP192;NUDCD3;CSNK1D
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2807641993832063,0.7213374428962744,0.8302808302808303,0.9438883028879413,1.0,12/38,22.05%,PTEN;SFRP5;OTUD3;DRD3;PTPRJ;TRIB3;PHLPP2;AKT1;XDH;EPHA2;PPP2R5C;THEM4
prerank,pre-miRNA processing (GO:0031054),-0.2729998330271484,-0.721287867019582,0.8507936507936508,0.970086556396254,1.0,6/14,27.23%,ADAR;DROSHA;AGO3;TUT4;MRPL44;AGO4
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.24989551809237648,-0.7211928692877221,0.881619937694704,0.968925662624653,1.0,5/18,22.24%,HIP1R;ZNF205;SLC35F6;BID;CHCHD10
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3476134379068292,0.7209182182891335,0.801829268292683,0.944003918705766,1.0,4/11,17.65%,NONO;FBXO7;HIF1A;ATF4
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2583277759027563,0.7205607183829643,0.8689809630459127,0.9440630970816511,1.0,15/63,21.99%,TNKS1BP1;E2F1;CNOT4;ATM;E2F8;CARM1;CDKN1B;PRKDC;MDM2;FBXO31;GADD45A;PLK2;CNOT2;RGCC;CNOT3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.30171090910054854,-0.7202586829823554,0.8016085790884718,0.9687497484212417,1.0,2/10,4.91%,DLGAP1;DLGAP2
prerank,inorganic ion transmembrane transport (GO:0098660),0.34657886897060586,0.7192265904699808,0.8065522620904836,0.9452661979500497,1.0,2/12,14.55%,PKD2;TRPM4
prerank,T cell proliferation (GO:0042098),0.33896325362847357,0.7184902150120352,0.8045454545454546,0.9457871670618422,1.0,3/13,11.94%,MSN;CTPS1;TNFRSF4
prerank,mitochondrial gene expression (GO:0140053),0.2738085090319622,0.7177189847011145,0.8566265060240964,0.9463267569340164,1.0,10/42,16.99%,MRPL57;IARS2;FOXO3;MRPS18A;RARS2;MRPS14;MRPS2;NDUFA7;LARS2;POLRMT
prerank,oligodendrocyte development (GO:0014003),0.32247255755824966,0.7173884495988981,0.7919655667144907,0.946324324413949,1.0,1/15,2.07%,B4GALT5
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2731706953655461,0.7169418006969834,0.8347406513872135,0.9465013023316791,1.0,6/41,12.48%,CACNA2D1;XCL1;ITPR1;PKD2;IBTK;FGF2
prerank,cellular response to chemical stress (GO:0062197),0.2481259582564084,0.71650297515493,0.8931297709923665,0.9466662663527061,1.0,16/96,15.71%,LRRK2;RAD52;AIF1;PKD2;ATM;ETV5;FOXO3;TMEM161A;NFE2L2;ATG7;GPX8;TXNRD1;TXNRD2;SETX;CYCS;ADNP2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.29012554956084174,-0.7164248601713473,0.8174157303370787,0.9721236860121769,1.0,4/11,23.55%,KAT5;TFAP4;RPS6KA6;TP53
prerank,sterol transport (GO:0015918),0.30884474119436656,0.715797893180593,0.8206896551724138,0.9471259278468427,1.0,4/19,13.62%,CD36;NPC2;OSBPL5;MSR1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2634693472727456,0.7153029301521098,0.8518957345971564,0.9473779466858707,1.0,15/48,20.96%,NUP37;RAE1;OGT;NUP153;GCK;KHK;NDC1;HIF1A;NUP35;RUBCNL;NUP188;SEC13;ZBTB7A;NUP214;NUP107
prerank,translation (GO:0006412),0.2331735838805713,0.7151039525372512,0.949290060851927,0.9472272203869587,1.0,45/208,21.55%,RPSA;RRBP1;ASMT;TNIP1;PPA1;RPL3L;MRPL57;YARS1;ABCE1;ZC3H15;AIMP1;EEF1E1;PABPC4;IARS2;TARS1;RPL12;MRPS18A;RARS2;EEFSEC;RWDD1;RARS1;RPL22;RPL14;MRPS14;MRPS2;RPL11;GARS1;GSPT1;NDUFA7;LARS2;MRPL55;RPL36A;MRPL52;RPS9;RPL6;RPLP2;AGO2;FARS2;MRPS33;ETF1;EIF4G1;N6AMT1;NARS1;TMA7;RPS27A
prerank,lipid droplet organization (GO:0034389),-0.2446129975688579,-0.7150539068679125,0.875,0.9725446187317801,1.0,7/22,25.62%,RAB18;CDS2;BSCL2;SQLE;PPIA;PLA2G4C;FITM2
prerank,positive regulation of cell killing (GO:0031343),0.339147616854597,0.7146033548684197,0.7862481315396114,0.9474386865646698,1.0,3/13,19.09%,WNT5A;RAC1;DVL2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.34162574453533195,0.7142308870972315,0.8009331259720062,0.9475326366338165,1.0,2/11,6.22%,NOL11;DDX11
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.30863419925979985,0.7137576894283647,0.8206896551724138,0.9477015590801213,1.0,3/20,8.54%,ACSL4;SCD5;HSD17B8
prerank,tRNA modification (GO:0006400),-0.18070197337647784,-0.7131406001248168,1.0,0.9734002202138566,1.0,26/62,30.56%,ALKBH8;TRMT9B;DTWD2;TYW5;ELP5;TRDMT1;PUS10;QTRT1;NSUN6;TRMT10A;LCMT2;TRMT5;CDKAL1;TRMT44;METTL6;OSGEP;TRMT6;TYW3;THUMPD1;PUS1;TRMT12;TRMT112;AARS1;TRMO;MOCS3;PUS7
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.34397727638415543,0.7124503818737311,0.8040123456790124,0.9488945169621082,1.0,4/11,11.08%,RAB21;MSN;PTPN23;EIPR1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3183803016783292,0.7121190093872566,0.8032305433186491,0.9489088621293736,1.0,7/16,26.53%,GART;PPAT;AMPD2;IMPDH2;AMPD3;IMPDH1;ADSL
prerank,histone H2A acetylation (GO:0043968),0.31900465914091974,0.7119123751954962,0.828696925329429,0.9488005016698234,1.0,9/16,29.69%,RUVBL1;SPHK2;EP400;MEAF6;TRRAP;MORF4L2;MORF4L1;RUVBL2;ING3
prerank,sensory perception (GO:0007600),0.26525643932932186,0.7114978746188184,0.858343337334934,0.9489237165056578,1.0,5/45,14.17%,PTGES;MYO7A;CCL2;P2RX7;GNAS
prerank,regulation of mRNA processing (GO:0050684),0.28394005202358713,0.711232049100841,0.8386683738796414,0.9488548551092733,1.0,8/32,19.24%,ZFP36L1;KHDRBS1;METTL16;SAFB;SAFB2;RBM39;IWS1;SON
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.2809775516346441,0.7108357311623716,0.8404669260700389,0.9489405182663437,1.0,8/33,18.20%,EGF;CBL;FBXW7;PDE6H;BTC;NEU3;AKT1;AGT
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3061972405911504,0.7103925339294953,0.8052325581395349,0.9491202593606047,1.0,3/17,15.97%,PLA2G12A;PLA2G4A;PLA2G4E
prerank,regulation of p38MAPK cascade (GO:1900744),0.27848011900009123,0.7102754561195929,0.8359375,0.9488852367640135,1.0,10/35,21.08%,TREM2;LGALS9;SASH1;PJA2;SPI1;MFHAS1;XDH;GADD45A;DLG1;ZC3H12A
prerank,regulation of histone deacetylation (GO:0031063),0.3320195583846555,0.7101451236341674,0.8272327964860908,0.9486870004428509,1.0,3/13,14.64%,CAMK2D;SPHK2;NIPBL
prerank,organelle disassembly (GO:1903008),0.28107186542542445,0.7096721324754922,0.8395522388059702,0.9488780416561123,1.0,7/33,17.80%,GBF1;UBA5;MTIF2;KIF5B;DDRGK1;KIF9;MCTS1
prerank,protein targeting to peroxisome (GO:0006625),0.2867418035447494,0.709495866442462,0.8509234828496042,0.9487299099898121,1.0,7/29,19.49%,PEX10;RAB8B;PEX19;ALDH3A2;PEX6;PEX12;HACL1
prerank,arachidonic acid secretion (GO:0050482),0.35189924045041493,0.7092880323472581,0.8209876543209876,0.948237489066475,1.0,2/10,9.77%,ANXA1;DRD3
prerank,arachidonate transport (GO:1903963),0.35189924045041493,0.7092880323472581,0.8209876543209876,0.948237489066475,1.0,2/10,9.77%,ANXA1;DRD3
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.29918429841544014,0.7092134352613145,0.8268698060941828,0.947956991980748,1.0,4/21,13.26%,HK2;H6PD;GCK;TALDO1
prerank,organelle fission (GO:0048285),0.2958604800769973,0.7090600086602374,0.8139223560910308,0.9477792043587792,1.0,6/24,20.02%,SEC16B;PEX19;TMCC1;PEX11A;CORO1C;WASHC5
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.2395783736780813,-0.7089705903425625,0.8540925266903915,0.976850125101829,1.0,7/19,25.89%,ADK;POLD3;GMPR;DCK;APRT;CDA;POLD2
prerank,cardiac cell development (GO:0055006),0.33662159731073527,0.7085664570208122,0.8096723868954758,0.9479921365377364,1.0,1/11,4.21%,JAG1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.2724841137139103,-0.708495429296956,0.858433734939759,0.9761131406549088,1.0,5/12,22.35%,HDAC4;CCN3;BDNF;HDAC3;BHLHE41
prerank,cellular response to exogenous dsRNA (GO:0071360),0.33812348809684317,0.7082551148542109,0.8146964856230032,0.9479918345909258,1.0,1/12,1.79%,COLEC12
prerank,rRNA processing (GO:0006364),0.23433456286410925,0.7082116308151964,0.9411764705882353,0.9476804829480673,1.0,43/172,22.01%,C1D;MAK16;NOL11;PES1;ERI1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;NOP14;NOP2;PELP1;PIH1D2;UTP3;NAT10;RPL12;MRM2;POP4;RPL22;RPL14;TEX10;RPL11;NOLC1;WDR36;BYSL;PRKDC;RPF1;MTREX;HELQ;RPL36A;RPS9;SRFBP1;RPL6;RPLP2;UTP11;RIOK2;LYAR;DHX37;BMS1;RSL1D1;DDX10;EXOSC5
prerank,intraciliary retrograde transport (GO:0035721),0.33265061278255625,0.7079309332903727,0.8045112781954887,0.9476524621473825,1.0,3/12,13.72%,DYNC2LI1;WDR35;DYNC2H1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.339918798367085,0.7078736068458322,0.8115727002967359,0.9473599008908551,1.0,2/12,8.61%,ACOX1;FADS1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.33304062612277424,0.707194537915526,0.8343558282208589,0.9477837622314336,1.0,7/13,29.93%,NOP14;BMS1;KRI1;TSR1;RCL1;RRS1;TBL3
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2347895707641141,0.7068254401454173,0.9327817993795243,0.9478426788506888,1.0,23/151,15.20%,TNIP1;CERS6;B4GALT5;PAM;MGST1;APOE;PRKD2;AKR1A1;HACD2;TYW1;VAPA;MOCS1;CSNK2A1;CSNK2A2;GSTK1;CSNK1G2;ELOVL6;SPHK2;CEPT1;SPTSSA;PLA2G4A;SGPL1;ALDH3A2
prerank,tryptophan catabolic process (GO:0006569),0.3335309599315275,0.7065242997992428,0.7953125,0.9478091579460096,1.0,1/11,7.20%,KYAT1
prerank,innate immune response in mucosa (GO:0002227),-0.2945807636770663,-0.7065052347379062,0.8410958904109589,0.9770107021065184,1.0,1/10,6.75%,DEFA6
prerank,interstrand cross-link repair (GO:0036297),-0.18544988456006178,-0.7064145306983318,0.9327731092436975,0.9758443734227962,1.0,22/53,29.19%,ERCC6L2;WDR48;UBC;RFWD3;DCLRE1A;FANCI;FAAP100;USP1;FANCM;ERCC1;DCLRE1B;MUS81;FAAP20;FANCB;FANCL;UBA52;FANCG;FAN1;NEIL3;RPA2;RAD51AP2;CENPX
prerank,mesenchyme development (GO:0060485),0.31755221211993595,0.7063899979459652,0.81089258698941,0.9475995582854848,1.0,5/15,23.91%,PKD2;TGFBR1;BMP7;HMGA2;BMPR2
prerank,negative regulation of mRNA processing (GO:0050686),0.3175738743289497,0.7062170825112959,0.8089080459770115,0.9474382358978144,1.0,4/15,15.90%,SAP18;SFSWAP;SRSF12;RBMX
prerank,regulation of TORC1 signaling (GO:1903432),0.2769372109198231,0.7058081639402142,0.8333333333333334,0.9475554600641724,1.0,11/33,21.82%,KLHL22;ATM;RRAGC;KPTN;SMCR8;LAMTOR5;GPR137;SIK3;TELO2;CLEC16A;SZT2
prerank,regulation of protein sumoylation (GO:0033233),0.307945915841735,0.7049721969072578,0.8054755043227666,0.948165121046509,1.0,3/17,12.80%,ZMIZ1;GNL3;RASD2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.2812740126509052,0.7047194071992254,0.8446215139442231,0.9481006721094142,1.0,6/28,17.54%,NAV3;AKAP9;RAC1;FES;TOGARAM1;CKAP5
prerank,microtubule anchoring (GO:0034453),-0.27820891459766606,-0.7042805279796266,0.8179419525065963,0.9769260050874428,1.0,1/12,0.78%,BICD1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.28780589817945423,-0.7034502919385067,0.8305555555555556,0.9765838378773235,1.0,6/11,34.86%,CAV1;TMEM199;ATP6V0D1;ATP6V1A;ATP6AP1;FAS
prerank,protein import (GO:0017038),0.24457796271171295,0.7031609372053564,0.9017660044150111,0.9495127223136716,1.0,19/84,19.56%,APOE;STAT3;PRICKLE1;FAM53B;LAMP2;RAB8B;NUP153;SNX33;TNPO1;PEX19;E2F3;ALDH3A2;NUP188;SEC13;AKT1;TOMM22;HEATR3;PEX12;NUP214
prerank,cellular response to amino acid stimulus (GO:0071230),0.27678391232050975,0.7028709261374134,0.8530927835051546,0.9494806051492021,1.0,9/33,19.41%,KLHL22;CPEB1;CAPN2;RPTOR;RRAGC;CPEB4;LAMTOR5;LAMTOR3;UBR1
prerank,protein catabolic process (GO:0030163),0.25207420121218327,0.7027595345026039,0.874133949191686,0.9492389231327456,1.0,10/59,15.41%,APOE;CTSD;SIAH2;LAMP2;BAG6;ADAMTS9;CLN6;FBXO2;RIPK1;PSMA8
prerank,negative regulation of inclusion body assembly (GO:0090084),0.3467154714015257,0.7026800243269585,0.8235294117647058,0.9489615320804987,1.0,2/10,10.97%,DNAJB1;DNAJB6
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2852328601109517,0.7025297607516359,0.8446726572528883,0.9487693725318407,1.0,8/28,18.84%,CXCL12;DBN1;BRK1;DBNL;ARHGAP35;RASA1;CTTN;PLEKHG2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.29524215615434457,0.7018573233552781,0.8369098712446352,0.9491777287324804,1.0,3/22,9.77%,CACNA1C;NF1;DRD3
prerank,dicarboxylic acid transport (GO:0006835),0.2837391990199947,0.7015813445124854,0.8473479948253557,0.9491321610274273,1.0,5/28,15.95%,SLC1A3;SLC13A5;PDPN;GIPC1;SLC25A10
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.326924846881091,0.7010869132063247,0.8185975609756098,0.9493086731755768,1.0,2/13,7.56%,ABCA2;SOAT1
prerank,regulation of macroautophagy (GO:0016241),0.2374084350908685,0.7010821316051384,0.8986125933831377,0.9489535138298091,1.0,22/105,18.35%,DCN;LRRK2;EXOC4;RPTOR;TRIM13;RRAGC;EXOC1;EXOC7;GAPDH;ATP6V1H;SNX5;SMCR8;ATP6V1G2;NEDD4;PRKAB1;LAMTOR5;ATP6V1G1;SH3GLB1;AKT1;ATP6V1D;USP36;LAMTOR3
prerank,transport along microtubule (GO:0010970),0.33855381473803303,0.7010484646397985,0.7952755905511811,0.9486301548192374,1.0,3/13,8.68%,BAG3;CDC42;COPG1
prerank,response to prostaglandin E (GO:0034695),-0.2929916733524898,-0.7009806142597176,0.862533692722372,0.9779637095442217,1.0,1/10,1.66%,TGFBR3
prerank,cellular protein-containing complex assembly (GO:0034622),0.2311440930261045,0.6999603841021177,0.9382080329557158,0.9495089960413818,1.0,26/159,17.71%,CLTC;TCF4;SMAD2;CHMP4A;CHMP4B;NCK1;NCK2;OMA1;STXBP1;COG4;ANGPT1;COX7A2L;TTC12;NUP153;SNX9;EPS15;TRAF2;SMAD3;SRC;SMAD4;NDC1;SMAD1;PSMD11;AIFM1;HSPD1;PICALM
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.22664176662282476,-0.6998823993668772,0.8979591836734694,0.9778560852624686,1.0,9/22,25.81%,ESR1;PSMC3;MED4;MED24;PSMC4;DHX36;TP53;MED30;SRF
prerank,rRNA metabolic process (GO:0016072),0.23194524871848166,0.6993843206790452,0.9376299376299376,0.949813063707782,1.0,37/160,22.01%,C1D;ERN2;NOL11;PES1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;NOP14;PELP1;PIH1D2;UTP3;XRN1;RPL12;MRM2;POP4;RPL22;RPL14;TEX10;RPL11;NOLC1;WDR36;BYSL;RPF1;MTREX;HELQ;RPL36A;RPS9;RPL6;RPLP2;UTP11;LYAR;DHX37;BMS1;DDX10;EXOSC5
prerank,positive regulation of cellular component movement (GO:0051272),-0.22307990221099444,-0.6992865251382866,0.9142857142857143,0.9772297450606778,1.0,9/24,32.40%,SPOCK2;CCDC25;TRIM32;RPS19;CFAP20;CSF1R;AKT2;NTN1;LYN
prerank,histone methylation (GO:0016571),0.2879518333406568,0.6987036508395645,0.8333333333333334,0.9502125476372784,1.0,5/26,16.10%,CREBBP;EHMT1;CARM1;NSD3;NSD1
prerank,histone H3-K9 demethylation (GO:0033169),0.32883884958813037,0.697675963626886,0.8126934984520123,0.9509762942775979,1.0,6/11,26.60%,KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,glycolipid metabolic process (GO:0006664),0.2607724796586037,0.697647697133458,0.8783132530120482,0.9506496727720416,1.0,10/47,17.90%,UGCG;PIGW;ABCA2;B4GALNT1;SMPD3;NEU3;GALC;NEU1;CTSA;CPTP
prerank,myeloid cell development (GO:0061515),0.30256972683231975,0.6975169426210773,0.8338068181818182,0.9504289357366895,1.0,6/18,20.99%,TLR2;SRC;NRROS;MED1;FOXP1;LYAR
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.2953669518126364,0.696918208789901,0.8242677824267782,0.9507309115834915,1.0,3/22,9.67%,PES1;ERI1;NOP14
prerank,response to ethanol (GO:0045471),0.3119540355143481,0.6966746076241241,0.8296943231441049,0.9506147030867649,1.0,2/14,9.77%,ADCY7;DRD3
prerank,regulation of telomerase activity (GO:0051972),0.262323249991526,0.6966168765881258,0.8796185935637664,0.950325955762753,1.0,12/45,23.02%,PARM1;ATM;PINX1;SMG6;SRC;PNKP;MAPK1;PARN;PKIB;PARP4;TERF1;MAP2K7
prerank,ribosome biogenesis (GO:0042254),0.2294069303363311,0.6959544631813389,0.9434737923946557,0.9507152648870298,1.0,47/187,22.01%,C1D;NOL11;PES1;NOC2L;ABCE1;RRP1B;RRP1;WDR74;EXOSC4;MPHOSPH6;NOP14;PELP1;NIP7;PIH1D2;GTF3A;UTP3;RPL12;LTO1;MRM2;DDX31;POP4;RPL22;RPL14;TEX10;RPL11;NOLC1;WDR36;NOP16;BYSL;RPF1;DHX29;MTREX;HELQ;RPL36A;RPS9;HEATR3;RPL6;RPLP2;UTP11;PAK1IP1;RIOK2;XPO1;LYAR;DHX37;BMS1;DDX10;EXOSC5
prerank,lipid biosynthetic process (GO:0008610),0.24592698739221874,0.6955065656592433,0.9173184357541899,0.9508457283163838,1.0,7/77,8.76%,LIPC;PAM;MVK;SCD5;HSD17B8;FADS1;LPL
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2745933991969218,0.6942524810750554,0.8531645569620253,0.9518731197882555,1.0,13/33,25.72%,TNKS1BP1;ZBTB48;PINX1;TERT;CTC1;PPP6C;TELO2;RFC1;TERF1;RPA1;RAD51;TERF2IP;TERF2
prerank,regulation of myoblast differentiation (GO:0045661),0.2714475595969345,0.6935011694708927,0.8392857142857143,0.9523408039330881,1.0,4/32,10.21%,ZFP36L1;FLOT2;BTG1;TBX3
prerank,tRNA 5'-leader removal (GO:0001682),0.3196690185609243,0.6925930961427703,0.8366111951588502,0.9529734641949499,1.0,2/13,12.47%,POP1;POP4
prerank,RNA methylation (GO:0001510),0.25176125593201126,0.6924004802901732,0.888509670079636,0.952809494965853,1.0,13/60,19.17%,ZC3H13;METTL16;METTL1;MTERF4;THUMPD3;NOP2;MRM2;TGS1;TRMT61B;THADA;RBM15;BCDIN3D;THUMPD2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2781731844298517,0.6920461102083293,0.8642131979695431,0.9528596043842831,1.0,7/30,14.52%,BAG6;EIF3H;CCAR2;OGT;GIPC1;DDRGK1;RPL11
prerank,global genome nucleotide-excision repair (GO:0070911),-0.21485683542864503,-0.6920400765665715,0.9493670886075949,0.9833685921585139,1.0,13/26,28.70%,ERCC3;UBC;CHD1L;DDB2;GTF2H2;ERCC1;GTF2H4;UBA52;GTF2H3;CETN2;RBX1;PARP1;XPC
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.26127573553054667,0.6919991188599129,0.8796068796068796,0.9525527043789157,1.0,13/41,20.96%,NUP37;RAE1;OGT;NUP153;GCK;NDC1;HIF1A;NUP35;NUP188;SEC13;ZBTB7A;NUP214;NUP107
prerank,ribosome assembly (GO:0042255),0.26103009554754786,0.6917810084005985,0.8717948717948718,0.9524281275712105,1.0,11/47,24.24%,RPSA;RPL3L;NOP2;MRPS2;RPL11;DHX29;RPL6;DHX37;MDN1;PPAN;EIF2A
prerank,regulation of TOR signaling (GO:0032006),0.24689985592844085,0.6909546215343753,0.9059350503919373,0.953004681249749,1.0,16/67,19.70%,TREM2;RICTOR;MIOS;NPRL2;RPTOR;RRAGC;TTI1;FNIP1;SMCR8;GPAT3;LAMTOR5;SEC13;GNA12;LAMTOR3;UBR1;TELO2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.29296720020641587,0.6908326247047001,0.86593707250342,0.9527734054592236,1.0,5/21,14.44%,JAK2;TGFB3;TGFBR1;WWTR1;SMAD4
prerank,response to ionizing radiation (GO:0010212),0.24142987441572256,0.6904269520134294,0.8907657657657657,0.952877497163999,1.0,15/70,19.28%,TNKS1BP1;BABAM2;INO80;ATM;TRIM13;GRB2;ANXA1;TANK;IKBIP;PAXIP1;USP28;CLOCK;RAD9A;SWI5;GADD45A
prerank,axonal transport of mitochondrion (GO:0019896),0.32665335029586823,0.6896466658953425,0.8258785942492013,0.9533791116417144,1.0,2/11,15.68%,TRAK1;HIF1A
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2105212135919358,-0.6895361235210307,0.9236641221374046,0.984664953541952,1.0,5/28,12.41%,MAP2;MAP1A;STMN2;STMN3;PRUNE1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3259518777750646,0.6886783674678044,0.827893175074184,0.9540574638905146,1.0,3/12,13.64%,CAMK2D;GJD3;CALM2
prerank,positive regulation of protein transport (GO:0051222),0.2462088488274478,0.6884616190670682,0.9040178571428571,0.9539349155779567,1.0,10/67,12.29%,TREM2;ABCG1;PPID;TGFB3;PCM1;FRMD4A;EXOC1;PCNT;TGFB2;TNF
prerank,histone H3-K36 demethylation (GO:0070544),-0.2841995911609152,-0.6883955744884697,0.8657894736842106,0.984529935687133,1.0,2/10,10.15%,PHF8;RIOX2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.24262207078967787,-0.6880697755529166,0.8825396825396825,0.9836045491190191,1.0,11/16,45.95%,PROX1;HEY2;ZFPM1;NOTCH1;ENG;TBX20;NOG;MYH6;NOTCH2;GATA4;ISL1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.25462936874481035,-0.6876680474737541,0.8853868194842407,0.9827548710962153,1.0,3/13,11.76%,EDEM2;BCAP31;SVIP
prerank,regulation of ATP metabolic process (GO:1903578),0.25076479482319664,0.6874419695624264,0.9160756501182034,0.9547020015654701,1.0,16/54,20.96%,NUP37;RAE1;COX7A2L;OGT;NUP153;GCK;SPHK2;NDC1;HIF1A;NUP35;NUP188;SEC13;ATP7A;ZBTB7A;NUP214;NUP107
prerank,response to histamine (GO:0034776),0.3367268992745879,0.6872963498674258,0.8137715179968701,0.9544894954429821,1.0,2/10,9.86%,DRD3;HRH1
prerank,T-helper cell differentiation (GO:0042093),0.30823352816142996,0.6867404702946429,0.8289085545722714,0.9547013571810921,1.0,1/14,3.16%,BATF
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3329507459947343,0.6864886821663782,0.8243451463790447,0.9546292052928647,1.0,1/10,5.49%,SEC14L1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.2887403192375296,0.6860989229047524,0.8480113636363636,0.9546999437625893,1.0,6/20,20.29%,PLOD2;GGCT;CNDP2;PTDSS2;GSS;PLSCR1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.32305792724538307,0.6858300055049086,0.8205928237129485,0.9546024461537498,1.0,3/11,14.54%,UBN1;ATRX;ASF1A
prerank,quinone biosynthetic process (GO:1901663),-0.25667811584781214,-0.6856699887059353,0.8682432432432432,0.9834043137747648,1.0,3/14,9.12%,PDSS1;COQ2;PDSS2
prerank,cognition (GO:0050890),0.2599744001426879,0.6854637322542566,0.8710843373493976,0.9546373631462076,1.0,9/42,16.60%,CHD7;NF1;HOXA1;TNF;HRH3;TUSC3;NIPBL;CHMP2B;SOBP
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2707576473336455,0.6854268628619792,0.866580310880829,0.9543172976347813,1.0,6/29,15.85%,EDC4;EXOSC4;DCP2;DCP1A;PATL1;LSM7
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2883465965266767,0.6852703679329831,0.8458333333333333,0.9541235637877723,1.0,7/20,26.53%,GART;PPAT;AMPD2;IMPDH2;AMPD3;IMPDH1;ADSL
prerank,negative regulation of DNA recombination (GO:0045910),0.25771515661041866,0.6852330303039048,0.8935406698564593,0.9538050850839944,1.0,14/43,25.72%,PARP3;SHLD3;FBH1;RIF1;ATRX;CGAS;POLR2L;POLR2K;TERF1;ZRANB3;POLR2D;MSH6;TERF2IP;TERF2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.2534521302055131,0.6848013133598896,0.8976190476190476,0.953869827665208,1.0,10/50,17.37%,SIAH2;SH3RF1;CSNK2A1;FNIP1;DNAJB6;TNF;SRC;LAMTOR5;AKT1;YWHAE
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.2907998720912185,0.6844289949522527,0.8438395415472779,0.9539068743152329,1.0,4/19,13.32%,EXT1;EXT2;HS2ST1;UGDH
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.24854256139111242,-0.6842132887383472,0.8830409356725146,0.9835401627188083,1.0,1/14,1.83%,ENTPD1
prerank,regulation of phosphatase activity (GO:0010921),0.2783138522906007,0.683803672351519,0.8425302826379543,0.9542110496860581,1.0,8/24,23.98%,PPP1R36;PPP1R2;MTMR9;PTPA;HSP90B1;PPP6R2;GPATCH2;PPP1R35
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.22303459848730095,0.6837858184240332,0.9595435684647303,0.9538688433122282,1.0,47/168,24.18%,RPSA;ZFP36L1;CTIF;TNKS1BP1;SMG7;CNOT4;ATM;ERI1;SAMD4A;SMG6;EXOSC4;DCP2;DHX34;NCBP2;PPP2R2A;XRN1;RPL12;RPL22;RPL14;RPL11;DCP1A;DXO;PATL1;GSPT1;RC3H2;THRAP3;RPL36A;TUT7;RPS9;PARN;RPL6;RPLP2;ETF1;EIF4G1;CNOT2;CSDE1;ZC3H12A;NBDY;RPS27A;CNOT3;EXOSC5;EIF3E;PATL2;POLR2D;RNPS1;SMG5;AGO1
prerank,protein-containing complex disassembly (GO:0032984),0.2508626991754583,0.6832881284319943,0.9031505250875146,0.9540374088185514,1.0,10/54,19.09%,FZD1;STX17;LRP6;VPS4A;LAMP2;GSK3B;CSNK1A1;RUBCNL;LIX1L;DVL2
prerank,male gonad development (GO:0008584),0.2626354452970125,0.6832088955988458,0.8617283950617284,0.9537607047158005,1.0,6/34,18.07%,GATA6;WNT5A;TGFB2;ADAM21;TFAP2C;INHBA
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3342804934892546,0.6830768810413275,0.8299845440494591,0.9535382492223942,1.0,1/10,3.16%,ATP5PO
prerank,hemidesmosome assembly (GO:0031581),0.33183338487117336,0.6830748743915177,0.8403614457831325,0.9531849314564953,1.0,1/11,2.10%,LAMC1
prerank,cellular amino acid catabolic process (GO:0009063),0.23835628771027975,0.6821394084696063,0.9113785557986871,0.9537866536777534,1.0,19/87,21.44%,SDSL;CRYM;ACADSB;HIBCH;AMT;GLDC;KYAT1;DLST;ALDH7A1;CARNS1;ECHS1;BCKDHB;MTRR;AUH;HYKK;QDPR;HIBADH;PIPOX;SLC25A21
prerank,regulation of ERAD pathway (GO:1904292),-0.271104382189588,-0.6815529858921179,0.8837837837837837,0.9847604522430896,1.0,3/11,17.63%,ATXN3;AQP11;RNF185
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3119723158675115,0.6815521661898988,0.8311111111111111,0.9540594492167673,1.0,4/14,17.41%,IRS1;PTPN2;AKT1;DDB1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.29998511005109385,0.6811740677575531,0.8428571428571429,0.9541119904876624,1.0,4/18,12.48%,RHOJ;AKT3;ANXA1;FGF2
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.20053994724307855,-0.6808741785359692,0.9444444444444444,0.9841336810081213,1.0,8/31,19.44%,PRKN;ATXN3;HSPA14;DNAJC18;ERN1;HSPB8;HSPA9;TMBIM6
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.29565157724192387,0.6804490964654428,0.8472622478386167,0.9545217962152639,1.0,6/16,20.69%,ZFPM2;TBX2;FGF2;GLI1;RBPJ;BMPR1A
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2629220779179662,0.6801693609056809,0.8686746987951808,0.9544341634028847,1.0,6/36,11.12%,TCF7L2;TNRC6B;WNT5A;PPP3CA;PLCB3;MOV10
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.25358616739632334,0.6798751477368766,0.892018779342723,0.9543897922188183,1.0,13/46,21.26%,HK2;RALA;TOMM7;FBXO7;TIMM17A;TIMM50;AIFM1;HSPD1;AKT1;TOMM22;TIMM23;TOMM40L;PITRM1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.27439371866775736,0.6797358008823634,0.8794233289646134,0.9541861089075108,1.0,5/26,15.83%,NAV3;AKAP9;RAC1;FES;TOGARAM1
prerank,protein targeting to membrane (GO:0006612),0.2388005969658898,0.6795925766918058,0.9233296823658269,0.9539737923380464,1.0,15/83,16.83%,CHMP4A;CHMP4B;ATG3;RAB8B;SSR2;SEC63;VPS37C;PEX19;SEC61A1;ZDHHC6;ZDHHC9;ALDH3A2;RTP4;SRP14;ZDHHC3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.29187146358262434,0.6789616160134402,0.8548850574712644,0.9542641325523423,1.0,7/19,22.13%,STIMATE;FKBP1B;PTPRJ;PTPRC;PRNP;PTGFR;TRPM2
prerank,negative regulation by host of viral transcription (GO:0043922),0.3200666238130349,0.6787185903487284,0.8382126348228043,0.9541653088233287,1.0,2/12,9.16%,CCL5;HDAC1
prerank,peptidyl-lysine modification (GO:0018205),0.2299258178450984,0.6785116152276588,0.9358288770053476,0.9540215357273778,1.0,20/99,18.03%,PLOD2;NUP37;RAE1;PIAS2;LOXL1;USPL1;LOXL3;SENP6;NUP153;VCPKMT;NSMCE2;EGR2;TRPM4;SIRT3;NDC1;NUP35;NUP188;P3H3;ETFBKMT;ATP7A
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.268671249314642,0.6783066670109278,0.8735332464146024,0.9538816840635699,1.0,9/31,19.53%,PEX10;TIMM17A;TIMM50;AIFM1;PEX6;HSPD1;PEX12;TIMM23;TOMM40L
prerank,ubiquinone metabolic process (GO:0006743),0.3025052546578568,0.6782510510478287,0.8270042194092827,0.9535802793226547,1.0,5/15,17.17%,AIFM2;COQ8B;COQ10B;COQ5;FDXR
prerank,positive regulation of ion transport (GO:0043270),0.2541233133051679,0.677434036903107,0.8997641509433962,0.954089753037061,1.0,14/48,20.51%,CCR1;TRPC6;CCL5;MYLK;CNKSR3;ATP2B1;P2RX7;KIF5B;SNX4;ORAI1;ANO6;STIM2;GDNF;DLG1
prerank,snRNA metabolic process (GO:0016073),0.2993586356068933,0.6771736272163402,0.8530259365994236,0.9539843208633149,1.0,5/17,20.34%,INTS1;ZCCHC8;INTS4;MTREX;INTS8
prerank,piRNA metabolic process (GO:0034587),0.29313628219967647,0.6766141378445052,0.8494318181818182,0.9541962080367616,1.0,1/19,4.62%,MYBL1
prerank,lipoxygenase pathway (GO:0019372),-0.24740741839323216,-0.6761485274417018,0.8580246913580247,0.9872059756848396,1.0,2/14,13.75%,PON2;HPGD
prerank,negative regulation of ATPase activity (GO:0032780),0.2974097153247415,0.6760965175804213,0.8535871156661786,0.9543416956344393,1.0,4/16,18.25%,PXK;VCPKMT;TNNT2;THADA
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.2750759594009054,0.6753220246258392,0.8754813863928113,0.9547797236260309,1.0,8/29,21.73%,E2F1;TENT5A;DHX34;FMR1;THRAP3;AXIN2;GDNF;YBX1
prerank,Golgi ribbon formation (GO:0090161),0.31400360668707106,0.6750934922991457,0.8429237947122862,0.9546372912453147,1.0,2/13,9.08%,STX6;TRIP11
prerank,peptidyl-arginine modification (GO:0018195),0.29999557956480016,0.6749776304204115,0.853448275862069,0.95440331877352,1.0,1/15,4.11%,PADI2
prerank,ether lipid biosynthetic process (GO:0008611),-0.2873453612388872,-0.6745354678354855,0.8778409090909091,0.9873469958391108,1.0,2/10,7.38%,CHPT1;LPCAT2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.31835129426481157,0.674383617192892,0.8149300155520995,0.9546477274907657,1.0,3/11,19.84%,PDPN;SRC;CORO1C
prerank,gliogenesis (GO:0042063),0.3092893867607287,0.6739913209343302,0.8428571428571429,0.9546886589896546,1.0,3/15,11.44%,CDK6;ANXA1;TGFB2
prerank,positive regulation of cilium assembly (GO:0045724),0.29589857038294876,0.6738835123759984,0.8595744680851064,0.9544427731513218,1.0,4/18,14.08%,ENTR1;CEP120;TAPT1;ARHGAP35
prerank,regulation of telomere capping (GO:1904353),0.27808225574699685,0.6734569594232185,0.85809906291834,0.9545167850793636,1.0,7/23,23.02%,ATM;SMG6;TNKS2;PNKP;MAPK1;PKIB;MAP2K7
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.2917525985651657,0.673158826079915,0.8700564971751412,0.9544692802613279,1.0,3/20,12.44%,BCL2;BCL2L2;GSK3B
prerank,acyl-CoA biosynthetic process (GO:0071616),0.29857819844985883,0.6729023201212172,0.8485273492286115,0.9543713469255586,1.0,4/16,19.14%,SCD5;HSD17B8;ACACA;FASN
prerank,glial cell differentiation (GO:0010001),0.26930983804400926,0.6721740384144412,0.8602564102564103,0.9547134582990655,1.0,3/28,5.93%,STAT3;SHH;PTPRZ1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.25876716581383025,-0.6714611834678845,0.8856304985337243,0.98870388609022,1.0,7/13,37.19%,CSTF2;TUT1;CPSF2;CPSF4;NUDT21;CPSF7;CPSF4L
prerank,protein deacylation (GO:0035601),0.28558061299162524,0.6708309069481229,0.8838797814207651,0.9557032754012641,1.0,7/23,18.30%,ABHD17C;HDAC1;LYPLAL1;ABHD17B;SIRT3;LYPLA2;HDAC5
prerank,cellular macromolecule catabolic process (GO:0044265),0.24789032150510165,0.6701393297506765,0.9024096385542169,0.9560495660071342,1.0,10/49,17.10%,SIAH2;PABPC4;ADAMTS9;RNASEH1;SND1;RNASEH2A;FBXO2;RIPK1;SIDT2;MTREX
prerank,eye photoreceptor cell development (GO:0042462),-0.24570534836677432,-0.6700898364874133,0.8878504672897196,0.9886130220780229,1.0,5/15,25.15%,RORB;RP1;BBS4;RPGRIP1L;TULP1
prerank,maturation of LSU-rRNA (GO:0000470),0.275605946754914,0.6693464693963471,0.8811748998664887,0.9565054704668484,1.0,3/26,10.06%,MAK16;PES1;NOP2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.26204711922532636,0.6688150247645148,0.9057071960297767,0.9566777515004377,1.0,6/35,19.14%,PAM;SCD5;HSD17B8;GGT7;ACACA;FASN
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.30315219831833784,0.668616121711859,0.851963746223565,0.9565383305941526,1.0,4/15,15.69%,PRKD2;FGFR1;FGF2;FGF18
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.22727910462597337,-0.6678238754233092,0.9301470588235294,0.9892982690690744,1.0,8/21,26.43%,NT5E;NUDT3;PDE4D;PDE2A;NUDT11;MLYCD;FITM2;NUDT16
prerank,regulation of T cell cytokine production (GO:0002724),0.30308230738258773,0.666780368993002,0.8607954545454546,0.9580039912206855,1.0,3/15,14.55%,XCL1;TRAF2;TRPM4
prerank,metal ion homeostasis (GO:0055065),0.2552744638000921,0.666524848334404,0.8990267639902676,0.9579027694633744,1.0,10/40,21.68%,SLC12A4;FAM20A;CYP27B1;SLC7A8;SELENON;SLC12A9;CNNM2;SLC12A8;LETM2;CNNM4
prerank,photoperiodism (GO:0009648),-0.2034675077544193,-0.6663240245194396,0.9592760180995475,0.9893421589440737,1.0,6/28,13.69%,PER1;SIK1;FBXL3;USP2;MTA1;PER2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.2555140840971153,-0.6658140595594139,0.8983516483516484,0.9885255160053537,1.0,4/12,20.87%,TOPBP1;HUS1;NAE1;ORC1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.25974893243557395,0.665439668262729,0.8823529411764706,0.9586184552099344,1.0,5/32,12.48%,TAOK1;NAV3;TPX2;CAMSAP2;FGF13
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3151338188008271,0.6647398302843538,0.8646153846153846,0.9589733551770333,1.0,3/11,17.16%,ATL2;VCPIP1;LPCAT3
prerank,B cell activation (GO:0042113),0.23333130917691058,0.6641852302075361,0.9288135593220339,0.9591432076003905,1.0,15/68,18.94%,CD40;BCL2;LAT2;MS4A1;CTPS1;PTPRJ;PTPN2;CASP8;KLF6;TCF3;PTPRC;HSPD1;HDAC5;ZBTB7A;ADGRG3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.29650700155627574,0.6637827239766013,0.8562962962962963,0.9591958338533548,1.0,5/15,16.21%,RAB3GAP2;RAB10;RAB3GAP1;SEC61A1;SRP14
prerank,mitochondrion organization (GO:0007005),0.22031539506205472,0.661404908614026,0.977366255144033,0.9611413512254244,1.0,32/165,18.27%,LRRK2;STOML2;PPRC1;AKT3;TRAK1;HK2;VPS13C;OMA1;ADCK1;PID1;AIFM2;MIGA2;COX7A2L;MTX2;TERT;TOMM7;ATPAF1;RAB32;FBXO7;AGTPBP1;TIMM17A;SPG7;GABPB1;MTX1;SIRT3;CYCS;TIMM50;AIFM1;POLRMT;HSPD1;ATP7A;TOMM22
prerank,negative regulation of GTPase activity (GO:0034260),0.28115973474335665,0.6607359872572931,0.8802919708029197,0.9614230764840893,1.0,2/22,7.54%,LRRK2;RRP1B
prerank,female gonad development (GO:0008585),0.2850609724506683,0.6598521227065328,0.8571428571428571,0.9618804272876704,1.0,8/19,26.92%,NR2F2;INHBB;INHBA;NUP107;VEGFA;EIF2B5;INHA;FSHR
prerank,gene expression (GO:0010467),0.2127610314673268,0.6594897246246004,0.9889669007021064,0.96188368560142,1.0,56/348,18.50%,RPSA;RRBP1;RBMS1;BCL3;APOBEC1;ASMT;TNIP1;ATXN1;SYNCRIP;RPL3L;NUP37;E2F1;SNRNP40;SMG7;RAE1;DDX17;PABPC4;SMG6;RRAGC;DHX8;ALKBH5;NCBP2;NUP153;POLR3A;RPL12;MRPS18A;AGFG1;NKX2-8;RPL22;RPL14;LMF2;RBM6;MRPS14;RPL11;MMS19;NDC1;BAZ2A;SETX;GSPT1;NUP35;NUP188;TSPAN14;HNRNPUL1;SEC13;MRPL55;HSPD1;ANGPT2;RPL36A;MRPL52;POLR2L;RPS9;POLR2K;PAX8;DDX20;RBM39;SRSF2
prerank,response to UV-B (GO:0010224),-0.24949748211831013,-0.6594373203738622,0.8885869565217391,0.9924834137698301,1.0,2/12,10.14%,MSH2;CRIP1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.32393259208085196,0.6588018045217537,0.8636363636363636,0.9621829233133452,1.0,1/10,6.81%,DGKH
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.2165880557969295,-0.6583165683594053,0.9459459459459459,0.9920762436511333,1.0,11/24,31.49%,CTNNA2;MAPK12;BNIP2;BOC;MYOCD;CDH2;MEF2C;MAPK14;CAMK1;OLFM2;CDON
prerank,neuron projection organization (GO:0106027),-0.23502661594771257,-0.6581821797687925,0.9096209912536443,0.9909310207571983,1.0,3/15,10.93%,INSR;MAP1A;APP
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3050256707137633,0.6580100877045522,0.8588235294117647,0.9625622216289645,1.0,1/13,5.25%,VDAC2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.25753507749650795,0.657892419163338,0.8988476312419974,0.9623165575151743,1.0,9/35,19.69%,ATM;ATR;CCT8;CCT3;TNKS2;PNKP;MAPK1;PARN;PKIB
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.29974313547928694,0.6576069673434385,0.8685376661742984,0.9622096743240893,1.0,4/15,21.28%,AK8;ENTPD7;ENTPD6;NME2
prerank,negative regulation of cell death (GO:0060548),0.22531981015120386,0.6572175818538188,0.9453551912568307,0.9622161937413249,1.0,23/88,22.97%,LRRK2;CCN4;CHMP4A;CHMP4B;NCK1;GPNMB;GSK3B;FGF2;TRAF2;BMP7;CCN5;ADNP2;NPAS2;AKT1;CCN6;DUS2;EIF4G1;WNT16;BECN1;VPS35;CLU;CSF1;CD200R1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.21547889697303593,0.6569887335612726,0.9587628865979382,0.9620898559216805,1.0,40/172,20.29%,PLD1;PIP5K1B;PTPN13;PTEN;PIP4K2A;CPNE7;PI4K2B;DGKH;PIK3R5;CSNK2A1;CSNK2A2;PGS1;PLA2G12A;FIG4;FGF2;PI4KA;GPAT3;PIK3R1;CEPT1;SACM1L;ARF1;ABHD8;PLA2G4A;MTMR9;PIK3R4;DDHD2;PIK3C3;LPCAT3;MTMR3;RUFY1;PTDSS2;PIP5K1A;CPNE3;PLEKHA2;MTMR2;MTMR6;MTMR1;MTM1;ETNK1;PLSCR1
prerank,base-excision repair (GO:0006284),0.2464713532011738,0.6565230690987187,0.9181708784596871,0.962178429292107,1.0,11/48,22.34%,MPG;DNA2;LIG1;XRCC1;POLG;PNKP;MBD4;HMGA2;NEIL1;RFC1;RPA1
prerank,purine nucleotide catabolic process (GO:0006195),0.309526119175853,0.656012044619054,0.8561046511627907,0.9623173315761158,1.0,4/13,21.20%,GDA;NT5C1A;XDH;HINT1
prerank,protein localization to microtubule organizing center (GO:1905508),0.2918907384454733,0.6555776686161877,0.8616541353383459,0.9623726736135928,1.0,4/15,17.00%,PCM1;SNX10;CEP192;CSNK1D
prerank,actin nucleation (GO:0045010),0.28487213465371247,0.6554721785273779,0.8834019204389575,0.9621205714905444,1.0,6/21,22.09%,ACTR2;SPIRE1;WASHC1;ARPC1B;TRIM27;ARPC2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.28375107913666076,0.6553336890501029,0.8923076923076924,0.9618878134314258,1.0,5/20,17.97%,ABCA2;FBXW7;BMP5;TRIB3;PRMT3
prerank,superoxide anion generation (GO:0042554),-0.2486600972496228,-0.6541441867326883,0.9123867069486404,0.9928261934941262,1.0,8/13,47.46%,NCF2;NOX1;TAFA4;CYBA;NCF1;NOX3;NCF4;DUOX1
prerank,ceramide catabolic process (GO:0046514),-0.2447801157323385,-0.6540924063539213,0.9046242774566474,0.9916157914190824,1.0,7/14,35.81%,ACER2;ASAH2;GM2A;ASAH1;ACER3;HEXB;NEU2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.2980053044190322,0.6532709634432778,0.8680124223602484,0.9634250645679617,1.0,3/14,14.77%,PTPN1;DDRGK1;HSPA5
prerank,negative regulation of leukocyte migration (GO:0002686),0.32137074806450927,0.6532477118100696,0.8415213946117274,0.9630865151978503,1.0,2/10,9.71%,EMILIN1;BMP5
prerank,ubiquinone biosynthetic process (GO:0006744),-0.23777461729942062,-0.6529322550113268,0.9249146757679181,0.991235296690805,1.0,3/15,9.12%,PDSS1;COQ2;PDSS2
prerank,regulation of microglial cell activation (GO:1903978),0.2942534229272776,0.6528269437945621,0.8663594470046083,0.9631444751136254,1.0,4/15,21.35%,TREM2;CX3CL1;PTPRC;NR1D1
prerank,gene silencing by miRNA (GO:0035195),0.2572888188524785,0.652622522990781,0.9036295369211514,0.9629619475734342,1.0,10/32,25.67%,PUM1;TNRC6B;DICER1;MOV10;WTIP;AGO2;SNIP1;AGO1;CNOT1;CNOT7
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.26602629208494133,-0.6525522507951073,0.856396866840731,0.9902754640201666,1.0,3/10,15.71%,DNAJC19;ABCA3;MFSD2A
prerank,cellular response to dsRNA (GO:0071359),0.2995867276075158,0.6511938689674266,0.8895800933125972,0.9639329660099397,1.0,1/15,1.79%,COLEC12
prerank,protein complex oligomerization (GO:0051259),0.2237092735753512,0.6511883677252422,0.9490238611713666,0.9635834820780101,1.0,13/85,16.69%,SLC9A1;STOML2;TMEM120B;PKD2;ATL2;MS4A1;RNF213;UGDH;TIFA;TMEM120A;RBMX;ALS2;TRMT61B
prerank,cGMP biosynthetic process (GO:0006182),0.3188324081233347,0.6506296691487847,0.8686868686868687,0.9637363476207089,1.0,1/10,6.15%,NPR2
prerank,positive regulation of JUN kinase activity (GO:0043507),0.27229975920524446,0.6502967956842408,0.8811475409836066,0.9636778497952567,1.0,4/23,13.07%,SASH1;TAOK3;TNF;TRAF2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.26793785278239973,0.6502627555705592,0.8891752577319587,0.9633550530607029,1.0,6/26,20.52%,CD36;TRAP1;SPHK2;COA8;CCN6;SLC18A2
prerank,histone deubiquitination (GO:0016578),-0.2321426053358167,-0.650127831219808,0.8928571428571429,0.9909335619730276,1.0,7/18,24.16%,USP49;USP7;KAT2A;USP16;TAF10;ENY2;USP15
prerank,protein polyglutamylation (GO:0018095),0.30577576744925145,0.6492736932502281,0.8641221374045801,0.9639034531514491,1.0,2/11,9.52%,CEP41;TPGS1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.30985352347721773,0.6492280067216191,0.8632075471698113,0.9635968985492063,1.0,2/11,10.32%,BAG6;UGGT2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.28358167814362567,0.647973054160281,0.8755364806866953,0.964377069256173,1.0,5/18,18.91%,CCT8;DCP2;RUVBL1;CCT3;PARN
prerank,inorganic anion transport (GO:0015698),0.24145608872898242,0.6476038754586377,0.9374262101534829,0.9643543358963143,1.0,1/53,0.33%,ENPP1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.29615325175025997,0.6472541938768659,0.8626062322946175,0.9643148010000211,1.0,8/15,29.74%,ACTR2;WASHC1;ARPC1B;TRIM27;ARPC2;JMY;WHAMM;ARPC3
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.2497779949441708,-0.646846910631395,0.9069767441860465,0.992167670305164,1.0,8/12,42.60%,RFWD3;PLK5;TP53;RPA2;PLK3;SDE2;CCND1;WAC
prerank,peripheral nervous system development (GO:0007422),0.2704165018405032,0.6463750400211817,0.8936742934051144,0.9647419218944127,1.0,4/23,15.20%,PMP22;NF1;EGR2;ALDH3A2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.26637329516371017,-0.6462229762806189,0.8852941176470588,0.99137295049732,1.0,1/10,1.13%,PRKCH
prerank,negative regulation of double-strand break repair (GO:2000780),0.2523192905760777,0.6458105308145136,0.9,0.9649188832604929,1.0,6/30,16.09%,UBR5;SHLD3;RNF169;FBH1;RIF1;CGAS
prerank,histone H4 acetylation (GO:0043967),0.2375395052342474,0.6449020244021239,0.9142857142857143,0.965351444574607,1.0,16/47,25.60%,KMT2A;KANSL1;OGT;RUVBL1;PHF20;ING5;KAT7;TADA3;EP400;KANSL3;ACTL6B;MEAF6;TRRAP;MORF4L2;ATF2;MORF4L1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2753807957699098,0.6446081064320677,0.8767908309455588,0.9652750305401939,1.0,7/20,21.40%,PSEN1;PSENEN;RHBDD1;NCSTN;ADAM9;PSEN2;HM13
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.25964490753855857,-0.644564693772081,0.9037900874635568,0.9913048784154488,1.0,4/12,21.94%,PRPSAP2;PRPSAP1;PRPS1;PRPS1L1
prerank,protein sumoylation (GO:0016925),0.23359320726131613,0.6441859754118433,0.9377203290246768,0.9653068581900079,1.0,10/49,16.22%,NUP37;RAE1;PIAS2;NUP153;NSMCE2;EGR2;TRPM4;NDC1;NUP35;NUP188
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.3038291422744273,0.6425547440658672,0.8518518518518519,0.9663623242529477,1.0,5/12,25.00%,SMO;PAX8;AGT;GDNF;VEGFA
prerank,positive regulation of histone deacetylation (GO:0031065),-0.25079809297447786,-0.6425305366638053,0.9180790960451978,0.9915323117407882,1.0,4/12,18.66%,SAP30BP;AKAP8;PRKD1;CTBP1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.26281169561206974,-0.6421233390514723,0.9058823529411765,0.9905478365949957,1.0,2/11,4.74%,TIPIN;SMARCAL1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.29145658366995647,0.6420345389052559,0.8875912408759125,0.9664835726034103,1.0,4/14,20.23%,ACTR2;TIMELESS;MMS19;ARID2
prerank,mitochondrial genome maintenance (GO:0000002),0.305223510889182,0.6418513036720119,0.8706624605678234,0.9662987896350362,1.0,1/11,4.37%,AKT3
prerank,carbohydrate transport (GO:0008643),-0.2581968857670386,-0.6412508621599958,0.9066666666666666,0.9899628874356821,1.0,6/11,48.32%,AQP11;SLC26A6;SLC2A2;AQP1;SLC2A5;AQP9
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.22928283580463035,0.6401504338099404,0.9470720720720721,0.9674153215292092,1.0,12/69,16.40%,APOE;MDK;BCL2;PTPRZ1;TGFB3;NONO;CCL2;UNC5B;CPEB4;CX3CL1;HIF1A;RASA1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.24902701389684473,0.6398389097072535,0.9097839898348158,0.9673312473137708,1.0,6/31,15.85%,EDC4;EXOSC4;DCP2;DCP1A;PATL1;LSM7
prerank,motor neuron axon guidance (GO:0008045),-0.24037559026346342,-0.6397844808205762,0.9303135888501742,0.989712005154829,1.0,6/15,20.76%,EPHA4;RHOG;TMEFF1;SLIT2;LAMC2;RHOH
prerank,regulation of cilium movement (GO:0003352),-0.2685900018176627,-0.6394038671935214,0.912568306010929,0.9887090906017016,1.0,8/10,41.61%,CCDC39;CFAP298;ODAD2;DRC1;CCDC65;CFAP43;CFAP206;CCDC40
prerank,protein import into peroxisome membrane (GO:0045046),-0.21209237188231778,-0.6384771758684988,0.9448529411764706,0.9881100556495636,1.0,9/22,27.01%,ABCD3;PEX3;GDAP1;ACBD5;PEX14;PEX26;PEX11B;SLC25A17;PEX13
prerank,snRNA transcription (GO:0009301),0.2281215666574655,0.6383415603470137,0.9492671927846674,0.9682675424489654,1.0,17/70,18.50%,SNAPC3;POU2F1;GTF2F2;USPL1;NCBP2;ELL2;INTS1;CDK7;GTF2F1;INTS4;CCNT1;INTS14;ICE1;POLR2L;POLR2K;CDK9;RPAP2
prerank,glycerophospholipid catabolic process (GO:0046475),0.2606929351406472,0.6383386012896393,0.9104084321475626,0.967917164896111,1.0,5/27,15.97%,LIPC;PLA2G7;ABHD16A;PLA2G4A;PLA2G4E
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.25979951813403,0.6370456340868463,0.8941798941798942,0.9686345916002088,1.0,5/26,17.65%,LRRK2;FBXO7;NFE2L2;AKT1;ATF4
prerank,mitochondrion transport along microtubule (GO:0047497),0.29516222429607786,0.6357738740484405,0.8895800933125972,0.9693648821472678,1.0,2/13,15.68%,MAP1S;HIF1A
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.24647640971410859,-0.6336787314523855,0.9204892966360856,0.9901240398636865,1.0,6/12,37.12%,B3GALT2;B3GNT2;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.23879897593649105,0.6335146448027339,0.9461988304093567,0.9708458424872141,1.0,12/50,20.67%,TNFAIP3;NXN;PINX1;OGT;SPRY2;DTX3L;SQSTM1;AKT1;PRMT3;FBXO5;ISG15;SVBP
prerank,maturation of SSU-rRNA (GO:0030490),0.24976233552830082,0.6319142805767574,0.910757946210269,0.9718189144273888,1.0,10/34,24.06%,NOL11;NOP14;UTP3;NAT10;SRFBP1;RIOK2;DHX37;BMS1;RRP36;TSR1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.2528113954792508,0.6313245959920988,0.9048239895697523,0.9719570527716778,1.0,2/28,3.78%,PTN;APOE
prerank,receptor recycling (GO:0001881),-0.269845460241252,-0.6307724652119276,0.9066666666666666,0.9908092058744037,1.0,5/10,21.45%,SORL1;RAB11B;EHD3;PHETA1;PLEKHJ1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.298284942496428,0.6303562822702394,0.8862179487179487,0.9724021496498226,1.0,3/12,17.14%,MIA3;BMP5;AKT1
prerank,mitochondrial translation (GO:0032543),0.21669678032929574,0.6302474597620036,0.9530416221985059,0.972142837083336,1.0,21/104,20.25%,MRPS26;MRPL57;MRPL48;DAP3;IARS2;MTIF2;MRPS18A;RARS2;MRPL19;MRPL15;MRPS14;MRPS2;EARS2;MTRF1L;NDUFA7;LARS2;MRPL55;MRPL52;MRPS27;MRPS33;MRPL49
prerank,tRNA 5'-end processing (GO:0099116),0.28473365434587616,0.6296143460607864,0.9171597633136095,0.9722966613156204,1.0,2/15,12.47%,POP1;POP4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.29814694119685115,0.6291247154465042,0.88,0.9723480087294771,1.0,1/11,5.04%,LGALS9
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.26089858095218466,0.6282084720518114,0.8979310344827586,0.9727322556562917,1.0,4/24,15.31%,GFPT2;PID1;COQ10B;CYCS
prerank,response to unfolded protein (GO:0006986),0.2322510935241099,0.6279455624257664,0.9168646080760094,0.9725999513364442,1.0,5/48,7.37%,DNAJB1;BAG3;SERPINH1;HSPE1;PTPN1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.22287654789689032,0.6277281397880086,0.9464692482915718,0.9724140226642127,1.0,22/64,23.84%,POLR1E;GTF2H1;GTF2F2;SETD2;NCBP2;CDK7;GTF2F1;CCNT1;MLLT1;POLR2L;POLR2K;CDK9;IWS1;CDK13;ERCC2;CDK12;CCNH;TCEA1;POLR2D;MNAT1;CDC73;PCID2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.2632341408924729,0.6272843637186374,0.892328398384926,0.9724093301701935,1.0,3/23,9.64%,PABIR1;VPS4A;SETMAR
prerank,epithelial cell development (GO:0002064),0.26795798650208824,0.6265154381041517,0.9197183098591549,0.9726508349314106,1.0,2/20,10.22%,SIPA1L3;SLC4A7
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.2982229935952774,0.6253358420266174,0.8908507223113965,0.9732293096689736,1.0,2/11,14.44%,MLIP;SMAD4
prerank,AMP metabolic process (GO:0046033),0.2870162031392794,0.6253059575339449,0.8959627329192547,0.9728991425847741,1.0,4/13,19.83%,AMPD2;NT5C1A;XDH;AMPD3
prerank,respiratory electron transport chain (GO:0022904),0.2775840042130664,0.6250482294019061,0.8943452380952381,0.9727559707395684,1.0,2/14,10.07%,ETFA;SDHB
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.24382018298552915,0.6247615348168631,0.9249061326658323,0.972637301408513,1.0,4/37,10.03%,BBC3;NCK1;BCL2;FBH1
prerank,mRNA transport (GO:0051028),0.2110597065619306,0.6225562332534985,0.9613733905579399,0.9740490114374124,1.0,33/101,26.96%,ZFP36L1;NUP37;SMG7;RAE1;SMG6;ALKBH5;NCBP2;NUP153;AGFG1;FMR1;NDC1;NUP35;NUP188;SEC13;SRSF2;NUP214;NUP107;FYTTD1;SLU7;SRSF11;THOC5;RNPS1;FIP1L1;CPSF3;SMG5;THOC2;GLE1;KIF5C;HNRNPA2B1;NUP42;NUP155;SRSF1;CPSF1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.235283330082808,-0.6224058191627035,0.9260273972602739,0.9947622737974817,1.0,2/13,11.34%,CYFIP2;PERP
prerank,regulation of sequestering of calcium ion (GO:0051282),0.29105777518006126,0.6217763547296952,0.902555910543131,0.9743248632004881,1.0,3/12,15.00%,FKBP1B;UBASH3B;ANXA6
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.22603973111790016,-0.6206312487997316,0.9290123456790124,0.9945569450619255,1.0,5/14,20.69%,NT5E;UPB1;NT5C3A;NT5C;DHODH
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2244749286788404,0.6198457742795931,0.9538638985005767,0.975441365553908,1.0,14/58,20.00%,BABAM2;ATM;DCLRE1C;SETMAR;HMGB2;KDM2A;MDC1;NSMCE2;RIF1;PAXIP1;PRKDC;PSMD14;ZBTB7A;SMC5
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2782515220701991,0.6197043228370009,0.8924889543446245,0.9752063547507746,1.0,3/15,19.43%,BCL2;MDM2;KDM1A
prerank,positive regulation of DNA repair (GO:0045739),0.23300425586702944,0.6196018922908527,0.9334945586457074,0.9749349814028508,1.0,10/46,18.04%,EGFR;BABAM2;DDX11;SPIRE1;TMEM161A;TIMELESS;MGMT;XRCC1;NPAS2;SLF2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2687055461790226,0.6195761940047729,0.9002890173410405,0.9746047832240259,1.0,4/16,16.09%,SHLD3;FBH1;RIF1;CGAS
prerank,regulation of glycogen metabolic process (GO:0070873),0.2897576235697068,0.6192628337899082,0.9165378670788253,0.9744938588976523,1.0,3/12,17.14%,KHK;RUBCNL;AKT1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2551814855140686,0.6185976304687463,0.9321808510638298,0.9746366207979413,1.0,3/25,10.60%,FAM20A;CYP27B1;SELENON
prerank,regulation of DNA recombination (GO:0000018),-0.1872629694778309,-0.6183284172198508,0.9819819819819819,0.9946853080587423,1.0,12/32,29.38%,SMARCAD1;MRE11;RTEL1;MSH2;MSH3;THOC1;RAD50;SHLD2;RPA2;H1-0;KPNA1;CHEK1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2792943714659261,0.6177165524978482,0.8995433789954338,0.9749705212290986,1.0,6/14,26.99%,FOXO3;EARS2;POLRMT;TWNK;TEFM;MTERF2
prerank,histone monoubiquitination (GO:0010390),0.25591959363491656,0.6149639438559704,0.9237057220708447,0.9766394420322847,1.0,10/24,27.59%,RNF2;SKP1;DTX3L;DDB1;UBE2E1;CDC73;RYBP;PAF1;RNF40;ATXN7L3
prerank,regulation of biosynthetic process (GO:0009889),0.2913428086292072,0.6147214162560977,0.8978328173374613,0.9764774989103783,1.0,2/11,18.98%,SPHK2;CCN6
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.22737410840629263,-0.6139573775542028,0.9424242424242424,0.9959475408189046,1.0,8/15,35.63%,OGA;EXTL2;CHST3;RENBP;CHST7;NAGK;CHST2;CHST5
prerank,steroid hormone biosynthetic process (GO:0120178),0.2453669115684863,0.6125377560469345,0.9343832020997376,0.9777500900093695,1.0,5/29,19.97%,SRD5A3;HSD17B8;FDXR;MED1;SRD5A1
prerank,cardiac muscle cell differentiation (GO:0055007),-0.2058810119806272,-0.6122774199898403,0.9527272727272728,0.9956403059735757,1.0,14/21,42.83%,CXADR;SIK1;MYOCD;MEF2C;KDM6B;CBY1;MYH11;TTN;NRG1;ALPK3;TCAP;IRX3;MYH6;ALPK2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.23478723093555862,-0.6121553252104048,0.9418960244648318,0.9944838504542477,1.0,7/14,32.99%,RPL7;RPL35;RPF2;RPL7L1;WDR12;NOL9;URB1
prerank,RNA splicing (GO:0008380),0.20868604887890418,0.6119295718300074,0.9677765843179377,0.9778476362489525,1.0,11/95,12.26%,PPP1R9B;SYNCRIP;SNRNP40;CCAR2;RRAGC;NONO;DHX8;NCBP2;PRPF18;SNRNP35;RNPC3
prerank,negative regulation of phosphatase activity (GO:0010923),0.2506935998612098,0.6118823996032289,0.9199475065616798,0.9775272715658022,1.0,5/25,17.13%,PPP1R36;FKBP1B;TGFB2;GSK3B;PTPA
prerank,protein neddylation (GO:0045116),0.28397196505927746,0.6112258857051508,0.9241486068111455,0.9776663762051049,1.0,2/13,8.87%,DCUN1D1;UBE2F
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2041367863368385,-0.6105841856281283,0.9545454545454546,0.9941309923166078,1.0,14/20,57.56%,STARD3;STAR;HSD17B10;TSPOAP1;STARD3NL;FDX2;TSPO;HSD3B2;AKR1C1;DHRS9;AKR1D1;CYP11B1;CYP46A1;CYP11A1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3019154221213028,0.6104237284451008,0.901294498381877,0.9778744807136396,1.0,2/10,10.14%,CPEB1;NCBP2
prerank,negative regulation of transmembrane transport (GO:0034763),0.30039326405838007,0.6101807755433756,0.9044006069802731,0.9776951741104727,1.0,3/10,17.14%,OAZ3;CTTNBP2NL;AKT1
prerank,telomere maintenance via telomerase (GO:0007004),0.24901503342690043,0.6101425754508158,0.9263157894736842,0.9773701828141467,1.0,10/28,25.72%,TNKS1BP1;PINX1;TERT;PPP6C;TELO2;RFC1;TERF1;RPA1;TERF2IP;TERF2
prerank,regulation of T cell mediated immunity (GO:0002709),0.2939367311072055,0.6100594488411729,0.9012539184952978,0.9770865466210895,1.0,10/10,70.62%,TRPM4;TNFRSF1B;FUT7;IL1B;RIPK3;WAS;HMGB1;CCR2;AGER;ZBTB1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.28040565991601135,0.6091546908948887,0.9034690799396682,0.9773709015600588,1.0,3/13,20.43%,NT5M;MBD4;NEIL1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.19743923572378042,-0.6085997535213274,0.943609022556391,0.9938924357999878,1.0,9/23,28.70%,COPS5;UBC;COPS7B;DDB2;UBA52;CETN2;RBX1;PARP1;XPC
prerank,carboxylic acid catabolic process (GO:0046395),0.2832258180240466,0.6085178780466232,0.91324200913242,0.9774661023907448,1.0,5/12,25.76%,AMDHD2;GNPDA2;NPL;PON3;GNPDA1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.18320133185802245,-0.6081611859515067,0.9774774774774775,0.9916591727151772,1.0,8/29,25.24%,ACBD6;GPAT4;ACLY;DBI;ACOT7;OXSM;ACSL6;MLYCD
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.18320133185802245,-0.6081611859515067,0.9774774774774775,0.9916591727151772,1.0,8/29,25.24%,ACBD6;GPAT4;ACLY;DBI;ACOT7;OXSM;ACSL6;MLYCD
prerank,regulation of dopamine secretion (GO:0014059),0.25147638180624954,0.6077373447573071,0.9325236167341431,0.9776914351495489,1.0,3/25,9.77%,DTNBP1;SYT2;DRD3
prerank,negative regulation of secretion (GO:0051048),0.2998322341854588,0.6076525295236977,0.8943217665615142,0.9773948921027319,1.0,1/10,5.75%,EGF
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.22703859262751325,0.6070497170172151,0.9629200463499421,0.9774720234755362,1.0,12/54,20.67%,TNFAIP3;TRIM21;NXN;PINX1;OGT;SPRY2;RPL11;SQSTM1;AKT1;PRMT3;ISG15;SVBP
prerank,ovarian follicle development (GO:0001541),-0.23441666621892504,-0.6050434267626829,0.952513966480447,0.9920364099979592,1.0,8/13,35.33%,KIT;EIF2B2;SOD1;FOXL2;ANG;EIF2B4;LHCGR;CEBPB
prerank,regulation of blood circulation (GO:1903522),0.2359714183649841,0.6048641942352162,0.9364881693648817,0.9786148606070417,1.0,7/34,19.44%,TBX2;CAMK2D;KCNMB4;KCNIP2;TNNT2;AGT;TPM1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.2787889031522407,0.6045110877882964,0.8918518518518519,0.9785006907270677,1.0,3/13,12.04%,SENP6;UBA5;ATG7
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.225047047428075,-0.6030701919020565,0.9451219512195121,0.9918722766002905,1.0,4/15,30.55%,DERL1;UFD1;NPLOC4;TMEM129
prerank,mucosal immune response (GO:0002385),-0.22151064230551895,-0.6026841260684754,0.9589905362776026,0.990837370063879,1.0,15/15,77.88%,DEFA6;OTUD7B;IFNLR1;NOS2;RAB17;IL4;CAMP;BPIFB1;DEFB1;FFAR2;LTF;PIGR;PLA2G1B;RPL39;RNASE3
prerank,regulation of protein metabolic process (GO:0051246),0.22688213366040474,0.6026839383003861,0.95260663507109,0.9794007115218766,1.0,5/44,9.92%,APOE;GSAP;SHH;SPOP;SSH1
prerank,negative regulation of secretion by cell (GO:1903531),0.2308250676522688,0.6026352374162455,0.9469026548672567,0.9790824949123103,1.0,6/38,13.82%,APOE;ANXA1;DRD3;TNFRSF1A;DPH3;HRH3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.25415167427172186,0.602135386505619,0.9276139410187667,0.9790941299235512,1.0,9/23,22.55%,PTEN;SACM1L;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1;PIP4P2
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.2746577009327321,0.6010668715697975,0.8875562218890555,0.9794707363691871,1.0,6/14,24.51%,TREM2;CX3CL1;PTPRC;NR1D1;CD200R1;TNFRSF1B
prerank,response to calcium ion (GO:0051592),0.2058913051507546,0.6007215013742628,0.9729437229437229,0.9793495184855113,1.0,16/102,18.99%,SEC31A;CAMK2D;PKD2;CPNE7;CPNE2;KCNMB4;SYT2;WNT5A;PPP3CA;CALM2;KCNIP2;NEDD4;HPCA;TNNT2;CPNE3;ADGRV1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2612276485264086,0.6005092628377144,0.9097222222222222,0.9791388521605157,1.0,5/18,17.14%,NONO;NFE2L2;TRAP1;HIF1A;AKT1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.2568518549014524,0.6002866869902854,0.9184247538677919,0.9789444105058561,1.0,6/21,18.80%,PDZD8;MICU2;MCUR1;ANXA6;MAIP1;MICU3
prerank,negative regulation of catabolic process (GO:0009895),0.22250053320058458,0.59993287522185,0.948051948051948,0.9788341011618578,1.0,3/47,4.15%,EGFR;IRAK3;MAD2L1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.22804217609318478,-0.5999094259646901,0.9472049689440993,0.9910288328030126,1.0,6/13,37.12%,B3GALT2;B3GNT2;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,regulation of neuron projection arborization (GO:0150011),0.2752027003065826,0.5995390051769254,0.9192634560906515,0.9787370127226657,1.0,3/15,11.12%,DLG4;WNT5A;MOV10
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.2907938768446916,0.5995344981368971,0.9079563182527302,0.9783914779922542,1.0,3/10,16.89%,NT5M;DPYD;NT5C1A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.21343222221297006,-0.5994691653039609,0.9504643962848297,0.9900588236984472,1.0,2/17,9.45%,LPGAT1;SERAC1
prerank,translational termination (GO:0006415),0.20712173628064487,0.5992129431922933,0.9764201500535906,0.9782636091355837,1.0,20/95,21.49%,MRPS26;MRPL57;MRPL48;DAP3;ABCE1;MRPS18A;MRPL19;MRPL15;MRPS14;MRPS2;MTRF1L;GSPT1;MRPL55;MRPL52;MRPS27;MRPS33;ETF1;MRPL49;N6AMT1;MRPL17
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.2875028734269308,0.5989683040297238,0.9114906832298136,0.978082590160479,1.0,1/12,5.11%,NUGGC
prerank,antibacterial humoral response (GO:0019731),0.26090423564974136,0.5983620290909628,0.9184549356223176,0.9781280777879908,1.0,1/16,5.65%,RNASE7
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.2592803992851651,0.5983164536579502,0.9212376933895922,0.9778025667086503,1.0,3/18,9.72%,TMEM119;HDAC1;FRS2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.25938233684806833,0.5981262893099937,0.932761087267525,0.9775825637826558,1.0,5/19,22.61%,RPTOR;NAB2;ICE1;PRDX5;CHD8
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2683147693708837,0.5979449530111822,0.920749279538905,0.977359804487965,1.0,6/16,27.36%,TOP2B;EME2;RMI1;SLX4;MSH4;SHOC1
prerank,histone H2A ubiquitination (GO:0033522),0.26128094062348356,0.5958520734120624,0.9415204678362573,0.9783664909227386,1.0,4/17,17.41%,RNF2;SKP1;DTX3L;DDB1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.24522524953550384,-0.5956767154764968,0.9283667621776505,0.9906501576839771,1.0,5/10,26.50%,RFWD3;FEM1B;DDX39B;THOC1;RPA2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.27497997976000144,0.5948785383341775,0.9296875,0.978633404143435,1.0,4/12,21.37%,KHDRBS1;NEDD4;NUP214;IFI27
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.24873259663066344,0.5945119320228016,0.9321074964639321,0.9785250925201037,1.0,3/22,10.32%,TRIM13;MAN1C1;UGGT2
prerank,ether lipid metabolic process (GO:0046485),0.2753211863835086,0.5941285284650109,0.922173274596182,0.9784201306464921,1.0,2/14,8.59%,DHRS7B;PLA2G7
prerank,RNA modification (GO:0009451),0.21799814917483737,0.5927901637177141,0.9722543352601156,0.97893646407182,1.0,14/54,22.93%,PUS7L;METTL1;PUS3;NOP2;ALKBH1;NAT10;MRM2;ANKRD16;RBM15;PARN;BCDIN3D;DTWD1;FTSJ3;TRMT61A
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.22519892481717652,0.5910046766258108,0.94049008168028,0.9797126033372107,1.0,5/45,11.65%,ATXN2;PUM1;METTL16;FOXO3;GCNT2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.2612870874478204,0.5896753019619562,0.9373177842565598,0.9802143070335977,1.0,5/17,25.46%,PTPRJ;PTPN2;PRNP;UBASH3A;THY1
prerank,mitochondrial transcription (GO:0006390),0.2846394136885574,0.5890963890963906,0.9206349206349206,0.9802385250393333,1.0,5/10,26.99%,FOXO3;POLRMT;TWNK;TEFM;MTERF2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.2731930400988391,0.5862698752617501,0.92018779342723,0.9816115705436748,1.0,2/13,10.21%,PRICKLE1;TBX3
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2090386073246089,0.5858175608950674,0.9751693002257337,0.9815307731905867,1.0,16/69,18.50%,SNAPC3;POU2F1;GTF2F2;NCBP2;ELL2;INTS1;CDK7;GTF2F1;INTS4;CCNT1;INTS14;ICE1;POLR2L;POLR2K;CDK9;RPAP2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.22539169426136907,-0.5840574036531075,0.943502824858757,0.9946012681405065,1.0,5/13,33.21%,CPE;HEY2;RYR2;NOTCH1;NPY5R
prerank,cellular copper ion homeostasis (GO:0006878),0.26627907049400246,0.5835309756432145,0.9337175792507204,0.9825276899431722,1.0,5/14,22.96%,SLC31A1;ARF1;ATP7A;PRNP;SLC31A2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.28460641124948954,0.5831082927351333,0.9229534510433387,0.9824212430803889,1.0,1/10,5.04%,LGALS9
prerank,mismatch repair (GO:0006298),0.23722185406164437,0.5822709648202066,0.9354005167958657,0.9825454013324291,1.0,4/27,10.37%,LIG1;SETD2;RNASEH2A;MCM9
prerank,cellular response to calcium ion (GO:0071277),0.20675588582564736,0.5817523742862057,0.9734104046242774,0.982532869582681,1.0,6/67,9.14%,CAMK2D;PKD2;CPNE7;CPNE2;SYT2;WNT5A
prerank,proteasome assembly (GO:0043248),-0.23376456977917745,-0.5810442105090604,0.9635854341736695,0.9946910178466194,1.0,5/11,35.25%,POMP;PSMD13;ADRM1;PSMD10;OTUD6B
prerank,regulation of chromatin binding (GO:0035561),0.2852748596134737,0.5799026308227957,0.9056,0.9832784542076128,1.0,3/10,18.98%,DDX11;DTX3L;WAPL
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.19873424572041817,-0.5797893781787876,0.9741935483870968,0.9940095501046798,1.0,8/17,38.11%,DHDDS;ALG1;DOLK;ALG12;DOLPP1;MVD;ALG3;ALG9
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.23678533586471995,-0.5788898675279658,0.9490616621983914,0.9931231040440088,1.0,5/10,42.68%,SAG;PDE6A;CNGB1;PDE6G;PDE6B
prerank,protein monoubiquitination (GO:0006513),0.2238189015068687,0.5777548341525552,0.9529702970297029,0.9841462564198301,1.0,13/36,27.59%,KLHL22;TRIM21;UBE2R2;UBE2W;DTX3L;PEX12;UBE2E1;UBE3D;CDC73;KLHL12;PAF1;RNF40;ATXN7L3
prerank,peptidyl-methionine modification (GO:0018206),-0.2205900807204232,-0.5761932684976299,0.9560439560439561,0.9930316200978779,1.0,2/12,13.46%,METAP2;NAA60
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.23368151450720903,0.5750203663770656,0.9569190600522193,0.9853449939827552,1.0,10/29,25.72%,TNKS1BP1;PINX1;TERT;PPP6C;TELO2;RFC1;TERF1;RPA1;TERF2IP;TERF2
prerank,snRNA 3'-end processing (GO:0034472),-0.19617660920200808,-0.5742953402584761,0.972972972972973,0.9926317246165547,1.0,6/19,21.18%,INTS2;EXOSC7;TUT1;EXOSC8;EXOSC3;TOE1
prerank,regulation of immunoglobulin production (GO:0002637),0.23645062112917983,0.5741821622570555,0.96,0.9854418456023967,1.0,5/23,24.69%,SASH3;TNFRSF4;PTPRC;GPI;XBP1
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.17508110154855422,-0.573785030398355,0.9885057471264368,0.9916320255125751,1.0,19/29,51.41%,RAD21;SIRT7;P3H4;PRDM9;MEI4;REC8;TRIP13;SYCE2;MEIOB;SYCP2;TEX12;ZCWPW1;IHO1;FANCD2;RAD21L1;RNF212B;ANKRD31;HORMAD1;TERB2
prerank,import into nucleus (GO:0051170),0.1998439258100776,0.5736535927591834,0.9845132743362832,0.9853849069741565,1.0,16/73,20.96%,STAT3;PRICKLE1;FAM53B;NUP153;TNPO1;E2F3;SMN1;NUP188;SEC13;BACH2;AKT1;DDX20;HEATR3;NUP214;SNRPB;NUP107
prerank,nuclear pore organization (GO:0006999),-0.21351259951777693,-0.5726786146500022,0.9626436781609196,0.9908392478999416,1.0,9/14,36.36%,NUP133;SEH1L;TMEM170A;NUP98;NUP93;AHCTF1;TPR;NUP205;RTN4
prerank,oligodendrocyte differentiation (GO:0048709),0.2449950353593888,0.5720793324371676,0.9391796322489392,0.9859054360631927,1.0,2/19,5.93%,SHH;PTPRZ1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.2662943641367658,0.5712674363118,0.9218989280245024,0.9860001794471784,1.0,7/12,31.20%,GART;PPAT;IMPDH2;IMPDH1;ADSL;LHPP;ADSS2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.2633574051093307,0.570712455251811,0.9304084720121029,0.9859474395624537,1.0,4/13,18.27%,SRSF12;PRPF31;PRPF3;DDX20
prerank,cell differentiation in hindbrain (GO:0021533),0.27780327119911885,0.5705196161918203,0.9274447949526814,0.9857004185415985,1.0,3/11,18.03%,OPHN1;AGTPBP1;ATP7A
prerank,sensory perception of chemical stimulus (GO:0007606),0.2510961359604333,0.570133019820427,0.9436201780415431,0.9855651393338374,1.0,2/15,14.17%,CD36;GNAS
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.21915389099199212,-0.5687376399856336,0.9803921568627451,0.9911089783680215,1.0,6/12,41.92%,STARD3;STAR;TSPOAP1;STARD3NL;FDX2;TSPO
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.2272901555287834,0.5679354326021884,0.9612817089452603,0.9863654901213956,1.0,8/29,20.12%,TNFRSF12A;SFRP1;TNF;TRAF2;RIPK1;INHBA;AGT;TNFSF12
prerank,detection of calcium ion (GO:0005513),0.26749724007291986,0.5647727922087096,0.940387481371088,0.9876274656694817,1.0,3/13,15.49%,KCNMB4;CALM2;KCNIP2
prerank,DNA replication checkpoint signaling (GO:0000076),0.2527158699704111,0.5640375558045649,0.9400584795321637,0.987640608972451,1.0,3/16,17.64%,DNA2;TIMELESS;RAD9A
prerank,ribosomal large subunit assembly (GO:0000027),0.2383754075794774,0.5637557640216825,0.965893587994543,0.9874201069768356,1.0,4/24,14.52%,RPL3L;NOP2;DDX28;RPL11
prerank,positive regulation of ruffle assembly (GO:1900029),0.2635094753513384,0.5627501721012708,0.9292035398230089,0.9875814476908764,1.0,6/13,27.04%,NDEL1;EPS8;DEF8;P2RY12;PLEKHM1;FAM98A
prerank,cellular response to oxygen levels (GO:0071453),-0.23492105441070943,-0.5624189526471136,0.9426229508196722,0.9921134193397646,1.0,5/10,31.53%,TMEM199;NDUFS2;ATP6V0D1;ATP6V1A;ATP6AP1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.2279937815909915,-0.5621699790876875,0.9638242894056848,0.9910071866657847,1.0,4/11,22.00%,LARP7;DKC1;EXOSC3;EXOSC10
prerank,phospholipid dephosphorylation (GO:0046839),0.2179511141142262,0.5610081654356945,0.9551681195516812,0.9880550505214564,1.0,9/37,19.90%,EPHX2;PTEN;SACM1L;MTMR9;MTMR3;MTMR2;MTMR6;MTMR1;MTM1
prerank,histone lysine demethylation (GO:0070076),0.22767124159515806,0.5604902095141044,0.967741935483871,0.9879585334572002,1.0,8/25,26.60%,PHF2;KDM2A;KDM1A;KDM3B;KDM7A;JMJD1C;KDM4B;KDM4D
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.26680953089807863,0.5593677919538174,0.9293739967897271,0.9881407563338327,1.0,2/10,13.39%,DCLRE1C;RIF1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.20346386995669022,-0.5560847928647801,0.9667673716012085,0.9918762624535644,1.0,1/15,1.76%,BMP4
prerank,regulation of histone methylation (GO:0031060),0.2643497821388165,0.5544460566696588,0.9383458646616541,0.9901044272417392,1.0,1/13,3.82%,MTHFR
prerank,cellular response to unfolded protein (GO:0034620),0.22639599633590884,0.5541379659851717,0.9602122015915119,0.9899054706031188,1.0,6/26,19.23%,BAG3;PTPN1;HSPA5;HSPD1;RHBDD1;HSPA13
prerank,regulation of catecholamine secretion (GO:0050433),0.22060440467519957,0.5523782470800118,0.9646596858638743,0.9903856940937222,1.0,4/29,13.82%,DTNBP1;SYT2;DRD3;HRH3
prerank,aminoglycan metabolic process (GO:0006022),0.2669846506004719,0.5522178783938119,0.9631410256410257,0.9901019283566481,1.0,6/10,32.00%,CLN6;B4GALT7;XYLT1;B3GAT3;GAL3ST3;XYLT2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.25778732862598464,0.5507540488739964,0.9363057324840764,0.9904444510457981,1.0,6/12,31.43%,SOAT1;LPCAT3;P4HB;SOAT2;APOC1;MTTP
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.23396171928239845,-0.5499859068406828,0.9736842105263158,0.99266506812872,1.0,1/10,2.62%,MALT1
prerank,carnitine metabolic process (GO:0009437),0.2598576909804452,0.5499118539040344,0.9445300462249615,0.9904709242785721,1.0,1/12,4.93%,TMLHE
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.22763723253651408,0.5477889088375827,0.9650837988826816,0.9910619711559876,1.0,6/25,18.23%,CBL;PDE6H;NEU3;AKT1;AGT;RBPJ
prerank,signal peptide processing (GO:0006465),0.26094853790556855,0.5464511074320795,0.943127962085308,0.9912849567983979,1.0,6/11,26.64%,SPPL3;SEC11A;HM13;CLN5;PCSK5;FURIN
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.19204868163580016,-0.5446353391659426,0.9937106918238994,0.9930459041660474,1.0,7/17,32.12%,RAB27A;SLC4A8;NLGN1;CACNA1I;RAB3D;SCAMP5;KCNB1
prerank,regulation of leukocyte migration (GO:0002685),0.24361518584645037,0.5438095919604357,0.95355587808418,0.992059060916509,1.0,3/16,14.73%,MIA3;ANXA1;RAC1
prerank,phosphate ion transmembrane transport (GO:0035435),0.2591463220597342,0.5419610743495932,0.9436619718309859,0.9924968060989652,1.0,3/12,15.95%,SLC20A1;SLC37A1;SLC25A10
prerank,regulation of microtubule-based process (GO:0032886),0.21164827833553077,0.5409262858798517,0.9845559845559846,0.9925784620691445,1.0,7/36,17.92%,TAOK1;EFNA5;MEMO1;GSK3B;PHLDB2;TPPP;PHLDB1
prerank,regulation of actin nucleation (GO:0051125),-0.21280459653427164,-0.5408876424181092,0.9603658536585366,0.9929277501019216,1.0,1/12,3.22%,GSN
prerank,acetyl-CoA metabolic process (GO:0006084),0.24631231574244306,0.5379233738629741,0.9621542940320232,0.9934803665806002,1.0,3/15,18.59%,MVK;NUDT7;ACACA
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.2354888857956799,0.5373030459366461,0.9602836879432625,0.9933698765335404,1.0,5/17,21.68%,CCL5;TGFB2;PIEZO1;ADAM9;P2RY12
prerank,serine family amino acid metabolic process (GO:0009069),-0.19631899444142734,-0.5356726193599571,0.9771986970684039,0.9932661835396516,1.0,5/16,28.22%,GCLC;SARS1;CBS;SEPHS2;CTH
prerank,metallo-sulfur cluster assembly (GO:0031163),0.22586134274969794,0.5355689290140256,0.9745308310991957,0.9937008573658437,1.0,4/22,14.72%,FXN;LYRM4;HSCB;MMS19
prerank,synaptonemal complex assembly (GO:0007130),-0.20174231008642268,-0.5351069360900118,0.9631901840490797,0.9910616574250654,1.0,1/15,2.33%,RAD21
prerank,synaptonemal complex organization (GO:0070193),-0.20174231008642268,-0.5351069360900118,0.9631901840490797,0.9910616574250654,1.0,1/15,2.33%,RAD21
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.20932236275431526,0.5349376538716442,0.9708491761723701,0.9935799811900793,1.0,7/37,17.92%,TAOK1;EFNA5;MAPRE2;GSK3B;PHLDB2;TPPP;PHLDB1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.25907307640309457,0.5344539341456485,0.9387096774193548,0.9934183751223886,1.0,2/10,16.90%,OGT;SDHAF3
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.24224826715655862,0.5338369752263268,0.952023988005997,0.9932973246690562,1.0,1/14,5.00%,PRKD2
prerank,phosphate ion transport (GO:0006817),0.24193297061908403,0.5330773779643385,0.9582089552238806,0.9932167872296461,1.0,3/16,15.95%,SLC20A1;SLC37A1;SLC25A10
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.2599034136837228,0.5326380380093997,0.9456,0.9930308003483707,1.0,2/10,15.60%,CAMK2D;NEDD4
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.23197292833724711,0.5300224818704973,0.9516358463726885,0.9936204082113828,1.0,2/17,7.67%,BAG6;EMC7
prerank,peptidyl-glutamic acid modification (GO:0018200),0.22134244564251698,0.5299491656234627,0.9673024523160763,0.9933053900664037,1.0,3/24,11.46%,CEP41;TPGS1;AGTPBP1
prerank,ncRNA 3'-end processing (GO:0043628),0.24456991882333345,0.5294071418640629,0.9613095238095238,0.993153865379108,1.0,4/14,24.05%,ERI1;INTS14;INTS8;INTS6L
prerank,water transport (GO:0006833),0.2462401611983091,0.5245830325034527,0.9662058371735791,0.9945167491326086,1.0,1/12,11.38%,PDPN
prerank,ribonucleoprotein complex assembly (GO:0022618),0.17754738656008134,0.5235165328580316,0.9978991596638656,0.9945316363647788,1.0,22/132,19.73%,RPSA;RPL3L;CELF1;EIF5;DICER1;NOP2;PRPF18;RAMAC;SMN1;RPL11;SNRNP200;SETX;PRKDC;TGS1;DHX29;DDX1;MCTS1;DDX20;RPL6;PUF60;CELF5;SNRPB
prerank,RNA stabilization (GO:0043489),0.20661550265267392,0.5225149809410669,0.9717444717444718,0.99452224417886,1.0,8/33,21.73%,E2F1;TENT5A;ZCCHC17;THRAP3;AXIN2;PARN;GDNF;YBX1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.21509448008672769,0.5219740177018182,0.9852744310575636,0.9943508837397441,1.0,4/23,17.16%,PLA2G12A;PLA2G4A;PLA2G4E;LPCAT3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.19547564967224626,0.5205365096645674,0.9858156028368794,0.9944671013615879,1.0,4/49,7.11%,BBC3;BCL2;BCL2L2;NOC2L
prerank,regulation of interleukin-1 production (GO:0032652),0.2369496949538613,0.5195308274133063,0.95900439238653,0.9944463327646094,1.0,4/15,21.82%,ANXA1;FOXP1;SIRPA;NLRP12
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.1840502354788069,-0.5190867576945688,0.9840255591054313,0.9937332564031699,1.0,17/17,81.62%,DERL1;UFD1;NPLOC4;TMEM129;SEL1L;VCP;HERPUD1;SELENOS;SYVN1;AUP1;FAF2;DERL2;SEC61B;OS9;HM13;HSP90B1;RHBDD1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.23738328028964667,0.5190376358966662,0.9547511312217195,0.9942477353599337,1.0,3/15,14.46%,CCT8;RUVBL1;CCT3
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.25132770803972315,0.5187164026215091,0.9684044233807267,0.9940072359826968,1.0,2/10,15.77%,EMC7;EMC1
prerank,positive regulation of telomere maintenance (GO:0032206),0.20705771931664926,0.5187072240993811,0.9861635220125786,0.9936639766371004,1.0,9/31,23.02%,ATM;GNL3;ATRX;TNKS2;PNKP;MAPK1;PKIB;SLX4;MAP2K7
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.21919023164947402,0.5160797220686157,0.9678770949720671,0.9941056396681299,1.0,2/18,10.32%,TRIM13;UGGT2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.17531541215721644,0.515628078790847,1.0,0.9938996077624354,1.0,10/117,10.01%,MTHFD1L;ACSL4;ACADSB;ALDH1A2;CD36;PPARG;LPL;CYP1A1;PANK2;ACSF2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.24627810796214947,0.5147580160580163,0.9588607594936709,0.9938353193422695,1.0,1/11,8.73%,PXDN
prerank,regulation of gastrulation (GO:0010470),0.23113810291547093,0.5145775642916435,0.9626307922272048,0.9935445233881071,1.0,3/14,17.92%,TENM4;PHLDB2;PHLDB1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.21168153145872143,0.5134368083280377,0.9844632768361582,0.99354404336512,1.0,4/23,18.76%,SEC16A;LMAN1;SEC13;HSP90B1
prerank,cellular response to cadmium ion (GO:0071276),0.21133620574237935,0.5124320782907792,0.9854111405835544,0.9935208175851692,1.0,3/24,17.14%,EGFR;MAPK1;AKT1
prerank,aerobic respiration (GO:0009060),0.21933118626083964,0.5098660500457383,0.9642365887207703,0.9939186196070173,1.0,5/20,18.51%,SDHB;UQCRC1;SIRT3;NDUFS7;NDUFS8
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.24968648771385327,0.5093512405987358,0.9581993569131833,0.9937304852567749,1.0,5/10,27.62%,TUT7;ISG15;RPS27A;CHFR;DIS3L2
prerank,nuclear envelope organization (GO:0006998),0.21983788675250518,0.5083727593214691,0.9861687413554634,0.9936639043674166,1.0,4/20,18.43%,VPS4A;LEMD2;SUN1;TOR1AIP1
prerank,protein K48-linked deubiquitination (GO:0071108),0.21333015979124567,0.5070679916936609,0.9744279946164199,0.993688227683354,1.0,3/23,14.40%,TNFAIP3;OTUD3;VCPIP1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.2127352320514688,0.5056060859286674,0.9709141274238227,0.9937561733571881,1.0,6/22,26.46%,PTPRJ;PTPN2;PRNP;UBASH3A;THY1;CD300A
prerank,apoptotic DNA fragmentation (GO:0006309),0.2268018328841101,0.5051795773744102,0.9826839826839827,0.9935431752072132,1.0,2/16,10.06%,DICER1;HMGB2
prerank,nuclear pore complex assembly (GO:0051292),0.24387760866685732,0.5046216529577744,0.9737274220032841,0.9933420248362147,1.0,3/10,20.96%,NUP153;NDC1;NUP107
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.18398255340407385,0.5037901659128724,0.9953757225433526,0.9932388343289159,1.0,11/55,21.19%,BBC3;BCL2;TNFRSF12A;TGFBR1;TNF;TRAF2;RIPK1;ING5;AGT;TNFSF12;BECN1
prerank,cGMP metabolic process (GO:0046068),0.23577600431171358,0.49992836108144667,0.9637795275590552,0.993906669052473,1.0,1/12,6.15%,NPR2
prerank,response to cadmium ion (GO:0046686),0.2016922185309254,0.497356643615379,0.9829619921363041,0.9942241151602065,1.0,3/26,17.14%,EGFR;MAPK1;AKT1
prerank,snRNA processing (GO:0016180),0.22044071215679412,0.49696263909765903,0.9756795422031473,0.9939861861225903,1.0,5/16,24.05%,INTS1;INTS4;INTS14;INTS8;INTS6L
prerank,regulation of ruffle assembly (GO:1900027),0.21282183409362,0.4960053381636074,0.9863201094391245,0.9938956569573796,1.0,8/23,27.04%,ARHGAP24;NDEL1;EPS8;DEF8;P2RY12;PFN2;PLEKHM1;FAM98A
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.23359909598844875,0.4916413729891458,0.9679878048780488,0.9946044424038054,1.0,13/13,76.66%,DOC2B;SYT10;CACNA1H;CACNA1G;ZP3;SYT4;CLTRN;STX1A;SYT1;HYAL3;KCNB1;SCAMP5;CACNA1I
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.18592643077705612,0.4916290625896242,0.9950678175092479,0.994262998974941,1.0,10/40,24.29%,KMT5A;NEK4;FMR1;NPAS2;CDK9;FBXO5;HMGA2;PRKCD;ETAA1;FXR2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.21453896208470938,0.491263909069032,0.980528511821975,0.9936532760937593,1.0,8/19,27.70%,ATRX;POLR2L;POLR2K;TERF1;POLR2D;TERF2IP;TERF2;TINF2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.21453896208470938,0.491263909069032,0.980528511821975,0.9936532760937593,1.0,8/19,27.70%,ATRX;POLR2L;POLR2K;TERF1;POLR2D;TERF2IP;TERF2;TINF2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.21699774568983032,0.4906124083149538,0.9814814814814815,0.9934633827470963,1.0,2/18,12.77%,BCL2;SPG7
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.15825375952401882,-0.48772366657930083,0.9855595667870036,0.9984476471681994,1.0,13/23,44.39%,CALM1;METAP2;SAG;PDE6A;GUCA1B;CNGB1;PPEF1;PDE6G;NMT1;PDE6B;NMT2;GUCY2D;GUCY2F
prerank,copper ion homeostasis (GO:0055070),0.216488179321405,0.4874507382637071,0.9814814814814815,0.9938553350731093,1.0,5/17,22.96%,SLC31A1;ARF1;ATP7A;PRNP;SLC31A2
prerank,reticulophagy (GO:0061709),0.23261779180426295,0.48651424367884816,0.9766423357664233,0.9937054005359038,1.0,2/12,13.32%,UBA5;DDRGK1
prerank,motile cilium assembly (GO:0044458),-0.18845808775712358,-0.4831115402625484,0.9788359788359788,0.9979466609692649,1.0,7/12,50.57%,CCDC39;DNAAF3;E2F4;CCDC40;RSPH6A;DNAAF1;BBS5
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.182810935631061,-0.4769104490442837,0.9912280701754386,0.9976070909846846,1.0,3/12,24.86%,DCK;DHODH;CDA
prerank,fluid transport (GO:0042044),0.22240393480835263,0.47529647467151726,0.9817629179331308,0.9956828133909029,1.0,1/12,11.38%,PDPN
prerank,vacuolar acidification (GO:0007035),0.20144670000164194,0.4746038500720695,0.9793388429752066,0.9954755456580526,1.0,3/21,12.92%,ATP6AP2;CLN6;ATP6V1H
prerank,telomere capping (GO:0016233),0.21054323417437346,0.473327174090234,0.9765739385065886,0.9953756444558277,1.0,7/16,27.70%,DCLRE1C;CTC1;PRKDC;TERF1;TERF2IP;TERF2;TINF2
prerank,cardiolipin metabolic process (GO:0032048),0.21839006891975157,0.47077803896314174,0.9765395894428153,0.9954915954268677,1.0,2/13,14.60%,PGS1;PLA2G4A
prerank,cellular response to alkaloid (GO:0071312),0.2056786773346665,0.46909579737300816,0.9830028328611898,0.9954541439765601,1.0,4/17,23.20%,CASP7;HTR1B;GSTM2;RAD51
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.21305780235864064,0.4659165510352352,0.9821162444113264,0.9956446848005395,1.0,4/14,25.19%,TIRAP;YBX3;HNRNPC;MYD88
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.18245359195287772,0.46397506701710234,0.9910714285714286,0.995638201965912,1.0,10/33,27.83%,PRKD2;PTPRJ;PTPN2;PRNP;UBASH3A;RELA;THY1;CD300A;RPS3;RAB29
prerank,regulation of DNA metabolic process (GO:0051052),0.17132861850396736,0.4638598387485818,0.9987745098039216,0.9953091990989605,1.0,12/44,25.72%,TOM1L1;SUB1;SMG6;NUCKS1;CDK9;KAT7;KPNA2;HDAC8;MPHOSPH8;SMG5;TERF2IP;TERF2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.20747568384209727,0.46233327392261947,0.9854227405247813,0.9952271606615869,1.0,6/15,28.85%,DDRGK1;GLI1;CDC73;KLHL18;PAF1;EZH2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.20532799882250127,0.461945223072217,0.9881831610044313,0.9949555269989862,1.0,1/15,7.20%,KYAT1
prerank,cellular response to purine-containing compound (GO:0071415),0.221503891539041,0.4581168645505463,0.9815384615384616,0.9952426392866867,1.0,10/10,77.86%,GSTM2;TRPM2;SLC8A1;CACNA1S;RYR1;RYR3;P2RY1;RYR2;CASQ2;P2RY6
prerank,leukotriene biosynthetic process (GO:0019370),0.20627928321386377,0.45345307045230115,0.9838945827232797,0.9955780770281301,1.0,2/14,15.89%,PLA2G4A;GGT7
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.17169941615920647,-0.45043768439792753,0.9971910112359551,0.999249483160254,1.0,13/13,82.85%,AQP11;WFS1;NR1H2;MBTPS2;ALOX5;MANF;USP19;FCGR2B;NUPR1;NR1H3;CLU;EIF2AK3;LPCAT3
prerank,axoneme assembly (GO:0035082),-0.1379085377184232,-0.45041095616438337,1.0,0.9980680417959451,1.0,12/30,36.65%,CCDC39;RP1;TTLL3;DNAAF3;LRGUK;SPAG1;GAS8;DRC1;JHY;FOXJ1;CCDC65;DNAAF2
prerank,DNA conformation change (GO:0071103),0.1958170063914097,0.44536060924160215,0.9861878453038674,0.9963245335776759,1.0,2/17,11.17%,HMGB2;TOP2B
prerank,nucleoside salvage (GO:0043174),-0.1809565654029626,-0.44467125229292415,1.0,0.9973738772912508,1.0,10/10,81.92%,DCK;CDA;UPP1;UPP2;HPRT1;UCK1;TK2;TK1;UCK2;UCKL1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.1730849956410013,0.43414907751167536,0.9961783439490446,0.9972897344350763,1.0,8/33,24.17%,CSTF1;TTF2;NCBP2;SETX;SNRPB;PCF11;FIP1L1;CPSF3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.17236973408436929,0.4264655719654892,0.9974391805377721,0.9977238785891513,1.0,13/29,30.71%,NOP14;UTP3;DHX37;BMS1;KRI1;RRP36;TSR1;RRS1;HELB;UTP6;TBL3;UTP4;HEATR1
prerank,positive regulation of telomere capping (GO:1904355),0.18506024561508239,0.423470534531905,0.9944598337950139,0.997666840417879,1.0,5/17,23.02%,TNKS2;PNKP;MAPK1;PKIB;MAP2K7
prerank,regulation of chromosome organization (GO:0033044),0.17287371330514398,0.41957472756679304,0.9972260748959778,0.9976807459363392,1.0,7/22,25.72%,SMG6;SETMAR;WAPL;HDAC8;SMG5;TERF2IP;TERF2
prerank,nuclear transport (GO:0051169),0.18391309807861356,0.4088709763313385,0.997093023255814,0.998163082517008,1.0,16/16,81.63%,ANP32A;XPO1;RSRC1;AAAS;NXT2;NXT1;RBM15B;RGS14;CITED1;PSIP1;HMGA1;NUP205;NPM1;BANF1;NUTF2;NUP98
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.16882610631968623,0.4012235019068312,0.99860529986053,0.9980130949178497,1.0,4/22,17.93%,ZDHHC6;ZDHHC9;ZDHHC3;CLIP3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.16882610631968623,0.4012235019068312,0.99860529986053,0.9980130949178497,1.0,4/22,17.93%,ZDHHC6;ZDHHC9;ZDHHC3;CLIP3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.1535330673389514,0.38725600147682443,1.0,0.9984334782076804,1.0,4/29,17.16%,PLA2G12A;PLA2G4A;PLA2G4E;LPCAT3
